<SEC-DOCUMENT>0001213900-25-085107.txt : 20250905
<SEC-HEADER>0001213900-25-085107.hdr.sgml : 20250905
<ACCEPTANCE-DATETIME>20250905165806
ACCESSION NUMBER:		0001213900-25-085107
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		31
CONFORMED PERIOD OF REPORT:	20250829
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250905
DATE AS OF CHANGE:		20250905

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CleanCore Solutions, Inc.
		CENTRAL INDEX KEY:			0001956741
		STANDARD INDUSTRIAL CLASSIFICATION:	SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS [2842]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				884042082
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42033
		FILM NUMBER:		251297346

	BUSINESS ADDRESS:	
		STREET 1:		13714 A STREET
		CITY:			OMAHA
		STATE:			NE
		ZIP:			68144
		BUSINESS PHONE:		877-860-3030

	MAIL ADDRESS:	
		STREET 1:		13714 A STREET
		CITY:			OMAHA
		STATE:			NE
		ZIP:			68144
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0255944-8k_clean.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:ZONE="http://cleancoresol.com/20250829">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_033_ZONE_cleancoresol.com_20250829 -->
<!-- Field: Set; Name: xdx; ID: xdx_045_20250829_20250829 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0001956741 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000004" name="dei:EntityCentralIndexKey">0001956741</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="zone-20250829.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-08-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001956741</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-08-29</xbrli:startDate>
        <xbrli:endDate>2025-08-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90E_edei--DocumentType_c20250829__20250829_zAk8ub3piuGi"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 OR 15(d) of The Securities
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
September 5, 2025 (<span id="xdx_902_edei--DocumentPeriodEndDate_c20250829__20250829_zZh85ZP2AS93"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">August 29, 2025</ix:nonNumeric></span>)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; width: 100%; font-size: 10pt; text-align: center"><span style="font-size: 12pt"><b><span id="xdx_90F_edei--EntityRegistrantName_c20250829__20250829_zrXB3cXdst8g"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000011" name="dei:EntityRegistrantName">CLEANCORE
    SOLUTIONS, INC.</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">(Exact name of registrant as specified in its charter)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20250829__20250829_zKPzC4CvT1b3"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90C_edei--EntityFileNumber_c20250829__20250829_ziQd1FuTAs8e"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000013" name="dei:EntityFileNumber">001-42033</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90A_edei--EntityTaxIdentificationNumber_c20250829__20250829_zgiQ3aCuEcl"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000014" name="dei:EntityTaxIdentificationNumber">88-4042082</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">(State or other jurisdiction<br/>
    of incorporation)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(Commission File Number)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(IRS Employer <br/>
    Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; width: 49%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_907_edei--EntityAddressAddressLine1_c20250829__20250829_zrXmBRtpAQN2"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000015" name="dei:EntityAddressAddressLine1">5920 S. 118th
    Circle</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressCityOrTown_c20250829__20250829_zySIVu6fJlP"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000016" name="dei:EntityAddressCityOrTown">Omaha</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressStateOrProvince_c20250829__20250829_zIV0pRj0Owqk"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000017" name="dei:EntityAddressStateOrProvince">NE</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 49%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_900_edei--EntityAddressPostalZipCode_c20250829__20250829_zNnHEh8o1Nec"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000018" name="dei:EntityAddressPostalZipCode">68137</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">(Address of principal executive offices)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 25%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 50%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(<span id="xdx_90E_edei--CityAreaCode_c20250829__20250829_zo1sTP2z7un"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000019" name="dei:CityAreaCode">877</ix:nonNumeric></span>)
    <span id="xdx_90C_edei--LocalPhoneNumber_c20250829__20250829_zjduNfStDvP4"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000020" name="dei:LocalPhoneNumber">860-3030</ix:nonNumeric></span></b></span></td>
    <td style="width: 25%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(Registrant&#8217;s telephone number, including area code)</span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; width: 100%; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">(Former name or former address, if changed since last report)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span id="xdx_904_edei--WrittenCommunications_c20250829__20250829_z43TAumVS9vh"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></td><td style="text-align: justify"><span style="font-size: 10pt">Written
                                            communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span id="xdx_903_edei--SolicitingMaterial_c20250829__20250829_zimzcvpVQNi3"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></td><td style="text-align: justify"><span style="font-size: 10pt">Soliciting
                                            material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span id="xdx_903_edei--PreCommencementTenderOffer_c20250829__20250829_z1wf2xsITfp1"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></td><td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement
                                            communications pursuant to Rule 14d-2(b) under the Exchange Act (17&#160;CFR&#160;240.14d-2(b))</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span id="xdx_901_edei--PreCommencementIssuerTenderOffer_c20250829__20250829_zrHNxmwNiEV6"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></td><td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement
                                            communications pursuant to Rule 13e-4(c) under the Exchange Act (17&#160;CFR&#160;240.13e-4(c))</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; width: 32%"><span style="font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="vertical-align: bottom; text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; width: 32%"><span style="font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="vertical-align: bottom; text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; width: 32%"><span style="font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><span id="xdx_904_edei--Security12bTitle_c20250829__20250829_z2QizzYkg06k"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000025" name="dei:Security12bTitle">Class B Common Stock, par value $0.0001 per
    share</ix:nonNumeric></span></span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><span id="xdx_901_edei--TradingSymbol_c20250829__20250829_ziFGgRBB0anj"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000026" name="dei:TradingSymbol">ZONE</ix:nonNumeric></span></span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><span id="xdx_90D_edei--SecurityExchangeName_c20250829__20250829_zqx0s9i7Yn1"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">NYSE American LLC</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging Growth Company <span id="xdx_90E_edei--EntityEmergingGrowthCompany_c20250829__20250829_zKj8F4dUKkPh"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt:booleantrue" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_900_edei--EntityExTransitionPeriod_c20250829__20250829_zwu133ex3R6l"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.75in"><b>Item 1.01
Entry into a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Securities Purchase Agreements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 1, 2025, CleanCore Solutions, Inc.
(the &#8220;<span style="text-decoration: underline">Company</span>&#8221;) entered into a securities purchase agreement (the &#8220;<span style="text-decoration: underline">Cash Purchase Agreement</span>&#8221;) with
certain purchasers (the &#8220;<span style="text-decoration: underline">Cash Purchasers</span>&#8221;), pursuant to which the Company agreed to issue and sell to the Cash Purchasers
pre-funded warrants to purchase an aggregate of 148,650,530 shares of class B common stock (the &#8220;<span style="text-decoration: underline">Cash Pre-Funded Warrants</span>&#8221;)
for aggregate gross proceeds of $148,650,530 (the &#8220;<span style="text-decoration: underline">Cash Offering</span>&#8221;). In the Cash Offering, the Cash Purchasers tendered
U.S. dollars to the Company as consideration for the Cash Pre-Funded Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 1, 2025, the Company also entered
into a securities purchase agreement (the &#8220;<span style="text-decoration: underline">Cryptocurrency Purchase Agreement</span>,&#8221; and together with the Cash Purchase
Agreement, the &#8220;<span style="text-decoration: underline">Purchase Agreements</span>&#8221;) with certain purchasers (the &#8220;<span style="text-decoration: underline">Cryptocurrency Purchasers</span>&#8221;
and together with the Cash Purchasers, the &#8220;<span style="text-decoration: underline">Purchasers</span>&#8221;), pursuant to which the Company agreed to issue and sell to
the Cryptocurrency Purchasers pre-funded warrants to purchase an aggregate of 26,349,890 shares of class B common stock (the &#8220;<span style="text-decoration: underline">Cryptocurrency
Pre-Funded Warrants</span>,&#8221; and together with the Cash Pre-Funded Warrants, the &#8220;<span style="text-decoration: underline">Pre-Funded Warrants</span>&#8221;) for aggregate
gross proceeds of $26,349,890 (the &#8220;<span style="text-decoration: underline">Cryptocurrency Offering</span>,&#8221; and together with the Cash Offering, the &#8220;<span style="text-decoration: underline">Offering</span>&#8221;).
In the Cryptocurrency Offering, the Cryptocurrency Purchasers tendered Dogecoin, Bitcoin, Ethereum, USDC or USDT as consideration for
the Cryptocurrency Pre-Funded Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Maxim Group LLC (&#8220;<span style="text-decoration: underline">Maxim</span>&#8221;)
and Curvature Securities, LLC (&#8220;<span style="text-decoration: underline">Curvature</span>&#8221;) acted as placement agents (together, the &#8220;<span style="text-decoration: underline">Placement Agents</span>&#8221;)
in connection with the Offering, pursuant to the terms and conditions of a placement agency agreement, dated September 1, 2025, among
the Company and the Placement Agents (the &#8220;<span style="text-decoration: underline">Placement Agreement</span>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 5, 2025, the Offering closed. Pursuant
to the Placement Agreement, the Placement Agents received a cash fee equal to 6% of the aggregate gross proceeds of the Offering and
reimbursement of certain out-of-pocket&#160;expenses. After deducting these and other offering expenses, the Company received net proceeds
of approximately $123,687,255, of which up to $1,100,000 will be used to pay off outstanding indebtedness and $4,400,000 will be used
for working capital and general corporate purposes, with the balance of the net proceeds being used to acquire Dogecoin.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Pre-Funded Warrants have a nominal exercise
price of $0.0001 (subject to standard adjustments for stock splits, stock dividends, recapitalizations, mergers and similar transactions),
include a cashless exercise provision, and may be exercised at any time commencing on the date that the Company files an amendment to
its articles of incorporation to increase the number of authorized shares of its class B common stock to a level sufficient to permit
the issuance of all securities (including the issuance of all shares of class B common stock underlying the Warrants (as defined below))
contemplated under the Purchase Agreements (the &#8220;<span style="text-decoration: underline">Authorization Amendment</span>&#8221;) until all of the Pre-Funded Warrants are
exercised in full, subject to the Exchange Cap (as defined below). </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Until the Company receives stockholder approval
for the issuance of all shares underlying the Pre-Funded Warrants, the Placement Agent Warrants (as defined below) and the Strategic
Advisor Warrants (as defined below) (collectively, the &#8220;<span style="text-decoration: underline">Warrants</span>&#8221;), the aggregate number of shares of class B common
stock that may be issued upon exercise of the Warrants may not exceed 19.99% of the number of shares of class B common stock issued and
outstanding immediately prior to the signing of the Purchase Agreements, or 2,773,858 shares (&#8220;<span style="text-decoration: underline">Exchange Cap</span>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Pre-Funded Warrants also contain a beneficial
ownership limitation which provides that the Company will not effect any exercise, and a holder will not have the right to exercise,
any portion of a Pre-Funded Warrant to the extent that, after giving effect to the exercise, such holder (together with such holder&#8217;s
affiliates) would beneficially own in excess of 4.99% (or, at the election of the holder, 9.99%) of the number of shares of class B common
stock outstanding immediately after giving effect to the issuance of shares issuable upon such exercise, <span style="font-family: Times New Roman, Times, Serif">which
such percentage may be increased or decreased, but not in excess of 9.99%, by the holder upon at least sixty-one (61)&#160;days&#8217;
prior notice to the Company</span>. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchase Agreements, the Placement Agreement
and the Pre-Funded <span style="font-family: Times New Roman, Times, Serif">Warrants </span>include customary representations, warranties
and covenants. They also provide that the Company will indemnify the Purchasers, the Placement Agents, their affiliates and/or their
respective directors, officers, shareholders, members, partners, employees and agents against certain liabilities against certain liabilities,
including liabilities under the Securities Act of 1933, as amended (the &#8220;<span style="text-decoration: underline">Securities Act</span>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, pursuant to the Purchase Agreements,
the Company agreed that, from the date of the Purchase Agreements until thirty (30) days after the Effective Date (as defined below),
neither the Company nor any subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance
of any shares of class B common stock or any securities convertible into or exercisable or exchangeable for, or that otherwise entitle
the holder thereof to receive, class B common stock, or (ii) file any registration statement or amendment or supplement thereto, other
than the Registration Statement (as defined below) or a registration statement on Form S-8 in connection with any employee benefit plan;
provided, however, the Company will be permitted to enter into a sales agreement with the Placement Agents and such other sales agents
as the Placement Agents may designate providing for the sale of shares of class B common stock in an &#8220;at-the-market&#8221; offering,
and file any such prospectus supplement or registration statement with the Securities and Exchange Commission (the &#8220;<span style="text-decoration: underline">SEC</span>&#8221;)
in connection with such sales agreement. Pursuant to the Purchase Agreements, &#8220;<span style="text-decoration: underline">Effective Date</span>&#8221; means the earliest
of the date that (a) the initial Registration Statement (as defined below) registering for resale all shares issuable upon exercise of
the Pre-Funded Warrants (the &#8220;<span style="text-decoration: underline">Pre-Funded Warrant Shares</span>&#8221;) has been declared effective by the SEC, (b) all of the Pre-Funded
Warrant Shares have been sold pursuant to Rule 144 promulgated by the SEC pursuant to the Securities Act (&#8220;<span style="text-decoration: underline">Rule 144</span>&#8221;)
or may be sold pursuant to Rule 144 without the requirement for the Company to be in compliance with the current public information requirement
of Rule 144 and without volume or manner-of-sale restrictions, (c) following the one (1) year anniversary of the closing, or (d) all
of the Pre-Funded Warrant Shares may be sold pursuant to an exemption from registration under Section 4(a)(1) of the Securities Act without
volume or manner-of-sale restrictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Purchase Agreements, the Company
also agreed that at any time during the period commencing from the six (6) month anniversary of the date of the Purchase Agreements and
ending at such time that all of the securities issued to a Purchaser may be sold without the requirement for the Company to be in compliance
with Rule 144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144, if the Company (i) shall fail for any reason
to satisfy the current public information requirement under Rule 144(c) or (ii) has ever been an issuer described in Rule 144(i)(1)(i)
or becomes such an issuer in the future, and the Company shall fail to satisfy any condition set forth in Rule 144(i)(2) (a &#8220;<span style="text-decoration: underline">Public
Information Failure</span>&#8221;) then, in addition to such Purchaser&#8217;s other available remedies, the Company shall pay to that Purchaser,
in cash, as partial liquidated damages and not as a penalty, by reason of any such delay in or reduction of its ability to sell its securities,
an amount in cash equal to $1,000 per day of a Public Information Failure until the earlier of (a) the date such Public Information Failure
is cured and (b) such time that such public information is no longer required for that Purchaser to transfer its securities pursuant
to Rule 144. In the event the Company fails to make such payments in a timely manner, other than during the pendency of any bona fide
dispute over whether an alleged Public Information Failure has occurred, such payments shall bear interest at the rate of 1.5% per month
(prorated for partial months) until paid in full. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing summary of the terms and conditions
of the Purchase Agreements, the Placement Agreement and the Pre-Funded <span style="font-family: Times New Roman, Times, Serif">Warrants
</span>does not purport to be complete and is qualified in its entirety by reference to the full text of those documents attached as
exhibits hereto, which are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Registration Rights Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Offering, the Company
also entered into a registration rights agreement with the Purchasers (the &#8220;<span style="text-decoration: underline">Registration Rights Agreement</span>&#8221;), pursuant
to which the Company agreed to file a registration statement on Form S-3 (the &#8220;<span style="text-decoration: underline">Registration Statement</span>&#8221;) with the SEC
within twenty (20) calendar days of the closing of the Offering (the &#8220;<span style="text-decoration: underline">Filing Date</span>&#8221;) in order to register the Pre-Funded
Warrant Shares, all shares of class B common stock issuable upon exercise of the Placement Agent Warrants and the Strategic Advisor Warrants
and any securities issued or then issuable upon any share split, dividend or other distribution, recapitalization or similar event with
respect to the foregoing (the &#8220;<span style="text-decoration: underline">Registrable Securities</span>&#8221;), and use its best efforts to cause the Registration Statement
to be declared effective under the Securities Act as promptly as possible after the filing thereof, but in any event no later than thirty
(30) calendar days following the Filing Date or, in the event of a full review by SEC, ninety (90) calendar days following the Filing
Date (the &#8220;<span style="text-decoration: underline">Effectiveness Date</span>&#8221;). If: (i) the Registration Statement is not filed on or prior to the Filing Date, (ii)
the Company fails to file with the SEC a request for acceleration of the Registration Statement in accordance with Rule 461 promulgated
by the SEC pursuant to the Securities Act within five (5) trading days of the date that the Company is notified by the SEC that the Registration
Statement will not be &#8220;reviewed&#8221; or will not be subject to further review, (iii) prior to the effective date of the Registration
Statement, the Company fails to file a pre-effective amendment and otherwise respond in writing to comments made by the SEC in respect
of the Registration Statement within ten (10) calendar days after the receipt of comments by or notice from the SEC that such amendment
is required in order for the Registration Statement to be declared effective, (iv) the Registration Statement registering for resale
all of the Registrable Securities, subject to the cutback limitations set forth in the Registration Rights Agreement, is not declared
effective by the SEC by the Effectiveness Date, or (v) after the effective date of the Registration Statement, the Registration Statement
ceases for any reason to remain continuously effective as to all Registrable Securities included in the Registration Statement, or the
Purchasers are otherwise not permitted to utilize the prospectus therein to resell such Registrable Securities, for more than ten (10)
consecutive calendar days or more than an aggregate of fifteen (15) calendar days (which need not be consecutive calendar days) during
any twelve (12) month period (any such failure or breach being referred to as an &#8220;<span style="text-decoration: underline">Event</span>&#8221;, and for the purposes of
clauses (i) and (iv) above, the date on which such Event occurs, and for the purpose of clause (ii) above, the date on which such five
(5) trading day period is exceeded, and for the purpose of clause (iii) above, the date which such ten (10) calendar day period is exceeded,
and for the purpose of clause (v) above, the date on which such ten (10) or fifteen (15) calendar day period, as applicable, is exceeded
being referred to as &#8220;<span style="text-decoration: underline">Event Date</span>&#8221;), then, in addition to any other rights the Purchasers may have under the Registration
Rights Agreement or under applicable law, on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable
Event shall not have been cured by such date) until the applicable Event is cured, the Company shall pay to each Purchaser an amount
in cash, as partial liquidated damages and not as a penalty, equal to $1,000 per day of such failure. If the Company fails to pay any
partial liquidated damages in full within seven (7) days after the date payable, the Company will pay interest thereon at a rate of 18%
per annum (or such lesser maximum amount that is permitted to be paid by applicable law) to the Purchaser, accruing daily from the date
such partial liquidated damages are due until such amounts, plus all such interest thereon, are paid in full.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Registration Rights Agreement includes customary
covenants and provides that the Company will indemnify the Purchasers, their affiliates and/or their respective directors, officers,
shareholders, members, partners, employees and agents against certain liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing summary of the terms and conditions
of the Registration Rights Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of
the form of the Registration Rights Agreement attached as an exhibit hereto, which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Placement Agent Warrants</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Offering and as partial
compensation for their services, on September 5, 2025, the Company issued a five-year warrant to purchase 3,150,008 shares of class B
common stock to Maxim and a five-year warrant to purchase 2,100,005 shares of class B common stock to Curvature (together, the &#8220;<span style="text-decoration: underline">Placement
Agent Warrants</span>&#8221;). Subject to the Exchange Cap, the Placement Agent Warrants may be exercised at any time commencing on the
date that the Authorization Amendment is effective at an exercise price of $1.33 (subject to standard adjustments for stock splits, stock
dividends, recapitalizations, mergers and similar transactions). The Placement Agent Warrants may be exercised on a cashless basis if
there is no effective registration statement registering the shares underlying the Placement Agent Warrants or the prospectus contained
therein is not available for the resale of such shares by the holder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Placement Agent Warrants also contain a beneficial
ownership limitation which provides that the Company will not effect any exercise, and a holder will not have the right to exercise,
any portion of a Placement Agent Warrant to the extent that, after giving effect to the exercise, such holder (together with such holder&#8217;s
affiliates) would beneficially own in excess of 4.99% (or, at the election of the holder, 9.99%) of the number of shares of class B common
stock outstanding immediately after giving effect to the issuance of shares issuable upon such exercise, <span style="font-family: Times New Roman, Times, Serif">which
such percentage may be increased or decreased, but not in excess of 9.99%, by the holder upon at least sixty-one (61)&#160;days&#8217;
prior notice to the Company</span>. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing summary of the terms and conditions
of the Placement Agent <span style="font-family: Times New Roman, Times, Serif">Warrants </span>does not purport to be complete and is
qualified in its entirety by reference to the full text of the Placement Agent Warrants attached as exhibits hereto, which are incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Asset Management Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Offering and use of proceeds
described above, on September 5, 2025, the Company entered into an asset management agreement (the &#8220;<span style="text-decoration: underline">Asset Management Agreement</span>&#8221;)
with Dogecoin Ventures, Inc., a wholly-owned subsidiary of House of Doge Inc. (the &#8220;<span style="text-decoration: underline">Asset Manager</span>&#8221;), and 21Shares
US LLC (&#8220;<span style="text-decoration: underline">21Shares</span>&#8221;), pursuant to which the Company appointed the Asset Manager to provide discretionary asset management
services and appointed 21Shares to provide non-discretionary recommendations to the Asset Manager with respect to the Treasury Assets.
The &#8220;<span style="text-decoration: underline">Treasury Assets</span>&#8221; shall consist of (i) certain cash net proceeds of the Offering deposited in the Company&#8217;s
account to be utilized for such purpose (the &#8220;<span style="text-decoration: underline">Account</span>&#8221;), (ii) cash proceeds the Company receives in connection with
additional capital raises, if any, with substantially similar objectives as the Offering and (iii) additional available cash or digital
assets placed in the Account, as well as all investments thereof, proceeds of, income on and additions or accretions to the same, including
all assets which are or were in the Account, but which are deployed in decentralized finance or similar blockchain transactions from
time to time in accordance with the investment strategy described in the Asset Management Agreement. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As compensation for their services, the Company
agreed to pay the Asset Manager and 21Shares a monthly fee in arrears computed at an annual rate as follows: (i) 2% in the aggregate
on amounts up to and including $1,000,000,000 in Account value, with 1.75% paid to the Asset Manager and 0.25% paid to 21Shares; (ii)
1.75% in the aggregate on amounts above $1,000,000,000 up to and including $1,500,000,000 in Account value, with 1.5% paid to the Asset
Manager and 0.25% paid to 21Shares; and (iii) 1.5% in the aggregate on amounts above $1,500,000,000 in Account value, with 1.25% paid
to the Asset Manager and 0.25% paid to 21Shares. Such payments may be made, in the sole discretion of the Asset Manager or 21Shares,
in shares of the Company&#8217;s class B common stock, cash, or Dogecoin and shall be pro-rated for partial periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Asset Management Agreement includes customary
representations, warranties and covenants and provides that the Company will indemnify the Asset Manager, 21Shares, their affiliates
and/or their respective directors, members, partners, shareholders, officers and employees against certain liabilities. The term of the
Asset Management Agreement is for ten (10) years with respect to the Asset Manager and five (5) years with respect to 21Shares; provided,
however, that with respect to 21Shares, the term may be extended upon the mutual written agreement of the Asset Manager and 21Shares.
Beginning on the first (1st) anniversary of the date of the Asset Management Agreement, the Asset Management Agreement may be terminated
by the Asset Manager or 21Shares for any reason upon at least ninety (90) days prior written notice to the other parties. Additionally,
the Asset Management Agreement may be terminated at any time for Cause (as defined in the Asset Management Agreement) (i) by the Company
upon at least thirty (30) days prior written notice to the Asset Manager and 21Shares (but only with respect to the party that committed
the Cause event), (ii) by the Asset Manager or 21Shares upon at least thirty (30) days prior written notice to the Company (but only
with respect to the party that is requesting the termination), or (iii) by the Asset Manager, solely with respect to 21Shares, upon at
least thirty (30) days prior written notice to 21Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing summary of the terms and conditions
of the Asset Management Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the
Asset Management Agreement attached as an exhibit hereto, which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Strategic Advisor Agreement and Warrants</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Offering and use of proceeds
described above, on September 5, 2025, the Company also entered into a strategic advisor agreement (the &#8220;<span style="text-decoration: underline">Strategic Advisor Agreement</span>&#8221;)
with the Asset Manager, pursuant to which the Company appointed the Asset Manager to provide certain advisory services relating to the
integration of cryptocurrency and digital asset strategies into the Company&#8217;s business, with an emphasis on Dogecoin in both its
product offerings and as part of its treasury management strategy, in exchange for (i) a five-year warrant to purchase 8,750,021 shares
of class B common stock at an exercise price of $1.00 (subject to standard adjustments for stock splits, stock dividends, recapitalizations,
mergers and similar transactions) and (ii) a five-year warrant to purchase 5,250,013 shares of class B common stock at an exercise price
of $1.33 (subject to standard adjustments for stock splits, stock dividends, recapitalizations, mergers and similar transactions) (together,
the &#8220;<span style="text-decoration: underline">Strategic Advisor Warrants</span>&#8221;). Subject to the Exchange Cap, the Strategic Advisor Warrants may be exercised at
any time commencing on the date that the Authorization Amendment is effective. The Strategic Advisor Warrants may be exercised on a cashless
basis if there is no effective registration statement registering the shares underlying the Strategic Advisor Warrants or the prospectus
contained therein is not available for the resale of such shares by the holder. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Strategic Advisor Warrants also contain a
beneficial ownership limitation which provides that the Company will not effect any exercise, and a holder will not have the right to
exercise, any portion of a Strategic Advisor Warrant to the extent that, after giving effect to the exercise, such holder (together with
such holder&#8217;s affiliates) would beneficially own in excess of 4.99% (or, at the election of the holder, 9.99%) of the number of
shares of class B common stock outstanding immediately after giving effect to the issuance of shares issuable upon such exercise, <span style="font-family: Times New Roman, Times, Serif">which
such percentage may be increased or decreased, but not in excess of 9.99%, by the holder upon at least sixty-one (61)&#160;days&#8217;
prior notice to the Company</span>. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Strategic Advisor Agreement includes customary
representations, warranties and covenants and provides that the Company will indemnify the Asset Manager, its affiliates and/or its directors,
officers, shareholders, members, partners, employees and agents against certain liabilities. The term of the Strategic Advisor Agreement
is for five (5) years. Either party may terminate the Strategic Advisor Agreement immediately upon written notice if one of the other
parties materially breaches the Strategic Advisor Agreement and fails to cure such breach within thirty (30) days after receiving written
notice of the breach.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing summary of the terms and conditions
of the Strategic Advisor Agreement <span style="font-family: Times New Roman, Times, Serif">and the Strategic Advisor Warrants </span>does
not purport to be complete and is qualified in its entirety by reference to the full text of those documents attached as exhibits hereto,
which are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Option Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 5, 2025, the Company also entered
into an option agreement (the &#8220;<span style="text-decoration: underline">Option Agreement</span>&#8221;) with Clayton Adams, the Company&#8217;s Chief Executive Officer,
pursuant to which the Company granted Mr. Adams an irrevocable option to elect, in his sole discretion, at any time commencing on the
date that is one hundred eighty (180) days after the closing of the Offering and ending on the third (3<sup>rd</sup>) anniversary of
such date, to either (i) direct the Company to consummate a spin-off of the Company&#8217;s business and operations as conducted immediately
prior to the closing of the Offering, excluding any digital asset treasury business or other business lines commenced after such date,
and including all assets, liabilities and employees primarily related thereto (the &#8220;<span style="text-decoration: underline">Legacy Business</span>&#8221;), or (ii) acquire,
or cause one or more entities designated by Mr. Adams to acquire, the Legacy Business at a price proposed by Mr. Adams that he believes
falls within a range that is considered fair, from a financial point of view, for the Legacy Business and that is confirmed as fair from
a financial point of view by a fairness opinion (the &#8220;<span style="text-decoration: underline">Option Price</span>&#8221;). The Option Price will assume that the Legacy
Business will have at least $500,000 in unrestricted cash and cash equivalents at the time of such spin-off or acquisition, and if the
unrestricted cash and cash equivalents of the Legacy Business are less than such amount, the Option Price shall be reduced, dollar for
dollar, by the amount of such shortfall.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Option Agreement includes customary representations,
warranties and covenants, including covenants relating to the operation of the Legacy Business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing summary of the terms and conditions
of the Option Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Option
Agreement attached as an exhibit hereto, which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 3.02 Unregistered Sales of Equity Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information set forth under Item 1.01 regarding
the issuance of the Warrants is incorporated by reference into this Item 3.02. The issuance of these securities is being made in reliance
upon an exemption from the registration requirements of Section 5 of the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.75in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><b>Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Resignation of Director</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 29, 2025, Brent Cox resigned from the
Board of Directors of the Company (the &#8220;<span style="text-decoration: underline">Board</span>&#8221;). Mr. Cox&#8217;s resignation was not due to any disagreement with
the Company on any matter relating to its operations, policies (including accounting or financial policies) or practices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Appointment of Directors</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 5, 2025, upon recommendation of
the Nominating and Corporate Governance Committee, the Board appointed Alexander Benjamin Spiro and Tim Stebbing to the Board to fill
an existing vacancy and the vacancy created by Mr. Cox&#8217;s resignation. Messrs. Spiro and Stebbing were also appointed to the Audit
Committee, the Compensation Committee and the Nominating and Corporate Governance Committee and Mr. Spiro was appointed to serve as Chairman
of the Board. The Board determined that Messrs. Spiro and Stebbing are independent within the meaning of the rules of NYSE American LLC.
Below is certain biographical information regarding the newly appointed directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Spiro is a well-known litigator and has served
as a Partner at Quinn Emanuel Urquhart &amp; Sullivan, LLP at its New York office since 2017. He serves as Co-Chair of the Investigations,
Government Enforcement &amp; White Collar Defense Practice. He was previously a Trial Attorney at Brafman &amp; Associates, P.C. and
a Prosecutor with the New York County District Attorney&#8217;s Office. Mr. Spiro is a graduate of Harvard Law School.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Stebbing is has served as the Chief Technology
Officer of House of Doge since March 2025. He is also on the board of the Dogecoin Foundation, serving as Director of Product since 2021
to spear-head the development of a broader Dogecoin ecosystem, and to increase its adoption as a global means of exchange. Prior to that,
he served as Chief Technology Officer at Ynomia Pty Ltd, a construction technology company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Messrs. Spiro and Stebbing were appointed until
their successors are duly elected and qualified. Messrs. Spiro and Stebbing were designated by the Company&#8217;s stockholder House
of Doge Inc. (&#8220;<span style="text-decoration: underline">HoD</span>&#8221;) and appointed pursuant to the terms of the Purchase Agreements, which provide that, for so long
as HoD continues to hold any shares of the Company&#8217;s class B common stock, in the event that either director, or such director&#8217;s
successor, resigns, is removed, dies, or becomes disabled, HoD shall have the right to designate one or more replacement directors reasonably
acceptable to the Board. There has been no transaction, nor is there any currently proposed transaction, between Mr. Spiro or Mr. Stebbing
on the one hand, and the Company on the other hand, that would require disclosure under Item 404(a) of Regulation S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 5, 2025, the Company entered into
an independent director agreement with Mr. Spiro (the &#8220;<span style="text-decoration: underline">Spiro Director Agreement</span>&#8221;), pursuant to which the Company agreed
to grant to Mr. Spiro (i) within five (5) business days after execution of the Spiro Director Agreement, 360,000 restricted stock units
under the Company&#8217;s 2022 Equity Incentive Plan, as amended (the &#8220;<span style="text-decoration: underline">Plan</span>&#8221;), which shall vest monthly in equal installments
over twelve (12) months, and (ii) after the first anniversary of the Spiro Director Agreement and for each year thereafter, within five
(5) business days, $360,000 worth of restricted stock units under the Plan priced at the closing price of the applicable anniversary
date, which shall vest monthly in equal installments over twelve (12) months. The Company also agreed to reimburse Mr. Spiro for pre-approved
reasonable business expenses incurred in good faith in connection with the performance of his duties for the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 5, 2025, the Company entered into
an independent director agreement with Mr. Stebbing (the &#8220;<span style="text-decoration: underline">Stebbing Director Agreement</span>&#8221;), pursuant to which the Company
agreed to grant to Mr. Stebbing (i) within five (5) business days after execution of the Stebbing Director Agreement, 120,000 restricted
stock units under the Plan, which shall vest monthly in equal installments over twelve (12) months, and (ii) after the first anniversary
of the Stebbing Director Agreement and for each year thereafter, within five (5) business days, $120,000 worth of restricted stock units
under the Plan priced at the closing price of the applicable anniversary date, which shall vest monthly in equal installments over twelve
(12) months. The Company also agreed to reimburse Mr. Stebbing for pre-approved reasonable business expenses incurred in good faith in
connection with the performance of his duties for the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 5, 2025, the Company also entered
into indemnification agreements with Messrs. Spiro and Stebbing (the &#8220;<span style="text-decoration: underline">Indemnification Agreements</span>&#8221;), pursuant to which
the Company agreed to indemnify Messrs. Spiro and Stebbing to the fullest extent permitted by law, maintain director and officer liability
insurance, and agreed to advance or reimburse all expenses incurred by or on behalf of Messrs. Spiro and Stebbing in connection with
any proceeding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing summary of the terms and conditions
of the Spiro Director Agreement, the Stebbing Director Agreement and the Director Indemnification Agreements does not purport to be complete
and is qualified in its entirety by reference to the full text of those documents attached as exhibits hereto, which are incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Appointment of Chief Investment Officer</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 5, 2025, the Board appointed Marco
Margiotta to serve as Chief Investment Officer of the Company. Below is certain biographical information regarding Mr. Margiotta.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Margiotta is a CPA with a proven record of
building and scaling financial technology companies. He has served as the Chief Executive Officer of HoD since April 2025. Prior to joining
the Company and HoD, he was Co-Founder &amp; CEO of payments company Payfare Inc., which was later acquired by Fiserv, Inc., from October
2019 to March 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Margiotta was appointed until his successor
is duly elected and qualified. Mr. Margiotta was designated by HoD and appointed pursuant to the terms of the Purchase Agreements, which
provide that, for so long as HoD continues to hold any shares of the Company&#8217;s class B common stock, in the event that Mr. Margiotta
resigns, dies, or becomes disabled, HoD may, subject to the Board&#8217;s reasonable approval, nominate a replacement reasonably acceptable
to the Board. There has been no transaction, nor is there any currently proposed transaction, between Mr. Margiotta and the Company that
would require disclosure under Item 404(a) of Regulation S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 5, 2025, the Company entered into
an executive consulting agreement (the &#8220;<span style="text-decoration: underline">Consulting Agreement</span>&#8221;) with Mr. Margiotta, pursuant to which Mr. Margiotta
agreed to serve as Chief Investment Officer as an independent contractor. Pursuant to the Consulting Agreement, Mr. Margiotta is entitled
to base compensation at the rate of $640,000 per year, payable monthly, and a discretionary annual performance bonus in the amount of
$100,000 if the Company maintains a digital asset treasury strategy for six (6) months. In addition to such annual bonus, Mr. Margiotta
will be entitled to receive an additional special bonus of $100,000 on the date that the Company&#8217;s digital asset treasury has total
digital assets that are equal to, or in excess of, $100 million. In addition, the Company agreed to grant Mr. Margiotta 4,000,000 shares
of restricted stock under the Plan within five (5) business days following the date that the number of available shares under the Plan
is increased such that there are a sufficient number of shares available to make such grant. The Company will also be responsible for
any travel or other costs or expenses incurred by Mr. Margiotta in connection with the performance of his services, provided that all
such expenses must be documented and receive the Company&#8217;s prior written approval. The term of the Consulting Agreement is for
three (3) years and it may be terminated by the Company with Cause (as defined in the Consulting Agreement) or by Mr. Margiotta for Good
Reason (as defined in the Consulting Agreement). If the Company terminates the Consulting Agreement without Cause, or if Mr. Margiotta
terminates the Consulting Agreement for Good Reason, any unvested restricted stock under any outstanding award agreement shall vest effective
immediately and Mr. Margiotta shall continue to receive his base compensation for the remainder of the term. The Consulting Agreement
includes customary representations, warranties and covenants, including with respect to confidentiality.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 5, 2025, the Company also entered
into an indemnification agreement with Mr. Margiotta (the &#8220;<span style="text-decoration: underline">Margiotta Indemnification Agreement</span>&#8221;), pursuant to which
the Company agreed to indemnify Mr. Margiotta to the fullest extent permitted by law, maintain director and officer liability insurance,
and agreed to advance or reimburse all expenses incurred by or on behalf of Mr. Margiotta in connection with any proceeding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing summary of the terms and conditions
of the Consulting Agreement <span style="font-family: Times New Roman, Times, Serif">and the </span>Margiotta Indemnification Agreement
does not purport to be complete and is qualified in its entirety by reference to the full text of those documents attached as exhibits
hereto, which are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>CEO Employment Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 5, 2025, the Company also entered
into an executive employment agreement (the &#8220;<span style="text-decoration: underline">Employment Agreement</span>&#8221;) with Clayton Adams, the Company&#8217;s Chief
Executive Officer. Pursuant to the Employment Agreement, Mr. Adams is entitled to an annual base salary of $640,000, a signing bonus
of $400,000 and a discretionary annual performance bonus of $100,000 if the Company maintains a digital asset treasury strategy for six
(6) months. In addition to such bonuses, Mr. Adams will be entitled to receive an additional special bonus of $100,000 on the date that
the Company&#8217;s digital asset treasury has total digital assets that are equal to, or in excess of, $100 million.&#160;In addition,
the Company agreed to grant Mr. Adams 3,250,000 shares of restricted under the Plan within five (5) business days following the date
that the number of available shares under the Plan is increased such that there are a sufficient number of shares available to make such
grant. Mr. Adams is also eligible to participate in all employee benefit plans commensurate with his position.&#160;The term of the Employment
Agreement is for three (3) years and shall be deemed to be automatically extended, upon the same terms and conditions, for successive
periods of one (1) year, unless either party provides written notice of its intention not to extend the term at least thirty (30) days
prior to the end of the initial term or such one-year extension thereof. The Employment Agreement may be terminated by either party upon
thirty (30) days&#8217; prior written notice. If the Employment Agreement is terminated by Mr. Adams without Good Reason (as defined
in the Employment Agreement) or by the Company with Cause (as defined in the Employment Agreement), then Mr. Adams shall be entitled
to the following: (i) any accrued but unpaid base salary and accrued but unused vacation/paid time off (if such unused vacation time/paid
time off is so required to be paid under the Company&#8217;s employment policies or applicable law); (ii) reimbursement for unreimbursed
business expenses properly incurred by Mr. Adams, which shall be subject to and paid in accordance with the Company&#8217;s expense reimbursement
policy; and (iii) such employee benefits (including equity compensation), if any, to which Mr. Adams may be entitled under the Company&#8217;s
employee benefit plans as of the date of termination. If the Employment Agreement is terminated by Mr. Adams with Good Reason or by the
Company without Cause, then Mr. Adams shall be entitled to the foregoing, and, subject to Mr. Adams&#8217; compliance with certain agreements
described in the Employment Agreement and his execution of a release of claims in favor of the Company, Mr. Adams will be entitled to
receive the following: (i) a lump sum payment equal to the greater of (a) the balance of the base salary that Mr. Adams would have received
through the remainder of the term of the Employment Agreement and (b) Mr. Adams&#8217; base salary for one (1) year; (ii) a payment equal
to (a) the full amount of the annual bonus and, (b) if the milestone associated with the special bonus has been achieved, but the special
bonus has not yet been paid, the full amount of the special bonus, shall be paid; and (iii) all unvested restricted stock units granted
under the Employment Agreement shall automatically vest and the treatment of any other outstanding equity awards shall be determined
in accordance with the terms of the Plan and the applicable award agreements. The Employment Agreement also contains customary confidentiality
provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing summary of the terms and conditions
of the Employment Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Employment
Agreement attached as an exhibit hereto, which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 8.01 Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the transactions described
above, the Company is supplementing the business description and risk factors previously disclosed in its Annual Report on Form 10-K
for the year ended June 30, 2025, and as supplemented by the Company&#8217;s subsequent periodic filings, with the following. References
in this Item 8.01 to &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; are to the Company and its consolidated subsidiary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Business Overview</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following the closing of the Offering, in addition
to managing our cryptocurrency treasury operations, we will continue focusing on the development and production of cleaning products
that produce pure aqueous ozone for professional, industrial, or home use as described in our Form 10-K for the fiscal year ended June
30, 2025 and other filings with the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Digital Asset Treasury Strategy &#8212;
Dogecoin (DOGE)</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the transactions described above,
we will adopt a digital asset treasury strategy focused on Dogecoin. After paying off our preexisting debt and allocation of funds for
our working capital, approximately $118 million of the net proceeds of the Offering will be allocated to fund the acquisition of Dogecoin and
the establishment of our cryptocurrency treasury operations. Pursuant to the Asset Management Agreement and Strategic Advisory Agreement
described above, we have established a multiyear advisory and asset-management program with the Asset Manager (which is a wholly-owned
subsidiary of House of Doge Inc., the commercial arm of the Dogecoin Foundation) and 21Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dogecoin is the native digital asset of the Dogecoin
blockchain, an open-source, proof-of-work network launched in 2013. Featuring one-minute block times, low transaction fees and an active
global community, Dogecoin is widely used for low-value transfers, micropayments and &#8220;tipping&#8221; across social-media and gaming
platforms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dogecoin employs an inflationary supply schedule under which its issuance
is fixed at approximately 5 billion new Dogecoins each year. As of the date hereof, the circulating supply is approximately 150 billion
Dogecoins, and average daily spot-market volume regularly exceeds US $600 million across major venues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Current Parameters</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><span style="text-decoration: underline">Asset</span>.
                                            Dogecoin (DOGE) only.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><span style="text-decoration: underline">Source
                                            of Funds</span>. A portion of the proceeds of the Offering.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Execution</span>. Spot purchases or dollar-cost average purchases for cash on U.S. or foreign digital-asset venues that are (i) registered with the Financial Crimes Enforcement Network of the Treasury Department as money-service businesses or otherwise subject to Bank Secrecy Act / Anti-Money Laundering obligations and (ii) approved by the Asset Manager. The Asset Manager and 21 Shares will work with industry-recognized crypto exchanges on staking-like rewards and yield opportunities.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><span style="text-decoration: underline">Asset
                                            Manager</span>. Under the Asset Management Agreement, the Asset Manager will act as discretionary
                                            asset manager with authority to execute purchases, sales or transfers with respect to the
                                            Treasury Assets consistent with the investment strategy described in the Asset Management
                                            Agreement. 21Shares will provide non-discretionary advice, research and analytics support
                                            to the Asset Manager on behalf of the Company with respect to the Treasury Assets.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><span style="text-decoration: underline">Custody</span>.
                                            Dogecoins acquired will be held in segregated wallets at Bitstamp (by Robinhood), through
                                            BitGo as the third-party custodian under &#8220;cold&#8221; or hardware-secured storage.
                                            Private keys will be controlled exclusively by the custodian. We do not self-custody. The
                                            Board has authorized management to evaluate additional U.S.-regulated qualified custodians
                                            from time to time in order to diversify counterparty risk.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use of Dogecoins</span>. A utility-led strategy is underway to establish Dogecoin as a leading cryptocurrency optimized for payments, tokenization, and everyday use. In parallel, discussions with industry-recognized crypto exchanges are focused on introducing staking-like rewards and yield opportunities for treasury holdings, creating additional value for holders.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><span style="text-decoration: underline">Reporting</span>.
                                            Holdings will be measured at fair value in accordance with Accounting Standards Update (&#8220;<span style="text-decoration: underline">ASU</span>&#8221;)
                                            2023-08, with changes in fair value reflected in earnings each reporting period. The Asset
                                            Manager and the Company shall cooperate in good faith to obtain information that can be provided
                                            to the Company as frequently as reasonably required by the Company, subject to any limitations
                                            imposed by the custodian.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><span style="text-decoration: underline">Liquidity
                                            and Working-Capital Treatment</span>. Dogecoin is not classified as cash or a cash equivalent
                                            for U.S. generally accepted accounting principles (&#8220;<span style="text-decoration: underline">GAAP</span>&#8221;) or NYSE American
                                            purposes. We will maintain a separate reserve of fiat cash sufficient to fund at least twelve
                                            (12) months of projected operating expenses to minimize or eliminate the need to sell Dogecoin
                                            holdings to meet any near-term obligations.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Rationale for Acquiring Dogecoins</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board determined that accumulating Dogecoins
is in the best interests of stockholders based on the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><span style="text-decoration: underline">Liquidity
                                            and Market Depth</span>. Dogecoin is among the most actively traded digital assets globally,
                                            with sophisticated U.S. dollar, euro and stable-coin markets that facilitate efficient entry
                                            and exit.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><span style="text-decoration: underline">Community
                                            and Ecosystem Growth</span>. Dogecoin maintains one of the largest, longest-standing grassroots
                                            communities in crypto. Ongoing technical work, including Dogecoin Improvement Proposals for
                                            faster synchronization and potential interoperability layers, could expand utility and long-term
                                            adoption.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><span style="text-decoration: underline">Inflationary
                                            yet Predictable Supply</span>. While Dogecoin&#8217;s supply is not capped, the fixed 5 billion-per-year
                                            issuance results in a declining percentage inflation rate, which the Board believes can make
                                            Dogecoin a stable medium for low-fee payments while still offering upside exposure to network
                                            growth.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><span style="text-decoration: underline">Strategic
                                            Partnership</span>. By partnering directly with a wholly-owned subsidiary of the commercial
                                            arm of the Dogecoin Foundation, the Company may benefit from such unique expertise and visibility
                                            into core-protocol road-maps, potential Layer-2 integrations and enterprise use cases (e.g.,
                                            micro-billing for our sustainability and cleaning-technology customers).</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Governance and Controls</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All Dogecoin transactions will be executed by
the Asset Manager under multi-signature authorization protocols that require dual approval. Position reconciliations are performed between
custodian statements and internally maintained ledgers. The Company, together with external auditors, tests the design and effectiveness
of digital-asset controls at least annually. Any deviation from Board mandates must be reported to the Audit Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Risk Management Considerations</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We recognize that the market price of Dogecoin
is volatile, that the regulatory landscape remains unsettled, and that custodial, cybersecurity, market-liquidity, tax, and accounting
risks could materially impact our results of operations. These risks, along with continued compliance with NYSE American listing standards,
will be reassessed at regular Board meetings and re-evaluated before expansion of the strategy. See &#8220;<i>Risk Factors</i>&#8221;
below for a description of the material risks that apply to our holdings of Dogecoin.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Forward-Looking Statements</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We intend to continue refining our Dogecoin treasury
strategy in response to market conditions, technological developments and regulatory guidance. Forward-looking statements herein are
subject to risks detailed in the &#8220;Risk Factors&#8221; section of our periodic reports, including volatility in Dogecoin prices,
evolving legal and tax treatment, counter-party exposure, and the potential need to liquidate digital assets under adverse conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Risk Factors </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Risks Related to Dogecoin Holdings</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Dogecoin is a highly volatile asset, and
significant fluctuations in its price may adversely affect our financial results, the market price of our securities, and our overall
business.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The market price of Dogecoin has experienced,
and is expected to continue to experience, extreme volatility. For example, Dogecoin soared from approximately $0.002 per coin in November
2020 to a historical high of approximately $0.74 per coin on May 8, 2021 and later retreated to approximately $0.05 in June 2022. A material
decline in the value of Dogecoin would directly reduce the fair value of our treasury holdings, could require us to recognize material
impairment or fair-value losses, and could negatively impact our net income and stockholders&#8217; equity in any given period. The price
of Dogecoin may be adversely affected by, among other factors:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">changes
                                            in user, consumer, or investor sentiment toward Dogecoin or the wider digital asset industry;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">negative
                                            publicity or social-media coverage, including on platforms that historically have driven
                                            Dogecoin trading activity or disassociation from influential public figures;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">changes
                                            in consumer preferences and the perceived value or prospects of Dogecoin;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">transactional
                                            activities such as (i) activities of highly active retail and institutional users, speculators
                                            and holders or (ii) actual or expected significant dispositions of Dogecoin by large holders,
                                            including the expected liquidation of digital assets seized by governments or associated
                                            with entities that have filed for bankruptcy protection;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">sales
                                            or anticipated sales of significant Dogecoin positions by large holders, including those
                                            required to liquidate assets in bankruptcy or enforcement proceedings;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">a
                                            proposed or actual change of protocol for Dogecoin that may result in a &#8216;fork&#8217;
                                            that may have a negative impact on the value or function of Dogecoin, and consequently, impacting
                                            the various players in Dogecoin&#8217;s network, including holders of Dogecoin;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">competition
                                            from other blockchains, centralized exchanges or decentralized exchanges that exhibit comparable
                                            or better speed, security, scalability or energy efficiency, or that feature other more favored
                                            characteristics;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">competition
                                            from other digital assets that feature other more favored characteristics, are backed by
                                            governments, including the U.S. government, or reserves of fiat currencies, or that represent
                                            ownership or security interests in physical assets;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">macroeconomic
                                            conditions such as inflation, rising interest rates, recessionary pressures, or geopolitical
                                            conflict;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">competition
                                            from other blockchains or digital assets that are perceived to have superior technological
                                            or economic characteristics;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">transaction
                                            congestion and fees associated with processing transactions on the Dogecoin network;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">disruption,
                                            failure, or suspension of Dogecoin trading venues, custodians, or payment processors; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">technological
                                            developments&#8212;such as advances in quantum computing&#8212;that could render the cryptography
                                            underlying the Dogecoin blockchain insecure or obsolete.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any of these events could materially and adversely
affect the value of our Dogecoin holdings and, in turn, the value of our class B common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>There is a possibility that Dogecoin may
be classified as a &#8220;security.&#8221; Any classification of Dogecoin as a &#8220;security&#8221; would subject us to additional
regulation and could materially impact the operation of our business.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither the SEC nor any other U.S. federal or
state regulator has publicly concluded that Dogecoin is, or is not, a &#8220;security,&#8221; and no federal or state court has yet addressed
Dogecoin&#8217;s status under the U.S. federal securities laws. Consequently, although we believe, based on our application of the analytical
framework for digital assets first adopted by the Staff of the SEC&#8217;s Division of Corporation Finance in 2018 (the &#8220;<span style="text-decoration: underline">2018
Digital Asset Framework</span>&#8221;), other existing guidance, and relevant case law, that Dogecoin is not a security within the meaning
of the federal securities laws and that registration of the Company under the Investment Company Act of 1940, as amended (the &#8220;<span style="text-decoration: underline">Investment
Company Act</span>&#8221;), is therefore unnecessary, a regulator or court could take a contrary view. Should any regulator or court determine
that Dogecoin is a security, we could be compelled to register as an investment company under the Investment Company Act or otherwise
alter our business in a manner that could be costly and disruptive.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have instituted a robust, continuing process
for analyzing the federal securities law status of Dogecoin and other digital assets as guidance evolves. In that process we rely on
(i) the definitional elements of a &#8220;security&#8221; contained in the Securities Act and the Securities Exchange Act of 1934, as
amended, (ii) seminal Supreme Court precedents such as SEC v. W.J. Howey Co. and Reves v. Ernst &amp; Young, and (iii) interpretive materials,
speeches, enforcement actions, and other public statements issued by the SEC and its staff, including the 2018 Digital Asset Framework.
Our conclusion that Dogecoin is not a security rests, among other factors, on our determination that Dogecoin does not satisfy the investment-contract
elements outlined in Howey when analyzed in light of the 2018 Digital Asset Framework and related SEC guidance. We accordingly view Dogecoin
as not subject to the federal securities laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nonetheless, application of the securities laws
to any digital asset remains complex, highly fact-specific, and subject to ongoing regulatory and judicial development. Even if our present
analysis is reasonable, it would not preclude the SEC, another regulator, or a court from reaching a different conclusion. If Dogecoin,
or any other digital asset we hold, were ultimately deemed a security, we could face enforcement actions, private litigation, injunctions,
cease-and-desist orders, and significant monetary penalties. We could also be required to register as an investment company under the
Investment Company Act, register Dogecoin offerings or sales under the Securities Act, modify or limit our products and services, or
cease certain operations altogether, any of which could materially and adversely affect our business, financial condition, results of
operations, and prospects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the application of the federal securities
and similar laws to digital assets is still evolving and because market participants apply differing interpretations of the 2018 Digital
Asset Framework and related guidance, other companies may reach conclusions about the security status of particular digital assets that
differ from ours. If our competitors adopt approaches that allow them to engage in activities that we believe are impermissible or too
risky under the 2018 Digital Asset Framework, they may obtain competitive advantages or revenue opportunities that are unavailable to
us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we were deemed to be an investment company
under the Investment Company Act, applicable restrictions likely would make it impractical for us to continue segments of our business
as currently contemplated.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Investment Company Act is intended to protect
investors (for example, by preventing insiders from managing investment companies to their benefit and to the detriment of public investors),
and it requires an issuer primarily engaged in the business of investing, reinvesting or trading in securities to register as an investment
company, unless a valid exemption applies. Under Sections 3(a)(1)(A) and (C) of the Investment Company Act, a company generally will
be deemed to be an &#8220;investment company&#8221; if (i) it is or holds itself out as being engaged primarily, or proposes to engage
primarily, in the business of investing, reinvesting, or trading in securities or (ii) it engages or proposes to engage in the business
of investing, reinvesting, owning, holding, or trading in securities, and it owns or proposes to acquire investment securities having
a value exceeding 40% of the value of its total assets (exclusive of U.S. government securities and cash items) on an unconsolidated
basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not believe that we are an &#8220;investment
company&#8221; as such term is defined in either Section 3(a)(1)(A) or Section 3(a)(1)(C) of the Investment Company Act since we believe
Dogecoin is not an investment security. With respect to Section 3(a)(1)(A), we do not hold ourselves out as being engaged primarily or
propose to engage primarily in the business of investing, reinvesting, or trading in securities within the meaning of such section. With
respect to Section 3(a)(1)(C), we do not own or propose to acquire investment securities having a value exceeding 40% of the value of
our total assets (exclusive of U.S. government securities and cash items) on an unconsolidated basis. Our stockholders will not have
the regulatory protections provided to investors in investment companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dogecoin and other digital assets, as well as
new business models and transactions enabled by blockchain technologies, present novel interpretive questions under the Investment Company
Act. There is a risk that assets or arrangements that we have concluded are not securities could be deemed to be securities by the SEC
or another authority for purposes of the Investment Company Act, which would increase the percentage of securities held by us for Investment
Company Act purposes. The SEC has requested information from a number of participants in the digital assets&#8217; ecosystem, regarding
the potential application of the Investment Company Act to their businesses. For example, in an action unrelated to the Company, in February
2022, the SEC issued a cease-and-desist order under the Investment Company Act to BlockFi Lending LLC (&#8220;BlockFi&#8221;), in which
the SEC alleged that BlockFi was operating as an unregistered investment company because it issued securities and also held more than
40% of its total assets, excluding cash, in investment securities, including the loans of digital assets made by BlockFi to institutional
borrowers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we were deemed to be an investment company,
Rule 3a-2 under the Investment Company Act is a safe harbor that provides a one-year grace period for transient investment companies
that have a bona fide intent to be engaged primarily, as soon as is reasonably possible (in any event by the termination of such one-year
period), in a business other than that of investing, reinvesting, owning, holding or trading in securities, with such intent evidenced
by the company&#8217;s business activities and an appropriate resolution of its board of directors. The grace period is available not
more than once every three years and runs from the earlier of (i) the date on which the issuer owns securities and/or cash having a value
exceeding 50% of the issuer&#8217;s total assets on either a consolidated or unconsolidated basis or (ii) the date on which the issuer
owns or proposes to acquire investment securities having a value exceeding 40% of the value of such issuer&#8217;s total assets (exclusive
of U.S. government securities and cash items) on an unconsolidated basis. Accordingly, the grace period may not be available at the time
that we seek to rely on Rule 3a-2; however, Rule 3a-2 is a safe harbor and we may rely on any exemption or exclusion from investment
company status available to us under the Investment Company Act at any given time. Furthermore, maintaining our status as a non-investment
company or reliance on Rule 3a-2 could require us to take actions to dispose of securities and/or acquire other assets, which dispositions
or acquisitions could be required to take place under unfavorable market conditions and could result in the incurrence of losses, and
could limit our ability to make certain investments or enter into joint ventures, or otherwise limit or change our service offerings
and operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we were to be deemed an investment company
in the future, restrictions imposed by the Investment Company Act, including limitations on our ability to issue different classes of
stock and equity compensation to directors, officers, and employees and restrictions on management, operations, and transactions with
affiliated persons, likely would make it impractical for us to continue our business as contemplated, and would have a material adverse
effect on our business, results of operations, financial condition, and prospects. In addition, if we were to become subject to the Investment
Company Act, any violation of the Investment Company Act could subject us to material adverse consequences, including potentially significant
regulatory penalties and the possibility that certain of our contracts would be deemed unenforceable. In such an event, there would be
no guarantee that we would be able to take actions to modify our operations to cease to be an investment company or to bring our operations
into compliance with the Investment Company Act. Furthermore, any steps we are able to take to ensure future compliance with the Investment
Company Act would not insulate us from liability for past violations. Any of these events could adversely affect our business, results
of operations, financial condition, and prospects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Dogecoin and other digital assets are subject
to significant legal and regulatory uncertainty that could materially impact the price of Dogecoin and our ability to hold, transfer,
or use Dogecoin.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dogecoin and other digital assets face significant
legal and regulatory uncertainty, which could materially impact their price and our ability to hold, transfer, stake, or use them. Regulators
in the United States and abroad continue to re-evaluate and update laws and regulations governing digital assets, with agencies such
as the SEC and the Commodity Futures Trading Commission (the &#8220;<span style="text-decoration: underline">CFTC</span>&#8221;) taking enforcement actions and proposing new
rules. Although some high-profile enforcement actions have been dismissed, the risk of future proceedings remains, which could affect
Dogecoin&#8217;s liquidity, value, or our ability to use it, and may result in substantial compliance costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Laws and regulations at the federal, state, and
international levels are evolving rapidly. Recent years have seen new executive orders, agency guidance, enforcement actions, and legislative
proposals aimed at clarifying the regulatory treatment of digital assets.&#160; For example, the Guiding and Establishing National Innovation
for U.S. Stablecoins Act (the &#8220;<span style="text-decoration: underline">GENIUS Act</span>&#8221;) was signed into law on July 18, 2025, establishing a federal regulatory
framework for payment stablecoins in the United States which are digital assets used, or designed to be used, as a means of payment and
are, among other things, convertible, redeemable or eligible for repurchase by the issuer for a fixed amount of monetary value.&#160;Under
the GENIUS Act, only permitted entities may issue payment stablecoins in the United States, subject to certain exceptions or safe harbors
adopted at the discretion of the Secretary of the Treasury. Although the GENIUS Act provides a level of regulatory clarity in the United
States, it remains to be seen how many stablecoins will actually qualify as payment stablecoins. To the extent stablecoins with a significant
market share do not qualify as payment stablecoins, the regulatory uncertainty and increased risk that comes with their use will remain
and could have a significant impact on the digital asset ecosystem (including Dogecoin). On July 17, 2025, the House of Representatives
passed the Digital Asset Market Clarity Act of 2025 (the &#8220;<span style="text-decoration: underline">CLARITY Act</span>&#8221;) which would establish a market structure for
digital assets, and, among other things, would divide regulatory authority between the SEC and the CFTC. However, until and unless the
CLARITY Act (or comparable legislation) is enacted, existing uncertainty regarding Dogecoin&#8217;s regulatory status will persist.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It is impossible to predict whether or when additional
laws, regulations, or court decisions will be adopted or how they will be interpreted. New or expanded regulations, enforcement actions,
or adverse judicial decisions could restrict our ability to buy, sell, lend, stake, or otherwise use Dogecoin, subject us to liability,
require registration or licensing, or increase compliance costs. As a result, our business, financial condition, and results of operations
and the market price of our securities could be materially and adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our Dogecoin treasury strategy will likely
subject us to enhanced regulatory oversight.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There has been increasing focus on the extent
to which digital assets can be used to launder the proceeds of illegal activities, fund criminal or terrorist activities, or circumvent
sanctions on regimes, including sanctions such as those imposed in response to the ongoing conflict between Russia and Ukraine. We plan
to implement and maintain policies and procedures reasonably designed to promote compliance with applicable anti-money laundering and
sanctions laws and regulations and only acquire our Dogecoin through entities subject to anti-money laundering regulation and related
compliance rules in the United States. Marco Margiotta, our Chief Investment Officer, will oversee compliance functions amongst other
responsibilities, and we may elect to identify others to serve in compliance roles to ensure appropriate oversight and compliance for
our digital asset treasury initiative. If we are found to have purchased any of our Dogecoin from bad actors that have used Dogecoin
to launder money or persons subject to sanctions, we may be subject to regulatory proceedings and any further transactions or dealings
in Dogecoin by us may be restricted or prohibited.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may incur indebtedness or enter into other
financial instruments in the future that may be collateralized by our Dogecoin holdings and/or may also consider pursuing strategies
to create income streams or otherwise generate funds using our Dogecoin holdings, in each case, to the extent permitted by applicable
law. These and any other Dogecoin-related transactions we may enter into, beyond simply acquiring and holding Dogecoin, may subject us
to additional regulatory compliance requirements and scrutiny, including under federal and state money services regulations, money transmitter
licensing requirements and various commodity and securities laws and regulations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Increased enforcement activity and changes in
the regulatory environment, including evolving or changing interpretations and the implementation of new or varying regulatory requirements
by the government or any new legislation affecting digital assets (and, in particular, Dogecoin), as well as enforcement actions involving
or impacting our trading venues, counterparties and custodians, may impose significant costs or significantly limit our ability to hold
and transact in Dogecoin.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, private actors that are wary of
digital assets (and, in particular, Dogecoin) or the regulatory concerns associated with digital assets (and, in particular, Dogecoin)
have in the past taken and may in the future take further actions that may have an adverse effect on our business or the market price
of our listed securities. For example, it is possible that a financial institution could restrict customers from buying our securities
if it were to determine that the value of our securities is closely tied to the performance of Dogecoin, signaling a reluctance to facilitate
exposure to virtual currencies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our Dogecoin asset holdings may not be
recognized as cash or financial assets under NYSE American listing standards, which could jeopardize our continued listing and adversely
affect the liquidity and market price of our class B common stock.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our holdings of Dogecoin assets may not be recognized
as cash or cash equivalents or as financial assets for purposes of meeting NYSE American&#8217;s continued listing standards, which could
adversely affect our ability to comply with such standards and result in the delisting of our class B common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under GAAP, digital assets such as Dogecoin are
not recognized as cash or cash equivalents and are not considered financial assets for purposes of meeting regulatory capital, liquidity,
or working capital requirements, including those required by NYSE American for continued listing. As a result, our Dogecoin holdings
do not count toward our cash and working capital balances for purposes of NYSE American&#8217;s continued listing standards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the value of our Dogecoin holdings declines
significantly, or if we are unable to access sufficient liquidity from other sources, we may be unable to meet our working capital requirements
or NYSE American&#8217;s continued listing standards, which could result in the delisting of our class B common stock. Furthermore, any
decrease in the fair value of Dogecoin below our carrying value could require us to incur a material impairment charge, which may negatively
impact our reported stockholders&#8217; equity and our ability to comply with NYSE American&#8217;s continued listing requirements. The
inability to count Dogecoin holdings toward required cash or working capital balances may also limit our flexibility in managing our
balance sheet and maintaining compliance with NYSE American&#8217;s rules, particularly during periods of digital asset price volatility
or market instability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we are unable to meet NYSE American&#8217;s
continued listing standards as a result of our Dogecoin holdings not being recognized as cash or financial assets, our class B common
stock could be delisted, which would have a material adverse effect on the liquidity and market price of our securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our Dogecoin treasury strategy could divert
resources and attention away from our business of developing and manufacturing cleaning products that produce pure aqueous ozone for
professional, industrial, or home use and adversely affect our operations.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have recently adopted a new Dogecoin treasury
strategy, pursuant to which we intend to raise significant capital and allocate a substantial portion of the proceeds to investments
in Dogecoin, a blockchain-based digital asset. This strategy represents a material shift from our historical focus on the development
and production of cleaning products that produce pure aqueous ozone for professional, industrial, or home use. As a result, a significant
portion of our newly raised capital will be allocated to Dogecoin investments rather than to our legacy business operations.&#160;Allocating
substantial resources to Dogecoin investments may divert financial and management attention away from our core cleaning solution business,
potentially resulting in the underinvestment and production of cleaning products, and commercialization efforts. This could impair our
ability to advance our product development or realize the anticipated benefits of our existing pipeline. In addition, the performance
of our Dogecoin investments is subject to significant volatility and uncertainty, and there can be no assurance that these investments
will generate positive returns or preserve capital. If our Dogecoin investments experience significant losses or fail to perform as expected,
our overall financial condition and liquidity could be adversely affected, which may further limit our ability to fund our legacy operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Moreover, the strategic shift in capital allocation
may create operational and strategic risks, including the potential for misalignment between our management team&#8217;s expertise and
the requirements of managing digital asset investments, as well as possible negative perceptions among our stakeholders, including investors,
partners, and regulators, regarding our commitment to our core legacy business. Any neglect or underinvestment in our legacy operations
could have a material adverse effect on our business, financial condition, results of operations, and prospects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The Option Agreement with our chief executive
officer could result in the disposition of the Legacy Business on terms that may not be favorable to the Company or our stockholders,
create significant conflicts of interest, and adversely affect our financial condition and future prospects.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Offering, we have entered
into the Option Agreement with our Chief Executive Officer, Clayton Adams. Under the Option Agreement, beginning on the date that is
one hundred eighty (180) days after the closing of the Offering and ending three years thereafter (subject to certain automatic extensions),
Mr. Adams possesses an irrevocable unilateral right to elect, in his sole discretion and without any further action by our stockholders,
to (i) cause us to spin-off all of our pre-existing Legacy Business, or (ii) purchase, or cause one or more designees to purchase, the
Legacy Business from us for an option price that is subject to a post-closing cash adjustment and is required only to be supported by
a third-party &#8220;fairness opinion.&#8221; Although consummating either alternative requires the approval of a majority of our independent
directors and the receipt of certain regulatory and other third-party consents, the Option Agreement nonetheless presents a number of
material risks to the Company and its stockholders, including the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><span style="text-decoration: underline">Potential
                                            Loss of Legacy Business and Revenue Streams</span>. If Mr. Adams exercises the option, we could
                                            permanently relinquish ownership of our Legacy Business, which currently represents our sole
                                            operating history, in exchange for consideration and terms that may prove inadequate relative
                                            to the value of those operations. Following either a spin-off or sale, our asset base, revenue
                                            profile and diversification would be materially reduced, leaving the Company almost entirely
                                            dependent on its digital asset treasury strategy and the performance of Dogecoin.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><span style="text-decoration: underline">Uncertain
                                            and Potentially Insufficient Consideration</span>. The option price for an outright sale will
                                            be negotiated only between Mr. Adams and the independent directors, need only be supported
                                            by a fairness opinion, and will be subject to downward post-closing adjustments if the Legacy
                                            Business does not hold a contractually specified level of cash. There is no assurance that
                                            the option price, or the implied valuation in a spin-off, will reflect the full fair market
                                            value of the Legacy Business or that the fairness opinion will adequately protect the interests
                                            of our unaffiliated stockholders.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><span style="text-decoration: underline">Conflicts
                                            of Interest</span>. Mr. Adams, as our Chief Executive Officer and a member of the Board, owes
                                            fiduciary duties to the Company, yet the Option Agreement affords him a personal opportunity
                                            to acquire or control the Legacy Business and to allocate up to 20% of the equity of any
                                            spin-off entity to himself, the Legacy Business management team, and other insiders. These
                                            dual roles may present inherent conflicts between Mr. Adams&#8217;s fiduciary duties to the
                                            Company and his personal financial interests in exercising the option on terms that are most
                                            favorable to him.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><span style="text-decoration: underline">Dilution
                                            of Governance Rights in Spin-Off Scenario</span>. If Mr. Adams elects the spin-off alternative,
                                            he will be entitled to designate a majority of the directors of the newly formed spin-off
                                            company and to serve as its Chief Executive Officer for at least one year, while the Company
                                            would have no continuing ownership or governance rights beyond its distribution of the spin-off
                                            company&#8217;s shares to existing stockholders. Accordingly, investors who retain the spin-off
                                            company&#8217;s shares will rely exclusively on Mr. Adams for the future strategic direction
                                            and performance of that entity.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><span style="text-decoration: underline">Unpredictable
                                            Timing and Market Impact</span>. Because Mr. Adams may exercise the option at any time during
                                            the three-year exercise window (subject to automatic extension under certain circumstances),
                                            the market cannot predict when, or if, the transaction will occur. Any announcement regarding
                                            the exercise of the option or the negotiation of transaction terms could create volatility
                                            in our stock price, disrupt our relationships with customers, suppliers, and employees of
                                            the Legacy Business, and adversely affect our ability to execute our strategic plans.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><span style="text-decoration: underline">Operational
                                            Distractions and Costs</span>. The Option Agreement obligates us to cooperate with Mr. Adams
                                            in effecting either a spin-off or sale, including undertaking potentially complex separation
                                            activities, negotiating definitive agreements, preparing financial statements of the Legacy
                                            Business, and obtaining numerous regulatory and third-party approvals. These efforts will
                                            require significant management attention and professional fees, which could divert resources
                                            from our core digital asset treasury initiative and negatively impact our operating results.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><span style="text-decoration: underline">Regulatory,
                                            Tax, and Execution Risks</span>. The spin-off is intended to qualify as tax-free under Section
                                            355 of the Internal Revenue Code, and the sale is conditioned on various regulatory approvals.
                                            However, there is no assurance that the required approvals will be obtained on a timely basis,
                                            that the spin-off will achieve its intended tax-free treatment, or that unforeseen liabilities
                                            will not arise in connection with either transaction, any of which could result in additional
                                            costs, taxes or penalties borne by the Company or our stockholders.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing risks could individually or in
the aggregate materially and adversely affect our financial condition, results of operations, cash flows and the value of your investment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We face risks relating to the custody of
Dogecoin, including the loss or destruction of private keys required to access Dogecoin and cyberattacks or other data loss relating
to Dogecoin, including smart contract related losses and vulnerabilities.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We plan to hold our Dogecoin with regulated custodians
that have duties to safeguard our private keys. Our custodial services contracts will not restrict our ability to reallocate our Dogecoin
among custodians, and our Dogecoin holdings may be concentrated with a single custodian. In light of the significant amount of Dogecoin
held as part of our treasury strategy we anticipate that we may continually seek to engage additional custodians to achieve a greater
degree of diversification in the custody of our Dogecoin as the extent of potential risk of loss is dependent, in part, on the degree
of diversification. However, multiple custodians may not be available or may not utilize suitable wallet infrastructure, cloud service
providers or software systems, which could increase systemic technology risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If there is a decrease in the availability of
digital asset custodians that we believe can safely custody our Dogecoin, for example, due to regulatory developments or enforcement
actions that cause custodians to discontinue or limit their services, we may need to enter into agreements that are less favorable or
take other measures to custody our Dogecoin, and our ability to seek a greater degree of diversification in the use of custodial services
would be materially adversely affected. While we will conduct due diligence on our custodians and any smart contract platforms we may
use, there can be no assurance that such diligence will uncover all risks, including operational deficiencies, hidden vulnerabilities
or legal noncompliance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any insurance that may cover losses of our Dogecoin
holdings may cover none or only a small fraction of the value of the entirety of our Dogecoin holdings, and there can be no guarantee
that such insurance will be maintained as part of the custodial services we have or that such coverage will cover losses with respect
to our Dogecoin. Moreover, our use of custodians exposes us to the risk that the Dogecoin our custodians hold on our behalf could be
subject to insolvency proceedings and we could be treated as a general unsecured creditor of the custodian, inhibiting our ability to
exercise ownership rights with respect to such Dogecoin. Any loss associated with such insolvency proceedings is unlikely to be covered
by any insurance coverage we may maintain related to our Dogecoin. The legal framework governing digital asset ownership and rights in
custodial or insolvency contexts remains uncertain and continues to evolve, which could result in unexpected losses, protracted recovery
processes or adverse treatment in insolvency proceedings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dogecoin is controllable only by the possessor
of both the unique public key and private key(s) relating to the local or online digital wallet in which the Dogecoin is held. While
the L1 blockchain ledger requires a public key relating to a digital wallet to be published when used in a transaction, private keys
must be safeguarded and kept private in order to prevent a third party from accessing the Dogecoin held in such wallet. To the extent
the private key(s) for a digital wallet are lost, destroyed, or otherwise compromised and no backup of the private key(s) is accessible,
neither we nor our custodians will be able to access the Dogecoin held in the related digital wallet. Furthermore, we cannot provide
assurance that our digital wallets, nor the digital wallets of our custodians held on our behalf, will not be compromised as a result
of a cyberattack. The Dogecoin and blockchain ledger, as well as other digital assets and blockchain technologies, have been, and may
in the future be, subject to security breaches, cyberattacks or other malicious activities. The public nature of our treasury strategy
may also increase the likelihood that malicious actors seek to make us and/or our counterparties a target.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As part of our treasury management strategy,
we may engage in staking, restaking, or other permitted activities that involve the use of &#8220;smart contracts&#8221; or decentralized
applications. The use of smart contracts or decentralized applications entails certain risks including risks stemming from the existence
of an &#8220;admin key&#8221; or coding flaws that could be exploited, potentially allowing a bad actor to issue or otherwise compromise
the smart contract or decentralized application, potentially leading to a loss of our Dogecoin. Like all software code, smart contracts
are exposed to risk that the code contains a bug or other security vulnerability, which can lead to loss of assets that are held on or
transacted through the contract or decentralized application. Smart contracts and decentralized applications may contain bugs, security
vulnerabilities or poorly designed permission structures that could result in the irreversible loss of Dogecoin or other digital assets.
Exploits, including those stemming from admin key misuse, admin key compromise, or protocol flaws, have occurred in the past and may
occur in the future. Certain employees or vendors may also be vulnerable to physical or psychological coercion, commonly referred to
as &#8220;wrench attacks,&#8221; as well as scams and social engineering tactics intended to obtain access to passwords or private cryptographic
keys, in order to then effectuate the unauthorized transfer or theft of digital assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our historical financial statements do
not reflect the potential variability in earnings that we may experience in the future relating to our Dogecoin holdings.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because we only recently initiated our Dogecoin
treasury strategy, our historical financial statements do not reflect the potential variability in earnings that we may experience in
the future from managing amounts of Dogecoin. The prices of digital assets have historically been subject to dramatic price fluctuations
and are highly volatile. In December 2023, the Financial Accounting Standards Board issued ASU 2023-08, &#8220;Intangibles-Goodwill and
Other-Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets,&#8221; which we are required to adopt under GAAP.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASU 2023-08 requires us to measure our Dogecoin
holdings at fair value in our statement of financial position, and to recognize gains and losses from changes in the fair value of our
Dogecoin in net income each reporting period. ASU 2023-08 also requires us to provide certain interim and annual disclosures with respect
to our Dogecoin holdings. As a result, volatility in our earnings may be significantly more than what we experienced in prior periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Unrealized fair value gains on our Dogecoin
holdings could cause us to become subject to the corporate alternative minimum tax under the Inflation Reduction Act of 2022.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The United States enacted the Inflation Reduction
Act of 2022 (&#8220;<span style="text-decoration: underline">IRA</span>&#8221;) in August 2022. Unless an exemption applies, the IRA imposes a 15% corporate alternative minimum
tax (&#8220;<span style="text-decoration: underline">CAMT</span>&#8221;) on a corporation with respect to an initial tax year and subsequent tax years, if the average annual
adjusted financial statement income for any consecutive three-tax-year period preceding the initial tax year exceeds $1 billion. On September
12, 2024, the Department of Treasury and the Internal Revenue Service issued proposed regulations with respect to the application of
the CAMT.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the implementation of our
Dogecoin treasury strategy, we expect to adopt ASU 2023-08. ASU 2023-08 requires us to measure our Dogecoin holdings at fair value in
our statement of financial position, with gains and losses from changes in the fair value of our Dogecoin recognized in net income each
reporting period. When determining whether we are subject to CAMT and when calculating any related tax liability for an applicable tax
year, the proposed regulations provide that, among other adjustments, our adjusted financial statement income must include this ratable
amount in addition to any unrealized gains or losses reported in the applicable tax year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accordingly, as a result of the enactment of
the IRA and our anticipated adoption of ASU 2023-08, unless the IRA is amended or the proposed regulations with respect to CAMT, when
finalized, are revised to provide relief (or other interim relief is granted), we could become subject to the CAMT in future tax years.
If we become subject to the CAMT, it could result in a material tax obligation that we would need to satisfy in cash, which could materially
affect our financial results, including our earnings and cash flow, and our financial condition. There are, however, significant net
operating losses for federal and state tax purposes that may be utilizable to offset these potential future CAMT liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Due to the unregulated nature and lack
of transparency surrounding the operations of many digital asset trading venues, digital asset trading venues may experience greater
fraud, security failures or regulatory or operational problems than trading venues for more established asset classes, which may result
in a loss of confidence in digital asset trading venues and adversely affect the value of Dogecoin.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Digital asset trading venues are relatively new
and, in many cases, unregulated. Furthermore, there are many digital asset trading venues which do not provide the public with significant
information regarding their ownership structure, management teams, corporate practices and regulatory compliance. As a result, the marketplace
may lose confidence in digital asset trading venues, including prominent exchanges that handle a significant volume of Dogecoin trading
and/or are subject to regulatory oversight, in the event one or more digital asset trading venues cease or pause for a prolonged period
the trading of Dogecoin or other digital assets, or experience fraud, significant volumes of withdrawal, security failures or operational
problems.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SEC alleged as part of its June 5, 2023,
complaint against Binance that Binance committed strategic and targeted &#8220;wash trading&#8221; through its affiliates to artificially
inflate the volume of certain digital assets traded on its exchange. The SEC has also brought actions against individuals and digital
asset market participants alleging that such persons artificially increased trading volumes in certain digital assets through wash trades,
or repeated buying and selling of the same assets in fictitious transactions to manipulate their underlying trading price. Such reports
and allegations may indicate that the digital asset market (and, in particular, the market for Dogecoin) is significantly smaller than
expected and that the United States makes up a significantly larger percentage of the digital asset market than is commonly understood.
Any actual or perceived wash trading in the digital asset market, and any other fraudulent or manipulative acts and practices, could
adversely affect the value of Dogecoin.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Negative perception, a lack of stability in the
broader digital asset markets and the closure, temporary shutdown or operational disruption of digital asset trading venues, lending
institutions, institutional investors, institutional miners, custodians, or other major participants in the Dogecoin ecosystem, due to
fraud, business failure, cybersecurity events, government-mandated regulation, bankruptcy, or for any other reason, may result in a decline
in confidence in Dogecoin and the broader digital asset ecosystem and greater volatility in the price of Dogecoin. For example, in 2022,
each of Celsius Network, Voyager Digital, Three Arrows Capital, FTX, and BlockFi filed for bankruptcy, following which digital assets
significantly declined. In addition, in June 2023, the SEC announced enforcement actions against Coinbase and Binance, two providers
of large trading venues for digital assets, which similarly was followed by a decrease in the market price of digital assets. These were
followed in November 2023, by an SEC enforcement action against Payward Inc. and Payward Ventures Inc., together known as Kraken, another
large trading venue for digital assets. While the complaint against Coinbase was dismissed in February 2025, the complaint against Payward
Inc. and Payward Ventures Inc. was dismissed with prejudice in March 2025, and the complaint against Binance was dismissed on May 29,
2025, the SEC or other regulatory agencies may initiate similar actions in the future. As the price of our listed securities may be significantly
affected by the value of our Dogecoin holdings, the failure of a major participant in the digital asset ecosystem could have a material
adverse effect on the market price of our listed securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The concentration of our Dogecoin holdings
could enhance the risks inherent in our Dogecoin treasury strategy.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The concentration of our Dogecoin holdings limits
the risk mitigation that we could achieve if we were to purchase a more diversified portfolio of assets within our treasury, and the
absence of diversification enhances the risks inherent in our Dogecoin treasury strategy. Any future significant declines in the price
of Dogecoin would have a more pronounced impact on our financial condition than if we used our cash to purchase a more diverse portfolio
of assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our Dogecoin holdings will be less liquid
than our cash and cash equivalents and may not be able to serve as a source of liquidity for us to the same extent as cash and cash equivalents.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Historically, the digital asset market has been
characterized by significant volatility in price, limited liquidity and trading volumes compared to other markets, relative anonymity,
a developing regulatory landscape, potential susceptibility to market abuse and manipulation, compliance and internal control failures
at exchanges, and various other risks inherent in its entirely electronic, virtual form and decentralized network. During times of market
instability, we may not be able to sell our Dogecoin at favorable prices or at all. As a result, our Dogecoin holdings may not be able
to serve as a source of liquidity for us to the same extent as cash and cash equivalents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, the Dogecoin we hold with our custodians
and transact with our trade execution partners does not enjoy the same protections as are available to cash or securities deposited with
or transacted by institutions subject to regulation by the Federal Deposit Insurance Corporation or the Securities Investor Protection
Corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, we may be unable to enter into
term loans or other capital raising transactions collateralized by our unencumbered Dogecoin or otherwise generate funds using our Dogecoin
holdings, including in particular during times of market instability or when the price of Dogecoin has declined significantly. If we
are unable to sell our Dogecoin, enter into additional capital raising transactions, including capital raising transactions using Dogecoin
as collateral, or otherwise generate funds using our Dogecoin holdings, or if we are forced to sell our Dogecoin at a significant loss,
in order to meet our working capital requirements, our business and financial condition could be negatively impacted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01 Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d) Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; width: 9%; padding-right: -5.1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Exhibit
    No.</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 90%"><span style="font-family: Times New Roman, Times, Serif"><b>Description
    of Exhibit</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">4.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ea025594401ex4-1_clean.htm">Form of Pre-Funded Warrant issued on September 5, 2025</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">4.2</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ea025594401ex4-2_clean.htm">Placement Agent Common Stock Purchase Warrant issued by CleanCore Solutions, Inc. to Maxim Group LLC on September 5, 2025</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">4.3</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ea025594401ex4-3_clean.htm">Placement Agent Common Stock Purchase Warrant issued by CleanCore Solutions, Inc. to Curvature Securities, LLC on September 5, 2025</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">4.4</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ea025594401ex4-4_clean.htm">Strategic Advisor Common Stock Purchase Warrant issued by CleanCore Solutions, Inc. to Dogecoin Ventures, Inc. on September 5, 2025</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">4.5</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ea025594401ex4-5_clean.htm">Strategic Advisor Common Stock Purchase Warrant issued by CleanCore Solutions, Inc. to Dogecoin Ventures, Inc. on September 5, 2025</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">10.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ea025594401ex10-1_clean.htm">Form of Securities Purchase Agreement (Cash), dated September 1, 2025</a> </span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">10.2</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ea025594401ex10-2_clean.htm">Form of Securities Purchase Agreement (Cryptocurrency), dated September 1, 2025</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">10.3</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ea025594401ex10-3_clean.htm">Placement Agency Agreement, dated September 1, 2025, among CleanCore Solutions, Inc., Maxim Group LLC and Curvature Securities, LLC</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">10.4</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ea025594401ex10-4_clean.htm">Form of Registration Rights Agreement, dated September 1, 2025</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">10.5</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ea025594401ex10-5_clean.htm">Asset Management Agreement, dated September 5, 2025, among CleanCore Solutions, Inc., Dogecoin Ventures, Inc. and 21Shares US LLC</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">10.6</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ea025594401ex10-6_clean.htm">Strategic Advisor Agreement, dated September 5, 2025, between CleanCore Solutions, Inc. and Dogecoin Ventures, Inc.</a> </span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">10.7</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ea025594401ex10-7_clean.htm">Option Agreement, dated September 5, 2025, between CleanCore Solutions, Inc. and Clayton Adams</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">10.8</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ea025594401ex10-8_clean.htm">Independent Director Agreement, dated September 5, 2025, between CleanCore Solutions, Inc. and Alexander Benjamin Spiro</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">10.9</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ea025594401ex10-9_clean.htm">Independent Director Agreement, dated September 5, 2025, between CleanCore Solutions, Inc. and Tim Stebbing</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">10.10</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ea025594401ex10-10_clean.htm">Indemnification Agreement, dated September 5, 2025, between CleanCore Solutions, Inc. and Alexander Benjamin Spiro</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">10.11</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ea025594401ex10-11_clean.htm">Indemnification Agreement, dated September 5, 2025, between CleanCore Solutions, Inc. and Tim Stebbing</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">10.12</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ea025594401ex10-12_clean.htm">Executive Consulting Agreement, dated September 5, 2025, between CleanCore Solutions, Inc. and Marco Margiotta</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">10.13</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ea025594401ex10-13_clean.htm">Indemnification Agreement, dated September 5, 2025, between CleanCore Solutions, Inc. and Marco Margiotta</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">10.14</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ea025594401ex10-14_clean.htm">Executive Employment Agreement, dated September 5, 2025, between CleanCore Solutions, Inc. and Clayton Adams</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">104</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cover Page Interactive Data File (embedded
    within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">Date: September 5, 2025</span></td>
    <td colspan="2"><span style="font-size: 10pt">CLEANCORE SOLUTIONS, INC.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">/s/ Clayton Adams</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 5%"><span style="font-size: 10pt">Name:&#160; </span></td>
    <td style="width: 35%"><span style="font-size: 10pt">Clayton Adams</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Title: </span></td>
    <td><span style="font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 20; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6PXSdf7g7HSriFBki3lYXpbg1I61/j+RbWjfEEAjJOV+OEKFY0FyXyHCY5hnssKpL5RByPCOjOaF3pMtVAn7meNHWsTKuWX9gSp5Bzww78ujvjfOuLRYJRONu1O/GA5Ay6Y1gshbBV0/JnHWBxmlVgjIFbJlq1ugUv9oPO/UkQ9WrSdojW00mAdmJWvkNcSRj2NBdPYivFrIsFUHYVCAWTLfau2ZPh+ZLwqzEysfZlv538AHF2kpS -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ea025594401ex4-1_clean.htm
<DESCRIPTION>FORM OF PRE-FUNDED WARRANT ISSUED ON SEPTEMBER 5, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PRE-FUNDED COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CLEANCORE SOLUTIONS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="font-size: 10pt">Warrant Shares: </TD>
    <TD STYLE="font-size: 10pt; text-align: right">Issue Date: September 5, 2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS PRE-FUNDED COMMON STOCK
PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, __________ or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) until this Warrant is exercised in full (the &ldquo;<U>Termination Date</U>&rdquo;),
to subscribe for and purchase from CleanCore Solutions, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), up to _________
shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of class B common stock of the Company, par value
0.0001 per share (the &ldquo;<U>Common Stock</U>&rdquo;). The purchase price of one share of Common Stock under this Warrant shall be
equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1. Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated September 1, 2025, among the Company and the several investors party thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2. Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a) <U>Exercise of Warrant</U>.
Notwithstanding any other provision in this Warrant, this Warrant shall not be exercised until the Company files an amendment to the Company&rsquo;s
articles of incorporation (the &ldquo;<U>Authorization Amendment</U>&rdquo;), duly adopted and filed with the Nevada Secretary of State,
that increases the number of authorized shares of Common Stock to a level sufficient to permit the issuance of all securities contemplated
under the Purchase Agreement. Exercise of the purchase rights represented by this Warrant (i) will occur automatically upon the later
to occur of (x) the date of effectiveness of the Stockholder Approval (as defined in the Purchase Agreement) and (y) the date of effectiveness
of the Authorization Amendment (the &ldquo;<U>Automatic Exercise Date</U>&rdquo;), with such automatic exercise to be effected based on
exercise amounts previously funded to the Company, or, in the event such amounts have not been funded, on a cashless basis, subject to
the limitations set forth in Section 2(e), without the requirement to deliver a Notice of Exercise (as defined below), and the Automatic
Exercise Date shall be deemed to be the date on which the Holder delivered to the Company a Notice of Exercise with respect to such automatic
exercise, and (ii)] may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the
Termination Date by delivery to the Company of a duly executed facsimile copy or PDF or Docusign copy submitted by e-mail (or e-mail attachment)
of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) one (1)
Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following
the date the Holder delivers the Notice of Exercise, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified
in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise
procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder
has purchased all of the Warrant Shares available hereunder and this Warrant has been exercised in full, in which case, the Holder shall
surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise
is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares
available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal
to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant
Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Trading
Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of
the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available
for purchase hereunder at any given time may be less than the amount stated on the face hereof. For purposes hereof, a &ldquo;Trading
Day&rdquo; is a day on which the Common Stock is traded on a Trading Market (and if the Common Stock is not then listed or quoted on a
Trading Market, Trading Day means a Business Day).</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b) <U>Exercise Price</U>.
The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the
Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price
of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder
shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance
or for any reason whatsoever. The remaining unpaid exercise price per Warrant Share under this Warrant shall be $0.0001, subject to adjustment
hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c) <U>Cashless Exercise</U>.
This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder
shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.1in"></TD><TD STYLE="width: 0.5in; text-align: left">(A) = </TD><TD STYLE="text-align: justify">as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section
2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior
to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of
the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P.
(&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of
Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including
until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii)
the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of
Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such
Trading Day;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1in"></TD><TD STYLE="width: 0.5in">(B) =</TD><TD STYLE="text-align: justify">the Exercise Price of this Warrant, as adjusted hereunder; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.1in"></TD><TD STYLE="width: 0.5in; text-align: left">(X) = </TD><TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon exercise
of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless
exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">If Warrant Shares are issued
in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant
Shares shall take on the characteristics of this Warrant being exercised, and the holding period of the Warrant Shares being issued may
be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market other than the OTCQB or OTCQX, the bid price of the Common Stock for the time in question (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the holders of a majority in interest of the Pre-Funded Warrants then outstanding and reasonably acceptable to the Company, the
reasonable fees and expenses of which shall be paid by the Company.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&ldquo;<U>VWAP</U>&rdquo; means,
for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted
on a Trading Market other than the OTCQB or OTCQX, the daily volume weighted average price of the Common Stock for such date (or the nearest
preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading
Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Pre-Funded Warrants then outstanding and reasonably acceptable
to the Company, the reasonable fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock are listed or quoted for trading on the date in question: the
New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq Capital Market, the
OTCQX, or the OTCQB.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d) <U>Mechanics of Exercise.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) <U>Delivery of Warrant
Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the
Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through
its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either
(A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the
Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144
(assuming cashless exercise of this Warrant), and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share
register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such
exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of (i) one (1) Trading Day after
the delivery to the Company of the Notice of Exercise, and (ii) the number of Trading Days comprising the Standard Settlement Period after
the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery
of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares
with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment
of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) one (1) Trading
Day and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the
Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery
Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject
to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing
to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant
Share Delivery Date until such Warrant Shares are delivered or the Holder rescinds such exercise. The Company agrees to maintain a transfer
agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard
Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary
Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing,
with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York City time) on the Initial Exercise Date, which
may be delivered at any time after the time of execution of the Purchase Agreement, the Company agrees to use commercially reasonable
efforts to deliver, or cause to be delivered, the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial
Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of
the aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date. Any portion
of this Warrant that has not previously been exercised as of the Automatic Exercise Date shall be automatically exercised as of such Automatic
Exercise Date pursuant to a cashless exercise, subject to the limitations set forth in Section 2(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) <U>Delivery of New Warrants
Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender
of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights
of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be
identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii) <U>Rescission Rights</U>.
If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant
Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv) <U>Compensation for Buy-In
on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if the Company
fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above
pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely due to any action or
inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase (in an
open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction
of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of this Warrant and equivalent number of Warrant Shares for which such exercise was not honored and return any amount received
by the Company in respect of the Exercise Price for those Warrant Shares (in which case such exercise shall be deemed rescinded) or deliver
to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery
obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with
respect to an attempted exercise of this Warrant with an aggregate sale price giving rise to such purchase obligation of $10,000, under
clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the
Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence
of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder,
at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s
failure to timely deliver Warrant Shares upon exercise of this Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v) <U>No Fractional Shares
or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any
fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either
pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round
up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vi) <U>Charges, Taxes and
Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vii) <U>Closing of Books</U>.
The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant
to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(e) <U>Holder&rsquo;s Exercise
Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion
of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth
on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting as a group
together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially
own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares
of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of Warrant Shares
issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of Warrant
Shares which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder
or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other
securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or
exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.
Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance
with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that
the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder
is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this
Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the
Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable
(in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this
Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify
or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined
in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section
2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common
Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B)
a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth
the number of shares of Common Stock outstanding (the &ldquo;<U>Reported Outstanding Share Number</U>&rdquo;). Upon the written or oral
request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall
be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of the Common Stock outstanding
immediately after giving effect to the issuance of Warrant Shares issuable upon exercise of this Warrant. The Holder, upon notice to the
Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership
Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance
of Warrant Shares upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any
increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company.
If the Company receives a Notice of Exercise from the Holder at a time when the actual number of outstanding shares of Common Stock is
less than the Reported Outstanding Share Number, the Company shall notify the Holder in writing of the number of shares of Common Stock
then outstanding and, to the extent that such Notice of Exercise would otherwise cause the beneficial ownership of Holder together with
the Attribution Parties, as determined pursuant to this Section 2(e), to exceed the Beneficial Ownership Limitation, the Holder shall
then notify the Company of a reduced number of Warrant Shares to be purchased pursuant to such Notice of Exercise (such notice, the &ldquo;<U>Reduction
Notice</U>&rdquo;). Such issuance shall not be deemed to have occurred until the Holder provides the Reduction Notice (or a notice that
no reduction is needed) to the Company. In the event that the issuance of Common Stock to the Holder upon exercise of this Warrant results
in the Holder, together with the Attribution Parties, collectively being deemed to beneficially own, in the aggregate, more than the Beneficial
Ownership Limitation, the number of shares so issued by which the aggregate beneficial ownership of the Holder and its Attribution Parties
exceeds such limitation (the &ldquo;<U>Excess Shares</U>&rdquo;) shall be deemed null and void and shall be cancelled ab initio, and the
Holder and/or the Attribution Parties shall not have the power to vote or to transfer the Excess Shares. As soon as reasonably practicable
after the issuance of the Excess Shares has been deemed null and void, the Company shall return to the Holder the exercise price paid
by the Holder for the Excess Shares and the Holder shall return the Excess Shares to the Company. The provisions of this paragraph shall
be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph
(or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to
make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(f) <U>Exchange Cap</U>. Notwithstanding
any other provision herein, the Company shall not be obligated to issue any shares of Common Stock upon exercise of this Warrant if the
issuance of such shares of Common Stock would exceed any cap or limitation on the number of shares (the &ldquo;<U>Exchange Cap&rdquo;</U>)
imposed by the rules or regulations of the Trading Market, if and to the extent applicable, except that such limitation shall not apply
in the event that the Company (i) obtains the approval of its stockholders as required by applicable rules and regulations of the Trading
Market for issuances of Common Stock in excess of the Exchange Cap, or (ii) obtains a written opinion from outside counsel to the Company
that such approval is not required. Until such approval or written opinion is obtained, no Holder of this Warrant shall be issued, upon
exercise this Warrant, shares of Common Stock in an amount that, when added to all Securities issued to such Holder, is greater than the
product of (x) the Exchange Cap amount multiplied by (y) a fraction, the numerator of which is the total number of Shares and shares of
Common Stock underlying this Warrant issued to such Holder pursuant to the Purchase Agreement on the Closing Date and the denominator
of which is the aggregate number of Shares and shares of Common Stock underlying all Pre-Funded Warrants issued to all Purchasers pursuant
to the Purchase Agreement (the &ldquo;<U>Cap Allocation Amount&rdquo;</U>). In the event that the Holder shall sell or otherwise transfer
any portion of this Warrant, the transferee shall be allocated a pro rata portion of the Holder&rsquo;s Cap Allocation Amount. In the
event that the Holder shall exercise all of this Warrant into a number of shares of Common Stock that, in the aggregate, is less than
the Holder&rsquo;s Cap Allocation Amount, then the difference between the Holder&rsquo;s Cap Allocation Amount and the number of shares of Common
Stock actually issued to such Holder shall be allocated to the remaining holders of Pre-Funded Warrants on a pro rata basis in proportion
to the shares of Common Stock underlying the Pre-Funded Warrants then held by each such holder. For the avoidance of doubt, the restrictions
of this Section 2(f) would no longer apply upon the receipt of the Stockholder Approval and the effectiveness of the Authorization Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(g) <U>Restrictive Legends</U>.
If all or any portion of a Warrant is exercised at a time (i) while a registration statement covering the resale of the Warrant Shares
is effective under the Securities Act, (ii) following any sale of such Warrant Shares pursuant to Rule 144 (assuming cashless exercise
of this Warrant) and the Company is then in compliance with the current public information required under Rule 144, (iii) if such Warrant
Shares are eligible for sale under Rule 144 (assuming cashless exercise of this Warrant) without volume or manner-of-sale restrictions,
(iv) if at any time on or after the date hereof the Holder certifies that it is not an &ldquo;affiliate&rdquo; of the Company (as such
term is used under Rule 144) and that the Holder&rsquo;s holding period for purposes of Rule 144 is at least six (6) months, or (v) if
such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements
issued by the staff of the Commission), the Warrant Shares issued upon such exercise shall be issued free of all legends. If at any time
following the date hereof a registration statement registering the resale of the Warrant Shares is not effective or is not otherwise available
for the resale of the Warrant Shares, the Company shall promptly notify the holders of the Pre-Funded Warrants in writing that such registration
statement is not then effective and thereafter shall promptly notify such holders when the registration statement is effective again and
available for the resale of the Warrant Shares (it being understood and agreed that the foregoing shall not impair the ability of the
Company to comply with applicable federal and state securities laws).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3. Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a) <U>Stock Dividends and
Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution
or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which,
for avoidance of doubt, shall not include any Warrant Shares issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding
shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of
Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock
of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares
of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the
number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant
shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant
to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive
such dividend or distribution, provided, however, that if such record date shall have been fixed and such dividend is not fully paid on
the date fixed therefor, the number of shares issuable upon exercise of this Warrant shall be recomputed accordingly as of the close of
business on such record date and thereafter the number of shares issuable upon exercise of this Warrant shall be adjusted pursuant to
this paragraph as of the time of actual payment of such dividends, and shall become effective immediately after the effective date in
the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b) <U>Subsequent Rights Offerings</U>.
In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents
or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock
(the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights,
the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Warrant Shares acquirable upon
complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights,
or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant,
issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to the extent that the Holder&rsquo;s right to participate
in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled
to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase
Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its
right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c) <U>Pro Rata Distributions</U>.
During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets
(or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation,
any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement,
scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant,
then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have
participated therein if the Holder had held the number of Warrant Shares acquirable upon complete exercise of this Warrant (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of
Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, that, to the extent that
the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then
the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common
Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit
of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d) <U>Fundamental Transaction</U>.
If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects
any merger or consolidation of the Company with or into another Person (excluding a merger effected solely to change the Company&rsquo;s
name), (ii) the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment,
transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii)
any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant
to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has
been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more
related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange
pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company,
directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination
(including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or
group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (each a &ldquo;<U>Fundamental
Transaction</U>&rdquo;); provided, however, no transaction contemplated under the Option Agreement (as defined in the Purchase Agreement)
shall be considered a Fundamental Transaction, then, upon any subsequent exercise of this Warrant, the Holder shall have the right to
receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number
of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional
consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of
the number of Warrant Shares for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to
any limitation in Section 2(e) on the exercise of this Warrant) (the &ldquo;<U>Fundamental Transaction Rights</U>&rdquo;). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the
Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any
different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property
to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives
upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations
of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant
to written agreements prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange
for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this
Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent
to the Warrant Shares acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this
Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of
capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the
value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting
the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction). Upon the occurrence of any
such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental
Transaction, the provisions of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead
to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company
under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company
herein; provided, however, that to the extent that the Holder&rsquo;s right to participate in any such Fundamental Transaction Rights
would result in the Holder and its Attribution Parties, collectively, beneficially owning in excess of the Beneficial Ownership Limitation
of the Common Stock that would be issued and outstanding following receipt of such Fundamental Transaction Rights (such excess amount
of Common Stock, the &ldquo;<U>Excess Fundamental Transaction Rights</U>&rdquo;), then the Holder shall not be entitled to participate
in such Fundamental Transaction Rights to the extent of the Excess Fundamental Transaction Rights (and shall not have the right to acquire
such Excess Fundamental Transaction Rights). The Excess Fundamental Transaction Rights shall be held in abeyance for the benefit of the
Holder until such time or times as (1) its right to receive some or all of the Excess Fundamental Transaction Rights would not result
in the Holder and its Attribution Parties beneficially owning Common Stock in excess of the Beneficial Ownership Limitation and (2) the
Holder so certifies in writing to the Company and specifies the number of shares of Common Stock it is able to receive without exceeding
the Beneficial Ownership Limitation, at which time or times the Holder shall be granted that portion of the Excess Fundamental Transaction
Rights (and any Excess Fundamental Transaction Rights granted, issued or sold on such initial Fundamental Transaction Rights or on any
subsequent Fundamental Transaction Rights to be held similarly in abeyance) to the same extent as if there had been no such limitation.
For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless of whether
the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(e) <U>Calculations</U>. All
calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(f) <U>Notice to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) <U>Adjustment to Exercise
Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to
the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) <U>Notice to Allow Exercise
by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company
shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting
to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any
rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock,
any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of all or substantially
all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or
(E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then,
in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address
as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date
hereinafter specified, a notice (unless such information is filed with the Commission, in which case a notice shall not be required) stating
(x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a
record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of
record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in
the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that
any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain
entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(g) <U>Voluntary Adjustment
By Company</U>. The Company may at any time during the term of this Warrant, with the prior written consent of the Holder, reduce the
then current Exercise Price to any amount for any period of time deemed appropriate by the Board of Directors of the Company unless such
reduction would result in the Company violating any rules of its principal Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(h) <U>Redemption Right</U>.
In the event that the Authorization Amendment is not effective within ninety (90) days from the date hereof, the Holder shall have the
right, exercisable for a period of fifteen (15) business days following such date to require the Company to (i) redeem this Warrant at
a per Pre-Funded Warrant redemption price equal to the Per Share Purchase Price minus the exercise price of the Pre-Funded Warrants and
(ii) pay the amount of any unpaid liquidated damages owed (if any) to the Holder, payable in the case of each of foregoing clause (i)
or (ii), in cash in the same proportion and form as the Holder shall have paid the Per Share Purchase Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4. Transfer of
Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4.1 of the Purchase Agreement, this
Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon
surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant
substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer
taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver
a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified
in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned,
and this Warrant shall promptly be cancelled. The Holder shall surrender this Warrant to the Company within three (3) Trading Days of
the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. This Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b) <U>New Warrants</U>. This
Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with
a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.
Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute
and deliver a new Warrant or Warrants in exchange for this Warrant or Warrants to be divided or combined in accordance with such notice.
All Warrants issued on transfers or exchanges shall be dated the original Issue Date and shall be identical with this Warrant except as
to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c) <U>Warrant Register</U>.
The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant Register</U>&rdquo;),
in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the
absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual
notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d) <U>Transfer Restrictions</U>.
If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not
be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities
or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements
pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant,
as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(e) <U>Representation by the
Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof,
will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling
such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to
sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5. Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a) <U>No Rights as Stockholder
Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as
a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.
Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to Section 2(c) or to
receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event including if the Company is for any reason
unable to issue and deliver Warrant Shares upon exercise of the this Warrant as required pursuant to the terms hereof, shall the Company
be required to net cash settle an exercise of this Warrant or cash settle in any other form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b) <U>Loss, Theft, Destruction
or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the
loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft
or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of this Warrant, shall not include the posting
of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver
a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c) <U>Saturdays, Sundays,
Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d) <U>Authorized Shares</U>.
On or prior to the date hereof, the Company has obtained the written consent of the holders of a majority of its outstanding Common Stock
regarding the Authorization Amendment and has filed the definitive Schedule 14C information statement providing notice of the Authorization
Amendment and will use its best efforts to respond to any comments received from the Commission as soon as practicable. The Company shall
file the Authorization Amendment with the Secretary of State of Nevada no later than the 21<SUP>st</SUP> day after the mailing of the
Schedule 14C information statement. From and after the date of the filing of the Authorization Amendment, the Company covenants that,
during the period this Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares
to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants
that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary
Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be
necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or
of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which
may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue). If the Authorization Amendment is not effective within 30 days following the Issue
Date of this Warrant (any such failure or breach being referred to as an &ldquo;<U>Event</U>&rdquo;, and the date on which such Event
occurs, being referred to as the <U>&ldquo;Event Date</U>&rdquo;), then, in addition to any other rights the Holder may have hereunder
or under applicable law, on the Event Date and on each monthly anniversary of each such Event Date (if the applicable Event shall not
have been cured by such date) until the applicable Event is cured, the Company shall pay to the Holder an amount in cash, as partial liquidated
damages and not as a penalty, equal to $1,000 per day for such failure. If the Company fails to pay any partial liquidated damages pursuant
to this Section in full within seven (7) days after the date payable, the Company will pay interest thereon at a rate of 18% per annum
(or such lesser maximum amount that is permitted to be paid by applicable law) to the Holder, accruing daily from the date such partial
liquidated damages are due until such amounts, plus all such interest thereon, are paid in full. The partial liquidated damages pursuant
to the terms hereof shall apply on daily pro rata basis for any portion of a month prior the cure of an Event. Except and to the extent
as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant. Before taking any action which would result in an adjustment in the
number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations
or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(e) <U>Jurisdiction</U>. All
questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with
the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(f) <U>Restrictions</U>. The
Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize
cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(g) <U>Nonwaiver and Expenses</U>.
No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right
or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this Warrant or the Purchase
Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts
due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(h) <U>Notices</U>. Any notice,
request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance
with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(i) <U>Limitation of Liability</U>.
No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no
enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of
any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(j) <U>Remedies</U>. The Holder,
in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance
of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by
reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for
specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(k) <U>Successors and Assigns</U>.
Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and
be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions
of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder
or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(l) <U>Amendment</U>. This
Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(m) <U>Severability</U>. Wherever
possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if
any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent
of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(n) <U>No Expense Reimbursement</U>.
The Holder shall in no way be required to pay, or to reimburse the Company for, any fees or expenses of the Transfer Agent in connection
with the issuance or holding or sale of Common Stock, this Warrant and/or Warrant Shares. The Company shall solely be responsible for
any and all such fees and expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(o) <U>Headings</U>. The headings
used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><B>CLEANCORE SOLUTIONS, INC.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 60%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Name:&nbsp;</TD>
    <TD STYLE="text-align: justify">Clayton Adams</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="text-align: justify">Chief Executive Officer</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TO: CLEANCORE SOLUTIONS, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The undersigned hereby elects
to purchase ______________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and
tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment shall take the form
of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
in lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please issue said Warrant
Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 1pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black">(4)
<U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Rule 501(a) of Regulation D promulgated
under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 40%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Name of Holder)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Signature)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Name of Authorized Signatory)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Title of Authorized Signatory)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Date)</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 11pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Address:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phone Number:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 40%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Name of Holder)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Signature)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Name of Authorized Signatory)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Title of Authorized Signatory)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Date)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ea025594401ex4-2_clean.htm
<DESCRIPTION>PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT ISSUED BY CLEANCORE SOLUTIONS, INC. TO MAXIM GROUP LLC ON SEPTEMBER 5, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CLEANCORE SOLUTIONS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="font-size: 10pt">Warrant Shares: 3,150,008</TD>
    <TD STYLE="font-size: 10pt; text-align: right">Issue Date: September 5, 2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS PLACEMENT AGENT COMMON
STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, Maxim Partners LLC or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) until September 5, 2030 (the &ldquo;<U>Termination Date</U>&rdquo;),
to subscribe for and purchase from CleanCore Solutions, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), 3,150,008 shares
(as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of class B common stock of the Company, par value 0.0001
per share (the &ldquo;<U>Common Stock</U>&rdquo;). The purchase price of one share of Common Stock under this Warrant shall be equal to
the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain Placement Agency Agreement, dated
as of September 1, 2025, by and among the Company, Maxim Group LLC and Curvature Securities LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1. Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated September 1, 2025, among the Company and the several investors party thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2. Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a) <U>Exercise of Warrant</U>.
Notwithstanding any other provision in this Warrant, this Warrant shall not be exercised until the Company files an amendment to the Company&rsquo;s
articles of incorporation (the &ldquo;<U>Authorization Amendment</U>&rdquo;), duly adopted and filed with the Nevada Secretary of State,
that increases the number of authorized shares of Common Stock to a level sufficient to permit the issuance of all securities contemplated
under the Purchase Agreement. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile
copy or PDF or Docusign copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice
of Exercise</U>&rdquo;). Within the earlier of (i) two (2) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement
Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise
Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United
States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.
No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of
any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date
on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion
of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree
that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of
Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof. For purposes
hereof, a &ldquo;Trading Day&rdquo; is a day on which the Common Stock is traded on a Trading Market.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b) <U>Exercise Price</U>.
The initial exercise price per share of Common Stock under this Warrant shall be $1.33, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c) <U>Cashless Exercise</U>.
Subject to Section 2(a), (e), and (f), if at any time after the Issue Date there is no effective registration statement registering the
Warrant Shares, as required pursuant to the terms and conditions of the Registration Rights Agreement, or the prospectus contained therein
is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part, at
any such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares
equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 81pt"></TD><TD STYLE="width: 27pt; text-align: left">(A) = </TD><TD STYLE="text-align: justify">as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section
2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior
to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of
the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P.
(&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of
Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including
until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii)
the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of
Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such
Trading Day;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 81pt"></TD><TD STYLE="width: 27pt">(B) =</TD><TD STYLE="text-align: justify">the Exercise Price of this Warrant, as adjusted hereunder; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 81pt"></TD><TD STYLE="width: 27pt; text-align: left">(X) = </TD><TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon exercise
of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless
exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">If Warrant Shares are issued
in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant
Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant Shares being issued may
be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market other than the OTCQB or OTCQX, the bid price of the Common Stock for the time in question (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the reasonable
fees and expenses of which shall be paid by the Company.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&ldquo;<U>VWAP</U>&rdquo; means,
for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted
on a Trading Market other than the OTCQB or OTCQX, the daily volume weighted average price of the Common Stock for such date (or the nearest
preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading
Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company,
the reasonable fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock are listed or quoted for trading on the date in question: the
New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq Capital Market, the
OTCQX, or the OTCQB.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d) <U>Mechanics of Exercise.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) <U>Delivery of Warrant
Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the
Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through
its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either
(A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the
Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144
(assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share
register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such
exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Day
after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to
the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice
of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;); <U>provided</U>, <U>however</U>, that if payment of the
aggregate Exercise Price is received after 12:00 P.M., New York City time on the Warrant Share Delivery Date, then the Warrant Share Delivery
Date shall be extended by one (1) additional Trading Day. Upon delivery of the Notice of Exercise, the Holder shall be deemed for all
corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective
of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless
exercise) is received within the earlier of (i) two (2) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement
Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject
to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not
as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin
to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or the Holder rescinds
such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains
outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed
in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of
delivery of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to
12:00 p.m. (New York City time) on the Initial Exercise Date, which may be delivered at any time after the time of execution of the Purchase
Agreement, the Company agrees to use commercially reasonable efforts to deliver, or cause to be delivered, the Warrant Shares subject
to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share
Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise)
is received by such Warrant Share Delivery Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) <U>Delivery of New Warrants
Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender
of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights
of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be
identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii) <U>Rescission Rights</U>.
If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant
Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv) <U>Compensation for Buy-In
on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if the Company
fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above
pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely due to any action or
inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase (in an
open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction
of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay
the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the
Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue
any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&rsquo;s failure to timely deliver Warrant Shares upon exercise of the Warrant as required
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v) <U>No Fractional Shares
or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any
fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either
pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round
up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vi) <U>Charges, Taxes and
Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vii) <U>Closing of Books</U>.
The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant
to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(viii) <U>Restrictive Legend</U>.
The Holder acknowledges that the Warrant Shares acquired upon exercise of this Warrant may not have been registered under the Securities
Act, or applicable state securities laws, and, unless so registered, the Warrant Shares will be issued as restricted securities. The Company
shall place a customary restrictive legend on any certificate or book-entry position representing the Warrant Shares. The Company agrees
to remove such legend (or cause it to be removed) from any Warrant Shares issued upon exercise of this Warrant if such shares are sold
pursuant to an effective registration statement under the Securities Act or at such time as such shares may be sold without restriction
under Rule 144 under the Securities Act, including without limitation, any volume or manner of sale restrictions, and the Company has
received such customary representations and other documentation as it may reasonably request to confirm compliance with this provision.
Notwithstanding the foregoing, if at any time such Warrant Shares are not freely tradable (due to the resale registration statement no
longer being effective or valid for use or any other reason), then the Company shall be able to add such legend back onto the Warrant
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(e) <U>Holder&rsquo;s Exercise
Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion
of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth
on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting as a group
together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially
own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares
of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of Warrant Shares
issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of Warrant
Shares which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder
or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other
securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or
exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.
Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance
with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that
the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder
is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this
Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the
Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable
(in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this
Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify
or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined
in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section
2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common
Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B)
a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth
the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one Trading Day
confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this
Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common
Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon election by a Holder prior to the
issuance of any Warrants, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance
of Warrant Shares issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial
Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the
number of shares of the Common Stock outstanding immediately after giving effect to the issuance of Warrant Shares upon exercise of this
Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation
will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any
portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes
or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply
to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(f) <U>Exchange Cap</U>. Notwithstanding
any other provision herein, the Company shall not be obligated to issue any shares of Common Stock upon exercise of this Warrant if the
issuance of such shares of Common Stock would exceed any cap or limitation on the number of shares (the &ldquo;<U>Exchange Cap&rdquo;</U>)
imposed by the rules or regulations of the Trading Market, if and to the extent applicable, except that such limitation shall not apply
in the event that the Company (i) obtains the approval of its stockholders as required by applicable rules and regulations of the Trading
Market for issuances of Common Stock in excess of the Exchange Cap, or (ii) obtains a written opinion from outside counsel to the Company
that such approval is not required. Until such approval or written opinion is obtained, no Holder of this Warrant shall be issued, upon
exercise this Warrant, shares of Common Stock in an amount that, when added to all Securities issued to such Holder, is greater than the
product of (x) the Exchange Cap amount multiplied by (y) a fraction, the numerator of which is the number of Warrant Shares issuable upon
exercise to such Holder pursuant to this Warrant and the denominator of which is the aggregate amount of all the Warrant Shares issuable
upon exercise to the Holders of all Warrants issued under the Purchase Agreement, the Strategic Advisor Agreement, the Placement Agency
Agreement or any other Transaction Document (the &ldquo;<U>Cap Allocation Amount&rdquo;</U>). In the event that the Holder shall sell
or otherwise transfer any portion of this Warrant, the transferee shall be allocated a pro rata portion of the Holder&rsquo;s Cap Allocation
Amount. In the event that the Holder shall exercise all of this Warrant into a number of shares of Common Stock that, in the aggregate,
is less than the Holder&rsquo;s Cap Allocation Amount, then the difference between the Holder&rsquo;s Cap Allocation Amount and the number of shares
of Common Stock actually issued to such Holder shall be allocated to the respective Cap Allocation Amounts of the Holders on a pro rata
basis in proportion to the number of Warrant Shares issuable upon exercise then held by the Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3. Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a) <U>Stock Dividends and
Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution
or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which,
for avoidance of doubt, shall not include any Warrant Shares issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding
shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of
Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock
of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares
of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the
number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant
shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant
to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive
such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination
or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b) <U>Subsequent Rights Offerings</U>.
In addition to any adjustments pursuant to Sections 3(a) or 3(b) above, if at any time the Company grants, issues or sells any Common
Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares
of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable to
such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Warrant
Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation,
the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase
Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the
grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to the extent that the Holder&rsquo;s right to participate
in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled
to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase
Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its
right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c) <U>Pro Rata Distributions</U>.
During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets
(or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation,
any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement,
scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant,
then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have
participated therein if the Holder had held the number of Warrant Shares acquirable upon complete exercise of this Warrant (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of
Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, that, to the extent that
the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then
the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common
Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit
of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d) <U>Fundamental Transaction</U>.
If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects
any merger or consolidation of the Company with or into another Person (excluding a merger effected solely to change the Company&rsquo;s
name), (ii) the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment,
transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii)
any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant
to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has
been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more
related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange
pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company,
directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination
(including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or
group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any
shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons
making or party to, such stock or share purchase agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;);
provided, however, no transaction contemplated under the Option Agreement (as defined in the Purchase Agreement) shall be considered a
Fundamental Transaction, then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant
Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option
of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the
&ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of Warrant
Shares for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section
2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately
adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common
Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable
manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given
any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same
choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company
shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;)
to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the
provisions of this Section 3(d) pursuant to written agreements prior to such Fundamental Transaction and shall, at the option of the Holder,
deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor
Entity (or its parent entity) equivalent to the Warrant Shares acquirable and receivable upon exercise of this Warrant (without regard
to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction). Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so
that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring
to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall
assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor
Entity had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(e) <U>Calculations</U>. All
calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(f) <U>Notice to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) <U>Adjustment to Exercise
Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to
the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) <U>Notice to Allow Exercise
by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company
shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting
to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any
rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock,
any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of all or substantially
all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or
(E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then,
in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address
as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date
hereinafter specified, a notice (unless such information is filed with the Commission, in which case a notice shall not be required) stating
(x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a
record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of
record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in
the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that
any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain
entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(g) <U>Voluntary Adjustment
By Company</U>. The Company may at any time during the term of this Warrant, with the prior written consent of the Holder, reduce the
then current Exercise Price to any amount for any period of time deemed appropriate by the Board of Directors of the Company unless such
reduction would result in the Company violating any rules of its principal Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4. Transfer of
Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a) <U>Transferability</U>.
Subject to FINRA Rule 5110(e), this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. The Holder shall surrender this Warrant to the Company within three (3) Trading
Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly
assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b) <U>New Warrants</U>. This
Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with
a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.
Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute
and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice.
All Warrants issued on transfers or exchanges shall be dated the original Issue Date and shall be identical with this Warrant except as
to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c) <U>Warrant Register</U>.
The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant Register</U>&rdquo;),
in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the
absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual
notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d) <U>Transfer Restrictions</U>.
If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not
be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities
or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements
pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant,
as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(e) <U>Representation by the
Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof,
will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling
such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to
sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5. Registration
Rights. </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a) To the extent the Company
does not maintain an effective registration statement for the Warrant Shares and in the further event that the Company files a registration
statement with the Commission covering the sale of its shares of Common Stock (other than a registration statement on Form S-4 or S-8,
or on another form, or in another context, in which such &ldquo;piggyback&rdquo; registration would be inappropriate), then, for a period
of five (5) years from the commencement of sales of the offering, the Company shall give written notice of such proposed filing to the
Holder as soon as practicable but in no event less than ten (10) days before the anticipated filing date, which notice shall describe
the amount and type of securities to be included in such offering, the intended method(s) of distribution, and the name of the proposed
managing underwriter or underwriters, if any, of the offering, and offer to the Holder in such notice the opportunity to register the
sale of such number of shares of Warrant Shares as such Holder may request in writing within five (5) business days following receipt
of such notice (a &ldquo;<U>Piggyback Registration</U>&rdquo;). The Company shall cause such Warrant Shares to be included in such registration
and shall use its commercially reasonable efforts to cause the managing underwriter or underwriters of a proposed underwritten offering
to permit the Warrant Shares requested to be included in a Piggyback Registration on the same terms and conditions as any similar securities
of the Company and to permit the sale or other disposition of such Warrant Shares in accordance with the intended method(s) of distribution
thereof. All Holders proposing to distribute their securities through a Piggyback Registration that involves an underwriter or underwriters
shall enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such Piggyback Registration.
Furthermore, each Holder must provide such information as reasonably requested by the Company (which information shall be limited to that
which is required for disclosure under the Securities Act and the forms, rules and regulations promulgated thereunder) to be included
in the registration statement timely or the Company may elect to exclude such Holder from the registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b) In addition, for a period
of five (5) years from the commencement of sales of the offering, upon the written demand of the Holders of at least 51% of the Warrants
and underlying Warrant Shares, the Holder shall be entitled to one (1) demand right for the registration of the Warrant Shares at the
Company&rsquo;s expense and one (1) demand right for the registration of the Warrant Shares at the Holder&rsquo;s expense (the &ldquo;<U>Demand
Registration</U>&rdquo;). In the event of a Demand Registration, the Company shall use its commercially reasonable efforts to register
the applicable Warrant Shares. All Holders of Warrant Shares proposing to distribute their securities through a Demand Registration that
involves an underwriter or underwriters shall enter into an underwriting agreement in customary form with the underwriter or underwriters
selected for such Demand Registration. Furthermore, each Holder must provide such information as reasonably requested by the Company (which
information shall be limited to that which is required for disclosure under the Securities Act and the forms, rules and regulations promulgated
thereunder) to be included in the registration statement timely or the Company may elect to exclude such Holder from the registration
statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c) Notwithstanding the foregoing,
the registration rights described in this Section 5 shall be subject to limitations imposed by the Commission&rsquo;s rules or comments
of the Commission staff in connection with its review of the registration statement for any such resale registration. Moreover, notwithstanding
the foregoing registration obligations of the Company, if the Company furnishes to the Holders requesting a Demand Registration a certificate
signed by the Company&rsquo;s chief executive officer stating that in the good faith judgment of the Company&rsquo;s Board of Directors
it would be materially detrimental to the Company and its stockholders for a registration statement to either become effective or remain
effective for as long as such registration statement otherwise would be required to remain effective, because such action would (i) materially
interfere with a significant acquisition, corporate reorganization, or other similar transaction involving the Company; (ii) require premature
disclosure of material information that the Company has a bona fide business purpose for preserving as confidential; or (iii) render the
Company unable to comply with requirements under the Securities Act or Exchange Act, then the Company shall have the right to defer taking
action with respect to such Demand Registration or withdraw a related registration statement for a period of not more than forty-five
(45) calendar days; provided, however, that the Company may not invoke this right more than twice in any twelve (12) month period or during
the twelve (12) month period prior to the Termination Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 6. Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a) <U>No Rights as Stockholder
Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as
a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.
Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to Section 2(c) or to
receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event including if the Company is for any reason
unable to issue and deliver Warrant Shares upon exercise of the this Warrant as required pursuant to the terms hereof, shall the Company
be required to net cash settle an exercise of this Warrant or cash settle in any other form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b) <U>Loss, Theft, Destruction
or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the
loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft
or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting
of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver
a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c) <U>Saturdays, Sundays,
Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d) <U>Authorized Shares</U>.
From and after the date of the filing of the Authorization Amendment, the Company covenants that, during the period the Warrant is outstanding,
it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant
Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall
constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the
purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares
may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon
which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase
rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant
Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges
created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such
issue). Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation,
amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue
or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may
be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality
of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant. Before taking any action which would result
in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain
all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having
jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(e) <U>Jurisdiction</U>. All
questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with
the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(f) <U>Restrictions</U>. The
Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize
cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(g) <U>Nonwaiver and Expenses</U>.
No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right
or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this Warrant or the Purchase
Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts
due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(h) <U>Notices</U>. Any notice,
request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance
with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(i) <U>Limitation of Liability</U>.
No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no
enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of
any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(j) <U>Remedies</U>. The Holder,
in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance
of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by
reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for
specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(k) <U>Successors and Assigns</U>.
Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and
be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions
of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder
or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(l) <U>Amendment</U>. This
Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(m) <U>Severability</U>. Wherever
possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if
any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent
of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(n) <U>Headings</U>. The headings
used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD></TD><TD COLSPAN="2" STYLE="text-align: left"><B>CLEANCORE SOLUTIONS, INC.</B></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 60%">&nbsp;</TD><TD STYLE="text-align: left; width: 5%">By:</TD>
               <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; width: 35%">/s/ Clayton Adams</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">Name:&nbsp;</TD>
               <TD STYLE="text-align: left">Clayton Adams</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">Title:</TD>
               <TD STYLE="text-align: left">Chief Executive Officer</TD></TR>
     </TABLE>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TO: CLEANCORE SOLUTIONS, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The undersigned hereby elects
to purchase ______________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and
tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment shall take the form
of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
in lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please issue said Warrant
Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 1pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black">(4)
<U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Rule 501(a) of Regulation D promulgated
under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 40%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Name of Holder)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Signature)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Name of Authorized Signatory)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Title of Authorized Signatory)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Date)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 11pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Address:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phone Number:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 40%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Name of Holder)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Signature)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Name of Authorized Signatory)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Title of Authorized Signatory)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Date)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>ea025594401ex4-3_clean.htm
<DESCRIPTION>PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT ISSUED BY CLEANCORE SOLUTIONS, INC. TO CURVATURE SECURITIES, LLC ON SEPTEMBER 5, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CLEANCORE SOLUTIONS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="font-size: 10pt; width: 50%">Warrant Shares: 2,100,005</TD>
    <TD STYLE="font-size: 10pt; text-align: right; width: 50%">Issue Date: September 5, 2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS PLACEMENT AGENT COMMON
STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, Curvature Securities LLC or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) until September 5, 2030 (the &ldquo;<U>Termination
Date</U>&rdquo;), to subscribe for and purchase from CleanCore Solutions, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;),
2,100,005 shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of class B common stock of the Company,
par value 0.0001 per share (the &ldquo;<U>Common Stock</U>&rdquo;). The purchase price of one share of Common Stock under this Warrant
shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain Placement Agency
Agreement, dated as of September 1, 2025, by and among the Company, Maxim Group LLC and Curvature Securities LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1. Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated September 1, 2025, among the Company and the several investors party thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2. Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a) <U>Exercise of Warrant</U>.
Notwithstanding any other provision in this Warrant, this Warrant shall not be exercised until the Company files an amendment to the Company&rsquo;s
articles of incorporation (the &ldquo;<U>Authorization Amendment</U>&rdquo;), duly adopted and filed with the Nevada Secretary of State,
that increases the number of authorized shares of Common Stock to a level sufficient to permit the issuance of all securities contemplated
under the Purchase Agreement. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile
copy or PDF or Docusign copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice
of Exercise</U>&rdquo;). Within the earlier of (i) two (2) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement
Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise
Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United
States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.
No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of
any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date
on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion
of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree
that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of
Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof. For purposes
hereof, a &ldquo;Trading Day&rdquo; is a day on which the Common Stock is traded on a Trading Market.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b) <U>Exercise Price</U>.
The initial exercise price per share of Common Stock under this Warrant shall be $1.33, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c) <U>Cashless Exercise</U>.
Subject to Section 2(a), (e), and (f), if at any time after the Issue Date there is no effective registration statement registering the
Warrant Shares, as required pursuant to the terms and conditions of the Registration Rights Agreement, or the prospectus contained therein
is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part, at
any such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares
equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 12%"></TD><TD STYLE="width: 3%; text-align: left">(A)</TD>
    <TD STYLE="text-align: center; width: 2%">=</TD><TD STYLE="text-align: justify; width: 83%">as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section
2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior
to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of
the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P.
(&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of
Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including
until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii)
the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of
Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such
Trading Day;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 12%"></TD><TD STYLE="width: 3%">(B) </TD>
    <TD STYLE="text-align: center; width: 2%">=</TD><TD STYLE="text-align: justify; width: 83%">the Exercise Price of this Warrant, as adjusted hereunder; and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -27pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 12%"></TD><TD STYLE="width: 3%; text-align: left">(X)</TD>
    <TD STYLE="text-align: center; width: 2%">=</TD><TD STYLE="text-align: justify; width: 83%">the number of Warrant Shares that would be issuable upon
exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a
cashless exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">If Warrant Shares are issued
in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant
Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant Shares being issued may
be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market other than the OTCQB or OTCQX, the bid price of the Common Stock for the time in question (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the reasonable
fees and expenses of which shall be paid by the Company.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&ldquo;<U>VWAP</U>&rdquo; means,
for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted
on a Trading Market other than the OTCQB or OTCQX, the daily volume weighted average price of the Common Stock for such date (or the nearest
preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading
Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company,
the reasonable fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock are listed or quoted for trading on the date in question: the
New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq Capital Market, the
OTCQX, or the OTCQB.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d) <U>Mechanics of Exercise.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) <U>Delivery of Warrant
Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the
Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through
its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either
(A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the
Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144
(assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share
register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such
exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Day
after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to
the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice
of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;); <U>provided</U>, <U>however</U>, that if payment of the
aggregate Exercise Price is received after 12:00 P.M., New York City time on the Warrant Share Delivery Date, then the Warrant Share Delivery
Date shall be extended by one (1) additional Trading Day. Upon delivery of the Notice of Exercise, the Holder shall be deemed for all
corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective
of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless
exercise) is received within the earlier of (i) two (2) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement
Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject
to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not
as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin
to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or the Holder rescinds
such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains
outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed
in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of
delivery of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to
12:00 p.m. (New York City time) on the Initial Exercise Date, which may be delivered at any time after the time of execution of the Purchase
Agreement, the Company agrees to use commercially reasonable efforts to deliver, or cause to be delivered, the Warrant Shares subject
to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share
Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise)
is received by such Warrant Share Delivery Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) <U>Delivery of New Warrants
Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender
of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights
of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be
identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii) <U>Rescission Rights</U>.
If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant
Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv) <U>Compensation for Buy-In
on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if the Company
fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above
pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely due to any action or
inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase (in an
open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction
of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay
the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the
Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue
any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&rsquo;s failure to timely deliver Warrant Shares upon exercise of the Warrant as required
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v) <U>No Fractional Shares
or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any
fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either
pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round
up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vi) <U>Charges, Taxes and
Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vii) <U>Closing of Books</U>.
The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant
to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(viii) <U>Restrictive Legend</U>.
The Holder acknowledges that the Warrant Shares acquired upon exercise of this Warrant may not have been registered under the Securities
Act, or applicable state securities laws, and, unless so registered, the Warrant Shares will be issued as restricted securities. The Company
shall place a customary restrictive legend on any certificate or book-entry position representing the Warrant Shares. The Company agrees
to remove such legend (or cause it to be removed) from any Warrant Shares issued upon exercise of this Warrant if such shares are sold
pursuant to an effective registration statement under the Securities Act or at such time as such shares may be sold without restriction
under Rule 144 under the Securities Act, including without limitation, any volume or manner of sale restrictions, and the Company has
received such customary representations and other documentation as it may reasonably request to confirm compliance with this provision.
Notwithstanding the foregoing, if at any time such Warrant Shares are not freely tradable (due to the resale registration statement no
longer being effective or valid for use or any other reason), then the Company shall be able to add such legend back onto the Warrant
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(e) <U>Holder&rsquo;s Exercise
Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion
of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth
on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting as a group
together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially
own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares
of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of Warrant Shares
issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of Warrant
Shares which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder
or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other
securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or
exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.
Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance
with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that
the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder
is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this
Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the
Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable
(in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this
Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify
or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined
in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section
2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common
Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B)
a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth
the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one Trading Day
confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this
Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common
Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon election by a Holder prior to the
issuance of any Warrants, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance
of Warrant Shares issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial
Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the
number of shares of the Common Stock outstanding immediately after giving effect to the issuance of Warrant Shares upon exercise of this
Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation
will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any
portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes
or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply
to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(f) <U>Exchange Cap</U>. Notwithstanding
any other provision herein, the Company shall not be obligated to issue any shares of Common Stock upon exercise of this Warrant if the
issuance of such shares of Common Stock would exceed any cap or limitation on the number of shares (the &ldquo;<U>Exchange Cap&rdquo;</U>)
imposed by the rules or regulations of the Trading Market, if and to the extent applicable, except that such limitation shall not apply
in the event that the Company (i) obtains the approval of its stockholders as required by applicable rules and regulations of the Trading
Market for issuances of Common Stock in excess of the Exchange Cap, or (ii) obtains a written opinion from outside counsel to the Company
that such approval is not required. Until such approval or written opinion is obtained, no Holder of this Warrant shall be issued, upon
exercise this Warrant, shares of Common Stock in an amount that, when added to all Securities issued to such Holder, is greater than the
product of (x) the Exchange Cap amount multiplied by (y) a fraction, the numerator of which is the number of Warrant Shares issuable upon
exercise to such Holder pursuant to this Warrant and the denominator of which is the aggregate amount of all the Warrant Shares issuable
upon exercise to the Holders of all Warrants issued under the Purchase Agreement, the Strategic Advisor Agreement, the Placement Agency
Agreement or any other Transaction Document (the &ldquo;<U>Cap Allocation Amount&rdquo;</U>). In the event that the Holder shall sell
or otherwise transfer any portion of this Warrant, the transferee shall be allocated a pro rata portion of the Holder&rsquo;s Cap Allocation
Amount. In the event that the Holder shall exercise all of this Warrant into a number of shares of Common Stock that, in the aggregate,
is less than the Holder&rsquo;s Cap Allocation Amount, then the difference between the Holder&rsquo;s Cap Allocation Amount and the number of shares
of Common Stock actually issued to such Holder shall be allocated to the respective Cap Allocation Amounts of the Holders on a pro rata
basis in proportion to the number of Warrant Shares issuable upon exercise then held by the Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3. Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a) <U>Stock Dividends and
Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution
or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which,
for avoidance of doubt, shall not include any Warrant Shares issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding
shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of
Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock
of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares
of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the
number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant
shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant
to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive
such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination
or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b) <U>Subsequent Rights Offerings</U>.
In addition to any adjustments pursuant to Sections 3(a) or 3(b) above, if at any time the Company grants, issues or sells any Common
Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares
of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable to
such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Warrant
Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation,
the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase
Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the
grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to the extent that the Holder&rsquo;s right to participate
in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled
to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase
Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its
right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c) <U>Pro Rata Distributions</U>.
During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets
(or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation,
any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement,
scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant,
then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have
participated therein if the Holder had held the number of Warrant Shares acquirable upon complete exercise of this Warrant (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of
Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, that, to the extent that
the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then
the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common
Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit
of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d) <U>Fundamental Transaction</U>.
If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects
any merger or consolidation of the Company with or into another Person (excluding a merger effected solely to change the Company&rsquo;s
name), (ii) the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment,
transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii)
any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant
to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has
been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more
related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange
pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company,
directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination
(including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or
group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any
shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons
making or party to, such stock or share purchase agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;);
provided, however, no transaction contemplated under the Option Agreement (as defined in the Purchase Agreement) shall be considered a
Fundamental Transaction, then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant
Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option
of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the
&ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of Warrant
Shares for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section
2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately
adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common
Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable
manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given
any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same
choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company
shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;)
to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the
provisions of this Section 3(d) pursuant to written agreements prior to such Fundamental Transaction and shall, at the option of the Holder,
deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor
Entity (or its parent entity) equivalent to the Warrant Shares acquirable and receivable upon exercise of this Warrant (without regard
to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction). Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so
that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring
to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall
assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor
Entity had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(e) <U>Calculations</U>. All
calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(f) <U>Notice to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) <U>Adjustment to Exercise
Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to
the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) <U>Notice to Allow Exercise
by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company
shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting
to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any
rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock,
any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of all or substantially
all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or
(E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then,
in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address
as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date
hereinafter specified, a notice (unless such information is filed with the Commission, in which case a notice shall not be required) stating
(x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a
record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of
record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in
the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that
any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain
entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(g) <U>Voluntary Adjustment
By Company</U>. The Company may at any time during the term of this Warrant, with the prior written consent of the Holder, reduce the
then current Exercise Price to any amount for any period of time deemed appropriate by the Board of Directors of the Company unless such
reduction would result in the Company violating any rules of its principal Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4. Transfer of
Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a) <U>Transferability</U>.
Subject to FINRA Rule 5110(e), this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. The Holder shall surrender this Warrant to the Company within three (3) Trading
Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly
assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b) <U>New Warrants</U>. This
Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with
a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.
Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute
and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice.
All Warrants issued on transfers or exchanges shall be dated the original Issue Date and shall be identical with this Warrant except as
to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c) <U>Warrant Register</U>.
The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant Register</U>&rdquo;),
in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the
absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual
notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d) <U>Transfer Restrictions</U>.
If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not
be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities
or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements
pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant,
as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(e) <U>Representation by the
Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof,
will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling
such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to
sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5. Registration
Rights. </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a) To the extent the Company
does not maintain an effective registration statement for the Warrant Shares and in the further event that the Company files a registration
statement with the Commission covering the sale of its shares of Common Stock (other than a registration statement on Form S-4 or S-8,
or on another form, or in another context, in which such &ldquo;piggyback&rdquo; registration would be inappropriate), then, for a period
of five (5) years from the commencement of sales of the offering, the Company shall give written notice of such proposed filing to the
Holder as soon as practicable but in no event less than ten (10) days before the anticipated filing date, which notice shall describe
the amount and type of securities to be included in such offering, the intended method(s) of distribution, and the name of the proposed
managing underwriter or underwriters, if any, of the offering, and offer to the Holder in such notice the opportunity to register the
sale of such number of shares of Warrant Shares as such Holder may request in writing within five (5) business days following receipt
of such notice (a &ldquo;<U>Piggyback Registration</U>&rdquo;). The Company shall cause such Warrant Shares to be included in such registration
and shall use its commercially reasonable efforts to cause the managing underwriter or underwriters of a proposed underwritten offering
to permit the Warrant Shares requested to be included in a Piggyback Registration on the same terms and conditions as any similar securities
of the Company and to permit the sale or other disposition of such Warrant Shares in accordance with the intended method(s) of distribution
thereof. All Holders proposing to distribute their securities through a Piggyback Registration that involves an underwriter or underwriters
shall enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such Piggyback Registration.
Furthermore, each Holder must provide such information as reasonably requested by the Company (which information shall be limited to that
which is required for disclosure under the Securities Act and the forms, rules and regulations promulgated thereunder) to be included
in the registration statement timely or the Company may elect to exclude such Holder from the registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b) In addition, for a period
of five (5) years from the commencement of sales of the offering, upon the written demand of the Holders of at least 51% of the Warrants
and underlying Warrant Shares, the Holder shall be entitled to one (1) demand right for the registration of the Warrant Shares at the
Company&rsquo;s expense and one (1) demand right for the registration of the Warrant Shares at the Holder&rsquo;s expense (the &ldquo;<U>Demand
Registration</U>&rdquo;). In the event of a Demand Registration, the Company shall use its commercially reasonable efforts to register
the applicable Warrant Shares. All Holders of Warrant Shares proposing to distribute their securities through a Demand Registration that
involves an underwriter or underwriters shall enter into an underwriting agreement in customary form with the underwriter or underwriters
selected for such Demand Registration. Furthermore, each Holder must provide such information as reasonably requested by the Company (which
information shall be limited to that which is required for disclosure under the Securities Act and the forms, rules and regulations promulgated
thereunder) to be included in the registration statement timely or the Company may elect to exclude such Holder from the registration
statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c) Notwithstanding the foregoing,
the registration rights described in this Section 5 shall be subject to limitations imposed by the Commission&rsquo;s rules or comments
of the Commission staff in connection with its review of the registration statement for any such resale registration. Moreover, notwithstanding
the foregoing registration obligations of the Company, if the Company furnishes to the Holders requesting a Demand Registration a certificate
signed by the Company&rsquo;s chief executive officer stating that in the good faith judgment of the Company&rsquo;s Board of Directors
it would be materially detrimental to the Company and its stockholders for a registration statement to either become effective or remain
effective for as long as such registration statement otherwise would be required to remain effective, because such action would (i) materially
interfere with a significant acquisition, corporate reorganization, or other similar transaction involving the Company; (ii) require premature
disclosure of material information that the Company has a bona fide business purpose for preserving as confidential; or (iii) render the
Company unable to comply with requirements under the Securities Act or Exchange Act, then the Company shall have the right to defer taking
action with respect to such Demand Registration or withdraw a related registration statement for a period of not more than forty-five
(45) calendar days; provided, however, that the Company may not invoke this right more than twice in any twelve (12) month period or during
the twelve (12) month period prior to the Termination Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 6. Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a) <U>No Rights as Stockholder
Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as
a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.
Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to Section 2(c) or to
receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event including if the Company is for any reason
unable to issue and deliver Warrant Shares upon exercise of the this Warrant as required pursuant to the terms hereof, shall the Company
be required to net cash settle an exercise of this Warrant or cash settle in any other form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b) <U>Loss, Theft, Destruction
or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the
loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft
or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting
of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver
a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c) <U>Saturdays, Sundays,
Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d) <U>Authorized Shares</U>.
From and after the date of the filing of the Authorization Amendment, the Company covenants that, during the period the Warrant is outstanding,
it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant
Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall
constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the
purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares
may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon
which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase
rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant
Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges
created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such
issue). Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation,
amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue
or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may
be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality
of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant. Before taking any action which would result
in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain
all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having
jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(e) <U>Jurisdiction</U>. All
questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with
the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(f) <U>Restrictions</U>. The
Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize
cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(g) <U>Nonwaiver and Expenses</U>.
No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right
or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this Warrant or the Purchase
Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts
due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(h) <U>Notices</U>. Any notice,
request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance
with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(i) <U>Limitation of Liability</U>.
No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no
enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of
any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(j) <U>Remedies</U>. The Holder,
in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance
of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by
reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for
specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(k) <U>Successors and Assigns</U>.
Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and
be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions
of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder
or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(l) <U>Amendment</U>. This
Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(m) <U>Severability</U>. Wherever
possible, each provision of this Warrant shall be interpreted in such manner as to be <U>effective</U> and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(n) <U>Headings</U>. The headings
used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CLEANCORE SOLUTIONS, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 60%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: justify; width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Clayton Adams</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clayton Adams</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TO: CLEANCORE SOLUTIONS, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 1in">(1) The undersigned hereby elects
to purchase ______________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and
tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment shall take the form
of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
in lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please issue said Warrant
Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in">(4) <U>Accredited Investor</U>. The undersigned is
an &ldquo;accredited investor&rdquo; as defined in Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 55%; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name of Holder)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name of Authorized Signatory)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Title of Authorized Signatory)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Date)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 6.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 11pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Address:<U>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phone Number:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 55%; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name of Holder)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name of Authorized Signatory)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Title of Authorized Signatory)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Date)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3.5in"></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>5
<FILENAME>ea025594401ex4-4_clean.htm
<DESCRIPTION>STRATEGIC ADVISOR COMMON STOCK PURCHASE WARRANT ISSUED BY CLEANCORE SOLUTIONS, INC. TO DOGECOIN VENTURES, INC. ON SEPTEMBER 5, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>STRATEGIC ADVISOR COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CLEANCORE SOLUTIONS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="font-size: 10pt; width: 50%">Warrant Shares: 8,750,021</TD>
    <TD STYLE="font-size: 10pt; text-align: right; width: 50%">Issue Date: September 5, 2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS STRATEGIC ADVISOR COMMON
STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, Dogecoin Ventures, Inc. or its assigns (the
&ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set
forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) until September 5, 2030 (the &ldquo;<U>Termination
Date</U>&rdquo;), to subscribe for and purchase from CleanCore Solutions, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;),
8,750,021 shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of class B common stock of the Company,
par value 0.0001 per share (the &ldquo;<U>Common Stock</U>&rdquo;). The purchase price of one share of Common Stock under this Warrant
shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1. Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated September 1, 2025, among the Company and the several investors party thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2. Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a) <U>Exercise of Warrant</U>.
Notwithstanding any other provision in this Warrant, this Warrant shall not be exercised until the Company files an amendment to the Company&rsquo;s
articles of incorporation (the &ldquo;<U>Authorization Amendment</U>&rdquo;), duly adopted and filed with the Nevada Secretary of State,
that increases the number of authorized shares of Common Stock to a level sufficient to permit the issuance of all securities contemplated
under the Purchase Agreement. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile
copy or PDF or Docusign copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice
of Exercise</U>&rdquo;). Within the earlier of (i) two (2) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement
Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise
Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United
States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.
No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of
any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date
on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion
of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree
that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of
Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof. For purposes
hereof, a &ldquo;Trading Day&rdquo; is a day on which the Common Stock is traded on a Trading Market.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b) <U>Exercise Price</U>.
The initial exercise price per share of Common Stock under this Warrant shall be $1.00, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c) <U>Cashless Exercise</U>.
Subject to Section 2(a), (e), and (f), if at any time after the Issue Date there is no effective registration statement registering the
Warrant Shares, as required pursuant to the terms and conditions of the Registration Rights Agreement, or the prospectus contained therein
is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part, at
any such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares
equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 12%"></TD><TD STYLE="width: 3%; text-align: left">(A)</TD>
    <TD STYLE="text-align: left; width: 2%">=</TD><TD STYLE="text-align: justify; width: 83%"> as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section
2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior
to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of
the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P.
(&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of
Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including
until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii)
the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of
Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such
Trading Day;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 12%"></TD><TD STYLE="width: 3%">(B) </TD>
    <TD STYLE="width: 2%">=</TD><TD STYLE="text-align: justify; width: 83%">the Exercise Price of this Warrant, as adjusted hereunder; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -27pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 12%"></TD><TD STYLE="width: 3%; text-align: left">(X)</TD>
    <TD STYLE="width: 2%">=</TD><TD STYLE="text-align: justify; width: 83%">the number of Warrant Shares that would be issuable upon
exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a
cashless exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">If Warrant Shares are issued
in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant
Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant Shares being issued may
be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market other than the OTCQB or OTCQX, the bid price of the Common Stock for the time in question (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the reasonable
fees and expenses of which shall be paid by the Company.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&ldquo;<U>VWAP</U>&rdquo; means,
for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted
on a Trading Market other than the OTCQB or OTCQX, the daily volume weighted average price of the Common Stock for such date (or the nearest
preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading
Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company,
the reasonable fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock are listed or quoted for trading on the date in question: the
New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq Capital Market, the
OTCQX, or the OTCQB.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d) <U>Mechanics of Exercise.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) <U>Delivery of Warrant
Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the
Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through
its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either
(A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the
Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144
(assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share
register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such
exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Day
after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to
the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice
of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;); <U>provided</U>, <U>however</U>, that if payment of the
aggregate Exercise Price is received after 12:00 P.M., New York City time on the Warrant Share Delivery Date, then the Warrant Share Delivery
Date shall be extended by one (1) additional Trading Day. Upon delivery of the Notice of Exercise, the Holder shall be deemed for all
corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective
of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless
exercise) is received within the earlier of (i) two (2) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement
Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject
to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not
as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin
to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or the Holder rescinds
such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains
outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed
in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of
delivery of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to
12:00 p.m. (New York City time) on the Initial Exercise Date, which may be delivered at any time after the time of execution of the Purchase
Agreement, the Company agrees to use commercially reasonable efforts to deliver, or cause to be delivered, the Warrant Shares subject
to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share
Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise)
is received by such Warrant Share Delivery Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) <U>Delivery of New Warrants
Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender
of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights
of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be
identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii) <U>Rescission Rights</U>.
If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant
Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv) <U>Compensation for Buy-In
on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if the Company
fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above
pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely due to any action or
inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase (in an
open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction
of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay
the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the
Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue
any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&rsquo;s failure to timely deliver Warrant Shares upon exercise of the Warrant as required
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v) <U>No Fractional Shares
or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any
fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either
pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round
up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vi) <U>Charges, Taxes and
Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vii) <U>Closing of Books</U>.
The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant
to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(viii) <U>Restrictive Legend</U>.
The Holder acknowledges that the Warrant Shares acquired upon exercise of this Warrant may not have been registered under the Securities
Act, or applicable state securities laws, and, unless so registered, the Warrant Shares will be issued as restricted securities. The Company
shall place a customary restrictive legend on any certificate or book-entry position representing the Warrant Shares. The Company agrees
to remove such legend (or cause it to be removed) from any Warrant Shares issued upon exercise of this Warrant if such shares are sold
pursuant to an effective registration statement under the Securities Act or at such time as such shares may be sold without restriction
under Rule 144 under the Securities Act, including without limitation, any volume or manner of sale restrictions, and the Company has
received such customary representations and other documentation as it may reasonably request to confirm compliance with this provision.
Notwithstanding the foregoing, if at any time such Warrant Shares are not freely tradable (due to the resale registration statement no
longer being effective or valid for use or any other reason), then the Company shall be able to add such legend back onto the Warrant
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(e) <U>Holder&rsquo;s Exercise
Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion
of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth
on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting as a group
together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially
own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares
of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of Warrant Shares
issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of Warrant
Shares which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder
or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other
securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or
exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.
Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance
with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that
the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder
is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this
Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the
Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable
(in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this
Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify
or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined
in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section
2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common
Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B)
a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth
the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one Trading Day
confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this
Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common
Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon election by a Holder prior to the
issuance of any Warrants, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance
of Warrant Shares issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial
Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the
number of shares of the Common Stock outstanding immediately after giving effect to the issuance of Warrant Shares upon exercise of this
Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation
will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any
portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes
or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply
to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(f) <U>Exchange Cap</U>. Notwithstanding
any other provision herein, the Company shall not be obligated to issue any shares of Common Stock upon exercise of this Warrant if the
issuance of such shares of Common Stock would exceed any cap or limitation on the number of shares (the &ldquo;<U>Exchange Cap&rdquo;</U>)
imposed by the rules or regulations of the Trading Market, if and to the extent applicable, except that such limitation shall not apply
in the event that the Company (i) obtains the approval of its stockholders as required by applicable rules and regulations of the Trading
Market for issuances of Common Stock in excess of the Exchange Cap, or (ii) obtains a written opinion from outside counsel to the Company
that such approval is not required. Until such approval or written opinion is obtained, no Holder of this Warrant shall be issued, upon
exercise this Warrant, shares of Common Stock in an amount that, when added to all Securities issued to such Holder, is greater than the
product of (x) the Exchange Cap amount multiplied by (y) a fraction, the numerator of which is the number of Warrant Shares issuable upon
exercise to such Holder pursuant to this Warrant and the denominator of which is the aggregate amount of all the Warrant Shares issuable
upon exercise to the Holders of all Warrants issued under the Purchase Agreement , the Strategic Advisor Agreement, the Placement Agency
Agreement or any other Transaction Document (the &ldquo;<U>Cap Allocation Amount&rdquo;</U>). In the event that the Holder shall sell
or otherwise transfer any portion of this Warrant, the transferee shall be allocated a pro rata portion of the Holder&rsquo;s Cap Allocation
Amount. In the event that the Holder shall exercise all of this Warrant into a number of shares of Common Stock that, in the aggregate,
is less than the Holder&rsquo;s Cap Allocation Amount, then the difference between the Holder&rsquo;s Cap Allocation Amount and the number of shares
of Common Stock actually issued to such Holder shall be allocated to the respective Cap Allocation Amounts of the Holders on a pro rata
basis in proportion to the number of Warrant Shares issuable upon exercise then held by the Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3. Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a) <U>Stock Dividends and
Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution
or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which,
for avoidance of doubt, shall not include any Warrant Shares issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding
shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of
Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock
of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares
of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the
number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant
shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant
to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive
such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination
or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b) <U>Subsequent Rights Offerings</U>.
In addition to any adjustments pursuant to Sections 3(a) or 3(b) above, if at any time the Company grants, issues or sells any Common
Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares
of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable to
such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Warrant
Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation,
the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase
Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the
grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to the extent that the Holder&rsquo;s right to participate
in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled
to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase
Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its
right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c) <U>Pro Rata Distributions</U>.
During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets
(or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation,
any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement,
scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant,
then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have
participated therein if the Holder had held the number of Warrant Shares acquirable upon complete exercise of this Warrant (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of
Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, that, to the extent that
the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then
the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common
Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit
of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d) <U>Fundamental Transaction</U>.
If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects
any merger or consolidation of the Company with or into another Person (excluding a merger effected solely to change the Company&rsquo;s
name), (ii) the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment,
transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii)
any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant
to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has
been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more
related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange
pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company,
directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination
(including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or
group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any
shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons
making or party to, such stock or share purchase agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;);
provided, however, no transaction contemplated under the Option Agreement (as defined in the Purchase Agreement) shall be considered a
Fundamental Transaction, then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant
Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option
of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the
&ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of Warrant
Shares for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section
2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately
adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common
Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable
manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given
any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same
choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company
shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;)
to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the
provisions of this Section 3(d) pursuant to written agreements prior to such Fundamental Transaction and shall, at the option of the Holder,
deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor
Entity (or its parent entity) equivalent to the Warrant Shares acquirable and receivable upon exercise of this Warrant (without regard
to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction). Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so
that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring
to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall
assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor
Entity had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(e) <U>Calculations</U>. All
calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(f) <U>Notice to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) <U>Adjustment to Exercise
Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to
the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) <U>Notice to Allow Exercise
by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company
shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting
to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any
rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock,
any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of all or substantially
all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or
(E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then,
in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address
as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date
hereinafter specified, a notice (unless such information is filed with the Commission, in which case a notice shall not be required) stating
(x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a
record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of
record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in
the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that
any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain
entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(g) <U>Voluntary Adjustment
By Company</U>. The Company may at any time during the term of this Warrant, with the prior written consent of the Holder, reduce the
then current Exercise Price to any amount for any period of time deemed appropriate by the Board of Directors of the Company unless such
reduction would result in the Company violating any rules of its principal Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4. Transfer of
Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4.1 of the Purchase Agreement, this
Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon
surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant
substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer
taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver
a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified
in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned,
and this Warrant shall promptly be cancelled. The Holder shall surrender this Warrant to the Company within three (3) Trading Days of
the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b) <U>New Warrants</U>. This
Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with
a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.
Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute
and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice.
All Warrants issued on transfers or exchanges shall be dated the original Issue Date and shall be identical with this Warrant except as
to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c) <U>Warrant Register</U>.
The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant Register</U>&rdquo;),
in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the
absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual
notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d) <U>Transfer Restrictions</U>.
If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not
be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities
or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements
pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant,
as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(e) <U>Representation by the
Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof,
will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling
such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to
sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5. Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a) <U>No Rights as Stockholder
Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as
a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.
Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to Section 2(c) or to
receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event including if the Company is for any reason
unable to issue and deliver Warrant Shares upon exercise of the this Warrant as required pursuant to the terms hereof, shall the Company
be required to net cash settle an exercise of this Warrant or cash settle in any other form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b) <U>Loss, Theft, Destruction
or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the
loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft
or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting
of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver
a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c) <U>Saturdays, Sundays,
Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d) <U>Authorized Shares</U>.
From and after the date of the filing of the Authorization Amendment, the Company covenants that, during the period the Warrant is outstanding,
it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant
Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall
constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the
purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares
may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon
which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase
rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant
Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges
created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such
issue). Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation,
amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue
or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may
be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality
of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant. Before taking any action which would result
in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain
all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having
jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(e) <U>Jurisdiction</U>. All
questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with
the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(f) <U>Restrictions</U>. The
Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize
cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(g) <U>Nonwaiver and Expenses</U>.
No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right
or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this Warrant or the Purchase
Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts
due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(h) <U>Notices</U>. Any notice,
request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance
with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(i) <U>Limitation of Liability</U>.
No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no
enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of
any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(j) <U>Remedies</U>. The Holder,
in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance
of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by
reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for
specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(k) <U>Successors and Assigns</U>.
Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and
be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions
of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder
or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(l) <U>Amendment</U>. This
Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(m) <U>Severability</U>. Wherever
possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if
any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent
of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(n) <U>Headings</U>. The headings
used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><B>CLEANCORE SOLUTIONS, INC.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 35%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">/s/ Clayton Adams</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Name: </TD>
    <TD STYLE="text-align: justify">Clayton Adams</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Title: </TD>
    <TD STYLE="text-align: justify">Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TO: CLEANCORE SOLUTIONS, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The undersigned hereby elects
to purchase ______________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and
tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment shall take the form
of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
in lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please issue said Warrant
Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<DIV STYLE="padding: 0in 7pt; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4) <U>Accredited Investor</U>. The undersigned is an &ldquo;accredited
investor&rdquo; as defined in Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 55%; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 45%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Name of Holder)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Signature)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Name of Authorized Signatory)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Title of Authorized Signatory)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Date)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 11pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Address:<U>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phone Number:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 50%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Name of Holder)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Signature)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Name of Authorized Signatory)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Title of Authorized Signatory)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Date)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.5
<SEQUENCE>6
<FILENAME>ea025594401ex4-5_clean.htm
<DESCRIPTION>STRATEGIC ADVISOR COMMON STOCK PURCHASE WARRANT ISSUED BY CLEANCORE SOLUTIONS, INC. TO DOGECOIN VENTURES, INC. ON SEPTEMBER 5, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>STRATEGIC ADVISOR COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CLEANCORE SOLUTIONS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="font-size: 10pt; width: 50%">Warrant Shares: 5,250,013</TD>
    <TD STYLE="font-size: 10pt; text-align: right; width: 50%">Issue Date: September 5, 2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS STRATEGIC ADVISOR COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;)
certifies that, for value received, Dogecoin Ventures, Inc. or its assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms
and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the &ldquo;<U>Initial
Exercise Date</U>&rdquo;) until September 5, 2030 (the &ldquo;<U>Termination Date</U>&rdquo;), to subscribe for and purchase from CleanCore
Solutions, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), 5,250,013 shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant
Shares</U>&rdquo;) of class B common stock of the Company, par value 0.0001 per share (the &ldquo;<U>Common Stock</U>&rdquo;). The purchase
price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1. Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated September 1, 2025, among the Company and the several investors party thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2. Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a) <U>Exercise of Warrant</U>.
Notwithstanding any other provision in this Warrant, this Warrant shall not be exercised until the Company files an amendment to the Company&rsquo;s
articles of incorporation (the &ldquo;<U>Authorization Amendment</U>&rdquo;), duly adopted and filed with the Nevada Secretary of State,
that increases the number of authorized shares of Common Stock to a level sufficient to permit the issuance of all securities contemplated
under the Purchase Agreement. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile
copy or PDF or Docusign copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice
of Exercise</U>&rdquo;). Within the earlier of (i) two (2) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement
Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise
Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United
States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.
No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of
any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date
on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion
of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree
that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of
Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof. For purposes
hereof, a &ldquo;Trading Day&rdquo; is a day on which the Common Stock is traded on a Trading Market.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b) <U>Exercise Price</U>.
The initial exercise price per share of Common Stock under this Warrant shall be $1.33, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c) <U>Cashless Exercise</U>.
Subject to Section 2(a), (e), and (f), if at any time after the Issue Date there is no effective registration statement registering the
Warrant Shares, as required pursuant to the terms and conditions of the Registration Rights Agreement, or the prospectus contained therein
is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part, at
any such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares
equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 12%"></TD><TD STYLE="width: 3%; text-align: left">(A)</TD>
    <TD STYLE="text-align: center; width: 2%">=</TD><TD STYLE="text-align: justify; width: 83%"> as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section
2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior
to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of
the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P.
(&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of
Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including
until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii)
the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of
Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such
Trading Day;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 12%"></TD><TD STYLE="width: 3%">(B) </TD>
    <TD STYLE="text-align: center; width: 2%">=</TD><TD STYLE="text-align: justify; width: 83%">the Exercise Price of this Warrant, as adjusted hereunder; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -27pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 12%"></TD><TD STYLE="width: 3%; text-align: left">(X)</TD>
    <TD STYLE="text-align: center; width: 2%">=</TD><TD STYLE="text-align: justify; width: 83%">the number of Warrant Shares that would be issuable upon
exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a
cashless exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">If Warrant Shares are issued
in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant
Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant Shares being issued may
be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market other than the OTCQB or OTCQX, the bid price of the Common Stock for the time in question (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the reasonable
fees and expenses of which shall be paid by the Company.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&ldquo;<U>VWAP</U>&rdquo; means,
for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted
on a Trading Market other than the OTCQB or OTCQX, the daily volume weighted average price of the Common Stock for such date (or the nearest
preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading
Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company,
the reasonable fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock are listed or quoted for trading on the date in question: the
New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq Capital Market, the
OTCQX, or the OTCQB.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d) <U>Mechanics of Exercise.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) <U>Delivery of Warrant
Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the
Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through
its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either
(A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the
Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144
(assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share
register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such
exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Day
after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to
the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice
of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;); <U>provided</U>, <U>however</U>, that if payment of the
aggregate Exercise Price is received after 12:00 P.M., New York City time on the Warrant Share Delivery Date, then the Warrant Share Delivery
Date shall be extended by one (1) additional Trading Day. Upon delivery of the Notice of Exercise, the Holder shall be deemed for all
corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective
of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless
exercise) is received within the earlier of (i) two (2) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement
Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject
to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not
as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin
to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or the Holder rescinds
such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains
outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed
in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of
delivery of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to
12:00 p.m. (New York City time) on the Initial Exercise Date, which may be delivered at any time after the time of execution of the Purchase
Agreement, the Company agrees to use commercially reasonable efforts to deliver, or cause to be delivered, the Warrant Shares subject
to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share
Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise)
is received by such Warrant Share Delivery Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) <U>Delivery of New Warrants
Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender
of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights
of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be
identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii) <U>Rescission Rights</U>.
If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant
Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv) <U>Compensation for Buy-In
on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if the Company
fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above
pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely due to any action or
inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase (in an
open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction
of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay
the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the
Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue
any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&rsquo;s failure to timely deliver Warrant Shares upon exercise of the Warrant as required
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v) <U>No Fractional Shares
or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any
fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either
pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round
up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vi) <U>Charges, Taxes and
Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vii) <U>Closing of Books</U>.
The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant
to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(viii) <U>Restrictive Legend</U>.
The Holder acknowledges that the Warrant Shares acquired upon exercise of this Warrant may not have been registered under the Securities
Act, or applicable state securities laws, and, unless so registered, the Warrant Shares will be issued as restricted securities. The Company
shall place a customary restrictive legend on any certificate or book-entry position representing the Warrant Shares. The Company agrees
to remove such legend (or cause it to be removed) from any Warrant Shares issued upon exercise of this Warrant if such shares are sold
pursuant to an effective registration statement under the Securities Act or at such time as such shares may be sold without restriction
under Rule 144 under the Securities Act, including without limitation, any volume or manner of sale restrictions, and the Company has
received such customary representations and other documentation as it may reasonably request to confirm compliance with this provision.
Notwithstanding the foregoing, if at any time such Warrant Shares are not freely tradable (due to the resale registration statement no
longer being effective or valid for use or any other reason), then the Company shall be able to add such legend back onto the Warrant
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(e) <U>Holder&rsquo;s Exercise
Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion
of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth
on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting as a group
together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially
own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares
of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of Warrant Shares
issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of Warrant
Shares which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder
or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other
securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or
exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.
Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance
with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that
the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder
is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this
Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the
Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable
(in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this
Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify
or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined
in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section
2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common
Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B)
a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth
the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one Trading Day
confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this
Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common
Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon election by a Holder prior to the
issuance of any Warrants, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance
of Warrant Shares issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial
Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the
number of shares of the Common Stock outstanding immediately after giving effect to the issuance of Warrant Shares upon exercise of this
Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation
will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any
portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes
or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply
to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(f) <U>Exchange Cap</U>. Notwithstanding
any other provision herein, the Company shall not be obligated to issue any shares of Common Stock upon exercise of this Warrant if the
issuance of such shares of Common Stock would exceed any cap or limitation on the number of shares (the &ldquo;<U>Exchange Cap&rdquo;</U>)
imposed by the rules or regulations of the Trading Market, if and to the extent applicable, except that such limitation shall not apply
in the event that the Company (i) obtains the approval of its stockholders as required by applicable rules and regulations of the Trading
Market for issuances of Common Stock in excess of the Exchange Cap, or (ii) obtains a written opinion from outside counsel to the Company
that such approval is not required. Until such approval or written opinion is obtained, no Holder of this Warrant shall be issued, upon
exercise this Warrant, shares of Common Stock in an amount that, when added to all Securities issued to such Holder, is greater than the
product of (x) the Exchange Cap amount multiplied by (y) a fraction, the numerator of which is the number of Warrant Shares issuable upon
exercise to such Holder pursuant to this Warrant and the denominator of which is the aggregate amount of all the Warrant Shares issuable
upon exercise to the Holders of all Warrants issued under the Purchase Agreement , the Strategic Advisor Agreement, the Placement Agency
Agreement or any other Transaction Document (the &ldquo;<U>Cap Allocation Amount&rdquo;</U>). In the event that the Holder shall sell
or otherwise transfer any portion of this Warrant, the transferee shall be allocated a pro rata portion of the Holder&rsquo;s Cap Allocation
Amount. In the event that the Holder shall exercise all of this Warrant into a number of shares of Common Stock that, in the aggregate,
is less than the Holder&rsquo;s Cap Allocation Amount, then the difference between the Holder&rsquo;s Cap Allocation Amount and the number of shares
of Common Stock actually issued to such Holder shall be allocated to the respective Cap Allocation Amounts of the Holders on a pro rata
basis in proportion to the number of Warrant Shares issuable upon exercise then held by the Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3. Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a) <U>Stock Dividends and
Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution
or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which,
for avoidance of doubt, shall not include any Warrant Shares issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding
shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of
Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock
of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares
of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the
number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant
shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant
to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive
such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination
or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b) <U>Subsequent Rights Offerings</U>.
In addition to any adjustments pursuant to Sections 3(a) or 3(b) above, if at any time the Company grants, issues or sells any Common
Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares
of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable to
such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Warrant
Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation,
the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase
Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the
grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to the extent that the Holder&rsquo;s right to participate
in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled
to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase
Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its
right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c) <U>Pro Rata Distributions</U>.
During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets
(or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation,
any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement,
scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant,
then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have
participated therein if the Holder had held the number of Warrant Shares acquirable upon complete exercise of this Warrant (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of
Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, that, to the extent that
the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then
the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common
Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit
of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d) <U>Fundamental Transaction</U>.
If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects
any merger or consolidation of the Company with or into another Person (excluding a merger effected solely to change the Company&rsquo;s
name), (ii) the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment,
transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii)
any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant
to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has
been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more
related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange
pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company,
directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination
(including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or
group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any
shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons
making or party to, such stock or share purchase agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;);
provided, however, no transaction contemplated under the Option Agreement (as defined in the Purchase Agreement) shall be considered a
Fundamental Transaction, then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant
Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option
of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the
&ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of Warrant
Shares for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section
2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately
adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common
Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable
manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given
any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same
choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company
shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;)
to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the
provisions of this Section 3(d) pursuant to written agreements prior to such Fundamental Transaction and shall, at the option of the Holder,
deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor
Entity (or its parent entity) equivalent to the Warrant Shares acquirable and receivable upon exercise of this Warrant (without regard
to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction). Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so
that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring
to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall
assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor
Entity had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(e) <U>Calculations</U>. All
calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(f) <U>Notice to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) <U>Adjustment to Exercise
Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to
the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) <U>Notice to Allow Exercise
by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company
shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting
to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any
rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock,
any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of all or substantially
all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or
(E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then,
in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address
as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date
hereinafter specified, a notice (unless such information is filed with the Commission, in which case a notice shall not be required) stating
(x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a
record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of
record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in
the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that
any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain
entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(g) <U>Voluntary Adjustment
By Company</U>. The Company may at any time during the term of this Warrant, with the prior written consent of the Holder, reduce the
then current Exercise Price to any amount for any period of time deemed appropriate by the Board of Directors of the Company unless such
reduction would result in the Company violating any rules of its principal Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4. Transfer of
Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4.1 of the Purchase Agreement, this
Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon
surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant
substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer
taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver
a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified
in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned,
and this Warrant shall promptly be cancelled. The Holder shall surrender this Warrant to the Company within three (3) Trading Days of
the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b) <U>New Warrants</U>. This
Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with
a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.
Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute
and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice.
All Warrants issued on transfers or exchanges shall be dated the original Issue Date and shall be identical with this Warrant except as
to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c) <U>Warrant Register</U>.
The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant Register</U>&rdquo;),
in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the
absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual
notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d) <U>Transfer Restrictions</U>.
If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not
be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities
or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements
pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant,
as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(e) <U>Representation by the
Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof,
will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling
such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to
sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5. Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a) <U>No Rights as Stockholder
Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as
a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.
Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to Section 2(c) or to
receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event including if the Company is for any reason
unable to issue and deliver Warrant Shares upon exercise of the this Warrant as required pursuant to the terms hereof, shall the Company
be required to net cash settle an exercise of this Warrant or cash settle in any other form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b) <U>Loss, Theft, Destruction
or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the
loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft
or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting
of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver
a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c) <U>Saturdays, Sundays,
Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d) <U>Authorized Shares</U>.
From and after the date of the filing of the Authorization Amendment, the Company covenants that, during the period the Warrant is outstanding,
it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant
Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall
constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the
purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares
may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon
which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase
rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant
Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges
created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such
issue). Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation,
amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue
or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may
be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality
of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant. Before taking any action which would result
in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain
all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having
jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(e) <U>Jurisdiction</U>. All
questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with
the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(f) <U>Restrictions</U>. The
Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize
cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(g) <U>Nonwaiver and Expenses</U>.
No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right
or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this Warrant or the Purchase
Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts
due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(h) <U>Notices</U>. Any notice,
request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance
with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(i) <U>Limitation of Liability</U>.
No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no
enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of
any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(j) <U>Remedies</U>. The Holder,
in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance
of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by
reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for
specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(k) <U>Successors and Assigns</U>.
Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and
be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions
of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder
or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(l) <U>Amendment</U>. This
Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(m) <U>Severability</U>. Wherever
possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if
any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent
of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(n) <U>Headings</U>. The headings
used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><B>CLEANCORE SOLUTIONS, INC.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 35%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">/s/ Clayton Adams</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Name: </TD>
    <TD STYLE="text-align: justify">Clayton Adams</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Title: </TD>
    <TD STYLE="text-align: justify">Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TO: CLEANCORE SOLUTIONS, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The undersigned hereby elects
to purchase ______________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and
tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment shall take the form
of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
in lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please issue said Warrant
Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4) <U>Accredited Investor</U>. The undersigned is an &ldquo;accredited
investor&rdquo; as defined in Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 55%; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 45%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Name of Holder)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Signature)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Name of Authorized Signatory)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Title of Authorized Signatory)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Date)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 11pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Address:<U>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phone Number:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 50%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Name of Holder)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Signature)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Name of Authorized Signatory)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Title of Authorized Signatory)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Date)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>7
<FILENAME>ea025594401ex10-1_clean.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT (CASH), DATED SEPTEMBER 1, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of September 1, 2025, between CleanCore Solutions, Inc., a corporation organized under
the laws of State of Nevada (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including
its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506(b)
of Regulation D promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not
jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company desires
to sell to the Purchasers, and each of the Purchasers desire to purchase from the Company in the offering contemplated by this Agreement
(the &ldquo;<U>Offering</U>&rdquo;), severally and not jointly, upon the terms and subject to the conditions stated in this Agreement,
Pre-Funded Warrants (as defined below) to purchase Shares (as defined below) substantially in the form attached hereto as <U>Exhibit A</U>.
The Securities (as defined below) consist of the Pre-Funded Warrants and the Pre-Funded Warrant Shares (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, contemporaneously
with the sale of the Securities, the parties hereto will execute and deliver the Registration Rights Agreement, substantially in the form
attached hereto as <U>Exhibit B</U>, pursuant to which the Company will agree to provide certain registration rights in respect of the
Pre-Funded Warrant Shares under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the sale of the Securities
sold in the Offering will be on a &ldquo;commercially reasonable best efforts&rdquo; basis and there will be no minimum or maxim offering
amount and no assurance can be given that all or any portion of the Securities offered hereby will be sold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, HoD (as defined below)
shall invest $10,000,000 in the Offering through the contribution of a combination of cash and Dogecoin (as defined below);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which
are hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE I.<BR>
DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1 <U>Definitions</U>. In
addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set
forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Acquiring Person</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Asset Management
Fees</U>&rdquo; shall have the meaning ascribed to such term in Section 5.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Asset Manager</U>&rdquo;
means collectively, HoD and 21Shares US LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Authorization
Amendment</U>&rdquo; means an amendment to the Company&rsquo;s Articles of <FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>1 </SUP></FONT>Incorporation,
duly adopted and filed with the Nevada Secretary of State, that increases the number of authorized shares of Common Stock to a level
sufficient to permit the issuance of all Pre-Funded Warrant Shares, the Strategic Advisor Warrant Shares and the shares issuable to
the Placement Agent upon the exercise of warrants issuable to the Placement Agent at Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board of Directors</U>&rdquo;
means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business Day</U>&rdquo;
means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by
law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to
remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any other similar
orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic
funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally are open for use by customers
on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing Date</U>&rdquo;
means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and
all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s obligations
to deliver the Pre-Funded Warrants, have been satisfied or waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock</U>&rdquo;
means the class B common stock of the Company, par value $0.0001 per share, and any other class of securities into which such securities
may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock Equivalents</U>&rdquo;
means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company Counsel</U>&rdquo;
means Bevilacqua PLLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>&ldquo;Company Nevada Counsel</U>&rdquo;
means Fennemore Craig, P.C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure Schedules</U>&rdquo;
means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure Time</U>&rdquo;
means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and before midnight
(New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date hereof, unless
otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight (New York City
time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof, unless otherwise
instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Dogecoin</U>&rdquo;
means the native token of the Dogecoin blockchain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effective Date</U>&rdquo;
means the earliest of the date that (a) the initial Registration Statement registering for resale all Pre-Funded Warrant Shares has been
declared effective by the Commission, (b) all of the Pre-Funded Warrant Shares have been sold pursuant to Rule 144 or may be sold pursuant
to Rule 144 without the requirement for the Company to be in compliance with the current public information requirement of Rule 144 and
without volume or manner-of-sale restrictions, (c) following the one year anniversary of the Closing, or (d) all of the Pre-Funded Warrant
Shares may be sold pursuant to an exemption from registration under Section 4(a)(1) of the Securities Act without volume or manner-of-sale
restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="text-align: left; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT></TD><TD STYLE="text-align: justify">We will be issuing PFWs only in the offering which will be
subject to shareholder approval. The majority shareholder&rsquo;s written consent was obtained and a Schedule 14C filed for the approval
of the offering. We also have written consent and a 14C filed for an increased in the authorized shares.</TD>
</TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Escrow Agent</U>&rdquo;
means Continental Stock Transfer &amp; Trust Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation Date</U>&rdquo; shall have the meaning ascribed
to such term in Section 3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange Act</U>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange Cap</U>&rdquo;
means the Company&rsquo;s principal Trading Market&rsquo;s limitation against a Purchaser&rsquo;s acquisition of shares of Common Stock
pursuant to the Transaction Documents, to the extent that after giving effect thereto, the aggregate number of shares of Common Stock
that would be issued pursuant to the Transaction Documents and the transactions contemplated thereby would exceed 19.99% of the number
of shares of Common Stock issued and outstanding immediately prior to the execution of this Agreement, which number of shares would be
reduced, on a share-for-share basis, by the number of shares of Common Stock issued or issuable pursuant to any transaction or series
of transactions that may be aggregated with the transactions contemplated by this Agreement under applicable rules of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt Issuance</U>&rdquo;
means the issuance (a) of shares of Common Stock or options to employees, officers or directors of the Company pursuant to any stock or
option plan or arrangement duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority
of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) of shares
of Common Stock upon the exercise or exchange or conversion of any Securities issued hereunder and/or securities (including options, rights
or warrants) exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement,
provided that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease
the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits or combinations)
or to extend the term of such securities; (c) of shares of Common Stock upon conversion or settlement of outstanding debt as of the date
hereof in an amount not to exceed $100,000; (d) of the Strategic Advisor Warrants, the Placement Agent Warrants, the Strategic Advisor
Warrant Shares and the Placement Agent Warrant Shares; (e) of shares of Common Stock or pre-funded warrants in a private placement or
other transaction with fundamental or technical institutional investors at a price per share or pre-funded warrant greater than the Per
PFW Purchase Price; (f) of securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested
directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and
carry no registration rights that require or permit the filing of any registration statement in connection therewith during the prohibition
period in Section 4.12(a) herein, and provided that any such issuance shall only be to a Person (or to the equityholders of a Person)
which is, itself or through its Subsidiaries, an operating company or an owner of an asset in a business synergistic with the business
of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction
in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing
in securities; and (g) of any shares of Common Stock issued pursuant to an at-the-market sales agreement entered into by the Company,
the Placement Agent and any sales agents designated by the Placement Agent provided that, prior to the 30 day anniversary of the Effective
Date, any such sales are at a price per share greater than the Per PFW Purchase Price; (h) of securities to banks, equipment lessors or
other financial institutions, or to real property lessors, pursuant to a debt financing, equipment leasing or real property leasing transaction
approved by a majority of the disinterested directors of the Company, (i) of securities issued to in connection with the provision of
goods pursuant to transactions approved by a majority of the disinterested directors of the Company and (j) of securities issued in connection
with sponsored research, collaboration, technology license, development, marketing or other similar agreements or strategic partnerships
approved a majority of the disinterested directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>HoD</U>&rdquo; means
House of Doge Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>HoD Contribution</U>&rdquo;
means a combination, valued at $10,000,000 in the aggregate, of (i) cash and (ii) Dogecoin. The Dogecoin comprising the HOD Contribution
shall equal (a) the portion of the contribution paid in Dogecoin, divided by (b) the spot exchange rate for Dogecoin as published by Coinbase.com
at 12:00 p.m. (New York City time) on the date of the execution and delivery of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Legacy Business</U>&rdquo;
means the business of the Company on the date hereof and immediately prior to the Closing and specifically excludes any digital asset
treasury business that the Company may engage in whether before or after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(bb).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual Property
Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Legend Removal Date</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lock-Up Agreements</U>&rdquo;
means the Lock-Up Agreements, dated as of the date hereof, by and among the Company and the directors and executive officers, in the form
of <U>Exhibit C</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material Adverse
Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material Permits</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(n).&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Option Agreement</U>&rdquo;
means that certain agreement in the form of <U>Exhibit D</U> hereto, by and between the Company and Clayton Adams, in his individual capacity,
pursuant to which Mr. Adams shall be granted an option (the &ldquo;<U>Option</U>&rdquo;), exercisable by Mr. Adams at any time following
the date that is one hundred eighty (180) days after the Closing Date, to elect, in his sole discretion, to either: (i) cause the Company
to effect a spin-off of the Legacy Business to all shareholders of the Company through a dividend of all equity interests of such business,
or (ii) permit Mr. Adams or one or more persons designated by him to acquire the Legacy Business a purchase price that is mutually agreeable
to the Company (as approved by a majority of the independent directors of the Company) and Mr. Adams, provided that such purchase price
is supported by an independent fairness opinion rendered by a Newbridge Securities Corporation or another nationally recognized investment
bank mutually selected by Mr. Adams and the independent directors of the Company, all on terms and conditions set forth in the Option
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per PFW Purchase
Price</U>&rdquo; equals $1.00, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other
similar transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agency
Agreement</U>&rdquo; means that certain Placement Agency Agreement by and between the Company and the Placement Agent in respect of the
placement of the Securities, dated September 1, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agent</U>&rdquo;
means, collectively, Maxim Group LLC and Curvature Securities LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agent
Warrants</U>&rdquo; means the warrants to purchase Common Stock issuable to the Placement Agent under the Placement Agency Agreement,
which Placement Agent Warrants shall not be exercisable until the filing of the Authorization Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agent
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon the exercise of the Placement Agent Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded Warrants</U>&rdquo;
means, collectively, the Pre-Funded Common Stock purchase warrants in the form of <U>Exhibit A</U> delivered to the Purchasers at the
Closing in accordance with Section&#8239;2.2(a)&#8239;hereof, which Pre-Funded Warrants shall be subject to the Exchange Cap and not be
exercisable until the filing of the Authorization Amendment and shall expire when exercised in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public Information
Failure</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public Information
Failure Payments</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser Party</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration Rights
Agreement</U>&rdquo; shall have the meaning ascribed to such term in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration Statement</U>&rdquo;
means a resale registration statement meeting the requirements of the Registration Rights Agreement and covering the resale by the Purchasers
of the Pre-Funded Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required Approvals</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Pre-Funded Warrants and the Pre-Funded Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities Act</U>&rdquo;
means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short Sales</U>&rdquo;
means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include
locating and/or borrowing shares of Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Strategic Advisor
Agreement</U>&rdquo; means that certain Strategic Advisor Agreement between HoD and the Company to be executed on or prior to the Closing
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Strategic Advisor
Warrants</U>&rdquo; means 8,750,021 warrants to purchase Common Stock having an exercise price of $1.00 and 5,250,013 warrants to purchase
Common Stock having an exercise price of $1.33 to be issued to HoD (or an affiliate thereof) in connection with the entry into the Strategic
Advisor Agreement, which Strategic Advisor Warrants shall not be exercisable until the filing of the Authorization Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Strategic Advisor
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Strategic Advisor Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription Amount</U>&rdquo;
means, as to each Purchaser, the aggregate amount to be paid for Pre-Funded Warrants purchased hereunder as specified below such Purchaser&rsquo;s
name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo; in United States dollars and in
immediately available funds (minus, if applicable, a Purchaser&rsquo;s aggregate exercise price of the Pre-Funded Warrants, which amounts
shall be paid as and when such Pre-Funded Warrants are exercised for cash).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth in the SEC Reports and shall, where applicable, also include any direct or indirect subsidiary
of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Day</U>&rdquo;
means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or
any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction Documents</U>&rdquo;
means this Agreement, the Lock-Up Agreements, the Registration Rights Agreement, the Pre-Funded Warrants, the Treasury Management Agreement,
the Strategic Advisor Agreement and all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection
with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer Agent</U>&rdquo;
means Securities Transfer Corporation, with a mailing address of 2901 N Dallas Parkway, Suite 380, Plano, TX 75093, and any successor
transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Treasury Management
Agreement</U>&rdquo; means that certain Asset Management Agreement among the Company and the Treasury Manager, to be executed on or prior
to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Treasury Manager</U>&rdquo;
means collectively, HoD and 21Shares US LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Common Stock is not then listed or quoted for trading on a Trading
Market and the Common Stock is listed or quoted for trading on the OTCQB or OTCQX, the volume weighted average price of the Common Stock
for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for
trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar organization or agency
succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other
cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers
of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which
shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE II.<BR>
PURCHASE AND SALE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1 <U>Closing</U>. On the
Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery
of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase,
the number of Pre-Funded Warrants, for the aggregate purchase price, set forth on the Purchaser&rsquo;s signature page. Each Purchaser
shall deliver to the Escrow Agent, via wire transfer, immediately available funds equal to such Purchaser&rsquo;s Subscription Amount
as set forth on the signature page hereto executed by such Purchaser, and the Company shall deliver to each Purchaser its respective Securities,
as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable
at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices
of the Placement Agent or such other location as the parties shall mutually agree, including taking place remotely by electronic transfer
of the Closing documentation. In the event that the Closing has not occurred within five (5) Business Days after the expected Closing
Date, unless otherwise agreed by the Company and a Purchaser solely in relation to such Purchaser&rsquo;s subscription hereunder, the
Company shall, promptly (but no later than one Business Day thereafter) return the previously wired Subscription Amount by wire transfer
of United States dollars in immediately available funds to the account specified by each applicable Purchaser; provided that, unless this
Agreement has been terminated pursuant to Section 5.1, such return of funds shall not terminate this Agreement or relieve such Purchaser
of its obligation to purchase, or the Company of its obligation to issue and sell, the Securities at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2 <U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) On or prior to the Closing
Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) this Agreement duly executed
by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) the legal opinions of
Company Counsel and Company Nevada Counsel, each dated as of the Closing Date, in forms reasonably acceptable and addressed to the Placement
Agent and the Purchasers and executed by such counsels;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) a copy of the irrevocable
instructions to the Transfer Agent, in form and substance reasonably satisfactory to the Purchasers, instructing the Transfer Agent to
deliver from time to time, upon exercise of the Pre-Funded Warrants, the Pre-Funded Warrant Shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iv) a Pre-Funded Warrant
registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s
Subscription Amount divided by the Per PFW Purchase Price, with an exercise price equal to $0.0001, which shall have been pre-funded at
the Closing, subject to adjustment as provided therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v) the Strategic Advisor
Warrants;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(vi) the Placement Agent Warrants;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(vii) the wire instructions
of the Escrow Agent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(viii) the Lock-Up Agreements
duly executed by the Company and the directors and executive officers signatory thereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ix) the Registration Rights
Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(x) the Treasury Management
Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xi) the Strategic Advisor
Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xii) a certificate of the
Secretary of the Company (the &ldquo;<U>Secretary&rsquo;s Certificate</U>&rdquo;), dated as of the Closing Date, (a) certifying the resolutions
adopted by the Board of Directors approving the transactions contemplated by this Agreement and the other Transaction Documents and the
issuance of the Pre-Funded Warrants (as applicable), (b) certifying the current versions of the Articles of the Incorporation of the Company
and Bylaws and (c) certifying as to the signatures and authority of persons signing the Transaction Documents and related documents on
behalf of the Company, in the form attached hereto as <U>Exhibit E</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xiii) a certificate dated
as of the Closing Date and signed by its Chief Executive Officer or its Chief Financial Officer, dated as of the Closing Date, certifying
to the fulfillment of the conditions specified in Sections 2.3(a)(i) and 2.3(a)(ii), in the form attached as <U>Exhibit F</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xiv) a certificate evidencing
the formation and good standing of the Company issued by the Secretary of State of Nevada, as of a date within five (5) Business Days
of the Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xv) a certified copy of the
Articles of Incorporation, as certified by the Secretary of State (or comparable office) of Nevada, as of a date within five (5) Business
Days of the Closing Date; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xvi) executed written consents
of Company stockholders holding the requisite number of the Company&rsquo;s voting shares that are needed to approve the following: (i)
the approval of the Authorization Amendment; (ii) the approval of the transactions as contemplated by the Transaction Documents; (iii)
the approval of the transactions as an issuance greater than the Exchange Cap pursuant to Section 713 of the NYSE American LLC Company
Guide for purposes of compliance with NYSE American rules; and (iv) such other approvals as are necessary or desirable in connection with
the transaction (approval of all such proposals, the &ldquo;<U>Stockholder Approval</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(xvii) evidence that the Pre-Funded Warrant Shares
(as applicable) to be issued to the Purchasers have been approved for listing on the Principal Market, subject only to official notice
of issuance;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(xviii) evidence that all the outstanding class
A common stock of the Company has been converted to class B common stock; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">(xix)
such other instruments, certificates, documents or materials as may be reasonably requested by Purchaser in connection with the consummation
of the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) On or prior to the Closing
Date, each Purchaser shall deliver or cause to be delivered to the Company, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) this Agreement duly executed
by such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) the Registration Rights
Agreement duly executed by such Purchaser; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) to the Escrow Agent,
such Purchaser&rsquo;s Subscription Amount by wire transfer to the account specified by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3 <U>Closing Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The obligations of the
Company hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) the accuracy in all material
respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) on
the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which
case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) all obligations, covenants
and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) the delivery by each
Purchaser of the items set forth in Section 2.2(b) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-indent: 34pt">(iv) the execution by the Company and Clayton
Adams, in his individual capacity, of the Option Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-indent: 34pt"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt">(v) no statute, rule,
regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by any court or governmental
authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by the Transaction Documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 0.5in">(vi) The Company shall
have obtained in a timely fashion any and all consents, Material Permits, approvals, registrations and waivers necessary for consummation
of the purchase and sale of the Pre-Funded Warrants, including the Pre-Funded Warrant Shares (including all Required Approvals), all of
which shall be and remain so long as necessary in full force and effect; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 0.5in">(vii) HoD or its wholly-owned
subsidiary Dogecoin Ventures, Inc. shall have delivered the HoD Contribution as of the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The respective obligations
of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) the accuracy in all respects
when made of the representations and warranties of the Company contained herein (unless as of a specific date therein in which case they
shall be accurate as of such date) and the accuracy in all material respects (or, to the extent representations or warranties are qualified
by materiality or Material Adverse Effect, in all respects) on the Closing Date of the representations and warranties of the Company contained
herein (unless as of a specific date therein in which case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) all obligations, covenants
and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) the delivery by the
Company of the items set forth in Section 2.2(a) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iv) there shall have been
no Material Adverse Effect with respect to the Company since the date hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v) from the date hereof to
the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s principal Trading
Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been
suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or any
Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall
there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in
its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser,
makes it impracticable or inadvisable to purchase the Securities at the Closing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt">(vi) no statute, rule,
regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by any court or governmental
authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by the Transaction Documents;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 0.5in">(vii) the Company
shall have obtained in a timely fashion any and all consents, permits, approvals, registrations and waivers necessary for consummation
of the purchase and sale of the Pre-Funded Warrants, including the Pre-Funded Warrant Shares (including all Required Approvals), all of
which shall be and remain so long as necessary in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.95pt; text-align: justify; text-indent: 34.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.4 <U>Exchange Cap; Authorization
Amendment</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The
Company shall not be obligated to issue any Pre-Funded Warrant Shares, Strategic Advisor Warrant Shares or Placement Agent Warrant Shares
(collectively, &ldquo;<U>Exchange-Cap Securities</U>&rdquo;) to the Purchasers, HoD or the Placement Agent, as applicable, pursuant to
any of the Transaction Documents if the issuance, when aggregated with all prior issuances of Shares and Exchange-Cap Securities to such
Persons, would exceed the Exchange Cap, except that such limitation shall not apply in the event that (A) the Stockholder Approval contemplated
by Section 2.2(a)(xvi) becomes effective in accordance with its terms, or (B) the Company obtains a written opinion from outside counsel
to the Company that such approval is not required, which opinion shall be reasonably satisfactory to HoD and the holders of a majority
in interest of the Securities still held by the Purchasers. Until such approval is obtained (or the delivery of such opinion), (A) HoD
shall not be able to exercise the Strategic Advisor Warrant, (B) the Placement Agent shall not be able to exercise the Placement Agent
Warrant, and (C) no Purchaser shall be issued Pre-Funded Warrant Shares, upon exercise of any of its rights under the Pre-Funded Warrants,
in an amount greater than the product of the Exchange Cap multiplied by a fraction, the numerator of which is the total number of Shares
and shares of Common Stock underlying the Securities issued to such Purchaser pursuant to this Agreement on the Closing Date and the denominator
of which is the aggregate number of Shares and shares of Common Stock underlying all the Securities issued to all the Purchasers pursuant
to this Agreement (with respect to each Purchaser, the &ldquo;<U>Exchange Cap Allocation</U>&rdquo;). In the event that any holder of
Securities shall exercise all of such holder&rsquo;s rights under the Transaction Documents into a number of shares of Common Stock which,
in the aggregate, is less than such holder&rsquo;s Exchange Cap Allocation, then the difference between such holder&rsquo;s Exchange Cap
Allocation and the number of shares of Common Stock actually issued to such holder shall be allocated to the respective Exchange Cap Allocations
of the remaining holders of Securities on a pro rata basis in proportion to the shares of Common Stock underlying the Securities then
held by each such holder. The Pre-Funded Warrants, the Strategic Investor Warrants and the Placement Agent Warrants shall contain prohibitions
on the exercise of such warrants that are consistent with this Section 2.4(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The Pre-Funded Warrants,
the Strategic Investor Warrants and the Placement Agent Warrants shall also prohibit the exercise of such warrants until the Authorization
Amendment becomes effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE III.<BR>
REPRESENTATIONS AND WARRANTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1 <U>Representations and
Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part hereof
and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section of
the Disclosure Schedules, the Company hereby makes the following representations and warranties as of the date hereof and as of the Closing
Date (unless as of a specific date therein, in which case as of such date) to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Subsidiaries</U>. All
of the direct and indirect Subsidiaries of the Company are set forth in the SEC Reports or have otherwise been disclosed to Purchasers
by the Company. The Company owns, directly or indirectly, all of its capital stock or other equity interests of each Subsidiary free and
clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully
paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries,
all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Organization and Qualification</U>.
The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties
and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of
any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents.
Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary,
except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result
in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document or the Treasury Management Agreement,
(ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the
Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material
respect on a timely basis its obligations under any Transaction Document or the Treasury Management Agreement (any of (i), (ii) or (iii),
a &ldquo;<U>Material Adverse Effect</U>&rdquo;), and no Proceeding has been instituted in any such jurisdiction revoking, limiting or
curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Authorization; Enforcement</U>.
The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement
and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery
of this Agreement and each of the other Transaction Documents or the Treasury Management Agreement by the Company and the consummation
by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company,
and no further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or
therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party
or the Treasury Management Agreement has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance
with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in
accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization,
moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>No Conflicts</U>. The
execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party or the
Treasury Management Agreement, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby
and thereby do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate
or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or
an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties
or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental
authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any
property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could
not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>Filings, Consents and
Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing
or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the
execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant to Section
4.4 of this Agreement, (ii) the notice and/or additional listing application(s) to each applicable Trading Market for the listing of the
Pre-Funded Warrant Shares for trading thereon in the time and manner required thereby; (iii) the registration statement required to be
filed by the Registration Rights Agreement, (iv) the filing of Form D with the Commission and such filings as are required to be made
under applicable state securities laws, and (v) filing the Second Definitive Information Statement (as defined below) with the Commission
in connection with the August 22 Written Consent (as defined below) (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;). For greater
certainty, the Company is not required to submit an original listing application to the Company&rsquo;s principal Trading Market in connection
with the offer and sale of the Securities and effecting the Doge treasury strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Issuance of the Securities</U>.
The Pre-Funded Warrants are duly and validly authorized and, when issued and paid for in accordance with this Agreement, will be duly
and validly issued and constitute the legal, valid and binding obligations of the Company, enforceable against the Company in accordance
with their terms, free and clear of all Liens <FONT STYLE="text-decoration: underline double">imposed by the Company</FONT> other than
restrictions on transfer provided for in the Transaction Documents. The Pre-Funded Warrant Shares, when issued in accordance with the
terms of the Pre-Funded Warrants, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company
other than restrictions on transfer provided for in the Transaction Documents. The Company has reserved from its duly authorized capital
stock the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Pre-Funded Warrants. Subject to the accuracy
of the representations and warranties made by the Purchasers in Section 3.2, the offer and sale of the Securities to the Purchaser is
and will be in compliance with applicable exemptions from (i) the registration and prospectus delivery requirements of the Securities
Act and (ii) the registration and qualification requirements of applicable securities laws of the states of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) <U>Capitalization</U>.
The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule 3.1(g)</U> shall
also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof.
Except as set forth on <U>Schedule 3.1(g)</U>, the Company has not issued any capital stock since its most recently filed periodic report
under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&rsquo;s stock option plans, the
issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion
and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act.
No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions
contemplated by the Transaction Documents. Except as set forth in <U>Schedule 3.1(g)</U> or as a result of the purchase and sale of the
Securities (and the issuance of the Strategic Advisor Warrants and Placement Agent Warrants) there are no outstanding options, warrants,
scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible
into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock or the
capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or
may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance
and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any
Person (other than the Purchasers). There are no outstanding securities or instruments of the Company or any Subsidiary with any provision
that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities by the Company
or any Subsidiary. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or
similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is
or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or
&ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock of the
Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities
laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase
securities. No further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and
sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s
capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) <U>SEC Reports; Financial
Statements</U>. Since April 25, 2024, except as set forth on <U>Schedule 3.1(h)</U>, the Company has filed all reports, schedules, forms,
statements and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to
Section 13(a) or 15(d) thereof, (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein,
being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received a valid extension of
such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the
SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none
of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated
therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.
There are no material outstanding or unresolved comment letters from the staff of the Division of Corporate Finance of the Commission
with respect to any of the SEC Reports as of the date hereof. The Company has never been an issuer subject to Rule 144(i) under the Securities
Act. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements
and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have
been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods
involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial statements or the notes thereto and except
that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial
position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows
for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. No other
financial statements or supporting schedules are required to be included pursuant to the Exchange Act. The other financial and statistical
information included in the SEC Reports present fairly the information included therein and have been prepared on a basis consistent with
that of the financial statements that are included in the SEC Reports and the books and records of the Company. There are no material
off-balance sheet transactions, arrangements or obligations (including contingent obligations) of the Company or other persons that would
reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) <U>Material Changes; Undisclosed
Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within the SEC Reports, except
as set forth in <U>Schedule 3.1(i)</U>, (i) there has been no event, occurrence or development that has had or that could reasonably be
expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than
(A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities
not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings made with the Commission,
(iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of
cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital
stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company
stock option plans. The Company does not have pending before the Commission any request for confidential treatment of information. Except
for the issuance of the Securities contemplated by this Agreement and the entry into the Treasury Management Agreement, no event, liability,
fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company
or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition that would be required
to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been
publicly disclosed at least 1 Trading Day prior to the date that this representation is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) <U>Litigation</U>. Except
as set forth on <U>Schedule 3.1(j)</U>, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or,
to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before
or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth on <U>Schedule 3.1(j)</U>, (i) adversely affects or challenges
the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable
decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director
or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities
laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated,
any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission
has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary
under the Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) <U>Labor Relations</U>.
No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could
reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees is a member
of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company nor any of
its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships
with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary is, or is now expected
to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement
or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued
employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any
of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and
regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the
failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l) <U>Compliance</U>. Neither
the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived that, with
notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary
received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other
agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation
has been waived), (ii) is in violation of any judgment, decree, or order of any court, arbitrator or other governmental authority or (iii)
is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation
all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality
and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m) <U>Environmental Laws</U>.
The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution or protection
of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws
relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances
or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating to the manufacture, processing,
distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees,
demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued,
entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have received all permits licenses or other
approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance with
all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply could
be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n) <U>Regulatory Permits</U>.
The Company and the Subsidiaries possess all certificates, authorizations, approvals, consents, registrations, licenses qualifications,
certifications and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their
respective businesses as such businesses are described in the SEC Reports, except where the failure to possess such permits could not
reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material Permits</U>&rdquo;), and neither the Company nor any
Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o) <U>Title to Assets</U>.
The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable
title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and
clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere with the
use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment of federal, state
or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and the payment of which is neither delinquent
nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under
valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p) <U>Intellectual Property</U>.
The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service
marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary
or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to so have could
have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither the Company
nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated
or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement. Neither
the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC Reports,
a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of
any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company,
all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual
Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and
value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q) <U>Insurance</U>. The
Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited
to, directors and officers insurance coverage in amount deemed prudent by the Company. Neither the Company nor any Subsidiary has any
reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar
coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r) <U>Transactions with Affiliates
and Employees</U>. Except as set forth in <U>Schedule 3.1(r)</U>, none of the officers, directors or beneficial holders of 5% or more
of any class of capital shares of the Company, or officers or directors of the Company or any Subsidiary and, to the knowledge of the
Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary
(other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the
furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from
or lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company,
any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder,
member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii)
reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under
any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s) <U>Sarbanes-Oxley; Internal
Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements of the Sarbanes-Oxley
Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder
that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting
controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management&rsquo;s general
or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with
GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s general or specific
authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate
action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls
and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange
Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules and forms. The
Company has not received any notice of correspondence from its independent registered public accounting firm, governmental entity or other
Person relating to any potential material weakness in any part of the internal controls over financial reporting of the Company. The Company&rsquo;s
certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as
of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation
Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying
officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since
the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange
Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control
over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(t) <U>Certain Fees</U>. Except
for the fees and expenses of the Placement Agent, no brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company
or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with
respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees
or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in
connection with the transactions contemplated by the Transaction Documents. For the avoidance of doubt, the Purchasers acknowledge that
the Asset Manager will receive payment for services rendered under the Asset Management Agreement and will be reimbursed for the Asset
Management Fees in connection with providing services under the Asset Management Agreement and in each case, such payment for the Asset
Management Fees may be made to the Asset Manager directly out of the funds that the Asset Manager is managing which will include the proceeds
from this Offering.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(u) <U>Private Placement</U>.
Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, no registration under the Securities
Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated hereby. The issuance and sale
of the Securities hereunder does not contravene the rules and regulations of the Company&rsquo;s Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v) <U>Investment Company;
Commodity Status of Dogecoin</U>. The Company is not, and is not an Affiliate of, and immediately after giving effect to the receipt of
payment for the Securities and the application of the proceeds contemplated by Section 4.7, will not be, and will not be deemed to be,
nor will it be controlled by or be under common control with, an &ldquo;investment company&rdquo; within the meaning of, or otherwise
subject to registration or regulation under, the Investment Company Act of 1940, as amended (the &ldquo;<U>ICA</U>&rdquo;). In furtherance
of the foregoing, the Company represents and warrants that Dogecoin, which constitutes the principal asset that the Company expects to
acquire, hold, exchange, stake, transfer, lend, pledge, or otherwise use or dispose of with the proceeds of the offering, is properly
characterized as a &ldquo;commodity&rdquo; within the meaning of the Commodity Exchange Act of 1936, as amended (the &ldquo;<U>CEA</U>&rdquo;),
and the regulations, interpretations, and guidance of the Commodity Futures Trading Commission (&ldquo;<U>CFTC</U>&rdquo;) promulgated
thereunder, and is not, and will not be deemed to be, a &ldquo;security&rdquo; as that term is defined in Section 2(a)(1) of the Securities
Act of 1933, as amended, Section 3(a)(10) of the Securities Exchange Act of 1934, as amended, or any analogous provision of state &ldquo;blue
sky&rdquo; or other securities laws. The Company has a reasonable basis, after consultation with experienced counsel, for the conclusion
that Dogecoin constitute a commodity for all purposes of the federal commodities laws and are outside the scope of the federal securities
laws, and no governmental authority having jurisdiction over the Company, Dogecoin, or the transactions contemplated hereby has asserted
to the Company that Dogecoin should be treated as a security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(w) <U>Registration Rights</U>.
Except as disclosed in Schedule 3.1(w) and other than to each of the Purchasers pursuant to the Registration Rights Agreement, no Person
has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company
or any Subsidiary. Other than pursuant to the Registration Rights Agreement, no Person has any right to cause the Company to effect the
registration under the Securities Act covering the transfer of any securities of the Company and there are no other stockholders agreements,
voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a party or, to
the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(x) <U>NYSE American</U><FONT STYLE="font-size: 10pt">.
The issued and outstanding shares of Common Stock are registered pursuant to Section 12(b) of the Exchange Act and are listed for trading
on the NYSE American under the symbol &ldquo;ZONE&rdquo;. As of the date of this Agreement and the Closing Date, the Company is in compliance
with all listing and maintenance requirements of NYSE American applicable to the Company. As of the date of this Agreement and the Closing
Date, there is no suit, action, proceeding or investigation pending or, to the knowledge of the Company, threatened against the Company
by NYSE American or the Commission, respectively, to prohibit or terminate the listing of the Common Stock on the NYSE American or to
deregister the Common Stock under the Exchange Act. The Company has taken no action as of the date of this Agreement and the Closing Date
that is designed to terminate the registration of the Common Stock under the Exchange Act. The Company is, and has no reason to believe
that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The shares
of Common Stock are currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation
and the Company is current in payment of the fees to the Depositary Trust Company (or such other established clearing corporation) in
connection with such electronic transfer. The Company has taken no action as of the date of this Agreement that is designed to terminate,
or which to the knowledge of the Company is likely to have the effect of terminating, the registration of the Common Stock under the Exchange
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(y) <U>Application of Takeover
Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable any control
share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover
provision under the Company&rsquo;s articles of incorporation (or similar charter documents) or the laws of its state of incorporation
that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or exercising
their rights under the Transaction Documents, including without limitation as a result of the offer and sale of the Securities, by the
Company to the Purchasers as contemplated hereby and the Purchasers&rsquo; ensuing ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(z) <U>Disclosure</U>. Except
with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents and the Asset Management
Agreement and the representations made in Section 3.1(i), the Company confirms that neither it nor any other Person acting on its behalf
has provided any of the Purchasers or their agents or counsel with any information that it believes constitutes or might constitute material,
non-public information. The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting
transactions in securities of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding
the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules
to this Agreement, is true and correct and does not contain any untrue statement of a material fact or omit to state any material fact
necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading.
The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain
any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which they were made and when made, not misleading. The Company acknowledges
and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby
other than those specifically set forth in Section 3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(aa) <U>No Integrated Offering</U>.
Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, neither the Company, nor any of
its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or
solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with prior
or ensuing offerings by the Company for purposes of (i) the Securities Act which would require the registration of any such securities
under the Securities Act, (ii) eliminate the availability of the exemption from registration under Regulation D under the Securities Act
in connection with the offer and sale by the Company of the Securities or (iii) any applicable shareholder approval provisions of any
Trading Market on which any of the securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(bb) <U>Indebtedness</U>.
<U>Schedule 3.1(bb)</U> sets forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary,
or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means
(x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable or accrued payroll liabilities
incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness
of others, whether or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto),
except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of
business; and (z) the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance
with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(cc) <U>Tax Status</U>. The
Company and its Subsidiaries each (i) has made or filed all material United States federal, state and local income and all foreign income
and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all material taxes
and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and
declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent
to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due
by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.
No audits, examinations, or other proceedings with respect to any material amounts of taxes of the Company and its subsidiaries are presently
in progress or have been asserted or proposed in writing without subsequently being paid, settled or withdrawn. There are no liens on
any of the assets of the Company. At all times since inception, the Company has been and continues to be classified as a corporation for
U.S. federal income tax purposes. Neither the Company nor any of its Subsidiaries has been a United States real property holding corporation
within the meaning of Code Section 897(c)-2 during the period specified in Code Section 897(c)(1)(A)(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(dd) <U>No General Solicitation</U>.
Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities as contemplated hereby by
any form of &ldquo;general solicitation&rdquo; or &ldquo;general advertising&rdquo; (as such terms are defined in Regulation D under the
Securities Act). The Company and any Person acting on behalf of the Company has offered the Securities for sale as contemplated hereby
only to the Purchasers and certain other &ldquo;qualified purchasers&rdquo; within the meaning of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ee) <U>Foreign Corrupt Practices</U>.
Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf
of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other
unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government
officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully
any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which
is in violation of law or (iv) violated in any material respect any provision of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ff) <U>Accountants</U>. The
Company&rsquo;s accounting firm is set forth in the SEC Reports. To the knowledge and belief of the Company, such accounting firm (i)
is an independent registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to
the financial statements to be included in the Company&rsquo;s Annual Report on Form 10-K for the fiscal year ended June 30, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(gg) <U>No Disagreements with
Accountants and Lawyers</U>. There are no disagreements of any kind presently existing, or reasonably anticipated by the Company to arise,
between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company is current with respect
to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any of its obligations under
any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(hh) <U>Acknowledgment Regarding
Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that, to its knowledge, each of the Purchasers is acting
solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that, to its knowledge, no Purchaser is acting as a financial advisor or fiduciary of the Company
(or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given
by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions
contemplated thereby is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each
Purchaser that the Company&rsquo;s decision to enter into this Agreement and the other Transaction Documents has been based solely on
the independent evaluation of the transactions contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) <U>Acknowledgment Regarding
Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except for Sections
3.2(g) and 4.14 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked by the Company
to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or &ldquo;derivative&rdquo;
securities based on securities issued by the Company or to hold the Securities for any specified term, (ii) past or future open market
or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &ldquo;derivative&rdquo; transactions,
before or after the closing of this or future private placement transactions, may negatively impact the market price of the Company&rsquo;s
publicly-traded securities, (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to which any such Purchaser
is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the Common Stock and (iv) each Purchaser shall
not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo; transaction.
The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various times during
the period that the Securities are outstanding, including, without limitation, during the periods that the value of the Pre-Funded Warrant
Shares deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of
the existing stockholders&rsquo; equity interests in the Company at and after the time that the hedging activities are being conducted.
The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(jj) <U>Regulation M Compliance</U>.
The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause
or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any
of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities, or (iii)
paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other than,
in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(kk) <U>Employee Benefits</U>.
Except as would not be reasonably likely to result in a Material Adverse Effect, each Benefit Plan has been established and administered
in accordance with its terms and in compliance with the applicable provisions of ERISA, the Code, the Patient Protection and Affordable
Care Act of 2010, as amended, and other applicable laws, rules and regulations. The Company and its Subsidiaries are in compliance with
all applicable federal, state and local laws, rules and regulations regarding employment, except for any failures to comply that are not
reasonably likely, individually or in the aggregate, to have a Material Adverse Effect. There is no labor dispute, strike or work stoppage
against the Company or its Subsidiaries pending or, to the knowledge of the Company, threatened which may interfere with the business
activities of the Company, except where such dispute, strike or work stoppage is not reasonably likely, individually or in the aggregate,
to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ll) <U>Off Balance Sheet
Arrangements</U>. There is no transaction, arrangement, or other relationship between the Company or any of the Subsidiaries and an unconsolidated
or other off balance sheet entity that is required to be disclosed by the Company in its Exchange Act filings and is not so disclosed
or that otherwise could be reasonably likely to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(mm) <U>Stock Option Plans</U>.
Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance with the terms of the
Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common Stock on the date
such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company&rsquo;s stock option
plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly
grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement
of material information regarding the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(nn) <U>Office of Foreign
Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent, employee
or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets
Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(oo) <U>U.S. Real Property
Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section
897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(pp) <U>Bank Holding Company
Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended
(the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal Reserve</U>&rdquo;).
Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the
outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank or any entity that is
subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or Affiliates exercises
a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal
Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(qq) <U>Anti-Bribery and Anti-Money
Laundering Laws</U>. Each of the Company, its subsidiaries and, to the knowledge of the Company, any of their respective officers, directors,
supervisors, managers, agents, or employees are and have at all times been in compliance with and its participation in the offering will
not violate: (A) anti-bribery laws, including but not limited to, any applicable law, rule, or regulation of any locality, including but
not limited to any law, rule, or regulation promulgated to implement the OECD Convention on Combating Bribery of Foreign Public Officials
in International Business Transactions, signed December 17, 1997, including the U.S. Foreign Corrupt Practices Act of 1977, as amended,
the U.K. Bribery Act 2010, or any other law, rule or regulation of similar purposes and scope or (B) anti-money laundering laws, including,
but not limited to, applicable federal, state, international, foreign or other laws, regulations or government guidance regarding anti-money
laundering, including, without limitation, Title 18 US. Code sections 1956 and 1957, the Patriot Act, the Bank Secrecy Act, and international
anti-money laundering principles or procedures by an intergovernmental group or organization, such as the Financial Action Task Force
on Money Laundering, of which the United States is a member and with which designation the United States representative to the group or
organization continues to concur, all as amended, and any executive order, directive, or regulation pursuant to the authority of any of
the foregoing, or any orders or licenses issued thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(rr) <U>No Disqualification
Events</U>. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506(b) of Regulation D under the Securities
Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company
participating in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity securities,
calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with
the Company in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo; and, together, &ldquo;<U>Issuer Covered
Persons</U>&rdquo;) is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii) under
the Securities Act (a &ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3).
The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company
has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Purchasers a copy
of any disclosures provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ss) <U>Other Covered Persons</U>.
Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person) that has been or will be
paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(tt) <U>Notice of Disqualification
Events</U>. The Company will notify the Purchasers and the Placement Agent in writing, prior to the Closing Date of (i) any Disqualification
Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, become a Disqualification Event relating
to any Issuer Covered Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(uu) <U>No Additional Agreements</U>.
There are no agreements or understandings between the Company and any Purchaser with respect to the transactions contemplated by the Transaction
Agreements other than (i) as specified in the Transaction Agreements and (ii) any side letter agreements with any of the Purchasers in
connection with such other Purchaser&rsquo;s agreement to purchase Securities thereunder on terms particular to compliance with any law,
regulation or policy specifically applicable to such other Purchaser or its affiliates or related funds or in connection with the taxable
status of such other Purchaser or its affiliates or related funds or other terms that are immaterial to such Purchaser, which side letters
the Company has shared with all Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(vv) <U>Cybersecurity</U>.
To the knowledge of the Company, there has been no security breach or other compromise of or relating to any of the Company&rsquo;s or
any Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software, data (including the data of its respective
customers, employees, suppliers, vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively,
&ldquo;<U>IT Systems and Data</U>&rdquo;) and (y) the Company and the Subsidiaries have not been notified of, and has no knowledge of
any event or condition that would reasonably be expected to result in, any security breach or other compromise to its IT Systems and Data,
in each case, except as could not reasonably be expected to, individually or in the aggregate, have a Material Adverse Effect; (ii) the
Company and the Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations
of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy
and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation
or modification, except as would not, individually or in the aggregate, have a Material Adverse Effect; (iii) the Company and the Subsidiaries
have implemented and maintained commercially reasonable safeguards to maintain and protect its material confidential information and the
integrity, continuous operation, redundancy and security of all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented
backup and disaster recovery technology consistent with industry standards and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ww) <U>Compliance with Data
Privacy Laws</U>. The Company and its subsidiaries are, and at all prior times were, in material compliance with all applicable state,
federal and foreign data privacy and security laws and regulations regarding the collection, use, storage, retention, disclosure, transfer,
disposal, or any other processing (collectively &ldquo;<U>Process</U>&rdquo; or &ldquo;<U>Processing</U>&rdquo;) of Personal Data, including
without limitation HIPAA, the UK General Data Protection Regulation (&ldquo;<U>GDPR</U>&rdquo;), and all other local, state, federal,
national, supranational and foreign laws relating to the regulation of the Company or its subsidiaries, and the regulations promulgated
pursuant to such statutes and any state or non-U.S. counterpart thereof (collectively, the &ldquo;<U>Privacy Laws</U>&rdquo;). To ensure
material compliance with the Privacy Laws, the Company and its subsidiaries have in place, comply with, and take all appropriate steps
necessary to ensure compliance in all material respects with their policies and procedures relating to data privacy and security, and
the Processing of Personal Data and Confidential Data (the &ldquo;<U>Privacy Statements</U>&rdquo;). The Company and its subsidiaries
have, except as would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect, at all times
since inception provided accurate notice of their Privacy Statements then in effect to its customers, employees, third party vendors and
representatives. None of such disclosures made or contained in any Privacy Statements have been materially inaccurate, misleading, incomplete,
or in material violation of any Privacy Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xx) <U>Transactions with
Affiliates and Employees</U>. No relationship, direct or indirect, exists between or among the Company, on the one hand, and the directors,
officers, stockholders, customers or suppliers of the Company, on the other hand, that is required to be described in the SEC Reports
that is not so described.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xx) Prior Stockholder Consents;
<U>Information Statements</U>. On August 11, 2025, Company stockholders owning as of such date at least a majority of the outstanding
shares of class A common stock and class B common stock of the Company, voting together as a single class, duly executed a written consent
in lieu of a meeting, dated August 11, 2025 (the &ldquo;<U>August 11 Written Consent</U>&rdquo;), which authorized and approved an amendment
to the Company&rsquo;s Articles of Incorporation to increase the Company&rsquo;s authorized shares of class B common stock from 250,000,000
shares to 2,000,000,000 shares. On August 12, 2025, the Company filed a preliminary information statement on Schedule 14C with the Commission
with respect to the August 11 Written Consent (the &ldquo;<U>First Preliminary Information Statement</U>&rdquo;), on August 22, 2025,
the Company filed a definitive information statement on Schedule 14C with the Commission with respect to the August 11 Written Consent
(the &ldquo;<U>First Definitive Information Statement</U>&rdquo;), and, on August 22, 2025, the Company first mailed the First Definitive
Information Statement to its stockholders, in each case, in accordance with applicable law. On August 22, 2025, Company stockholders owning
as of such date at least a majority of the outstanding shares of class A common stock and class B common stock of the Company, voting
together as a single class, duly executed a written consent in lieu of a meeting, dated August 22, 2025 (the &ldquo;<U>August 22 Written
Consent</U>&rdquo; and, together with the August 11 Written Consent, the &ldquo;Written Consents&rdquo;), which approved the issuance
of up to $250 million of securities in one or more non-public offerings, on the terms and conditions described in the Second Preliminary
Information Statement (as defined below). On August 22, 2025, the Company filed a preliminary information statement on Schedule 14C with
the Commission with respect to the August 22 Written Consent (the &ldquo;<U>Second Preliminary Information Statement</U>&rdquo;) in accordance
with applicable law. The Written Consents were duly adopted in accordance with applicable law and the Company&rsquo;s Articles of Incorporation
and Bylaws, and no other stockholder consents or approvals are required from the Company&rsquo;s stockholders in order for the Company&rsquo;s
stockholders to approve the Authorization Amendment, the transactions contemplated by the Transaction Documents or the transactions as
an issuance greater than the Exchange Cap pursuant to Section 713 of the NYSE American LLC Company Guide for purposes of compliance with
NYSE American rules. Other than the completion of the procedures set forth herein and the approval for listing on the Principal Market
of the Pre-Funded Warrant Shares (as applicable) issued or to be issued to the Purchasers, subject only to official notice of issuance,
no further consent, approval, waiver, authorization, registration, license, qualification, certificate, notice or filing is required to
file and make effective the Authorization Amendment with the Secretary of State of Nevada.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2 <U>Representations and
Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, severally and not jointly, hereby represents
and warrants as of the date hereof and as of the Closing Date (unless as of a specific date therein, in which case they shall be accurate
as of such date) to the Company as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>(a) Organization; Authority</U>.
Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws
of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power
and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its
obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the
transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership, limited liability
company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a party has been duly
executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally
binding obligation of such Purchaser, enforceable against it in accordance with its terms, except (i) as limited by general equitable
principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement
of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief
or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Understandings or Arrangements</U>.
Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement or understandings
with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty not limiting such
Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal
and state securities laws). Such Purchaser understands that the Securities are &ldquo;restricted securities&rdquo; within the meaning
of, and have not been registered under, the Securities Act or any applicable state securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Investment Representations
and Warranties</U>. The Purchaser hereby represents and warrants that, as of the date of this Agreement and the Closing Date, it is, if
an entity, a &ldquo;qualified institutional buyer&rdquo; (as defined in Rule 144A under the Securities Act) or an institutional &ldquo;accredited
investor&rdquo; as that term is defined in Rule 501(a) under Regulation D promulgated pursuant to the Securities Act; or (ii) if an individual,
is an &ldquo;accredited investor&rdquo; as that term is defined in Rule 501(a) of Regulation D of the Securities Act and has such knowledge
and experience in financial and business matters as to be able to protect its own interests in connection with an investment in the Securities.
The Purchaser further represents and warrants that (x) it is capable of evaluating the merits and risk of such investment, and (y) that
it has not been organized for the purpose of acquiring the Securities and is an &ldquo;institutional account&rdquo; as defined by FINRA
Rule 4512(c). The Purchaser understands and agrees that the offering and sale of the Securities has not been registered under the Securities
Act or any applicable state securities laws and is being made in reliance upon federal and state exemptions for transactions not involving
a public offering which depend upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser&rsquo;s
representations as expressed herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Intent</U>. The Purchaser
is purchasing the Securities, solely for the Purchaser&rsquo;s own account and not for the account of others, and not with a view to the
resale or distribution of any part thereof in violation of the Securities Act, and the Purchaser has no present intention of selling,
granting any participation in, or otherwise distributing the same in violation of the Securities Act without prejudice, however, to the
Purchaser&rsquo;s right at all times to sell or otherwise dispose of all or any part of such Securities in compliance with applicable
federal and state securities laws. Notwithstanding the foregoing, if the Purchaser is purchasing the Securities as a fiduciary or agent
for one or more investor accounts, the Purchaser has full investment discretion with respect to each such account, and the full power
and authority to make the acknowledgements, representations and agreements herein on behalf of each owner of each such account. The Purchaser
has no present arrangement to sell the Securities to or through any person or entity. The Purchaser understands that the Securities must
be held indefinitely unless such Securities are resold pursuant to a registration statement under the Securities Act or an exemption from
registration is available. Nothing contained herein shall be deemed a representation or warranty by the Purchaser to hold the Securities
for any period of time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>Investment Experience;
Ability to Protect Its Own Interests and Bear Economic Risks</U>. The Purchaser acknowledges that it can bear the economic risk and complete
loss of its investment in the Securities and has knowledge and experience in finance, securities, taxation, investments and other business
matters as to be capable of evaluating the merits and risks of investments of the kind described in this Agreement and contemplated hereby,
and the Purchaser has had an opportunity to seek, and has sought, such accounting, legal, business and tax advice as the Purchaser has
considered necessary to make an informed investment decision. The Purchaser acknowledges that the Purchaser (i) is a sophisticated investor,
experienced in investing in private placements of equity securities and capable of evaluating investment risks independently, both in
general and with regard to all transactions and investment strategies involving a security or securities and (ii) has exercised independent
judgment in evaluating its participation in the purchase of the Securities. The Purchaser acknowledges that the Purchaser is aware that
there are substantial risks incident to the purchase and ownership of the Securities, including those set forth in the Company&rsquo;s
filings with the Commission. Alone, or together with any professional advisor(s), the Purchaser has adequately analyzed and fully considered
the risks of an investment in the Securities and determined that the Securities are a suitable investment for the Purchaser. The Purchaser
is, at this time and in the foreseeable future, able to afford the loss of the Purchaser&rsquo;s entire investment in the Securities and
the Purchaser acknowledges specifically that a possibility of total loss exists.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Independent Investment
Decision</U>. The Purchaser understands that nothing in the Transaction Agreements or any other materials presented by or on behalf of
the Company to the Purchaser in connection with the purchase of the Securities constitutes legal, tax or investment advice. The Purchaser
has consulted such professional advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with its purchase
of the Securities hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) <U>Securities Not Registered;
Legends</U>. The Purchaser acknowledges and agrees that the Securities are being offered in a transaction not involving any public offering
within the meaning of the Securities Act, and the Purchaser understands that the Securities have not been registered under the Securities
Act, by reason of their issuance by the Company in a transaction exempt from the registration requirements of the Securities Act, and
that the Securities must continue to be held and may not be offered, resold, transferred, pledged or otherwise disposed of by the Purchaser
unless a subsequent disposition thereof is registered under the Securities Act or is exempt from such registration and in each case in
accordance with any applicable securities laws of any state of the United States. The Purchaser understands that the exemptions from registration
afforded by Rule 144 (the provisions of which are known to it) promulgated under the Securities Act depend on the satisfaction of various
conditions including, but not limited to, the time and manner of sale, the holding period and on requirements relating to the Company
which are outside of the Purchaser&rsquo;s control and which the Company may not be able to satisfy, and that, if applicable, Rule 144
may afford the basis for sales only in limited amounts. The Purchaser acknowledges and agrees that it has been advised to consult legal
counsel prior to making any offer, resale, transfer, pledge or disposition of any of the Securities. The Purchaser acknowledges that no
federal or state agency has passed upon or endorsed the merits of the offering of the Securities or made any findings or determination
as to the fairness of this investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Purchaser understands
that any certificates or book entry notations evidencing the Securities may bear one or more legends in substantially the following form
and substance:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 7%; text-align: left"></TD><TD STYLE="text-align: justify; width: 86%">&ldquo;THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES.
THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED UNLESS (I) SUCH SECURITIES HAVE BEEN REGISTERED
FOR SALE PURSUANT TO THE SECURITIES ACT, (II) SUCH SECURITIES MAY BE SOLD PURSUANT TO AN EXEMPTION FROM REGISTRATION SUCH AS RULE 144
UNDER THE SECURITIES ACT, (III) THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO IT THAT SUCH TRANSFER MAY LAWFULLY
BE MADE WITHOUT REGISTRATION UNDER THE SECURITIES ACT, OR (IV) THE SECURITIES ARE TRANSFERRED WITHOUT CONSIDERATION TO AN AFFILIATE OF
SUCH HOLDER OR A CUSTODIAL NOMINEE (WHICH FOR THE AVOIDANCE OF DOUBT SHALL REQUIRE NEITHER CONSENT NOR THE DELIVERY OF AN OPINION).&rdquo;</TD>
    <TD STYLE="width: 7%">&nbsp;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the Securities
may contain a legend regarding affiliate status of the Purchaser, if applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) <U>No General Solicitation</U>.
The Purchaser acknowledges and agrees that the Purchaser is purchasing the Securities directly from the Company. Purchaser became aware
of this offering of the Securities solely by means of direct contact from the Placement Agent or directly from the Company as a result
of a pre-existing, substantive relationship with the Company or the Placement Agent, and/or their respective advisors (including, without
limitation, attorneys, accountants, bankers, consultants and financial advisors), agents, control persons, representatives, affiliates,
directors, officers, managers, members, and/or employees, and/or the representatives of such persons. The Securities were offered to Purchaser
solely by direct contact between Purchaser and the Company, the Placement Agent and/or their respective representatives. Purchaser did
not become aware of this offering of the Securities, nor were the Securities offered to Purchaser, by any other means, and none of the
Company and/or its respective representatives (other than the Placement Agent acting as a broker-dealer) acted as investment advisor,
broker or dealer to Purchaser. The Purchaser is not purchasing the Securities as a result of any general or public solicitation or general
advertising, or publicly disseminated advertisement, article, notice or other communication regarding the Securities published in any
newspaper, magazine or similar media or broadcast over television, radio or the internet or presented at any seminar or any other general
solicitation or general advertisement, including any of the methods described in Section 502(c) of Regulation D under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) <U>Risk Factors</U>. The
Purchaser understands and acknowledges that its purchase of the Securities is a speculative investment that involves a high degree of
risk and the potential loss of their entire investment and has carefully read and considered the matters and Risk factors set forth in
the SEC Reports and in <U>Exhibit G</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) <U>Certain Trading Activities</U>.
Other than consummating the transaction contemplated hereby, the Purchaser has not, nor has any Person acting on behalf of or pursuant
to any understanding with the Purchaser, directly or indirectly executed any purchases or sales, including Short Sales, of the securities
of the Company during the period commencing as of the time that the Purchaser was first contacted by the Company or any other Person acting
on the Company&rsquo;s behalf regarding the transaction contemplated hereby and ending immediately prior to the date of this Agreement.
Notwithstanding the foregoing, in the case of an Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers
manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions
made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only
apply with respect to the portion of the assets managed by the portfolio manager that made the investment decision to purchase the Securities
covered by this Agreement. Other than to other Persons party to this Agreement and to its advisors and agents who had a need to know such
information, the Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including
the existence and terms of this transaction). Notwithstanding the foregoing, for avoidance of doubt, nothing contained herein shall constitute
a representation or warranty, or preclude any actions, with respect to the identification of the availability of, or securing of, available
shares to borrow in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) <U>Disqualification Event</U>.
To the extent the Purchaser is one of the covered persons identified in Rule 506(d)(1), the Purchaser represents that no Disqualification
Event is applicable to the Purchaser or any of its Rule 506(d) Related Parties (as defined below), except, if applicable, for a Disqualification
Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is applicable. The Purchaser hereby agrees that it shall notify the Company promptly
in writing in the event a Disqualification Event becomes applicable to the Purchaser or any of its Rule 506(d) Related Parties, except,
if applicable, for a Disqualification Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is applicable. For purposes of this Section,
&ldquo;<U>Rule 506(d) Related Party</U>&rdquo; means a person or entity that is a beneficial owner of the Purchaser&rsquo;s securities
for purposes of Rule 506(d) of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l) <U>Access to Information</U>.
Such Purchaser acknowledges and agrees that other than materials that were prepared by the Company and expressly approved by the Company
for dissemination by the Placement Agent to the Purchaser, if any, , neither the Placement Agent nor any Affiliate of the Placement Agent
has provided such Purchaser with any information or advice with respect to the Securities nor is such information or advice necessary
or desired. Such Purchaser further acknowledges and agrees that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities
and the merits and risks of investing in the Securities; (ii) access to publicly available information about the Company and its financial
condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and
(iii) the opportunity to obtain such additional publicly available information that the Company possesses or can acquire without unreasonable
effort or expense that is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges
and agrees that neither the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any such information
or advice with respect to the Securities nor is such information or advice necessary or desired from the Placement Agent or any Affiliate
of the Placement Agent. Neither the Placement Agent nor any Affiliate has made or makes any representation as to the Company or the quality
of the Securities. The Placement Agent and any Affiliate may have acquired non-public information with respect to the Company which such
Purchaser agrees need not be provided to it. In connection with the issuance of the Securities to such Purchaser, neither the Placement
Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m) <U>Investment Company
Act Acknowledgment</U>. The Purchaser acknowledges that the Company&rsquo;s representation in Section 3.1(v) is based solely upon the
Company&rsquo;s operations and intended operations as they exist as of the date of this Agreement and the Closing Date, including the
Company&rsquo;s present intention to use the proceeds from the sale of Securities under this Agreement as described in Section 4.7, and
that the Company&rsquo;s status as an &ldquo;investment company&rdquo; is subject to change based upon one or more changes in the laws
or regulations regarding the Company&rsquo;s operations by one or more governmental authorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n) <U>Certain Transactions
and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has any Person acting
on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or sales, including Short
Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first received a term sheet (written
or oral) from the Company or any other Person representing the Company setting forth the material terms of the transactions contemplated
hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed
investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers
have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s
assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that
made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement
or to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors, partners, legal and other advisors,
employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this
transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing
contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares
in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company acknowledges and agrees that the representations
contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on the Company&rsquo;s representations
and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document, or any other
document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated
hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty,
or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and each of the Purchasers acknowledge
and agree that no party to this Agreement has made or makes any representations or warranties with respect to the transactions contemplated
hereby other than those specifically set forth in this Article III and the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE IV.<BR>
OTHER AGREEMENTS OF THE PARTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1 <U>Transfer Restrictions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The Securities may only
be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities other than pursuant
to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection with a pledge as
contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of counsel selected
by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to
the Company, to the effect that such transfer does not require registration under the Securities Act. As a condition of transfer (other
than pursuant to an effective Registration Statement or Rule 144), any such transferee shall agree in writing to be bound by the terms
of this Agreement and the Registration Rights Agreement and shall have the rights and obligations of a Purchaser under this Agreement
and the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The Purchasers agree to
the imprinting, so long as is required by this Section 4.1, of a legend in the form set forth in Section 3.2(g) hereof. The Company acknowledges
and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant
a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo; as defined
in Rule 501(a) of Regulation D under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer
pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company
and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no
notice shall be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable
documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities,
including, if the Securities are subject to registration pursuant to Section 4.4 of this Agreement, the preparation and filing of any
required prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately
amend the list of selling stockholders thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) Certificates evidencing
the Pre-Funded Warrant Shares shall not contain any legend (including the legend set forth in Section 3.2(g), (i) while a registration
statement (including the Registration Statement) covering the resale of such security is effective under the Securities Act, (ii) following
any sale of such Pre-Funded Warrant Shares pursuant to Rule 144, (iii) if such Pre-Funded Warrant Shares may be sold under Rule 144, without
the requirement for the Company to be in compliance with the current public information requirement under Rule 144 as to such Pre-Funded
Warrant Shares and without volume or manner-of-sale restrictions under Rule 144, or (iv) if such legend is not required under applicable
requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission). The
Company shall cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser promptly after the Effective Date if required
by the Transfer Agent to effect the removal of the legend hereunder, or if requested by a Purchaser, respectively. If all or any portion
of a Pre-Funded Warrant is exercised at a time when there is an effective registration statement to cover the resale of the Pre-Funded
Warrant Shares, or if the Pre-Funded Warrant Shares may be sold under Rule 144 and the Company is then in compliance with the current
public information required under Rule 144, or if the Pre-Funded Warrant Shares may be sold under Rule 144 without the requirement for
the Company to be in compliance with the current public information required under Rule 144 as to such Pre-Funded Warrant Shares or if
such legend is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements
issued by the staff of the Commission), then such Pre-Funded Warrant Shares shall be issued free of all legends. The Company shall cause
its counsel to issue a legal opinion to the Transfer Agent promptly after the Effective Date if required by the Transfer Agent to effect
the removal of the legend hereunder or if reasonably required by a Purchaser. The Company agrees that following the Effective Date or
at such time as such legend is no longer required under this Section 4.1(c), it will, no later than the earlier of (i) one (1) Trading
Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser
to the Company or the Transfer Agent of a certificate representing the Pre-Funded Warrant Shares, as the case may be, issued with a restrictive
legend (such date, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to be delivered to such Purchaser a certificate representing
such shares that is free from all restrictive and other legends. The Company may not make any notation on its records or give instructions
to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4.1. Certificates for Securities subject to
legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser&rsquo;s
prime broker with the Depository Trust Company as directed by such Purchaser. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of a certificate representing Pre-Funded Warrant Shares issued with a restrictive
legend. The Purchaser shall provide the Company written notice of a removal request (the &ldquo;<U>Request Notice</U>&rdquo;) at least
one (1) Trading Day prior to delivery of the legended Share certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) In addition to such Purchaser&rsquo;s
other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated damages and not as a penalty, for each
$1,000 of Pre-Funded Warrant Shares (based on the VWAP of the Common Stock on the date such Securities are submitted to the Transfer Agent)
delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading Day (increasing to $20 per Trading Day
five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the Legend Removal Date (or, if later, four
days after the Request Notice date) until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and
deliver (or cause to be delivered) to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to
the Company by such Purchaser that is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser
purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of
all or any portion of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion
of the number of shares of Common Stock that such Purchaser anticipated receiving from the Company without any restrictive legend, then,
an amount equal to the excess of such Purchaser&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket
expenses, if any) for the Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;<U>Buy-In
Price</U>&rdquo;) over the product of (A) such number of Pre-Funded Warrant Shares that the Company was required to deliver to such Purchaser
by the Legend Removal Date multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing
on the date of the delivery by such Purchaser to the Company of the applicable Pre-Funded Warrant Shares and ending on the date of such
delivery and payment under this clause (ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) The Purchasers agree with
the Company that such Purchaser will sell any Securities pursuant to either the registration requirements of the Securities Act, including
any applicable prospectus delivery requirements, or an exemption therefrom, and that if Securities are sold pursuant to a Registration
Statement, they will be sold in compliance with the plan of distribution set forth therein, and acknowledges that the removal of the restrictive
legend from certificates representing Securities as set forth in this Section 4.1 is predicated upon the Company&rsquo;s reliance upon
this understanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2 <U>Furnishing of Information;
Public Information</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) For at least two years
after the Closing Date, the Company covenants to maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange
Act and to timely file (or timely obtain extensions in respect thereof and file within the applicable grace period) all reports required
to be filed by the Company with the Commission after the date hereof pursuant to the Exchange Act even if the Company is not then subject
to the reporting requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) At any time during the
period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the Securities of a Purchaser
may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation
pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current public information requirement under Rule 144(c)
or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or becomes such an issuer in the future, and the Company shall fail to
satisfy any condition set forth in Rule 144(i)(2) (a &ldquo;<U>Public Information Failure</U>&rdquo;) then, in addition to such Purchaser&rsquo;s
other available remedies, the Company shall pay to that Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason
of any such delay in or reduction of its ability to sell the Securities, an amount in cash equal to $1,000 per day of a Public Information
Failure until the earlier of (a) the date such Public Information Failure is cured and (b) such time that such public information is no
longer required for that Purchaser to transfer the Pre-Funded Warrant Shares pursuant to Rule 144. The payments to which a Purchaser shall
be entitled pursuant to this Section 4.2(b) are referred to herein as &ldquo;<U>Public Information Failure Payments</U>.&rdquo; Public
Information Failure Payments shall be paid on the earlier of (i) the last day of the calendar month during which such Public Information
Failure Payments are incurred and (ii) the third (3<SUP>rd</SUP>) Business Day after the event or failure giving rise to the Public Information
Failure Payments is cured. In the event the Company fails to make Public Information Failure Payments in a timely manner, other than during
the pendency of any bona fide dispute over whether an alleged Public Information Failure has occurred, such Public Information Failure
Payments shall bear interest at the rate of 1.5% per month (prorated for partial months) until paid in full. Nothing herein shall limit
such Purchaser&rsquo;s right to pursue actual damages for the Public Information Failure, and such Purchaser shall have the right to pursue
all remedies available to it at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3 <U>Integration</U>. The
Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section
2 of the Securities Act) that would be integrated with the offer or sale of the Securities hereunder in a manner that would require the
registration under the Securities Act of the sale of the Securities hereunder or that would be integrated with the offer or sale of the
Securities hereunder for purposes of the rules and regulations of any Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4 <U>Securities Laws Disclosure;
Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of the transactions contemplated
hereby (including the entry into and material terms of the Asset Management Agreement), and (b) file a Current Report on Form 8-K, including
the Transaction Documents and such press release as exhibits thereto (and the Asset Management Agreement as an exhibit thereto, or a summary
of the material terms thereof), with the Commission within the time required by the Exchange Act. From and after the issuance of such
press release, the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered
to any of the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents
in connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such press
release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written
or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates
on the one hand, and any of the Purchasers or any of their Affiliates on the other hand, shall terminate. The Company and each Purchaser
shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the
Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior consent of
the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press
release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in
which case the disclosing party only shall promptly provide the other party with prior notice of such public statement or communication.
Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser
in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except
(a) as required by federal securities law in connection with (i) any registration statement contemplated by this Agreement and the Registration
Rights Agreement, (ii) the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required
by law or Trading Market regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted
under this clause (b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5 <U>Shareholder Rights
Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is
an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents
or under any other agreement between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6 <U>Non-Public Information</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents and the Treasury
Management Agreement, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other
Person acting on its behalf will provide or has provided any Purchaser or its agents or counsel with any information that constitutes,
or the Company reasonably believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented
to the receipt of such information and agreed with the Company to keep such information confidential. The Company understands and confirms
that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that
the Company delivers any material, non-public information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants
and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective
officers, directors, agents, employees or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers,
directors, agents, employees or Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser
shall remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains,
material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the
Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the
foregoing covenant in effecting transactions in securities of the Company. The Company acknowledges and agrees that any failure to timely
cleanse any material, non-public information shall entitle the Purchasers to seek injunctive relief and/or damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7 <U>Use of Proceeds</U>.
The Company shall deliver the net proceeds from the sale of the Securities hereunder to the Asset Manager on the Closing Date to be allocated
to fund the acquisition of cryptocurrency and the establishment of the Company&rsquo;s cryptocurrency treasury operations. The Company
shall use the net proceeds from the sale of the Securities hereunder as follows: (a) up to $1,100,000 shall be used to pay off the Company&rsquo;s
outstanding Indebtedness, (b) $4,400,000 shall be allocated to fund the Company&rsquo;s working capital and for general corporate purposes,
and (c) the balance of the net proceeds shall be used to acquire Dogecoin. The Company shall not use such proceeds: (a) for the redemption
of any Common Stock or Common Stock Equivalents, (b) for the settlement of any outstanding litigation, or (c) in violation of FCPA or
OFAC regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8 <U>Indemnification of
Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors, officers,
shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such
titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section
15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or
employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title
or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any and all losses, liabilities,
obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and
reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of or relating
to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other
Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates,
by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated
by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party&rsquo;s representations,
warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such
stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which
is finally judicially determined to constitute fraud, gross negligence or willful misconduct). If any action shall be brought against
any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify
the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably
acceptable to the Purchaser Party, and such counsel shall provide regular and timely progress updates to the Purchasers. Any Purchaser
Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses
of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has been specifically
authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ
counsel or (iii) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the
position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees
and expenses of no more than one such separate counsel. The Company may not settle, compromise or consent to the entry of any judgment
in any pending or threatened action in which indemnification may be sought by any Purchaser Party hereunder (whether or not any Purchaser
Party is an actual or potential party thereto), without the prior written consent of each such Purchaser Party (which will not be unreasonably
delayed or withheld) unless such settlement, compromise or consent provides for an unconditional and irrevocable release of each such
Purchaser Party from any and all liability arising out of such Claim. The Company will not be liable to any Purchaser Party under this
Agreement (y) for any settlement by a Purchaser Party effected without the Company&rsquo;s prior written consent, which shall not be unreasonably
withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser
Party&rsquo;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement
or in the other Transaction Documents. The indemnification required by this Section 4.8 shall be made by periodic payments of the amount
thereof during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained
herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities
the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.9 <U>Reservation of Common
Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times,
free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant
to this Agreement. Until the Authorization Amendment becomes effective, the Company shall not reserve for issuance the Pre-Funded Warrant
Shares issuable pursuant to any exercise of the Pre-Funded Warrants, Placement Agent Warrant Shares issuable pursuant to any exercise
of the Placement Agent Warrants, and Strategic Advisor Warrant Shares issuable pursuant to any exercise of the Strategic Advisor Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10 <U>Listing of Common
Stock</U>. The Company hereby agrees to use its best efforts to maintain the listing or quotation of the Common Stock on the Trading Market
on which it is currently listed, and the Company shall apply to list or quote all of the Pre-Funded Warrant Shares and the Strategic Advisor
Warrant Shares on such Trading Market prior to the Closing and promptly secure the listing of all of the Pre-Funded Warrant Shares on
such Trading Market prior to Closing. The Company further agrees, if the Company applies to have the Common Stock traded on any other
Trading Market, it will then include in such application all of the Pre-Funded Warrant Shares and will take such other action as is necessary
to cause all of the Pre-Funded Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company
will then take all action reasonably necessary to maintain the listing and trading of its Common Stock on a Trading Market and will comply
in all respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The
Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another
established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other
established clearing corporation in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11 <U>Management Appointments</U>.
The authorized size of the Board of Directors (the &ldquo;<U>Board</U>&rdquo;) shall not exceed five (5) members. Effective as of the
Closing, the Board shall fill two (2) vacancies on the Board by appointing the individuals designated by HoD, it being acknowledged that
Alexander Benjamin Spiro and Timothy Stebbing are the initial individuals so designated and agreed to by the Board and HoD (each, together
with any successor designated in accordance with this Section 4.11, an &ldquo;<U>HoD Director</U>&rdquo;). For so long as HoD continues
to hold any shares of the Company&rsquo;s Common Stock, in the event that an HoD Director resigns, is removed, dies, or becomes disabled,
HoD shall have the right to designate one or more replacement directors reasonably acceptable to the Board (each, a &ldquo;<U>Replacement
HoD Director</U>&rdquo;). Upon receipt of written notice from HoD identifying (i) the HoD Director who has resigned, died, or become disabled,
and (ii) the individual nominated to serve as the Replacement HoD Director, the Board shall promptly evaluate the Replacement HoD Director
and confirm whether the Replacement HoD Director is reasonably satisfactory to the Board and upon such determination shall promptly (and
in any event within five (5) Business Days) deliver the written request contemplated by the applicable Director Agreement, accept the
tendered resignation (if applicable), and take all corporate action necessary to appoint the Replacement HoD Director to the resulting
vacancy. Concurrently with the Closing, the Company shall appoint (a) Marco Margiatto to the Company&rsquo;s management team and (b) a
finance executive reasonably acceptable to the Board and designated by HoD (the &ldquo;<U>Finance Executive</U>&rdquo;). For so long as
HoD continues to hold any shares of the Company&rsquo;s Common Stock, in the event that either Marco Margiatto or the Finance Executive
resigns, dies, or becomes disabled, HoD may, subject to the Board&rsquo;s reasonable approval, nominate one or more replacement individuals
reasonably acceptable to the Board, and the Company shall take all corporate action necessary to effect any such replacement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.12 <U>Subsequent Equity
Sales</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) From the date hereof until
thirty (30) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or
announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement
or amendment or supplement thereto, other than (A) a registration statement on Form S-8 in connection with any employee benefit plan;
provided, however, the Company will be permitted to enter into a sales agreement with the Placement Agent and such other sales agents
as the Placement Agent may designate (each, a &ldquo;<U>Sales Agreement</U>&rdquo;) providing for the sale of shares of Common Stock in
an &ldquo;at-the-market&rdquo; offering, and file any such prospectus supplement or registration statement with the Commission in connection
with such Sales Agreement or (B) the registration statement described in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) Notwithstanding the foregoing,
this Section 4.12 shall not apply in respect of an Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.13 <U>Equal Treatment of
Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend
or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is also offered to
all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right granted to each
Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class
and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting
of Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.14 <U>Certain Transactions
and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it, nor any Affiliate
acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales, of any of the
Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such time that the transactions
contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4. Each Purchaser,
severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement
are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4, such Purchaser will maintain
the confidentiality of the existence and terms of this transaction and the information included in the Disclosure Schedules. Notwithstanding
the foregoing and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees
that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities
of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial
press release as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any
securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by
this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser shall
have any duty of confidentiality or duty not to trade in the securities of the Company to the Company or its Subsidiaries after the issuance
of the initial press release as described in Section 4.4. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed
investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers
have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s
assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made
the investment decision to purchase the Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.15 <U>Form D; Blue Sky Filings</U>.
The Company agrees to timely file a Form D with respect to the Securities as required under Regulation D under the Securities Act and
to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under
applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States and shall provide evidence of such actions promptly
upon request of any Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.16 <U>Acknowledgment of
Dilution</U>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding Common Stock, which
dilution may be substantial under certain market conditions. The Company further acknowledges that its obligations under the Transaction
Documents, including, without limitation, its obligation to issue the Pre-Funded Warrant Shares pursuant to the Transaction Documents,
are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of
any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive effect that such issuance may
have on the ownership of the other stockholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.17 <U>Exercise Procedures</U>.
The form of Notice of Exercise included in the Pre-Funded Warrants set forth the totality of the procedures required of the Purchasers
in order to exercise the Pre-Funded Warrants. No additional legal opinion, other information or instructions shall be required of the
Purchasers to exercise their Pre-Funded Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be
required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in
order to exercise the Pre-Funded Warrants. The Company shall honor exercises of the Pre-Funded Warrants and shall deliver Pre-Funded Warrant
Shares in accordance with the terms, conditions and time periods set forth in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.18 <U>Lock-Up Agreements</U>.
The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements without the prior written consent
of the Placement Agent, except to extend the term of the lock-up period, and shall enforce the provisions of each Lock-Up Agreement in
accordance with its terms. If any party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly
use its best efforts to seek specific performance of the terms of such Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt">4.19 <U>Principal Market
Compliance</U>. In the event that the Principal Market requires the Company to (i) modify the terms of this Agreement or any of the transactions
contemplated hereby, or (ii) take any other action in connection with the transactions contemplated by this Agreement that necessitates
the cooperation, consent, or action of the Purchasers, including, without limitation, the execution of any amendment to this Agreement
or any related Transaction Documents, each Purchaser hereby covenants and agrees to cooperate in good faith with the Company and to take
all such actions, execute and deliver all such documents, and provide all such information as may be reasonably requested by the Company
to effectuate any such modification or action, in each case to the extent necessary to satisfy any concerns or requirements of the Principal
Market in connection with the transactions contemplated by this Agreement. Notwithstanding the foregoing, if any modification or action
required by the Principal Market would adversely affect a Purchaser&rsquo;s rights or obligations under this Agreement or the related
transaction documents, such Purchaser shall have the option, in its sole discretion, to either (a) agree to such modification or action,
or (b) terminate this Agreement with respect to itself upon written notice to the Company, whereupon this Agreement shall be of no further
force or effect with respect to such Purchaser (except for those provisions that expressly survive termination).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt">4.20 <U>Information
Statement</U>. The Company shall file a definitive information statement on Schedule 14C with the Commission with respect to the August
22 Written Consent on September 2, 2025 (the &ldquo;Second Definitive Information Statement&rdquo;), and shall first mail the Second Definitive
Information Statement to its stockholders on or prior to September 5, 2025, in each case, in accordance with applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-indent: 34pt"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-indent: 34pt">4.21 <U>Filing of Authorization Amendment</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The Company shall, as
promptly as practicable following the Closing Date (and in any event within twenty-one (21) days after the mailing of the First Definitive
Information Statement, prepare, execute and file with the Secretary of State of the State of Nevada the Authorization Amendment in form
and substance reasonably acceptable to HoD and the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The Company shall use
its commercially reasonable best efforts to cause the Authorization Amendment to become effective under the laws of the State of Nevada
as promptly as practicable following its filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) The Company shall not
take any action or omit to take any action that would materially delay, prevent or impair (i) the filing or effectiveness of the Authorization
Amendment, or (ii) the Company&rsquo;s ability to reserve and issue, upon exercise of the Pre-Funded Warrants, Strategic Advisor Warrants
or Placement Agent Warrants, the shares of Common Stock issuable thereunder in accordance with the terms of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt">4.22 <U>Redemption
Right</U>. In the event that the Authorization Amendment is not effective within ninety (90) days from the date hereof, each Purchaser
shall have the right, exercisable for a period of fifteen (15) days to require the Company to (i) redeem the Pre-Funded Warrant purchased
by such Purchaser pursuant to this Agreement at a per Pre-Funded Warrant redemption price equal to the Per PFW Purchase Price minus the
Pre-Funded Warrant exercise price of $0.0001; and (ii) pay the amount of any unpaid liquidated damages owed (if any) to such Purchaser
pursuant to the terms of the Pre-Funded Warrants and the Registration Rights Agreement (as applicable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE V.<BR>
MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1 <U>Termination</U>. This
Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated
on or before the fifth (5th) Trading Day following the date hereof; provided, however, that no such termination will affect the right
of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2 <U>Fees and Expenses</U>.
Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers,
counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation,
execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any
fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered by a Purchaser),
stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers, as well as fees and
expenses of the Asset Manager (including the expenses of its representatives) (the &ldquo;<U>Asset Management Fees</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3 <U>Entire Agreement</U>.
The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties with respect
to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such
matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.4 <U>Notices</U>. Any and
all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed
given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via email attachment
at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day,
(b) the next Trading Day after the time of transmission, if such notice or communication is delivered viaemail attachment at the email
address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City
time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices
and communications shall be as set forth on the signature pages attached hereto. To the extent that any notice provided pursuant to any
Transaction Document constitutes, or contains material, non-public information regarding the Company or any of the Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.5 <U>Amendments; Waivers</U>.
No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of
an amendment or waiver, by the Company, HoD and each Purchaser (or, prior to the Closing Date, the Company and each Purchaser). No waiver
of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in
the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay
or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed amendment or
waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser relative to the comparable
rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment
effected in accordance with this Section 5.5 shall be binding upon each Purchaser, holder of Securities and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.6 <U>Headings</U>. The headings
herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.7 <U>Successors and Assigns</U>.
This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may
not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger).
Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities,
provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction
Documents that apply to the &ldquo;Purchasers&rdquo; (other than in respect of a transfer pursuant to an effective registration statement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.8 <U>Third-Party Beneficiaries</U>.
The Placement Agent shall be the third-party beneficiary of the representations and warranties of the Company in Section 3.1 and the representations
and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit of the parties hereto and their respective
successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except
as otherwise set forth in Section 4.8 and this Section 5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.9 <U>Governing Law</U>.
All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by
and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action
or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section
4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.10 <U>Survival</U>. The
representations, warranties, agreements and covenants contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.11 <U>Execution</U>. This
Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered or by e-mail delivery of a &ldquo;.pdf&rdquo;
format data file or DocuSign, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such
signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; or DocuSign signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.12 <U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.13 <U>Rescission and Withdrawal
Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction
Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not
timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion
from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to
its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission of an exercise of a Pre-Funded Warrant,
the applicable Purchaser shall be required to return any Common Stock subject to any such rescinded exercise notice concurrently with
the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration of such Purchaser&rsquo;s
right to acquire such shares pursuant to such Purchaser&rsquo;s Pre-Funded Warrant (including, issuance of a replacement warrant certificate
evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.14 <U>Replacement of Securities</U>.
If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to
be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor,
a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction.
The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including
customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.15 <U>Remedies</U>. In addition
to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and
the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not
be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby
agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would
be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.16 <U>Payment Set Aside</U>.
To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces
or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are
subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded,
repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any
bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation
or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not
been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.17 <U>Independent Nature
of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several and not
joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For
reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through
the legal counsel to the Placement Agent. The legal counsel of the Placement Agent does not represent any of the Purchasers and only represents
the Placement Agent. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience
of the Company and not because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that
each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and
not between the Company and the Purchasers collectively and not between and among the Purchasers. Each Purchaser shall be entitled to
independently protect and enforce its rights, including without limitation the rights arising out of this Agreement or out of the other
Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for
such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents.
The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and
not because it was required or requested to do so by any Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.18 <U>Liquidated Damages</U>.
The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing
obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding
the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall
have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.19 <U>Saturdays, Sundays,
Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.20 <U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and number of shares of Common Stock or Securities, in any Transaction Document shall be subject to adjustment for any stock
split, subdivision, dividend, distribution payable in shares of Common Stock (or other securities or rights convertible into, or entitling
the holder thereof to receive directly or indirectly shares of Common Stock), combination or other similar recapitalization or event occurring
after the date hereof and prior to the Closing, of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.21 <B><U>WAIVER OF JURY
TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY
AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY
WAIVES FOREVER TRIAL BY JURY.</U></B></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>CleanCORE SOLUTIONS,
INC.</B></FONT></P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><U>Address for Notice</U>:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; width: 4%; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; width: 36%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 20%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 40%; font-size: 10pt"><FONT STYLE="font-size: 10pt">CleanCore Solutions, Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Name: Clayton Adams</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Attn: Clayton Adams, CEO</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Title: CEO</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">5920 S 118<SUP>th</SUP> Circle</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Omaha, NE 68137</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">E-Mail: </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">With a copy to (which shall not constitute notice):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 60%"></TD><TD STYLE="text-align: justify"><P STYLE="margin-top: 0; margin-bottom: 0">Bevilacqua PLLC</P>
                                                            <P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">1050 Connecticut Avenue, NW, Suite 500</P>
                                                            <P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">Washington, DC 20036</P>
                                                            <P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">Attn: Louis A. Bevilacqua, Esq.</P>
                                                            <P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">Email:</P></TD>
</TR></TABLE>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO <FONT STYLE="text-transform: uppercase">CLEANCORE
SOLUTIONS, INC.</FONT> SECURITIES PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 40%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name of Purchaser:</FONT></TD>
    <TD STYLE="vertical-align: top; width: 60%; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-size: 10pt"><I>Signature of Authorized Signatory of Purchaser:</I></FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name of Authorized Signatory:</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-size: 10pt">Title of Authorized Signatory:</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-size: 10pt">Email Address of Authorized Signatory:</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice to Purchaser:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">___________________________________________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Address for Delivery of Securities to Purchaser
(if not same as address for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subscription Amount for Securities purchased hereunder:
$_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Portion of Subscription Amount paid in Dogecoin
$_________________ (HoD Contribution Only)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Per PFW Purchase Price: $_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pre-Funded Warrants: __________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advance Payment of Exercise of Pre-Funded Warrants:
________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Warrant Shares (Beneficial Ownership Blocker
&#9744; 4.99% or &#9744; 9.99%)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">EIN Number: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>8
<FILENAME>ea025594401ex10-2_clean.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT (CRYPTOCURRENCY), DATED SEPTEMBER 1, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of September 1, 2025, between CleanCore Solutions, Inc., a corporation organized under
the laws of State of Nevada (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including
its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506(b)
of Regulation D promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not
jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company desires
to sell to the Purchasers, and each of the Purchasers desire to purchase from the Company in the offering contemplated by this Agreement
(the &ldquo;<U>Offering</U>&rdquo;), severally and not jointly, upon the terms and subject to the conditions stated in this Agreement,
Pre-Funded Warrants (as defined below) to purchase Shares (as defined below) substantially in the form attached hereto as <U>Exhibit A</U>.
The Securities (as defined below) consist of the Pre-Funded Warrants and the Pre-Funded Warrant Shares (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, contemporaneously
with the sale of the Securities, the parties hereto will execute and deliver the Registration Rights Agreement, substantially in the form
attached hereto as <U>Exhibit B</U>, pursuant to which the Company will agree to provide certain registration rights in respect of the
Pre-Funded Warrant Shares under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the sale of the Securities
sold in the Offering will be on a &ldquo;commercially reasonable best efforts&rdquo; basis and there will be no minimum or maxim offering
amount and no assurance can be given that all or any portion of the Securities offered hereby will be sold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, HoD (as defined below)
shall invest $10,000,000 in the Offering through the contribution of a combination of cash and Dogecoin (as defined below);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which
are hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE I.<BR>
DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1 <U>Definitions</U>. In
addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set
forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Acquiring Person</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Asset Management
Fees</U>&rdquo; shall have the meaning ascribed to such term in Section 5.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Asset Manager</U>&rdquo;
means collectively, HoD and 21Shares US LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Authorization Amendment</U>&rdquo;
means an amendment to the Company&rsquo;s Articles of Incorporation, duly adopted and filed with the Nevada Secretary of State, that increases
the number of authorized shares of Common Stock to a level sufficient to permit the issuance of all Pre-Funded Warrant Shares, the Strategic
Advisor Warrant Shares and the shares issuable to the Placement Agent upon the exercise of warrants issuable to the Placement Agent at
Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board of Directors</U>&rdquo;
means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business Day</U>&rdquo;
means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by
law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to
remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any other similar
orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic
funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally are open for use by customers
on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing Date</U>&rdquo;
means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and
all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s obligations
to deliver the Pre-Funded Warrants, have been satisfied or waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock</U>&rdquo;
means the class B common stock of the Company, par value $0.0001 per share, and any other class of securities into which such securities
may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock Equivalents</U>&rdquo;
means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company Counsel</U>&rdquo;
means Bevilacqua PLLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&ldquo;</FONT><U>Company
Nevada Counsel</U>&rdquo; means Fennemore Craig, P.C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;&ldquo;<U>Cryptocurrency Amount</U>&rdquo; shall have the
meaning ascribed to such term in Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;&ldquo;<U>Custodial Account</U>&rdquo; shall have the meaning
ascribed to such term in Section 2.2(a)w(vii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure Schedules</U>&rdquo;
means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure Time</U>&rdquo;
means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and before midnight
(New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date hereof, unless
otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight (New York City
time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof, unless otherwise
instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Dogecoin</U>&rdquo;
means the native token of the Dogecoin blockchain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effective Date</U>&rdquo;
means the earliest of the date that (a) the initial Registration Statement registering for resale all Pre-Funded Warrant Shares has been
declared effective by the Commission, (b) all of the Shares and Pre-Funded Warrant Shares have been sold pursuant to Rule 144 or may
be sold pursuant to Rule 144 without the requirement for the Company to be in compliance with the current public information requirement
of Rule 144 and without volume or manner-of-sale restrictions, (c) following the one year anniversary of the Closing, or (d) all of the
Pre-Funded Warrant Shares may be sold pursuant to an exemption from registration under Section 4(a)(1) of the Securities Act without
volume or manner-of-sale restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation Date</U>&rdquo; shall have the meaning ascribed to such term in
Section 3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange Act</U>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange Cap</U>&rdquo;
means the Company&rsquo;s principal Trading Market&rsquo;s limitation against a Purchaser&rsquo;s acquisition of shares of Common Stock
pursuant to the Transaction Documents, to the extent that after giving effect thereto, the aggregate number of shares of Common Stock
that would be issued pursuant to the Transaction Documents and the transactions contemplated thereby would exceed 19.99% of the number
of shares of Common Stock issued and outstanding immediately prior to the execution of this Agreement, which number of shares would be
reduced, on a share-for-share basis, by the number of shares of Common Stock issued or issuable pursuant to any transaction or series
of transactions that may be aggregated with the transactions contemplated by this Agreement under applicable rules of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt Issuance</U>&rdquo;
means the issuance (a) of shares of Common Stock or options to employees, officers or directors of the Company pursuant to any stock or
option plan or arrangement duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority
of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) of shares
of Common Stock upon the exercise or exchange or conversion of any Securities issued hereunder and/or securities (including options, rights
or warrants) exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement,
provided that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease
the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits or combinations)
or to extend the term of such securities; (c) of shares of Common Stock upon conversion or settlement of outstanding debt as of the date
hereof in an amount not to exceed $100,000; (d) of the Strategic Advisor Warrants, the Placement Agent Warrants, the Strategic Advisor
Warrant Shares and the Placement Agent Warrant Shares; (e) of shares of Common Stock or pre-funded warrants in a private placement or
other transaction with fundamental or technical institutional investors at a price per share or pre-funded warrant greater than the Per
PFW Purchase Price; (f) of securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested
directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and
carry no registration rights that require or permit the filing of any registration statement in connection therewith during the prohibition
period in Section 4.12(a) herein, and provided that any such issuance shall only be to a Person (or to the equityholders of a Person)
which is, itself or through its Subsidiaries, an operating company or an owner of an asset in a business synergistic with the business
of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction
in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing
in securities; and (g) of any shares of Common Stock issued pursuant to an at-the-market sales agreement entered into by the Company,
the Placement Agent and any sales agents designated by the Placement Agent provided that, prior to the 30 day anniversary of the Effective
Date, any such sales are at a price per share greater than the Per PFW Purchase Price; (h) of securities to banks, equipment lessors or
other financial institutions, or to real property lessors, pursuant to a debt financing, equipment leasing or real property leasing transaction
approved by a majority of the disinterested directors of the Company, (i) of securities issued to in connection with the provision of
goods pursuant to transactions approved by a majority of the disinterested directors of the Company and (j) of securities issued in connection
with sponsored research, collaboration, technology license, development, marketing or other similar agreements or strategic partnerships
approved a majority of the disinterested directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>HoD</U>&rdquo; means
House of Doge Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>HoD Contribution</U>&rdquo;
means a combination, valued at $10,000,000 in the aggregate, of (i) cash and (ii) Dogecoin. The Dogecoin comprising the HOD Contribution
shall equal (a) the portion of the contribution paid in Dogecoin, divided by (b) the spot exchange rate for Dogecoin as published by Coinbase.com
at 12:00 p.m. (New York City time) on the date of the execution and delivery of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Legacy Business</U>&rdquo;
means the business of the Company on the date hereof and immediately prior to the Closing and specifically excludes any digital asset
treasury business that the Company may engage in whether before or after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(bb).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual Property
Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Legend Removal Date</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lock-Up Agreements</U>&rdquo;
means the Lock-Up Agreements, dated as of the date hereof, by and among the Company and the directors and executive officers, in the form
of <U>Exhibit C</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material Adverse
Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material Permits</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(n).&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Option Agreement</U>&rdquo;
means that certain agreement in the form of <U>Exhibit D</U> hereto, by and between the Company and Clayton Adams, in his individual capacity,
pursuant to which Mr. Adams shall be granted an option (the &ldquo;<U>Option</U>&rdquo;), exercisable by Mr. Adams at any time following
the date that is one hundred eighty (180) days after the Closing Date, to elect, in his sole discretion, to either: (i) cause the Company
to effect a spin-off of the Legacy Business to all shareholders of the Company through a dividend of all equity interests of such business,
or (ii) permit Mr. Adams or one or more persons designated by him to acquire the Legacy Business a purchase price that is mutually agreeable
to the Company (as approved by a majority of the independent directors of the Company) and Mr. Adams, provided that such purchase price
is supported by an independent fairness opinion rendered by a Newbridge Securities Corporation or another nationally recognized investment
bank mutually selected by Mr. Adams and the independent directors of the Company, all on terms and conditions set forth in the Option
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per PFW Purchase
Price</U>&rdquo; equals $1.00, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other
similar transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agency
Agreement</U>&rdquo; means that certain Placement Agency Agreement by and between the Company and the Placement Agent in respect of the
placement of the Securities, dated September 1, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agent</U>&rdquo;
means, collectively, Maxim Group LLC and Curvature Securities LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agent
Warrants</U>&rdquo; means the warrants to purchase Common Stock issuable to the Placement Agent under the Placement Agency Agreement,
which Placement Agent Warrants shall not be exercisable until the filing of the Authorization Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agent
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon the exercise of the Placement Agent Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded Warrants</U>&rdquo;
means, collectively, the Pre-Funded Common Stock purchase warrants in the form of <U>Exhibit A</U> delivered to the Purchasers at the
Closing in accordance with Section&#8239;2.2(a)&#8239;hereof, which Pre-Funded Warrants shall be subject to the Exchange Cap and not be
exercisable until the filing of the Authorization Amendment and shall expire when exercised in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public Information
Failure</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public Information
Failure Payments</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser Digital
Wallet</U>&rdquo; shall have the meaning ascribed to such term in Section 3.2(o).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser Party</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration Rights
Agreement</U>&rdquo; shall have the meaning ascribed to such term in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration Statement</U>&rdquo;
means a resale registration statement meeting the requirements of the Registration Rights Agreement and covering the resale by the Purchasers
of the Pre-Funded Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required Approvals</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Pre-Funded Warrants and the Pre-Funded Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities Act</U>&rdquo;
means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short Sales</U>&rdquo;
means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include
locating and/or borrowing shares of Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Strategic Advisor
Agreement</U>&rdquo; means that certain Strategic Advisor Agreement between HoD and the Company to be executed on or prior to the Closing
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Strategic Advisor
Warrants</U>&rdquo; means 8,750,021 warrants to purchase Common Stock having an exercise price of $1.00 and 5,250,013 warrants to purchase
Common Stock having an exercise price of $1.33 to be issued to HoD (or an affiliate thereof) in connection with the entry into the Strategic
Advisor Agreement, which Strategic Advisor Warrants shall not be exercisable until the filing of the Authorization Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Strategic Advisor
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Strategic Advisor Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription Amount</U>&rdquo;
means, as to each Purchaser, the aggregate amount to be paid for Pre-Funded Warrants purchased hereunder as specified below such Purchaser&rsquo;s
name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo; in Dogecoin, Bitcoin, Ethereum,
USDC or USDT (minus, if applicable, a Purchaser&rsquo;s aggregate exercise price of the Pre-Funded Warrants, which amounts shall be paid
as and when such Pre-Funded Warrants are exercised for cash).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth in the SEC Reports and shall, where applicable, also include any direct or indirect subsidiary
of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Day</U>&rdquo;
means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or
any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction Documents</U>&rdquo;
means this Agreement, the Lock-Up Agreements, the Registration Rights Agreement, the Pre-Funded Warrants, the Treasury Management Agreement,
the Strategic Advisor Agreement and all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection
with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer Agent</U>&rdquo;
means Securities Transfer Corporation, with a mailing address of 2901 N Dallas Parkway, Suite 380, Plano, TX 75093, and any successor
transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Treasury Management
Agreement</U>&rdquo; means that certain Asset Management Agreement among the Company and the Treasury Manager, to be executed on or prior
to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Treasury Manager</U>&rdquo;
means collectively, HoD and 21Shares US LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Common Stock is not then listed or quoted for trading on a Trading
Market and the Common Stock is listed or quoted for trading on the OTCQB or OTCQX, the volume weighted average price of the Common Stock
for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for
trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar organization or agency
succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other
cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers
of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which
shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE II.<BR>
PURCHASE AND SALE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1 <U>Closing</U>. On the
Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery
of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase,
the number of Pre-Funded Warrants, for the aggregate purchase price, set forth on the Purchaser&rsquo;s signature page. Each Purchaser
shall deliver Dogecoin, Bitcoin, Ethereum, USDC or USDT, as instructed by the Placement Agent equal to such Purchaser&rsquo;s Subscription
Amount as set forth on the signature page hereto executed by such Purchaser, and the Company shall deliver to each Purchaser its respective
Securities, as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section
2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall
occur at the offices of the Placement Agent or such other location as the parties shall mutually agree, including taking place remotely
by electronic transfer of the Closing documentation. The Subscription Amount may be paid in Dogecoin, Bitcoin, Ethereum, USDC or USDT
in such amounts as indicated in Purchaser&rsquo;s signature page of this Agreement. The amount of Dogecoin, Bitcoin, Ethereum, USDC or
USDT to be paid to the Company shall equal (a) the Subscription Amount, divided by (b) the spot exchange rate for Dogecoin, Bitcoin, Ethereum,
USDC or USDT as published by Coinbase.com at 12:00p.m. (New York City time) as of the date of execution of this Agreement (the &ldquo;Cryptocurrency
Amount&rdquo;). In the event that the Closing has not occurred within five (5) Business Days after the expected Closing Date, unless otherwise
agreed by the Company and a Purchaser solely in relation to such Purchaser&rsquo;s subscription hereunder, the Company shall, promptly
(but no later than one Business Day thereafter) return the previously delivered Dogecoin, Bitcoin, Ethereum, USDC or USDT as instructed
by each applicable Purchaser; provided that, unless this Agreement has been terminated pursuant to Section 5.1, such return of Dogecoin,
Bitcoin, Ethereum, USDC or USDT shall not terminate this Agreement or relieve such Purchaser of its obligation to purchase, or the Company
of its obligation to issue and sell, the Securities at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2 <U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) On or prior to the Closing
Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) this Agreement duly executed
by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) the legal opinions of
Company Counsel and Company Nevada Counsel, each dated as of the Closing Date, in forms reasonably acceptable and addressed to the Placement
Agent and the Purchasers and executed by such counsels;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) a copy of the irrevocable
instructions to the Transfer Agent, in form and substance reasonably satisfactory to the Purchasers, instructing the Transfer Agent to
deliver from time to time, upon exercise of the Pre-Funded Warrants, the Pre-Funded Warrant Shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iv) a Pre-Funded Warrant
registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s
Subscription Amount divided by the Per PFW Purchase Price, with an exercise price equal to $0.0001, which shall have been pre-funded at
the Closing, subject to adjustment as provided therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v) the Strategic Advisor
Warrants;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(vi) the Placement Agent Warrants;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(vii) an applicable wallet
address maintained by _______ and in the name of ______ (the &ldquo;Custodial Account&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(viii) the Lock-Up Agreements
duly executed by the Company and the directors and executive officers signatory thereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ix) the Registration Rights
Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(x) the Treasury Management
Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xi) the Strategic Advisor
Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xii) a certificate of the
Secretary of the Company (the &ldquo;<U>Secretary&rsquo;s Certificate</U>&rdquo;), dated as of the Closing Date, (a) certifying the resolutions
adopted by the Board of Directors approving the transactions contemplated by this Agreement and the other Transaction Documents and the
issuance of the Pre-Funded Warrants (as applicable), (b) certifying the current versions of the Articles of the Incorporation of the Company
and Bylaws and (c) certifying as to the signatures and authority of persons signing the Transaction Documents and related documents on
behalf of the Company, in the form attached hereto as <U>Exhibit E</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xiii) a certificate dated
as of the Closing Date and signed by its Chief Executive Officer or its Chief Financial Officer, dated as of the Closing Date, certifying
to the fulfillment of the conditions specified in Sections 2.3(a)(i) and 2.3(a)(ii), in the form attached as <U>Exhibit F</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xiv) a certificate evidencing
the formation and good standing of the Company issued by the Secretary of State of Nevada, as of a date within five (5) Business Days
of the Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xv) a certified copy of the
Articles of Incorporation, as certified by the Secretary of State (or comparable office) of Nevada, as of a date within five (5) Business
Days of the Closing Date; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xvi) executed written consents
of Company stockholders holding the requisite number of the Company&rsquo;s voting shares that are needed to approve the following: (i)
the approval of the Authorization Amendment; (ii) the approval of the transactions as contemplated by the Transaction Documents; (iii)
the approval of the transactions as an issuance greater than the Exchange Cap pursuant to Section 713 of the NYSE American LLC Company
Guide for purposes of compliance with NYSE American rules; and (iv) such other approvals as are necessary or desirable in connection with
the transaction (approval of all such proposals, the &ldquo;<U>Stockholder Approval</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(xvii) evidence that the Pre-Funded Warrant Shares
(as applicable) to be issued to the Purchasers have been approved for listing on the Principal Market, subject only to official notice
of issuance;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(xviii) evidence that all the outstanding class
A common stock of the Company has been converted to class B common stock; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">(xix)
such other instruments, certificates, documents or materials as may be reasonably requested by Purchaser in connection with the consummation
of the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) On or prior to the Closing
Date, each Purchaser shall deliver or cause to be delivered to the Company, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) this Agreement duly executed
by such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) the Registration Rights
Agreement duly executed by such Purchaser; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) such Purchaser&rsquo;s
Subscription Amount by transfer of the Cryptocurrency Amount to the following Custodial Account:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">A.</TD><TD STYLE="text-align: justify">Dogecoin at _____________</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">B.</TD><TD STYLE="text-align: justify">Bitcoin at _______________</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">C.</TD><TD STYLE="text-align: justify">Ethereum at _____________</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">D.</TD><TD STYLE="text-align: justify">Tether at ________________</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">E.</TD><TD STYLE="text-align: justify">USDC at ________________</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3 <U>Closing Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The obligations of the
Company hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) the accuracy in all material
respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) on
the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which
case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) all obligations, covenants
and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) the delivery by each
Purchaser of the items set forth in Section 2.2(b) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-indent: 34pt">(iv) the execution by the Company and Clayton
Adams, in his individual capacity, of the Option Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt">(v) no statute, rule,
regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by any court or governmental
authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by the Transaction Documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 0.5in">(vi) The Company shall
have obtained in a timely fashion any and all consents, Material Permits, approvals, registrations and waivers necessary for consummation
of the purchase and sale of the Pre-Funded Warrants, including the Pre-Funded Warrant Shares (including all Required Approvals), all of
which shall be and remain so long as necessary in full force and effect; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 0.5in">(vii) HoD or its wholly-owned
subsidiary Dogecoin Ventures, Inc. shall have delivered the HoD Contribution as of the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The respective obligations
of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) the accuracy in all respects
when made of the representations and warranties of the Company contained herein (unless as of a specific date therein in which case they
shall be accurate as of such date) and the accuracy in all material respects (or, to the extent representations or warranties are qualified
by materiality or Material Adverse Effect, in all respects) on the Closing Date of the representations and warranties of the Company contained
herein (unless as of a specific date therein in which case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) all obligations, covenants
and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) the delivery by the
Company of the items set forth in Section 2.2(a) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iv) there shall have been
no Material Adverse Effect with respect to the Company since the date hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v) from the date hereof to
the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s principal Trading
Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been
suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or any
Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall
there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in
its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser,
makes it impracticable or inadvisable to purchase the Securities at the Closing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt">(vi) no statute, rule,
regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by any court or governmental
authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by the Transaction Documents;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 0.5in">(vii) the Company
shall have obtained in a timely fashion any and all consents, permits, approvals, registrations and waivers necessary for consummation
of the purchase and sale of the Pre-Funded Warrants, including the Pre-Funded Warrant Shares (including all Required Approvals), all of
which shall be and remain so long as necessary in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.95pt; text-align: justify; text-indent: 34.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.95pt; text-align: justify; text-indent: 34.05pt"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.95pt; text-align: justify; text-indent: 34.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.4 <U>Exchange Cap; Authorization
Amendment</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The
Company shall not be obligated to issue any Pre-Funded Warrant Shares, Strategic Advisor Warrant Shares or Placement Agent Warrant Shares
(collectively, &ldquo;<U>Exchange-Cap Securities</U>&rdquo;) to the Purchasers, HoD or the Placement Agent, as applicable, pursuant to
any of the Transaction Documents if the issuance, when aggregated with all prior issuances of Shares and Exchange-Cap Securities to such
Persons, would exceed the Exchange Cap, except that such limitation shall not apply in the event that (A) the Stockholder Approval contemplated
by Section 2.2(a)(xvi) becomes effective in accordance with its terms, or (B) the Company obtains a written opinion from outside counsel
to the Company that such approval is not required, which opinion shall be reasonably satisfactory to HoD and the holders of a majority
in interest of the Securities still held by the Purchasers. Until such approval is obtained (or the delivery of such opinion), (A) HoD
shall not be able to exercise the Strategic Advisor Warrant, (B) the Placement Agent shall not be able to exercise the Placement Agent
Warrant, and (C) no Purchaser shall be issued Pre-Funded Warrant Shares, upon exercise of any of its rights under the Pre-Funded Warrants,
in an amount greater than the product of the Exchange Cap multiplied by a fraction, the numerator of which is the total number of Shares
and shares of Common Stock underlying the Securities issued to such Purchaser pursuant to this Agreement on the Closing Date and the denominator
of which is the aggregate number of Shares and shares of Common Stock underlying all the Securities issued to all the Purchasers pursuant
to this Agreement (with respect to each Purchaser, the &ldquo;<U>Exchange Cap Allocation</U>&rdquo;). In the event that any holder of
Securities shall exercise all of such holder&rsquo;s rights under the Transaction Documents into a number of shares of Common Stock which, in
the aggregate, is less than such holder&rsquo;s Exchange Cap Allocation, then the difference between such holder&rsquo;s Exchange Cap Allocation and
the number of shares of Common Stock actually issued to such holder shall be allocated to the respective Exchange Cap Allocations of the
remaining holders of Securities on a pro rata basis in proportion to the shares of Common Stock underlying the Securities then held by
each such holder. The Pre-Funded Warrants, the Strategic Investor Warrants and the Placement Agent Warrants shall contain prohibitions
on the exercise of such warrants that are consistent with this Section 2.4(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The Pre-Funded Warrants,
the Strategic Investor Warrants and the Placement Agent Warrants shall also prohibit the exercise of such warrants until the Authorization
Amendment becomes effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE III.<BR>
REPRESENTATIONS AND WARRANTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1 <U>Representations and
Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part hereof
and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section of
the Disclosure Schedules, the Company hereby makes the following representations and warranties as of the date hereof and as of the Closing
Date (unless as of a specific date therein, in which case as of such date) to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Subsidiaries</U>. All
of the direct and indirect Subsidiaries of the Company are set forth in the SEC Reports or have otherwise been disclosed to Purchasers
by the Company. The Company owns, directly or indirectly, all of its capital stock or other equity interests of each Subsidiary free and
clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully
paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries,
all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Organization and Qualification</U>.
The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties
and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of
any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents.
Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary,
except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result
in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document or the Treasury Management Agreement,
(ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the
Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material
respect on a timely basis its obligations under any Transaction Document or the Treasury Management Agreement (any of (i), (ii) or (iii),
a &ldquo;<U>Material Adverse Effect</U>&rdquo;), and no Proceeding has been instituted in any such jurisdiction revoking, limiting or
curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Authorization; Enforcement</U>.
The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement
and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery
of this Agreement and each of the other Transaction Documents or the Treasury Management Agreement by the Company and the consummation
by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company,
and no further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or
therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party
or the Treasury Management Agreement has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance
with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in
accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization,
moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>No Conflicts</U>. The
execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party or the
Treasury Management Agreement, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby
and thereby do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate
or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or
an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties
or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental
authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any
property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could
not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>Filings, Consents and
Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing
or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the
execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant to Section
4.4 of this Agreement, (ii) the notice and/or additional listing application(s) to each applicable Trading Market for the listing of the
Pre-Funded Warrant Shares for trading thereon in the time and manner required thereby; (iii) the registration statement required to be
filed by the Registration Rights Agreement, (iv) the filing of Form D with the Commission and such filings as are required to be made
under applicable state securities laws, and (v) filing the Second Definitive Information Statement (as defined below) with the Commission
in connection with the August 22 Written Consent (as defined below) (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;). For greater
certainty, the Company is not required to submit an original listing application to the Company&rsquo;s principal Trading Market in connection
with the offer and sale of the Securities and effecting the Doge treasury strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Issuance of the Securities</U>.
The Pre-Funded Warrants are duly and validly authorized and, when issued and paid for in accordance with this Agreement, will be duly
and validly issued and constitute the legal, valid and binding obligations of the Company, enforceable against the Company in accordance
with their terms, free and clear of all Liens <FONT STYLE="text-decoration: underline double">imposed by the Company</FONT> other than
restrictions on transfer provided for in the Transaction Documents. The Pre-Funded Warrant Shares, when issued in accordance with the
terms of the Pre-Funded Warrants, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company
other than restrictions on transfer provided for in the Transaction Documents. The Company has reserved from its duly authorized capital
stock the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Pre-Funded Warrants. Subject to the accuracy
of the representations and warranties made by the Purchasers in Section 3.2, the offer and sale of the Securities to the Purchaser is
and will be in compliance with applicable exemptions from (i) the registration and prospectus delivery requirements of the Securities
Act and (ii) the registration and qualification requirements of applicable securities laws of the states of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) <U>Capitalization</U>.
The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule 3.1(g)</U> shall
also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof.
Except as set forth on <U>Schedule 3.1(g)</U>, the Company has not issued any capital stock since its most recently filed periodic report
under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&rsquo;s stock option plans, the
issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion
and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act.
No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions
contemplated by the Transaction Documents. Except as set forth in <U>Schedule 3.1(g)</U> or as a result of the purchase and sale of the
Securities (and the issuance of the Strategic Advisor Warrants and Placement Agent Warrants) there are no outstanding options, warrants,
scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible
into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock or the
capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or
may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance
and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any
Person (other than the Purchasers). There are no outstanding securities or instruments of the Company or any Subsidiary with any provision
that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities by the Company
or any Subsidiary. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or
similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is
or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or
&ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock of the
Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities
laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase
securities. No further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and
sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s
capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) <U>SEC Reports; Financial
Statements</U>. Since April 25, 2024, except as set forth on <U>Schedule 3.1(h)</U>, the Company has filed all reports, schedules, forms,
statements and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to
Section 13(a) or 15(d) thereof, (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein,
being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received a valid extension of
such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the
SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none
of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated
therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.
There are no material outstanding or unresolved comment letters from the staff of the Division of Corporate Finance of the Commission
with respect to any of the SEC Reports as of the date hereof. The Company has never been an issuer subject to Rule 144(i) under the Securities
Act. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements
and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have
been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods
involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial statements or the notes thereto and except
that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial
position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows
for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. No other
financial statements or supporting schedules are required to be included pursuant to the Exchange Act. The other financial and statistical
information included in the SEC Reports present fairly the information included therein and have been prepared on a basis consistent with
that of the financial statements that are included in the SEC Reports and the books and records of the Company. There are no material
off-balance sheet transactions, arrangements or obligations (including contingent obligations) of the Company or other persons that would
reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) <U>Material Changes; Undisclosed
Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within the SEC Reports, except
as set forth in <U>Schedule 3.1(i)</U>, (i) there has been no event, occurrence or development that has had or that could reasonably be
expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than
(A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities
not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings made with the Commission,
(iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of
cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital
stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company
stock option plans. The Company does not have pending before the Commission any request for confidential treatment of information. Except
for the issuance of the Securities contemplated by this Agreement and the entry into the Treasury Management Agreement, no event, liability,
fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company
or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition that would be required
to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been
publicly disclosed at least 1 Trading Day prior to the date that this representation is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) <U>Litigation</U>. Except
as set forth on <U>Schedule 3.1(j)</U>, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or,
to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before
or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth on <U>Schedule 3.1(j)</U>, (i) adversely affects or challenges
the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable
decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director
or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities
laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated,
any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission
has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary
under the Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) <U>Labor Relations</U>.
No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could
reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees is a member
of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company nor any of
its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships
with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary is, or is now expected
to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement
or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued
employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any
of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and
regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the
failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l) <U>Compliance</U>. Neither
the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived that, with
notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary
received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other
agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation
has been waived), (ii) is in violation of any judgment, decree, or order of any court, arbitrator or other governmental authority or (iii)
is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation
all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality
and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m) <U>Environmental Laws</U>.
The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution or protection
of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws
relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances
or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating to the manufacture, processing,
distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees,
demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued,
entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have received all permits licenses or other
approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance with
all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply could
be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n) <U>Regulatory Permits</U>.
The Company and the Subsidiaries possess all certificates, authorizations, approvals, consents, registrations, licenses qualifications,
certifications and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their
respective businesses as such businesses are described in the SEC Reports, except where the failure to possess such permits could not
reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material Permits</U>&rdquo;), and neither the Company nor any
Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o) <U>Title to Assets</U>.
The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable
title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and
clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere with the
use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment of federal, state
or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and the payment of which is neither delinquent
nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under
valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p) <U>Intellectual Property</U>.
The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service
marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary
or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to so have could
have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither the Company
nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated
or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement. Neither
the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC Reports,
a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of
any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company,
all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual
Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and
value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q) <U>Insurance</U>. The
Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited
to, directors and officers insurance coverage in amount deemed prudent by the Company. Neither the Company nor any Subsidiary has any
reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar
coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r) <U>Transactions with Affiliates
and Employees</U>. Except as set forth in <U>Schedule 3.1(r)</U>, none of the officers, directors or beneficial holders of 5% or more
of any class of capital shares of the Company, or officers or directors of the Company or any Subsidiary and, to the knowledge of the
Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary
(other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the
furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from
or lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company,
any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder,
member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii)
reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under
any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s) <U>Sarbanes-Oxley; Internal
Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements of the Sarbanes-Oxley
Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder
that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting
controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management&rsquo;s general
or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with
GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s general or specific
authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate
action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls
and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange
Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules and forms. The
Company has not received any notice of correspondence from its independent registered public accounting firm, governmental entity or other
Person relating to any potential material weakness in any part of the internal controls over financial reporting of the Company. The Company&rsquo;s
certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as
of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation
Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying
officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since
the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange
Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control
over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(t) <U>Certain Fees</U>. Except
for the fees and expenses of the Placement Agent, no brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company
or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with
respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees
or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in
connection with the transactions contemplated by the Transaction Documents. For the avoidance of doubt, the Purchasers acknowledge that
the Asset Manager will receive payment for services rendered under the Asset Management Agreement and will be reimbursed for the Asset
Management Fees in connection with providing services under the Asset Management Agreement and in each case, such payment for the Asset
Management Fees may be made to the Asset Manager directly out of the funds that the Asset Manager is managing which will include the proceeds
from this Offering.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(u) <U>Private Placement</U>.
Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, no registration under the Securities
Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated hereby. The issuance and sale
of the Securities hereunder does not contravene the rules and regulations of the Company&rsquo;s Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v) <U>Investment Company;
Commodity Status of Dogecoin</U>. The Company is not, and is not an Affiliate of, and immediately after giving effect to the receipt of
payment for the Securities and the application of the proceeds contemplated by Section 4.7, will not be, and will not be deemed to be,
nor will it be controlled by or be under common control with, an &ldquo;investment company&rdquo; within the meaning of, or otherwise
subject to registration or regulation under, the Investment Company Act of 1940, as amended (the &ldquo;<U>ICA</U>&rdquo;). In furtherance
of the foregoing, the Company represents and warrants that Dogecoin, which constitutes the principal asset that the Company expects to
acquire, hold, exchange, stake, transfer, lend, pledge, or otherwise use or dispose of with the proceeds of the offering, is properly
characterized as a &ldquo;commodity&rdquo; within the meaning of the Commodity Exchange Act of 1936, as amended (the &ldquo;<U>CEA</U>&rdquo;),
and the regulations, interpretations, and guidance of the Commodity Futures Trading Commission (&ldquo;<U>CFTC</U>&rdquo;) promulgated
thereunder, and is not, and will not be deemed to be, a &ldquo;security&rdquo; as that term is defined in Section 2(a)(1) of the Securities
Act of 1933, as amended, Section 3(a)(10) of the Securities Exchange Act of 1934, as amended, or any analogous provision of state &ldquo;blue
sky&rdquo; or other securities laws. The Company has a reasonable basis, after consultation with experienced counsel, for the conclusion
that Dogecoin constitute a commodity for all purposes of the federal commodities laws and are outside the scope of the federal securities
laws, and no governmental authority having jurisdiction over the Company, Dogecoin, or the transactions contemplated hereby has asserted
to the Company that Dogecoin should be treated as a security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(w) <U>Registration Rights</U>.
Except as disclosed in Schedule 3.1(w) and other than to each of the Purchasers pursuant to the Registration Rights Agreement, no Person
has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company
or any Subsidiary. Other than pursuant to the Registration Rights Agreement, no Person has any right to cause the Company to effect the
registration under the Securities Act covering the transfer of any securities of the Company and there are no other stockholders agreements,
voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a party or, to
the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(x) <U>NYSE American</U><FONT STYLE="font-size: 10pt">.
The issued and outstanding shares of Common Stock are registered pursuant to Section 12(b) of the Exchange Act and are listed for trading
on the NYSE American under the symbol &ldquo;ZONE&rdquo;. As of the date of this Agreement and the Closing Date, the Company is in compliance
with all listing and maintenance requirements of NYSE American applicable to the Company. As of the date of this Agreement and the Closing
Date, there is no suit, action, proceeding or investigation pending or, to the knowledge of the Company, threatened against the Company
by NYSE American or the Commission, respectively, to prohibit or terminate the listing of the Common Stock on the NYSE American or to
deregister the Common Stock under the Exchange Act. The Company has taken no action as of the date of this Agreement and the Closing Date
that is designed to terminate the registration of the Common Stock under the Exchange Act. The Company is, and has no reason to believe
that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The shares
of Common Stock are currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation
and the Company is current in payment of the fees to the Depositary Trust Company (or such other established clearing corporation) in
connection with such electronic transfer. The Company has taken no action as of the date of this Agreement that is designed to terminate,
or which to the knowledge of the Company is likely to have the effect of terminating, the registration of the Common Stock under the Exchange
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(y) <U>Application of Takeover
Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable any control
share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover
provision under the Company&rsquo;s articles of incorporation (or similar charter documents) or the laws of its state of incorporation
that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or exercising
their rights under the Transaction Documents, including without limitation as a result of the offer and sale of the Securities, by the
Company to the Purchasers as contemplated hereby and the Purchasers&rsquo; ensuing ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(z) <U>Disclosure</U>. Except
with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents and the Asset Management
Agreement and the representations made in Section 3.1(i), the Company confirms that neither it nor any other Person acting on its behalf
has provided any of the Purchasers or their agents or counsel with any information that it believes constitutes or might constitute material,
non-public information. The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting
transactions in securities of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding
the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules
to this Agreement, is true and correct and does not contain any untrue statement of a material fact or omit to state any material fact
necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading.
The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain
any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which they were made and when made, not misleading. The Company acknowledges
and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby
other than those specifically set forth in Section 3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(aa) <U>No Integrated Offering</U>.
Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, neither the Company, nor any of
its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or
solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with prior
or ensuing offerings by the Company for purposes of (i) the Securities Act which would require the registration of any such securities
under the Securities Act, (ii) eliminate the availability of the exemption from registration under Regulation D under the Securities Act
in connection with the offer and sale by the Company of the Securities or (iii) any applicable shareholder approval provisions of any
Trading Market on which any of the securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(bb) <U>Indebtedness</U>.
<U>Schedule 3.1(bb)</U> sets forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary,
or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means
(x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable or accrued payroll liabilities
incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness
of others, whether or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto),
except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of
business; and (z) the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance
with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(cc) <U>Tax Status</U>. The
Company and its Subsidiaries each (i) has made or filed all material United States federal, state and local income and all foreign income
and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all material taxes
and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and
declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent
to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due
by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.
No audits, examinations, or other proceedings with respect to any material amounts of taxes of the Company and its subsidiaries are presently
in progress or have been asserted or proposed in writing without subsequently being paid, settled or withdrawn. There are no liens on
any of the assets of the Company. At all times since inception, the Company has been and continues to be classified as a corporation for
U.S. federal income tax purposes. Neither the Company nor any of its Subsidiaries has been a United States real property holding corporation
within the meaning of Code Section 897(c)-2 during the period specified in Code Section 897(c)(1)(A)(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(dd) <U>No General Solicitation</U>.
Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities as contemplated hereby by
any form of &ldquo;general solicitation&rdquo; or &ldquo;general advertising&rdquo; (as such terms are defined in Regulation D under the
Securities Act). The Company and any Person acting on behalf of the Company has offered the Securities for sale as contemplated hereby
only to the Purchasers and certain other &ldquo;qualified purchasers&rdquo; within the meaning of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ee) <U>Foreign Corrupt Practices</U>.
Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf
of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other
unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government
officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully
any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which
is in violation of law or (iv) violated in any material respect any provision of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ff) <U>Accountants</U>. The
Company&rsquo;s accounting firm is set forth in the SEC Reports. To the knowledge and belief of the Company, such accounting firm (i)
is an independent registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to
the financial statements to be included in the Company&rsquo;s Annual Report on Form 10-K for the fiscal year ended June 30, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(gg) <U>No Disagreements with
Accountants and Lawyers</U>. There are no disagreements of any kind presently existing, or reasonably anticipated by the Company to arise,
between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company is current with respect
to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any of its obligations under
any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(hh) <U>Acknowledgment Regarding
Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that, to its knowledge, each of the Purchasers is acting
solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that, to its knowledge, no Purchaser is acting as a financial advisor or fiduciary of the Company
(or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given
by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions
contemplated thereby is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each
Purchaser that the Company&rsquo;s decision to enter into this Agreement and the other Transaction Documents has been based solely on
the independent evaluation of the transactions contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) <U>Acknowledgment Regarding
Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except for Sections
3.2(g) and 4.14 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked by the Company
to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or &ldquo;derivative&rdquo;
securities based on securities issued by the Company or to hold the Securities for any specified term, (ii) past or future open market
or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &ldquo;derivative&rdquo; transactions,
before or after the closing of this or future private placement transactions, may negatively impact the market price of the Company&rsquo;s
publicly-traded securities, (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to which any such Purchaser
is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the Common Stock and (iv) each Purchaser shall
not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo; transaction.
The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various times during
the period that the Securities are outstanding, including, without limitation, during the periods that the value of the Pre-Funded Warrant
Shares deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of
the existing stockholders&rsquo; equity interests in the Company at and after the time that the hedging activities are being conducted.
The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(jj) <U>Regulation M Compliance</U>.
The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause
or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any
of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities, or (iii)
paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other than,
in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(kk) <U>Employee Benefits</U>.
Except as would not be reasonably likely to result in a Material Adverse Effect, each Benefit Plan has been established and administered
in accordance with its terms and in compliance with the applicable provisions of ERISA, the Code, the Patient Protection and Affordable
Care Act of 2010, as amended, and other applicable laws, rules and regulations. The Company and its Subsidiaries are in compliance with
all applicable federal, state and local laws, rules and regulations regarding employment, except for any failures to comply that are not
reasonably likely, individually or in the aggregate, to have a Material Adverse Effect. There is no labor dispute, strike or work stoppage
against the Company or its Subsidiaries pending or, to the knowledge of the Company, threatened which may interfere with the business
activities of the Company, except where such dispute, strike or work stoppage is not reasonably likely, individually or in the aggregate,
to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ll) <U>Off Balance Sheet
Arrangements</U>. There is no transaction, arrangement, or other relationship between the Company or any of the Subsidiaries and an unconsolidated
or other off balance sheet entity that is required to be disclosed by the Company in its Exchange Act filings and is not so disclosed
or that otherwise could be reasonably likely to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(mm) <U>Stock Option Plans</U>.
Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance with the terms of the
Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common Stock on the date
such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company&rsquo;s stock option
plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly
grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement
of material information regarding the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(nn) <U>Office of Foreign
Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent, employee
or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets
Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(oo) <U>U.S. Real Property
Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section
897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(pp) <U>Bank Holding Company
Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended
(the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal Reserve</U>&rdquo;).
Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the
outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank or any entity that is
subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or Affiliates exercises
a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal
Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(qq) <U>Anti-Bribery and Anti-Money
Laundering Laws</U>. Each of the Company, its subsidiaries and, to the knowledge of the Company, any of their respective officers, directors,
supervisors, managers, agents, or employees are and have at all times been in compliance with and its participation in the offering will
not violate: (A) anti-bribery laws, including but not limited to, any applicable law, rule, or regulation of any locality, including but
not limited to any law, rule, or regulation promulgated to implement the OECD Convention on Combating Bribery of Foreign Public Officials
in International Business Transactions, signed December 17, 1997, including the U.S. Foreign Corrupt Practices Act of 1977, as amended,
the U.K. Bribery Act 2010, or any other law, rule or regulation of similar purposes and scope or (B) anti-money laundering laws, including,
but not limited to, applicable federal, state, international, foreign or other laws, regulations or government guidance regarding anti-money
laundering, including, without limitation, Title 18 US. Code sections 1956 and 1957, the Patriot Act, the Bank Secrecy Act, and international
anti-money laundering principles or procedures by an intergovernmental group or organization, such as the Financial Action Task Force
on Money Laundering, of which the United States is a member and with which designation the United States representative to the group or
organization continues to concur, all as amended, and any executive order, directive, or regulation pursuant to the authority of any of
the foregoing, or any orders or licenses issued thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(rr) <U>No Disqualification
Events</U>. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506(b) of Regulation D under the Securities
Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company
participating in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity securities,
calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with
the Company in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo; and, together, &ldquo;<U>Issuer Covered
Persons</U>&rdquo;) is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii) under
the Securities Act (a &ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3).
The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company
has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Purchasers a copy
of any disclosures provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ss) <U>Other Covered Persons</U>.
Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person) that has been or will be
paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(tt) <U>Notice of Disqualification
Events</U>. The Company will notify the Purchasers and the Placement Agent in writing, prior to the Closing Date of (i) any Disqualification
Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, become a Disqualification Event relating
to any Issuer Covered Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(uu) <U>No Additional Agreements</U>.
There are no agreements or understandings between the Company and any Purchaser with respect to the transactions contemplated by the Transaction
Agreements other than (i) as specified in the Transaction Agreements and (ii) any side letter agreements with any of the Purchasers in
connection with such other Purchaser&rsquo;s agreement to purchase Securities thereunder on terms particular to compliance with any law,
regulation or policy specifically applicable to such other Purchaser or its affiliates or related funds or in connection with the taxable
status of such other Purchaser or its affiliates or related funds or other terms that are immaterial to such Purchaser, which side letters
the Company has shared with all Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(vv) <U>Cybersecurity</U>.
To the knowledge of the Company, there has been no security breach or other compromise of or relating to any of the Company&rsquo;s or
any Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software, data (including the data of its respective
customers, employees, suppliers, vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively,
&ldquo;<U>IT Systems and Data</U>&rdquo;) and (y) the Company and the Subsidiaries have not been notified of, and has no knowledge of
any event or condition that would reasonably be expected to result in, any security breach or other compromise to its IT Systems and Data,
in each case, except as could not reasonably be expected to, individually or in the aggregate, have a Material Adverse Effect; (ii) the
Company and the Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations
of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy
and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation
or modification, except as would not, individually or in the aggregate, have a Material Adverse Effect; (iii) the Company and the Subsidiaries
have implemented and maintained commercially reasonable safeguards to maintain and protect its material confidential information and the
integrity, continuous operation, redundancy and security of all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented
backup and disaster recovery technology consistent with industry standards and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ww) <U>Compliance with Data
Privacy Laws</U>. The Company and its subsidiaries are, and at all prior times were, in material compliance with all applicable state,
federal and foreign data privacy and security laws and regulations regarding the collection, use, storage, retention, disclosure, transfer,
disposal, or any other processing (collectively &ldquo;<U>Process</U>&rdquo; or &ldquo;<U>Processing</U>&rdquo;) of Personal Data, including
without limitation HIPAA, the UK General Data Protection Regulation (&ldquo;<U>GDPR</U>&rdquo;), and all other local, state, federal,
national, supranational and foreign laws relating to the regulation of the Company or its subsidiaries, and the regulations promulgated
pursuant to such statutes and any state or non-U.S. counterpart thereof (collectively, the &ldquo;<U>Privacy Laws</U>&rdquo;). To ensure
material compliance with the Privacy Laws, the Company and its subsidiaries have in place, comply with, and take all appropriate steps
necessary to ensure compliance in all material respects with their policies and procedures relating to data privacy and security, and
the Processing of Personal Data and Confidential Data (the &ldquo;<U>Privacy Statements</U>&rdquo;). The Company and its subsidiaries
have, except as would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect, at all times
since inception provided accurate notice of their Privacy Statements then in effect to its customers, employees, third party vendors and
representatives. None of such disclosures made or contained in any Privacy Statements have been materially inaccurate, misleading, incomplete,
or in material violation of any Privacy Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xx) <U>Transactions with
Affiliates and Employees</U>. No relationship, direct or indirect, exists between or among the Company, on the one hand, and the directors,
officers, stockholders, customers or suppliers of the Company, on the other hand, that is required to be described in the SEC Reports
that is not so described.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(yy) <U>Prior Stockholder
Consents; Information Statements</U>. On August 11, 2025, Company stockholders owning as of such date at least a majority of the outstanding
shares of class A common stock and class B common stock of the Company, voting together as a single class, duly executed a written consent
in lieu of a meeting, dated August 11, 2025 (the &ldquo;<U>August 11 Written Consent</U>&rdquo;), which authorized and approved an amendment
to the Company&rsquo;s Articles of Incorporation to increase the Company&rsquo;s authorized shares of class B common stock from 250,000,000
shares to 2,000,000,000 shares. On August 12, 2025, the Company filed a preliminary information statement on Schedule 14C with the Commission
with respect to the August 11 Written Consent (the &ldquo;<U>First Preliminary Information Statement</U>&rdquo;), on August 22, 2025,
the Company filed a definitive information statement on Schedule 14C with the Commission with respect to the August 11 Written Consent
(the &ldquo;<U>First Definitive Information Statement</U>&rdquo;), and, on August 22, 2025, the Company first mailed the First Definitive
Information Statement to its stockholders, in each case, in accordance with applicable law. On August 22, 2025, Company stockholders owning
as of such date at least a majority of the outstanding shares of class A common stock and class B common stock of the Company, voting
together as a single class, duly executed a written consent in lieu of a meeting, dated August 22, 2025 (the &ldquo;<U>August 22 Written
Consent</U>&rdquo; and, together with the August 11 Written Consent, the &ldquo;Written Consents&rdquo;), which approved the issuance
of up to $250 million of securities in one or more non-public offerings, on the terms and conditions described in the Second Preliminary
Information Statement (as defined below). On August 22, 2025, the Company filed a preliminary information statement on Schedule 14C with
the Commission with respect to the August 22 Written Consent (the &ldquo;<U>Second Preliminary Information Statement</U>&rdquo;) in accordance
with applicable law. The Written Consents were duly adopted in accordance with applicable law and the Company&rsquo;s Articles of Incorporation
and Bylaws, and no other stockholder consents or approvals are required from the Company&rsquo;s stockholders in order for the Company&rsquo;s
stockholders to approve the Authorization Amendment, the transactions contemplated by the Transaction Documents or the transactions as
an issuance greater than the Exchange Cap pursuant to Section 713 of the NYSE American LLC Company Guide for purposes of compliance with
NYSE American rules. Other than the completion of the procedures set forth herein and the approval for listing on the Principal Market
of the Pre-Funded Warrant Shares (as applicable) issued or to be issued to the Purchasers, subject only to official notice of issuance,
no further consent, approval, waiver, authorization, registration, license, qualification, certificate, notice or filing is required to
file and make effective the Authorization Amendment with the Secretary of State of Nevada.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2 <U>Representations and
Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, severally and not jointly, hereby represents
and warrants as of the date hereof and as of the Closing Date (unless as of a specific date therein, in which case they shall be accurate
as of such date) to the Company as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>(a) Organization; Authority</U>.
Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws
of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power
and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its
obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the
transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership, limited liability
company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a party has been duly
executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally
binding obligation of such Purchaser, enforceable against it in accordance with its terms, except (i) as limited by general equitable
principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement
of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief
or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Understandings or Arrangements</U>.
Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement or understandings
with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty not limiting such
Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal
and state securities laws). Such Purchaser understands that the Securities are &ldquo;restricted securities&rdquo; within the meaning
of, and have not been registered under, the Securities Act or any applicable state securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Investment Representations
and Warranties</U>. The Purchaser hereby represents and warrants that, as of the date of this Agreement and the Closing Date, it is, if
an entity, a &ldquo;qualified institutional buyer&rdquo; (as defined in Rule 144A under the Securities Act) or an institutional &ldquo;accredited
investor&rdquo; as that term is defined in Rule 501(a) under Regulation D promulgated pursuant to the Securities Act; or (ii) if an individual,
is an &ldquo;accredited investor&rdquo; as that term is defined in Rule 501(a) of Regulation D of the Securities Act and has such knowledge
and experience in financial and business matters as to be able to protect its own interests in connection with an investment in the Securities.
The Purchaser further represents and warrants that (x) it is capable of evaluating the merits and risk of such investment, and (y) that
it has not been organized for the purpose of acquiring the Securities and is an &ldquo;institutional account&rdquo; as defined by FINRA
Rule 4512(c). The Purchaser understands and agrees that the offering and sale of the Securities has not been registered under the Securities
Act or any applicable state securities laws and is being made in reliance upon federal and state exemptions for transactions not involving
a public offering which depend upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser&rsquo;s
representations as expressed herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Intent</U>. The Purchaser
is purchasing the Securities, solely for the Purchaser&rsquo;s own account and not for the account of others, and not with a view to the
resale or distribution of any part thereof in violation of the Securities Act, and the Purchaser has no present intention of selling,
granting any participation in, or otherwise distributing the same in violation of the Securities Act without prejudice, however, to the
Purchaser&rsquo;s right at all times to sell or otherwise dispose of all or any part of such Securities in compliance with applicable
federal and state securities laws. Notwithstanding the foregoing, if the Purchaser is purchasing the Securities as a fiduciary or agent
for one or more investor accounts, the Purchaser has full investment discretion with respect to each such account, and the full power
and authority to make the acknowledgements, representations and agreements herein on behalf of each owner of each such account. The Purchaser
has no present arrangement to sell the Securities to or through any person or entity. The Purchaser understands that the Securities must
be held indefinitely unless such Securities are resold pursuant to a registration statement under the Securities Act or an exemption from
registration is available. Nothing contained herein shall be deemed a representation or warranty by the Purchaser to hold the Securities
for any period of time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>Investment Experience;
Ability to Protect Its Own Interests and Bear Economic Risks</U>. The Purchaser acknowledges that it can bear the economic risk and complete
loss of its investment in the Securities and has knowledge and experience in finance, securities, taxation, investments and other business
matters as to be capable of evaluating the merits and risks of investments of the kind described in this Agreement and contemplated hereby,
and the Purchaser has had an opportunity to seek, and has sought, such accounting, legal, business and tax advice as the Purchaser has
considered necessary to make an informed investment decision. The Purchaser acknowledges that the Purchaser (i) is a sophisticated investor,
experienced in investing in private placements of equity securities and capable of evaluating investment risks independently, both in
general and with regard to all transactions and investment strategies involving a security or securities and (ii) has exercised independent
judgment in evaluating its participation in the purchase of the Securities. The Purchaser acknowledges that the Purchaser is aware that
there are substantial risks incident to the purchase and ownership of the Securities, including those set forth in the Company&rsquo;s
filings with the Commission. Alone, or together with any professional advisor(s), the Purchaser has adequately analyzed and fully considered
the risks of an investment in the Securities and determined that the Securities are a suitable investment for the Purchaser. The Purchaser
is, at this time and in the foreseeable future, able to afford the loss of the Purchaser&rsquo;s entire investment in the Securities and
the Purchaser acknowledges specifically that a possibility of total loss exists.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Independent Investment
Decision</U>. The Purchaser understands that nothing in the Transaction Agreements or any other materials presented by or on behalf of
the Company to the Purchaser in connection with the purchase of the Securities constitutes legal, tax or investment advice. The Purchaser
has consulted such professional advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with its purchase
of the Securities hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) <U>Securities Not Registered;
Legends</U>. The Purchaser acknowledges and agrees that the Securities are being offered in a transaction not involving any public offering
within the meaning of the Securities Act, and the Purchaser understands that the Securities have not been registered under the Securities
Act, by reason of their issuance by the Company in a transaction exempt from the registration requirements of the Securities Act, and
that the Securities must continue to be held and may not be offered, resold, transferred, pledged or otherwise disposed of by the Purchaser
unless a subsequent disposition thereof is registered under the Securities Act or is exempt from such registration and in each case in
accordance with any applicable securities laws of any state of the United States. The Purchaser understands that the exemptions from registration
afforded by Rule 144 (the provisions of which are known to it) promulgated under the Securities Act depend on the satisfaction of various
conditions including, but not limited to, the time and manner of sale, the holding period and on requirements relating to the Company
which are outside of the Purchaser&rsquo;s control and which the Company may not be able to satisfy, and that, if applicable, Rule 144
may afford the basis for sales only in limited amounts. The Purchaser acknowledges and agrees that it has been advised to consult legal
counsel prior to making any offer, resale, transfer, pledge or disposition of any of the Securities. The Purchaser acknowledges that no
federal or state agency has passed upon or endorsed the merits of the offering of the Securities or made any findings or determination
as to the fairness of this investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Purchaser understands
that any certificates or book entry notations evidencing the Securities may bear one or more legends in substantially the following form
and substance:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify">&ldquo;THE SECURITIES REPRESENTED HEREBY HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), OR THE SECURITIES LAWS OF ANY STATE
OF THE UNITED STATES. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED UNLESS (I) SUCH SECURITIES
HAVE BEEN REGISTERED FOR SALE PURSUANT TO THE SECURITIES ACT, (II) SUCH SECURITIES MAY BE SOLD PURSUANT TO AN EXEMPTION FROM REGISTRATION
SUCH AS RULE 144 UNDER THE SECURITIES ACT, (III) THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO IT THAT SUCH
TRANSFER MAY LAWFULLY BE MADE WITHOUT REGISTRATION UNDER THE SECURITIES ACT, OR (IV) THE SECURITIES ARE TRANSFERRED WITHOUT CONSIDERATION
TO AN AFFILIATE OF SUCH HOLDER OR A CUSTODIAL NOMINEE (WHICH FOR THE AVOIDANCE OF DOUBT SHALL REQUIRE NEITHER CONSENT NOR THE DELIVERY
OF AN OPINION).&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the Securities
may contain a legend regarding affiliate status of the Purchaser, if applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) <U>No General Solicitation</U>.
The Purchaser acknowledges and agrees that the Purchaser is purchasing the Securities directly from the Company. Purchaser became aware
of this offering of the Securities solely by means of direct contact from the Placement Agent or directly from the Company as a result
of a pre-existing, substantive relationship with the Company or the Placement Agent, and/or their respective advisors (including, without
limitation, attorneys, accountants, bankers, consultants and financial advisors), agents, control persons, representatives, affiliates,
directors, officers, managers, members, and/or employees, and/or the representatives of such persons. The Securities were offered to Purchaser
solely by direct contact between Purchaser and the Company, the Placement Agent and/or their respective representatives. Purchaser did
not become aware of this offering of the Securities, nor were the Securities offered to Purchaser, by any other means, and none of the
Company and/or its respective representatives (other than the Placement Agent acting as a broker-dealer) acted as investment advisor,
broker or dealer to Purchaser. The Purchaser is not purchasing the Securities as a result of any general or public solicitation or general
advertising, or publicly disseminated advertisement, article, notice or other communication regarding the Securities published in any
newspaper, magazine or similar media or broadcast over television, radio or the internet or presented at any seminar or any other general
solicitation or general advertisement, including any of the methods described in Section 502(c) of Regulation D under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) <U>Risk Factors</U>. The
Purchaser understands and acknowledges that its purchase of the Securities is a speculative investment that involves a high degree of
risk and the potential loss of their entire investment and has carefully read and considered the matters and Risk factors set forth in
the SEC Reports and in <U>Exhibit G</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) <U>Certain Trading Activities</U>.
Other than consummating the transaction contemplated hereby, the Purchaser has not, nor has any Person acting on behalf of or pursuant
to any understanding with the Purchaser, directly or indirectly executed any purchases or sales, including Short Sales, of the securities
of the Company during the period commencing as of the time that the Purchaser was first contacted by the Company or any other Person acting
on the Company&rsquo;s behalf regarding the transaction contemplated hereby and ending immediately prior to the date of this Agreement.
Notwithstanding the foregoing, in the case of an Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers
manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions
made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only
apply with respect to the portion of the assets managed by the portfolio manager that made the investment decision to purchase the Securities
covered by this Agreement. Other than to other Persons party to this Agreement and to its advisors and agents who had a need to know such
information, the Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including
the existence and terms of this transaction). Notwithstanding the foregoing, for avoidance of doubt, nothing contained herein shall constitute
a representation or warranty, or preclude any actions, with respect to the identification of the availability of, or securing of, available
shares to borrow in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) <U>Disqualification Event</U>.
To the extent the Purchaser is one of the covered persons identified in Rule 506(d)(1), the Purchaser represents that no Disqualification
Event is applicable to the Purchaser or any of its Rule 506(d) Related Parties (as defined below), except, if applicable, for a Disqualification
Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is applicable. The Purchaser hereby agrees that it shall notify the Company promptly
in writing in the event a Disqualification Event becomes applicable to the Purchaser or any of its Rule 506(d) Related Parties, except,
if applicable, for a Disqualification Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is applicable. For purposes of this Section,
&ldquo;<U>Rule 506(d) Related Party</U>&rdquo; means a person or entity that is a beneficial owner of the Purchaser&rsquo;s securities
for purposes of Rule 506(d) of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l) <U>Access to Information</U>.
Such Purchaser acknowledges and agrees that other than materials that were prepared by the Company and expressly approved by the Company
for dissemination by the Placement Agent to the Purchaser, if any, , neither the Placement Agent nor any Affiliate of the Placement Agent
has provided such Purchaser with any information or advice with respect to the Securities nor is such information or advice necessary
or desired. Such Purchaser further acknowledges and agrees that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities
and the merits and risks of investing in the Securities; (ii) access to publicly available information about the Company and its financial
condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and
(iii) the opportunity to obtain such additional publicly available information that the Company possesses or can acquire without unreasonable
effort or expense that is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges
and agrees that neither the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any such information
or advice with respect to the Securities nor is such information or advice necessary or desired from the Placement Agent or any Affiliate
of the Placement Agent. Neither the Placement Agent nor any Affiliate has made or makes any representation as to the Company or the quality
of the Securities. The Placement Agent and any Affiliate may have acquired non-public information with respect to the Company which such
Purchaser agrees need not be provided to it. In connection with the issuance of the Securities to such Purchaser, neither the Placement
Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m) <U>Investment Company
Act Acknowledgment</U>. The Purchaser acknowledges that the Company&rsquo;s representation in Section 3.1(v) is based solely upon the
Company&rsquo;s operations and intended operations as they exist as of the date of this Agreement and the Closing Date, including the
Company&rsquo;s present intention to use the proceeds from the sale of Securities under this Agreement as described in Section 4.7, and
that the Company&rsquo;s status as an &ldquo;investment company&rdquo; is subject to change based upon one or more changes in the laws
or regulations regarding the Company&rsquo;s operations by one or more governmental authorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n) <U>Certain Transactions
and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has any Person acting
on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or sales, including Short
Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first received a term sheet (written
or oral) from the Company or any other Person representing the Company setting forth the material terms of the transactions contemplated
hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed
investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers
have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s
assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that
made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement
or to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors, partners, legal and other advisors,
employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this
transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing
contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares
in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o) <U>Cryptocurrency Subscriptions</U>.
(i) Purchaser has all rights, title and interest in and to the Dogecoin, Bitcoin, Ethereum, USDC or USDT to be contributed by it to the
Company pursuant to this Agreement, (ii) such Dogecoin, Bitcoin, Ethereum, USDC or USDT is held in a digital wallet held or operated by
or on behalf of the Purchaser at or by an appropriately regulated custodian and/or in accordance with industry-standard security practices
(the &ldquo;<U>Purchaser Digital Wallet</U>&rdquo;) and neither such Dogecoin, Bitcoin, Ethereum, USDC or USDT nor such Purchaser Digital
Wallet is subject to any liens, encumbrances or other restrictions, (iii) Purchaser has taken commercially reasonable steps to protect
its Purchaser Digital Wallet and such Dogecoin, Bitcoin, Ethereum, USDC or USDT and (iv) Purchaser has the exclusive ability to control
such Purchaser Digital Wallet, including by use of &ldquo;private keys&rdquo; or other equivalent means or through custody arrangements
or other equivalent means.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p) <U>Taxes</U>. Purchaser
acknowledges (a) that Company makes no representation or warranty with respect to any tax implications of the Transaction to Purchaser;
(b) Purchaser shall be solely and exclusively responsible for the payment of any and all taxes to Purchaser as a result of the Transaction;
(c) Purchaser represents that (i) Purchaser will not retain any rights in the Dogecoin, Bitcoin, Ethereum, USDC or USDT transferred by
Purchaser to the Company are subject to liabilities that are assumed by the Company, (ii) none of the Dogecoin, Bitcoin, Ethereum, USDC
or USDT transferred by Purchaser to the Company are subject to liabilities that are assumed by the Company, (iii) the fair market value
of the Dogecoin, Bitcoin, Ethereum, USDC or USDT contributed to the Company is at least equal to or greater than Purchaser&rsquo;s tax
basis in applicable Dogecoin, Bitcoin, Ethereum, USDC or USDT; (d) Purchaser has paid its own expenses, in any, incurred in connection
with entering into this Agreement; and (e) Purchaser is not a party to any binding commitments and has no current plans or intention to
sell the stock of the Company purchased pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company acknowledges and agrees that the representations
contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on the Company&rsquo;s representations
and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document, or any other
document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated
hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty,
or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company and each of the Purchasers acknowledge
and agree that no party to this Agreement has made or makes any representations or warranties with respect to the transactions contemplated
hereby other than those specifically set forth in this Article III and the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE IV.<BR>
OTHER AGREEMENTS OF THE PARTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1 <U>Transfer Restrictions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The Securities may only
be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities other than pursuant
to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection with a pledge as
contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of counsel selected
by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to
the Company, to the effect that such transfer does not require registration under the Securities Act. As a condition of transfer (other
than pursuant to an effective Registration Statement or Rule 144), any such transferee shall agree in writing to be bound by the terms
of this Agreement and the Registration Rights Agreement and shall have the rights and obligations of a Purchaser under this Agreement
and the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The Purchasers agree to
the imprinting, so long as is required by this Section 4.1, of a legend in the form set forth in Section 3.2(g) hereof. The Company acknowledges
and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant
a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo; as defined
in Rule 501(a) of Regulation D under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer
pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company
and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no
notice shall be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable
documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities,
including, if the Securities are subject to registration pursuant to Section 4.4 of this Agreement, the preparation and filing of any
required prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately
amend the list of selling stockholders thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) Certificates evidencing
the Pre-Funded Warrant Shares shall not contain any legend (including the legend set forth in Section 3.2(g), (i) while a registration
statement (including the Registration Statement) covering the resale of such security is effective under the Securities Act, (ii) following
any sale of such Pre-Funded Warrant Shares pursuant to Rule 144, (iii) if such Pre-Funded Warrant Shares may be sold under Rule 144, without
the requirement for the Company to be in compliance with the current public information requirement under Rule 144 as to such Pre-Funded
Warrant Shares and without volume or manner-of-sale restrictions under Rule 144, or (iv) if such legend is not required under applicable
requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission). The
Company shall cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser promptly after the Effective Date if required
by the Transfer Agent to effect the removal of the legend hereunder, or if requested by a Purchaser, respectively. If all or any portion
of a Pre-Funded Warrant is exercised at a time when there is an effective registration statement to cover the resale of the Pre-Funded
Warrant Shares, or if the Pre-Funded Warrant Shares may be sold under Rule 144 and the Company is then in compliance with the current
public information required under Rule 144, or if the Pre-Funded Warrant Shares may be sold under Rule 144 without the requirement for
the Company to be in compliance with the current public information required under Rule 144 as to such Pre-Funded Warrant Shares or if
such legend is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements
issued by the staff of the Commission), then such Pre-Funded Warrant Shares shall be issued free of all legends. The Company shall cause
its counsel to issue a legal opinion to the Transfer Agent promptly after the Effective Date if required by the Transfer Agent to effect
the removal of the legend hereunder or if reasonably required by a Purchaser. The Company agrees that following the Effective Date or
at such time as such legend is no longer required under this Section 4.1(c), it will, no later than the earlier of (i) one (1) Trading
Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser
to the Company or the Transfer Agent of a certificate representing the Pre-Funded Warrant Shares, as the case may be, issued with a restrictive
legend (such date, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to be delivered to such Purchaser a certificate representing
such shares that is free from all restrictive and other legends. The Company may not make any notation on its records or give instructions
to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4.1. Certificates for Securities subject to
legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser&rsquo;s
prime broker with the Depository Trust Company as directed by such Purchaser. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of a certificate representing Pre-Funded Warrant Shares issued with a restrictive
legend. The Purchaser shall provide the Company written notice of a removal request (the &ldquo;<U>Request Notice</U>&rdquo;) at least
one (1) Trading Day prior to delivery of the legended Share certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) In addition to such Purchaser&rsquo;s
other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated damages and not as a penalty, for each
$1,000 of Pre-Funded Warrant Shares (based on the VWAP of the Common Stock on the date such Securities are submitted to the Transfer Agent)
delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading Day (increasing to $20 per Trading Day
five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the Legend Removal Date (or, if later, four
days after the Request Notice date) until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and
deliver (or cause to be delivered) to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to
the Company by such Purchaser that is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser
purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of
all or any portion of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion
of the number of shares of Common Stock that such Purchaser anticipated receiving from the Company without any restrictive legend, then,
an amount equal to the excess of such Purchaser&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket
expenses, if any) for the Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;<U>Buy-In
Price</U>&rdquo;) over the product of (A) such number of Pre-Funded Warrant Shares that the Company was required to deliver to such Purchaser
by the Legend Removal Date multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing
on the date of the delivery by such Purchaser to the Company of the applicable Pre-Funded Warrant Shares and ending on the date of such
delivery and payment under this clause (ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) The Purchasers agree with
the Company that such Purchaser will sell any Securities pursuant to either the registration requirements of the Securities Act, including
any applicable prospectus delivery requirements, or an exemption therefrom, and that if Securities are sold pursuant to a Registration
Statement, they will be sold in compliance with the plan of distribution set forth therein, and acknowledges that the removal of the restrictive
legend from certificates representing Securities as set forth in this Section 4.1 is predicated upon the Company&rsquo;s reliance upon
this understanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2 <U>Furnishing of Information;
Public Information</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) For at least two years
after the Closing Date, the Company covenants to maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange
Act and to timely file (or timely obtain extensions in respect thereof and file within the applicable grace period) all reports required
to be filed by the Company with the Commission after the date hereof pursuant to the Exchange Act even if the Company is not then subject
to the reporting requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) At any time during the
period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the Securities of a Purchaser
may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation
pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current public information requirement under Rule 144(c)
or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or becomes such an issuer in the future, and the Company shall fail to
satisfy any condition set forth in Rule 144(i)(2) (a &ldquo;<U>Public Information Failure</U>&rdquo;) then, in addition to such Purchaser&rsquo;s
other available remedies, the Company shall pay to that Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason
of any such delay in or reduction of its ability to sell the Securities, an amount in cash equal to $1,000 per day of a Public Information
Failure until the earlier of (a) the date such Public Information Failure is cured and (b) such time that such public information is no
longer required for that Purchaser to transfer the Pre-Funded Warrant Shares pursuant to Rule 144. The payments to which a Purchaser shall
be entitled pursuant to this Section 4.2(b) are referred to herein as &ldquo;<U>Public Information Failure Payments</U>.&rdquo; Public
Information Failure Payments shall be paid on the earlier of (i) the last day of the calendar month during which such Public Information
Failure Payments are incurred and (ii) the third (3<SUP>rd</SUP>) Business Day after the event or failure giving rise to the Public Information
Failure Payments is cured. In the event the Company fails to make Public Information Failure Payments in a timely manner, other than during
the pendency of any bona fide dispute over whether an alleged Public Information Failure has occurred, such Public Information Failure
Payments shall bear interest at the rate of 1.5% per month (prorated for partial months) until paid in full. Nothing herein shall limit
such Purchaser&rsquo;s right to pursue actual damages for the Public Information Failure, and such Purchaser shall have the right to pursue
all remedies available to it at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3 <U>Integration</U>. The
Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section
2 of the Securities Act) that would be integrated with the offer or sale of the Securities hereunder in a manner that would require the
registration under the Securities Act of the sale of the Securities hereunder or that would be integrated with the offer or sale of the
Securities hereunder for purposes of the rules and regulations of any Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4 <U>Securities Laws Disclosure;
Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of the transactions contemplated
hereby (including the entry into and material terms of the Asset Management Agreement), and (b) file a Current Report on Form 8-K, including
the Transaction Documents and such press release as exhibits thereto (and the Asset Management Agreement as an exhibit thereto, or a summary
of the material terms thereof), with the Commission within the time required by the Exchange Act. From and after the issuance of such
press release, the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered
to any of the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents
in connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such press
release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written
or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates
on the one hand, and any of the Purchasers or any of their Affiliates on the other hand, shall terminate. The Company and each Purchaser
shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the
Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior consent of
the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press
release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in
which case the disclosing party only shall promptly provide the other party with prior notice of such public statement or communication.
Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser
in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except
(a) as required by federal securities law in connection with (i) any registration statement contemplated by this Agreement and the Registration
Rights Agreement, (ii) the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required
by law or Trading Market regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted
under this clause (b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5 <U>Shareholder Rights
Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is
an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents
or under any other agreement between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6 <U>Non-Public Information</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents and the Treasury
Management Agreement, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other
Person acting on its behalf will provide or has provided any Purchaser or its agents or counsel with any information that constitutes,
or the Company reasonably believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented
to the receipt of such information and agreed with the Company to keep such information confidential. The Company understands and confirms
that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that
the Company delivers any material, non-public information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants
and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective
officers, directors, agents, employees or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers,
directors, agents, employees or Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser
shall remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains,
material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the
Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the
foregoing covenant in effecting transactions in securities of the Company. The Company acknowledges and agrees that any failure to timely
cleanse any material, non-public information shall entitle the Purchasers to seek injunctive relief and/or damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7 <U>Use of Proceeds</U>.
The Company shall deliver the net proceeds from the sale of the Securities hereunder to the Asset Manager on the Closing Date to be allocated
to fund the acquisition of cryptocurrency and the establishment of the Company&rsquo;s cryptocurrency treasury operations. The Company
shall use the net proceeds from the sale of the Securities hereunder as follows: (a) up to $1,100,000 shall be used to pay off the Company&rsquo;s
outstanding Indebtedness, (b) $4,400,000 shall be allocated to fund the Company&rsquo;s working capital and for general corporate purposes,
and (c) the balance of the net proceeds shall be used to acquire Dogecoin. The Company shall not use such proceeds: (a) for the redemption
of any Common Stock or Common Stock Equivalents, (b) for the settlement of any outstanding litigation, or (c) in violation of FCPA or
OFAC regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8 <U>Indemnification of
Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors, officers,
shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such
titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section
15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or
employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title
or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any and all losses, liabilities,
obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and
reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of or relating
to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other
Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates,
by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated
by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party&rsquo;s representations,
warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such
stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which
is finally judicially determined to constitute fraud, gross negligence or willful misconduct). If any action shall be brought against
any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify
the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably
acceptable to the Purchaser Party, and such counsel shall provide regular and timely progress updates to the Purchasers. Any Purchaser
Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses
of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has been specifically
authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ
counsel or (iii) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the
position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees
and expenses of no more than one such separate counsel. The Company may not settle, compromise or consent to the entry of any judgment
in any pending or threatened action in which indemnification may be sought by any Purchaser Party hereunder (whether or not any Purchaser
Party is an actual or potential party thereto), without the prior written consent of each such Purchaser Party (which will not be unreasonably
delayed or withheld) unless such settlement, compromise or consent provides for an unconditional and irrevocable release of each such
Purchaser Party from any and all liability arising out of such Claim. The Company will not be liable to any Purchaser Party under this
Agreement (y) for any settlement by a Purchaser Party effected without the Company&rsquo;s prior written consent, which shall not be unreasonably
withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser
Party&rsquo;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement
or in the other Transaction Documents. The indemnification required by this Section 4.8 shall be made by periodic payments of the amount
thereof during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained
herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities
the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.9 <U>Reservation of Common
Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times,
free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant
to this Agreement. Until the Authorization Amendment becomes effective, the Company shall not reserve for issuance the Pre-Funded Warrant
Shares issuable pursuant to any exercise of the Pre-Funded Warrants, Placement Agent Warrant Shares issuable pursuant to any exercise
of the Placement Agent Warrants, and Strategic Advisor Warrant Shares issuable pursuant to any exercise of the Strategic Advisor Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10 <U>Listing of Common
Stock</U>. The Company hereby agrees to use its best efforts to maintain the listing or quotation of the Common Stock on the Trading Market
on which it is currently listed, and the Company shall apply to list or quote all of the Pre-Funded Warrant Shares and the Strategic Advisor
Warrant Shares on such Trading Market prior to the Closing and promptly secure the listing of all of the Pre-Funded Warrant Shares on
such Trading Market prior to Closing. The Company further agrees, if the Company applies to have the Common Stock traded on any other
Trading Market, it will then include in such application all of the Pre-Funded Warrant Shares and will take such other action as is necessary
to cause all of the Pre-Funded Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company
will then take all action reasonably necessary to maintain the listing and trading of its Common Stock on a Trading Market and will comply
in all respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The
Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another
established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other
established clearing corporation in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11 <U>Management Appointments</U>.
The authorized size of the Board of Directors (the &ldquo;<U>Board</U>&rdquo;) shall not exceed five (5) members. Effective as of the
Closing, the Board shall fill two (2) vacancies on the Board by appointing the individuals designated by HoD, it being acknowledged that
Alexander Benjamin Spiro and Timothy Stebbing are the initial individuals so designated and agreed to by the Board and HoD (each, together
with any successor designated in accordance with this Section 4.11, an &ldquo;<U>HoD Director</U>&rdquo;). For so long as HoD continues
to hold any shares of the Company&rsquo;s Common Stock, in the event that an HoD Director resigns, is removed, dies, or becomes disabled,
HoD shall have the right to designate one or more replacement directors reasonably acceptable to the Board (each, a &ldquo;<U>Replacement
HoD Director</U>&rdquo;). Upon receipt of written notice from HoD identifying (i) the HoD Director who has resigned, died, or become disabled,
and (ii) the individual nominated to serve as the Replacement HoD Director, the Board shall promptly evaluate the Replacement HoD Director
and confirm whether the Replacement HoD Director is reasonably satisfactory to the Board and upon such determination shall promptly (and
in any event within five (5) Business Days) deliver the written request contemplated by the applicable Director Agreement, accept the
tendered resignation (if applicable), and take all corporate action necessary to appoint the Replacement HoD Director to the resulting
vacancy. Concurrently with the Closing, the Company shall appoint (a) Marco Margiatto to the Company&rsquo;s management team and (b) a
finance executive reasonably acceptable to the Board and designated by HoD (the &ldquo;<U>Finance Executive</U>&rdquo;). For so long as
HoD continues to hold any shares of the Company&rsquo;s Common Stock, in the event that either Marco Margiatto or the Finance Executive
resigns, dies, or becomes disabled, HoD may, subject to the Board&rsquo;s reasonable approval, nominate one or more replacement individuals
reasonably acceptable to the Board, and the Company shall take all corporate action necessary to effect any such replacement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.12 <U>Subsequent Equity
Sales</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) From the date hereof until
thirty (30) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or
announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement
or amendment or supplement thereto, other than (A) a registration statement on Form S-8 in connection with any employee benefit plan;
provided, however, the Company will be permitted to enter into a sales agreement with the Placement Agent and such other sales agents
as the Placement Agent may designate (each, a &ldquo;<U>Sales Agreement</U>&rdquo;) providing for the sale of shares of Common Stock in
an &ldquo;at-the-market&rdquo; offering, and file any such prospectus supplement or registration statement with the Commission in connection
with such Sales Agreement or (B) the registration statement described in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) Notwithstanding the foregoing,
this Section 4.12 shall not apply in respect of an Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.13 <U>Equal Treatment of
Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend
or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is also offered to
all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right granted to each
Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class
and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting
of Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.14 <U>Certain Transactions
and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it, nor any Affiliate
acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales, of any of the
Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such time that the transactions
contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4. Each Purchaser,
severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement
are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4, such Purchaser will maintain
the confidentiality of the existence and terms of this transaction and the information included in the Disclosure Schedules. Notwithstanding
the foregoing and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees
that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities
of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial
press release as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any
securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by
this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser shall
have any duty of confidentiality or duty not to trade in the securities of the Company to the Company or its Subsidiaries after the issuance
of the initial press release as described in Section 4.4. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed
investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers
have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s
assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made
the investment decision to purchase the Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.15 <U>Form D; Blue Sky Filings</U>.
The Company agrees to timely file a Form D with respect to the Securities as required under Regulation D under the Securities Act and
to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under
applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States and shall provide evidence of such actions promptly
upon request of any Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.16 <U>Acknowledgment of
Dilution</U>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding Common Stock, which
dilution may be substantial under certain market conditions. The Company further acknowledges that its obligations under the Transaction
Documents, including, without limitation, its obligation to issue the Pre-Funded Warrant Shares pursuant to the Transaction Documents,
are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of
any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive effect that such issuance may
have on the ownership of the other stockholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.17 <U>Exercise Procedures</U>.
The form of Notice of Exercise included in the Pre-Funded Warrants set forth the totality of the procedures required of the Purchasers
in order to exercise the Pre-Funded Warrants. No additional legal opinion, other information or instructions shall be required of the
Purchasers to exercise their Pre-Funded Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be
required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in
order to exercise the Pre-Funded Warrants. The Company shall honor exercises of the Pre-Funded Warrants and shall deliver Pre-Funded Warrant
Shares in accordance with the terms, conditions and time periods set forth in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.18 <U>Lock-Up Agreements</U>.
The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements without the prior written consent
of the Placement Agent, except to extend the term of the lock-up period, and shall enforce the provisions of each Lock-Up Agreement in
accordance with its terms. If any party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly
use its best efforts to seek specific performance of the terms of such Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-indent: 34pt">4.19 <U>Principal Market Compliance</U>.
In the event that the Principal Market requires the Company to (i) modify the terms of this Agreement or any of the transactions contemplated
hereby, or (ii) take any other action in connection with the transactions contemplated by this Agreement that necessitates the cooperation,
consent, or action of the Purchasers, including, without limitation, the execution of any amendment to this Agreement or any related Transaction
Documents, each Purchaser hereby covenants and agrees to cooperate in good faith with the Company and to take all such actions, execute
and deliver all such documents, and provide all such information as may be reasonably requested by the Company to effectuate any such
modification or action, in each case to the extent necessary to satisfy any concerns or requirements of the Principal Market in connection
with the transactions contemplated by this Agreement. Notwithstanding the foregoing, if any modification or action required by the Principal
Market would adversely affect a Purchaser&rsquo;s rights or obligations under this Agreement or the related transaction documents, such
Purchaser shall have the option, in its sole discretion, to either (a) agree to such modification or action, or (b) terminate this Agreement
with respect to itself upon written notice to the Company, whereupon this Agreement shall be of no further force or effect with respect
to such Purchaser (except for those provisions that expressly survive termination).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-indent: 34pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-indent: 34pt">4.20 <U>Information Statement</U>. The Company
shall file a definitive information statement on Schedule 14C with the Commission with respect to the August 22 Written Consent on September
2, 2025 (the &ldquo;Second Definitive Information Statement&rdquo;), and shall first mail the Second Definitive Information Statement
to its stockholders on or prior to September 5, 2025, in each case, in accordance with applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-indent: 34pt">4.21 <U>Filing of Authorization Amendment</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The Company shall, as
promptly as practicable following the Closing Date (and in any event within twenty-one (21) days after the mailing of the First Definitive
Information Statement,, prepare, execute and file with the Secretary of State of the State of Nevada the Authorization Amendment in form
and substance reasonably acceptable to HoD and the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The Company shall use
its commercially reasonable best efforts to cause the Authorization Amendment to become effective under the laws of the State of Nevada
as promptly as practicable following its filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) The Company shall not
take any action or omit to take any action that would materially delay, prevent or impair (i) the filing or effectiveness of the Authorization
Amendment, or (ii) the Company&rsquo;s ability to reserve and issue, upon exercise of the Pre-Funded Warrants, Strategic Advisor Warrants
or Placement Agent Warrants, the shares of Common Stock issuable thereunder in accordance with the terms of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt">4.22 <U>Redemption
Right</U>. In the event that the Authorization Amendment is not effective within ninety (90) days from the date hereof, each Purchaser
shall have the right, exercisable for a period of fifteen (15) days to require the Company to (i) redeem the Pre-Funded Warrant purchased
by such Purchaser pursuant to this Agreement at a per Pre-Funded Warrant redemption price equal to the Per PFW Purchase Price minus the
Pre-Funded Warrant exercise price of $0.0001; and (ii) pay the amount of any unpaid liquidated damages owed (if any) to such Purchaser
pursuant to the terms of the Pre-Funded Warrants and the Registration Rights Agreement (as applicable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE V.<BR>
MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1 <U>Termination</U>. This
Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated
on or before the fifth (5th) Trading Day following the date hereof; provided, however, that no such termination will affect the right
of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2 <U>Fees and Expenses</U>.
Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers,
counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation,
execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any
fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered by a Purchaser),
stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers, as well as fees and
expenses of the Asset Manager (including the expenses of its representatives) (the &ldquo;<U>Asset Management Fees</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3 <U>Entire Agreement</U>.
The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties with respect
to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such
matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.4 <U>Notices</U>. Any and
all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed
given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via email attachment
at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day,
(b) the next Trading Day after the time of transmission, if such notice or communication is delivered via email attachment at the email
address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City
time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices
and communications shall be as set forth on the signature pages attached hereto. To the extent that any notice provided pursuant to any
Transaction Document constitutes, or contains material, non-public information regarding the Company or any of the Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.5 <U>Amendments; Waivers</U>.
No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of
an amendment or waiver, by the Company, HoD and each Purchaser, (or, prior to the Closing Date, the Company and each Purchaser). No waiver
of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in
the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay
or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed amendment or
waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser relative to the comparable
rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment
effected in accordance with this Section 5.5 shall be binding upon each Purchaser, holder of Securities and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.6 <U>Headings</U>. The headings
herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.7 <U>Successors and Assigns</U>.
This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may
not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger).
Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities,
provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction
Documents that apply to the &ldquo;Purchasers&rdquo; (other than in respect of a transfer pursuant to an effective registration statement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.8 <U>Third-Party Beneficiaries</U>.
The Placement Agent shall be the third-party beneficiary of the representations and warranties of the Company in Section 3.1 and the representations
and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit of the parties hereto and their respective
successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except
as otherwise set forth in Section 4.8 and this Section 5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.9 <U>Governing Law</U>.
All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by
and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action
or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section
4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.10 <U>Survival</U>. The
representations, warranties, agreements and covenants contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.11 <U>Execution</U>. This
Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered or by e-mail delivery of a &ldquo;.pdf&rdquo;
format data file or DocuSign, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such
signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; or DocuSign signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.12 <U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.13 <U>Rescission and Withdrawal
Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction
Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not
timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion
from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to
its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission of an exercise of a Pre-Funded Warrant,
the applicable Purchaser shall be required to return any Common Stock subject to any such rescinded exercise notice concurrently with
the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration of such Purchaser&rsquo;s
right to acquire such shares pursuant to such Purchaser&rsquo;s Pre-Funded Warrant (including, issuance of a replacement warrant certificate
evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.14 <U>Replacement of Securities</U>.
If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to
be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor,
a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction.
The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including
customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.15 <U>Remedies</U>. In addition
to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and
the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not
be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby
agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would
be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.16 <U>Payment Set Aside</U>.
To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces
or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are
subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded,
repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any
bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation
or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not
been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.17 <U>Independent Nature
of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several and not
joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For
reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through
the legal counsel to the Placement Agent. The legal counsel of the Placement Agent does not represent any of the Purchasers and only represents
the Placement Agent. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience
of the Company and not because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that
each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and
not between the Company and the Purchasers collectively and not between and among the Purchasers. Each Purchaser shall be entitled to
independently protect and enforce its rights, including without limitation the rights arising out of this Agreement or out of the other
Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for
such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents.
The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and
not because it was required or requested to do so by any Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.18 <U>Liquidated Damages</U>.
The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing
obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding
the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall
have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.19 <U>Saturdays, Sundays,
Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.20 <U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and number of shares of Common Stock or Securities, in any Transaction Document shall be subject to adjustment for any stock
split, subdivision, dividend, distribution payable in shares of Common Stock (or other securities or rights convertible into, or entitling
the holder thereof to receive directly or indirectly shares of Common Stock), combination or other similar recapitalization or event occurring
after the date hereof and prior to the Closing, of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.21 <B><U>WAIVER OF JURY
TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY
AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES
FOREVER TRIAL BY JURY. </U></B></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>CleanCORE SOLUTIONS,
INC.</B></FONT></P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><U>Address for Notice</U>:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; width: 4%; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; width: 36%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 20%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 40%; font-size: 10pt"><FONT STYLE="font-size: 10pt">CleanCore Solutions, Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Name: Clayton Adams</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Attn: Clayton Adams, CEO</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Title: CEO</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">5920 S 118<SUP>th</SUP> Circle</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Omaha, NE 68137</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">E-Mail: </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">With a copy to (which shall not constitute notice):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 60%"></TD><TD STYLE="text-align: justify"><P STYLE="margin-top: 0; margin-bottom: 0">Bevilacqua PLLC</P>
                                                            <P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">1050 Connecticut Avenue, NW, Suite 500</P>
                                                            <P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">Washington, DC 20036</P>
                                                            <P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">Attn: Louis A. Bevilacqua, Esq.</P>
                                                            <P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">Email:</P></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO <FONT STYLE="text-transform: uppercase">CLEANCORE
SOLUTIONS, INC.</FONT> SECURITIES PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 40%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name of Purchaser:</FONT></TD>
    <TD STYLE="vertical-align: top; width: 60%; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-size: 10pt"><I>Signature of Authorized Signatory of Purchaser:</I></FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name of Authorized Signatory:</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-size: 10pt">Title of Authorized Signatory:</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-size: 10pt">Email Address of Authorized Signatory:</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice to Purchaser:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">___________________________________________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Address for Delivery of Securities to Purchaser
(if not same as address for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 40%">Subscription Amount for Securities purchased hereunder:</TD>
<TD STYLE="text-align: justify; width: 10%">$_________________</TD>
<TD STYLE="text-align: justify; width: 50%">&nbsp;(in Dogecoin)</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 40%">&nbsp;</TD>
<TD STYLE="text-align: justify; width: 10%">$_________________</TD>
<TD STYLE="text-align: justify; width: 50%">&nbsp;(in Bitcoin)</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 40%"></TD><TD STYLE="text-align: justify; width: 10%">$_________________</TD>
                               <TD STYLE="text-align: justify; width: 50%">&nbsp;(in Ethereum)</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 40%"></TD><TD STYLE="text-align: justify; width: 10%">$_________________</TD>
                               <TD STYLE="text-align: justify; width: 50%">&nbsp;(in USDC)</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 40%"></TD><TD STYLE="text-align: justify; width: 10%">$_________________</TD>
                               <TD STYLE="text-align: justify; width: 50%">&nbsp;(in USDT)</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 40%"></TD><TD STYLE="text-align: justify; width: 10%">$_________________</TD>
                               <TD STYLE="text-align: justify; width: 50%">&nbsp;(in cash)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Per PFW Purchase Price: $_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pre-Funded Warrants: __________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advance Payment of Exercise of Pre-Funded Warrants:
________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Warrant Shares (Beneficial Ownership Blocker
&#9744; 4.99% or &#9744; 9.99%)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">EIN Number: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 38; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>9
<FILENAME>ea025594401ex10-3_clean.htm
<DESCRIPTION>PLACEMENT AGENCY AGREEMENT, DATED SEPTEMBER 1, 2025, AMONG CLEANCORE SOLUTIONS, INC., MAXIM GROUP LLC AND CURVATURE SECURITIES, LLC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 10.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: right; text-indent: 0.5in">September 1, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CleanCore Solutions, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">5920 S 118<SUP>th</SUP> Circle</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Omaha, NE 68137</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Clayton Adams, Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Re: Placement Agency Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Mr. Adams:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This letter (this &ldquo;<B>Agreement</B>&rdquo;)
constitutes the agreement by and among Maxim Group LLC (&ldquo;<B>Maxim</B>&rdquo;), Curvature Securities LLC (&ldquo;<B>Curvature</B>&rdquo;,
together with Maxim, the &ldquo;<B>Placement Agent</B>&rdquo;), and CleanCore Solutions, Inc., a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;),
that the Placement Agent shall serve as the co-exclusive placement agents for the Company, on a &ldquo;reasonable best efforts&rdquo;
basis, in connection with the proposed placement (the &ldquo;<B>Placement</B>&rdquo;) of pre-funded Common Stock purchase warrants (the
&ldquo;<B>Pre-Funded Warrants</B>&rdquo; or the &ldquo;<B>Securities</B>&rdquo;) to purchase shares of the Company&rsquo;s Class B common
stock, par value $0.0001 per share (the &ldquo;<B>Common Stock</B>&rdquo;). The terms of the Placement shall be mutually agreed upon by
the Company and the purchaser of the Securities (the &ldquo;<B>Purchaser</B>&rdquo;), and nothing herein constitutes that the Placement
Agent would have the power or authority to bind the Company or the Purchaser, or an obligation for the Company to issue any securities
or complete the Placement. The Company expressly acknowledges and agrees that the Placement Agent&rsquo;s obligations hereunder are on
a reasonable best efforts basis only and that the execution of this Agreement does not constitute a commitment by the Placement Agent
to purchase the Securities and does not ensure the successful placement of the Securities or any portion thereof or the success of the
Placement Agent with respect to securing any other financing on behalf of the Company. The Placement Agent may retain other brokers or
dealers to act as sub-agents or selected-dealers on its behalf in connection with the Placement. Certain affiliates of the Placement Agent
may participate in the Placement by purchasing some of the Securities. The sale of Securities to the Purchaser will be evidenced by a
securities purchase agreement (the &ldquo;<B>Purchase Agreement</B>&rdquo;) between the Company and such Purchaser, in a form reasonably
acceptable to the Company and the Purchaser. Payment for the Purchaser&rsquo;s Subscription Amount shall initially be deposited in an
escrow account in the name of the Company held by Continental Stock Transfer &amp; Trust Company, as escrow agent, until the Closing Date
and such payment shall be made by instruction countersigned by the Placement Agent and Company, by wire transfer to the Company. Capitalized
terms that are not otherwise defined herein have the meanings given to such terms in the Purchase Agreement. Prior to the signing of any
Purchase Agreement, officers of the Company will be available to answer inquiries from the prospective Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 1</U>. <U>REPRESENTATIONS
AND WARRANTIES OF THE COMPANY; COVENANTS OF THE COMPANY</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">A. <U>Representations of the
Company</U>. With respect to the Securities, each of the representations and warranties (together with any related disclosure schedules
thereto) and covenants made by the Company to the Purchaser in the Purchase Agreement in connection with the Placement, are hereby incorporated
herein by reference into this Agreement (as though fully restated herein) and is, as of the date of this Agreement and as of the Closing
Date, hereby made to, and in favor of, the Placement Agent. In addition to the foregoing, the Company represents and warrants that there
are no affiliations with any FINRA (as defined below) member firm among the Company&rsquo;s officers, directors or, to the knowledge of
the Company, any five percent (5.0%) or greater securityholder of the Company, except as set forth in the Purchase Agreement., and that<B>:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">1. (i) The Company has full
right, power and authority to enter into this Agreement and the Transaction Documents and to perform all of its obligations hereunder
and thereunder; (ii) each of this Agreement and the Transaction Documents has been duly authorized and executed and constitutes a legal,
valid and binding agreement of such party enforceable in accordance with its terms except (a) as limited by general equitable principles
and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo;
rights generally, (b) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies
and (c) insofar as indemnification and contribution provisions may be limited by applicable law; and (iii) the execution and delivery
of this Agreement and the Transaction Documents and the consummation of the transactions contemplated hereby and thereby does not conflict
with or result in a breach of, in any material respect, (y) the Company&rsquo;s certificate of incorporation or by-laws or other charter
documents or (z) any agreement to which the Company is a party or by which any of its property or assets is bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2. All disclosure provided
by the Company to the Placement Agent regarding the Company, its business and the transactions contemplated hereby, taken together with
all filings the Company has made with the Securities and Exchange Commission, is true and correct in all material aspects and does not
contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein,
in the light of the circumstances under which they were made, not misleading. Each filing made by the Company with the Securities and
Exchange Commission did not at the time of release contain any untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading. To the best of the Company&rsquo;s knowledge and belief, other than the current capital raising (of which this Agreement relates),
no event or circumstance has occurred or information exists with respect to the Company or its business, properties, prospects, operations
or financial conditions, which, under the applicable laws, rules or regulations, requires public disclosure or announcement by the Company
but which has not been so publicly announced or disclosed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">3. The Company has not taken
and will not take any action, directly or indirectly, so as to cause the Placement to fail to be entitled to rely upon the exemption from
registration afforded by Section 4(a)(2) of the Securities Act, as amended (the &ldquo;<B>Act</B>&rdquo;). In effecting the Placement,
the Company agrees to comply in all material respects with applicable provisions of the Act and any regulations thereunder and any applicable
laws, rules, regulations and requirements (including, without limitation, all U.S. state law and all national, provincial, city or other
legal requirements).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">4. The Company has the power
to submit, and pursuant to Section 10 of this Agreement, has legally, validly, effectively and irrevocably submitted, to the non-exclusive
personal jurisdiction of any New York State or United States federal court located in the City of New York, Borough of Manhattan, (each,
a &ldquo;<B>New York Court</B>&rdquo;). The Company has the power to designate, appoint and authorize, and pursuant to Section 10 of this
Agreement, has legally, validly, effectively and irrevocably designated, appointed an authorized agent for service of process in any action
arising out of or relating to this Agreement or the Placement in any New York Court, and service of process effected on such authorized
agent will be effective to confer valid personal jurisdiction over the Company as provided in Section 10 of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">B. <U>Covenants of the Company</U>.
The Company covenants and agrees to continue to retain (i) a firm of independent PCAOB registered public accountants for a period of at
least two (2) years after the Closing Date and (ii) a competent transfer agent with respect to the Common Stock for a period of five (5)
years after the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">1. <U>Subsequent Equity Sales</U>.
From the date hereof until thirty (30) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into
any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii)
file any registration statement or amendment or supplement thereto, other than (A) a registration statement on Form S-8 in connection
with any employee benefit plan; provided, however, the Company will be permitted to enter into a sales agreement with the Placement Agent
and such other sales agents as the Placement Agent may designate (each, a &ldquo;Sales Agreement&rdquo;) providing for the sale of shares
of Common Stock in an &ldquo;at-the-market&rdquo; offering, and file any such prospectus supplement or registration statement with the
Commission in connection with such Sales Agreement or (B) the registration statement described in the Registration Rights Agreement. Notwithstanding
the foregoing, this Section 1(B)(1) shall not apply in respect of an Exempt Issuance (as defined in the Purchase Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 2</U>. <U>REPRESENTATIONS
OF THE PLACEMENT AGENT</U>. The Placement Agent represents and warrants that it (i) is a member in good standing of FINRA, (ii) is registered
as a broker/dealer under the Exchange Act, (iii) is licensed as a broker/dealer under the laws of the United States of America, applicable
to the offers and sales of the Securities by the Placement Agent, (iv) is and will be a corporate body validly existing under the laws
of its place of incorporation, (v) has full power and authority to enter into and perform its obligations under this Agreement, (vi) has
not taken and will not take any action, directly or indirectly, so as to cause the Placement to fail to be entitled to rely upon the exemption
from registration afforded by Section 4(a)(2) of the Act; (vii) in effecting the Placement, the Placement Agent agrees to comply in all
material respects with applicable provisions of the Act and any regulations thereunder and any applicable laws, rules, regulations and
requirements (including, without limitation, all U.S. state law and all national, provincial, city or other legal requirements), (viii)
this Agreement has been duly authorized and executed and constitutes a legal, valid and binding agreement of the Placement Agent enforceable
in accordance with its terms, and (ix) neither the Placement Agent, any person compensated for soliciting investors in the Placement,
nor any general partner, managing member, executive officer, director or officer of the Placement Agent participating in the Placement
is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a
&ldquo;<B>Disqualification Event</B>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2). The Placement Agent will
immediately notify the Company in writing of any change in its status as such. The Placement Agent covenants that it will conduct the
Placement hereunder in compliance with the provisions of this Agreement and the requirements of applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 3</U>. <U>COMPENSATION</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A. <U>Cash Fee</U>. In consideration
of the services to be provided for hereunder, the Company shall pay to the Placement Agent and/or its respective designees a cash fee
(the &ldquo;<B>Cash Fee</B>&rdquo;) equal to 6% of the aggregate purchase price paid by each Purchaser from the sale of the Securities
(the &ldquo;<B>Offering</B>&rdquo;), with Maxim receiving 60% of the Cash Fee and Curvature receiving 40% of the Cash Fee. The Cash Fee
shall be paid on the Closing Date from the gross proceeds of the Securities sold. Concurrently out of the proceeds of the closing the
Company also agrees to reimburse the Placement Agent for accountable legal fees and other out-of-pocket expenses incurred by the Placement
Agent in connection with the Placement in an amount not to exceed $150,000, as well as non-accountable expenses (the &ldquo;<B>NAE</B>&rdquo;)
including, but not limited to, IPREO software related expenses, background check(s), tombstones, marketing related expenses; i.e. roadshow,
travel, et al. and any other expenses incurred by the Placement Agent in connection with the Placement, (provided, however, that such
reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement). Upon written request
of the Company, the Placement Agent will provide an accounting of legal and out-of-pocket expenses and NAE prior to payment. The Placement
Agent reserves the right to reduce any item of compensation, including the reimbursement of expenses, or adjust the terms thereof as specified
herein in the event that a determination shall be made by FINRA to the effect that the Placement Agent&rsquo;s aggregate compensation
is in excess of FINRA Rules or that the terms thereof require adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B. <U>Placement Agent Warrants</U>.
The Company shall issue to the Placement Agent warrants (the &ldquo;<B>Placement Agent Warrants</B>&rdquo;) to purchase that number of
shares of Common Stock equal to 3.0% of the aggregate amount of Securities sold and/or issued in the Offering with Maxim receiving 60%
of the Placement Agent Warrants and Curvature receiving 40% of the Placement Agent Warrants. The Placement Agent Warrants will be immediately
exercisable following the effective date of the registration statement and will expire five (5) years after the Closing Date. The Placement
Agent Warrants will be exercisable at a price per share equal to 133% of the price of the Securities paid by the Investors in connection
with the Offering. The Placement Agent Warrants shall not be redeemable. To the extent that the Investors are granted registration rights
with respect to the Securities they purchase in the Offering (or components thereof), the Company will grant identical rights to the Placement
Agent with respect to the Securities underlying the Placement Agent Warrants consistent with FINRA Rule 5110. The Placement Agent will
be entitled to customary demand and &ldquo;piggyback&rdquo; rights pursuant to FINRA Rule 5110, which shall include one demand registration
at the Company&rsquo;s expense, an additional demand registration at the warrant holders&rsquo; expense and unlimited &ldquo;piggyback&rdquo;
registration rights. The Placement Agent Warrants (and the underlying securities) may not be transferred, assigned or hypothecated for
a period of six (6) months following initial Closing, except that they may be assigned, in whole or in part, to any successor, officer
or member of the Placement Agent (or to officers or partners of any such successor or member), or except as permitted pursuant to FINRA
Rule 5110(e)(2). The Placement Agent Warrants may be exercised in whole or in part, shall provide for &ldquo;cashless&rdquo; exercise
if the underlying warrant shares are not registered for resale at the time of exercise, and shall provide for customary anti-dilution
protection (adjustment in the number and price of such warrants and the shares underlying such warrants) resulting from corporate events
involving stock dividends, recapitalizations, reorganizations, mergers, stock splits, and similar events, and, for the avoidance of doubt,
will not include antidilution protection relating to the sale of securities below the exercise price of the Placement Agent Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C. <U>Right of First Refusal</U>.
Upon any Closing of the Offering, for a period of twelve (12) months from the Closing, the Company grants the Placement Agent the right
of first refusal (the &ldquo;<B>Right of First Refusal</B>&rdquo;) to act as exclusive managing underwriters and sole book runners, exclusive
placement agents, or exclusive sales agents, for any and all future public and private equity, equity-linked, convertible or debt offerings
during such twelve (12) month period of the Company, or any successor to or any subsidiary of the Company (a &ldquo;<B>Subsequent Offering</B>&rdquo;).
With respect to such Subsequent Offerings, Maxim shall have the right to be the lead underwriter or agent with a minimum of 60% economics,
and Curvature shall have the right to be underwriter or agent with a minimum of 40% economics; provided, however, that if the Subsequent
Offering is an &ldquo;at-the-market&rdquo; (ATM) offering, then Maxim and Curvature shall split the economics evenly (50%/50%). The Company
shall provide the Placement Agent with written notice of no less than three (3) business days following its election to engage in a Subsequent
Offering, which notice shall describe the proposed terms and conditions of such Subsequent Offering. The Placement Agent shall notify
the Company within fifteen (15) days of its receipt of the written offer contemplated above as to whether it agrees to accept such retention.
The Company shall not offer to retain any entity or person in connection with any Subsequent Offering on terms more favorable than terms
on which it offers to retain Placement Agent. If one Placement Agent should decline such retention, the non-declining Placement Agent
shall have the right to be exclusive underwriter or agent for such Subsequent Offering. If both Placement Agents decline such retention,
the Company shall have the right to retain any other person or persons to provide such services on terms and conditions which are not
materially more favorable to such other person or persons than the terms declined by the Placement Agents. Notwithstanding the foregoing,
the Right of First Refusal shall not apply to any PIPE that (a) is effected without the engagement of, or compensation to, any broker-dealer,
placement agent, finder or other intermediary retained by the Company, and (b) is conducted solely with investors with whom the Company,
its officers, directors or existing equity holders had a substantive pre-existing business or personal relationship, including, without
limitation, &ldquo;friends and family&rdquo; investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D. <U>Tail Financing</U>.
If, within twelve (12) months after the Closing Date, the Company completes any public or private offering of equity, equity-linked, convertible
or debt securities or other capital raising activity of the Company with, or receives any proceeds from, any of the Investors who were
contacted or introduced by the Placement Agent in connection with the Offering, the Company will pay to the Placement Agent upon the closing
of such financing or the receipt of such proceeds the compensation set forth in Section 3A and 3B.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 4</U>. <U>INDEMNIFICATION</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A. To the extent permitted
by law, with respect to the Securities, the Company will indemnify the Placement Agent and its affiliates, stockholders, directors, officers,
employees, members and controlling persons (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act)
against all losses, claims, damages, expenses and liabilities, as the same are incurred (including the reasonable fees and expenses of
counsel), relating to or arising out of its activities hereunder or pursuant to this Agreement, except to the extent that any losses,
claims, damages, expenses or liabilities (or actions in respect thereof) are found in a final judgment (not subject to appeal) by a court
of law to have resulted primarily and directly from the Placement Agent&rsquo;s fraud, willful misconduct or gross negligence in performing
the services described herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B. Promptly after receipt
by the Placement Agent of notice of any claim or the commencement of any action or proceeding with respect to which the Placement Agent
is entitled to indemnity hereunder, the Placement Agent will notify the Company in writing of such claim or of the commencement of such
action or proceeding, but failure to so notify the Company shall not relieve the Company from any obligation it may have under this Section
4, except and only to the extent such failure results in the forfeiture by the Company of substantial rights and defenses. If the Company
so elects or is requested by the Placement Agent, the Company will assume the defense of such action or proceeding and will employ counsel
reasonably satisfactory to the Placement Agent and will pay the reasonable fees and expenses of such counsel. Notwithstanding the preceding
sentence, the Placement Agent will be entitled to employ counsel separate from counsel for the Company and from any other party in such
action if counsel for the Placement Agent reasonably determines that it would be inappropriate under the applicable rules of professional
responsibility for the same counsel to represent both the Company and the Placement Agent. In such event, the reasonable fees and disbursements
of no more than one (1) such separate counsel will be paid by the Company, in addition to fees of local counsel. The Company will have
the right to settle the claim or proceeding provided that the Company will not settle any such claim, action or proceeding without the
prior written consent of the Placement Agent, which will not be unreasonably withheld. The Company shall not be liable for any settlement
of any action effected without its written consent, which will not be unreasonably withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C. The Company agrees to notify
the Placement Agent promptly of the assertion against it or any other person of any claim or the commencement of any action or proceeding
relating to the Placement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D. If for any reason the foregoing
indemnity is unavailable to the Placement Agent or insufficient to hold the Placement Agent harmless, then the Company shall contribute
to the amount paid or payable by the Placement Agent as a result of such losses, claims, damages or liabilities in such proportion as
is appropriate to reflect not only the relative benefits received by the Company on the one hand and the Placement Agent on the other,
but also the relative fault of the Company on the one hand and the Placement Agent on the other that resulted in such losses, claims,
damages or liabilities, as well as any relevant equitable considerations. The amounts paid or payable by a party in respect of losses,
claims, damages and liabilities referred to above shall be deemed to include any legal or other fees and expenses incurred in defending
any litigation, proceeding or other action or claim. Notwithstanding the provisions hereof, the Placement Agent&rsquo;s share of the liability
hereunder shall not be in excess of the amount of fees actually received, or to be received, by the Placement Agent under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">E. These indemnification provisions
shall remain in full force and effect whether or not the Placement is completed and shall survive the termination of this Agreement, and
shall be in addition to any liability that the Company might otherwise have to any indemnified party under this Agreement or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 5</U>. <U>ENGAGEMENT
TERM</U>. The Placement Agent&rsquo;s engagement hereunder will commence on the date hereof and continue through the Closing Date. The
date of termination of this Agreement is referred to herein as the &ldquo;<B>Termination Date</B>.&rdquo; In the event, however, in the
course of the Placement Agent&rsquo;s performance of due diligence it deems it reasonably necessary to terminate the engagement, the Placement
Agent may do so prior to the Termination Date. The Company may elect to terminate the engagement hereunder for any reason prior to the
Termination Date but will remain responsible for reasonable and documented out of pocket accountable legal fees and other expenses. Notwithstanding
anything to the contrary contained herein, the provisions concerning the Company&rsquo;s obligation to pay any fees or expenses actually
earned pursuant to Section 3 hereof and the provisions concerning confidentiality, indemnification and contribution contained herein will
survive any expiration or termination of this Agreement, subject to the terms herein. If this Agreement is terminated prior to the completion
of the Placement, all fees or expenses due to the Placement Agent pursuant to this Agreement shall be paid by the Company to the Placement
Agent on or before the Termination Date (in the event such fees or expenses are earned or owed as of the Termination Date). The Placement
Agent agrees not to use any confidential information concerning the Company provided to the Placement Agent by the Company for any purposes
other than those contemplated under this Agreement. During the period between the date hereof and the Termination Date, the Placement
Agent shall be the Company&rsquo;s exclusive Placement Agent with the Placement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 6</U>. <U>PLACEMENT
AGENT INFORMATION</U>. The Company agrees that any information or advice rendered by the Placement Agent in connection with this engagement
is for the confidential use of the Company only in its evaluation of the Placement and, except as otherwise required by law, the Company
will not disclose or otherwise refer to the advice or information in any manner without the Placement Agent&rsquo;s prior written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 7</U>. <U>NO FIDUCIARY
RELATIONSHIP</U>. This Agreement does not create, and shall not be construed as creating rights enforceable by any person or entity not
a party hereto, except those entitled hereto by virtue of the indemnification provisions hereof. The Company acknowledges and agrees that
the Placement Agent is not and shall not be construed as a fiduciary of the Company and shall have no duties or liabilities to the equity
holders or the creditors of the Company or any other person by virtue of this Agreement or the retention of the Placement Agent hereunder,
all of which are hereby expressly waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 8</U>. <U>CLOSING</U>.
The obligations of the Placement Agent, and the Closing of the sale of the Securities hereunder are subject to the accuracy, when made
and on the Closing Date, of the representations and warranties on the part of the Company contained herein and in the Purchase Agreement,
to the accuracy of the statements of the Company and its subsidiaries made in any certificates pursuant to the provisions hereof, to the
performance by the Company of its obligations hereunder and in the Purchase Agreement, and to each of the following additional terms and
conditions, except as otherwise disclosed to and acknowledged and waived by the Placement Agent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">A. All corporate proceedings
and other legal matters incident to the authorization, form, execution, delivery and validity of each of this Agreement, the Securities,
and all other legal matters relating to this Agreement and the transactions contemplated hereby with respect to the Securities shall be
reasonably satisfactory in all material respects to counsel for the Placement Agent, and the Company shall have furnished to such counsel
all documents and information that they may reasonably request to enable them to pass upon such matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">B. The Placement Agent shall
have received from counsel to the Company and Nevada counsel to the Company such counsel&rsquo;s written opinion with respect to the Securities,
addressed to the Placement Agent and dated as of the Closing Date, in form and substance reasonably satisfactory to the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">C. (i) Neither the Company nor
any of its subsidiaries shall have sustained, since the date of the latest audited or unaudited financial statements included or incorporated
by reference in its reports publicly filed with the Securities and Exchange Commission, any material loss or interference with its business
from fire, explosion, flood, terrorist act or other calamity, whether or not covered by insurance, or from any labor dispute or court
or governmental action, order or decree, otherwise than as set forth in or contemplated by the Purchase Agreement and disclosure schedules
thereto and (ii) since such date there shall not have been any material change in the capital stock or long-term debt of the Company or
any of its subsidiaries or any material change, or any development involving a prospective material change, in or affecting the business,
general affairs, management, financial position, stockholders&rsquo; equity or results of operations or prospects of the Company and its
subsidiaries, otherwise as set forth in or contemplated by the Purchase Agreement and disclosure schedules thereto, the effect of which,
in any such case described in clause (i) or (ii), is, in the reasonable judgment of the Placement Agent, so material and adverse as to
make it impracticable or inadvisable to proceed with the sale or delivery of the Securities on the terms and in the manner contemplated
by the Purchase Agreement and disclosure schedules thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">D. Subsequent to the execution
and delivery of this Agreement and up to the Closing Date, there shall not have occurred any of the following: (i) trading in the Company&rsquo;s
securities generally on the applicable trading market shall have been suspended or minimum or maximum prices or maximum ranges for prices
shall have been established on any such exchange or such market by the Securities and Exchange Commission or by such exchange or by any
other regulatory body or governmental authority having jurisdiction, (ii) a banking moratorium shall have been declared by federal or
state authorities or a material disruption has occurred in commercial banking or securities settlement or clearance services in the United
States, (iii) the United States shall have become engaged in hostilities in which it is not currently engaged, the subject of an act of
terrorism, there shall have been an escalation in hostilities involving the United States, or there shall have been a declaration of a
national emergency or war by the United States, or (iv) there shall have occurred any other calamity or crisis or any material change
in general economic, political or financial conditions in the United States or elsewhere, if the effect of any such event in clauses (i)-(iv)
makes it, in the sole and reasonable judgment of the Placement Agent, impracticable or inadvisable to proceed with the sale or delivery
of the Securities on the terms and in the manner contemplated by the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">E. No action shall have been
taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental agency or body which would,
as of the Closing Date, prevent the issuance or sale of the Securities or materially and adversely affect or potentially and adversely
affect the business or operations of the Company; and no injunction, restraining order or order of any other nature by any federal or
state court of competent jurisdiction shall have been issued as of the Closing Date which would prevent the issuance or sale of the Securities
or materially and adversely affect or potentially and adversely affect the business or operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">F. The Company shall have entered
into a Purchase Agreement with the Purchasers of the Securities and such agreement shall be in full force and effect and shall contain
representations, warranties and covenants of the Company as agreed upon between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">G. The Placement Agent shall
have received customary certificates of the Company&rsquo;s executive officers, as to the accuracy of the representations and warranties
contained in the Purchase Agreement, a CFO certificate, as to certain financial data as requested by the Placement Agent, and a certificate
of the Company&rsquo;s secretary certifying that each of the Company&rsquo;s charter documents are true and complete, have not been modified
and are in full force and effect; (ii) that the resolutions of the Company&rsquo;s Board of Directors relating to the Placement are in
full force and effect and have not been modified; and (iii) as to the incumbency of the officers of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">H. The Placement Agent shall
have received a certificate of good standing from the secretary of state of the state of organization of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">I. The Placement Agent shall
have received the Placement Agent Warrants, the Strategic Advisor Warrants and the Pre-Funded Warrants in the name of such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">J. The Common Stock is registered
under the Exchange Act and the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants, upon such exercise being permitted
pursuant to the terms and condition the Pre-Funded Warrants, shall be, if and as applicable, listed and admitted and authorized for trading
on the Trading Market or other applicable U.S. national exchange (subject to any restrictions or conditions that may be imposed by the
Trading Market or other applicable U.S. national exchange) and satisfactory evidence of such action shall have been provided to the Placement
Agent. For three (3) years from the Closing Date, the Company shall have taken no action designed to, or likely to have the effect of
terminating the registration of the Common Stock under the Exchange Act or, if applicable, delisting or suspending from trading the Common
Stock from the Trading Market or other applicable U.S. national exchange, nor has the Company received any information suggesting that
the Commission or the Trading Market or other U.S. applicable national exchange is contemplating terminating such registration or listing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">K. FINRA shall have raised no
objection to the fairness and reasonableness of the terms and arrangements of this Agreement. In addition, the Company shall, if requested
by the Placement Agent, make or authorize Placement Agent&rsquo;s counsel to make on the Company&rsquo;s behalf, any necessary filing
with the FINRA Corporate Financing Department with respect to the Placement and pay all filing fees required in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">L. The Placement Agent and the
Purchasers shall have received the legal opinion of Company Counsel and Company Nevada Counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">M. The Transfer Agent shall
have received a copy of the irrevocable instructions to deliver from time to time, upon exercise of the Pre-Funded Warrants, the Pre-Funded
Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">N. The Placement Agent shall
have received the Lock-Up Agreements duly executed by the Company and the directors and executive officers signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">O. The Placement Agent shall
have received the Registration Rights Agreement, Asset Management Agreement and Strategic Advisor Agreement duly executed by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">P. The Placement Agent shall
have received a certified copy of the Certificate of Incorporation of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Q. The Company shall have received
an executed consent of Company stockholders holding the requisite number of the Company&rsquo;s voting shares that are needed for the
Stockholder Approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">R. The Pre-Funded Warrant Shares
to be issued to the Purchasers shall have been approved for listing on the Trading Market, subject only to official notice of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">S. The outstanding class A common
stock of the Company shall have been converted to class B common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All opinions, letters, evidence
and certificates mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if
they are in form and substance reasonably satisfactory to counsel for the Placement Agent. If any of the conditions specified in this
Section 8 shall not have been fulfilled when and as required by this Agreement, all obligations of the Placement Agent hereunder may be
cancelled by the Placement Agent at, or at any time prior to, the Closing Date. Notice of such cancellation shall be given to the Company
in writing or orally. Any such oral notice shall be confirmed promptly thereafter in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 9</U>. <U>GOVERNING
LAW</U>. This Agreement will be governed by, and construed in accordance with, the laws of the State of New York applicable to agreements
made and to be performed entirely in such State, without regard to its conflict of laws principles. This Agreement may not be assigned
by either party without the prior written consent of the other party. This Agreement shall be binding upon and inure to the benefit of
the parties hereto, and their respective successors and permitted assigns. Any right to trial by jury with respect to any dispute arising
under this Agreement or any transaction or conduct in connection herewith is waived. Any dispute arising under this Agreement may be brought
into the courts of the State of New York or into the Federal Court located in New York, New York and, by execution and delivery of this
Agreement, the Company hereby accepts for itself and in respect of its property, generally and unconditionally, the jurisdiction of aforesaid
courts. Each party hereto hereby irrevocably waives personal service of process and consents to process being served in any such suit,
action or proceeding by delivering a copy thereof via overnight delivery (with evidence of delivery) to such party at the address in effect
for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. If either
party shall commence an action or proceeding to enforce any provisions of this Agreement, then the prevailing party in such action or
proceeding shall be reimbursed by the other party for its attorney&rsquo;s fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 10</U>. <U>ENTIRE
AGREEMENT/MISCELLANEOUS</U>. This Agreement embodies the entire agreement and understanding between the parties hereto, and supersedes
all prior agreements and understandings, relating to the subject matter hereof. If any provision of this Agreement is determined to be
invalid or unenforceable in any respect, such determination will not affect such provision in any other respect or any other provision
of this Agreement, which will remain in full force and effect. This Agreement may not be amended or otherwise modified or waived except
by an instrument in writing signed by both the Placement Agent and the Company. The representations, warranties, agreements and covenants
contained herein shall survive the Closing Dates of the Placement and delivery of the Securities. This Agreement may be executed in two
or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when
counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the
same counterpart. In the event that any signature is delivered by facsimile transmission or a .pdf format file, such signature shall create
a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as
if such facsimile or .pdf signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 11</U>. <U>NOTICES</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is sent to the email address
specified on the signature pages attached hereto prior to 6:30 p.m. (New York City time) on a business day, (b) the next business day
after the date of transmission, if such notice or communication is sent to the email address on the signature pages attached hereto on
a day that is not a business day or later than 6:30 p.m. (New York City time) on any business day, (c) the third business day following
the date of mailing, if sent by U.S. internationally recognized air courier service, or (d) upon actual receipt by the party to whom such
notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 12</U>. <U>PRESS
ANNOUNCEMENTS</U>. The Company agrees that the Placement Agent shall, on and after the Closing Date, have the right to reference the Placement
and the Placement Agent&rsquo;s role in connection therewith in the Placement Agent&rsquo;s marketing materials and on its website and
to place advertisements in financial and other newspapers and journals, in each case at its own expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 13</U>. <U>SECURITIES
AND OTHER LAW COMPLIANCE</U>. The Company, at its own expense, will use its best efforts to obtain any registration, qualification or
approval required to sell any securities under the laws (including U.S. state &ldquo;blue-sky&rdquo; laws) of any applicable jurisdictions
or any instrumentality thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>The remainder of this page has been intentionally
left blank.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please confirm that the foregoing
correctly sets forth our agreement by signing and returning to the Placement Agent the enclosed copy of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>MAXIM GROUP LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%; text-align: justify"><FONT STYLE="font-size: 10pt">/s/ Larry Glassberg</FONT></TD>
    <TD STYLE="width: 60%; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-size: 10pt">Larry Glassberg</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Co-Head of Investment Banking</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Address for notice:</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">300 Park Avenue Fl 16</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">New York, NY 10022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>CURVATURE SECURITIES LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%; text-align: justify"><FONT STYLE="font-size: 10pt">/s/ Michael Bodner</FONT></TD>
    <TD STYLE="width: 60%; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Michael Bodner</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">President</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Address for notice:</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">39 Main Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Chatham, NJ 07928</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Attn: Michael Bodner</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accepted and Agreed to as of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">the date first written above:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>CLEANCORE SOLUTIONS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%; text-align: justify"><FONT STYLE="font-size: 10pt">/s/ Clayton Adams</FONT></TD>
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Clayton Adams</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Address for notice</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CleanCore Solutions, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Attn: Clayton Adams, CEO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">5920 S 118<SUP>th</SUP> Circle</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Omaha, NE 68137</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page to Placement Agency Agreement.</I>]&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">9</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>10
<FILENAME>ea025594401ex10-4_clean.htm
<DESCRIPTION>FORM OF REGISTRATION RIGHTS AGREEMENT, DATED SEPTEMBER 1, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION RIGHTS AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Registration Rights Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of September 1, 2025, between CleanCore Solutions, Inc., a Nevada corporation
(the &ldquo;<U>Company</U>&rdquo;), and each of the several purchasers signatory hereto (each such purchaser, a &ldquo;<U>Purchaser</U>&rdquo;
and, collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement is made pursuant
to the Securities Purchase Agreement, dated as of September 1, 2025, between the Company and the Purchasers named therein (the &ldquo;<U>Purchase
Agreement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and each Purchaser
hereby agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">1. <U>Definitions</U>.
Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such
terms in the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Advice</U>&rdquo;
shall have the meaning set forth in Section 6(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Common Stock</U>&rdquo;
means the class B common stock of the Company, par value $0.0001 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Effectiveness Date</U>&rdquo;
means (i) with respect to the initial Registration Statement required to be filed pursuant to Section 2(a), the earlier of the (A) the
30<SUP>th</SUP> calendar day following the Filing Date and (B) the 2nd Business Day after the date the Company is notified (orally or
in writing, whichever is earlier) by the SEC that such Registration Statement will not be reviewed or will not be subject to further review
(or, in the event of a &ldquo;full review&rdquo; by the Commission, the 90<SUP>th&nbsp;</SUP>calendar day following the Filing Date) and
(ii) with respect to any additional Registration Statements that may be required to be filed by the Company pursuant to this Agreement,
the earlier of the (A) 45<SUP>th</SUP> calendar day following the date on which the Company was required to file such additional Registration
Statement and (B) 2nd Business Day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that
such Registration Statement will not be reviewed or will not be subject to further review (or, in the event of a &ldquo;full review&rdquo;
by the Commission, the 90<SUP>th&nbsp;</SUP>calendar day following the Filing Date).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Effectiveness Period</U>&rdquo;
shall have the meaning set forth in Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Event</U>&rdquo;
shall have the meaning set forth in Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Event Date</U>&rdquo;
shall have the meaning set forth in Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Filing Date</U>&rdquo;
means, with respect to the Initial Registration Statement required hereunder, the earlier of (i) the 20<SUP>th</SUP> calendar day following
the Closing Date, or (ii) 1 Business Day after the Stockholder Approval becomes effective. With respect to any additional Registration
Statements which may be required pursuant to Section 2(c) or Section 3(c), &ldquo;Filing Date&rdquo; means the earliest practical date
on which the Company is permitted by SEC Guidance to file such additional Registration Statement related to the Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Holder</U>&rdquo;
or &ldquo;<U>Holders</U>&rdquo; means the holder or holders, as the case may be, from time to time of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Indemnified Party</U>&rdquo;
shall have the meaning set forth in Section 5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Indemnifying Party</U>&rdquo;
shall have the meaning set forth in Section 5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Initial Registration
Statement</U>&rdquo; means the initial Registration Statement filed pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Losses</U>&rdquo;
shall have the meaning set forth in Section 5(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Plan of Distribution</U>&rdquo;
shall have the meaning set forth in Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously
omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the Commission
pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of
any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus,
including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Registrable Securities</U>&rdquo;
means, as of any date of determination or subsequently acquired, (a) all the Pre-Funded Warrant Shares, (b) all the Placement Agent Warrant
Shares, (c) all Strategic Advisor Warrant Shares, and (d) any securities issued or then issuable upon any share split, dividend or other
distribution, recapitalization or similar event with respect to the foregoing; <U>provided, however</U>, that any such Registrable Securities
shall cease to be Registrable Securities (and the Company shall not be required to maintain the effectiveness of any, or file another,
Registration Statement hereunder with respect thereto) to the extent (a) a Registration Statement with respect to the sale of such Registrable
Securities is declared effective by the Commission under the Securities Act and such Registrable Securities have been transferred, exchanged
or disposed of by the Holder in accordance with such effective Registration Statement, (b) such Registrable Securities have been previously
sold in accordance with Rule 144, or (c) such securities become eligible for resale without volume or manner-of-sale restrictions and
without current public information pursuant to Rule 144 as set forth in a written opinion letter to such effect, addressed, delivered
and acceptable to the Transfer Agent and the affected Holders (assuming that such securities and any securities issuable upon exercise,
conversion or exchange of which, or as a dividend upon which, such securities were issued or are issuable, were at no time held by any
Affiliate of the Company, as reasonably determined by the Company, upon the advice of counsel to the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Registration Statement</U>&rdquo;
means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration statements contemplated
by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such registration statement
or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated by reference or deemed
to be incorporated by reference in any such registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Rule 415</U>&rdquo;
means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>Selling Shareholder
Questionnaire</U>&rdquo; shall have the meaning set forth in Section 3(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&ldquo;<U>SEC Guidance</U>&rdquo;
means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements or requests of the Commission
staff, (ii) the Securities Act and (iii) any other rules and regulations of the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Registration</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) On
or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale of all
of the Registrable Securities that are not then registered on an effective Registration Statement for an offering to be made on a continuous
basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form S-1 or such other appropriate form in accordance
herewith, subject to the provisions of Section 2(e) and shall contain substantially the &ldquo;<U>Plan of Distribution</U>&rdquo; attached
hereto as <U>Annex A</U> and substantially the &ldquo;<U>Selling Shareholder</U>&rdquo; section attached hereto as <U>Annex B</U>; <U>provided</U>,
<U>however</U>, that no Holder shall be required to be named as an &ldquo;underwriter&rdquo; without such Holder&rsquo;s express prior
written consent. Subject to the terms of this Agreement, the Company shall use its best efforts to cause a Registration Statement filed
under this Agreement (including, without limitation, under Section 3(c)) to be declared effective under the Securities Act as promptly
as possible after the filing thereof, but in any event no later than the applicable Effectiveness Date, and shall use its best efforts
to keep such Registration Statement continuously effective under the Securities Act, and to be supplemented and amended to the extent
necessary to ensure that such Registration Statement is available or, if not available, that another Registration Statement is available,
for the resale of all the Registrable Securities held by the Holders until the date that all Registrable Securities covered by such Registration
Statement (i) have been sold, thereunder or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale restrictions pursuant
to Rule 144 and without the requirement for the Company to be in compliance with the current public information requirement under Rule
144, as determined by the counsel to the Company pursuant to a written opinion letter to such effect, addressed and acceptable to the
Transfer Agent and the affected Holders (the period commencing on the Effectiveness Date and ending on the later of the dates set forth
in clause (i) or (ii) of the provision, the &ldquo;<U>Effectiveness Period</U>&rdquo;). The Company shall telephonically request effectiveness
of a Registration Statement as of 5:00 p.m. (New York City time) on a Trading Day. The Company shall immediately notify the Holders via
facsimile or by e-mail of the effectiveness of a Registration Statement on the same Trading Day that the Company telephonically confirms
effectiveness with the Commission, which shall be the date requested for effectiveness of such Registration Statement. The Company shall,
by 9:30 a.m. (New York City time) on the Trading Day after the effective date of such Registration Statement, file a final Prospectus
with the Commission as required by Rule 424. Failure to so notify the Holder within one (1) Trading Day of such notification of effectiveness
or failure to file a final Prospectus as foresaid shall be deemed an Event under Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) Notwithstanding
the registration obligations set forth in Section 2(a), if the Commission informs the Company that all of the Registrable Securities cannot,
as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration statement, the Company
agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments to the Initial Registration
Statement as required by the Commission, covering the maximum number of Registrable Securities permitted to be registered by the Commission,
on Form S-1 or such other form available to register for resale the Registrable Securities as a secondary offering, subject to the provisions
of Section 2(e); with respect to filing on Form S-1 or other appropriate form, and subject to the provisions of Section 2(d) with respect
to the payment of liquidated damages; <U>provided</U>, <U>however</U>, that prior to filing such amendment, the Company shall be obligated
to use reasonable best efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance
with the SEC Guidance, including without limitation, Securities Act Rules Compliance and Disclosure Interpretation Question 612.09.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) Notwithstanding
any other provision of this Agreement and subject to the payment of liquidated damages pursuant to Section 2(d), if the Commission or
any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular Registration
Statement as a secondary offering (and notwithstanding that the Company used diligent efforts to advocate with the Commission for the
registration of all or a greater portion of Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable
Securities, the number of Registrable Securities to be registered on such Registration Statement will be reduced as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) First, the Company shall
reduce or eliminate any securities to be included other than Registrable Securities; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) Second, the Company shall
reduce Registrable Securities represented by Pre-Funded Warrant Shares, Placement Agent Warrant Shares and Strategic Advisor Warrant Shares
(applied, in the case that some Pre-Funded Warrant Shares, Placement Agent Warrant Shares and Strategic Advisor Warrant Shares may be
registered, to the Holders on a pro rata basis based on the total number of unregistered Pre-Funded Warrant Shares, Placement Agent Warrant
Shares and Strategic Advisor Warrant Shares held by such Holders).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">In the event of a cutback
hereunder, the Company shall give the Holder at least five (5) Trading Days prior written notice along with the calculations as to such
Holder&rsquo;s allotment. In the event the Company amends the Initial Registration Statement in accordance with the foregoing, the Company
will use its best efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company or
to registrants of securities in general, one or more registration statements on Form S-1 or such other form available to register for
resale those Registrable Securities that were not registered for resale on the Initial Registration Statement, as amended, and to use
its commercially reasonable efforts to cause the Commission to declare such registration statement covering the Registrable Securities
that were not registered for resale on the Initial Registration Statement, as amended, effective as soon as practicable after the date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) If:
(i) the Initial Registration Statement is not filed on or prior to its Filing Date (if the Company files the Initial Registration Statement
without affording the Holders the opportunity to review and comment on the same as required by Section 3(a) herein or the Company subsequently
withdraws the filing of the Registration Statement, for reasons other than at the request of the Holders of a majority in interest of
the Registrable Securities to withdraw the Registration Statement, the Company shall be deemed to have not satisfied this clause (i) and
any such event or circumstance shall thus constitute an &ldquo;Event&rdquo; as defined below), or (ii) the Company fails to file with
the Commission a request for acceleration of a Registration Statement in accordance with Rule 461 promulgated by the Commission pursuant
to the Securities Act, within five (5) Trading Days of the date that the Company is notified (orally or in writing, whichever is earlier)
by the Commission that such Registration Statement will not be &ldquo;reviewed&rdquo; or will not be subject to further review, or (iii)
prior to the effective date of a Registration Statement, the Company fails to file a pre-effective amendment and otherwise respond in
writing to comments made by the Commission in respect of such Registration Statement within ten (10) calendar days after the receipt of
comments by or notice from the Commission that such amendment is required in order for such Registration Statement to be declared effective,
or (iv) a Registration Statement registering for resale all of the Registrable Securities, subject to the cutback limitations set forth
in Section 2(c) of this Agreement, is not declared effective by the Commission by the Effectiveness Date of the Initial Registration Statement
(provided that, if the Registration Statement does not allow for the resale of Registrable Securities at prevailing market prices (i.e.,
only allows for fixed price sales), the Company shall have been deemed to have not satisfied this clause and any such event or circumstance
shall thus constitute an &ldquo;Event&rdquo; as defined below), or (v) after the effective date of a Registration Statement, such Registration
Statement ceases for any reason to remain continuously effective as to all Registrable Securities included in such Registration Statement,
or the Holders are otherwise not permitted to utilize the Prospectus therein to resell such Registrable Securities, for more than ten
(10) consecutive calendar days or more than an aggregate of fifteen (15) calendar days (which need not be consecutive calendar days) during
any 12-month period (any such failure or breach being referred to as an &ldquo;<U>Event</U>&rdquo;, and for purposes of clauses (i) and
(iv), the date on which such Event occurs, and for purpose of clause (ii) the date on which such five (5) Trading Day period is exceeded,
and for purpose of clause (iii) the date which such ten (10) calendar day period is exceeded, and for purpose of clause (v) the date on
which such ten (10) or fifteen (15) calendar day period, as applicable, is exceeded being referred to as &ldquo;<U>Event Date</U>&rdquo;),
then, in addition to any other rights the Holders may have hereunder or under applicable law, on each such Event Date and on each monthly
anniversary of each such Event Date (if the applicable Event shall not have been cured by such date) until the applicable Event is cured,
the Company shall pay to each Holder an amount in cash, as partial liquidated damages and not as a penalty, equal to $1,000 per day of
such failure. If the Company fails to pay any partial liquidated damages pursuant to this Section in full within seven days after the
date payable, the Company will pay interest thereon at a rate of 18% per annum (or such lesser maximum amount that is permitted to be
paid by applicable law) to the Holder, accruing daily from the date such partial liquidated damages are due until such amounts, plus all
such interest thereon, are paid in full. The partial liquidated damages pursuant to the terms hereof shall apply on a daily pro rata basis
for any portion of a month prior to the cure of an Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) The
Company shall register the resale of the Registrable Securities on Form S-3 under the Securities Act&nbsp;&nbsp;(or in the event that
the Company is ineligible to use such form, such other form as the Company is eligible to use under the Securities Act provided that such
other form shall be converted into an S-3 as soon as Form S-3 becomes available to the Company), provided that the Company shall maintain
and effectiveness of and update as required the Registration Statement then in effect until such time as a Registration Statement on Form
S-3 covering the Registrable Securities has been declared effective by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) Notwithstanding
anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate of a Holder as any
Underwriter without the prior written consent of such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Registration
Procedures</U>. In connection with the Company&rsquo;s registration obligations hereunder, the Company shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) Not
less than five (5) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior to the
filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated or deemed to
be incorporated therein by reference), the Company shall (i) furnish to each Holder copies of all such documents proposed to be filed,
which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review of such Holders,
and (ii) cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall
be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning
of the Securities Act, provided that the Company shall redact any sections of such documents that may contain material non-public information
unless the Holder consents in writing to receive such information and agree to hold it in confidence. The Company shall not file a Registration
Statement or any such Prospectus or any amendments or supplements thereto to which the Holders of a majority of the Registrable Securities
shall reasonably object in good faith, provided that, the Company is notified of such objection in writing no later than five (5) Trading
Days after the Holders have been so furnished copies of a Registration Statement or one (1) Trading Day after the Holders have been so
furnished copies of any related Prospectus or amendments or supplements thereto. Each Holder agrees to furnish to the Company a completed
questionnaire in the form attached to this Agreement as <U>Annex C </U>(a &ldquo;<U>Selling Shareholder Questionnaire</U>&rdquo;) on a
date that is not less than two (2) Trading Days prior to the Filing Date or by the end of the fourth (4<SUP>th</SUP>) Trading Day following
the date on which such Holder receives draft materials in accordance with this Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) (i)
Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus
used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable
Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to register
for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended or supplemented
by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant
to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to a Registration
Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies of all correspondence
from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information contained therein
which would constitute material non-public information regarding the Company or any of its Subsidiaries), and (iv) comply in all material
respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable
Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this Agreement) with
the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in such Prospectus
as so supplemented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) If
during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock
then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior to the
applicable Filing Date, an additional Registration Statement covering the resale by the Holders of not less than the number of such Registrable
Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) Notify
the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied by
an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible (and,
in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person) confirm such
notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective
amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether there will be a &ldquo;review&rdquo;
of such Registration Statement and whenever the Commission comments in writing on such Registration Statement, and (C) with respect to
a Registration Statement or any post-effective amendment, when the same has become effective, (ii) of any request by the Commission or
any other federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional
information, (iii) of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending
the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for
that purpose, (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption
from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding
for such purpose, (v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration
Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any document incorporated
or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to a Registration Statement,
Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the case may be, it will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading, and (vi) of the occurrence or existence of any pending
corporate development with respect to the Company that the Company believes may be material and that, in the determination of the Company,
makes it not in the best interest of the Company to allow continued availability of a Registration Statement or Prospectus; <U>provided</U>,
<U>however</U>, that in no event shall any such notice contain any information which would constitute material, non-public information
regarding the Company or any of its Subsidiaries and the Company agrees that the Holders shall not have any duty of confidentiality to
the Company or any of its Subsidiaries and shall not have any duty to the Company or any of its Subsidiaries not to trade on the basis
of such information. In the event that any notice or communication provided to a Holder contains or is deemed to contain material, non-public
information regarding the Company or any of its Subsidiaries, the Company shall, as promptly as practicable and in any event within one
(1) Business Day, publicly disclose such information in a manner compliant with Regulation FD, so as to cleanse such information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) Use
its best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the effectiveness
of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities
for sale in any jurisdiction, at the earliest practicable moment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) Furnish
to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including
financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested
by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference)
promptly after the filing of such documents with the Commission, provided that any such item which is available on the EDGAR system (or
successor thereto) need not be furnished in physical form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) Subject
to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by
each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any
amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) The
Company shall cooperate with any broker-dealer through which a Holder proposes to resell its Registrable Securities in effecting a filing
with the FINRA Corporate Financing Department pursuant to FINRA Rule 5110, as requested by any such Holder, and the Company shall pay
the filing fee required by such filing within two (2) Business Days of receipt of a request therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) Prior
to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate with
the selling Holders in connection with the registration or qualification (or exemption from the registration or qualification) of such
Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United States
as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during the
Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions of
the Registrable Securities covered by each Registration Statement, provided that the Company shall not be required to qualify generally
to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction
where it is not then so subject or file a general consent to service of process in any such jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j) If
requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates, or book-entry notification
as applicable, representing Registrable Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates
or book-entry notification shall be free, to the extent permitted by the Purchase Agreement, of all restrictive legends, and to enable
such Registrable Securities to be in such denominations and registered in such names as any such Holder may request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k) Upon
the occurrence of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into account
the Company&rsquo;s good faith assessment of any adverse consequences to the Company and its shareholders of the premature disclosure
of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to
the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document
so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading. If the Company notifies the Holders in accordance with clauses (iii) through (vi) of Section
3(d) above to suspend the use of any Prospectus until the requisite changes to such Prospectus have been made, then the Holders shall
suspend use of such Prospectus. The Company will use its best efforts to ensure that the use of the Prospectus may be resumed as promptly
as is practicable. The Company shall be entitled to exercise its right under this Section 3(k) to suspend the availability of a Registration
Statement and Prospectus, subject to the payment of partial liquidated damages otherwise required pursuant to Section 2(d), for a period
not to exceed 60 calendar days (which need not be consecutive days) in any 12-month period. The Company shall use its best efforts to
minimize the duration and frequency of any such suspension, and shall not exercise its right to suspend sales for the purpose of limiting
or restricting any Holder&rsquo;s ability to sell Registrable Securities for competitive or other non-disclosure-related reasons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l) Otherwise
use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities Act and
the Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any supplement
or amendment thereof, with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing if, at
any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof,
the Holders are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take such other actions
as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m) The
Company shall use its reasonable best efforts to obtain and maintain eligibility for use of Form S-3 (or any successor form thereto) for
the registration of the resale of the Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n) The
Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock beneficially
owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive control over the
shares. During any periods that the Company is unable to meet its obligations hereunder with respect to the registration of the Registrable
Securities solely because any Holder fails to furnish such information within three Trading Days of the Company&rsquo;s request, any liquidated
damages that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise occur solely because of
such delay shall be suspended as to such Holder only, until such information is delivered to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o) Notwithstanding
any other provisions of this Agreement to the contrary, the Company shall cause (i) each Registration Statement (as of the effective date
of Registration Statement), any amendment thereof (as of the effective date thereof) or supplement thereto (as of its date), (A) to comply
in all material respects with applicable SEC Guidance and (B) not to contain any untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary in order to make the statements therein not misleading, and (ii) any related
Prospectus (including any preliminary Prospectus) and any amendment thereof or supplement thereto, as of its date, (A) to comply in all
material respects with applicable SEC Guidance and (B) not to contain any untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary in order to make the statements therein, not misleading; provided, however, the Company
shall have no such obligations or liabilities with respect to any written information pertaining to any Holder and furnished in writing
to the Company by or on behalf of such Holder specifically for inclusion therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(p) The
Company covenants that it will file the reports required to be filed by it under the Securities Act and the Exchange Act and the rules
and regulations adopted by the Commission thereunder (or, if the Company is not required to file such reports, it will, upon the reasonable
request of any Holder, make publicly available such necessary information for so long as necessary to permit sales pursuant to Rules 144,
144A or Regulation S under the Securities Act), and it will take such further action as any Holder may reasonably request, all to the
extent required from time to time to enable the Holders, to sell Registrable Securities without registration under the Securities Act
within the limitation of the exemptions provided by (i) Rules 144, 144A or Regulation S under the Securities Act, as such rules may be
amended from time to time, or (ii) any similar rule or regulation hereafter adopted by the Commission. Upon the reasonable request of
a Holder, the Company will deliver to such Holder a written statement as to whether it has complied with such requirements and, if not,
the specifics thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <U>Registration
Expenses</U>. All fees and expenses incident to the performance of or compliance with this Agreement by the Company shall be borne by
the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to
in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees
and expenses of the Company&rsquo;s counsel and independent registered public accountants) (A) with respect to filings made with the Commission,
(B) with respect to filings required to be made with any Trading Market on which the shares of Common Stock are then listed for trading,
and (C) in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing (including, without
limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions of the Registrable
Securities), and (D) if not previously paid by the Company with respect to any filing that may be required to be made by any broker through
which a Holder intends to make sales of Registrable Securities with FINRA pursuant to FINRA Rule 5110, so long as the broker is receiving
no more than a customary brokerage commission in connection with such sale, (ii) printing expenses (including, without limitation, expenses
of printing certificates for Registrable Securities), (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of
counsel for the Company, (v) Securities Act liability insurance, if the Company so desires such insurance, and (vi) fees and expenses
of all other Persons retained by the Company in connection with the consummation of the transactions contemplated by this Agreement. In
addition, the Company shall be responsible for all of its internal expenses incurred in connection with the consummation of the transactions
contemplated by this Agreement (including, without limitation, all salaries and expenses of its officers and employees performing legal
or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing of the Registrable
Securities on any securities exchange as required hereunder. In no event shall the Company be responsible for any broker, underwriter
or similar commissions of any Holder or, except to the extent provided for in the Transaction Documents, any legal fees or other costs
of the Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. <U>Indemnification</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <U>Indemnification
by the Company</U>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless, to the fullest
extent permitted by applicable law, each Holder, the officers, directors, members, partners, agents and employees, brokers (including
brokers who offer and sell Registrable Securities as principal as a result of a pledge or any failure to perform under a margin call),
investment advisors and employees (and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding
a lack of such title or any other title) of each of them, each Person who controls any such Holder (within the meaning of Section 15 of
the Securities Act or Section 20 of the Exchange Act) and the officers, directors, members, shareholders, partners, agents and employees
(and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any
other title) of each such controlling Person, from and against any and all losses, claims, damages, liabilities, costs (including, without
limitation, reasonable attorneys&rsquo; fees) and expenses (collectively, &ldquo;<U>Losses</U>&rdquo;), as incurred in investigating,
preparing or defending against any litigation, commenced or threatened, or any claim, arising out of or relating to (1) any failure by
the Company to comply with the covenants and agreements contained in this Agreement, (2) <FONT STYLE="background-color: white">any failure
to register or qualify Registrable Securities in any state where the Company or its agents have affirmatively undertaken or agreed in
writing that the Company (the undertaking of any underwriter being attributed to the Company) will undertake such registration or qualification
on behalf of the Holders of such Registrable Securities (<U>provided</U>&nbsp;that in such instance the Company shall not be so liable
if it has undertaken its reasonable best efforts to so register or qualify such Registrable Securities), (3)</FONT> any untrue or alleged
untrue statement of a material fact contained in a Registration Statement, any Prospectus or any form of prospectus or in any amendment
or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material
fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in
light of the circumstances under which they were made) not misleading or (4) any violation or alleged violation by the Company of the
Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder, in connection with the performance
of its obligations under this Agreement, except to the extent, but only to the extent, that (i) such untrue statements or omissions are
based solely upon information regarding such Holder furnished in writing to the Company by such Holder expressly for use therein, or to
the extent that such information relates to such Holder or such Holder&rsquo;s proposed method of distribution of Registrable Securities
and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement, such Prospectus or in
any amendment or supplement thereto (it being understood that the Holder has approved Annex A hereto for this purpose) or (ii) in the
case of an occurrence of an event of the type specified in Section 3(d)(iii)-(vi), the use by such Holder of an outdated, defective or
otherwise unavailable Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated, defective or otherwise
unavailable for use by such Holder and prior to the receipt by such Holder of the Advice contemplated in Section 6(c). The Company shall
notify the Holders promptly of the institution, threat or assertion of any Proceeding arising from or in connection with the transactions
contemplated by this Agreement of which the Company is aware. Such indemnity shall remain in full force and effect regardless of any investigation
made by or on behalf of such indemnified person and shall survive the transfer of any Registrable Securities by any of the Holders in
accordance with Section 6(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <U>Indemnification
by Holders</U>. Each Holder shall, severally and not jointly, indemnify and hold harmless, to the fullest extent permitted by applicable
law, the Company, its directors, officers, agents and employees, each Person who controls the Company (within the meaning of Section 15
of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons,
from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged untrue statement of
a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto or in any preliminary
prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary
to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were
made) not misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained in any information
so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such Prospectus or (ii)
to the extent, but only to the extent, that such information relates to such Holder&rsquo;s information provided in the Selling Shareholder
Questionnaire or the proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such
Holder expressly for use in a Registration Statement (it being understood that the Holder has approved Annex A hereto for this purpose),
such Prospectus or in any amendment or supplement thereto. In no event shall the liability of a selling Holder be greater in amount than
the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and
the amount of any damages such Holder has otherwise been required to pay by reason of such untrue statement or omission) received by such
Holder upon the sale of the Registrable Securities included in the Registration Statement giving rise to such indemnification obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <U>Conduct
of Indemnification Proceedings</U>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder
(an &ldquo;<U>Indemnified Party</U>&rdquo;), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the
&ldquo;<U>Indemnifying Party</U>&rdquo;) in writing, and the Indemnifying Party shall have the right to assume the defense thereof, including
the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses incurred in connection
with defense thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party
of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be finally determined by a
court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure shall have materially
and adversely prejudiced the Indemnifying Party. The Indemnified Party shall provide the Indemnifying Party with regular and timely progress
updates with respect to any Proceedings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">An Indemnified Party shall
have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees and expenses
of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed in writing
to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding and to employ
counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named parties to any such Proceeding (including
any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to the Indemnified Party shall reasonably
believe that a material conflict of interest is likely to exist if the same counsel were to represent such Indemnified Party and the Indemnifying
Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to employ separate counsel at
the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense thereof and the reasonable
fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying Party). The Indemnifying Party shall
not be liable for any settlement of any such Proceeding effected without its written consent, which consent shall not be unreasonably
withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement of
any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes an unconditional release
of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Subject to the terms of this
Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent incurred in
connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall be paid to
the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party, provided that the Indemnified
Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions for which
such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further
review) not to be entitled to indemnification hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) <U>Contribution</U>.
If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to hold an Indemnified Party
harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified Party, in such
proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions,
statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such
Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in question, including
any untrue statement of a material fact or omission of a material fact, has been taken or made by, or relates to information supplied
by, such Indemnifying Party or Indemnified Party, and the parties&rsquo; relative intent, knowledge, access to information and opportunity
to correct or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed
to include, subject to the limitations set forth in this Agreement, any reasonable attorneys&rsquo; or other fees or expenses incurred
by such party in connection with any Proceeding to the extent such party would have been indemnified for such fees or expenses if the
indemnification provided for in this Section was available to such party in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">The parties hereto agree that
it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata allocation or by any other
method of allocation that does not take into account the equitable considerations referred to in the immediately preceding paragraph.
In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the dollar amount of the
proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the amount of any damages
such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission) received
by it upon the sale of the Registrable Securities giving rise to such contribution obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">The indemnity and contribution
agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to the Indemnified Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <U>Remedies</U>.
The failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party to exercise such right
or remedy, shall not operate as a waiver thereof. In the event of a breach by the Company or by a Holder of any of their respective obligations
under this Agreement, each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by
law and under this Agreement, including recovery of damages, shall be entitled to specific performance of its rights under this Agreement.
Each of the Company and each Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by reason
of a breach by it of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance
in respect of such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <U>No
Piggyback on Registrations; Prohibition on Filing Other Registration Statements</U>. Except as disclosed in Section 3.1(w) of the Purchase
Agreement, neither the Company nor any of its security holders (other than the Holders in such capacity pursuant hereto) may include securities
of the Company in any Registration Statements other than the Registrable Securities. The Company shall not file any other registration
statements until all Registrable Securities are registered pursuant to a Registration Statement that is declared effective by the Commission,
provided that this Section 6(b) shall not prohibit the Company from (i) filing amendments to registration statements filed prior to the
date of this Agreement so long as no new securities are registered on any such existing registration statements, (ii) filing registration
statements on Form S-8 or (iii) filing registration statements related to an &ldquo;at-the-market&rdquo; offering of the Sales Agreement
or New Sales Agreement as permitted by the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <U>Discontinued
Disposition</U>. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from the Company of the
occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue disposition of
such Registrable Securities under a Registration Statement until it is advised in writing (the &ldquo;<U>Advice</U>&rdquo;) by the Company
that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will use its best
efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company agrees and acknowledges that
any periods during which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be subject
to the provisions of Section 2(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) <U>Piggy
Back Registrations</U>. If, at any time during the Effectiveness Period, there is not an effective Registration Statement covering all
of the Registrable Securities and the Company shall determine to prepare and file with the Commission a registration statement relating
to an offering for its own account or the account of others under the Securities Act of any of its equity securities, other than on Form
S-4 or Form S-8 (each as promulgated under the Securities Act) or their then equivalents relating to equity securities to be issued solely
in connection with any acquisition of any entity or business or equity securities issuable in connection with the Company&rsquo;s stock
option or other employee benefit plans, then the Company shall deliver to the Holder a written notice of such determination as soon as
practicable, and in no event less than 15 days prior to the date of filing of such registration statement, and, if within ten (10) days
after the date of the delivery of such notice, any such Holder shall so request in writing, the Company shall include in such registration
statement all Registrable Securities such Holder requests to be registered; provided, however, that the Company shall not be required
to register any Registrable Securities pursuant to this Section 6(d) that are eligible for resale pursuant to Rule 144 (without volume
restrictions or current public information requirements) promulgated by the Commission pursuant to the Securities Act or that are the
subject of a then effective Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) <U>Amendments
and Waivers</U>. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented,
and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing and signed by the
Company and the Holders of 50.1% or more of the then outstanding Registrable Securities (for purposes of clarification, this includes
any Registrable Securities issuable upon exercise or conversion of any Security), provided that, if any amendment, modification or waiver
disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder (or group
of Holders) shall be required. If a Registration Statement does not register all of the Registrable Securities pursuant to a waiver or
amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered for each Holder shall
be reduced pro rata among all Holders and each Holder shall have the right to designate which of its Registrable Securities shall be omitted
from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect
to a matter that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly affect the rights
of other Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver or consent relates;
<U>provided</U>, <U>however</U>, that the provisions of this sentence may not be amended, modified, or supplemented except in accordance
with the provisions of the first sentence of this Section 6(e). No consideration shall be offered or paid to any Person to amend or consent
to a waiver or modification of any provision of this Agreement unless the same consideration also is offered to all of the parties to
this Agreement. Notwithstanding anything above to the contrary, an amendment, modification, supplement, waiver or consent to (i) extend
either the Filing Date and/or the Effectiveness Date shall require the unanimous vote of the Holders and (ii) Section 2(d) shall require
the consent of a Holder to be effective against such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) <U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as set forth
in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) <U>Successors
and Assigns</U>. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each of the
parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger, subject to any successor entity assuming
in writing all of the obligations of the Company under this Agreement) its rights or obligations hereunder without the prior written consent
of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign their respective rights hereunder in the
manner and to the Persons as permitted under Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) <U>No
Inconsistent Agreements</U>. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the Company
or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities, that would
have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof. Neither
the Company nor any of its Subsidiaries has previously entered into any agreement granting any registration rights with respect to any
of its securities to any Person that have not been satisfied in full, other than with respect to the registration rights granted to the
holders of the Placement Agent Warrants (as defined in the Purchase Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Execution
and Counterparts</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party,
it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a &ldquo;.pdf&rdquo; format data file or Docusign, such signature shall create a valid and binding obligation
of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo;
or Docusign signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j) <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined in
accordance with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k) <U>Cumulative
Remedies</U>. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l) <U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m) <U>Headings</U>.
The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be deemed to limit or
affect any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n) <U>Independent
Nature of Holders&rsquo; Obligations and Rights</U>. The obligations of each Holder hereunder are several and not joint with the obligations
of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder
hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken by any Holder
pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture or any other kind
of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity with respect to
such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges that the Holders
are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations or transactions.
Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out of this Agreement,
and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose. The use of
a single agreement with respect to the obligations of the Company contained was solely in the control of the Company, not the action or
decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested to do so by
any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company and a Holder,
solely, and not between the Company and the Holders collectively and not between and among Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
have executed this Registration Rights Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 238.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 238.5pt; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CLEANCORE SOLUTIONS, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 60%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: justify; width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="text-align: justify"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 238.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[SIGNATURE PAGE OF HOLDERS FOLLOWS]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">[SIGNATURE
PAGE OF HOLDERS TO CLEANCORE SOLUTIONS, Inc., RRA]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Holder: __________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Holder</I>:
__________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: _________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: __________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>Annex A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Plan of Distribution</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each selling shareholder
(the &ldquo;<U>Selling Shareholder</U>&rdquo;) of the securities and any of their donees, pledgees, transferees, assignees and successors-in-interest
may, from time to time, sell, transfer or otherwise dispose of any or all of their securities covered hereby on the principal trading
market or any other stock exchange, market or trading facility on which the securities are traded or in private tr<FONT STYLE="font-family: Times New Roman, Times, Serif">ansactions.
These dispositions may be at fixed or prices at prevailing market prices at the time of sale, at prices relating to the prevailing market
price, at varying price determined at the time of sale or at negotiated prices. A Selling Shareholder may use any one or more of the
following methods when disposing securities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">ordinary
                                            brokerage transactions and transactions in which the broker-dealer solicits purchasers;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">block
                                            trades (which may include crosses) in which the broker-dealer will attempt to sell the securities
                                            as agent but may position and resell a portion of the block as principal to facilitate the
                                            transaction;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">purchases
                                            by a broker-dealer as principal and resale by the broker-dealer for its account;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">an
                                            exchange distribution in accordance with the rules of the applicable exchange and/or secondary
                                            distributions;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">directly
                                            to purchasers, including through specific bidding, auction or other process in privately
                                            negotiated transactions;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">underwritten
                                            offerings;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">settlement
                                            of short sales;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">in
                                            transactions through broker-dealers that agree with the Selling Shareholders to sell a specified
                                            number of such securities at a stipulated price per security;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">through
                                            the writing or settlement of options or other hedging transactions, whether through an options
                                            exchange or otherwise, including, without limitation, any securities sold, borrowed or purchased
                                            by a counterparty to a Selling Shareholder as a hedge to such transaction;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">through
                                            the distribution of the shares of common stock by a Selling Shareholder to its employees,
                                            partners (including limited partners), members or stockholders;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">through
                                            delayed delivery requirements;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">a
                                            combination of any such methods of sale; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">any
                                            other method permitted pursuant to applicable law.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Selling Shareholders may, from time to time, pledge or grant a security interest in some or all of the shares of common stock owned by
them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares
of common stock, from time to time, under this prospectus, or under an amendment to this prospectus under Rule 424(b)(3) or other applicable
provision of the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), amending the list of selling stockholders
to include t</FONT>he pledgee, transferee, or other successors in interest as selling stockholders under this prospectus. The Selling
Shareholders also may transfer the shares of common stock in other circumstances, in which case the transferees, pledgees or other successors
in interest will be the selling beneficial owners for purposes of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Shareholders may
also sell securities under Rule 144 or any other exemption from registration under the Securities Act, if available, rather than under
this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Broker-dealers engaged by
the Selling Shareholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts
from the Selling Shareholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts
to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a
customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in
compliance with FINRA Rule 2121.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the sale
of the securities or interests therein, the Selling Shareholders may enter into hedging transactions with broker-dealers or other financial
institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling
Shareholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities
to broker-dealers that in turn may sell these securities. The Selling Shareholders may also enter into option or other transactions with
broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer
or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution
may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Shareholders and
any broker-dealers or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo; within the meaning
of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any
profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities
Act. Each Selling Shareholders has informed the Company that it does not have any written or oral agreement or understanding, directly
or indirectly, with any person to distribute the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is required to
pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company has agreed to indemnify
the Selling Shareholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We agreed to keep this prospectus
effective until the earlier of (i) the date on which the securities may be resold by the Selling Shareholders without registration and
without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance
with the current public information under Rule 144 under the Securities Act or any other rule of similar effect or (ii) all of the securities
have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The resale securities
will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in
certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable
state or an exemption from the registration or qualification requirement is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under applicable rules and
regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market
making activities with respect to the shares of Common Stock for the applicable restricted period, as defined in Regulation M, prior to
the commencement of the distribution. In addition, the Selling Shareholders will be subject to applicable provisions of the Exchange Act
and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the shares of Common
Stock by the Selling Shareholders or any other person. We will make copies of this prospectus available to the Selling Shareholders and
have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by
compliance with Rule 172 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>Annex B</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SELLING SHAREHOLDERS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The shares of Common Stock
being offered by the selling shareholders are those previously issued to the selling shareholders, and those issuable to the selling shareholders,
upon exercise of the pre-funded warrants. For additional information regarding the issuances of those shares of Common Stock, see &ldquo;Private
Placement&rdquo; in the Purchase Agreement. We are registering the shares of Common Stock in order to permit the selling shareholders
to offer the shares for resale from time to time. Except for the ownership of the shares of common stock and the pre-funded warrants,
the selling shareholders have not had any material relationship with us within the past three years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below lists the
selling shareholders and other information regarding the beneficial ownership of the shares of common stock by each of the selling shareholders.
The second column lists the number of shares of common stock beneficially owned by each selling shareholder, based on its ownership of
the shares of common stock and pre-funded warrants, as of ________, 2025, assuming exercise of the pre-funded warrants held by the selling
shareholders on that date, without regard to any limitations on exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The third column lists the
shares of Common Stock being offered by this prospectus by the selling shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with the terms
of a registration rights agreement with the selling shareholders, this prospectus generally covers the resale of the sum of (i) the number
of shares of common stock issued to the selling shareholders in the &ldquo;Private Placement&rdquo; described above and (ii) the maximum
number of shares of common stock issuable upon exercise of the related warrants, determined as if the outstanding warrants were exercised
in full as of the trading day immediately preceding the date this registration statement was initially filed with the SEC, each as of
the trading day immediately preceding the applicable date of determination and all subject to adjustment as provided in the registration
right agreement, without regard to any limitations on the exercise of the pre-funded warrants. The fourth column assumes the sale of all
of the shares offered by the selling shareholders pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the terms of the pre-funded
warrants, a selling shareholder may not exercise the warrants to the extent such exercise would cause such selling shareholder, together
with its affiliates and attribution parties, to beneficially own a number of Ordinary Shares which would exceed 4.99% or 9.99%, as set
forth in the warrants of such selling shareholder, of our then outstanding shares of common stock following such exercise, excluding for
purposes of such determination shares of common stock issuable upon exercise of the warrants which have not been exercised. The number
of shares in the second column does not reflect this limitation. The selling shareholders may sell all, some or none of their shares in
this offering. See &quot;Plan of Distribution.&quot;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 37%; border-bottom: black 1.5pt solid; text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Name of Selling Shareholder</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 20%; border-bottom: black 1.5pt solid; text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Number of shares of Common Stock Owned Prior to Offering</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 20%; border-bottom: black 1.5pt solid; text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Maximum Number of shares of Common Stock to be Sold Pursuant to this Prospectus</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 20%; border-bottom: black 1.5pt solid; text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Number of shares of Common Stock Owned After Offering</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B><U>Annex C</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>CLEANCORE
SOLUTIONS, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Selling Shareholder Notice and Questionnaire</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned beneficial
owner of shares of Common Stock (the &ldquo;<U>Registrable Securities</U>&rdquo;) of CleanCore Solutions, Inc., a Nevada corporation (the
&ldquo;<U>Company</U>&rdquo;), understands that the Company has filed or intends to file with the Securities and Exchange Commission (the
&ldquo;<U>Commission</U>&rdquo;) a registration statement (the &ldquo;<U>Registration Statement</U>&rdquo;) for the registration and resale
under Rule 415 of the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), of the Registrable Securities, in
accordance with the terms of the Registration Rights Agreement (the &ldquo;<U>Registration Rights Agreement</U>&rdquo;) to which this
document is annexed. A copy of the Registration Rights Agreement is available from the Company upon request at the address set forth below.
All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain legal consequences
arise from being named as a selling shareholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial
owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or
not being named as a selling shareholder in the Registration Statement and the related prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The undersigned beneficial owner (the &ldquo;<U>Selling
Shareholder</U>&rdquo;) of Registrable Securities hereby elects to include the Registrable Securities owned by it in the Registration
Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The undersigned hereby provides the following information
to the Company and represents and warrants that such information is accurate:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>QUESTIONNAIRE</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49px; text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>1.</B></FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Name.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="width: 96%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Full Legal Name of Selling Shareholder</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="width: 96%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities are held:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="width: 96%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities covered by this Questionnaire):</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49px; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>2.</B></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Address for Notices to Selling Shareholder:</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Telephone:</FONT></TD>
    <TD STYLE="width: 90%; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Fax:</FONT></TD>
    <TD STYLE="width: 95%; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Contact Person:</FONT></TD>
    <TD STYLE="width: 85%; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49px; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>3.</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Broker-Dealer Status:</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="width: 96%; text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">Are you a broker-dealer?</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt">Yes <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT> No <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="width: 96%; text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">If &ldquo;yes&rdquo; to Section 3(a), did you receive your Registrable Securities as compensation for investment banking services to the Company?</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt">Yes <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT> No <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">Note:</FONT></TD>
    <TD STYLE="width: 96%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">If &ldquo;no&rdquo; to Section 3(b), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="width: 96%; text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">Are you an affiliate of a broker-dealer?</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">Yes <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT> No <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="width: 96%; text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">If you are an affiliate of a broker-dealer, do you certify that you purchased the Registrable Securities in the ordinary course of business, and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities?</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">Yes <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT> No <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">Note:</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">If &ldquo;no&rdquo; to Section 3(d), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>4.</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Beneficial Ownership of Securities of the Company Owned by the Selling Shareholder.</B></FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>Except as set forth below in this
Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company other than the securities issuable
pursuant to the Purchase Agreement.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="width: 96%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Type and Amount of other securities beneficially
owned by the Selling Shareholder:</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>5.</B></FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Relationships with the Company:</B></FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>Except as set forth below, neither
the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities
of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or
affiliates) during the past three years.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">State any exceptions here:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned agrees to promptly notify the
Company of any material inaccuracies or changes in the information provided herein that may occur subsequent to the date hereof at any
time while the Registration Statement remains effective; provided, that the undersigned shall not be required to notify the Company of
any changes to the number of securities held or owned by the undersigned or its affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">By signing below, the undersigned consents to
the disclosure of the information contained herein in its answers to Items 1 through 5 and the inclusion of such information in the Registration
Statement and the related prospectus and any amendments or supplements thereto. The undersigned understands that such information will
be relied upon by the Company in connection with the preparation or amendment of the Registration Statement and the related prospectus
and any amendments or supplements thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF the undersigned,
by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized
agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1pt; width: 42%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 17%; font-size: 10pt; vertical-align: bottom"><FONT STYLE="font-size: 10pt">Beneficial Owner:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1pt; width: 35%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 35%"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>PLEASE FAX A COPY (OR EMAIL A .PDF COPY) OF
THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE TO: Andrea@bevilacquapllc.com</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%">&nbsp;</TD>
    <TD STYLE="width: 33%; text-align: center; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 33%; text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>11
<FILENAME>ea025594401ex10-5_clean.htm
<DESCRIPTION>ASSET MANAGEMENT AGREEMENT, DATED SEPTEMBER 5, 2025, AMONG CLEANCORE SOLUTIONS, INC., DOGECOIN VENTURES, INC. AND 21SHARES US LLC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSET MANAGEMENT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This ASSET MANAGEMENT AGREEMENT
(this &ldquo;Agreement&rdquo;), effective September 5, 2025 (the &ldquo;Effective Date&rdquo;), is entered into by and between CleanCore
Solutions, Inc. (the &ldquo;Client&rdquo;), Dogecoin Ventures, Inc., a wholly-owned subsidiary of House of Doge Inc. (the &ldquo;Asset
Manager&rdquo;), and 21Shares US LLC (&ldquo;21Shares&rdquo; and together with the Client and the Asset Manager, each a &ldquo;Party&rdquo;
or collectively the &ldquo;Parties&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Client wishes
to appoint the Asset Manager to provide discretionary asset management services with respect to certain assets of the Client identified
in this Agreement (the &ldquo;Discretionary Services&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Client wishes
to appoint 21Shares&nbsp;to provide non-discretionary recommendations to the Asset Manager in connection with the Asset Manager&rsquo;s
provision of Discretionary Services to the Client with respect to such assets (the &ldquo;Non-Discretionary Services&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, each of the Asset
Manager and 21Shares wish to be appointed by the Client to perform the Discretionary Services and the Non-Discretionary Services, respectively,
subject to and in accordance with the terms and conditions contained herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the mutual promises contained herein, and for such other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the Parties agree to be bound on the terms and conditions set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;<U>Appointment of
the Asset Manager; Authority</U>. The Client hereby appoints the Asset Manager to provide the Discretionary Services with respect to the
Treasury Assets (as defined below), as further described in Section 3, in the accounts or digital asset &ldquo;wallets&rdquo; identified
in <U>Schedule A</U> attached hereto as amended from time to time (collectively, the &ldquo;Account&rdquo;) maintained with one or more
custodian(s) or digital asset wallet providers acceptable to the Asset Manager, provided that only digital asset wallets controlled by
the Client, to which the Asset Manager has managing access consistent with the terms of this Agreement, shall be permitted (collectively,
the &ldquo;Custodian&rdquo;). To the extent the Client, or the Client with the assistance of the Asset Manager, opens a new account or
digital asset wallet the assets in which the Parties desire to have managed by the Asset Manager pursuant to this Agreement, Schedule
A shall be amended to reflect the details of such new account or wallet and it shall become part of the Account. Further, the Client hereby
appoints 21Shares to provide the Non-Discretionary Services to the Asset Manager as further described in Section 3 with respect to the
Treasury Assets and authorizes the Asset Manager to provide 21Shares with read-only access to such information with respect to the Treasury
Assets and the Account as are reasonably required for 21Shares to provide the Non-Discretionary Services. The Asset Manager hereby accepts
its appointment and agrees to provide the Discretionary Services and upon the terms and conditions set forth herein. 21Shares hereby accepts
its appointment and agrees to provide the Non-Discretionary Services upon the terms and conditions set forth herein. With the prior written
consent of the Client, which will not be unreasonably withheld, conditioned or delayed, each of the Asset Manager and 21Shares may provide
the Discretionary Services and the Non-Discretionary Services, respectively, via their duly appointed affiliates (&ldquo;Manager Affiliates&rdquo;).
The Parties understand and agree that changes to Schedule A may be made from time to time following the date of execution of this Agreement
by mutual agreement of the Client and the Asset Manager.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&nbsp;<U>Treasury Assets</U>.
The &ldquo;Treasury Assets&rdquo; shall consist of (a) certain cash net proceeds of the offering of the Client&rsquo;s securities in accordance
with Section 4 of that certain Securities Purchase Agreement, dated September 1, 2025, between the Client and each purchaser identified
on the signature pages thereto (the &ldquo;Initial Capital Raise&rdquo;), (b) cash proceeds the Client receives in connection with additional
capital raises, if any, with substantially similar objectives as the Initial Capital Raise and (c) additional available cash or digital
assets placed in the Account in accordance with this Section 2, as well as all investments thereof, proceeds of, income on and additions
or accretions to same, including all assets which are or were in the Account, but which are deployed in decentralized finance or similar
blockchain transactions from time to time in accordance with the investment strategy applicable to the Account set forth in&nbsp;<U>Schedule
B</U> (the &ldquo;Investment Strategy&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Client may contribute
assets to the Account at any time with the consent of the Asset Manager and may withdraw assets from the Account by providing at least
five days&rsquo; advance written notice to the Asset Manager; provided, that the Client understands and agrees that certain types of investments
may only be liquidated at certain (sometimes infrequent) times and reasonable extensions to such five days&rsquo; notice period shall
be permitted by the Client in good faith to account for market conditions or other events that in good faith require an extension. The
Client acknowledges and agrees that withdrawals will be funded first by accessing free cash balances and money market instruments; funds
derived from the liquidation of all other assets will be deliverable upon final settlement of the trade(s) funding the withdrawal. Withdrawals
will not affect: (a) the validity of any actions the Asset Manager has previously taken, or (b) the Client&rsquo;s liabilities or obligations
for transactions started before withdrawal. The Client&rsquo;s ability to withdraw assets from the Account is subject to any liquidity
restrictions applicable to a particular investment and compliance with any internal corporate procedures and policies applicable to the
Client.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Client acknowledges that
the Treasury Assets may constitute only a part of the assets of the Client, and that the Asset Manager may act without regard to or consideration
of any other assets that may from time to time be held by the Client and shall have no responsibility, duty or liability with respect
to any assets not Treasury Assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Parties agree that the
&ldquo;Treasury Assets&rdquo; shall not include &ldquo;securities&rdquo; as defined in the Investment Advisers Act of 1940, as amended
(the &ldquo;Advisers Act&rdquo;). Neither the Asset Manager with respect to the Discretionary Services nor 21 Shares with respect to the
Non-Discretionary Services will provide advice with respect to the value of securities, the advisability of investing in, purchasing,
or selling securities, or any analyses or reports concerning securities. Accordingly, the Client understands and agrees that (i) it is
not engaging the Asset Manager or 21Shares to provide investment advice about securities and (ii) for so long as the Treasury Assets do
not include securities and the Asset Manager&rsquo;s and 21Shares&rsquo; services hereunder are confined to non-securities, the Client
is not an &ldquo;advisory client&rdquo; for purposes of the Advisers Act, and to the fullest extent permitted by applicable law, shall
not be afforded the protections of advisory clients under the Advisers Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&nbsp;<U>Powers</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Asset Manager</U>.
The Asset Manager shall have sole responsibility and authority regarding the management of the Treasury Assets and shall direct the investment
and reinvestment of such assets in the Account subject to the Investment Strategy and the terms of this Agreement. Accordingly, with respect
to the Account and Treasury Assets, the Asset Manager&rsquo;s Discretionary Services include the full power and authority to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">purchase, acquire, hold, invest, reinvest, sell, redeem, dispose of, or otherwise deal in any financial
instruments, and place orders with respect to, arrange or otherwise enter into any transactions or other undertakings that the Asset Manager
may deem necessary or advisable to carry out the Investment Strategy, including but not limited to, the ability to buy, sell, exchange,
convert, swap, redeem, and otherwise trade in digital assets and/or interact with blockchain networks and applications;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">select brokers, dealers, exchanges, digital asset wallet providers and other counterparties, which may
or may not be affiliated with the Asset Manager or 21Shares, as may be necessary to execute transactions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">execute, in the name and on behalf of Account, all such documents and take all such other actions which
the Asset Manager deems appropriate or advisable to carry out its duties hereunder, provided such actions shall not cause any Treasury
Assets to be custodied by any party other than the Custodian;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">engage such independent agents, including, without limitation, administrators, sub-advisors (including
Manager Affiliates), attorneys and accountants as the Asset Manager deems appropriate or advisable to assist with its management of the
Treasury Assets; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">take any other action with respect to the Treasury Assets as necessary or desirable to carry out its obligations
under this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement constitutes
the Client&rsquo;s authorization for the Custodian to assist the Asset Manager in effectuating any of the foregoing powers pursuant to
the terms of this Agreement, including opening accounts, exercising or abstaining from the exercise of any rights with respect to the
Treasury Assets, and paying reasonable fees and charges to service providers or other counterparties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>21Shares</U>.
21Shares agrees to provide non-binding recommendations to the Asset Manager in connection with the Asset Manager&rsquo;s Discretionary
Services with respect to the Account. The Parties hereby acknowledge and agree that, with respect to 21Shares&rsquo;s Non-Discretionary
Services, decisions to purchase, hold or sell assets in the Account, or actions otherwise outlined in Section 3(a), shall be made solely
by the Asset Manager and not by 21Shares. The Asset Manager will have no obligation to accept any recommendation made by 21Shares. Should
the Asset Manager accept an investment recommendation from 21Shares, the Asset Manager shall effect the transaction on behalf of the Account.
21Shares shall have no responsibility with respect to the execution of any transaction, and shall have no ability to bind the Account
to any transaction. The Asset Manager understands, however, that 21Shares&rsquo; recommendations may be integrated and interdependent,
and/or time sensitive, and that implementing a recommendation in isolation or delaying instructions may limit the effect of a recommendation,
or render such recommendation moot, which may not meet with the Investment Strategy. Solely with respect to the Asset Manager&rsquo;s
exercise of its discretion with respect to a recommendation made by 21Shares, 21Shares shall have no liability with respect to the Asset
Manager&rsquo;s decision to, or not to, implement any recommendation of 21Shares or with respect to the manner in which the Asset Manager
implements any such recommendation. The Asset Manager shall promptly notify 21Shares of each decision regarding each of 21Shares&rsquo;
non-binding recommendations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Power of Attorney</U>.
In furtherance of the authority set forth in paragraph (a) above, the Client hereby irrevocably designates and appoints the Asset Manager
as its agent and attorney-in-fact, with full power and authority and without further approval of the Client, in the Client&rsquo;s name,
place and stead, to (i) negotiate, make, execute, sign, acknowledge, swear to, deliver, record and file any agreements, documents or instruments
which may be considered necessary or desirable by the Asset Manager to carry out fully the provisions of this Agreement and (ii) to perform
all other acts contemplated by this Agreement or necessary, advisable or convenient to carry out its duties hereunder. Because this limited
power of attorney shall be deemed to be coupled with an interest, it shall be irrevocable and survive and not be affected by the Client&rsquo;s
insolvency or dissolution. However, this limited power of attorney will become revocable upon the expiration of such interest and, therefore,
this limited power of attorney will terminate upon termination of this Agreement in accordance with Section 13 of this Agreement. To the
extent applicable, the Client shall ensure that any materials related to any rights and duties delivered or provided in respect of the
Account&rsquo;s holding of the applicable assets, including to the Client, a Custodian or any other counterparty, shall promptly and timely
be delivered to the Asset Manager in order that the Asset Manager may have such reasonable notice prior to the required time for the exercise
of such right or duty as may be needed for the Asset Manager to make its determination in regard thereto. The Asset Manager shall not
be responsible for directing any decision in respect of such right or duty to the extent it has not timely received all such information
required to be delivered to it pursuant to the preceding sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Investment Strategy</U>.
The Client understands and agrees that neither the Asset Manager nor 21Shares guarantees any particular result in connection with the
Discretionary Services and the Non-Discretionary Services, respectively. The Client and the Asset Manager may mutually agree from time
to time to update the Investment Strategy. The Client and the Asset Manager will promptly notify 21Shares of any change to the Investment
Strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&nbsp;<U>Custody of Assets</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Assets held by
Custodian</U>. Title to the Accounts and all Treasury Assets shall be held in the name of the Client, provided that for convenience in
buying, selling and exchanging assets, title to such assets may be held in the name of the Custodian, or its nominee, or the street name
of the Client&rsquo;s Custodian. Neither the Asset Manager nor any of its affiliates shall take physical custody, possession, or have
any authority to take physical custody or possession of, or handle any cash, mortgages or deeds of trust, or other indicia of ownership
of any of the Treasury Assets. Notwithstanding any transactions authorized by this Agreement and executed by the Asset Manager pursuant
to authority granted herein, all Treasury Assets shall be custodied by the Custodian. Neither the Asset Manager nor 21Shares shall under
any circumstances act as custodian for the Accounts or take, have title, possession, or any authority to take physical custody or possession
of the Treasury Assets. Instructions by the Asset Manager to the Custodian with respect to the Treasury Assets shall be made electronically
(e.g., through an API feed), in writing, or by other documented means agreeable to the Asset Manager and the Custodian.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Expenses of the
Custodian; No Liability</U>. The Client shall pay all charges, fees and expenses of the Custodian and any sub-custodian(s). The fees charged
to the Client by the Custodian are exclusive of, and in addition to, the management fees and other charges, discussed herein. The Asset
Manager shall have no liability with respect to the choice of Custodian or loss of private keys or access to the Account, except for any
recommendation made or such loss of access relating to the Asset Manager&rsquo;s own conduct or credentials (which recommendation or loss
of access is not otherwise exculpated or indemnified in accordance with Section 11). 21Shares shall not have access to any of Client&rsquo;s
private keys, and shall have no liability with respect to the choice of Custodian or the loss of private keys or access to the Account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&nbsp;<U>Proper Instructions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) All instructions communicated
hereunder to the Asset Manager from the Client shall be made in writing and transmitted to the Asset Manager by persons properly authorized
by the Client, including without limitation the Client&rsquo;s Chief Investment Officer. Any such communication appropriately indicating
that it reflects action or instruction by the Client may be so accepted by the Asset Manager and the Asset Manager shall have no obligation
to inquire further with respect thereto and shall be fully protected in relying and acting upon the writing so indicating the action or
instruction of the Client.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The Client shall provide
the Asset Manager with a list of authorized persons and their specimen signatures from whom the Asset Manager may accept written day to
day instructions, confirmations or authority under this Agreement (&ldquo;<U>Proper Instructions</U>&rdquo;) and the Asset Manager shall
be fully protected in relying on such list until notified in writing by the Client to the contrary. Proper Instructions may be sent via
email, Adobe&rsquo;s Portable Document Format (&ldquo;<U>PDF</U>&rdquo;) or other electronic transmission.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.&nbsp;<U>Management Fees;
Account Expenses</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) As compensation for the
Asset Manager&rsquo;s and 21Shares&rsquo; Discretionary Services and Non-Discretionary Services, respectively, the Client shall pay the
management fees described in&nbsp;<U>Schedule C</U>&nbsp;attached hereto (the &ldquo;<U>Fee Schedule</U>&rdquo;). The Fee Schedule shall
be deemed to have been adopted and made a part of this Agreement as if fully rewritten herein. The Asset Manager will furnish invoices
monthly, and all fees shall be payable from the Account not later than ten (10) Business Days following Client&rsquo;s receipt of such
invoice. The Client hereby acknowledges that it is the Client&rsquo;s responsibility to verify the accuracy of the calculation of the
Asset Manager&rsquo;s fees. For purposes of this Agreement, a &ldquo;Business Day&rdquo; means any day on which banks are open in New
York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The Asset Manager and
21Shares shall each individually bear the overhead and operating expenses incurred by each of them in rendering the Discretionary Services
and the Non-Discretionary Services, respectively. The Account shall pay or reimburse the Asset Manager and 21Shares for all reasonable
and documented expenses related to the provision of the Discretionary Services and the Non-Discretionary Services, respectively. Such
expenses shall include, without limitation: (i) custodial fees (including in connection with the operation of digital asset wallets);
(ii) bank service fees; (iii) brokerage commissions and all other brokerage transaction costs (including decentralized finance transactions);
(iv) clearing and settlement fees (including fees of blockchain-based settlement); (v) interest and withholding or transfer taxes incurred
in connection with trading for the Account; and (vi) any other reasonable and documented fees and expenses related to the purchase, sale,
transmittal or preservation of Treasury Assets. Any expense common to the Account and to any other clients managed by the Asset Manager,
21Shares or a Manager Affiliate generally shall be paid pro rata by such entities based on the approximate size of the relevant investment
relating to such expense or otherwise based on assets under management, as appropriate (or in any other manner deemed fair and equitable
by the Asset Manager, in its sole discretion).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.&nbsp;<U>Representations
of the Asset Manager and 21Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(A)</TD><TD STYLE="text-align: justify">The Asset Manager represents to the Client as follows:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) the Asset Manager has
been duly organized and is validly existing and in good standing under the laws of its jurisdiction of organization, with power and authority
to own its own properties and conduct its business as currently conducted;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) the Asset Manager has
or will obtain all other governmental authorizations, approvals, consents or filings required in connection with the execution, delivery
or performance of this Agreement by the Asset Manager;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) this Agreement constitutes
a binding obligation of the Asset Manager, enforceable against the Asset Manager in accordance with its terms, except as such enforceability
may be limited by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar laws relating to or affecting
creditors&rsquo; rights or by general equity principles, regardless of whether such enforceability is considered in a proceeding in equity
or at law; and&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) the execution, delivery
and performance of this Agreement do not conflict with any obligation by which the Asset Manager is bound, whether arising by contract,
operation of law or otherwise, or any applicable law, in each case in a manner that would result in a material adverse effect on the Asset
Manager or the Client or that would materially impede the Asset Manager&rsquo;s ability to perform its obligations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing representations
and warranties shall be continuing during the term of the Agreement, and if at any time during the term of this Agreement any event has
occurred which would make any of the foregoing representations and warranties untrue or inaccurate in any material respect, the Asset
Manager shall promptly notify the Client of such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(B)</TD><TD STYLE="text-align: justify">21Shares represents to the Client as follows:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) 21Shares has been duly
organized and is validly existing and in good standing under the laws of its jurisdiction of organization, with power and authority to
own its own properties and conduct its business as currently conducted;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) 21Shares has or will obtain
all other governmental authorizations, approvals, consents or filings required in connection with the execution, delivery or performance
of this Agreement by 21Shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) this Agreement constitutes
a binding obligation of 21Shares, enforceable against 21Shares in accordance with its terms, except as such enforceability may be limited
by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar laws relating to or affecting creditors&rsquo;
rights or by general equity principles, regardless of whether such enforceability is considered in a proceeding in equity or at law; and&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) the execution, delivery
and performance of this Agreement do not conflict with any obligation by which 21Shares is bound, whether arising by contract, operation
of law or otherwise, or any applicable law, in each case in a manner that would result in a material adverse effect on the 21Shares or
the Client or that would materially impede 21Shares&rsquo; ability to perform its obligations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing representations
and warranties shall be continuing during the term of the Agreement, and if at any time during the term of this Agreement any event has
occurred which would make any of the foregoing representations and warranties untrue or inaccurate in any material respect, 21Shares shall
promptly notify the Client of such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.&nbsp;<U>Representations
of the Client</U>. The Client represents and warrants to the Asset Manager and 21Shares as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) the Client has been duly
organized and is validly existing and in good standing under the laws of its jurisdiction of organization, with power and authority to
own its own properties and conduct its business as currently conducted;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) the Client has the authority
to appoint (i) the Asset Manager to provide the Discretionary Services and (ii) 21Shares to provide the Non-Discretionary Services, and
has, by appropriate action, duly authorized the execution and implementation of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) this Agreement constitutes
a binding obligation of the Client, enforceable against the Client in accordance with its terms, except as such enforceability may be
limited by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar laws relating to or affecting creditors&rsquo;
rights or by general equity principles, regardless of whether such enforceability is considered in a proceeding in equity or at law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) the execution, delivery
and performance of this Agreement do not conflict with any obligation by which the Client is bound, whether arising by contract, operation
of law or otherwise, or any applicable law, in each case in a manner that would result in a material adverse effect on the Asset Manager,
21Shares or the Client or that would materially impede the Client&rsquo;s ability to perform its obligations hereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) except in either case
to the extent the Client has notified the Asset Manager and 21Shares in writing: (i) the Treasury Assets belong to the Client free and
clear of any liens or encumbrances, and (ii) the Client will not pledge or encumber any Treasury Assets;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) the Client is not, and
does not propose to be, an investment company (as that term is defined in the Investment Company Act of 1940, as amended (the &ldquo;<U>Investment
Company Act</U>&rdquo;));</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) the Client is aware of
the risks associated with engaging asset managers in general, and it understands the risks associated with the investments contemplated
hereby as well as the risk that the Account could suffer substantial diminution in value, including complete loss;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) the Client has reviewed
all other materials and agreements provided by the Asset Manager and 21Shares relating to the Account and to the investments contemplated
hereby, understands such materials and agreements and has had the opportunity to ask questions regarding such materials and agreements;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) the Client is an &ldquo;accredited
investor&rdquo; as that term is or may in the future be defined in Rule 501 under the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) the Client is a &ldquo;United
States person&rdquo; as defined in Section 7701(a)(30) of the U.S. Internal Revenue Code of 1986, as amended;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) the Client is not a &ldquo;bad
actor&rdquo; or otherwise disqualified from investing under any relevant laws;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l) the Treasury Assets held
in the Account are not assets: of an &ldquo;employee benefit plan&rdquo; as defined in and subject to the fiduciary responsibility provisions
of the U.S. Employee Retirement Security Act of 1974, as amended (&ldquo;<U>ERISA</U>&rdquo;); a &ldquo;plan&rdquo; as defined in and
subject to Section 4975 of the Code; a government plan, foreign plan, or church plan subject to laws similar to ERISA or Section 4975
of the Code; or an entity that holds &ldquo;plan assets&rdquo; as defined in Section 3(42) of ERISA;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m) the Client understands,
acknowledges, represents and agrees that (i) it is each of the Asset Manager&rsquo;s and 21Shares&rsquo;s policy to comply with anti-money
laundering, embargo and trade sanctions, or similar laws, regulations, requirements (whether or not with force of law) or regulatory policies
applicable to it (collectively &ldquo;Requirements&rdquo;) and to interpret them broadly in favor of disclosure, (ii) each of the Asset
Manager and 21Shares could be requested or required to obtain certain assurances from the Client, disclose information pertaining to it
to governmental, regulatory or other authorities or to financial intermediaries or engage in due diligence or take other related actions
in the future, (iii) the Client will provide additional information or take such other actions as may be necessary or advisable for the
Asset Manager or 21Shares, as applicable, to comply with any Requirements, related legal process or appropriate requests (whether formal
or informal) or otherwise, and (iv) the Asset Manager, 21Shares and each of their agents may disclose to relevant third parties information
pertaining to the Client in respect of Requirements or information requests related thereto, and the Client understands and agrees that
it shall have no claim against the Asset Manager, 21Shares or any other Covered Person (as defined below) for any form of damages as a
result of any of the aforementioned actions;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n) the assets included in
the Treasury Assets are of legal source and do not originate from an illegal activity according to U.S. Treasury Department laws and regulations;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o) the Client has not been
designated by the U.S. Department of Treasury&rsquo;s Office of Foreign Assets Control (&ldquo;OFAC&rdquo;) as a Specially Designated
National or blocked person, has no reason to believe that it would be considered a blocked person by OFAC, is domiciled in the United
States and is not employed by, acting as agent of, or partially owned or controlled by a government, a government-controlled entity or
a government corporation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p) the Client has received,
read and understood each of the Asset Manager&rsquo;s and 21Shares&rsquo; privacy policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing representations
and warranties shall be continuing during the term of the Agreement, and if at any time during the term of this Agreement any event has
occurred which would make any of the foregoing representations and warranties untrue or inaccurate in any material respect, the Client
shall promptly notify the Asset Manager and 21Shares of such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.&nbsp;<U>Client Acknowledgements</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Cooperation</U>.
The Client acknowledges that the information provided by the Client on any Account opening forms, including without limitation, information
pertaining to the Client&rsquo;s legal or tax status, address or other contact information will be relied upon by the Asset Manager and
21Shares, and the Client agrees that if any such information shall hereafter change or become inaccurate, the Client shall notify the
Asset Manager and 21Shares in writing of such change or inaccuracy as soon as reasonably practicable. The Client shall cooperate with
the Asset Manager and 21Shares in the performance of its services under this Agreement and, upon the Asset Manager&rsquo;s and/or 21Shares&rsquo;
reasonable request, shall provide the Asset Manager and/or 21Shares with timely access to and use of personnel, facilities, equipment,
data and information to the extent necessary to permit the Asset Manager and 21Shares to perform its services under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Conflicts of Interest;
Non-Exclusive Management</U>. The Client acknowledges that the Asset Manager, 21Shares, their affiliates and/or their respective directors,
members, partners, shareholders, officers and employees (the &ldquo;Covered Persons&rdquo;) each may have and continue to have investments
in their own names, that the Covered Persons currently engage in similar activities for others, that the Covered Persons may serve as
an officer, director, stockholder or partner of one or more investment funds, and that it may not always be possible or in the best interests
of the various persons or funds to whom the Covered Persons give investment advice to take or liquidate the same investment positions
at the same time. The Client further acknowledges that advice given and actions taken under this Agreement for the Account may differ
from advice given or the timing and nature of action taken by the Asset Manager and/or 21Shares in the management of other clients or
accounts of the Covered Persons. The Asset Manager may transact in assets for the Account in which the Covered Persons may have and continue
to have or may acquire a position or interest and nothing in this Agreement shall prevent the Covered Persons from acquiring or disposing
of any assets. In addition, nothing in this Agreement shall be deemed to impose on the Asset Manager any obligation to purchase or sell
for the Account any asset which the Covered Persons may directly or indirectly purchase or sell for its or their own accounts or for the
account of any other client. As a result of the foregoing, the Covered Persons will, from time to time, have conflicts of interest in
allocating their time and activity between the Account, their other clients or accounts and their other businesses in allocating investments
and expenses among the Account and their other clients or accounts, and in effecting transactions between the Account and their other
clients or accounts, including ones in which such Covered Persons may have a greater financial interest, whether through the receipt of
compensation, such as performance compensation or management fee, or through personal investments. The Client acknowledges that it understands
the risks and conflicts of interest disclosures described above and authorizes the Asset Manager and 21Shares to provide the Discretionary
Services and the Non-Discretionary Services, respectively, notwithstanding any of these actual or potential conflicts of interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Order Aggregation
and Allocation</U>. The Asset Manager may, in its discretion, aggregate sale and purchase orders of assets held in the Account with similar
orders being made simultaneously or contemporaneously for other accounts managed by the Asset Manager. In such event, the assets so purchased
or sold, and any related expenses incurred, will be allocated by the Asset Manager among the Account and any other such accounts in proportion
to the size of the respective investment made by each such account and in an equitable manner over time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Brokerage Practices</U>.
The Asset Manager is authorized to determine the counterparty to be used for each transaction for the Account. In connection with the
foregoing, the Account may trade directly with buyers or sellers on Digital Asset exchanges, engage intermediaries and/or hire other third-party
service providers for completing transactions. In selecting counterparties to execute transactions, the Asset Manager need not solicit
competitive bids and does not have an obligation to seek the lowest available commission cost, thus the Account may be deemed to be paying
for research, brokerage or other services provided by the broker which are included in the commission rate;&nbsp;<I>provided</I>&nbsp;that
the Asset Manager determines in good faith that the amount of each such commission paid to a counterparty is reasonable in relation to
the value of the brokerage and research services provided by such counterparty.&nbsp;The Asset Manager may take into account a full range
of applicable factors for completing transactions, including, without limitation, the general expertise and background, financial stability
and reputation of the firms, creditworthiness, efficiency of execution and error resolution, the actual executed price and the commission,
custodial and other services provided for the enhancement of the Asset Manager&rsquo;s portfolio management capabilities. 21Shares shall
have no responsibility with respect to the recommendation or selection of counterparties to be used for transactions for the Account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Legal Proceedings</U>.
Unless otherwise agreed in writing by the Asset Manager, the Asset Manager shall have no obligations to take any action on behalf of the
Client in any legal proceedings, including bankruptcies or class actions, involving any Treasury Assets or issuers related thereto. At
the Client&rsquo;s request, the Asset Manager will endeavor to assist with administrative matters in respect of any settlement or judgment.
Nonetheless, this provision shall not apply for any actions involving the Asset Manager&rsquo;s and 21Shares&rsquo; conduct or the performance
of its duties under this Agreement. 21 Shares shall have no obligations to take any action on behalf of the Client in any legal proceedings,
including bankruptcies or class actions, involving any Treasury Assets or issuers related thereto, nor to participate or to assist with
administrative matters in respect of any settlement or judgment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.&nbsp;<U>Client Records,
Reports and Transparency</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The Asset Manager shall
maintain the books and records pertaining to the management and oversight of the Treasury Assets throughout the term of this Agreement
and for a period of five years after the end of the year in which this Agreement terminates. Such books and records shall be made available
upon written request at any time by the Client reasonably requested and upon Client&rsquo;s expense, upon no less than five (5) Business
Days&rsquo; prior written notice; provided, however, that in providing such information, the Asset Manager shall not be required to disclose,
and may take such steps as are necessary to assure the confidentiality of, the identities of any other parties (including clients) that
have a relationship with the Asset Manager, including requesting that the Client enter into an industry standard non-disclosure agreement
in a form approved by the Client.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The Asset Manager and
the Client shall cooperate in good faith to obtain information that can be provided to Client as frequently as reasonably required by
the Client, subject to any limitations imposed by the Custodian.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.&nbsp;<U>Liability</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) Except in the cases of
willful misconduct, gross negligence, fraud, or material breach of this Agreement (each, a &ldquo;<U>Disqualifying Action</U>&rdquo;),
none of the Covered Persons shall have any liability (whether direct or indirect, in contract or tort or otherwise) for any claims, liabilities,
losses, damages, penalties, obligations or expenses of any kind whatsoever, including reasonable and documented attorneys&rsquo; fees
and court costs (&ldquo;<U>Losses</U>&rdquo;) suffered by the Client as the result of any act or omission by the Asset Manager or 21Shares
in connection with, arising out of or relating to the performance of the Discretionary Services and the Non-Discretionary Services, respectively.
The Client further agrees that no Covered Person shall be liable for any Losses caused, directly or indirectly, by any act or omission
of the Client or a Custodian, any other counterparty or platform, application or service with which the Account interacts (collectively,
&ldquo;<U>Platform</U>&rdquo;), the bankruptcy, insolvency, receivership, administrative or similar proceeding involving a Platform, a
pause in or suspension of withdrawals from a Platform (however described and for whatever reason), the hack of a Platform, or by any other
cause that does not constitute a Covered Person&rsquo;s Disqualifying Action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The Asset Manager, 21Shares
and any person acting on their behalf shall be entitled to rely in good faith upon information, opinions, reports or statements of legal
counsel (as to matters of law) and accountants (as to matters of accounting or tax) and, accordingly, such good faith reliance by a person
shall not constitute a Disqualifying Action so long as such counsel or accountant is qualified and was selected and consulted with due
care. Under no circumstances shall the Asset Manager, 21Shares or any Covered Person be liable for any special, incidental, exemplary,
consequential, punitive, lost profits or indirect damages.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) The Client agrees to indemnify
and hold harmless each of the Covered Persons against any Losses suffered or incurred by reason of, relating to, based upon, arising from
or in connection with this Agreement or the Account, except to the extent that such Losses are determined by a court of competent jurisdiction,
upon entry of a final judgment, to be attributable to a Disqualifying Action of such Covered Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) To the fullest extent
permitted by law, the Client shall, upon the request of any Covered Person, advance or promptly reimburse such Covered Person&rsquo;s
out-of-pocket costs of investigation (whether internal or external), litigation or appeal, including attorneys&rsquo; reasonable and documented
fees and disbursements, reasonably incurred in responding to, litigating or endeavoring to settle any claim, action, suit, investigation
or proceeding, whether or not pending or threatened, and whether or not any Covered Person is a party, arising out of or in connection
with or relating to the operations, business or affairs of the or in furtherance of the interests of the Client (a &ldquo;<U>Claim</U>&rdquo;);&nbsp;<I>provided</I>&nbsp;that
the affected Covered Person shall, as a condition of such Covered Person&rsquo;s right to receive such advances and reimbursements, undertake
in writing to promptly repay the applicable funds for all such advancements or reimbursements if a final judgment of a court of competent
jurisdiction has determined that such Covered Person is not then entitled to indemnification under this Section 11. If any Covered Person
recovers any amounts in respect of any Claims from insurance coverage or any third-party source, then such Covered Person shall, to the
extent that such recovery is duplicative, reimburse the Client for any amounts previously paid to it by the Client in respect of such
Claims.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) Promptly after receipt
by a Covered Person of notice of any Claim or of the commencement of any action or proceeding involving a Claim, such Covered Person shall,
if a claim for indemnification in respect thereof is to be made against the Client, give written notice to the Client of the receipt of
such Claim or the commencement of such action or proceeding;&nbsp;<I>provided</I>, that the failure of any Covered Person to give notice
as provided herein shall not relieve the Client of its obligations hereunder, except to the extent that the Client is actually prejudiced
by such failure to give notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) Each Covered Person shall
cooperate with the Client and its counsel in responding to, defending and endeavoring to settle any proceedings or Losses that may be
subject to indemnification by the Client pursuant to this Section 11. Without limiting the generality of the immediately preceding sentence,
if any proceeding is commenced against a Covered Person, the Client shall be entitled to participate in and to assume the defense thereof
to the extent that the Client may wish, with counsel reasonably satisfactory to such Covered Person. After notice from the Client to such
Covered Person of the Client&rsquo;s election to assume the defense thereof, the Client shall not be liable for expenses subsequently
incurred by such Covered Person without the consent of the Client (which shall not be unreasonably withheld) in connection with the defense
thereof. Without the Covered Person&rsquo;s consent, the Client will not consent to entry of any judgment in or enter into any settlement
of any such action or proceeding which does not include as an unconditional term thereof the giving by every claimant or plaintiff to
such Covered Person of a release from all liability in respect of such claim or litigation.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) The right of any Covered
Person to indemnification as provided herein shall be cumulative of, and in addition to, any and all rights to which such Covered Person
may otherwise be entitled by contract or as a matter of law or equity and shall extend to such Covered Person&rsquo;s successors, assigns
and legal representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) The federal laws may impose
liabilities under certain circumstances on persons who act in good faith; therefore, nothing herein shall in any way constitute a waiver
or limitation of any rights which the Client may have under any applicable federal law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.&nbsp;<U>Confidentiality</U>.&nbsp;The
Asset Manager and 21Shares shall regard as confidential all information concerning the affairs of the Client, but shall be permitted to
disclose the Client&rsquo;s confidential information to (a) the Covered Persons and their respective service providers, in each case,
that have a bona fide need to know such confidential information, (b) third parties regarding the fact that the Asset Manager or 21Shares
is performing asset management activities on the Client&rsquo;s behalf, which specifically includes the Asset Manager&rsquo;s or 21Shares&rsquo;
inclusion of references to the Client in written marketing materials distributed by the Asset Manager or 21Shares, (c) third parties regarding
information regarding Account holdings and performance (without reference to the Client&rsquo;s name) in connection with the establishment
of a track record of the Asset Manager and (d) as otherwise required by any regulatory authority, law or regulation, or by legal process.
The Client acknowledges that it may receive or have access to confidential proprietary information of the Asset Manager and/or 21Shares
which is proprietary in nature and non-public, including, without limitation, information regarding the Asset Manager&rsquo;s or 21Shares&rsquo;
methodologies, systems and forms, trade secrets and the like (collectively, &ldquo;Confidential Information&rdquo;). The Client agrees
not to disclose or cause to be disclosed any Confidential Information to any person or use any Confidential Information other than in
connection with the Account and its obligations under this Agreement, except as otherwise required by any regulatory authority, law or
regulation, or by legal process;&nbsp;<I>provided, however</I>, that the Client shall provide the Asset Manager and 21Shares with prior
notice of any such disclosure and the circumstances surrounding such request so that the Asset Manager and/or 21Shares may seek a protective
order or other appropriate remedy. If, in the absence of a protective order or other remedy by the disclosing party, the Client, in the
written opinion of legal counsel satisfactory to the Asset Manager and/or 21Shares, is nonetheless legally compelled to disclose Confidential
Information or else stand liable for contempt or suffer other censure or penalty, the Client may, without liability hereunder, disclose
only that portion of the Confidential information which such counsel advises the receiving party is legally required to be disclosed,
provided that the receiving party exercise its best efforts to preserve the confidentiality of the Confidential information, including,
without limitation, by cooperating with the Asset Manager and/or 21Shares to obtain an appropriate protective order or other reliable
assurance that confidential treatment will be accorded the Confidential information. For the avoidance of doubt, all investment advice
furnished by the Asset Manager and 21Shares to the Client on behalf of the Account shall be treated as confidential and shall not be utilized
in trading (i) by the Client outside of this Agreement or (ii) for the Client&rsquo;s and its affiliates&rsquo; other accounts. This Section
shall survive the termination of this Agreement.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13.&nbsp;<U>Term and Survival;
Exclusivity</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) This Agreement shall be
effective on the Effective Date and will, unless earlier terminated in accordance with the provisions of this Section 13, continue in
effect until (i) the tenth (10th) anniversary of the Effective Date with respect to the Asset Manager and (ii) the fifth (5<SUP>th</SUP>)
anniversary of the Effective Date with respect to 21Shares (the period during which this Agreement is in effect, the &ldquo;<U>Term</U>&rdquo;);
provided, however, with respect to 21Shares, the Term may be extended upon the mutual written agreement of the Asset Manager and 21Shares.
Notwithstanding anything to the contrary set forth herein, the rights and obligations of the Parties hereunder are not effective until
the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) Beginning on the first
(1st) anniversary of the Effective Date, this Agreement may be terminated by the Asset Manager or 21Shares for any reason upon at least
ninety (90) days prior written notice to the other Parties. Additionally, this Agreement may be terminated at any time for Cause (i) by
the Client upon at least thirty (30) days prior written notice to the Asset Manager and 21Shares (but only with respect to the party that
committed the Cause event), (ii) by the Asset Manager or 21Shares upon at least thirty (30) days prior written notice to the Client (but
only with respect to the party that is requesting the termination pursuant to this Section 13), or (iii) by the Asset Manager, solely
with respect to 21Shares, upon at least thirty (30) days prior written notice to 21Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) For the purposes hereof,
the term &ldquo;<U>Cause</U>&rdquo; means (i) with respect to the Asset Manager and 21Shares, (A) a Disqualifying Action;&nbsp;<I>provided</I>,
that the Asset Manager and 21Shares shall have a cure period of fifteen (15) days following notice of an occurrence of Disqualifying Action
(other than fraud) to the extent such Disqualifying Action is curable as determined in good faith by the Client), (B) an Act of Insolvency
occurring with respect to the Asset Manager or 21Shares;&nbsp;<I>provided</I>&nbsp;that an Act of Insolvency shall not be deemed to occur
if the Asset Manager or 21Shares assigns its obligations under this Agreement to a Manager Affiliate that is not subject to an Act of
Insolvency, or (C) is dissolved;&nbsp;<I>provided</I>&nbsp;that such dissolution shall not be deemed to occur if the Asset Manager or
21Shares assigns its obligations under this Agreement to a Manager Affiliate that is not subject to dissolution; (ii) solely with respect
to 21Shares, if the Asset Manager and/or the Client has reasonable grounds to believe that 21Shares may be engaging in actions that are
reasonably likely to expose the &nbsp;Asset Manager and/or the Client to regulatory or reputational risk, and (iii) with respect to the
Client, (A) a Disqualifying Action;&nbsp;<I>provided</I>, that the Client shall have a cure period of fifteen (15) days following notice
of an occurrence of Disqualifying Action (other than fraud) to the extent such Disqualifying Action is curable as determined in good faith
by the Asset Manager or 21Shares, as applicable), (B) an Act of Insolvency occurring with respect to the Client or (C) it becomes unlawful
under any applicable law (as determined by the Asset Manager or 21Shares each in its sole discretion) for the Asset Manager or 21Shares
to perform its obligations under the Agreement, in which case the Asset Manager or 21Shares may immediately suspend its performance of
all obligations under this Agreement and terminate this Agreement upon notice to the Client.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) For the purposes hereof,
&ldquo;<U>Act of Insolvency</U>&rdquo; means such Party (i) is dissolved (other than pursuant to a consolidation, amalgamation or merger);
(ii)(A) institutes or has instituted against it, by a regulator, supervisor or any similar official with primary insolvency, rehabilitative
or regulatory jurisdiction over it in the jurisdiction of its incorporation or organization or the jurisdiction of its head or home office,
a proceeding seeking a judgment of insolvency or bankruptcy or any other relief under any bankruptcy or insolvency law or other similar
law affecting creditors&rsquo; rights, or a petition is presented for its winding-up or liquidation by it or such regulator, supervisor
or similar official, or (B) has instituted against it a proceeding seeking a judgment of insolvency or bankruptcy or any other relief
under any bankruptcy or insolvency law or other similar law affecting creditors&rsquo; rights, or a petition is presented for its winding-up
or liquidation, and such proceeding or petition is instituted or presented by a person or entity not described in clause (A) above and
either (I) results in a judgment of insolvency or bankruptcy or the entry of an order for relief or the making of an order for its winding-up
or liquidation or (II) is not dismissed, discharged, stayed or restrained in each case within 60 days of the institution or presentation
thereof; (iii) has a resolution passed for its winding-up, official management or liquidation (other than pursuant to a consolidation,
amalgamation or merger); (iv) seeks or becomes subject to the appointment of an administrator, provisional liquidator, conservator, receiver,
trustee, custodian or other similar official for it or for all or substantially all its assets; or (v) has a secured party take possession
of all or substantially all its assets or has a distress, execution, attachment, sequestration or other legal process levied, enforced
or sued on or against all or substantially all its assets and such secured party maintains possession, or any such process is not dismissed,
discharged, stayed or restrained, in each case within 60 days thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) Termination shall not
affect liabilities or obligations incurred or arising from transactions initiated under this Agreement prior to such termination, including
the provisions regarding arbitration, which shall survive any expiration or termination of this Agreement. Upon termination, it is the
Client&rsquo;s responsibility to monitor the Treasury Assets and it is understood and acknowledged that neither the Asset Manager nor
21Shares will have any further obligation to act or advise with respect to those Treasury Assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">14.&nbsp;<U>Notice of Engagement</U>.&nbsp;The
Client acknowledges and agrees that it currently has no agreement, and will not enter into any agreement after the Effective Date, with
any investment manager, asset manager or other service provider (a &ldquo;<U>Competing Asset Manager</U>&rdquo;) pursuant to which such
Competing Asset Manager provides similar services for the Client as those provided by the Asset Manager and/or 21Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.&nbsp;<U>Electronic Delivery</U>.&nbsp;The
Client hereby agrees and provides its consent to have the Asset Manager and 21Shares electronically deliver Client Communications. &ldquo;Client
Communications&rdquo; means this Agreement (including all supplements and amendments hereto) and all notices and other information, documents,
data and records regarding the Treasury Assets. Electronic communications include e-mail delivery as well as electronically making available
to the Client the Client Communications on the Asset Manager&rsquo;s and/or 21Shares&rsquo; Internet site, if applicable. By signing this
Agreement, the Client consents to electronic delivery as described in the preceding three sentences. It is the Client&rsquo;s affirmative
obligation to notify the Asset Manager and/or 21Shares in writing if the Client&rsquo;s email address changes. The Client may revoke or
restrict its consent to electronic delivery of Client Communications at any time by notifying the Asset Manager and 21Shares, in writing,
of the Client&rsquo;s intention to do so. Neither the Asset Manager, 21Shares nor their affiliates will be liable for any interception
of Client Communications. The Client should note that no additional charge for electronic delivery will be assessed, but the Client may
incur charges from its Internet service provider or other Internet access provider. Client shall be solely responsible for possessing
and maintaining computer systems sufficient to receive electronic delivery, including necessary software to receive e-mail, access websites,
and review PDFs. In addition, Client acknowledges that there are risks, such as systems outages, that are associated with electronic delivery.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16.&nbsp;<U>General Provisions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Assignment</U>.
This Agreement shall be binding upon and inure to the benefit of the Client, the Asset Manager, 21Shares and their respective successors
and permitted assigns. No Party to this Agreement may assign all or any portion of its rights, obligations or liabilities under this Agreement
without the consent of the other Parties to this Agreement; provided, however, that the Asset Manager and/or 21Shares may assign this
Agreement to an entity that is controlling, under common control, or controlled by the Asset Manager or 21Shares (as applicable) with
the prior written consent of the Client, which will not be unreasonably withheld, conditioned or delayed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Independent Contractor</U>.
It is understood and agreed that the Asset Manager and 21Shares shall each be deemed to be an independent contractor of the Client and
that the Asset Manager and 21Shares shall not have authority to act for or represent the Client in any way and shall not otherwise be
deemed to be agent of the Client. Nothing contained herein shall create or constitute the Parties as members of any partnership, joint
venture, association, syndicate, unincorporated business, or other separate entity, nor shall be deemed to confer on any of them any express,
implied, or apparent authority to incur any obligation or liability on behalf of any other such entity.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Third Party Beneficiaries</U>.
This Agreement is not intended to and does not convey any rights to persons not a Party to this Agreement, except that a Covered Person
may in its own right enforce Section 11 of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Entire Agreement</U>.
This Agreement, including the Schedules attached hereto, constitutes the entire agreement between the Parties concerning the subject matter
hereof and supersedes all prior agreements and understandings, oral or written, between them regarding such subject matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Amendments</U>.
Except to the extent otherwise expressly provided herein, this Agreement may not be amended except in a writing signed by the Parties
hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Waivers</U>. Each
Party may by written consent waive, either prospectively or retrospectively and either for a specified period of time or indefinitely,
the operation or effect of any provision of this Agreement. No failure or delay by a Party in exercising any right hereunder shall operate
as a waiver thereof, nor shall any waiver of any such right constitute any further waiver of such or any other right hereunder. No waiver
of any right by any Party hereto shall be construed as a waiver of the same or any other right at any other time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>Notices</U>. Except
as otherwise expressly provided in this Agreement, whenever any notice is required or permitted to be given under any provision of this
Agreement, such notice shall be in writing, shall be signed by or on behalf of the Party giving the notice and shall be mailed by first
class mail or sent by courier or by email (including email with an attached PDF) or other electronic transmission with confirmation of
transmission to the other Party at the address set forth below or to such other address as a Party may from time to time specify to the
other Party by such notice hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If to the Asset Manager:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">House of Doge Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2045 NW 1st Ave</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Miami, Florida, USA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">33127</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with
a copy to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If to 21Shares:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">21Shares US LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">477 Madison Avenue, 6<SUP>th</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">New York, New York 10022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with
a copy to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If to the Client:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CleanCore Solutions, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Attention: Clayton Adams</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">5920 S. 118th Circle</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Omaha, NE, 68137</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With a copy to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Attention: Louis A. Bevilacqua</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1050 Connecticut Avenue, NW, Suite 500</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Washington, DC 20036</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any such communications, notices,
instructions or disclosures shall be deemed duly given when deposited by first class mail address as provided above, when delivered to
such address by courier or when sent by email (including email with an attached PDF) or other electronic transmission (with the receipt
confirmed).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;<U>Governing Law</U>.
This Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of New York, without giving
effect to its principles of conflicts of law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Arbitration</U>.
Notwithstanding anything herein to the contrary, including the Parties&rsquo; submission to jurisdiction of the federal and state courts
of New York pursuant to Section 16(j) below, any dispute, claim or controversy arising out of or relating to this Agreement or the breach,
termination, enforcement, interpretation or validity thereof, including the determination of the scope or applicability of this agreement
to arbitrate, shall be determined by arbitration in the New York offices of the Judicial Arbitration and Mediation Service Inc. or its
successor (&ldquo;<U>JAMS</U>&rdquo;) before a single arbitrator selected through the JAMS strike and rank process. The arbitrator must
be a former U.S. federal or state court judge with experience in the financial industry. The arbitration shall be administered by JAMS
under its Comprehensive Arbitration Rules and Procedures (the &ldquo;<U>Rules</U>&rdquo;) and in accordance with the Expedited Procedures
set forth in the Rules as those Rules exist on the effective date of this Agreement. All aspects of the arbitration proceedings, hearing,
evidence, testimony, interim awards, or final awards shall remain confidential. The Parties agree that the final award may be entered
in any court having competent jurisdiction. Any Party may, without inconsistency with this arbitration provision, apply to any state or
federal court sitting in New York, New York and seek interim provisional, emergency injunctive or other emergency equitable relief until
the final award is rendered. The arbitration will be conducted in the English language. The prevailing Party on substantially all its
claims shall be entitled to an award of all of its reasonable attorney&rsquo;s fees, costs, and expenses incurred in the arbitration.&nbsp;
The arbitration provisions contained herein are self-executing and will remain in full force and effect after expiration or termination
of this Agreement.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;<U>Submission to
Jurisdiction; Consent to Service of Process</U>. Subject to Section 16(i) above, the Parties hereto hereby irrevocably submit to the jurisdiction
of and consent to service of process and venue in the state and federal courts in the County of New York, State of New York in any dispute,
claim, controversy, action, suit or proceeding between the Parties arising out of this Agreement which are permitted to be filed or determined
in such court. Subject to Section 16(i) above, the Parties hereby irrevocably waive, to the fullest extent permitted by applicable law,
any objection which they may now or hereafter have to the laying of venue of any such dispute brought in such court or any defense of
inconvenient forum for the maintenance of such dispute. For purposes of this Section and Section 16(i) above, the Parties agree that process
may be served in any action, suit, arbitration or proceeding by mailing copies thereof by registered or certified mail (or its equivalent)
postage prepaid, to the Party&rsquo;s address set forth in Section 16(g) of this Agreement or to such other address to which the Party
shall have given written notice to the other Party. The Parties agree that such service shall be deemed in every respect effective service
of process upon such Party in any such action, suit, arbitration or proceeding and shall, to the fullest extent permitted by law, be taken
and held to be valid personal service upon and personal delivery to such Party. Nothing in this Section 16(j) shall affect the right of
the Parties to serve process in any manner permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;<U>Force Majeure</U>.
No Party to this Agreement shall be liable for damages resulting from delayed or defective performance when such delays or defects arise
out of causes beyond the control and without the fault or negligence of the offending Party. Such causes may include, but are not restricted
to, acts of God or of the public enemy, terrorism, acts of the state in its sovereign capacity, fires, floods, earthquakes, power failure,
tariffs, government regulations or executive orders, disabling strikes, epidemics, pandemics, quarantine restrictions and freight embargoes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;<U>Headings</U>.
The headings contained in this Agreement are intended solely for convenience and shall not affect the rights of the Parties to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&nbsp;<U>Severability</U>.
In the event any provision of this Agreement shall be held invalid or unenforceable, by any court of competent jurisdiction, such holding
shall not invalidate or render unenforceable any other provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&nbsp;<U>Counterparts;
Electronic Signature and Delivery</U>. This Agreement may be executed in counterparts, including counterparts executed using electronic
or digital signature technology (&ldquo;E-signature&rdquo;), each of which, when taken together shall constitute one and the same instrument.
Each Party acknowledges and agrees that whether the E-signature is a computer-generated signature, an electronic copy of a true ink signature
or otherwise, the E-signature shall be treated by each Party as valid and binding as a true ink signature. This Agreement may also be
executed and delivered by electronic mail or other transmission method, and any counterpart so delivered shall be deemed to have been
duly and validly delivered and be valid and effective for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, each of
the Parties has caused this Agreement to be duly executed as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CLEANCORE SOLUTIONS, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="width: 5%; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="width: 35%; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Clayton Adams</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clayton Adams</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DOGECOIN VENTURES, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Marco Margiotta</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marco Margiotta</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>21SHARES US LLC</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Duncan Moir</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Duncan Moir</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ACCOUNTS/WALLETS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">1)</TD><TD STYLE="text-align: justify">Bitstamp (by Robinhood) account</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Client will generally fund the Account by
(i) issuing debt or equity securities or engaging in other capital raising transactions with the objective of using the proceeds to purchase
Dogecoin and (ii) acquiring Dogecoin with the Client&rsquo;s liquid assets that exceed working capital requirements. In the future, the
Client intends to primarily fund the Account through issuances of its Class B Common Stock and a variety of fixed-income instruments,
including debt, convertible notes and preferred stock. The Client, in consultation with the Asset Manager, will continue to monitor market
conditions in determining whether to engage in additional financings to further fund the Account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The investment strategy of the Account is to seek
to achieve attractive returns by managing a portfolio comprised primarily of Dogecoin and cash. In order to effectuate the foregoing,
the Asset Manager is authorized to select and engage operational partners to provide digital asset management and related services and
deploy Treasury Assets in decentralized finance or similar blockchain transactions from time to time provided such transactions are in
compliance with the terms of this Agreement and with applicable law. The Asset Manager views the Client&rsquo;s Dogecoin holdings as long-term
holdings and expects to continue to accumulate Dogecoin. The Asset Manager and the Client have not set any specific target for the amount
of Dogecoin to be held on behalf of the Client.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, the Client may (i) with the
consent of the Asset Manager, enter into additional capital raising transactions that are collateralized by the Treasury Assets, and (ii)
subject to applicable law, request that the Asset Manager pursue strategies to create income streams or otherwise generate funds using
the Treasury Assets provided such transactions are in compliance with the terms of this Agreement.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As long as the Asset Manager and 21Shares (collectively,
the &ldquo;Managers&rdquo;) are engaged with providing their respective Discretionary Services and Non-Discretionary Services and that
this Agreement is not terminated pursuant to Section 13, the Client shall pay the Managers a monthly fee (the &ldquo;Management Fee&rdquo;)
in arrears computed at an annual rate as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">2% in the aggregate on amounts up to and including $1,000,000,000 in Account value with (i) 1.75% paid
to the Asset Manager and (ii) .25% paid to 21 Shares;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">1.75% in the aggregate on amounts above $1,000,000,000 up to and including $1,500,000,000 in Account value
with (i) 1.5% paid to the Asset Manager and (ii) .25% paid to 21 Shares; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">1.5% in the aggregate on amounts above $1,500,000,000 in Account value with (i) 1.25% paid to the Asset
Manager and (ii) .25% paid to 21 Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Payments made to a Manager under this Agreement
may be made, in the sole discretion of such Manager, in Shares of the Client&rsquo;s Class B Common Stock, cash, or Dogecoin.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the avoidance of doubt, the Management Fee
rate will be determined based on the value in the Account as of the end of the applicable month or other applicable period and will apply
to the relevant tiers for the entire month (i.e., it will not be a blended rate). For example, if as of the end of a month, the Account
value is $1,200,000,000, a rate of 2% will be paid on the first $1,000,000,000 pursuant to clause (i) and a rate of 1.75% will be paid
on the excess $200,000,000 pursuant to clause (ii). In the event 21 Shares is no longer providing Non-Discretionary Services pursuant
to this Agreement, the aggregate Management Fee pursuant to clauses (i)-(iii) above shall be payable to the Asset Manager. The value in
the Account as of the end of each month or other applicable period will be determined by the Client (with input from the Custodian) using
the last available traded price of the primary trading venue for the Treasury Assets during the applicable period as of 5:00pm in New
York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The value of the Client&rsquo;s Class B Common
Stock and/or the value of Dogecoin shall be calculated as of the end of each month or other applicable period for which a Management Fee
is due and, to the extent the Client does not have adequate authorized Class B Common Stock to make the Management Fee payment to the
Asset Manager pursuant to the immediately preceding sentence in any given period, it shall promptly notify the Asset Manager and the Asset
Manager may, in its sole discretion, choose to be paid the amounts owed with either cash or Dogecoin (or a combination of both) in lieu
of the Class B Common Stock. In the event the Management Fee is paid in Dogecoin, all charges and fees in connection with such payments
(e.g., any fees or other blockchain-based settlement charges incurred to send the Management Fee to the Asset Manager&rsquo;s and/or 21Shares&rsquo;
wallet(s), as well as the cost of conversion from USD or other assets into Dogecoin) shall be borne by the Client. However, any fluctuation
in value between Class B Common Stock of the Client, Dogecoin and USD or other assets from the date of conversion until payment is received
shall be borne by the Asset Manager or 21Shares, as applicable; provided, however, in the event of a stock split, recapitalization, or
other similar transaction of the Client prior to issuance of the Class B Common Stock to the Asset Manager, the number of shares of the
Client&rsquo;s Class B Common Stock deliverable hereunder shall be equitably adjusted to preserve the economic value of the consideration.
In connection with the foregoing, the Client shall provide the Custodian with a standing order that instructs the Custodian to effectuate
such conversions within five days of the following month.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event that the Asset Manager or 21Shares
is not performing Discretionary Services or Non-Discretionary Services, respectively, for an entire month, the Management Fee shall be
prorated to reflect the portion of such month in which the Asset Manager and/or 21Shares is providing such services. The Management Fee
will also be pro rated in the event this Agreement is terminated other than at the end of a month.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>12
<FILENAME>ea025594401ex10-6_clean.htm
<DESCRIPTION>STRATEGIC ADVISOR AGREEMENT, DATED SEPTEMBER 5, 2025, BETWEEN CLEANCORE SOLUTIONS, INC. AND DOGECOIN VENTURES, INC.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.6</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>STRATEGIC ADVISOR AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Strategic Advisor Agreement (the &ldquo;<B>Agreement</B>&rdquo;)
is entered into as of September 5, 2025 (the &ldquo;<B>Effective Date</B>&rdquo;), by and among CleanCore Solutions, Inc., a Nevada corporation
with its principal place of business at 5920 S 118th Circle, Omaha, NE 68137 (&ldquo;<B>Client</B>&rdquo;) and Dogecoin Ventures, Inc.,
a wholly-owned subsidiary of House of Doge Inc., a Texas corporation with its principal place of business at 2045 NW 1st Avenue, Miami,
Florida, USA. 33127 (&ldquo;<B>HOD</B>&rdquo;). Client and HOD are referred to individually as a &ldquo;Party&rdquo; and collectively
as the &ldquo;Parties.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">RECITALS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>WHEREAS</B>, Client is listed on the NYSE American
and desires to expand and diversify its business through integration of cryptocurrency and digital asset strategies, with an emphasis
on Dogecoin in both its product offerings and as part of its treasury management strategy;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>AND WHEREAS</B>, HOD is the official corporate
arm of the Dogecoin Foundation who has particular technical advisory expertise in the cryptocurrency Dogecoin;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOW, THEREFORE</B>, in consideration of the
mutual covenants and promises herein contained, the parties agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify"><B>Engagement</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">a)</TD><TD STYLE="text-align: justify">Services. HOD agrees to provide strategic advisory services to Client as described in Schedule A attached
hereto (the &ldquo;<B>Services</B>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">b)</TD><TD STYLE="text-align: justify">Independent Contractor. HOD shall perform the Services as an independent contractor and not as an employee,
agent, or partner of Client. Nothing in this Agreement shall be construed to create a joint venture, partnership, or agency relationship
between the Parties.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify"><B>Term and Termination</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">a)</TD><TD STYLE="text-align: justify">Term. This Agreement shall commence on the Effective Date and shall continue for a period of five (5)
years, unless earlier terminated in accordance with this Section 2 (the &ldquo;<B>Term</B>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">b)</TD><TD STYLE="text-align: justify">Termination for Cause. The Parties may terminate this Agreement immediately upon written notice if one
of the other Parties materially breaches this Agreement and fails to cure such breach within thirty (30) days after receiving written
notice of the breach.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">c)</TD><TD STYLE="text-align: justify">Termination by Mutual Agreement. The Parties may agree in writing to terminate this agreement by mutual
agreement at any point during the Term.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">d)</TD><TD STYLE="text-align: justify">Effect of Termination for Cause or by Mutual Agreement. Upon termination of this Agreement, HOD shall
cease providing the Services, and Client shall pay HOD any fees due and payable under this Agreement up to the effective date of termination.
For avoidance of doubt, termination of this Agreement shall have no effect on any other agreements between the parties unless otherwise
specifically terminated, including any asset management agreement between the Parties.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify"><B>Compensation</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">a)</TD><TD STYLE="text-align: justify">Compensation. Client shall pay HOD the compensation set forth in Schedule B attached hereto (the &ldquo;<B>Compensation</B>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify"><B>Confidentiality</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.3pt; text-align: justify; text-indent: -35.3pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.3pt">a)</TD><TD STYLE="text-align: justify">Confidential Information. &ldquo;<B>Confidential Information</B>&rdquo; Means non-public information regarding
the disclosing Party&rsquo;s business affairs, products, services, confidential intellectual property, trade secrets, third-party confidential
information and other sensitive or proprietary information, whether orally or in visual, written, electronic, or other form or media,
and whether or not marked, designated, or otherwise identified as &ldquo;confidential.&rdquo;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.3pt; text-align: justify; text-indent: -35.3pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.3pt">b)</TD><TD STYLE="text-align: justify">HOD shall be permitted to disclose the Client&rsquo;s Confidential Information (a) to its affiliates and/or
their respective directors, members, partners, shareholders, officers and employees (collectively with HOD, the &ldquo;Covered Persons&rdquo;)
and their respective service providers, in each case, that have a bona fide need to know such Confidential Information, (b) to third parties
regarding the fact that HOD is performing services on the Client&rsquo;s behalf, which specifically includes HOD&rsquo;s inclusion of
references to the Client in written marketing materials distributed by HOD, and (c) as otherwise required by any regulatory authority,
law or regulation, or by legal process. The Client agrees not to disclose or cause to be disclosed any Confidential Information to any
person or use any Confidential Information other than in connection with its obligations under this Agreement, except as otherwise required
by any regulatory authority, law or regulation, or by legal process;&nbsp;provided, however, that the Client shall provide HOD with prior
notice of any such disclosure and the circumstances surrounding such request so that HOD may seek a protective order or other appropriate
remedy. If, in the absence of a protective order or other remedy by the disclosing party, the Client, in the written opinion of legal
counsel satisfactory to HOD, is nonetheless legally compelled to disclose Confidential Information or else stand liable for contempt or
suffer other censure or penalty, the Client may, without liability hereunder, disclose only that portion of the Confidential Information
which such counsel advises the receiving party is legally required to be disclosed, provided that the receiving party exercise its best
efforts to preserve the confidentiality of the Confidential Information, including, without limitation, by cooperating with HOD to obtain
an appropriate protective order or other reliable assurance that confidential treatment will be accorded the Confidential information.
This Section shall survive the termination of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify"><B>Limitation of Liability; Indemnification</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.3pt; text-align: justify; text-indent: -35.3pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.3pt">a)</TD><TD STYLE="text-align: justify">Liability Cap. Each Party&rsquo;s total liability under this Agreement, whether in contract, tort, or
otherwise, shall be limited to the total Compensation paid under this Agreement provided, however, any liability resulting from the willful
misconduct, gross negligence, fraud, or material breach of this Agreement (collectively, a &ldquo;Disqualifying Action&rdquo;) by a Party
shall not be limited.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">b)</TD><TD STYLE="text-align: justify">Indemnification. The Client agrees to indemnify and hold harmless each of the Covered Persons against
any claims, liabilities, losses, damages, penalties, obligations or expenses of any kind whatsoever, including reasonable and documented
attorneys&rsquo; fees and court costs (&ldquo;<U>Losses</U>&rdquo;) suffered or incurred by reason of, relating to, based upon, arising
from or in connection with this Agreement, except to the extent that such Losses are determined by a court of competent jurisdiction,
upon entry of a final judgment, to be attributable to a Disqualifying Action of such Covered Person. To the fullest extent permitted by
law, the Client shall, upon the request of any Covered Person, advance or promptly reimburse such Covered Person&rsquo;s out-of-pocket
costs of investigation (whether internal or external), litigation or appeal, including attorneys&rsquo; reasonable and documented fees
and disbursements, reasonably incurred in responding to, litigating or endeavoring to settle any claim, action, suit, investigation or
proceeding, whether or not pending or threatened, and whether or not any Covered Person is a party, arising out of or in connection with
or relating to the operations, business or affairs of the or in furtherance of the interests of the Client (a &ldquo;<U>Claim</U>&rdquo;);&nbsp;<I>provided</I>&nbsp;that
the affected Covered Person shall, as a condition of such Covered Person&rsquo;s right to receive such advances and reimbursements, undertake
in writing to promptly repay the applicable funds for all such advancements or reimbursements if a final judgment of a court of competent
jurisdiction has determined that such Covered Person is not then entitled to indemnification under this Section 5(b). If any Covered Person
recovers any amounts in respect of any Claims from insurance coverage or any third-party source, then such Covered Person shall, to the
extent that such recovery is duplicative, reimburse the Client for any amounts previously paid to it by the Client in respect of such
Claims.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">c)</TD><TD STYLE="text-align: justify">Exclusion of Consequential Damages. Neither Party shall be liable to the other Party for any indirect,
incidental, consequential, special, or punitive damages, including loss of profits or revenue, arising out of or related to this Agreement,
even if advised of the possibility of such damages.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify"><B>Representations and Warranties</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.3pt; text-align: justify; text-indent: -35.3pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.3pt">a)</TD><TD STYLE="text-align: justify">Mutual Representations. Each Party represents and warrants to each other that:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.3pt; text-align: justify; text-indent: 0.7pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">i.</TD><TD STYLE="text-align: justify">it has been duly organized and is validly existing and in
good standing under the laws of its jurisdiction of organization, with power and authority to own its own properties and conduct its
business as currently conducted;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.3pt; text-align: justify; text-indent: 0.7pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.3pt; text-align: justify; text-indent: 0.7pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.3pt; text-align: justify; text-indent: 0.7pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">ii.</TD><TD STYLE="text-align: justify">this Agreement constitutes a binding obligation of the Party,
enforceable against the other Party in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency,
fraudulent transfer, reorganization, moratorium and other similar laws relating to or affecting creditors&rsquo; rights or by general
equity principles, regardless of whether such enforceability is considered in a proceeding in equity or at law;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.3pt; text-align: justify; text-indent: 0.7pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">iii.</TD><TD STYLE="text-align: justify">the execution, delivery and performance of this Agreement
do not conflict with any obligation by which the Party is bound, whether arising by contract, operation of law or otherwise, or any applicable
law, in each case in a manner that would result in a material adverse effect on the Parties or that would materially impede a Party&rsquo;s
ability to perform its obligations hereunder; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.3pt; text-align: justify; text-indent: 0.7pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">iv.</TD><TD STYLE="text-align: justify">it has or will obtain all other governmental authorizations,
approvals, consents or filings required in connection with the execution, delivery or performance of this Agreement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">b)</TD><TD STYLE="text-align: justify">Disclaimer. Except as expressly set forth in this Agreement, HOD makes no warranties, express or implied,
including any warranties of merchantability, fitness for a particular purpose, or non-infringement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">c)</TD><TD STYLE="text-align: justify">Investor Status. Each Party represents that it is either: (i) an &ldquo;accredited investor&rdquo; as
defined in Rule 501(a) of Regulation D under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;) or (ii) a &ldquo;qualified
institutional buyer&rdquo; as defined in Rule 144A(a)(1) under the Securities Act. To the extent a Party is one of the covered persons
identified in Rule 506(d)(1), such Party hereby represents that neither it nor any of its Rule 506(d) Related Parties (as defined below)
is a &ldquo;bad actor&rdquo; within the meaning of Rule 506(d) of Regulation D under the Securities Act. For purposes of this Agreement,
&ldquo;Rule 506(d) Related Party&rdquo; shall mean a person or entity covered by the &ldquo;Bad Actor disqualification&rdquo; provision
of Rule 506(d) of Regulation D under the Securities Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.</TD><TD STYLE="text-align: justify"><B>Miscellaneous</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">a)</TD><TD STYLE="text-align: justify">Governing Law and Dispute Resolution. This Agreement shall be governed by the laws of the State of New
York. Notwithstanding anything herein to the contrary, including the Parties&rsquo; submission to jurisdiction of the federal and state
courts of New York pursuant to the below, any dispute, claim or controversy arising out of or relating to this Agreement or the breach,
termination, enforcement, interpretation or validity thereof, including the determination of the scope or applicability of this agreement
to arbitrate, shall be determined by arbitration in the New York offices of the Judicial Arbitration and Mediation Service Inc. or its
successor (&ldquo;<U>JAMS</U>&rdquo;) before a single arbitrator selected through the JAMS strike and rank process. The arbitrator must
be a former U.S. federal or state court judge with experience in the financial industry. The arbitration shall be administered by JAMS
under its Comprehensive Arbitration Rules and Procedures (the &ldquo;<U>Rules</U>&rdquo;) and in accordance with the Expedited Procedures
set forth in the Rules as those Rules exist on the effective date of this Agreement. All aspects of the arbitration proceedings, hearing,
evidence, testimony, interim awards, or final awards shall remain confidential. The Parties agree that the final award may be entered
in any court having competent jurisdiction. Any Party may, without inconsistency with this arbitration provision, apply to any state or
federal court sitting in New York, New York and seek interim provisional, emergency injunctive or other emergency equitable relief until
the final award is rendered. The arbitration will be conducted in the English language. The prevailing Party on substantially all its
claims shall be entitled to an award of all of its reasonable attorney&rsquo;s fees, costs, and expenses incurred in the arbitration.&nbsp;
The arbitration provisions contained herein are self-executing and will remain in full force and effect after expiration or termination
of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">Subject to the above, the Parties
hereto hereby irrevocably submit to the jurisdiction of and consent to service of process and venue in the state and federal courts in
the County of New York, State of New York in any dispute, claim, controversy, action, suit or proceeding between the Parties arising out
of this Agreement which are permitted to be filed or determined in such court. Subject to the above, the Parties hereby irrevocably waive,
to the fullest extent permitted by applicable law, any objection which they may now or hereafter have to the laying of venue of any such
dispute brought in such court or any defense of inconvenient forum for the maintenance of such dispute. For purposes of this Section 7(a),
the Parties agree that process may be served in any action, suit, arbitration or proceeding by mailing copies thereof by registered or
certified mail (or its equivalent) postage prepaid, to the Party&rsquo;s address. The Parties agree that such service shall be deemed
in every respect effective service of process upon such Party in any such action, suit, arbitration or proceeding and shall, to the fullest
extent permitted by law, be taken and held to be valid personal service upon and personal delivery to such Party. Nothing in this Section
7(a) shall affect the right of the Parties to serve process in any manner permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">b)</TD><TD STYLE="text-align: justify">Entire Agreement. This Agreement, including its Schedules, constitutes the entire agreement between the
Parties and supersedes all prior agreements, understandings, and communications, whether written or oral, relating to the subject matter
hereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">c)</TD><TD STYLE="text-align: justify">Amendments. This Agreement may only be amended in writing signed by all Parties.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">d)</TD><TD STYLE="text-align: justify">Assignment. The Parties may not assign this Agreement without the prior written consent of the other Party;
provided, however, that HOD may assign this Agreement to an entity that is controlling, under common control, or controlled by HOD without
the prior written consent of the Client.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">e)</TD><TD STYLE="text-align: justify">Notices. All notices under this Agreement shall be in writing and delivered to the addresses set forth
above by certified mail, courier, or email (with confirmation of receipt).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">f)</TD><TD STYLE="text-align: justify">Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same instrument.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">IN WITNESS WHEREOF, the
Parties have executed this Agreement as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>CLEANCORE SOLUTIONS, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Clayton Adams</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Clayton Adams</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DOGECOIN VENTURES, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Marco Margiotta</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Marco Margiotta</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE A &ndash; SERVICES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">HOD shall provide the following Services to the Client:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Strategic Integration and Diversification.</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Expand and diversify the Client&rsquo;s
business operations through the integration of cryptocurrency and digital asset strategies, with an emphasis on Dogecoin, in the Client&rsquo;s
product offerings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Treasury and Industry Advisory.</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Provide the Client with ongoing technical
advisory services regarding the digital asset ecosystem, including, but not limited to, Dogecoin and related technologies. This encompasses
monitoring and analyzing developments in the Dogecoin ecosystem, payments systems, and the broader digital asset industry, and advising
the Client on the potential impact of such developments on its operations and strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Vendor Selection and Strategic Partnerships.</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Assist in the identification, evaluation
and selection of third-party vendors and service providers with respect to digital asset management, custody, security and related services.
Provide strategic advice regarding the structuring of the Client&rsquo;s digital asset treasury operations, including recommendations
for risk management, compliance and operational efficiency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Reporting and Board Advisory.</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Prepare and deliver regular written and/or
oral reports to the Client&rsquo;s management and board of directors regarding the status, performance, and strategic implications of
the Client&rsquo;s digital asset holdings and treasury activities. This includes providing updates on market trends, regulatory developments,
risk assessments, and the performance of Dogecoin and other digital assets held by the Client. HOD shall be available to attend board
meetings (in person or virtually, as requested) to present findings, answer questions, and provide recommendations to the board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Ongoing Strategic Support.</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Provide ongoing support and advice to
the Client&rsquo;s executive team and board of directors on matters related to the implementation, monitoring, and adjustment of the Client&rsquo;s
digital asset strategy, including responding to ad hoc requests for information, analysis, or recommendations as needed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE B &ndash; COMPENSATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Capitalized terms used and not otherwise defined
herein shall have the meanings set forth in that certain Securities Purchase Agreement (the &ldquo;Purchase Agreement&rdquo;), dated September
1, 2025, among the Company and the several investors party thereto</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">HOD shall receive as compensation for the Services
set out in this Agreement a number of warrants in the form attached hereto as Schedule C (the &ldquo;Warrants&rdquo;) to purchase shares
of Common Stock that is equal to 8% of the total number of shares of Common Stock sold in the Offering. Warrants to purchase a total of
5% of the total number of shares of Common Stock sold in the Offering will have an exercise price of $1.00 and Warrants to purchase a
total of 3% of the total number of shares of Common Stock sold in the Offering will have an exercise price of $1.33. All Warrants shall
be granted on the Effective Date, concurrent with the date of closing of the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>13
<FILENAME>ea025594401ex10-7_clean.htm
<DESCRIPTION>OPTION AGREEMENT, DATED SEPTEMBER 5, 2025, BETWEEN CLEANCORE SOLUTIONS, INC. AND CLAYTON ADAMS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.7</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OPTION AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Option Agreement (this
&ldquo;<U>Agreement</U>&rdquo;) is entered into as of September 5, 2025 (the &ldquo;<U>Effective Date</U>&rdquo;) by and between <B>CLEANCORE
SOLUTIONS, INC.</B>, a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), and <B>CLAYTON ADAMS</B>, an individual resident of the
State of Nebraska (&ldquo;<U>Adams</U>,&rdquo; and together with the Company, each a &ldquo;<U>Party</U>&rdquo; and collectively, the
&ldquo;<U>Parties</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A. The
Company and certain purchasers are parties to that certain Securities Purchase Agreement, dated as of September 1, 2025 (the &ldquo;<U>SPA</U>&rdquo;),
pursuant to which the Company has agreed to issue and sell, and the purchasers have agreed to purchase, certain securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B. In
connection with the transactions contemplated by the SPA, the Company has agreed to grant to Adams, as partial consideration for his continued
service as Chief Executive Officer, an option to elect, in his sole discretion, to cause the Company to effect a spin-off of the Legacy
Business (as defined below) or to acquire the Legacy Business, on the terms and subject to the conditions set forth in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C. The
Parties desire to set forth the terms and conditions of such option and the procedures for effecting either a spin-off or acquisition
of the Legacy Business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the mutual covenants and agreements contained herein and for other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the Parties agree as follows:</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">1. DEFINITIONS
AND INTERPRETATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(a) </FONT>Defined
Terms<FONT STYLE="font-weight: normal">. As used in this Agreement, the following terms shall have the meanings set forth below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Acquisition Closing</U>&rdquo;
means the consummation of the purchase and sale of the Legacy Business pursuant to Section 8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliates</U>&rdquo;
has the meaning given in Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business Day</U>&rdquo;
means any day other than a Saturday, Sunday or other day on which commercial banks in New York City are authorized or required by law
to close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing Date</U>&rdquo;
means the &ldquo;Closing Date&rdquo; as defined in the SPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effective Time</U>&rdquo;
means 12:01 a.m. New York City time on the date of the Spin-Off Closing or the Acquisition Closing, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Fairness Opinion</U>&rdquo;
means a written opinion of Newbridge Securities Corporation or another nationally recognized investment banking firm addressed to the
Board&rsquo;s independent directors and to Adams, to the effect that the Option Price (as may be adjusted pursuant hereto) is fair, from
a financial point of view, to the Company and its stockholders, and otherwise in form and substance reasonably satisfactory to each of
the Board&rsquo;s independent directors and Adams.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Governmental Authority</U>&rdquo;
means any U.S. or non-U.S. federal, state, provincial, municipal, local or other governmental, regulatory or administrative authority,
agency, court or body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Legacy Business</U>&rdquo;
means the Company&rsquo;s business and operations as conducted immediately prior to the Closing Date of the SPA, excluding any digital
asset treasury business or other business lines commenced after such date, and including all assets, liabilities and employees primarily
related thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Minimum Cash Amount</U>&rdquo;
means $500,000 in unrestricted cash and cash equivalents of the Legacy Business as of 11:59 p.m. New York City time on the day immediately
preceding the Effective Time, as determined in accordance with GAAP and Section 9.3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Option Price</U>&rdquo;
means a price proposed by Mr. Adams that he believes falls within a range that is considered fair, from a financial point of view for
the Legacy Business and that is confirmed as fair from a financial point of view by the Fairness Opinion (subject to adjustment pursuant
to Article 9).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Spin-Off</U>&rdquo;
means the distribution by the Company to all holders of its outstanding Common Stock, on a pro rata basis, of all of the issued and outstanding
equity securities of SpinCo, in a transaction intended to qualify as tax-free under Section 355 of the Internal Revenue Code of 1986,
as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities Act</U>&rdquo;
means the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>SpinCo</U>&rdquo;
means a newly formed Nevada corporation, wholly owned by the Company immediately prior to the Spin-Off, to which the Company shall contribute
the Legacy Business in accordance with Section 7.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(b) </FONT>Interpretation<FONT STYLE="font-weight: normal">.
Capitalized terms used but not defined herein have the meanings given in the SPA. Headings are for convenience only and shall not affect
interpretation. Unless the context otherwise requires, words importing the singular include the plural and vice versa, and the words &ldquo;include,&rdquo;
&ldquo;includes&rdquo; and &ldquo;including&rdquo; shall be deemed to be followed by the phrase &ldquo;without limitation.&rdquo;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">2. GRANT
OF OPTION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(a) </FONT>Grant<FONT STYLE="font-weight: normal">.
The Company hereby grants to Adams an irrevocable option (the &ldquo;<U>Option</U>&rdquo;) to elect, in Adams&rsquo;s sole discretion,
at any time during the Option Exercise Period, to either:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(i) </FONT>Spin-Off
Election<FONT STYLE="font-weight: normal">. Direct the Company to consummate the Spin-Off in accordance with Article 7; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(ii) </FONT>Acquisition
Election<FONT STYLE="font-weight: normal">. Acquire, or cause one or more entities designated by Adams to acquire, the Legacy Business
in accordance with Article 8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(b) </FONT>Consideration<FONT STYLE="font-weight: normal">.
The Option is granted as partial consideration for Adams&rsquo;s continued service as Chief Executive Officer of the Company and in reliance
on Adams&rsquo;s execution of this Agreement.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">3. EXERCISE
OF OPTION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(a) </FONT>Option
Exercise Period<FONT STYLE="font-weight: normal">. The Option shall be exercisable at any time during the period commencing on the date
that is one hundred eighty (180) days after the Closing Date of the SPA (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and ending at
5:00 p.m. New York City time on the third (3rd) anniversary of the Initial Exercise Date (the &ldquo;<U>Option Exercise Period</U>&rdquo;).
Notwithstanding anything to the contrary in this Agreement, if the exercise of the Option or the consummation of the Spin-Off or Acquisition
is delayed due to the failure to obtain any Required Approvals (as defined below) for reasons outside of Adams&rsquo; control, the Option Exercise
Period shall be automatically extended until such Required Approvals are obtained and the applicable closing may occur, provided that
Adams continues to use commercially reasonable efforts to obtain such approval or consent. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(b) </FONT>Exercise
Notice<FONT STYLE="font-weight: normal">. Adams may exercise the Option by delivering to the Company a written and irrevocable notice
(an &ldquo;<U>Exercise Notice</U>&rdquo;) specifying whether Adams elects the Spin-Off or the Acquisition. The Exercise Notice shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(i) state
the intended Effective Time;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(ii) include
Adams&rsquo;s proposed allocation of assets and liabilities, or any proposed excluded assets, if applicable; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(iii) be
accompanied by</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(A) draft
transaction documents reasonably necessary to consummate the chosen transaction, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(B) in
the case of an Acquisition, an executed engagement letter evidencing engagement of the investment banking firm selected by Adams and the
Board&rsquo;s independent directors to deliver the Fairness Opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(c) </FONT>Irrevocability;
Lapse<FONT STYLE="font-weight: normal">. Once delivered, an Exercise Notice may not be revoked except with the written consent of the
Company. If the Option is not validly exercised prior to the expiration of the Option Exercise Period, it shall automatically terminate
and be of no further force or effect.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4. CONDITIONS
PRECEDENT TO SPIN-OFF CLOSING OR ACQUISITION CLOSING</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Adams may not consummate a
Spin-Off Closing or Acquisition Closing unless each of the following conditions has been satisfied or waived by the Company and Adams,
as applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(a) in
the case of an Acquisition Closing, delivery to the Company and to Adams of the Fairness Opinion;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(b) receipt
of all required approvals of the Company&rsquo;s Board of Directors, including the approval of a majority of the independent directors
and of the Company&rsquo;s audit committee;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(c) receipt
of stockholder approval, if necessary, and completion of any applicable notice or waiting-period requirements under the Securities Exchange
Act of 1934, the NYSE American Company Guide, or any other applicable laws;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(d) receipt
or completion of all material consents, notices and filings with any Governmental Authority or other third party required in connection
with the Spin-Off or Acquisition; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(e) the
absence of any injunction, order or other legal restraint prohibiting consummation of the contemplated transaction.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5. REPRESENTATIONS
AND WARRANTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(a) </FONT>Representations
and Warranties of the Company<FONT STYLE="font-weight: normal">. The Company represents and warrants to Adams, as of the date hereof and
as of the Effective Time, that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(i) </FONT>Organization
and Authority<FONT STYLE="font-weight: normal">. The Company is duly organized, validly existing and in good standing under the laws of
the State of Nevada and has all requisite corporate power and authority to execute, deliver and perform this Agreement and to consummate
the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(ii) </FONT>Authorization<FONT STYLE="font-weight: normal">.
The execution, delivery and performance of this Agreement have been duly authorized by all necessary corporate action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(iii) </FONT>Enforceability<FONT STYLE="font-weight: normal">.
This Agreement constitutes the valid and binding obligation of the Company, enforceable against it in accordance with its terms, subject
to applicable bankruptcy, insolvency and similar laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(iv) </FONT>No
Conflict<FONT STYLE="font-weight: normal">. The execution and delivery of this Agreement and the consummation of the transactions contemplated
hereby do not conflict with the Company&rsquo;s organizational documents, any material agreement binding on the Company, or any applicable
law, except as would not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the Legacy Business
or the Company&rsquo;s ability to perform its obligations hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(v) </FONT>Title
to Assets<FONT STYLE="font-weight: normal">. The Company has good and valid title to (or a valid leasehold interest in) the assets comprising
the Legacy Business, free and clear of all liens other than Permitted Liens (as defined in the SPA).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(b) </FONT>Representations
and Warranties of Adams<FONT STYLE="font-weight: normal">. Adams represents and warrants to the Company that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(i) </FONT>Authority<FONT STYLE="font-weight: normal">.
Adams has full legal capacity and authority to execute, deliver and perform this Agreement and to consummate the transactions contemplated
hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(ii) </FONT>Enforceability<FONT STYLE="font-weight: normal">.
This Agreement constitutes the valid and binding obligation of Adams, enforceable against him in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(iii) </FONT>No
Proceedings<FONT STYLE="font-weight: normal">. There are no actions, suits or proceedings pending or, to Adams&rsquo;s knowledge, threatened
against Adams that would reasonably be expected to impair or delay his ability to perform his obligations under this Agreement.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">6. COVENANTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(a) </FONT>Conduct
of Legacy Business Pending Exercise<FONT STYLE="font-weight: normal">. During the Option Exercise Period, the Company shall operate the
Legacy Business in the ordinary course consistent with past practice and shall not, without Adams&rsquo;s prior written consent (not to
be unreasonably withheld, conditioned or delayed):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(i) sell,
lease or otherwise dispose of any material asset of the Legacy Business (other than inventory in the ordinary course);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(ii) create,
incur, assume, or guarantee any indebtedness or issue any debt securities, except (A) as expressly permitted by this Agreement or (B)
that will not remain as indebtedness of the Legacy Business at the Effective Time;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(iii) materially
amend, terminate or waive rights under any material contract of the Legacy Business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(iv) make
any material capital expenditures or commitments therefor, except as required in the ordinary course of business consistent with past
practice;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(v) increase
or change the compensation or benefits of any employee, officer, or director of the Legacy Business, or hire or terminate any such employee,
except as required by applicable law or in the ordinary course of business consistent with past practice;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(vi) settle
or compromise any litigation, arbitration, proceeding, or claim involving the Legacy Business, or waive or release any material rights
or claims;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(vii) take
any action to materially change the accounting methods, principles, or practices of the Legacy Business;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(viii) make
any loans, advances, or capital contributions to, or investments in, any other person or entity (other than to wholly owned subsidiaries
in the ordinary course of business consistent with past practice);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(ix) take
any other action outside the ordinary course of business that would reasonably be expected to have a material adverse effect on the Legacy
Business or Adams&rsquo;s rights under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(b) </FONT>Affirmative
Covenants<FONT STYLE="font-weight: normal">. During the Option Exercise Period, the Company shall, and shall cause its Affiliates to,
with respect to the Legacy Business:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(i) maintain
in full force and effect insurance policies (including, without limitation, general liability, property, and directors&rsquo; and officers&rsquo;
insurance) in such amounts and covering such risks as are reasonable and customary for businesses of similar size and nature;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(ii) use
commercially reasonable efforts to preserve intact the business organization of the Legacy Business, maintain its rights, franchises,
and goodwill, and preserve its relationships with customers, suppliers, employees, licensors, licensees, and other business relations;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(iii) maintain
the Legacy Business in good standing under the laws of its jurisdiction of organization and in compliance in all material respects with
all applicable laws;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(iv) promptly
notify Adams of any material event, development, or change relating to the Legacy Business;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(v) keep
Adams reasonably informed of the operations and financial condition of the Legacy Business and provide such information as Adams may reasonably
request for purposes of evaluating and effecting the Spin-Off or Acquisition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(c) </FONT>Access;
Information<FONT STYLE="font-weight: normal">. The Company shall afford Adams and his representatives reasonable access, during normal
business hours and upon reasonable notice, to the books, records, personnel and facilities of the Legacy Business and shall furnish such
information regarding the Legacy Business as Adams may reasonably request for purposes of evaluating and effecting the Spin-Off or Acquisition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(d) </FONT>Further
Assurances; Reasonable Best Efforts. <FONT STYLE="font-weight: normal">Each Party shall, and shall cause its respective Affiliates to,
use its reasonable best efforts to (a) cause to be taken, all actions and to do, or cause to be done, all things reasonably necessary,
desirable or advisable to consummate the transactions contemplated hereby, including the preparation, execution and filing of all documentation
required under applicable laws, (b) obtain, as promptly as practicable, all consents, waivers, permits, approvals, authorizations, registrations
and declarations of, and to provide all notices and make all filings with, any Governmental Authority or other third party that are necessary,
advisable or required in connection with the execution, delivery and performance of this Agreement and the consummation of the transactions
contemplated hereby (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;), and (c) take, or cause to be taken, all actions and do,
or cause to be done, all things necessary, proper or advisable to perform and satisfy, in all material respects and within the applicable
time periods, each covenant, agreement and obligation required to be performed or satisfied by such Party under this Agreement, including
at or prior to the Spin-Off Closing or the Acquisition Closing, as applicable. Without limiting the foregoing, each Party shall (i) make
all required filings with, and supply any supplemental information requested by, any Governmental Authority or other third party in connection
with obtaining the Required Approvals, (ii) promptly inform the other Party of any material communication received by such Party from
any Governmental Authority or other third party with respect to the transactions contemplated by this Agreement, and (iii) cooperate fully
with and provide reasonable assistance to the other Party in connection with the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(e) </FONT>Negotiation
and Execution of Ancillary Agreements<FONT STYLE="font-weight: normal">. In connection with the exercise of the Option and the consummation
of the Spin-Off or Acquisition, as applicable, each Party shall, and shall cause its respective Affiliates to, negotiate in good faith
and use reasonable best efforts to finalize, execute and deliver any agreements, instruments, or other documents (including, without limitation,
an asset purchase agreement, separation and distribution agreement, transition services agreement, or other customary transaction documents)
that are necessary or advisable to effectuate the transactions contemplated by this Agreement. </FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">7. SPIN-OFF
MECHANICS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(a) </FONT>Pre-Spin-Off
Reorganization<FONT STYLE="font-weight: normal">. Prior to the Spin-Off Closing, the Company shall cause all assets, liabilities and employees
primarily related to the Legacy Business to be transferred to SpinCo in accordance with a separation and distribution agreement in customary
form for transactions of this type. The Spin-Off shall be effected in compliance with all applicable securities laws, including, if required,
the preparation and filing of a Form 10 or other registration statement or filings with the Securities and Exchange Commission or any
other applicable regulatory authority. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(b) </FONT>Spin-Off
Closing. <FONT STYLE="font-weight: normal">On the Spin-Off Closing date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(i) the
Company shall distribute to each holder of record of Company Common Stock as of the record date determined by the Board one share of common
stock of SpinCo for each share of Company Common Stock held unless the Parties mutually agree on a different ratio of SpinCo common stock
to Company Common Stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(ii) all
equity interests of SpinCo shall be fully paid and non-assessable and free of liens except pursuant to applicable securities laws; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(iii) if
requested by Adams or the Company, the Company and SpinCo shall enter into a transition services agreement, tax matters agreement and
such other ancillary agreements as are reasonable and customary, each in form reasonably satisfactory to Adams and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(c) </FONT>Governance
of SpinCo<FONT STYLE="font-weight: normal">. Effective as of the Effective Time, Adams shall serve as a member of the board of directors
of SpinCo and as its Chief Executive Officer for an initial term of not less than one (1) year, subject to customary employment terms.
The other officers and directors of SpinCo shall be selected exclusively by Adams. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(d)
</FONT><B>Equity Grants to SpinCo Officers and Directors.</B> <FONT STYLE="font-weight: normal">Notwithstanding anything to the contrary
herein, Adams shall have the right, immediately prior to the Spin-Off, to cause SpinCo to adopt a new equity incentive plan and to issue
to its officers and directors, in the aggregate, up to twenty percent (20%) of the equity of SpinCo (on a fully diluted basis) under
such plan. The specific allocation and terms of such issuances shall be determined by Adams in his sole discretion, and such awards shall
be intended to incentivize the management and performance of SpinCo. </FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">8. ACQUISITION
MECHANICS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(a) </FONT>Purchase
and Sale<FONT STYLE="font-weight: normal">. In the event of an Acquisition Election, the Company shall sell, convey, transfer and assign
to Adams (or his designee) all right, title and interest in and to the Legacy Business, and Adams (or his designee) shall purchase and
assume the same, free and clear of all liens other than Permitted Liens, for the Option Price (as adjusted pursuant to Article 9).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(b) </FONT>Acquisition
Closing Deliverables. <FONT STYLE="font-weight: normal">At the Acquisition Closing:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(i) The
parties shall enter into an Asset Purchase Agreement in customary form for transactions of this nature pursuant to which Adams (or his
designee) shall acquire all or substantially all of the assets of the Legacy Business;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(ii) Adams
shall deliver to the Company the Option Price, by wire transfer of immediately available funds, against delivery by the Company of duly
executed bills of sale, assignment and assumption agreements and other conveyance documents reasonably necessary to transfer the Legacy
Business; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(iii) each
Party shall deliver all certificates, consents and other documents required by this Agreement or reasonably requested by the other Party
to evidence the consummation of the Acquisition.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">9. PURCHASE
PRICE ADJUSTMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(a) </FONT>Minimum
Cash Representation<FONT STYLE="font-weight: normal">. The Option Price will assume that the Legacy Business will have at least the Minimum
Cash Amount as of the Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(b) </FONT>Adjustment
for Cash Shortfall<FONT STYLE="font-weight: normal">. If the unrestricted cash and cash equivalents of the Legacy Business as of the Effective
Time (the &ldquo;<U>Closing Cash</U>&rdquo;) are less than the Minimum Cash Amount, the Option Price shall be reduced, dollar for dollar,
by the amount of such shortfall (the &ldquo;<U>Cash Shortfall</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(c) </FONT>Determination
of Closing Cash<FONT STYLE="font-weight: normal">. Within thirty (30) days after the Effective Time, the Company (in the case of a Spin-Off)
or Adams (in the case of an Acquisition) shall prepare and deliver to the other Party a statement setting forth its calculation of Closing
Cash and any resulting adjustment. The receiving Party may dispute such calculation within fifteen (15) days; any unresolved disputes
shall be submitted to an independent public accounting firm of nationally recognized standing jointly selected by the Parties, whose determination
shall be final and binding, and whose fees shall be borne fifty percent (50%) by each Party.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">10. GOVERNANCE
AND CONTROL POST-EXERCISE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(a) </FONT>Spin-Off.
<FONT STYLE="font-weight: normal">During the one-year period following the Spin-Off Closing: (a) Adams shall have the right to nominate
a majority of the members of SpinCo&rsquo;s board of directors; and (b) the Company shall refrain from taking any action to impede Adams&rsquo;s
ability to manage and control SpinCo.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT><P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(b) </FONT>Acquisition<FONT STYLE="font-weight: normal">.
Upon the Acquisition Closing, the Legacy Business shall be wholly owned and controlled by Adams (or his designee), and the Company shall
have no further ownership interest or control rights, except as expressly provided in any transition services agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal"></FONT>&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">11. INDEMNIFICATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(a) </FONT>Indemnification
by the Company<FONT STYLE="font-weight: normal">. The Company shall indemnify, defend and hold harmless Adams, his Affiliates and their
respective directors, officers, employees and agents from and against all losses arising out of any breach by the Company of its representations,
warranties or covenants under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(b) </FONT>Indemnification
by Adams<FONT STYLE="font-weight: normal">. Adams shall indemnify, defend and hold harmless the Company and its Affiliates against all
losses arising out of any breach by Adams of his representations, warranties or covenants hereunder.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">12. TERM,
TERMINATION AND REMEDIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(a) </FONT>Term<FONT STYLE="font-weight: normal">.
This Agreement shall commence on the Effective Date and shall automatically terminate upon the earliest to occur of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(i) the
expiration of the Option Exercise Period without a valid Exercise Notice;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(ii) mutual
written agreement of the Parties; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(iii) completion
of the Spin-Off Closing or Acquisition Closing and satisfaction of all post-closing adjustments and indemnification obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(b) </FONT>Remedies<FONT STYLE="font-weight: normal">.
Each Party acknowledges and agrees that monetary damages may be inadequate to compensate for any breach of this Agreement and that any
such breach may cause irreparable harm to the non-breaching Party. Accordingly, in the event of any actual or threatened breach of this
Agreement, the non-breaching Party shall be entitled, in addition to any other remedies available at law or in equity, to seek and obtain
specific performance, injunctive relief (whether temporary, preliminary, or permanent), and any other equitable remedies to prevent or
restrain any such breach or threatened breach, without the necessity of proving actual damages or posting bond or other security. Each
Party further agrees not to oppose the granting of such equitable relief on the basis that monetary damages would be adequate or that
the other Party has an adequate remedy at law. The prevailing Party in any action to enforce this Agreement shall be entitled to reimbursement
of its reasonable attorneys&rsquo; fees and costs.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">13. MISCELLANEOUS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(a) </FONT>Notices<FONT STYLE="font-weight: normal">.
All notices, requests, consents, claims, demands, waivers, and other communications under this Agreement (each, a &ldquo;<U>Notice</U>&rdquo;)
must be in writing and addressed to the respective Party at the address set forth on the signature page to this Agreement (or to such
other address as that Party may designate by Notice to the other Party in accordance with this Section). All Notices must be delivered
by personal delivery, nationally recognized overnight courier (with all fees pre-paid), certified or registered mail (in each case, return
receipt requested, postage prepaid), or by email. Except as otherwise provided in this Agreement, a Notice is effective only (a) upon
receipt by the receiving Party, and (b) if the Party giving the Notice has complied with the requirements of this Section. Either Party
may change its address for Notice by providing Notice to the other Party in accordance with this Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(b) </FONT>Assignment<FONT STYLE="font-weight: normal">.
Neither Party may assign its rights or delegate its obligations hereunder without the prior written consent of the other Party, except
that Adams may assign his rights (but not his obligations) to any person or entity that he designates; provided that Adams remains liable
for all obligations hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(c) </FONT>Amendments;
Waivers<FONT STYLE="font-weight: normal">. No amendment or waiver shall be effective unless in writing and signed by each Party. No failure
or delay by either Party in exercising any right hereunder shall operate as a waiver thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(d) </FONT>Entire
Agreement; Conflict<FONT STYLE="font-weight: normal">. This Agreement, together with the SPA and the other Transaction Documents (as defined
in the SPA), constitutes the entire agreement between the Parties with respect to the subject matter hereof and supersedes all prior discussions
and writings. In the event of a conflict between this Agreement and the SPA, this Agreement shall control solely with respect to the Option
and the transactions contemplated herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(e) </FONT>Severability<FONT STYLE="font-weight: normal">.
If any provision of this Agreement is held invalid or unenforceable, the remaining provisions shall remain in full force and effect, and
the Parties shall negotiate in good faith to substitute a valid provision that most nearly reflects the original intent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(f) </FONT>Governing
Law; Jurisdiction<FONT STYLE="font-weight: normal">. This Agreement shall be governed by and construed in accordance with the laws of
the State of New York, without regard to its conflicts-of-law principles. Each Party irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in New York County, New York, and waives trial by jury.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(g) </FONT>Counterparts;
Electronic Signatures<FONT STYLE="font-weight: normal">. This Agreement may be executed in counterparts, each of which shall be deemed
an original and all of which together shall constitute one instrument. Signatures transmitted by electronic means (e.g., PDF or DocuSign)
shall be deemed original signatures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Signature page follows)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the Parties have executed this Option Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>CLEANCORE SOLUTIONS, INC.&#9;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.25pt; text-align: left"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%; text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">/s/ David Enholm</FONT></TD>
    <TD STYLE="width: 60%; text-align: left; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">David Enholm</FONT></TD>
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD>
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 197.6pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%; text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Address:&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 32%; text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">5920 S 118th Circle</FONT></TD>
    <TD STYLE="width: 60%; text-align: left; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Omaha, NE 68137</FONT></TD>
    <TD STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; layout-grid-mode: line">Attn:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt"> Chief Financial Officer</FONT></TD>
    <TD STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Email:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>CLAYTON ADAMS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">/s/ Clayton Adams</FONT></TD>
    <TD STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; layout-grid-mode: line; width: 7%">&nbsp;</TD>
    <TD STYLE="text-align: left; layout-grid-mode: line; width: 32%">&nbsp;</TD>
    <TD STYLE="text-align: left; layout-grid-mode: line; width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Address:&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">c/o CleanCore Solutions, Inc.</FONT></TD>
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">5920 S 118th Circle</FONT></TD>
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Omaha, NE 68137</FONT></TD>
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Email:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.25pt; text-align: left; text-indent: 198.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">10</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>14
<FILENAME>ea025594401ex10-8_clean.htm
<DESCRIPTION>INDEPENDENT DIRECTOR AGREEMENT, DATED SEPTEMBER 5, 2025, BETWEEN CLEANCORE SOLUTIONS, INC. AND ALEXANDER BENJAMIN SPIRO
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.8</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDEPENDENT DIRECTOR AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">INDEPENDENT DIRECTOR AGREEMENT
(this &ldquo;<B>Agreement</B>&rdquo;), dated September 5, 2025, by and between <FONT STYLE="font-variant: small-caps"><B>CleanCore Solutions,
Inc.</B></FONT>, a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;), and the undersigned (the &ldquo;<B>Director</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company desires to appoint
the Director to serve on the Company&rsquo;s board of directors (the &ldquo;<B>Board</B>&rdquo;), which may include membership on one
or more committees of the Board, and the Director desires to accept such appointment to serve on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW THEREFORE, in consideration
of the mutual promises contained herein, the adequacy and sufficiency of which are hereby acknowledged, and intending to be legally bound
hereby, the Company and the Director hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">1. <FONT STYLE="font-variant: small-caps"><B><U>Duties</U></B></FONT>.
The Company requires that the Director be available to perform the duties of an independent director customarily related to this function
as may be determined and assigned by the Board and as may be required by the Company&rsquo;s constituent instruments, including its Articles
of Incorporation and Bylaws, as amended, and its corporate governance and board committee charters, each as amended or modified from time
to time, and by applicable law, including the Nevada Revised Statutes. The Director agrees to devote as much time as is necessary to perform
completely the duties as a Director of the Company, including duties as a member of one or more committees of the Board to which the Director
may hereafter be appointed. The Director will perform such duties described herein in accordance with the general fiduciary duty of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">2. <FONT STYLE="font-variant: small-caps"><B><U>Term</U></B></FONT>.
The term of this Agreement shall commence as of the effective date of the Director&rsquo;s appointment to the Board and shall continue
until the Director&rsquo;s resignation or removal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">3. <FONT STYLE="font-variant: small-caps"><B><U>Compensation</U></B></FONT>.
As exclusive compensation for all services to be rendered by the Director in any capacity hereunder, the Company shall issue to the Director
a Restricted Award in the form of Restricted Stock Units (&ldquo;<B>RSUs</B>&rdquo;) under the Company&rsquo;s Equity Incentive Plan,
as amended (the &ldquo;<B>Plan</B>&rdquo;) in accordance with the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) Within
five business days after the execution of this Agreement, the Company shall grant Three Hundred and Sixty Thousand (360,000) shares of
the Company&rsquo;s Class B Common Stock (the &ldquo;<B>Initial Grant</B>&rdquo;), which shall vest monthly in equal installments over
a total of Twelve (12) Months. In connection with the Initial Grant, the Director and the Company shall enter into a Restricted Stock
Unit Award Agreement (the &ldquo;<B>Award Agreement</B>&rdquo;) substantially in the Company&rsquo;s standard form. The Director shall
be responsible for his or her own individual income tax payment on such compensation in jurisdictions where the Director resides.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) After
the first anniversary of the date of this Agreement and for each year thereafter, within five business days, the Company shall grant US$360,000
worth of shares (the &ldquo;<B>RSU Grant</B>&rdquo;) of the Company&rsquo;s Class B Common Stock priced at the closing price of the applicable
anniversary date of this agreement; provided, however, the Director shall be duly appointed and continue to serve as the director of the
Company. The RSU Grant shall vest monthly in equal installments over a total of Twelve (12) Months. In connection with the RSU Grant,
the Director and the Company shall enter into an Award Agreement substantially in the Company&rsquo;s standard form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4. <FONT STYLE="font-variant: small-caps"><B><U>Expenses</U></B></FONT>.
The Company shall reimburse the Director for pre-approved reasonable business related expenses incurred in good faith in connection with
the performance of the Director&rsquo;s duties for the Company. Such reimbursement shall be made by the Company upon submission by the
Director of a signed statement itemizing the expenses incurred, which shall be accompanied by sufficient documentation to support the
expenditures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5. <FONT STYLE="font-variant: small-caps"><B><U>Independence</U></B></FONT>.
The Director acknowledges that the Director&rsquo;s appointment hereunder is contingent upon the Board&rsquo;s determination that the
Director is &ldquo;independent&rdquo; with respect to the Company, in accordance with the listing requirements of the Nasdaq and NYSE
stock exchanges, and that the appointment may be terminated by the Company in the event that the Director does not maintain such independence
standard.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">6. <FONT STYLE="font-variant: small-caps"><B><U>Other
Agreements</U></B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Confidential
Information and Insider Trading</U>. The Company and the Director each acknowledge that, in order for the intentions and purposes of this
Agreement to be accomplished, the Director shall necessarily be obtaining access to certain confidential information concerning the Company
and its affairs, including, but not limited to, business methods, information systems, financial data and strategic plans which are unique
assets of the Company (as further defined below, the &ldquo;<B>Confidential Information</B>&rdquo;) and that the communication of such
Confidential Information to third parties could irreparably injure the Company and its business. Accordingly, the Director agrees that,
during his association with the Company and thereafter, he will treat and safeguard as confidential and secret all Confidential Information
received by him at any time and that, without the prior written consent of the Company, he will not disclose or reveal any of the Confidential
Information to any third party whatsoever or use the same in any manner except in connection with the business of the Company and in any
event in no way harmful to or competitive with the Company or its business. For purposes of this Agreement, &ldquo;<B>Confidential Information</B>&rdquo;
includes any information not generally known to the public or recognized as confidential according to standard industry practice, any
trade secrets, know-how, development, manufacturing, marketing and distribution plans and information, inventions, formulas, methods or
processes, whether or not patented or patentable, pricing policies and records of the Company (and such other information normally understood
to be confidential or otherwise designated as such in writing by the Company), all of which the Director expressly acknowledges and agrees
shall be confidential and proprietary information belonging to the Company. Upon termination of his association with the Company, the
Director shall return to the Company all documents and papers relating to the Company, including any Confidential Information, together
with any copies thereof, or certify that he or she has destroyed all such documents and papers. Furthermore, the Director recognizes that
the Company has received and in the future will receive confidential or proprietary information from third parties subject to a duty on
the Company&rsquo;s part to maintain the confidentiality of such information and, in some cases, to use it only for certain limited purposes.
The Director agrees that the Director owes the Company and such third parties, both during the term of the Director&rsquo;s association
with the Company and thereafter, a duty to hold all such confidential or proprietary information in the strictest confidence and not to,
except as is consistent with the Company&rsquo;s agreement with the third party, disclose it to any person or entity or use it for the
benefit of anyone other than the Company or such third party, unless expressly authorized to act otherwise by an officer of the Company.
In addition, the Director acknowledges and agrees that the Director may have access to &ldquo;material non-public information&rdquo; for
purposes of the federal securities laws and that the Director will abide by all securities laws relating to the handling of and acting
upon such information; provided, however, that nothing in this paragraph shall preclude the Director from complying with all obligations
imposed by law or legal compulsion, and provided, further, however, that nothing in this paragraph shall be deemed applicable to any testimony
given by the Director in any legal or administrative proceedings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Disparaging
Statements</U>. At all times during and after the period in which the Director is a member of the Board and at all times thereafter, the
Director shall not either verbally, in writing, electronically or otherwise: (i) make any derogatory or disparaging statements about the
Company, any of its affiliates, any of their respective officers, directors, shareholders, employees and agents, or any of the Company&rsquo;s
current or past customers or employees, or (ii) make any public statement or perform or do any other act prejudicial or injurious to the
reputation or goodwill of the Company or any of its affiliates or otherwise interfere with the business of the Company or any of its affiliates;
provided, however, that nothing in this paragraph shall preclude the Director from complying with all obligations imposed by law or legal
compulsion, and provided, further, however, that nothing in this paragraph shall be deemed applicable to any testimony given by the Director
in any legal or administrative proceedings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Enforcement</U>.
The Director acknowledges and agrees that the covenants contained herein are reasonable, that valid consideration has been and will be
received and that the agreements set forth herein are the result of arms-length negotiations between the parties hereto. The Director
recognizes that the provisions of this Section 6 are vitally important to the continuing welfare of the Company and its affiliates and
that any violation of this Section 6 could result in irreparable harm to the Company and its affiliates for which money damages would
constitute a totally inadequate remedy. Accordingly, in the event of any such violation by the Director, the Company and its affiliates,
in addition to any other remedies they may have, shall have the right to institute and maintain a proceeding to compel specific performance
thereof or to obtain an injunction or other equitable relief restraining any action by the Director in violation of this Section 6 without
posting any bond therefore or demonstrating actual damages, and the Director will not claim as a defense thereto that the Company has
an adequate remedy at law or require the posting of a bond. If any of the restrictions or activities contained in this Section 6 shall
for any reason be held by a court of competent jurisdiction to be excessively broad as to duration, geographical scope, activity or subject,
such restrictions shall be construed so as thereafter to be limited or reduced to be enforceable to the extent compatible with the applicable
law; it being understood that by the execution of this Agreement the parties hereto regard such restrictions as reasonable and compatible
with their respective rights. The Director acknowledges that injunctive relief may be granted immediately upon the commencement of any
such action without notice to the Director and in addition Company may recover monetary damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Separate
Agreement</U>. The parties hereto further agree that the provisions of Section 6 are separate from and independent of the remainder of
this Agreement and that Section 6 is specifically enforceable by the Company notwithstanding any claim made by the Director against the
Company. The terms of this Section 6 shall survive termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">7. <FONT STYLE="font-variant: small-caps"><B><U>Market
Stand-Off Agreement</U></B></FONT>. In the event of a public or private offering of the Company&rsquo;s securities and upon request of
the Company, the underwriters or placement agents placing the offering of the Company&rsquo;s securities, the Director agrees not to sell,
make any short sale of, loan, grant any option for the purchase of, or otherwise dispose of any securities of the Company that the Director
may own, other than those included in the registration statement, without the prior written consent of the Company or such underwriters,
as the case may be, for such period of time from the effective date of such registration statement as may be requested by the Company
or such placement agent or underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">8. <FONT STYLE="font-variant: small-caps"><B><U>Termination</U></B></FONT>.
With or without cause, the Company and the Director may each terminate this Agreement at any time upon ten (10) days written notice, and
the Company shall be obligated to pay to the Director the compensation and expenses due up to the date of the termination. Nothing contained
herein or omitted herefrom shall prevent the stockholder(s) of the Company from removing the Director with immediate effect at any time
for any reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">9. <FONT STYLE="font-variant: small-caps"><B><U>Indemnification</U></B></FONT>.
The Company shall indemnify, defend and hold harmless the Director, to the full extent allowed by the law of the State of Nevada, and
as provided by, or granted pursuant to, any charter provision, bylaw provision, agreement (including, without limitation, the Indemnification
Agreement executed herewith), vote of stockholders or disinterested directors or otherwise, both as to action in the Director&rsquo;s
official capacity and as to action in another capacity while holding such office. The Company and the Director are executing an indemnification
agreement in the Company&rsquo;s standard form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">10. <FONT STYLE="font-variant: small-caps"><B><U>Effect
Of Waiver</U></B></FONT>. The waiver by either party of the breach of any provision of this Agreement shall not operate as or be construed
as a waiver of any subsequent breach thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">11. <FONT STYLE="font-variant: small-caps"><B><U>Notice</U></B></FONT>.
Any and all notices referred to herein shall be sufficient if furnished in writing at the addresses specified on the signature page hereto
or, if to the Company, to the Company&rsquo;s address as specified in filings made by the Company with the U.S. Securities and Exchange
Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">12. <FONT STYLE="font-variant: small-caps"><B><U>Governing
Law</U></B></FONT>. This Agreement shall be interpreted in accordance with, and the rights of the parties hereto shall be determined by,
the laws of the State of Nevada without reference to that state&rsquo;s conflicts of laws principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">13. <FONT STYLE="font-variant: small-caps"><B><U>Assignment</U></B></FONT>.
The rights and benefits of the Company under this Agreement shall be transferable, and all the covenants and agreements hereunder shall
inure to the benefit of, and be enforceable by or against, its successors and assigns. The duties and obligations of the Director under
this Agreement are personal and therefore the Director may not assign any right or duty under this Agreement without the prior written
consent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">14. <FONT STYLE="font-variant: small-caps"><B><U>Miscellaneous</U></B></FONT>.
If any provision of this Agreement shall be declared invalid or illegal, for any reason whatsoever, then, notwithstanding such invalidity
or illegality, the remaining terms and provisions of this Agreement shall remain in full force and effect in the same manner as if the
invalid or illegal provision had not been contained herein. The article headings contained in this Agreement are for reference purposes
only and shall not affect in any way the meaning or interpretation of this Agreement. This Agreement may be executed in any number of
counterparts, each of which shall be deemed an original but all of which taken together shall constitute one and the same instrument.
Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal
ESIGN Act of 2000, <I>e.g.</I>, www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have
been duly and validly delivered and be valid and effective for all purposes. Except as provided elsewhere herein, this Agreement sets
forth the entire agreement of the parties with respect to its subject matter and supersedes all prior agreements, promises, covenants,
arrangements, communications, representations or warranties, whether oral or written, by any officer, employee or representative of any
party to this Agreement with respect to such subject matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Page Follows]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Independent Director Agreement to be duly executed and signed as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><B>&nbsp;</B></TD>
    <TD COLSPAN="2"><B><U>COMPANY</U></B>:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; layout-grid-mode: line">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps"><B>CleanCore Solutions, Inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; layout-grid-mode: line">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; width: 60%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%">/s/ Clayton Adams</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:&nbsp;</TD>
    <TD> Clayton Adams</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Executive Officer</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><B>&nbsp;</B></TD>
    <TD COLSPAN="2"><B><U>DIRECTOR</U>:</B></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">/s/ Alexander Benjamin Spiro</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Alexander Benjamin Spiro</TD>
    </TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify; layout-grid-mode: line">Address:&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="text-align: justify; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="text-align: justify; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>15
<FILENAME>ea025594401ex10-9_clean.htm
<DESCRIPTION>INDEPENDENT DIRECTOR AGREEMENT, DATED SEPTEMBER 5, 2025, BETWEEN CLEANCORE SOLUTIONS, INC. AND TIM STEBBING
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.9</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDEPENDENT DIRECTOR AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">INDEPENDENT DIRECTOR AGREEMENT
(this &ldquo;<B>Agreement</B>&rdquo;), dated September 5, 2025, by and between <FONT STYLE="font-variant: small-caps"><B>CleanCore Solutions,
Inc.</B></FONT>, a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;), and the undersigned (the &ldquo;<B>Director</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company desires to appoint
the Director to serve on the Company&rsquo;s board of directors (the &ldquo;<B>Board</B>&rdquo;), which may include membership on one
or more committees of the Board, and the Director desires to accept such appointment to serve on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW THEREFORE, in consideration
of the mutual promises contained herein, the adequacy and sufficiency of which are hereby acknowledged, and intending to be legally bound
hereby, the Company and the Director hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">1. <FONT STYLE="font-variant: small-caps"><B><U>Duties</U></B></FONT>.
The Company requires that the Director be available to perform the duties of an independent director customarily related to this function
as may be determined and assigned by the Board and as may be required by the Company&rsquo;s constituent instruments, including its Articles
of Incorporation and Bylaws, as amended, and its corporate governance and board committee charters, each as amended or modified from time
to time, and by applicable law, including the Nevada Revised Statutes. The Director agrees to devote as much time as is necessary to perform
completely the duties as a Director of the Company, including duties as a member of one or more committees of the Board to which the Director
may hereafter be appointed. The Director will perform such duties described herein in accordance with the general fiduciary duty of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">2. <FONT STYLE="font-variant: small-caps"><B><U>Term</U></B></FONT>.
The term of this Agreement shall commence as of the effective date of the Director&rsquo;s appointment to the Board and shall continue
for a term of one year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">3. <FONT STYLE="font-variant: small-caps"><B><U>Compensation</U></B></FONT>.
As exclusive compensation for all services to be rendered by the Director in any capacity hereunder, the Company shall issue to the Director
a Restricted Award in the form of Restricted Stock Units (&ldquo;<B>RSUs</B>&rdquo;) under the Company&rsquo;s Equity Incentive Plan,
as amended (the &ldquo;<B>Plan</B>&rdquo;) in accordance with the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) Within
five business days after the execution of this Agreement, the Company shall grant One Hundred and Twenty Thousand (120,000) shares of
the Company&rsquo;s Class B Common Stock (the &ldquo;<B>Initial Grant</B>&rdquo;), which shall vest monthly in equal installments over
a total of Twelve (12) Months. In connection with the Initial Grant, the Director and the Company shall enter into a Restricted Stock
Unit Award Agreement (the &ldquo;<B>Award Agreement</B>&rdquo;) substantially in the Company&rsquo;s standard form. The Director shall
be responsible for his or her own individual income tax payment on such compensation in jurisdictions where the Director resides.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) After
the first anniversary of the date of this Agreement and for each year thereafter, within five business days, the Company shall grant US$120,000
worth of shares (the &ldquo;<B>RSU Grant</B>&rdquo;) of the Company&rsquo;s Class B Common Stock priced at the closing price of the applicable
anniversary date of this agreement; provided, however, the Director shall be duly appointed and continue to serve as the director of the
Company. The RSU Grant shall vest monthly in equal installments over a total of Twelve (12) Months. In connection with the RSU Grant,
the Director and the Company shall enter into an Award Agreement substantially in the Company&rsquo;s standard form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4. <FONT STYLE="font-variant: small-caps"><B><U>Expenses</U></B></FONT>.
The Company shall reimburse the Director for pre-approved reasonable business related expenses incurred in good faith in connection with
the performance of the Director&rsquo;s duties for the Company. Such reimbursement shall be made by the Company upon submission by the
Director of a signed statement itemizing the expenses incurred, which shall be accompanied by sufficient documentation to support the
expenditures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5. <FONT STYLE="font-variant: small-caps"><B><U>Independence</U></B></FONT>.
The Director acknowledges that the Director&rsquo;s appointment hereunder is contingent upon the Board&rsquo;s determination that the
Director is &ldquo;independent&rdquo; with respect to the Company, in accordance with the listing requirements of the Nasdaq and NYSE
stock exchanges, and that the appointment may be terminated by the Company in the event that the Director does not maintain such independence
standard.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">6. <FONT STYLE="font-variant: small-caps"><B><U>Other
Agreements</U></B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Confidential
Information and Insider Trading</U>. The Company and the Director each acknowledge that, in order for the intentions and purposes of this
Agreement to be accomplished, the Director shall necessarily be obtaining access to certain confidential information concerning the Company
and its affairs, including, but not limited to, business methods, information systems, financial data and strategic plans which are unique
assets of the Company (as further defined below, the &ldquo;<B>Confidential Information</B>&rdquo;) and that the communication of such
Confidential Information to third parties could irreparably injure the Company and its business. Accordingly, the Director agrees that,
during his association with the Company and thereafter, he will treat and safeguard as confidential and secret all Confidential Information
received by him at any time and that, without the prior written consent of the Company, he will not disclose or reveal any of the Confidential
Information to any third party whatsoever or use the same in any manner except in connection with the business of the Company and in any
event in no way harmful to or competitive with the Company or its business. For purposes of this Agreement, &ldquo;<B>Confidential Information</B>&rdquo;
includes any information not generally known to the public or recognized as confidential according to standard industry practice, any
trade secrets, know-how, development, manufacturing, marketing and distribution plans and information, inventions, formulas, methods or
processes, whether or not patented or patentable, pricing policies and records of the Company (and such other information normally understood
to be confidential or otherwise designated as such in writing by the Company), all of which the Director expressly acknowledges and agrees
shall be confidential and proprietary information belonging to the Company. Upon termination of his association with the Company, the
Director shall return to the Company all documents and papers relating to the Company, including any Confidential Information, together
with any copies thereof, or certify that he or she has destroyed all such documents and papers. Furthermore, the Director recognizes that
the Company has received and in the future will receive confidential or proprietary information from third parties subject to a duty on
the Company&rsquo;s part to maintain the confidentiality of such information and, in some cases, to use it only for certain limited purposes.
The Director agrees that the Director owes the Company and such third parties, both during the term of the Director&rsquo;s association
with the Company and thereafter, a duty to hold all such confidential or proprietary information in the strictest confidence and not to,
except as is consistent with the Company&rsquo;s agreement with the third party, disclose it to any person or entity or use it for the
benefit of anyone other than the Company or such third party, unless expressly authorized to act otherwise by an officer of the Company.
In addition, the Director acknowledges and agrees that the Director may have access to &ldquo;material non-public information&rdquo; for
purposes of the federal securities laws and that the Director will abide by all securities laws relating to the handling of and acting
upon such information; provided, however, that nothing in this paragraph shall preclude the Director from complying with all obligations
imposed by law or legal compulsion, and provided, further, however, that nothing in this paragraph shall be deemed applicable to any testimony
given by the Director in any legal or administrative proceedings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Disparaging
Statements</U>. At all times during and after the period in which the Director is a member of the Board and at all times thereafter, the
Director shall not either verbally, in writing, electronically or otherwise: (i) make any derogatory or disparaging statements about the
Company, any of its affiliates, any of their respective officers, directors, shareholders, employees and agents, or any of the Company&rsquo;s
current or past customers or employees, or (ii) make any public statement or perform or do any other act prejudicial or injurious to the
reputation or goodwill of the Company or any of its affiliates or otherwise interfere with the business of the Company or any of its affiliates;
provided, however, that nothing in this paragraph shall preclude the Director from complying with all obligations imposed by law or legal
compulsion, and provided, further, however, that nothing in this paragraph shall be deemed applicable to any testimony given by the Director
in any legal or administrative proceedings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Enforcement</U>.
The Director acknowledges and agrees that the covenants contained herein are reasonable, that valid consideration has been and will be
received and that the agreements set forth herein are the result of arms-length negotiations between the parties hereto. The Director
recognizes that the provisions of this Section 6 are vitally important to the continuing welfare of the Company and its affiliates and
that any violation of this Section 6 could result in irreparable harm to the Company and its affiliates for which money damages would
constitute a totally inadequate remedy. Accordingly, in the event of any such violation by the Director, the Company and its affiliates,
in addition to any other remedies they may have, shall have the right to institute and maintain a proceeding to compel specific performance
thereof or to obtain an injunction or other equitable relief restraining any action by the Director in violation of this Section 6 without
posting any bond therefore or demonstrating actual damages, and the Director will not claim as a defense thereto that the Company has
an adequate remedy at law or require the posting of a bond. If any of the restrictions or activities contained in this Section 6 shall
for any reason be held by a court of competent jurisdiction to be excessively broad as to duration, geographical scope, activity or subject,
such restrictions shall be construed so as thereafter to be limited or reduced to be enforceable to the extent compatible with the applicable
law; it being understood that by the execution of this Agreement the parties hereto regard such restrictions as reasonable and compatible
with their respective rights. The Director acknowledges that injunctive relief may be granted immediately upon the commencement of any
such action without notice to the Director and in addition Company may recover monetary damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Separate
Agreement</U>. The parties hereto further agree that the provisions of Section 6 are separate from and independent of the remainder of
this Agreement and that Section 6 is specifically enforceable by the Company notwithstanding any claim made by the Director against the
Company. The terms of this Section 6 shall survive termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">7. <FONT STYLE="font-variant: small-caps"><B><U>Market
Stand-Off Agreement</U></B></FONT>. In the event of a public or private offering of the Company&rsquo;s securities and upon request of
the Company, the underwriters or placement agents placing the offering of the Company&rsquo;s securities, the Director agrees not to sell,
make any short sale of, loan, grant any option for the purchase of, or otherwise dispose of any securities of the Company that the Director
may own, other than those included in the registration statement, without the prior written consent of the Company or such underwriters,
as the case may be, for such period of time from the effective date of such registration statement as may be requested by the Company
or such placement agent or underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">8. <FONT STYLE="font-variant: small-caps"><B><U>Termination</U></B></FONT>.
With or without cause, the Company and the Director may each terminate this Agreement at any time upon ten (10) days written notice, and
the Company shall be obligated to pay to the Director the compensation and expenses due up to the date of the termination. Nothing contained
herein or omitted herefrom shall prevent the stockholder(s) of the Company from removing the Director with immediate effect at any time
for any reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">9. <FONT STYLE="font-variant: small-caps"><B><U>Indemnification</U></B></FONT>.
The Company shall indemnify, defend and hold harmless the Director, to the full extent allowed by the law of the State of Nevada, and
as provided by, or granted pursuant to, any charter provision, bylaw provision, agreement (including, without limitation, the Indemnification
Agreement executed herewith), vote of stockholders or disinterested directors or otherwise, both as to action in the Director&rsquo;s
official capacity and as to action in another capacity while holding such office. The Company and the Director are executing an indemnification
agreement in the Company&rsquo;s standard form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">10. <FONT STYLE="font-variant: small-caps"><B><U>Effect
Of Waiver</U></B></FONT>. The waiver by either party of the breach of any provision of this Agreement shall not operate as or be construed
as a waiver of any subsequent breach thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">11. <FONT STYLE="font-variant: small-caps"><B><U>Notice</U></B></FONT>.
Any and all notices referred to herein shall be sufficient if furnished in writing at the addresses specified on the signature page hereto
or, if to the Company, to the Company&rsquo;s address as specified in filings made by the Company with the U.S. Securities and Exchange
Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">12. <FONT STYLE="font-variant: small-caps"><B><U>Governing
Law</U></B></FONT>. This Agreement shall be interpreted in accordance with, and the rights of the parties hereto shall be determined by,
the laws of the State of Nevada without reference to that state&rsquo;s conflicts of laws principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">13. <FONT STYLE="font-variant: small-caps"><B><U>Assignment</U></B></FONT>.
The rights and benefits of the Company under this Agreement shall be transferable, and all the covenants and agreements hereunder shall
inure to the benefit of, and be enforceable by or against, its successors and assigns. The duties and obligations of the Director under
this Agreement are personal and therefore the Director may not assign any right or duty under this Agreement without the prior written
consent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">14. <FONT STYLE="font-variant: small-caps"><B><U>Miscellaneous</U></B></FONT>.
If any provision of this Agreement shall be declared invalid or illegal, for any reason whatsoever, then, notwithstanding such invalidity
or illegality, the remaining terms and provisions of this Agreement shall remain in full force and effect in the same manner as if the
invalid or illegal provision had not been contained herein. The article headings contained in this Agreement are for reference purposes
only and shall not affect in any way the meaning or interpretation of this Agreement. This Agreement may be executed in any number of
counterparts, each of which shall be deemed an original but all of which taken together shall constitute one and the same instrument.
Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal
ESIGN Act of 2000, <I>e.g.</I>, www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have
been duly and validly delivered and be valid and effective for all purposes. Except as provided elsewhere herein, this Agreement sets
forth the entire agreement of the parties with respect to its subject matter and supersedes all prior agreements, promises, covenants,
arrangements, communications, representations or warranties, whether oral or written, by any officer, employee or representative of any
party to this Agreement with respect to such subject matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Page Follows]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Independent Director Agreement to be duly executed and signed as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>COMPANY</U></B>:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 60%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font: small-caps 10pt Times New Roman, Times, Serif"><B>CleanCore Solutions, Inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Clayton Adams</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clayton Adams</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>DIRECTOR</U>:</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Tim Stebbing</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tim Stebbing</FONT></TD>
    </TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify; layout-grid-mode: line"></TD>
    <TD STYLE="width: 7%">Address:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 32%; text-align: justify; layout-grid-mode: line"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; layout-grid-mode: line">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; layout-grid-mode: line">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; layout-grid-mode: line">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.10
<SEQUENCE>16
<FILENAME>ea025594401ex10-10_clean.htm
<DESCRIPTION>INDEMNIFICATION AGREEMENT, DATED SEPTEMBER 5, 2025, BETWEEN CLEANCORE SOLUTIONS, INC. AND ALEXANDER BENJAMIN SPIRO
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.10</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDEMNIFICATION AGREEMENT </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">INDEMNIFICATION AGREEMENT
(this &ldquo;<B>Agreement</B>&rdquo;) is entered into as of September 5, 2025 by and between CleanCore Solutions, Inc., a Nevada corporation
(the &ldquo;<B>Company</B>&rdquo;) and the undersigned, a director and/or an officer of the Company (&ldquo;<B>Indemnitee</B>&rdquo;),
as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BACKGROUND</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">The Board of Directors of
the Company (the &ldquo;<B>Board of Directors</B>&rdquo;) has determined that the inability to attract and retain highly competent persons
to serve the Company is detrimental to the best interests of the Company and its shareholders and that it is reasonable and necessary
for the Company to provide adequate protection to such persons against risks of claims and actions against them arising out of their services
to the corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AGREEMENT </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">In consideration of the premises
and the covenants contained herein, the Company and Indemnitee do hereby covenant and agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>A.</B></TD><TD STYLE="text-align: justify"><B>DEFINITIONS</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Definitions</U>.
The following terms shall have the meanings defined below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Expenses</I></B> shall
include, without limitation, damages, judgments, fines, penalties, settlements and costs, attorneys&rsquo; fees and disbursements and
costs of attachment or similar bond, investigations, and any other expenses paid or incurred in connection with investigating, defending,
being a witness in, participating in (including on appeal), or preparing for any of the foregoing in, any Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Indemnifiable Event</I></B>
means any event or occurrence that takes place either before or after the execution of this Agreement, related to the fact that Indemnitee
is or was a director or an officer of the Company, or is or was serving at the request of the Company as a director or officer of another
corporation, partnership, joint venture or other entity, or related to anything done or not done by Indemnitee in any such capacity, including,
but not limited to, neglect, breach of duty, error, misstatement, misleading statement or omission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Participant</I></B>
means a person who is a party to, or witness or participant (including on appeal) in, a Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Proceeding</I></B> means
any threatened, pending, or completed action, suit, arbitration or proceeding, or any inquiry, hearing or investigation, whether civil,
criminal, administrative, investigative or other, including appeal, in which Indemnitee may be or may have been involved as a party or
otherwise by reason of an Indemnifiable Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>B.</B></TD><TD STYLE="text-align: justify"><B>AGREEMENT TO INDEMNIFY</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>General
Agreement to Indemnify</U>. In the event Indemnitee was, is, or becomes a Participant in, or is threatened to be made a Participant in,
a Proceeding, the Company shall indemnify the Indemnitee from and against any and all Expenses which Indemnitee incurs or becomes obligated
to incur in connection with such Proceeding, whether or not such Proceeding proceeds to judgment or is settled or is otherwise brought
to a final disposition, to the fullest extent permitted by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Indemnification
of Expenses of Successful Party</U>. Notwithstanding any other provision of this Agreement, to the extent that Indemnitee has been successful
on the merits in defense of any Proceeding or in defense of any claim, issue or matter in such Proceeding, the Company shall indemnify
Indemnitee against all Expenses incurred in connection with such Proceeding or such claim, issue or matter, whether or not such Proceeding
proceeds to judgment or is settled or is otherwise brought to a final disposition, as the case may be, offset by the amount of cash, if
any, received by the Indemnitee resulting from his/her success therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Partial
Indemnification</U>. If Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for a portion of
Expenses, but not for the total amount of Expenses, the Company shall indemnify the Indemnitee for the portion of such Expenses to which
Indemnitee is entitled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <U>Exclusions</U>.
Notwithstanding anything in this Agreement to the contrary, Indemnitee shall not be entitled to indemnification under this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) to
the extent that payment is actually made to Indemnitee under a valid, enforceable and collectible insurance policy;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) to
the extent that Indemnitee is indemnified and actually paid other than pursuant to this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) subject
to Section C.2(a), in connection with a judicial action by or in the right of the Company, in respect of any claim, issue or matter as
to which the Indemnitee shall have been adjudicated by a court of competent jurisdiction, in a decision from which there is no further
right of appeal, to be liable for gross negligence or knowing or willful misconduct in the performance of his/her duty to the Company
unless and only to the extent that any court in which such action was brought shall determine upon application that, despite the adjudication
of liability but in view of all the circumstances of the case, the Indemnitee is fairly and reasonably entitled to indemnity for such
Expenses as such court shall deem proper;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) in
connection with any Proceeding initiated by Indemnitee against the Company, any director or officer of the Company or any other party,
and not by way of defense, unless (i) the Company has joined in or the Board of Directors has consented to the initiation of such Proceeding;
or (ii) the Proceeding is one to enforce indemnification rights under this Agreement or any applicable law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) brought
about by the dishonesty or fraud of the Indemnitee seeking payment hereunder; provided, however, that the Company shall indemnify Indemnitee
under this Agreement as to any claims upon which suit may be brought against him/her by reason of any alleged dishonesty on his/her part,
unless a judgment or other final adjudication thereof adverse to the Indemnitee establishes that he/she committed (i) acts of active and
deliberate dishonesty, (ii) with actual dishonest purpose and intent, and (iii) which acts were material to the cause of action so adjudicated;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) for
any judgment, fine or penalty which the Company is prohibited by applicable law from paying as indemnity;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) arising
out of Indemnitee&rsquo;s breach of an employment agreement with the Company (if any) or any other agreement with the Company or any of
its subsidiaries, or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) arising
out of Indemnitee&rsquo;s personal income tax payable on any salaries, bonuses, director&rsquo;s fees, including fees for attending meetings,
or gain on disposition of shares, options or restricted shares of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. <U>No
Employment Rights</U>. Nothing in this Agreement is intended to create in Indemnitee any right to continued employment with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. <U>Contribution</U>.
If the indemnification provided in this Agreement is unavailable and may not be paid to Indemnitee for any reason other than those set
forth in Section B.4, then the Company shall contribute to the amount of Expenses paid in settlement actually and reasonably incurred
and paid or payable by Indemnitee in such proportion as is appropriate to reflect (i) the relative benefits received by the Company on
the one hand and by the Indemnitee on the other hand from the transaction or events from which such Proceeding arose, and (ii) the relative
fault of the Company on the one hand and of the Indemnitee on the other hand in connection with the events which resulted in such Expenses,
as well as any other relevant equitable considerations. The relative fault of the Company on the one hand and of the Indemnitee on the
other hand shall be determined by reference to, among other things, the parties&rsquo; relative intent, knowledge, access to information
and opportunity to correct or prevent the circumstances resulting in such Expenses, judgments, fines or settlement amounts. The Company
agrees that it would not be just and equitable if contribution pursuant to this Section B.6 were determined by pro rata allocation or
any other method of allocation which does not take account of the foregoing equitable considerations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>C.</B></TD><TD STYLE="text-align: justify"><B>INDEMNIFICATION PROCESS</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Notice
and Cooperation by Indemnitee</U>. Indemnitee shall, as a condition precedent to his/her right to be indemnified under this Agreement,
give the Company notice in writing as soon as practicable of any claim made against Indemnitee for which indemnification will or could
be sought under this Agreement, provided that the delay of Indemnitee to give notice hereunder shall not prejudice any of Indemnitee&rsquo;s
rights hereunder, unless such delay results in the Company&rsquo;s forfeiture of substantive rights or defenses. Notice to the Company
shall be given in accordance with Section F.7 below. If, at the time of receipt of such notice, the Company has directors&rsquo; and officers&rsquo;
liability insurance policies in effect, the Company shall give prompt notice to its insurers of the Proceeding relating to the notice.
The Company shall thereafter take all necessary and desirable action to cause such insurers to pay, on behalf of Indemnitee, all Expenses
payable as a result of such Proceeding. In addition, Indemnitee shall give the Company such cooperation as the Company may reasonably
request and the Company shall give the Indemnitee such cooperation as the Indemnitee may reasonably request, including providing any documentation
or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee or the Company,
as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Indemnification
Payment</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <I>Advancement
of Expenses</I>. Indemnitee may submit a written request with reasonable particulars to the Company requesting that the Company advance
to Indemnitee all Expenses that may be reasonably incurred in advance by Indemnitee in connection with a Proceeding. The Company shall,
within ten (10) business days of receiving such a written request by Indemnitee, advance all requested Expenses to Indemnitee. Any excess
of the advanced Expenses over the actual Expenses will be repaid to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <I>Reimbursement
of Expenses</I>. To the extent Indemnitee has not requested any advanced payment of Expenses from the Company, Indemnitee shall be entitled
to receive reimbursement for the Expenses incurred in connection with a Proceeding from the Company as soon as practicable and, in any
event, within thirty (30) days after Indemnitee makes a written request to the Company for reimbursement unless the Company refers the
indemnification request to the Reviewing Party in compliance with Section C.2(c) below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <I>Determination
by the Reviewing Party</I>. If the Company reasonably believes that it is not obligated under this Agreement to indemnify the Indemnitee,
the Company shall, within ten (10) days after the Indemnitee&rsquo;s written request for an advancement or reimbursement of Expenses,
notify the Indemnitee that the request for advancement of Expenses or reimbursement of Expenses will be submitted to the Reviewing Party
(as hereinafter defined). The Reviewing Party shall make a determination on the request within thirty (30) days after the Indemnitee&rsquo;s
written request for an advancement or reimbursement of Expenses. Notwithstanding anything foregoing to the contrary, in the event the
Reviewing Party informs the Company that Indemnitee is not entitled to indemnification in connection with a Proceeding under this Agreement
or applicable law, the Company shall be entitled to be reimbursed by Indemnitee for all the Expenses previously advanced or otherwise
paid to Indemnitee in connection with such Proceeding; <U>provided</U>, <U>however</U>, that Indemnitee may bring a suit to enforce his/her
indemnification right in accordance with Section C.3 below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Suit
to Enforce Rights</U>. Regardless of any action by the Reviewing Party, if Indemnitee has not received full indemnification within thirty
(30) days after making a written demand in accordance with Section C.2 above or fifty (50) days if the Company submits a request for advancement
or reimbursement to the Reviewing Party under Section C.2(c), Indemnitee shall have the right to enforce its indemnification rights under
this Agreement by commencing litigation in any court of competent jurisdiction seeking a determination by the court or challenging any
determination by the Reviewing Party or with respect to any breach in any aspect of this Agreement. Any determination by the Reviewing
Party not challenged by Indemnitee and any judgment entered by the court shall be binding on the Company and Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <U>Assumption
of Defense</U>. In the event the Company is obligated under this Agreement to advance or bear any Expenses for any Proceeding against
Indemnitee, the Company shall be entitled to assume the defense of such Proceeding, with counsel approved by Indemnitee, upon delivery
to Indemnitee of written notice of its election to do so. After delivery of such notice, approval of such counsel by Indemnitee and the
retention of such counsel by the Company, the Company will not be liable to Indemnitee under this Agreement for any fees of counsel subsequently
incurred by Indemnitee with respect to the same Proceeding, unless (i) the employment of counsel by Indemnitee has been previously authorized
by the Company, (ii) Indemnitee shall have reasonably concluded, based on written advice of counsel, that there may be a conflict of interest
of such counsel retained by the Company between the Company and Indemnitee in the conduct of any such defense, or (iii) the Company ceases
or terminates the employment of such counsel with respect to the defense of such Proceeding, in any of which events the fees and expenses
of Indemnitee&rsquo;s counsel shall be at the expense of the Company. At all times, Indemnitee shall have the right to employ counsel
in any Proceeding at Indemnitee&rsquo;s expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. <U>Burden
of Proof and Presumptions</U>. Upon making a request for indemnification, Indemnitee shall be presumed to be entitled to indemnification
under this Agreement and the Company shall have the burden of proof to overcome that presumption in reaching any contrary determination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. <U>No
Settlement Without Consent</U>. Neither party to this Agreement shall settle any Proceeding in any manner that would impose any damage,
loss, penalty or limitation on Indemnitee without the other party&rsquo;s written consent. Neither the Company nor Indemnitee shall unreasonably
withhold its consent to any proposed settlement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7. <U>Company
Participation</U>. Subject to Section B.6, the Company shall not be liable to indemnify the Indemnitee under this Agreement with regard
to any judicial action if the Company was not given a reasonable and timely opportunity, at its expense, to participate in the defense,
conduct and/or settlement of such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8. <U>Reviewing
Party</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) For
purposes of this Agreement, the Reviewing Party with respect to each indemnification request of Indemnitee that is referred by the Company
pursuant to Section C.2(c) above shall be shall be (A) the Board of Directors by a majority vote of a quorum consisting of Disinterested
Directors (as hereinafter defined), or (B) if a quorum of the Board of Directors consisting of Disinterested Directors is not obtainable
or, even if obtainable, said Disinterested Directors so direct, by Independent Counsel in a written opinion to the Board of Directors,
a copy of which shall be delivered to Indemnitee. If the Reviewing Party determines that Indemnitee is entitled to indemnification, payment
to Indemnitee shall be made within ten (10) days after such determination. Indemnitee shall cooperate with the person, persons or entity
making such determination with respect to Indemnitee&rsquo;s entitlement to indemnification, including providing to such person, persons
or entity upon reasonable advance request any documentation or information which is not privileged or otherwise protected from disclosure
and which is reasonably available to Indemnitee and reasonably necessary to such determination. Any Independent Counsel or member of the
Board of Directors shall act reasonably and in good faith in making a determination under this Agreement of the Indemnitee&rsquo;s entitlement
to indemnification. Any reasonable costs or expenses (including reasonable attorneys&rsquo; fees and disbursements) incurred by Indemnitee
in so cooperating with the person, persons or entity making such determination shall be borne by the Company (irrespective of the determination
as to Indemnitee&rsquo;s entitlement to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom.
&ldquo;<U>Disinterested Director</U>&rdquo; means a director of the Company who is not and was not a party to the Proceeding in respect
of which indemnification is sought by Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) If
the determination of entitlement to indemnification is to be made by Independent Counsel, the Independent Counsel shall be selected as
provided in this Section C.8(b). The Independent Counsel shall be selected by Indemnitee (unless Indemnitee shall request that such selection
be made by the Board of Directors, in which event the proceeding sentence shall apply), and Indemnitee shall give written notice to the
Company advising it of the identity of the Independent Counsel so selected. In either event, Indemnitee or the Company, as the case may
be, may, within 10 days after such written notice of selection shall have been given, deliver to the Company or to Indemnitee, as the
case may be, a written objection to such selection; <I>provided</I>, <I>however</I>, that such objection may be asserted only on the ground
that the Independent Counsel so selected does not meet the requirements of &ldquo;<U>Independent Counsel</U>&rdquo; as defined in Section
C.8(d) of this Agreement, and the objection shall set forth with particularity the factual basis of such assertion. Absent a proper and
timely objection, the person so selected shall act as Independent Counsel. If a written objection is made and substantiated, the Independent
Counsel selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court has determined that such
objection is without merit. If, within 20 days after submission by Indemnitee of a written request for indemnification, no Independent
Counsel shall have been selected and not objected to, either the Company or Indemnitee may petition the a court of competent jurisdiction
for resolution of any objection which shall have been made by the Company or Indemnitee to the other&rsquo;s selection of Independent
Counsel and/or for the appointment as Independent Counsel of a person selected by the court or by such other person as the court shall
designate, and the person with respect to whom all objections are so resolved or the person so appointed shall act as Independent Counsel.
The Company shall pay any and all reasonable fees and expenses of Independent Counsel incurred by such Independent Counsel in connection
with acting under this Agreement, and the Company shall pay all reasonable fees and expenses incident to the procedures of this Section
C.8(b), regardless of the manner in which such Independent Counsel was selected or appointed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) In
making a determination with respect to entitlement to indemnification hereunder, the Reviewing Party shall presume that Indemnitee is
entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification in accordance with this Agreement,
and the Company shall have the burden of proof to overcome that presumption in connection with the making by any person, persons or entity
of any determination contrary to that presumption. The termination of any Proceeding or of any claim, issue or matter therein, by judgment,
order, settlement (with or without court approval), conviction, or upon a plea of <I>nolo contendere</I> or its equivalent, shall not
(except as otherwise expressly provided in this Agreement) of itself adversely affect the right of Indemnitee to indemnification or create
a presumption that Indemnitee did not act in good faith and in a manner which he/she reasonably believed to be in or not opposed to the
best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that his/her
conduct was unlawful. For purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith if Indemnitee&rsquo;s
action is based on the records or books of account of the Company and any other corporation, partnership, joint venture or other entity
of which Indemnitee is or was serving at the written request of the Company as a director, officer, employee, agent or fiduciary, including
financial statements, or on information supplied to Indemnitee by the officers and directors of the Company or such other corporation,
partnership, joint venture or other entity in the course of their duties, or on the advice of legal counsel for the Company or such other
corporation, partnership, joint venture or other entity or on information or records given or reports made to the Company or such other
corporation, partnership, joint venture or other entity by an independent certified public accountant or by an appraiser or other expert
selected with reasonable care by the Company or such other corporation, partnership, joint venture or other entity. In addition, the knowledge
and/or actions, or failure to act, of any director, officer, agent or employee of the Company or such other corporation, partnership,
joint venture or other entity shall not be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement.
The provisions of this Section C.8(c) shall not be deemed to be exclusive or to limit in any way the other circumstances in which the
Indemnitee may be deemed to have met the applicable standard of conduct set forth in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)  &ldquo;<B>Independent
Counsel</B>&rdquo; means a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither presently
is, nor in the past five (5) years has been, retained to represent (i) the Company or Indemnitee in any matter material to either such
party (other than with respect to matters concerning the Indemnitee under this Agreement, or of other indemnitees under similar indemnification
agreements), or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing,
the term &ldquo;Independent Counsel&rdquo; shall not include any person who, under the applicable standards of professional conduct then
prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee&rsquo;s
rights under this Agreement. The Company agrees to pay the reasonable fees of the Independent Counsel referred to above and to fully indemnify
such counsel against any and all Expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement
pursuant hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>D.</B></TD><TD STYLE="text-align: justify"><B>DIRECTOR AND OFFICER LIABILITY INSURANCE</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Maintenance
of Director and Officer Liability Insurance</U>. The Company shall at all times maintain a policy or policies of insurance with reputable
insurance companies providing the officers and directors of the Company with coverage for losses incurred in connection with their services
to the Company or to ensure the Company&rsquo;s performance of its indemnification obligations under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Coverage
of Indemnitee</U>. Within the Company&rsquo;s insurance policy or policies providing directors&rsquo; and officers&rsquo; liability insurance,
Indemnitee shall be covered by such policy or policies, in accordance with its or their terms, to the maximum extent of the coverage available
for any of the Company&rsquo;s directors or officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>E.</B></TD><TD STYLE="text-align: justify"><B>NON-EXCLUSIVITY; FEDERAL PREEMPTION; TERM</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Non-Exclusivity</U>.
The indemnification provided by this Agreement shall not be deemed exclusive of any rights to which Indemnitee may be entitled under the
Company&rsquo;s memorandum and articles of association, as may be amended from time to time, applicable law or any written agreement between
Indemnitee and the Company (including its subsidiaries and affiliates). The indemnification provided under this Agreement shall continue
to be available to Indemnitee for any action taken or not taken while serving in an indemnified capacity even though he/she may have ceased
to serve in any such capacity at the time of any Proceeding. To the extent that a change in the laws of the State of Nevada permits greater
indemnification by agreement than would be afforded under the Articles of Incorporation or this Agreement, it is the intent of the parties
hereto that Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Federal
Preemption</U>. Notwithstanding the foregoing, both the Company and Indemnitee acknowledge that in certain instances, U.S. federal law
or public policy may override applicable law and prohibit the Company from indemnifying its directors and officers under this Agreement
or otherwise. Such instances include, but are not limited to, the U.S. Securities and Exchange Commission&rsquo;s (the &ldquo;<B>SEC</B>&rdquo;)
position that indemnification for liabilities arising under certain Federal securities laws is not available. Indemnitee understands and
acknowledges that the Company has undertaken or may be required in the future to undertake with the SEC to submit the question of indemnification
to a court in certain circumstances for a determination of the Company&rsquo;s right under public policy to indemnify Indemnitee for liabilities
arising under certain Federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Company
Indemnitor of First Resort</U>. The Company hereby acknowledges that the Indemnitee may have certain rights to indemnification, advancement
of expenses and/or insurance provided by one or more of his or her employers and certain of their Affiliates (collectively, the &ldquo;<B>Employer
Indemnitors</B>&rdquo;). The Company hereby agrees (i) that it is the indemnitor of first resort (i.e., its obligations to Indemnitee
is primary and any obligation of the Employer Indemnitors to advance expenses or to provide indemnification for the same expenses or liabilities
incurred by Indemnitee are secondary), (ii) that it shall be required to advance the full amount of expenses incurred by Indemnitee and
shall be liable for the full amount of all expenses, judgments, penalties, fines and amounts paid in settlement by or on behalf of any
Indemnitee to the extent legally permitted and as required by this Agreement (or any agreement between the Company and such Indemnitee),
without regard to any rights such Indemnitee may have against the Employer Indemnitors and (iii) it irrevocably waives, relinquishes and
releases the Employer Indemnitors from any and all claims against the Employer Indemnitors for contribution, subrogation or any other
recovery of any kind in respect thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <U>Duration
of Agreement</U>. All agreements and obligations of the Company contained herein shall continue during the period Indemnitee is an officer
and/or a director of the Company (or is or was serving at the request of the Company as a director, officer, employee or agent of another
corporation, partnership, joint venture, trust or other enterprise) and shall continue thereafter so long as Indemnitee shall be subject
to any Proceeding by reason of his/her former or current capacity at the Company or any other enterprise at the Company&rsquo;s request,
whether or not he/she is acting or serving in any such capacity at the time any Expense is incurred for which indemnification can be provided
under this Agreement. This Agreement shall continue in effect regardless of whether Indemnitee continues to serve as an officer and/or
a director of the Company or any other enterprise at the Company&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>F.</B></TD><TD STYLE="text-align: justify"><B>MISCELLANEOUS</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Amendment
of this Agreement</U>. No supplement, modification, or amendment of this Agreement shall be binding unless executed in writing by the
parties hereto. No waiver of any of the provisions of this Agreement shall operate as a waiver of any other provisions (whether or not
similar), nor shall such waiver constitute a continuing waiver. Except as specifically provided in this Agreement, no failure to exercise
or any delay in exercising any right or remedy shall constitute a waiver.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Subrogation</U>.
In the event of payment to Indemnitee by the Company under this Agreement, the Company shall be subrogated to the extent of such payment
to all of the rights of recovery of Indemnitee, who shall execute all papers required and shall do everything that may be necessary to
secure such rights, including the execution of such documents necessary to enable the Company to bring suit to enforce such rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Assignment;
Binding Effect</U>. Neither this Agreement nor any of the rights or obligations hereunder may be assigned by either party hereto without
the prior written consent of the other party; except that the Company may, without such consent, assign all such rights and obligations
to a successor in interest to the Company which assumes all obligations of the Company under this Agreement. Notwithstanding the foregoing,
this Agreement shall be binding upon and inure to the benefit of and be enforceable by and against the parties hereto and the Company&rsquo;s
successors (including any direct or indirect successor by purchase, merger, consolidation, or otherwise to all or substantially all of
the business and/or assets of the Company) and assigns, as well as Indemnitee&rsquo;s spouses, heirs, and personal and legal representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <U>Severability
and Construction</U>. Nothing in this Agreement is intended to require or shall be construed as requiring the Company to do or fail to
do any act in violation of applicable law. The Company&rsquo;s inability, pursuant to a court order, to perform its obligations under
this Agreement shall not constitute a breach of this Agreement. In addition, if any portion of this Agreement shall be held by a court
of competent jurisdiction to be invalid, void, or otherwise unenforceable, the remaining provisions shall remain enforceable to the fullest
extent permitted by applicable law. The parties hereto acknowledge that they each have opportunities to have their respective counsels
review this Agreement. Accordingly, this Agreement shall be deemed to be the product of both of the parties hereto, and no ambiguity shall
be construed in favor of or against either of the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. <U>Counterparts</U>.
This Agreement may be executed in two counterparts, both of which taken together shall constitute one instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. <U>Governing
Law</U>. This agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed,
construed and interpreted in accordance with the laws of the State of Nevada, without giving effect to conflicts of law provisions thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7. <U>Notices</U>.
All notices, demands, and other communications required or permitted under this Agreement shall be made in writing and shall be deemed
to have been duly given if delivered by hand, against receipt, or mailed via postage prepaid, certified or registered mail, return receipt
requested, and addressed to the Company at:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.95pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.95pt; text-align: left">CleanCore Solutions, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.95pt; text-align: left">5920 South 118th Circle, Suite 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.95pt; text-align: left">Omaha, NE 68137</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt; text-align: justify">and to Indemnitee at his/her address
last known to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8. <U>Entire
Agreement</U>. This Agreement constitutes the entire agreement and supersedes all prior agreements and understandings, both written and
oral, between the parties with respect to the subject matter hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">IN WITNESS WHEREOF, the parties
hereto execute this Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B></B>&nbsp;</P></TD>
    <TD COLSPAN="2" STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt"><B>COMPANY:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; layout-grid-mode: line; width: 60%">&nbsp;</TD>
    <TD STYLE="text-align: left; layout-grid-mode: line; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: left; layout-grid-mode: line; width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">CleanCore Solutions, Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">/s/ Clayton Adams</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Clayton Adams</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt"><B>INDEMNITEE:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left; layout-grid-mode: line">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">/s/ Alexander Benjamin Spiro</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; layout-grid-mode: line">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Alexander Benjamin Spiro</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 229.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 229.5pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Options: NewSection Last; Value: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 229.5pt; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.11
<SEQUENCE>17
<FILENAME>ea025594401ex10-11_clean.htm
<DESCRIPTION>INDEMNIFICATION AGREEMENT, DATED SEPTEMBER 5, 2025, BETWEEN CLEANCORE SOLUTIONS, INC. AND TIM STEBBING
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.11</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDEMNIFICATION AGREEMENT </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">INDEMNIFICATION AGREEMENT
(this &ldquo;<B>Agreement</B>&rdquo;) is entered into as of September 5, 2025 by and between CleanCore Solutions, Inc., a Nevada corporation
(the &ldquo;<B>Company</B>&rdquo;) and the undersigned, a director and/or an officer of the Company (&ldquo;<B>Indemnitee</B>&rdquo;),
as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BACKGROUND</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board of Directors of
the Company (the &ldquo;<B>Board of Directors</B>&rdquo;) has determined that the inability to attract and retain highly competent persons
to serve the Company is detrimental to the best interests of the Company and its shareholders and that it is reasonable and necessary
for the Company to provide adequate protection to such persons against risks of claims and actions against them arising out of their services
to the corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AGREEMENT </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In consideration of the premises
and the covenants contained herein, the Company and Indemnitee do hereby covenant and agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A. DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Definitions</U>.
The following terms shall have the meanings defined below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Expenses</I></B> shall
include, without limitation, damages, judgments, fines, penalties, settlements and costs, attorneys&rsquo; fees and disbursements and
costs of attachment or similar bond, investigations, and any other expenses paid or incurred in connection with investigating, defending,
being a witness in, participating in (including on appeal), or preparing for any of the foregoing in, any Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Indemnifiable Event</I></B>
means any event or occurrence that takes place either before or after the execution of this Agreement, related to the fact that Indemnitee
is or was a director or an officer of the Company, or is or was serving at the request of the Company as a director or officer of another
corporation, partnership, joint venture or other entity, or related to anything done or not done by Indemnitee in any such capacity, including,
but not limited to, neglect, breach of duty, error, misstatement, misleading statement or omission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Participant</I></B>
means a person who is a party to, or witness or participant (including on appeal) in, a Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Proceeding</I></B> means
any threatened, pending, or completed action, suit, arbitration or proceeding, or any inquiry, hearing or investigation, whether civil,
criminal, administrative, investigative or other, including appeal, in which Indemnitee may be or may have been involved as a party or
otherwise by reason of an Indemnifiable Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>B. AGREEMENT
TO INDEMNIFY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>General
Agreement to Indemnify</U>. In the event Indemnitee was, is, or becomes a Participant in, or is threatened to be made a Participant in,
a Proceeding, the Company shall indemnify the Indemnitee from and against any and all Expenses which Indemnitee incurs or becomes obligated
to incur in connection with such Proceeding, whether or not such Proceeding proceeds to judgment or is settled or is otherwise brought
to a final disposition, to the fullest extent permitted by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Indemnification
of Expenses of Successful Party</U>. Notwithstanding any other provision of this Agreement, to the extent that Indemnitee has been successful
on the merits in defense of any Proceeding or in defense of any claim, issue or matter in such Proceeding, the Company shall indemnify
Indemnitee against all Expenses incurred in connection with such Proceeding or such claim, issue or matter, whether or not such Proceeding
proceeds to judgment or is settled or is otherwise brought to a final disposition, as the case may be, offset by the amount of cash, if
any, received by the Indemnitee resulting from his/her success therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Partial
Indemnification</U>. If Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for a portion of
Expenses, but not for the total amount of Expenses, the Company shall indemnify the Indemnitee for the portion of such Expenses to which
Indemnitee is entitled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <U>Exclusions</U>.
Notwithstanding anything in this Agreement to the contrary, Indemnitee shall not be entitled to indemnification under this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) to
the extent that payment is actually made to Indemnitee under a valid, enforceable and collectible insurance policy;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) to
the extent that Indemnitee is indemnified and actually paid other than pursuant to this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) subject
to Section C.2(a), in connection with a judicial action by or in the right of the Company, in respect of any claim, issue or matter as
to which the Indemnitee shall have been adjudicated by a court of competent jurisdiction, in a decision from which there is no further
right of appeal, to be liable for gross negligence or knowing or willful misconduct in the performance of his/her duty to the Company
unless and only to the extent that any court in which such action was brought shall determine upon application that, despite the adjudication
of liability but in view of all the circumstances of the case, the Indemnitee is fairly and reasonably entitled to indemnity for such
Expenses as such court shall deem proper;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) in
connection with any Proceeding initiated by Indemnitee against the Company, any director or officer of the Company or any other party,
and not by way of defense, unless (i) the Company has joined in or the Board of Directors has consented to the initiation of such Proceeding;
or (ii) the Proceeding is one to enforce indemnification rights under this Agreement or any applicable law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) brought
about by the dishonesty or fraud of the Indemnitee seeking payment hereunder; provided, however, that the Company shall indemnify Indemnitee
under this Agreement as to any claims upon which suit may be brought against him/her by reason of any alleged dishonesty on his/her part,
unless a judgment or other final adjudication thereof adverse to the Indemnitee establishes that he/she committed (i) acts of active and
deliberate dishonesty, (ii) with actual dishonest purpose and intent, and (iii) which acts were material to the cause of action so adjudicated;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) for
any judgment, fine or penalty which the Company is prohibited by applicable law from paying as indemnity;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) arising
out of Indemnitee&rsquo;s breach of an employment agreement with the Company (if any) or any other agreement with the Company or any of
its subsidiaries, or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) arising
out of Indemnitee&rsquo;s personal income tax payable on any salaries, bonuses, director&rsquo;s fees, including fees for attending meetings,
or gain on disposition of shares, options or restricted shares of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. <U>No
Employment Rights</U>. Nothing in this Agreement is intended to create in Indemnitee any right to continued employment with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. <U>Contribution</U>.
If the indemnification provided in this Agreement is unavailable and may not be paid to Indemnitee for any reason other than those set
forth in Section B.4, then the Company shall contribute to the amount of Expenses paid in settlement actually and reasonably incurred
and paid or payable by Indemnitee in such proportion as is appropriate to reflect (i) the relative benefits received by the Company on
the one hand and by the Indemnitee on the other hand from the transaction or events from which such Proceeding arose, and (ii) the relative
fault of the Company on the one hand and of the Indemnitee on the other hand in connection with the events which resulted in such Expenses,
as well as any other relevant equitable considerations. The relative fault of the Company on the one hand and of the Indemnitee on the
other hand shall be determined by reference to, among other things, the parties&rsquo; relative intent, knowledge, access to information
and opportunity to correct or prevent the circumstances resulting in such Expenses, judgments, fines or settlement amounts. The Company
agrees that it would not be just and equitable if contribution pursuant to this Section B.6 were determined by pro rata allocation or
any other method of allocation which does not take account of the foregoing equitable considerations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>C. INDEMNIFICATION PROCESS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Notice
and Cooperation by Indemnitee</U>. Indemnitee shall, as a condition precedent to his/her right to be indemnified under this Agreement,
give the Company notice in writing as soon as practicable of any claim made against Indemnitee for which indemnification will or could
be sought under this Agreement, provided that the delay of Indemnitee to give notice hereunder shall not prejudice any of Indemnitee&rsquo;s
rights hereunder, unless such delay results in the Company&rsquo;s forfeiture of substantive rights or defenses. Notice to the Company
shall be given in accordance with Section F.7 below. If, at the time of receipt of such notice, the Company has directors&rsquo; and officers&rsquo;
liability insurance policies in effect, the Company shall give prompt notice to its insurers of the Proceeding relating to the notice.
The Company shall thereafter take all necessary and desirable action to cause such insurers to pay, on behalf of Indemnitee, all Expenses
payable as a result of such Proceeding. In addition, Indemnitee shall give the Company such cooperation as the Company may reasonably
request and the Company shall give the Indemnitee such cooperation as the Indemnitee may reasonably request, including providing any documentation
or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee or the Company,
as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Indemnification
Payment</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <I>Advancement
of Expenses</I>. Indemnitee may submit a written request with reasonable particulars to the Company requesting that the Company advance
to Indemnitee all Expenses that may be reasonably incurred in advance by Indemnitee in connection with a Proceeding. The Company shall,
within ten (10) business days of receiving such a written request by Indemnitee, advance all requested Expenses to Indemnitee. Any excess
of the advanced Expenses over the actual Expenses will be repaid to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <I>Reimbursement
of Expenses</I>. To the extent Indemnitee has not requested any advanced payment of Expenses from the Company, Indemnitee shall be entitled
to receive reimbursement for the Expenses incurred in connection with a Proceeding from the Company as soon as practicable and, in any
event, within thirty (30) days after Indemnitee makes a written request to the Company for reimbursement unless the Company refers the
indemnification request to the Reviewing Party in compliance with Section C.2(c) below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <I>Determination
by the Reviewing Party</I>. If the Company reasonably believes that it is not obligated under this Agreement to indemnify the Indemnitee,
the Company shall, within ten (10) days after the Indemnitee&rsquo;s written request for an advancement or reimbursement of Expenses,
notify the Indemnitee that the request for advancement of Expenses or reimbursement of Expenses will be submitted to the Reviewing Party
(as hereinafter defined). The Reviewing Party shall make a determination on the request within thirty (30) days after the Indemnitee&rsquo;s
written request for an advancement or reimbursement of Expenses. Notwithstanding anything foregoing to the contrary, in the event the
Reviewing Party informs the Company that Indemnitee is not entitled to indemnification in connection with a Proceeding under this Agreement
or applicable law, the Company shall be entitled to be reimbursed by Indemnitee for all the Expenses previously advanced or otherwise
paid to Indemnitee in connection with such Proceeding; <U>provided</U>, <U>however</U>, that Indemnitee may bring a suit to enforce his/her
indemnification right in accordance with Section C.3 below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Suit
to Enforce Rights</U>. Regardless of any action by the Reviewing Party, if Indemnitee has not received full indemnification within thirty
(30) days after making a written demand in accordance with Section C.2 above or fifty (50) days if the Company submits a request for advancement
or reimbursement to the Reviewing Party under Section C.2(c), Indemnitee shall have the right to enforce its indemnification rights under
this Agreement by commencing litigation in any court of competent jurisdiction seeking a determination by the court or challenging any
determination by the Reviewing Party or with respect to any breach in any aspect of this Agreement. Any determination by the Reviewing
Party not challenged by Indemnitee and any judgment entered by the court shall be binding on the Company and Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <U>Assumption
of Defense</U>. In the event the Company is obligated under this Agreement to advance or bear any Expenses for any Proceeding against
Indemnitee, the Company shall be entitled to assume the defense of such Proceeding, with counsel approved by Indemnitee, upon delivery
to Indemnitee of written notice of its election to do so. After delivery of such notice, approval of such counsel by Indemnitee and the
retention of such counsel by the Company, the Company will not be liable to Indemnitee under this Agreement for any fees of counsel subsequently
incurred by Indemnitee with respect to the same Proceeding, unless (i) the employment of counsel by Indemnitee has been previously authorized
by the Company, (ii) Indemnitee shall have reasonably concluded, based on written advice of counsel, that there may be a conflict of interest
of such counsel retained by the Company between the Company and Indemnitee in the conduct of any such defense, or (iii) the Company ceases
or terminates the employment of such counsel with respect to the defense of such Proceeding, in any of which events the fees and expenses
of Indemnitee&rsquo;s counsel shall be at the expense of the Company. At all times, Indemnitee shall have the right to employ counsel
in any Proceeding at Indemnitee&rsquo;s expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. <U>Burden
of Proof and Presumptions</U>. Upon making a request for indemnification, Indemnitee shall be presumed to be entitled to indemnification
under this Agreement and the Company shall have the burden of proof to overcome that presumption in reaching any contrary determination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. <U>No
Settlement Without Consent</U>. Neither party to this Agreement shall settle any Proceeding in any manner that would impose any damage,
loss, penalty or limitation on Indemnitee without the other party&rsquo;s written consent. Neither the Company nor Indemnitee shall unreasonably
withhold its consent to any proposed settlement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7. <U>Company
Participation</U>. Subject to Section B.6, the Company shall not be liable to indemnify the Indemnitee under this Agreement with regard
to any judicial action if the Company was not given a reasonable and timely opportunity, at its expense, to participate in the defense,
conduct and/or settlement of such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8. <U>Reviewing
Party</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) For
purposes of this Agreement, the Reviewing Party with respect to each indemnification request of Indemnitee that is referred by the Company
pursuant to Section C.2(c) above shall be shall be (A) the Board of Directors by a majority vote of a quorum consisting of Disinterested
Directors (as hereinafter defined), or (B) if a quorum of the Board of Directors consisting of Disinterested Directors is not obtainable
or, even if obtainable, said Disinterested Directors so direct, by Independent Counsel in a written opinion to the Board of Directors,
a copy of which shall be delivered to Indemnitee. If the Reviewing Party determines that Indemnitee is entitled to indemnification, payment
to Indemnitee shall be made within ten (10) days after such determination. Indemnitee shall cooperate with the person, persons or entity
making such determination with respect to Indemnitee&rsquo;s entitlement to indemnification, including providing to such person, persons
or entity upon reasonable advance request any documentation or information which is not privileged or otherwise protected from disclosure
and which is reasonably available to Indemnitee and reasonably necessary to such determination. Any Independent Counsel or member of the
Board of Directors shall act reasonably and in good faith in making a determination under this Agreement of the Indemnitee&rsquo;s entitlement
to indemnification. Any reasonable costs or expenses (including reasonable attorneys&rsquo; fees and disbursements) incurred by Indemnitee
in so cooperating with the person, persons or entity making such determination shall be borne by the Company (irrespective of the determination
as to Indemnitee&rsquo;s entitlement to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom.
&ldquo;<U>Disinterested Director</U>&rdquo; means a director of the Company who is not and was not a party to the Proceeding in respect
of which indemnification is sought by Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) If
the determination of entitlement to indemnification is to be made by Independent Counsel, the Independent Counsel shall be selected as
provided in this Section C.8(b). The Independent Counsel shall be selected by Indemnitee (unless Indemnitee shall request that such selection
be made by the Board of Directors, in which event the proceeding sentence shall apply), and Indemnitee shall give written notice to the
Company advising it of the identity of the Independent Counsel so selected. In either event, Indemnitee or the Company, as the case may
be, may, within 10 days after such written notice of selection shall have been given, deliver to the Company or to Indemnitee, as the
case may be, a written objection to such selection; <I>provided</I>, <I>however</I>, that such objection may be asserted only on the ground
that the Independent Counsel so selected does not meet the requirements of &ldquo;<U>Independent Counsel</U>&rdquo; as defined in Section
C.8(d) of this Agreement, and the objection shall set forth with particularity the factual basis of such assertion. Absent a proper and
timely objection, the person so selected shall act as Independent Counsel. If a written objection is made and substantiated, the Independent
Counsel selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court has determined that such
objection is without merit. If, within 20 days after submission by Indemnitee of a written request for indemnification, no Independent
Counsel shall have been selected and not objected to, either the Company or Indemnitee may petition the a court of competent jurisdiction
for resolution of any objection which shall have been made by the Company or Indemnitee to the other&rsquo;s selection of Independent
Counsel and/or for the appointment as Independent Counsel of a person selected by the court or by such other person as the court shall
designate, and the person with respect to whom all objections are so resolved or the person so appointed shall act as Independent Counsel.
The Company shall pay any and all reasonable fees and expenses of Independent Counsel incurred by such Independent Counsel in connection
with acting under this Agreement, and the Company shall pay all reasonable fees and expenses incident to the procedures of this Section
C.8(b), regardless of the manner in which such Independent Counsel was selected or appointed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) In
making a determination with respect to entitlement to indemnification hereunder, the Reviewing Party shall presume that Indemnitee is
entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification in accordance with this Agreement,
and the Company shall have the burden of proof to overcome that presumption in connection with the making by any person, persons or entity
of any determination contrary to that presumption. The termination of any Proceeding or of any claim, issue or matter therein, by judgment,
order, settlement (with or without court approval), conviction, or upon a plea of <I>nolo contendere</I> or its equivalent, shall not
(except as otherwise expressly provided in this Agreement) of itself adversely affect the right of Indemnitee to indemnification or create
a presumption that Indemnitee did not act in good faith and in a manner which he/she reasonably believed to be in or not opposed to the
best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that his/her
conduct was unlawful. For purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith if Indemnitee&rsquo;s
action is based on the records or books of account of the Company and any other corporation, partnership, joint venture or other entity
of which Indemnitee is or was serving at the written request of the Company as a director, officer, employee, agent or fiduciary, including
financial statements, or on information supplied to Indemnitee by the officers and directors of the Company or such other corporation,
partnership, joint venture or other entity in the course of their duties, or on the advice of legal counsel for the Company or such other
corporation, partnership, joint venture or other entity or on information or records given or reports made to the Company or such other
corporation, partnership, joint venture or other entity by an independent certified public accountant or by an appraiser or other expert
selected with reasonable care by the Company or such other corporation, partnership, joint venture or other entity. In addition, the knowledge
and/or actions, or failure to act, of any director, officer, agent or employee of the Company or such other corporation, partnership,
joint venture or other entity shall not be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement.
The provisions of this Section C.8(c) shall not be deemed to be exclusive or to limit in any way the other circumstances in which the
Indemnitee may be deemed to have met the applicable standard of conduct set forth in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) &nbsp;&ldquo;<B>Independent
Counsel</B>&rdquo; means a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither presently
is, nor in the past five (5) years has been, retained to represent (i) the Company or Indemnitee in any matter material to either such
party (other than with respect to matters concerning the Indemnitee under this Agreement, or of other indemnitees under similar indemnification
agreements), or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing,
the term &ldquo;Independent Counsel&rdquo; shall not include any person who, under the applicable standards of professional conduct then
prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee&rsquo;s
rights under this Agreement. The Company agrees to pay the reasonable fees of the Independent Counsel referred to above and to fully indemnify
such counsel against any and all Expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement
pursuant hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>D. DIRECTOR AND OFFICER LIABILITY INSURANCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Maintenance
of Director and Officer Liability Insurance</U>. The Company shall at all times maintain a policy or policies of insurance with reputable
insurance companies providing the officers and directors of the Company with coverage for losses incurred in connection with their services
to the Company or to ensure the Company&rsquo;s performance of its indemnification obligations under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Coverage
of Indemnitee</U>. Within the Company&rsquo;s insurance policy or policies providing directors&rsquo; and officers&rsquo; liability insurance,
Indemnitee shall be covered by such policy or policies, in accordance with its or their terms, to the maximum extent of the coverage available
for any of the Company&rsquo;s directors or officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>E. NON-EXCLUSIVITY; FEDERAL PREEMPTION;
TERM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Non-Exclusivity</U>.
The indemnification provided by this Agreement shall not be deemed exclusive of any rights to which Indemnitee may be entitled under the
Company&rsquo;s memorandum and articles of association, as may be amended from time to time, applicable law or any written agreement between
Indemnitee and the Company (including its subsidiaries and affiliates). The indemnification provided under this Agreement shall continue
to be available to Indemnitee for any action taken or not taken while serving in an indemnified capacity even though he/she may have ceased
to serve in any such capacity at the time of any Proceeding. To the extent that a change in the laws of the State of Nevada permits greater
indemnification by agreement than would be afforded under the Articles of Incorporation or this Agreement, it is the intent of the parties
hereto that Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Federal
Preemption</U>. Notwithstanding the foregoing, both the Company and Indemnitee acknowledge that in certain instances, U.S. federal law
or public policy may override applicable law and prohibit the Company from indemnifying its directors and officers under this Agreement
or otherwise. Such instances include, but are not limited to, the U.S. Securities and Exchange Commission&rsquo;s (the &ldquo;<B>SEC</B>&rdquo;)
position that indemnification for liabilities arising under certain Federal securities laws is not available. Indemnitee understands and
acknowledges that the Company has undertaken or may be required in the future to undertake with the SEC to submit the question of indemnification
to a court in certain circumstances for a determination of the Company&rsquo;s right under public policy to indemnify Indemnitee for liabilities
arising under certain Federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Company
Indemnitor of First Resort</U>. The Company hereby acknowledges that the Indemnitee may have certain rights to indemnification, advancement
of expenses and/or insurance provided by one or more of his or her employers and certain of their Affiliates (collectively, the &ldquo;<B>Employer
Indemnitors</B>&rdquo;). The Company hereby agrees (i) that it is the indemnitor of first resort (i.e., its obligations to Indemnitee
is primary and any obligation of the Employer Indemnitors to advance expenses or to provide indemnification for the same expenses or liabilities
incurred by Indemnitee are secondary), (ii) that it shall be required to advance the full amount of expenses incurred by Indemnitee and
shall be liable for the full amount of all expenses, judgments, penalties, fines and amounts paid in settlement by or on behalf of any
Indemnitee to the extent legally permitted and as required by this Agreement (or any agreement between the Company and such Indemnitee),
without regard to any rights such Indemnitee may have against the Employer Indemnitors and (iii) it irrevocably waives, relinquishes and
releases the Employer Indemnitors from any and all claims against the Employer Indemnitors for contribution, subrogation or any other
recovery of any kind in respect thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <U>Duration
of Agreement</U>. All agreements and obligations of the Company contained herein shall continue during the period Indemnitee is an officer
and/or a director of the Company (or is or was serving at the request of the Company as a director, officer, employee or agent of another
corporation, partnership, joint venture, trust or other enterprise) and shall continue thereafter so long as Indemnitee shall be subject
to any Proceeding by reason of his/her former or current capacity at the Company or any other enterprise at the Company&rsquo;s request,
whether or not he/she is acting or serving in any such capacity at the time any Expense is incurred for which indemnification can be provided
under this Agreement. This Agreement shall continue in effect regardless of whether Indemnitee continues to serve as an officer and/or
a director of the Company or any other enterprise at the Company&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>F. MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Amendment
of this Agreement</U>. No supplement, modification, or amendment of this Agreement shall be binding unless executed in writing by the
parties hereto. No waiver of any of the provisions of this Agreement shall operate as a waiver of any other provisions (whether or not
similar), nor shall such waiver constitute a continuing waiver. Except as specifically provided in this Agreement, no failure to exercise
or any delay in exercising any right or remedy shall constitute a waiver.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Subrogation</U>.
In the event of payment to Indemnitee by the Company under this Agreement, the Company shall be subrogated to the extent of such payment
to all of the rights of recovery of Indemnitee, who shall execute all papers required and shall do everything that may be necessary to
secure such rights, including the execution of such documents necessary to enable the Company to bring suit to enforce such rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Assignment;
Binding Effect</U>. Neither this Agreement nor any of the rights or obligations hereunder may be assigned by either party hereto without
the prior written consent of the other party; except that the Company may, without such consent, assign all such rights and obligations
to a successor in interest to the Company which assumes all obligations of the Company under this Agreement. Notwithstanding the foregoing,
this Agreement shall be binding upon and inure to the benefit of and be enforceable by and against the parties hereto and the Company&rsquo;s
successors (including any direct or indirect successor by purchase, merger, consolidation, or otherwise to all or substantially all of
the business and/or assets of the Company) and assigns, as well as Indemnitee&rsquo;s spouses, heirs, and personal and legal representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <U>Severability
and Construction</U>. Nothing in this Agreement is intended to require or shall be construed as requiring the Company to do or fail to
do any act in violation of applicable law. The Company&rsquo;s inability, pursuant to a court order, to perform its obligations under
this Agreement shall not constitute a breach of this Agreement. In addition, if any portion of this Agreement shall be held by a court
of competent jurisdiction to be invalid, void, or otherwise unenforceable, the remaining provisions shall remain enforceable to the fullest
extent permitted by applicable law. The parties hereto acknowledge that they each have opportunities to have their respective counsels
review this Agreement. Accordingly, this Agreement shall be deemed to be the product of both of the parties hereto, and no ambiguity shall
be construed in favor of or against either of the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. <U>Counterparts</U>.
This Agreement may be executed in two counterparts, both of which taken together shall constitute one instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. <U>Governing
Law</U>. This agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed,
construed and interpreted in accordance with the laws of the State of Nevada, without giving effect to conflicts of law provisions thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7. <U>Notices</U>.
All notices, demands, and other communications required or permitted under this Agreement shall be made in writing and shall be deemed
to have been duly given if delivered by hand, against receipt, or mailed via postage prepaid, certified or registered mail, return receipt
requested, and addressed to the Company at:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.95pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">CleanCore Solutions, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5920 South 118th Circle, Suite 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Omaha, NE 68137</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">and to Indemnitee at his/her address
last known to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8. <U>Entire
Agreement</U>. This Agreement constitutes the entire agreement and supersedes all prior agreements and understandings, both written and
oral, between the parties with respect to the subject matter hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">IN WITNESS WHEREOF, the parties
hereto execute this Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 229.5pt; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; layout-grid-mode: line"><FONT STYLE="font-size: 10pt"><B>COMPANY: </B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; layout-grid-mode: line">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">CleanCore Solutions, Inc.</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; layout-grid-mode: line">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="text-align: left; layout-grid-mode: line; width: 5%"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; layout-grid-mode: line; width: 35%"><FONT STYLE="font-size: 10pt">/s/ Clayton Adams</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Clayton Adams</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="text-align: justify; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Chief Executive Officer </FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; layout-grid-mode: line">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; layout-grid-mode: line"><FONT STYLE="font-size: 10pt"><B>INDEMNITEE: </B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; layout-grid-mode: line">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">/s/ Tim Stebbing</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Tim Stebbing</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 229.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 229.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">9</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 229.5pt; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 229.5pt; text-align: justify"><U><BR></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.12
<SEQUENCE>18
<FILENAME>ea025594401ex10-12_clean.htm
<DESCRIPTION>EXECUTIVE CONSULTING AGREEMENT, DATED SEPTEMBER 5, 2025, BETWEEN CLEANCORE SOLUTIONS, INC. AND MARCO MARGIOTTA
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.12</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Executive
Consulting Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">EXECUTIVE CONSULTING AGREEMENT,
dated as of September 5, 2025 (this &ldquo;<B>Agreement</B>&rdquo;), between <B>CLEANCORE SOLUTIONS, INC.</B>, a Nevada corporation (the
&ldquo;<B>Company</B>&rdquo;), and <B>Marco Margiotta</B>, an individual (&ldquo;<B>Consultant</B>&rdquo;). Each of the Company and Executive
are sometimes referred to in this individually as a &ldquo;<B>Party</B>&rdquo; and, collectively, as the &ldquo;<B>Parties</B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; text-decoration: none; vertical-align: baseline">1.
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps; vertical-align: baseline; background-color: white"><B><U>Services</U></B></FONT><FONT STYLE="text-decoration: none">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1 The
Company hereby engages Consultant, and Consultant hereby accepts such engagement, as an independent contractor to provide certain services
to the Company on the terms and conditions set forth in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.2 Consultant
shall serve as the Chief Investment Officer of the Company, including such duties and responsibilities to the Company as are customary
for such a position in companies comparable to the Company, and as are reasonably assigned, delegated, and determined with notice from
time to time by the Company to Consultant (the &ldquo;<B>Services</B>&rdquo;) and the Consultant shall report to the Chief Executive Officer
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.3 The
Company shall provide Consultant with access to its premises, materials, information, and systems to the extent necessary for the performance
of the Services. The Company shall furnish, at Consultant&rsquo;s reasonable request, the materials, equipment, and other resources necessary
to perform the Services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.4 Consultant
shall comply with all reasonable rules and procedures communicated to Consultant in writing by the Company, including those related to
safety, security, and confidentiality.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.5 Consultant
shall devote such amount of Consultant&rsquo;s business time, attention, and effort as is reasonably necessary to perform the Services
in a diligent and timely manner and to fulfill the duties and responsibilities of the Chief Investment Officer of the Company. While it
is anticipated that the Services may require a significant portion of Consultant&rsquo;s business time, nothing in this Agreement shall
be construed to require Consultant to devote all of Consultant&rsquo;s business time exclusively to the Company, nor to restrict Consultant
from engaging in other business activities, provided that such activities do not interfere with the performance of the Services or create
a conflict of interest with the Company. The Parties acknowledge and agree that Consultant shall at all times retain discretion over the
allocation of Consultant&rsquo;s business time, subject to the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U STYLE="text-decoration: none">2. </U></FONT><U><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps; vertical-align: baseline; background-color: white"><B>Term</B></FONT></U>.
The term of this Agreement shall commence the date hereof and shall end the third (3<SUP>rd</SUP>) anniversary of the date hereof, unless
earlier terminated in accordance with Section 8 (the &ldquo;<B>Term</B>&rdquo;). Any extension of the Term will be subject to mutual written
agreement between Consultant and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal; vertical-align: baseline"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; text-decoration: none; vertical-align: baseline">3.
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps; vertical-align: baseline; background-color: white"><B><U>Fees
and expenses</U></B></FONT><FONT STYLE="text-decoration: none">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1 <U>Base
Compensation</U>. The Company shall pay to the Consultant base compensation for all services to be rendered by the Consultant under this
Agreement at the rate of $640,000 per year (the &ldquo;<B>Base Compensation</B>&rdquo;), which Base Compensation shall be paid in approximately
equal monthly installments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2 <U>Annual
and Special Bonus</U>. Commencing in the calendar year 2025 and each calendar year thereafter during Executive&rsquo;s employment with
the Company, the Executive will be eligible to receive a discretionary annual performance bonus in the amount of $100,000 (the &ldquo;<B>Annual
Bonus</B>&rdquo;), which Annual Bonus shall not be prorated, but instead, paid in full. The Annual Bonus shall be payable in full if the
Company maintains a digital asset treasury strategy for six months. Any Annual Bonus earned by the Executive pursuant to this Section
shall be paid to the Executive in accordance with Company policies, less authorized deductions and required withholding obligations, and
is payable within 15 days following the achievement of the aforementioned milestone. In addition to the Annual Bonus, the Executive will
receive an additional special bonus of $100,000 on the date that the Company&rsquo;s digital asset treasury has total digital assets that
equal to, or in excess of, $100 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.3 <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U>Equity
Awards</U></FONT>. <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U STYLE="text-decoration: none">Within</U></FONT>
five (5) business days following the date that the number of available shares under the Company&rsquo;s Equity Incentive Plan, as amended
(the &ldquo;<B>Plan</B>&rdquo;) is increased such that there are a sufficient number of shares available to make the award contemplated
by this Section 3.3, the Company shall issue to the Consultant 4,000,000 shares of restricted stock under the Plan, which shall vest in
full on the date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.4 The
Company shall be responsible for any travel or other costs or expenses incurred by Consultant in connection with the performance of the
Services, provided that all such expenses must be documented and receive the Company&rsquo;s prior written approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; text-decoration: none; vertical-align: baseline">4.
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps; vertical-align: baseline; background-color: white"><B><U>Relationship
of the parties</U></B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1 Consultant
is an independent contractor of the Company, and this Agreement shall not be construed to create any association, partnership, joint venture,
employment, or agency relationship between Consultant and the Company for any purpose. Consultant has no authority (and shall not hold
himself out as having authority) to bind the Company and Consultant shall not make any agreements or representations on the Company&rsquo;s
behalf without the Company&rsquo;s prior written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2 Without
limiting <FONT STYLE="font-family: Times New Roman, Times, Serif">Section 4.1</FONT>, Consultant will not be eligible to participate in
any vacation, group medical or life insurance, disability, profit sharing or retirement benefits, or any other fringe benefits or benefit
plans offered by the Company to its employees, and the Company will not be responsible for withholding or paying any income, payroll,
Social Security, or other federal, state, or local taxes, making any insurance contributions, including for unemployment or disability,
or obtaining workers&rsquo; compensation insurance on Consultant&rsquo;s behalf. Consultant shall be responsible for, and shall indemnify
the Company against, all such taxes or contributions, including penalties and interest. Any persons employed or engaged by Consultant
in connection with the performance of the Services shall be Consultant&rsquo;s employees or contractors and Consultant shall be fully
responsible for them and indemnify the Company against any claims made by or on behalf of any such employee or contractor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal; vertical-align: baseline"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U STYLE="text-decoration: none">5. </U></FONT><U><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps; vertical-align: baseline; background-color: white"><B>Intellectual
property rights</B></FONT></U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1 All
documents, work product, and other materials that are delivered under this Agreement and all other writings, technology, inventions, discoveries,
processes, techniques, methods, ideas, concepts, research, proposals, and materials, and all other work product of any nature whatsoever,
that are created, prepared, produced, authored, edited, modified, conceived, or reduced to practice in the course of performing the Services
(&ldquo;<B>Work Product</B>&rdquo;), and all patents, copyrights, trademarks (together with the goodwill symbolized thereby), trade secrets,
know-how, and other confidential or proprietary information, and other intellectual property rights (collectively &ldquo;<B>Intellectual
Property Rights</B>&rdquo;) therein, shall be owned exclusively by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2 Consultant
shall not disclose to any third party the nature or details of any Work Product inventions without the prior written consent of the Company.
Any patent application for or application for registration of any Intellectual Property Rights in any Work Product that Consultant may
file during the Term or thereafter will belong to the Company, and Consultant hereby irrevocably assigns to the Company, for no additional
consideration, Consultant&rsquo;s entire right, title, and interest in and to such application, all Intellectual Property Rights disclosed
or claimed therein, and any patent or registration issuing or resulting therefrom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3 As
between Consultant and the Company, the Company is, and will remain, the sole and exclusive owner of all right, title, and interest in
and to any documents, specifications, data, know-how, methodologies, software, and other materials provided to you by the Company (&ldquo;<B>Company
Materials</B>&rdquo;), and all Intellectual Property Rights therein. Consultant has no right or license to reproduce or use any Company
Materials except solely during the Term to the extent necessary to perform Consultant&rsquo;s obligations under this Agreement. All other
rights in and to the Company Materials are expressly reserved by the Company. Consultant has no right or license to use the Company&rsquo;s
trademarks, service marks, trade names, logos, symbols, or brand names without its prior written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U STYLE="text-decoration: none">6. </U></FONT><U><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps; vertical-align: baseline; background-color: white"><B>Confidentiality</B></FONT></U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.1 Consultant
acknowledges that Consultant will have access to information that is treated as confidential and proprietary by the Company, whether spoken,
written, printed, electronic, or in any other form or medium (collectively, the &ldquo;<B>Confidential Information</B>&rdquo;). Any Confidential
Information that Consultant accesses or develops in connection with the Services, including but not limited to any Work Product, shall
be subject to the terms and conditions of this clause. Consultant agrees to treat all Confidential Information as strictly confidential,
not to disclose Confidential Information or permit it to be disclosed, in whole or part, to any third party without the prior written
consent of the Company in each instance, and not to use any Confidential Information for any purpose except as required in the performance
of the Services. Consultant shall notify the Company immediately in the event Consultant become aware of any loss or disclosure of any
Confidential Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.2 Confidential
Information shall not include information that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) is
or becomes generally available to the public other than through Consultant&rsquo;s breach of this Agreement; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) is
communicated to Consultant by a third party that had no confidentiality obligations with respect to such information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.3 Nothing
herein shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) be
construed to prevent disclosure of Confidential Information as may be required by applicable law or regulation, or pursuant to the valid
order of a court of competent jurisdiction or an authorized government agency, provided that the disclosure does not exceed the extent
of disclosure required by such law, regulation, or order; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) prohibit
or restrict Consultant (or Consultant&rsquo;s attorney) from initiating communications directly with, responding to an inquiry from, providing
testimony before, or otherwise participating in any investigation or proceeding conducted by the Securities and Exchange Commission (&ldquo;<B>SEC</B>&rdquo;),
the Financial Industry Regulatory Authority (&ldquo;<B>FINRA</B>&rdquo;), any other self-regulatory organization, or any other federal
or state regulatory authority regarding possible securities law violations without the need for permission from or notice to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.4 Notice
of Immunity Under the Defend Trade Secrets Act of 2016 (&ldquo;<B>DTSA</B>&rdquo;). Notwithstanding any other provision of this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) Consultant
will not be held criminally or civilly liable under any federal or state trade secret law for any disclosure of a trade secret that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(i) is
made: (A) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (B) solely
for the purpose of reporting or investigating a suspected violation of law; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(ii) is
made in a complaint or other document that is filed under seal in a lawsuit or other proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) If
Consultant files a lawsuit for retaliation by the Company for reporting a suspected violation of law, Consultant may disclose the Company&rsquo;s
trade secrets to Consultant&rsquo;s attorney and use the trade secret information in the court proceeding if Consultant:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(i) files
any document containing the trade secret under seal; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(ii) does
not disclose the trade secret, except pursuant to court order.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U STYLE="text-decoration: none">7. </U></FONT><U><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps; vertical-align: baseline; background-color: white"><B>Representations
and warranties</B></FONT></U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.1 Consultant
represents and warrants to the Company that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) Consultant
has the right to enter into this Agreement, to grant the rights granted herein, and to perform fully all of Consultant&rsquo;s obligations
in this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) Consultant&rsquo;s
entering into this Agreement with the Company and Consultant&rsquo;s performance of the Services do not and will not conflict with or
result in any breach or default under any other agreement to which Consultant is subject;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) Consultant
has the required skill, experience, and qualifications to perform the Services, Consultant shall perform the Services in a professional
and workmanlike manner in accordance with generally recognized industry standards for similar services, and Consultant shall devote sufficient
resources to ensure that the Services are performed in a timely and reliable manner;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) Consultant
shall perform the Services in compliance with all applicable federal, state, and local laws and regulations, including by maintaining
all licenses, permits, and registrations required to perform the Services; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) the
Company will receive good and valid title to all Work Product, free and clear of all encumbrances and liens of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.2 The
Company hereby represents and warrants to Consultant that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) it
has the full right, power, and authority to enter into this Agreement and to perform its obligations hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) the
execution of this Agreement by its representative whose signature is set forth at the end of this Agreement has been duly authorized by
all necessary corporate action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U STYLE="text-decoration: none">8. </U></FONT><U><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps; vertical-align: baseline; background-color: white"><B>Termination</B></FONT></U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.1 During
the Term, the Company shall not terminate this Agreement without <B>Cause</B>, which shall mean (a) willful failure to perform the Services,
(b) willful failure to comply with any valid and legal directive of the Chief Executive Officer or the board of directors of the Company,
(c) engagement in dishonesty, illegal conduct, or gross misconduct, which is in each case, injurious to the Company or its affiliates,
(d) embezzlement or misappropriation or fraud, whether or not related to the Consultant&rsquo;s engagement with the Company, (e) conviction
of or plea of guilty or nolo contendere to a crime that constitutes a felony or a crime that constitutes a misdemeanor involving moral
turpitude, (f) material violation of the Company&rsquo;s written policies or codes of conduct, including written policies relating to
discrimination, harassment, performance of illegal or unethical activities and ethical misconduct, (g) material breach of any material
obligation under this Agreement or any other written agreement between the Consultant and the Company and (h) engagement in conduct that
brings or is reasonably likely to bring the Company negative publicity or into public disgrace or embarrassment. Consultant may terminate
this Agreement for &ldquo;<B>Good Reason</B>&rdquo;, which shall mean the occurrence of any of the following events without Consultant&rsquo;s
prior written consent: (a) a material reduction in the Consultant&rsquo;s RSU Award, (b) a relocation of the Consultant&rsquo;s principal
work location by more than thirty (30) miles unless the Consultant is a remote worker at such time in accordance with this Agreement,
(c) any material breach by the Company of any material provision of this Agreement or any material provision of any other agreement between
the Consultant and the Company (d) the Company&rsquo;s failure to obtain an agreement from any successor to the Company to assume and
agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no succession
had taken place, except where such assumption occurs by operation of law, (e) a material, adverse change in the Consultant&rsquo;s s title,
authority, duties, or responsibilities (other than temporarily while the Consultant is physically or mentally incapacitated or as required
by applicable law), provided that Consultant gives written notice to the Company of the event constituting Good Reason and the Company
fails to cure such event within thirty (30) days of receiving such notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.2
If the Company terminates this Agreement without Cause, or if Consultant terminates this Agreement for Good Reason, any unvested RSUs
under any outstanding Award Agreement shall vest effective immediately and the Consultant shall continue to receive his base compensation
for the remainder of the Term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.3 The
terms and conditions of this clause shall survive the expiration or termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U STYLE="text-decoration: none">9. </U></FONT><U><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps; vertical-align: baseline; background-color: white"><B>Assignment</B></FONT></U>.
Neither Party may assign any rights or delegate or subcontract any obligations under this Agreement without the other Party&rsquo;s prior
written consent. Any assignment in violation of the foregoing shall be deemed null and void. Subject to the limits on assignment stated
above, this Agreement will inure to the benefit of, be binding on, and be enforceable against each of the Parties hereto and their respective
successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">10. <FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps; vertical-align: baseline; background-color: white"><B><U>Remedies</U></B></FONT>.
In the event either Party breaches or threatens to breach <FONT STYLE="font-family: Times New Roman, Times, Serif">any provisions </FONT>of
this Agreement, each Party hereby acknowledges and agrees that money damages would not afford an adequate remedy and that the other Party
shall be entitled to seek a temporary or permanent injunction or other equitable relief restraining such breach or threatened breach from
any court of competent jurisdiction without the necessity of showing any actual damages. Any equitable relief shall be in addition to,
not in lieu of, legal remedies, monetary damages, or other available forms of relief.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">11. <FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps; vertical-align: baseline; background-color: white"><B><U>Governing
law, jurisdiction, and venue</U></B></FONT>. This Agreement and all related documents, including all schedules attached hereto and all
matters arising out of or relating to this Agreement and the Services provided hereunder, whether sounding in contract, tort, or statute,
for all purposes shall be governed by and construed in accordance with the laws of the State of Nevada, without giving effect to any conflict
of laws principles that would cause the laws of any other jurisdiction to apply. Each party hereto irrevocably consents to the jurisdiction
of the courts of the state of Nevada or the U.S. federal court of the District of Nevada, in either case, located in Las Vegas in connection
with any action, suit or other proceeding arising out of or relating to this Agreement or any action taken or omitted hereunder, and waives
any claim of forum non conveniens and any objections as to laying of venue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U STYLE="text-decoration: none">12. </U></FONT><U><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps; vertical-align: baseline; background-color: white"><B>Miscellaneous</B></FONT></U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.1 Consultant
shall not export, directly or indirectly, any technical data acquired from the Company, or any products utilizing any such data, to any
country in violation of any applicable export laws or regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.2 All
notices, requests, consents, claims, demands, waivers, and other communications hereunder (each, a &ldquo;<B>Notice</B>&rdquo;) shall
be in writing and addressed to the Parties at the addresses set forth on the signature page of this Agreement (or to such other address
that may be designated by the receiving party from time to time in accordance with this Section). All Notices shall be delivered by personal
delivery, nationally recognized overnight courier (with all fees prepaid), email, or certified or registered mail (in each case, return
receipt requested, postage prepaid). Except as otherwise provided in this Agreement, a Notice is effective only if: (a) the receiving
party has received the Notice; and (b) the party giving the Notice has complied with the requirements of this Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.3 This
Agreement, together with any other documents incorporated herein by reference and related exhibits and schedules, constitutes the sole
and entire agreement of the Parties to this Agreement with respect to the subject matter contained herein, and supersedes all prior and
contemporaneous understandings, agreements, representations, and warranties, both written and oral, with respect to such subject matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.4 This
Agreement may only be amended, modified, or supplemented by an agreement in writing signed by each party hereto, and any of the terms
thereof may be waived, only by a written document signed by each party to this Agreement or, in the case of waiver, by the party or parties
waiving compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.5 If
any term or provision of this Agreement is invalid, illegal, or unenforceable in any jurisdiction, such invalidity, illegality, or unenforceability
shall not affect any other term or provision of this Agreement or invalidate or render unenforceable such term or provision in any other
jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.6 This
Agreement may be executed in multiple counterparts and by electronic signature, each of which shall be deemed an original and all of which
together shall constitute one instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Parties
hereto have caused this Agreement to be duly executed and delivered as of the date first set forth above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CleanCore Solutions, Inc.</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Clayton Adams</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clayton Adams</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5920 S. 118<SUP>th</SUP> Circle</FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Omaha NE 68137</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Marco Margiotta</B></FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Marco Margiotta</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 33%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>19
<FILENAME>ea025594401ex10-13_clean.htm
<DESCRIPTION>INDEMNIFICATION AGREEMENT, DATED SEPTEMBER 5, 2025, BETWEEN CLEANCORE SOLUTIONS, INC. AND MARCO MARGIOTTA
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.13</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDEMNIFICATION AGREEMENT </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">INDEMNIFICATION AGREEMENT
(this &ldquo;<B>Agreement</B>&rdquo;) is entered into as of September 5, 2025 by and between CleanCore Solutions, Inc., a Nevada corporation
(the &ldquo;<B>Company</B>&rdquo;) and the undersigned, a director and/or an officer of the Company (&ldquo;<B>Indemnitee</B>&rdquo;),
as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BACKGROUND</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">The Board of Directors of
the Company (the &ldquo;<B>Board of Directors</B>&rdquo;) has determined that the inability to attract and retain highly competent persons
to serve the Company is detrimental to the best interests of the Company and its shareholders and that it is reasonable and necessary
for the Company to provide adequate protection to such persons against risks of claims and actions against them arising out of their services
to the corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AGREEMENT </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">In consideration of the premises
and the covenants contained herein, the Company and Indemnitee do hereby covenant and agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A. &nbsp;DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Definitions</U>.
The following terms shall have the meanings defined below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Expenses</I></B> shall
include, without limitation, damages, judgments, fines, penalties, settlements and costs, attorneys&rsquo; fees and disbursements and
costs of attachment or similar bond, investigations, and any other expenses paid or incurred in connection with investigating, defending,
being a witness in, participating in (including on appeal), or preparing for any of the foregoing in, any Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Indemnifiable Event</I></B>
means any event or occurrence that takes place either before or after the execution of this Agreement, related to the fact that Indemnitee
is or was a director or an officer of, or consultant to, the Company, or is or was serving at the request of the Company as a director
or officer of another corporation, partnership, joint venture or other entity, or related to anything done or not done by Indemnitee in
any such capacity, including, but not limited to, neglect, breach of duty, error, misstatement, misleading statement or omission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Participant</I></B>
means a person who is a party to, or witness or participant (including on appeal) in, a Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Proceeding</I></B> means
any threatened, pending, or completed action, suit, arbitration or proceeding, or any inquiry, hearing or investigation, whether civil,
criminal, administrative, investigative or other, including appeal, in which Indemnitee may be or may have been involved as a party or
otherwise by reason of an Indemnifiable Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>B. AGREEMENT
TO INDEMNIFY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>General
Agreement to Indemnify</U>. In the event Indemnitee was, is, or becomes a Participant in, or is threatened to be made a Participant in,
a Proceeding, the Company shall indemnify the Indemnitee from and against any and all Expenses which Indemnitee incurs or becomes obligated
to incur in connection with such Proceeding, whether or not such Proceeding proceeds to judgment or is settled or is otherwise brought
to a final disposition, to the fullest extent permitted by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Indemnification
of Expenses of Successful Party</U>. Notwithstanding any other provision of this Agreement, to the extent that Indemnitee has been successful
on the merits in defense of any Proceeding or in defense of any claim, issue or matter in such Proceeding, the Company shall indemnify
Indemnitee against all Expenses incurred in connection with such Proceeding or such claim, issue or matter, whether or not such Proceeding
proceeds to judgment or is settled or is otherwise brought to a final disposition, as the case may be, offset by the amount of cash, if
any, received by the Indemnitee resulting from his/her success therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Partial
Indemnification</U>. If Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for a portion of
Expenses, but not for the total amount of Expenses, the Company shall indemnify the Indemnitee for the portion of such Expenses to which
Indemnitee is entitled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <U>Exclusions</U>.
Notwithstanding anything in this Agreement to the contrary, Indemnitee shall not be entitled to indemnification under this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) to
the extent that payment is actually made to Indemnitee under a valid, enforceable and collectible insurance policy;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) to
the extent that Indemnitee is indemnified and actually paid other than pursuant to this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) subject
to Section C.2(a), in connection with a judicial action by or in the right of the Company, in respect of any claim, issue or matter as
to which the Indemnitee shall have been adjudicated by a court of competent jurisdiction, in a decision from which there is no further
right of appeal, to be liable for gross negligence or knowing or willful misconduct in the performance of his/her duty to the Company
unless and only to the extent that any court in which such action was brought shall determine upon application that, despite the adjudication
of liability but in view of all the circumstances of the case, the Indemnitee is fairly and reasonably entitled to indemnity for such
Expenses as such court shall deem proper;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) in
connection with any Proceeding initiated by Indemnitee against the Company, any director or officer of the Company or any other party,
and not by way of defense, unless (i) the Company has joined in or the Board of Directors has consented to the initiation of such Proceeding;
or (ii) the Proceeding is one to enforce indemnification rights under this Agreement or any applicable law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) brought
about by the dishonesty or fraud of the Indemnitee seeking payment hereunder; provided, however, that the Company shall indemnify Indemnitee
under this Agreement as to any claims upon which suit may be brought against him/her by reason of any alleged dishonesty on his/her part,
unless a judgment or other final adjudication thereof adverse to the Indemnitee establishes that he/she committed (i) acts of active and
deliberate dishonesty, (ii) with actual dishonest purpose and intent, and (iii) which acts were material to the cause of action so adjudicated;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) for
any judgment, fine or penalty which the Company is prohibited by applicable law from paying as indemnity;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) arising
out of Indemnitee&rsquo;s breach of an employment agreement with the Company (if any) or any other agreement with the Company or any of
its subsidiaries, or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) arising
out of Indemnitee&rsquo;s personal income tax payable on any salaries, bonuses, director&rsquo;s fees, including fees for attending meetings,
or gain on disposition of shares, options or restricted shares of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. <U>No
Employment Rights</U>. Nothing in this Agreement is intended to create in Indemnitee any right to continued employment with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. <U>Contribution</U>.
If the indemnification provided in this Agreement is unavailable and may not be paid to Indemnitee for any reason other than those set
forth in Section B.4, then the Company shall contribute to the amount of Expenses paid in settlement actually and reasonably incurred
and paid or payable by Indemnitee in such proportion as is appropriate to reflect (i) the relative benefits received by the Company on
the one hand and by the Indemnitee on the other hand from the transaction or events from which such Proceeding arose, and (ii) the relative
fault of the Company on the one hand and of the Indemnitee on the other hand in connection with the events which resulted in such Expenses,
as well as any other relevant equitable considerations. The relative fault of the Company on the one hand and of the Indemnitee on the
other hand shall be determined by reference to, among other things, the parties&rsquo; relative intent, knowledge, access to information
and opportunity to correct or prevent the circumstances resulting in such Expenses, judgments, fines or settlement amounts. The Company
agrees that it would not be just and equitable if contribution pursuant to this Section B.6 were determined by pro rata allocation or
any other method of allocation which does not take account of the foregoing equitable considerations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>C. INDEMNIFICATION PROCESS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Notice
and Cooperation by Indemnitee</U>. Indemnitee shall, as a condition precedent to his/her right to be indemnified under this Agreement,
give the Company notice in writing as soon as practicable of any claim made against Indemnitee for which indemnification will or could
be sought under this Agreement, provided that the delay of Indemnitee to give notice hereunder shall not prejudice any of Indemnitee&rsquo;s
rights hereunder, unless such delay results in the Company&rsquo;s forfeiture of substantive rights or defenses. Notice to the Company
shall be given in accordance with Section F.7 below. If, at the time of receipt of such notice, the Company has directors&rsquo; and officers&rsquo;
liability insurance policies in effect, the Company shall give prompt notice to its insurers of the Proceeding relating to the notice.
The Company shall thereafter take all necessary and desirable action to cause such insurers to pay, on behalf of Indemnitee, all Expenses
payable as a result of such Proceeding. In addition, Indemnitee shall give the Company such cooperation as the Company may reasonably
request and the Company shall give the Indemnitee such cooperation as the Indemnitee may reasonably request, including providing any documentation
or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee or the Company,
as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Indemnification
Payment</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <I>Advancement
of Expenses</I>. Indemnitee may submit a written request with reasonable particulars to the Company requesting that the Company advance
to Indemnitee all Expenses that may be reasonably incurred in advance by Indemnitee in connection with a Proceeding. The Company shall,
within ten (10) business days of receiving such a written request by Indemnitee, advance all requested Expenses to Indemnitee. Any excess
of the advanced Expenses over the actual Expenses will be repaid to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <I>Reimbursement
of Expenses</I>. To the extent Indemnitee has not requested any advanced payment of Expenses from the Company, Indemnitee shall be entitled
to receive reimbursement for the Expenses incurred in connection with a Proceeding from the Company as soon as practicable and, in any
event, within thirty (30) days after Indemnitee makes a written request to the Company for reimbursement unless the Company refers the
indemnification request to the Reviewing Party in compliance with Section C.2(c) below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <I>Determination
by the Reviewing Party</I>. If the Company reasonably believes that it is not obligated under this Agreement to indemnify the Indemnitee,
the Company shall, within ten (10) days after the Indemnitee&rsquo;s written request for an advancement or reimbursement of Expenses,
notify the Indemnitee that the request for advancement of Expenses or reimbursement of Expenses will be submitted to the Reviewing Party
(as hereinafter defined). The Reviewing Party shall make a determination on the request within thirty (30) days after the Indemnitee&rsquo;s
written request for an advancement or reimbursement of Expenses. Notwithstanding anything foregoing to the contrary, in the event the
Reviewing Party informs the Company that Indemnitee is not entitled to indemnification in connection with a Proceeding under this Agreement
or applicable law, the Company shall be entitled to be reimbursed by Indemnitee for all the Expenses previously advanced or otherwise
paid to Indemnitee in connection with such Proceeding; <U>provided</U>, <U>however</U>, that Indemnitee may bring a suit to enforce his/her
indemnification right in accordance with Section C.3 below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Suit
to Enforce Rights</U>. Regardless of any action by the Reviewing Party, if Indemnitee has not received full indemnification within thirty
(30) days after making a written demand in accordance with Section C.2 above or fifty (50) days if the Company submits a request for advancement
or reimbursement to the Reviewing Party under Section C.2(c), Indemnitee shall have the right to enforce its indemnification rights under
this Agreement by commencing litigation in any court of competent jurisdiction seeking a determination by the court or challenging any
determination by the Reviewing Party or with respect to any breach in any aspect of this Agreement. Any determination by the Reviewing
Party not challenged by Indemnitee and any judgment entered by the court shall be binding on the Company and Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <U>Assumption
of Defense</U>. In the event the Company is obligated under this Agreement to advance or bear any Expenses for any Proceeding against
Indemnitee, the Company shall be entitled to assume the defense of such Proceeding, with counsel approved by Indemnitee, upon delivery
to Indemnitee of written notice of its election to do so. After delivery of such notice, approval of such counsel by Indemnitee and the
retention of such counsel by the Company, the Company will not be liable to Indemnitee under this Agreement for any fees of counsel subsequently
incurred by Indemnitee with respect to the same Proceeding, unless (i) the employment of counsel by Indemnitee has been previously authorized
by the Company, (ii) Indemnitee shall have reasonably concluded, based on written advice of counsel, that there may be a conflict of interest
of such counsel retained by the Company between the Company and Indemnitee in the conduct of any such defense, or (iii) the Company ceases
or terminates the employment of such counsel with respect to the defense of such Proceeding, in any of which events the fees and expenses
of Indemnitee&rsquo;s counsel shall be at the expense of the Company. At all times, Indemnitee shall have the right to employ counsel
in any Proceeding at Indemnitee&rsquo;s expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. <U>Burden
of Proof and Presumptions</U>. Upon making a request for indemnification, Indemnitee shall be presumed to be entitled to indemnification
under this Agreement and the Company shall have the burden of proof to overcome that presumption in reaching any contrary determination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. <U>No
Settlement Without Consent</U>. Neither party to this Agreement shall settle any Proceeding in any manner that would impose any damage,
loss, penalty or limitation on Indemnitee without the other party&rsquo;s written consent. Neither the Company nor Indemnitee shall unreasonably
withhold its consent to any proposed settlement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7. <U>Company
Participation</U>. Subject to Section B.6, the Company shall not be liable to indemnify the Indemnitee under this Agreement with regard
to any judicial action if the Company was not given a reasonable and timely opportunity, at its expense, to participate in the defense,
conduct and/or settlement of such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8. <U>Reviewing
Party</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) For
purposes of this Agreement, the Reviewing Party with respect to each indemnification request of Indemnitee that is referred by the Company
pursuant to Section C.2(c) above shall be shall be (A) the Board of Directors by a majority vote of a quorum consisting of Disinterested
Directors (as hereinafter defined), or (B) if a quorum of the Board of Directors consisting of Disinterested Directors is not obtainable
or, even if obtainable, said Disinterested Directors so direct, by Independent Counsel in a written opinion to the Board of Directors,
a copy of which shall be delivered to Indemnitee. If the Reviewing Party determines that Indemnitee is entitled to indemnification, payment
to Indemnitee shall be made within ten (10) days after such determination. Indemnitee shall cooperate with the person, persons or entity
making such determination with respect to Indemnitee&rsquo;s entitlement to indemnification, including providing to such person, persons
or entity upon reasonable advance request any documentation or information which is not privileged or otherwise protected from disclosure
and which is reasonably available to Indemnitee and reasonably necessary to such determination. Any Independent Counsel or member of the
Board of Directors shall act reasonably and in good faith in making a determination under this Agreement of the Indemnitee&rsquo;s entitlement
to indemnification. Any reasonable costs or expenses (including reasonable attorneys&rsquo; fees and disbursements) incurred by Indemnitee
in so cooperating with the person, persons or entity making such determination shall be borne by the Company (irrespective of the determination
as to Indemnitee&rsquo;s entitlement to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom.
&ldquo;<U>Disinterested Director</U>&rdquo; means a director of the Company who is not and was not a party to the Proceeding in respect
of which indemnification is sought by Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) If
the determination of entitlement to indemnification is to be made by Independent Counsel, the Independent Counsel shall be selected as
provided in this Section C.8(b). The Independent Counsel shall be selected by Indemnitee (unless Indemnitee shall request that such selection
be made by the Board of Directors, in which event the proceeding sentence shall apply), and Indemnitee shall give written notice to the
Company advising it of the identity of the Independent Counsel so selected. In either event, Indemnitee or the Company, as the case may
be, may, within 10 days after such written notice of selection shall have been given, deliver to the Company or to Indemnitee, as the
case may be, a written objection to such selection; <I>provided</I>, <I>however</I>, that such objection may be asserted only on the ground
that the Independent Counsel so selected does not meet the requirements of &ldquo;<U>Independent Counsel</U>&rdquo; as defined in Section
C.8(d) of this Agreement, and the objection shall set forth with particularity the factual basis of such assertion. Absent a proper and
timely objection, the person so selected shall act as Independent Counsel. If a written objection is made and substantiated, the Independent
Counsel selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court has determined that such
objection is without merit. If, within 20 days after submission by Indemnitee of a written request for indemnification, no Independent
Counsel shall have been selected and not objected to, either the Company or Indemnitee may petition the a court of competent jurisdiction
for resolution of any objection which shall have been made by the Company or Indemnitee to the other&rsquo;s selection of Independent
Counsel and/or for the appointment as Independent Counsel of a person selected by the court or by such other person as the court shall
designate, and the person with respect to whom all objections are so resolved or the person so appointed shall act as Independent Counsel.
The Company shall pay any and all reasonable fees and expenses of Independent Counsel incurred by such Independent Counsel in connection
with acting under this Agreement, and the Company shall pay all reasonable fees and expenses incident to the procedures of this Section
C.8(b), regardless of the manner in which such Independent Counsel was selected or appointed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) In
making a determination with respect to entitlement to indemnification hereunder, the Reviewing Party shall presume that Indemnitee is
entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification in accordance with this Agreement,
and the Company shall have the burden of proof to overcome that presumption in connection with the making by any person, persons or entity
of any determination contrary to that presumption. The termination of any Proceeding or of any claim, issue or matter therein, by judgment,
order, settlement (with or without court approval), conviction, or upon a plea of <I>nolo contendere</I> or its equivalent, shall not
(except as otherwise expressly provided in this Agreement) of itself adversely affect the right of Indemnitee to indemnification or create
a presumption that Indemnitee did not act in good faith and in a manner which he/she reasonably believed to be in or not opposed to the
best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that his/her
conduct was unlawful. For purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith if Indemnitee&rsquo;s
action is based on the records or books of account of the Company and any other corporation, partnership, joint venture or other entity
of which Indemnitee is or was serving at the written request of the Company as a director, officer, employee, agent or fiduciary, including
financial statements, or on information supplied to Indemnitee by the officers and directors of the Company or such other corporation,
partnership, joint venture or other entity in the course of their duties, or on the advice of legal counsel for the Company or such other
corporation, partnership, joint venture or other entity or on information or records given or reports made to the Company or such other
corporation, partnership, joint venture or other entity by an independent certified public accountant or by an appraiser or other expert
selected with reasonable care by the Company or such other corporation, partnership, joint venture or other entity. In addition, the knowledge
and/or actions, or failure to act, of any director, officer, agent or employee of the Company or such other corporation, partnership,
joint venture or other entity shall not be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement.
The provisions of this Section C.8(c) shall not be deemed to be exclusive or to limit in any way the other circumstances in which the
Indemnitee may be deemed to have met the applicable standard of conduct set forth in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) &ldquo;<B>Independent
Counsel</B>&rdquo; means a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither presently
is, nor in the past five (5) years has been, retained to represent (i) the Company or Indemnitee in any matter material to either such
party (other than with respect to matters concerning the Indemnitee under this Agreement, or of other indemnitees under similar indemnification
agreements), or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing,
the term &ldquo;Independent Counsel&rdquo; shall not include any person who, under the applicable standards of professional conduct then
prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee&rsquo;s
rights under this Agreement. The Company agrees to pay the reasonable fees of the Independent Counsel referred to above and to fully indemnify
such counsel against any and all Expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement
pursuant hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>D. DIRECTOR AND OFFICER LIABILITY INSURANCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Maintenance
of Director and Officer Liability Insurance</U>. The Company shall at all times maintain a policy or policies of insurance with reputable
insurance companies providing the officers and directors of the Company with coverage for losses incurred in connection with their services
to the Company or to ensure the Company&rsquo;s performance of its indemnification obligations under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Coverage
of Indemnitee</U>. Within the Company&rsquo;s insurance policy or policies providing directors&rsquo; and officers&rsquo; liability insurance,
Indemnitee shall be covered by such policy or policies, in accordance with its or their terms, to the maximum extent of the coverage available
for any of the Company&rsquo;s directors or officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>E. NON-EXCLUSIVITY; FEDERAL PREEMPTION;
TERM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Non-Exclusivity</U>.
The indemnification provided by this Agreement shall not be deemed exclusive of any rights to which Indemnitee may be entitled under the
Company&rsquo;s memorandum and articles of association, as may be amended from time to time, applicable law or any written agreement between
Indemnitee and the Company (including its subsidiaries and affiliates). The indemnification provided under this Agreement shall continue
to be available to Indemnitee for any action taken or not taken while serving in an indemnified capacity even though he/she may have ceased
to serve in any such capacity at the time of any Proceeding. To the extent that a change in the laws of the State of Nevada permits greater
indemnification by agreement than would be afforded under the Articles of Incorporation or this Agreement, it is the intent of the parties
hereto that Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Federal
Preemption</U>. Notwithstanding the foregoing, both the Company and Indemnitee acknowledge that in certain instances, U.S. federal law
or public policy may override applicable law and prohibit the Company from indemnifying its directors and officers under this Agreement
or otherwise. Such instances include, but are not limited to, the U.S. Securities and Exchange Commission&rsquo;s (the &ldquo;<B>SEC</B>&rdquo;)
position that indemnification for liabilities arising under certain Federal securities laws is not available. Indemnitee understands and
acknowledges that the Company has undertaken or may be required in the future to undertake with the SEC to submit the question of indemnification
to a court in certain circumstances for a determination of the Company&rsquo;s right under public policy to indemnify Indemnitee for liabilities
arising under certain Federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Company
Indemnitor of First Resort</U>. The Company hereby acknowledges that the Indemnitee may have certain rights to indemnification, advancement
of expenses and/or insurance provided by one or more of his or her employers and certain of their Affiliates (collectively, the &ldquo;<B>Employer
Indemnitors</B>&rdquo;). The Company hereby agrees (i) that it is the indemnitor of first resort (i.e., its obligations to Indemnitee
is primary and any obligation of the Employer Indemnitors to advance expenses or to provide indemnification for the same expenses or liabilities
incurred by Indemnitee are secondary), (ii) that it shall be required to advance the full amount of expenses incurred by Indemnitee and
shall be liable for the full amount of all expenses, judgments, penalties, fines and amounts paid in settlement by or on behalf of any
Indemnitee to the extent legally permitted and as required by this Agreement (or any agreement between the Company and such Indemnitee),
without regard to any rights such Indemnitee may have against the Employer Indemnitors and (iii) it irrevocably waives, relinquishes and
releases the Employer Indemnitors from any and all claims against the Employer Indemnitors for contribution, subrogation or any other
recovery of any kind in respect thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <U>Duration
of Agreement</U>. All agreements and obligations of the Company contained herein shall continue during the period Indemnitee is an officer
and/or a director of the Company (or is or was serving at the request of the Company as a director, officer, employee or agent of another
corporation, partnership, joint venture, trust or other enterprise) and shall continue thereafter so long as Indemnitee shall be subject
to any Proceeding by reason of his/her former or current capacity at the Company or any other enterprise at the Company&rsquo;s request,
whether or not he/she is acting or serving in any such capacity at the time any Expense is incurred for which indemnification can be provided
under this Agreement. This Agreement shall continue in effect regardless of whether Indemnitee continues to serve as an officer and/or
a director of the Company or any other enterprise at the Company&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>F. MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Amendment
of this Agreement</U>. No supplement, modification, or amendment of this Agreement shall be binding unless executed in writing by the
parties hereto. No waiver of any of the provisions of this Agreement shall operate as a waiver of any other provisions (whether or not
similar), nor shall such waiver constitute a continuing waiver. Except as specifically provided in this Agreement, no failure to exercise
or any delay in exercising any right or remedy shall constitute a waiver.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Subrogation</U>.
In the event of payment to Indemnitee by the Company under this Agreement, the Company shall be subrogated to the extent of such payment
to all of the rights of recovery of Indemnitee, who shall execute all papers required and shall do everything that may be necessary to
secure such rights, including the execution of such documents necessary to enable the Company to bring suit to enforce such rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Assignment;
Binding Effect</U>. Neither this Agreement nor any of the rights or obligations hereunder may be assigned by either party hereto without
the prior written consent of the other party; except that the Company may, without such consent, assign all such rights and obligations
to a successor in interest to the Company which assumes all obligations of the Company under this Agreement. Notwithstanding the foregoing,
this Agreement shall be binding upon and inure to the benefit of and be enforceable by and against the parties hereto and the Company&rsquo;s
successors (including any direct or indirect successor by purchase, merger, consolidation, or otherwise to all or substantially all of
the business and/or assets of the Company) and assigns, as well as Indemnitee&rsquo;s spouses, heirs, and personal and legal representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <U>Severability
and Construction</U>. Nothing in this Agreement is intended to require or shall be construed as requiring the Company to do or fail to
do any act in violation of applicable law. The Company&rsquo;s inability, pursuant to a court order, to perform its obligations under
this Agreement shall not constitute a breach of this Agreement. In addition, if any portion of this Agreement shall be held by a court
of competent jurisdiction to be invalid, void, or otherwise unenforceable, the remaining provisions shall remain enforceable to the fullest
extent permitted by applicable law. The parties hereto acknowledge that they each have opportunities to have their respective counsels
review this Agreement. Accordingly, this Agreement shall be deemed to be the product of both of the parties hereto, and no ambiguity shall
be construed in favor of or against either of the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. <U>Counterparts</U>.
This Agreement may be executed in two counterparts, both of which taken together shall constitute one instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. <U>Governing
Law</U>. This agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed,
construed and interpreted in accordance with the laws of the State of Nevada, without giving effect to conflicts of law provisions thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7. <U>Notices</U>.
All notices, demands, and other communications required or permitted under this Agreement shall be made in writing and shall be deemed
to have been duly given if delivered by hand, against receipt, or mailed via postage prepaid, certified or registered mail, return receipt
requested, and addressed to the Company at:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.95pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">CleanCore Solutions, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5920 South 118th Circle, Suite 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Omaha, NE 68137</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt; text-align: justify">and to Indemnitee at his/her address
last known to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8. <U>Entire
Agreement</U>. This Agreement constitutes the entire agreement and supersedes all prior agreements and understandings, both written and
oral, between the parties with respect to the subject matter hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.6pt">IN WITNESS WHEREOF, the parties
hereto execute this Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 229.5pt; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; layout-grid-mode: line"><FONT STYLE="font-size: 10pt"><B>COMPANY: </B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; layout-grid-mode: line">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">CleanCore Solutions, Inc.</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; layout-grid-mode: line">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="text-align: left; layout-grid-mode: line; width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; layout-grid-mode: line; width: 35%"> <FONT STYLE="font-size: 10pt">/s/ Clayton Adams</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; layout-grid-mode: line"> <FONT STYLE="font-size: 10pt">Clayton Adams</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="text-align: justify; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Chief Executive Officer </FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; layout-grid-mode: line">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; layout-grid-mode: line"><FONT STYLE="font-size: 10pt"><B>INDEMNITEE: </B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; layout-grid-mode: line">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">/s/ Marco Margiotta</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Marco Margiotta</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 229.5pt; text-align: justify"><U><BR></U>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 229.5pt; text-align: justify"><U></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 229.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">9</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.14
<SEQUENCE>20
<FILENAME>ea025594401ex10-14_clean.htm
<DESCRIPTION>EXECUTIVE EMPLOYMENT AGREEMENT, DATED SEPTEMBER 5, 2025, BETWEEN CLEANCORE SOLUTIONS, INC. AND CLAYTON ADAMS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.14</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXECUTIVE EMPLOYMENT AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This EXECUTIVE EMPLOYMENT
AGREEMENT (the &ldquo;<B>Employment Agreement</B>&rdquo;) is made and entered into as of September 5, 2025, by and between <B>CLEANCORE
SOLUTIONS, INC.</B>, a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;), and <B>Clayton Adams</B>, an individual (the &ldquo;<B>Executive</B>&rdquo;).
The Company and the Executive are referred to herein from time to time on a collective basis as the &ldquo;<B>Parties</B>&rdquo; and each
on individual basis as a &ldquo;<B>Party</B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company wishes to secure
the services of the Executive as Chief Executive Officer of the Company upon the terms and conditions hereinafter set forth, and the Executive
wishes to render such services to the Company upon the terms and conditions hereinafter set forth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the mutual covenants, promises, and obligations set forth herein, the parties agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">1. </FONT><FONT STYLE="background-color: white"><U>Term</U></FONT>.
Subject to Section 5 of this Agreement, the Executive&rsquo;s initial term of employment hereunder shall be from the period
beginning on the date of this Agreement (the &ldquo;<B>Effective Date</B>&rdquo;) and ending on the third (3<SUP>rd</SUP>)
anniversary the Effective Date (the &ldquo;<B>Initial Term</B>&rdquo;). Thereafter, the Agreement shall be deemed to be
automatically extended, upon the same terms and conditions, for successive periods of one year, unless either party provides written
notice of its intention not to extend the term at least 30 days prior to the end of the Initial Term or one-year extension thereof.
The period during which the Executive is employed by the Company hereunder is hereinafter referred to as the &ldquo;<B>Employment
Term</B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">2. </FONT><FONT STYLE="background-color: white"><U>Position
and Duties</U></FONT>. During the Employment Term (as hereinafter defined), the Company shall employ Executive in the position
of Chief Executive Officer. The Executive accepts such employment and shall have such duties and responsibilities as are reasonably assigned,
delegated and determined as are customarily assigned to individuals serving in such position and such other duties consistent with the
Executive&rsquo;s title (with such other duties and/or offices in the Company and its affiliates as may be assigned from time to time
by the Company, or its Board of Directors and as agreed to by the Executive) and the Executive accepts such employment and agrees to perform
such duties. The Executive agrees to devote his full customary business time and energies to the business of the Company and/or its affiliates
and subsidiaries to perform his duties hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline; background-color: white"><U>Place
of Performance</U></FONT>. The Executive will perform his or her work duties for the Company primarily in Omaha, Nebraska. However, the
Executive shall undertake such occasional travel, within or outside the United States, as is reasonably necessary in the interests of
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">4. </FONT><FONT STYLE="background-color: white"><U>Compensation</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; vertical-align: baseline">4.1 <U>Base
Salary</U> The Company shall pay to the Executive a base salary for all services to be rendered by the Executive under this Employment Agreement
at the rate of $640,000 per year (the &ldquo;</FONT><FONT STYLE="vertical-align: baseline"><B>Base Salary</B><FONT STYLE="font-weight: normal">&rdquo;),
which Base Salary shall be paid in approximately equal installments (less applicable payroll deductions and taxes) in accordance with
the Company&rsquo;s normal payroll schedule, procedures and policies (which schedules, procedures and policies may be modified from time
to time in the Company&rsquo;s sole discretion), but not less frequently than monthly.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; vertical-align: baseline"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U>4.2 Signing,
Annual and Special Bonus</U></FONT>. Upon signing this Agreement, the Executive will receive a signing bonus in the amount of $400,000.
Commencing in the calendar year 2025 and each calendar year thereafter during Executive&rsquo;s employment with the Company, the Executive
will be eligible to receive a discretionary annual performance bonus in the amount of $100,000 (the &ldquo;<B>Annual Bonus</B>&rdquo;),
which <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U STYLE="text-decoration: none">Annual</U></FONT> Bonus
shall not be prorated, but instead, paid in full. The Annual Bonus shall be payable in full if the Company maintains a digital asset treasury
strategy for six months. Any Annual Bonus <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U STYLE="text-decoration: none">earned</U></FONT>
by the Executive pursuant to this Section shall be paid to the Executive in accordance with Company policies, less authorized deductions
and required withholding obligations, and is payable within 15 days following the achievement of the aforementioned milestone. In addition
to the Annual Bonus, the Executive will receive an additional special bonus of $100,000 on the date that the Company&rsquo;s digital asset
treasury has total digital assets that equal to, or in excess of, $100 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.3 <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U>Equity
Awards</U></FONT>. <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U STYLE="text-decoration: none">Within</U></FONT>
five (5) business days following the date that the number of available shares under the Company&rsquo;s Equity Incentive Plan, as amended
(the &ldquo;<B>Plan</B>&rdquo;) is increased such that there are a sufficient number of shares available to make the award contemplated
by this Section 4.3, the Company shall issue to the Executive 3,250,000 shares of restricted stock under the Plan, which shall vest in
full on the date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">4.4 <U>Fringe
Benefits and Perquisites</U></FONT>. <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U STYLE="text-decoration: none">During</U></FONT>
the Employment Term, the Executive shall be entitled to fringe benefits and perquisites <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U STYLE="text-decoration: none">consistent</U></FONT>
with those provided to similarly situated executives of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">4.5
<U>Employee Benefits</U></FONT>. <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U STYLE="text-decoration: none">During</U></FONT>
the Employment Term, the Executive shall be entitled to participate in all employee benefit plans, practices, and programs maintained
by the Company, as in effect from time to time (<FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">collectively</FONT>,
&ldquo;<B>Employee Benefit Plans</B>&rdquo;), on a basis which is no less favorable than is provided to other similarly situated executives
of the Company, to the extent consistent with applicable law and the terms of the applicable Employee Benefit Plans. The Company reserves
the right to amend or terminate any Employee Benefit Plans at any time in its sole discretion, subject to the terms of such Employee
Benefit Plan and applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">4.6
<U>Vacation; Paid Time Off</U></FONT>. During the Employment Term, the Executive shall be entitled to twenty (20) paid vacation days
per calendar year (prorated for partial years) in accordance with the Company&rsquo;s vacation <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">policies</FONT>,
as in effect from time to time. The Executive shall receive other paid time off in accordance <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">with</FONT>
the Company&rsquo;s policies for executive officers as such policies may exist from time to time and as required by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">4.7
<U>Business Expenses</U></FONT>. The Executive shall be entitled to reimbursement for all reasonable and necessary out-of-pocket <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">business</FONT>,
entertainment, and travel expenses incurred by the Executive in connection with the performance of the Executive&rsquo;s duties hereunder
in accordance with the Company&rsquo;s expense reimbursement policies and procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.8 <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U>Indemnification</U></FONT>.
The Company shall indemnify and hold the Executive harmless to the fullest extent applicable to any other <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U STYLE="text-decoration: none">officer</U></FONT>
or director of the Company/to the maximum extent permitted under applicable law and the Company&rsquo;s bylaws for acts and omissions
in the Executive&rsquo;s capacity as an officer, director, or employee of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">4.9
<U>Clawback Provisions</U></FONT>. Any <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">amounts</FONT>
payable under this Agreement are subject to any policy (whether in existence as of the Effective Date or later adopted) established by
the Company providing for clawback or recovery of amounts that were paid to the Executive. The Company will make any determination for
clawback or recovery in its sole discretion and in accordance with any <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">applicable</FONT>
law or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline; background-color: white"><U>Termination
of Employment</U></FONT>. The Employment Term and the Executive&rsquo;s employment hereunder may be terminated by either the Company or
the Executive at any time and for any reason or for no particular reason; provided that, unless otherwise provided herein, either party
shall be required to give the other party at least 30 days advance written notice of any termination of the Executive&rsquo;s employment.
Upon termination of the Executive&rsquo;s employment during the Employment Term, the Executive shall be entitled to the compensation and
benefits described in this Section 5 and shall have no further rights to any compensation or any other benefits from the Company or any
of its affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">5.1
<U>Expiration of the Term, For Cause, or Without Good Reason</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) The
Executive&rsquo;s employment hereunder may be terminated by the Company for Cause or by the Executive without Good Reason and the Executive
shall be entitled to receive:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(i) any
accrued but unpaid Base Salary and accrued but unused vacation/paid time off (if such unused vacation time/paid time off is so required
to be paid under the Company&rsquo;s employment policies or applicable law) which shall be paid within one (1) week following the date
of the Executive&rsquo;s termination in accordance with the Company&rsquo;s customary payroll procedures;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(ii) any
earned but unpaid Annual Bonus with respect to any completed fiscal year immediately preceding the date of the Executive&rsquo;s termination,
which shall be paid on the otherwise applicable payment date except to the extent payment is otherwise deferred pursuant to any applicable
deferred compensation arrangement; provided that, if the Executive&rsquo;s employment is terminated by the Company for Cause or the Executive
resigns without Good Reason, then any such earned but unpaid Annual Bonus shall be forfeited;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(iii) reimbursement
for unreimbursed business expenses properly incurred by the Executive, which shall be subject to and paid in accordance with the Company&rsquo;s
expense reimbursement policy; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(iv) such
employee benefits (including equity compensation), if any, to which the Executive may be entitled under the Company&rsquo;s employee benefit
plans as of the date of the Executive&rsquo;s termination; provided that, in no event shall the Executive be entitled to any payments
in the nature of severance or termination payments except as specifically provided herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Items 5.1(a)(i) through 5.1(a)(iv)
are referred to herein collectively as the &ldquo;<B>Accrued Amounts</B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) For
purposes of this Agreement, &ldquo;<B>Cause</B>&rdquo; shall mean:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(i) the
Executive&rsquo;s willful failure to perform the Executive&rsquo;s duties (other than any such failure resulting from incapacity due to
physical or mental illness);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(ii) the
Executive&rsquo;s willful failure to comply with any valid and legal directive of the Board;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(iii) the
Executive&rsquo;s engagement in dishonesty, illegal conduct, or gross misconduct, which is, in each case, injurious to the Company or
its affiliates;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(iv) the
Executive&rsquo;s embezzlement, misappropriation, or fraud, whether or not related to the Executive&rsquo;s employment with the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(v) the
Executive&rsquo;s conviction of or plea of guilty or nolo contendere to a crime that constitutes a felony (or state law equivalent) or
a crime that constitutes a misdemeanor involving moral turpitude;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(vi) the
Executive&rsquo;s material violation of the Company&rsquo;s written policies or codes of conduct, including written policies related to
discrimination, harassment, performance of illegal or unethical activities, and ethical misconduct;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(vii) the
Executive&rsquo;s material breach of any material obligation under this Agreement or any other written agreement between the Executive
and the Company; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(viii) the
Executive&rsquo;s engagement in conduct that brings or is reasonably likely to bring the Company negative publicity or into public disgrace,
embarrassment, or disrepute.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">For purposes of this provision,
none of the Executive&rsquo;s acts or failures to act shall be considered &ldquo;willful&rdquo; unless the Executive acts, or fails to
act, in bad faith or without reasonable belief that the action or failure to act was in the best interests of the Company. The Executive&rsquo;s
actions, or failures to act, based upon authority given pursuant to a resolution duly adopted by the Board or upon the advice of counsel
for the Company shall be conclusively presumed to be in good faith and in the best interests of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Except for a failure, breach,
or refusal which, by its nature, cannot reasonably be expected to be cured, the Executive shall have 15 business days from the delivery
of written notice by the Company within which to cure any acts constituting Cause.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c) For
purposes of this Agreement, &ldquo;<B>Good Reason</B>&rdquo; shall mean the occurrence of any of the following, in each case during the
Employment Term without the Executive&rsquo;s prior written consent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(i) a
material reduction in the Executive&rsquo;s Base Salary;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(ii) a
relocation of the Executive&rsquo;s principal place of employment by more than thirty (30) miles unless the Executive is a remote worker
at such time in accordance with this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(iii) any
material breach by the Company of any material provision of this Agreement or any material provision of any other agreement between the
Executive and the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(iv) the
Company&rsquo;s failure to obtain an agreement from any successor to the Company to assume and agree to perform this Agreement in the
same manner and to the same extent that the Company would be required to perform if no succession had taken place, except where such assumption
occurs by operation of law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(v) the
Company&rsquo;s failure to nominate the Executive for election to the Board and to use its best efforts to have him elected and re-elected,
as applicable; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(vi) a
material, adverse change in the Executive&rsquo;s title, authority, duties, or responsibilities (other than temporarily while the Executive
is physically or mentally incapacitated or as required by applicable law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">To terminate the Executive&rsquo;s
employment for Good Reason, the Executive must provide written notice to the Company of the existence of the circumstances providing grounds
for termination for Good Reason within 30 days of the initial existence of such grounds and the Company must have at least 30 days from
the date on which such notice is provided to cure such circumstances. If the Executive does not terminate the Executive&rsquo;s employment
for Good Reason within 30 days after the first occurrence of the applicable grounds, then the Executive will be deemed to have waived
the Executive&rsquo;s right to terminate for Good Reason with respect to such grounds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.2 <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U>Without
Cause or for Good Reason</U></FONT>. The Employment Term and the Executive&rsquo;s employment hereunder may be terminated by the Executive
for Good Reason or by the Company without Cause. In the event of such termination, the Executive shall be entitled to receive the Accrued
Amounts, and <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U STYLE="text-decoration: none">subject</U></FONT>
to the Executive&rsquo;s compliance with Section 6 of this Agreement and the agreements <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U STYLE="text-decoration: none">referenced</U></FONT>
therein and the Executive&rsquo;s execution, within 30 days following receipt, of a release of claims in favor of the Company, its affiliates
and their respective officers and directors in a form provided by the Company (the &ldquo;<B>Release</B>&rdquo;) that is reasonably acceptable
to the Executive, and the Release becoming effective according to its terms, the Executive shall be entitled to receive the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) a
lump sum payment equal to the greater of (i) the balance of the Executive&rsquo;s Base Salary that the Executive would have received through
the remainder of the Term and (ii) the Executive&rsquo;s Base Salary for one year;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) a
payment equal to (i) the full amount of the Annual Bonus and, (ii) if the milestone associated with the Special Bonus has been achieved,
but the Special Bonus has not yet been paid, the full amount of the Special Bonus, shall be paid; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c) all
unvested RSUs granted to the Executive under this Agreement shall automatically vest and the treatment of any other outstanding equity
awards shall be determined in accordance with the terms of the Plan and the applicable award agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d) If
the Executive timely and properly elects health continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985
(&ldquo;<B>COBRA</B>&rdquo;), the Company shall reimburse the Executive for the difference between the monthly COBRA premium paid by the
Executive for the Executive and the Executive&rsquo;s dependents and the monthly premium amount paid by similarly situated active executives.
Such reimbursement shall be paid to the Executive on the 1st of the month immediately following the month in which the Executive timely
remits the premium payment. The Executive shall be eligible to receive such reimbursement until the earliest of: (i) the twelve-month
anniversary of the date of the Executive&rsquo;s termination; (ii) the date the Executive is no longer eligible to receive COBRA continuation
coverage; and (iii) the date on which the Executive receives/becomes eligible to receive substantially similar coverage from another employer
or other source. Notwithstanding the foregoing, if the Company&rsquo;s making payments under this Section 5.2(c) would violate the nondiscrimination
rules applicable to non-grandfathered, insured group health plans under the Affordable Care Act (the &ldquo;<B>ACA</B>&rdquo;), or result
in the imposition of penalties under the ACA and the related regulations and guidance promulgated thereunder, the parties agree to reform
this Section 5.2(c) in a manner as is necessary to comply with the ACA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">5.3
<U>Death or Disability</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) The
Executive&rsquo;s employment hereunder shall terminate automatically upon the Executive&rsquo;s death during the Employment Term, and
the Company may terminate the Executive&rsquo;s employment on account of the Executive&rsquo;s Disability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) If
the Executive&rsquo;s employment is terminated during the Employment Term on account of the Executive&rsquo;s death or Disability, the
Executive (or the Executive&rsquo;s estate and/or beneficiaries, as the case may be) shall be entitled to receive the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(i) the
Accrued Amounts; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(ii) a
lump sum payment equal to the Pro Rata Bonus, if any, that the Executive would have earned for the fiscal year that includes the date
of the Executive&rsquo;s termination based on the achievement of applicable performance goals for such year, which shall be payable on
the date that annual bonuses are paid to the Company&rsquo;s similarly situated executives, but in no event later than two-and-a-half
(2 1/2) months following the end of the fiscal year that includes the date of the Executive&rsquo;s termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Notwithstanding any other
provision contained herein, all payments made in connection with the Executive&rsquo;s Disability shall be provided in a manner which
is consistent with federal and state law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c) For
purposes of this Agreement, &ldquo;<B>Disability</B>&rdquo; shall mean the Executive&rsquo;s inability, due to physical or mental incapacity,
to perform the essential functions of the Executive&rsquo;s job, with or without reasonable accommodation, for one hundred eighty (180)
days out of any three hundred sixty-five (365) day period or one hundred twenty (120) consecutive days. Any question as to the existence
of the Executive&rsquo;s Disability as to which the Executive and the Company cannot agree shall be determined in writing by a qualified
independent physician mutually acceptable to the Executive and the Company. The determination of Disability made in writing to the Company
and the Executive shall be final and conclusive for all purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; vertical-align: baseline"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">5.4
<U>Notice of Termination</U></FONT>. Any termination of the Executive&rsquo;s employment hereunder by the Company or by the Executive
during the Employment Term (other than termination pursuant to Section 5.3(a) on account of the Executive&rsquo;s death) shall be communicated
by written notice of <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U STYLE="text-decoration: none">termination</U></FONT>
(&ldquo;<B>Notice of Termination</B>&rdquo;) to the other party hereto in accordance with Section 17. The Notice of Termination shall
specify:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) the
termination provision of this Agreement relied upon;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) to
the extent applicable, the facts and circumstances claimed to provide a basis for termination of the Executive&rsquo;s employment under
the provision so indicated; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c) the
applicable date of termination, which shall be no less than 30 days following the date on which the Notice of Termination is delivered
if the Company terminates the Executive&rsquo;s employment without Cause, or no less than 30 days following the date on which the Notice
of Termination is delivered if the Executive terminates the Executive&rsquo;s employment with or without Good Reason; provided that, the
Company shall have the option to provide the Executive with a lump sum payment in lieu of such notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">5.5
<U>Resignation of All Other Positions</U></FONT>. Upon termination of the Executive&rsquo;s employment hereunder for <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U STYLE="text-decoration: none">any</U></FONT>
reason, the Executive shall be deemed to have resigned from all positions that the Executive holds as an officer or member of the Board
(or a committee thereof) of the Company or any of its <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U STYLE="text-decoration: none">affiliates</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">6.
<FONT STYLE="background-color: white"><U>Confidential Information and Restrictive Covenants</U></FONT></FONT>. As a condition of the
Executive&rsquo;s employment with the Company, the Executive shall enter into and abide by the Company&rsquo;s Employee Confidential
Information and Inventions Assignment Agreement or any similar agreement in effect relating to confidentiality.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">7.
<FONT STYLE="background-color: white"><U>Arbitration</U></FONT></FONT>. Any dispute, controversy, or claim arising out of or related
to the Executive&rsquo;s employment by the Company, or termination of employment, including but not limited to claims arising under or
related to this Agreement or any breach of this Agreement, and any alleged violation of federal, state, or local statute, regulation,
common law, or public policy, shall be submitted to and decided by binding arbitration with one arbitrator mutually selected by the parties.
Arbitration shall be administered exclusively by JAMS and shall be conducted in Omaha, Nebraska consistent with the rules of JAMS in
effect at the time the arbitration is commenced, except as modified by this Agreement. The Parties waive all rights to have their disputes
heard or decided by a jury or in a court trial and the right to pursue any class or collective action or representative claims against
each other in court, arbitration, or any other proceeding. Any arbitral award determination shall be final and binding upon the parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal; vertical-align: baseline"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">8.
<FONT STYLE="background-color: white"><U>Governing Law, Jurisdiction, and Venue</U></FONT></FONT>. This Agreement, for all purposes,
shall be construed in accordance with the laws of Nebraska without regard to conflicts of law principles. Any action or proceeding by
either of the parties to enforce this Agreement shall be brought only in a state or federal court located in the state of Nebraska, county
of Douglas. The parties hereby irrevocably submit to the exclusive jurisdiction of such courts and waive the defense of inconvenient
forum to the maintenance of any such action or proceeding in such venue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">9.
<U><FONT STYLE="background-color: white">Entire Agreement</FONT></U></FONT>. Unless specifically provided herein, this Agreement, together
with the Employee Confidential Information and Inventions Assignment Agreement, contains all of the understandings and representations
between the Executive and the Company pertaining to the subject matter hereof and supersedes all prior and contemporaneous understandings,
agreements, representations and warranties, both written and oral, with respect to such subject matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">10.
<FONT STYLE="background-color: white"><U>Modification and Waiver</U></FONT></FONT>. No provision of this Agreement may be amended or
modified unless such amendment or modification is agreed to in writing and signed by the Executive and by at least one other officer
of the Company. No waiver by either of the parties of any breach by the other party hereto of any condition or provision of this Agreement
to be performed by the other party hereto shall be deemed a waiver of any similar or dissimilar provision or condition at the same or
any prior or subsequent time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11. <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline; background-color: white"><U>Severability</U></FONT>.
Should any provisions of this Agreement be held to be invalid, illegal, or unenforceable in any respect, such invalidity, illegality,
or unenforceability shall not affect any other provisions hereof, and if such provision or provisions are not modified as provided above,
this Agreement shall be construed as if such invalid, illegal, or unenforceable provisions had not been set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">12.
<FONT STYLE="background-color: white"><U>Captions</U></FONT></FONT>. Captions and headings of the sections and paragraphs of this Agreement
are intended solely for convenience and no provision of this Agreement is to be construed by reference to the caption or heading of any
section or paragraph.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">13.
<FONT STYLE="background-color: white"><U>Counterparts</U></FONT></FONT>. This Agreement may be executed in separate counterparts, each
of which shall be deemed an original, but all of which taken together shall constitute one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">14.
<FONT STYLE="background-color: white"><U>Section 409A</U></FONT></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">14.1
<U>General Compliance</U></FONT>. This Agreement is intended to comply with Section 409A or an exemption thereunder and shall be construed
and administered in accordance with such intent. Notwithstanding any other provision of this Agreement, payments provided under this
Agreement may only be made upon an event and in a manner that complies with Section 409A or an applicable exemption. Any nonqualified
deferred compensation payments under this Agreement that may be excluded from Section 409A either as separation pay due to an involuntary
separation from service or as a short-term deferral shall be excluded from Section 409A to the maximum extent possible. For purposes
of Section 409A, each installment payment provided under this Agreement shall be treated as a separate payment. Any payments to be made
under this Agreement upon a termination of employment shall <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline"><U STYLE="text-decoration: none">only</U></FONT>
be made upon a &ldquo;separation from service&rdquo; under Section 409A. Notwithstanding the foregoing, the Company makes no representations
that the payments and benefits provided under this Agreement comply with Section 409A, and in no event shall the Company be liable for
all or any portion of any taxes, penalties, interest, or other expenses that may be incurred by the Executive on account of non-compliance
with Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; vertical-align: baseline"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">14.2
<U>Specified Employees</U></FONT>. Notwithstanding any other provision of this Agreement, if any payment or benefit provided to the Executive
in connection with the Executive&rsquo;s termination of employment is determined to constitute &ldquo;nonqualified deferred compensation&rdquo;
within the meaning of Section 409A and the Executive is determined to be a &ldquo;specified employee&rdquo; as defined in Section 409A(a)(2)(b)(i),
then such payment or benefit shall not be paid until the first payroll date to occur following the six-month anniversary of the date
of the Executive&rsquo;s termination or, if earlier, on the Executive&rsquo;s death (the &ldquo;<B>Specified Employee Payment Date</B>&rdquo;).
The aggregate of any payments that would otherwise have been paid before the Specified Employee Payment Date and interest on such amounts
calculated based on the applicable federal rate published by the Internal Revenue Service for the month in which the Executive&rsquo;s
separation from service occurs shall be paid to the Executive in a lump sum on the Specified Employee Payment Date and thereafter, any
remaining payments shall be paid without delay in accordance with their original schedule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">14.3 </FONT><U>Reimbursements</U>.
To the extent required by Section 409A, each reimbursement or in-kind benefit provided under this Agreement shall be provided in accordance
with the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) the
amount of expenses eligible for reimbursement, or in-kind benefits provided, during each calendar year cannot affect the expenses eligible
for reimbursement, or in-kind benefits to be provided, in any other calendar year;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) any
reimbursement of an eligible expense shall be paid to the Executive on or before the last day of the calendar year following the calendar
year in which the expense was incurred; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c) any
right to reimbursements or in-kind benefits under this Agreement shall not be subject to liquidation or exchange for another benefit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">15.
<FONT STYLE="background-color: white"><U>Successors and Assigns</U></FONT></FONT>. This Agreement is personal to the Executive and shall
not be assigned by the Executive. Any purported assignment by the Executive shall be null and void from the initial date of the purported
assignment. The Company may assign this Agreement to any successor or assign (whether direct or indirect, by purchase, merger, consolidation,
or otherwise) to all or substantially all of the business or assets of the Company. This Agreement shall inure to the benefit of the
Company and permitted successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16. <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline; background-color: white"><U>Notice</U></FONT>.
Any notice or other communication required or which may be given hereunder shall be in writing and shall be delivered personally, telecopied,
telegraphed or telexed, or sent by certified, registered or express mail, postage prepaid, or emailed to the Parties at the addresses
specified on the signature page hereto, or at such other addresses as shall be specified by the parties by like notice, and shall be deemed
given so long as such provides a receipt of delivery, when so delivered personally, telecopied, telegraphed or telexed, mailed, or emailed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">17. <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline; background-color: white"><U>Representations
of the Executive</U></FONT>. The Executive represents and warrants to the Company that the Executive&rsquo;s acceptance of employment
with the Company and the performance of the Executive&rsquo;s duties hereunder will not (a) conflict with or result in a violation of,
a breach of, or a default under any contract, agreement, or understanding to which the Executive is a party or is otherwise bound or (b)
violate any non-solicitation, non-competition, or other similar covenant or agreement of a prior employer or third-party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">18.
<FONT STYLE="background-color: white"><U>Withholding</U></FONT></FONT>. The Company shall have the right to withhold from any amount
payable hereunder any Federal, state, and local taxes in order for the Company to satisfy any withholding tax obligation it may have
under any applicable law or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">19.
<FONT STYLE="background-color: white"><U>Survival</U></FONT></FONT>. Upon the expiration or other termination of this Agreement, the
respective rights and obligations of the parties hereto shall survive such expiration or other termination to the extent necessary to
carry out the intentions of the parties under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal; vertical-align: baseline">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; vertical-align: baseline">20.
<FONT STYLE="background-color: white"><U>Acknowledgement of Full Understanding</U></FONT></FONT>. THE EXECUTIVE ACKNOWLEDGES AND AGREES
THAT THE EXECUTIVE HAS FULLY READ, UNDERSTANDS AND VOLUNTARILY ENTERS INTO THIS AGREEMENT. THE EXECUTIVE ACKNOWLEDGES AND AGREES THAT
THE EXECUTIVE HAS HAD AN OPPORTUNITY TO ASK QUESTIONS AND CONSULT WITH AN ATTORNEY OF THE EXECUTIVE&rsquo;S CHOICE BEFORE SIGNING THIS
AGREEMENT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">[signature page follows]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
have executed this Employment Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">COMPANY:</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 35%">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: normal; text-indent: 0in; font-size: 12pt"><FONT STYLE="font: small-caps 10pt Times New Roman, Times, Serif">CleanCore Solutions, Inc.</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-indent: 0in; font-size: 12pt"></TD>
    <TD STYLE="font-weight: normal; text-indent: 0in; font-size: 12pt"></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> /s/ David Enholm</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Name: </TD>
    <TD STYLE="text-align: left">David Enholm</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Title: </TD>
    <TD STYLE="text-align: left">Chief Financial Officer</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.85pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.85pt; text-align: justify">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Address:</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">5920 S. 118<SUP>th</SUP> Circle</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Omaha NE 68137</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Attn: </TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">CFO</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Email:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">EXECUTIVE:</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: left">/s/ Clayton Adams</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">Clayton Adams</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.85pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.85pt; text-align: justify">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Address:&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">5920 S. 118<SUP>th</SUP> Circle</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Omaha NE 68137</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Attn: CFO</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Email:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">11</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>21
<FILENAME>zone-20250829.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qRZo7xRiXhun8uNbXQsSaqIeaPtypR1mYkxs2t0HXla/y8gY2I26iLopP6WIdcN -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:ZONE="http://cleancoresol.com/20250829" elementFormDefault="qualified" targetNamespace="http://cleancoresol.com/20250829">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://cleancoresol.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="zone-20250829_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="zone-20250829_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>22
<FILENAME>zone-20250829_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>23
<FILENAME>zone-20250829_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="zone-20250829.xsd#Cover" roleURI="http://cleancoresol.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://cleancoresol.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 29, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 29,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-42033<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CLEANCORE
    SOLUTIONS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001956741<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">88-4042082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5920 S. 118th
    Circle<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Omaha<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">68137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">877<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">860-3030<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class B Common Stock, par value $0.0001 per
    share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ZONE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea0255944-8k_clean.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cleancoresol.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0255944-8k_clean.htm">ea0255944-8k_clean.htm</File>
    <File>zone-20250829.xsd</File>
    <File>zone-20250829_lab.xml</File>
    <File>zone-20250829_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>31
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0255944-8k_clean.htm": {
   "nsprefix": "ZONE",
   "nsuri": "http://cleancoresol.com/20250829",
   "dts": {
    "inline": {
     "local": [
      "ea0255944-8k_clean.htm"
     ]
    },
    "schema": {
     "local": [
      "zone-20250829.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "zone-20250829_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "zone-20250829_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://cleancoresol.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-08-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0255944-8k_clean.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-08-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0255944-8k_clean.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://cleancoresol.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>32
<FILENAME>0001213900-25-085107-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-085107-xbrl.zip
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M==Q;Q:-).,KBJKK.3[?&?/8_UT=\>WM0QHG6.L_FTV&1;6$ XAO: 4PA](A
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M7WA<A8D:ISDG4+.O</=0:V(M1R%7GAQ@#(-UV?WA8+_GV;YRE9U;V9,R/9\
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M&) H=+8TU:[)HN9]1^<]5P7<G4@TN?BT#&-8,G4%+'X#5^ZT(G:"WR4I9T$
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M\%VS)PIRE9J<9SV;O&"8#S!OJQ1T%K@;0+2".-]*M]D\B#@T+.D?N>.)MJ%
M>DE>-$ATOF93XJV!OK7$?$C>P7Q^G6VB)V8E(&C&E,B/^A'-!AX1[8AT)OHG
MVPWT[S%J>W2CP'U%WLQ+-*406Q.+M1P-AF) N/N%MG&CWDG1Z[92V!IT^X1L
M$W-R+:F2!(S,[M?2<0BAKZN9S3+9-1RL+B*>$DPC9O_2>_=-9^9-/08LOGSA
MP#E#PYP-'H<]\0BR >1J%)6YQF!#CHH9)^A&L"N7ZD('2;Q+'O1%]BW5[/MT
M22.L8G*%&?(POM2.^YO\=ZB.LH]9_Q"_"^*J_S>HKH*9 ZQ('EN:+%[(VNV
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M!D2Z>DD/C@HIJZ;C&%3AL>B'Z*XJ<HS NQAW-^-]80]G]D:_HT(I.!L6IEB
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M"$I&1J-]V=O9W</03EQ2T43;W8S_-HZ,-CEXE"=Q8'C&[#=K4:W75:V.+X)
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MY?9K'CVP;X$KXB<@E,>$5+C'<0W"[RX527CI\]*9R2&.3S"F\+M]3.O7FE?
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M KQ^K&3&J\O!NK.]UN]4^4TBY'@UJY2RN[$HKM0J#ML"4B#**6!XQUO3$14
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M!NY_=2FZDLT=!>\;,*8/XL'^]>3&<?MXC'*K'.H2)KFE\+LB5]2[!OM4C90
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MY:@2ZZM$[+-R4E,5%OIO+N.Y067TT( $-UE;#C#3!H&8F?]&F>#]&.!<C0T
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MD3M9^RW*VI<IYU^L*FI_H"H_TH3>H[)*M'J&K X2-3P;J1PKC!=X!E"18;>
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MV\ &N3B)+_$.*MNBV:!A^>"EO:ME#SR+'7\5+4S02V7S1,BR"%I*C]N5B=^
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MM$Q6"C$61>FV9B0^H>R0T/BQ/%+Q$78(9P1]!M2@6';"VB=EKRC?"4Z8V'K
MVWWR-C2,:&MDYMM/++E%TDZO+D9%QL0M-P)E19;*7*O4.D5?$/2EWSIE)SS6
M'=!MMF")O7<2%,I&E@._Z+V4[L*3>96*8C>KYJ,)W4PCBMK\__:NM3EM9(E^
MUZ]0I>Y6);6R#=CXD;V;*HQ-XL2Q?8T=)_ME2R !(B!8"1FSO_Y./^:A!YAD
M;8>P_G+OQC9",SW3T]-]^ARX\L :)U9@;"/O^!'5#T!6@??K%!1#>C:?0([<
MM<:Q&+=E RS>@0;@^T0(2:PR$_!K[320@8KU*M@8P?CC*?9IC71&O!W-QI-1
M-W+'8FU;$-LYJ;AM A$AP;X2RA(C"S/)7?\ME>DZI*DL?MF9Y(BJGXG6RKO/
M5>ITE;KZ7*5> 49MDWBX"!KIC5@*1/=PZTH,()-<38GONYC\T"EY NPKOM1T
M1&[>2@NS>VM4U92]#%-.*RCZ:\9"^ND*H96[1C@YENAB8]D/:"S+,!:>QHJ>
ME,J-J;.>[T01IDMS[I].8_WZ2,_@ARD>A<BES@IFE "U+2(5(/%W#*F";D]\
ME+L)B(#X2$PEMCY72I5M:HYHJ+F!MJPDQ%765 ( V!Q- :QGUYK7^,F-TKXC
M3^(3$3R)DU4<[?'&6W%%(V1:Z%GG$,QLU/&\M&LLW-9,6L+UB!??KI8V=DNO
M7IO?2L08'B"X@1J";XJI)ZB37I&:NY&?QA@ 1SHC$$'!9QUN>GK:==**\MU<
MTII33Q!KU9 ]40TBO 5@<O7.D-R/CFQN5%H.=I=B_E"A*G"!:WE*12.1$JVQ
M#$9H.\1L'2H'H^HOJ:!HN8Y-<VU1V)@9*6=MU(4/NZ>A?Q[K7E![QWHBK9O%
M107M--.\[0:=-L^5VO=2^#HE"(GT>LC$/F6WH%T"1M%B=Y*J-@B2K&E4=QTR
M)[IG+@%:,IP.RR],[G<RZ ];/LE*:Q]'E[YH/,(^#)/93UQJ@F$R!.@G;W3"
M"W=8>/32ESSQM3:N<K&N*FMT0,+A<1U"^@$<-72M^*&\,!?.@V7,@_V2'??2
ML/*3RQHCP=GYOH*U74NZD-/&J15O,R!Z"6CC&G*C(3:4,0.B> 8KK<*&*U=_
M66Q:"TS[S2]:KWV\RKXI(J_E=RF,LE$[ _Y/C"L&N)ZPJQ%OC4DKQC![HGX.
M5[T.XRVH $:.QR("HY2,F_:R[/8ZK)*+S)#<(DZ-E(#8QJ\E1P&I_[:O,':Y
ME_/O2';C/V5;!"@#S'J<AV+]C"=XMEOEB@-FV:&9/X)FGHGT]U<R5I*0QQS*
MODEE7'GD"[=+&2%#(#PWAQ-BV)1I%4"@(/1:V&,-CM\YQ+MY >74H5<0E?(!
MP>L.XQ3CU$L?@4N<\_;<<]Y:ZIS'D7S?V:[?P5!\RA_S5OZ8OX'\B%2AA5],
M>[XL!2' 2Q\ L'RHT Z?$8%P.^%+$.PC56L6^V*@8G7F5N/%B/DF]\XBQ@4J
M2Q4L9QE:0'#O2"D :M?3S&1,HKC$3L=:'Z7JX)D!BK9@RS<C#XV>!_) ,^'%
MU"G*1Z>"1RC!.(GU2HT-?<(:;+(4)T1&=8S@+>*$X]5LR1-%P;4,)1;<5[PA
M4_>5A,XH=1J!Z ,E_[C&MY2K@T7IX(JT8 F@R1R^A-P&G#J7"PI(3/V._5*E
M=F70RK\0[]!%](WWRC'A)$6A$.X&L024;#6?29L6R;W-_Q1J3.>:;K1@!#R*
M&V!Q17(L2W UB;N+Q2_CSHQD0N)>&D*A 6U6(1B?$?@IQ)@972-.0\+Q-0JO
M ,TO:?I<*.GV)"K51/<*%V3I?DCIU$!JQO<0E4/:)9B;%0-7:J,*J@6:EXA8
ME>GJ4:<3^U(MQY U(4.@78QNJC4-\X\2Q>T/ODJBRKF@B^>'V_YJ278#$7,@
M_$4<6I'P>2J:T0T8+.$RRS6^4CT+@Y'86?C;;!9&XJ@[D9MXNI*#(D-X*40!
M)X5='44IW*+8M,+@Q+459K^I(]G4H5HJT1^,K@4=0]T8#._$I7W<9K+. \1C
MPB=P:F_AL K;6U* /X.Z=ETN-4<+9R32_,D#  -/(<WEL+0H2"&C!8R5F4%_
M3*37N'_-L1TY/:AC P5B("B=H? 6A$CS@]Y3*P 1D%FCV0RD>X;[#O 4ZC8T
M1I"G5&,TY9XU3#:=MM!,*&.Q!WT$40Q&6&->=LF9GAGKA,#"K0BOV3F*__8&
M?EK=#G(FR3 MJ<N/MAB%D8GJS V(Q=!NCWH1\)2_)5IG0[U@D:7:"!&!% MF
M$@C+)-Y_("(X*L^*F--B"AB/Y27N*[AB@=3P*M*;Y :-VQH6@Q>Y4U $+'0X
MAHNQI(M9@W@-<A#-XSK@"OQN&A8,[<CO$V'#JD-Y9@N7+H!$;1>CVXE]&(0:
M>27_07I91 XK"6#PGHJ0'?%C6?R%4($M*O/!$BH 7ZY89JG/1EQ  )&.X4F
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M,G[_T,]>]G2Y;V*VXJUL0//]$Y+!6NZ6%H,M^<^JA4A*\R7QB*$'V84+(?W
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MC^&/6SPC15+\PV'GGCSNF+G=E)*C:*<E'\4@4FO)QRC.LFJK93N?W9U6S^G
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M9QO( B(_7$+P\ L4E RO=Z#H"(K'#A5?OU!+;X6U#GV_6W4S?/P&(XWJDRD
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M%;54OB=189.S,OH-L7Z.]V=Q2M/1&5\?8'4%64(4$-:R\]WV.1NAD-YZE'I
MB6LWI:N3HT<1MQ.(P>U,>OTDZ&=LW&C/XA'K.D/ *+[24$PIVZ)@/@=Q/99=
M=I&0L@ITPP;TKNVQ&80C?1#%R6@RXWW_MVP)QB.WM3"3H!'\"-.U>+^XE;9T
MH^.":T]!I2&.^LI@ 1$8H5.ZK@>3V&G0I()B>5-3\]U[^ Q5VRZKP@Z&.D<N
M9F="@'+'WC\^YN1R:LW+;[:-]/_/'A_\\AQ]YVY,_AMSS4VO.\ZU*HX18W(A
MO?OHZJKQMSLQ-\W@^2]/'\/+ER #GCSY&?[_V%1CM&WPIE"=//UN$SF;JQG(
MF=-!\N+G)\]^^N;O?1&_UF56[FC/U[]0RFU#E(EKO62/P>Y.CJ7K:.85T8'8
M,G'*][T,P-G%NPFBW$YDXWC;1*ZTHZ<B75POT7W5F40G.+P281 \*A)$J;6+
M7/4&XD[*2H%,"R$S5B?W7G8H5QE)VX"[U8L<SGSP^M70;=OP]=V_ZW\NJ.DF
M1EPHBOBVS//RNOY_W^?MW95N#D[_?!^<EN#TS_?!Z74BB,7X#Y%^]M7#T^2?
MP\O3P<5%\L^_#\X'9V_3WD(@FT^+;T)T)GV&%CWC0IT@P^X/WU>=K*&HAX2$
M$) 8(O+%TPO0'NZH(BA7+6I@6OO7 ^*US6"0!Y8?"7%!?]T18(8PP,%9\"^\
M/$F.SY! IW][\-11(Q[D$+RP%1AT#Z>5R1[.RPQ6FIL"5OGJ[=GI93CIA[7Y
M7\TSIU<?G[V'P7][R=@2_+5@4Q!@\D4T^M+)N:UZ@;@<N_S6TK]VQ.??>L!G
MT8AW3YTU"[A#9MC@F'Q/MO@V.W<'H_QYEKYYG]^L7H8[VGG/3>9-5X9][4P>
MU8^28WBT*8OD*%/S^L_):9L72::7?=$&LG^[8_P?3M!+K.K?S,+?C)8SHR?)
M@&%$5]IVXOES4O4_1R#>K44T/#T9O#\=7@X&/\ H^@_<[ 6F<(NI]P@/>L.!
M_SX/?%_%=93KSXJB\V]T\;N:XVU""U.5?PA^N<,3\F7K=@CU;Q-C??KTER[W
MW&E4=_,;;P.)_.4P.:-"_/HEOMBV=7ZGZL;%HW[9\GC4+[>/1]U9<.C+&>S1
MF[.3WZ@8X^^7[]^]_O]02P,$%     @ 08<E6P^='=[Y*P  2]X  !P   !E
M83 R-34Y-#0P,65X,3 M,3%?8VQE86XN:'1M[5U9;QM)DGX7P/]0:V &$D#+
MU]C=8WL,R!+=+:PM&Y(\LXW%/B2KDF2VBU6<.B1S?OW&E4=E%2FYQT=/T_W0
MED165F9D9)Q?1#[_^?+-ZQ>CO><_3XY.X-\$_WM^>7KY>O+B^3W^%SZ])Q\_
M?_GVY)?DXO*7UY._W9F51?,T>7!_U2279JGKY$Q?)^?E4A5C_L,XN="5F=V!
M!^'1=Y_ZW+-DJ:JY*9XF^-7[SY)&?VSNJMS,X4^5F2^:.R^>OWPQ^;@P4]/
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M:H3@@4X<(R07.3>2BI9"HZ%:P6CC[,80[)%D#+\),T6DZ!L,Z+LX1W?&L6#
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M>>:O\@F53P>;,I4DI\3M^=M6N'IL!V)6\-I=8&-_8NTU09$_!";1DE*'CE;
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M+RA;[>Z/Y(O#2'#Y>&K=8B5,'"&W1I9MG""Q.W_M?&P=!A982#\L<KDM 3V
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M$?S<DN@B(Y)3M64T=Q6(:Q45&1FI[J531X5$"1#4Y<2,]/IPKKNYZJ$T]Q9
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M'!I1\I/K18DDIX@J-K0/2'["Y9!S^4;Z^1LSKN]LJ[7R;C&<9*5UYV/1+(#
MP6!$U\=*) QSAN4JUW@<V+H"(;HV0.JJFIK&ZM0H2VSCHT2$B2G^LS85')6%
M9BE#@BZ0BR#)%YI9@;DR.0BT% Q1,'!S:#Z##Z:F'JYT2Z!>>980'%_9>?P&
MFC5P5(.SOU0;8+'X&GXB%6R*SB1HM<RO<&Z>VHAA8>/78!\@#V%3ECE7TL/[
M[YBT?G_5_O51Z,V[?)]87]_/^ZK@_P3GHE*@@SH)C)+'TL*&E'[XD\4VB?V
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M30^!OTY_ ?(B(^I"%)*3H\= TZ,^-46A,@$6*?+ZU,H,5JK(+XQHL,@K3.V
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MN$O+Z&J5X=LSF<?Y?L=UO5ZN7#[&*;O^>XI11$#2F\T+ZTRA<@^*\1#>!!>
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M/*8-4].:996Z)D/&EECLNZ*2R_)UWD5?+I7EYEPR.52/HT,UE6MR(IY6SGJ
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M[XCC1\'HF"^AE]!=HZ8[5;P[];B"JT^D"(4=?M06:=Y]5TMQX1)RR/ M4[3
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M[LP69_:/WYW97T98OVO7D[/DWY/+L_'%1?+O?X[/Q^_?C'I3:6S\+;YOSID
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MH?(9;RX8M#GEH6R4#]"3I:)SW"@1:3ZD>M5NWS$^($EJ "Q"525</MUI,HL
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MV7"H4!A V3$'@I;TB"S N(C?58DJ#LW]%>0)0+6S$H&QA\@':_6H6JI1&$+
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M$KQ1\$@L\9896^+22%\/V5S5H^EQJPDL[Q&4O4<P,]&\KS9?/B#JO>\#Z)9
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M5N0)U/8@FGZA9P1]F@BZ!]OZ*K$,6D<61?^_1TD*5!N:*3(1E-2= UX[/(V
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MW8D7>IZ]#-54#='LCV;^U,IT/;=H<E8Y0\2S">U[D-1^(DGM   "8TVC$S2
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M,#!948F3\"[MY5')^+H=#'$1/S<,3KG'QRS);*X%!BK\V= 0,W11;4&['NI
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MIA.NC4%V+CN+,% [64O1><5"=%U[?K/;.4.--$PYOJ6MET1:[12.6=-*@G(
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MAR_]Z*#_Y<O9R?X!$,Y_OMA^07^?['_\:/^^\W*N3%R.\=7M_W28B@7FU+0
MD+7_>D&0]N[\U$[0Y+( SB\L-)Y_=&N'?[J'P#!PZ4?_?+'[(@"H8-<'Q[_
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M,A]!X9#?2*VS$\L'0/W5U]FJ-A/TL>^]MW[N\[,WIP/.[7.85;@5B*BJUO"
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M&+(SM,_/RJMT5H+8_AM^C]"X&%/AAU:CF, H3"O>] Q>I,JF:Z66Z$E<?[J
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M) S:=.E0XC8YORF(X"97LN7[*X&%QE^!Z#%W)W1DT7/A @)YLB6K%Y(K+O+
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M.\/5*\M575\'V)8S-7PI>A2W8S;$U=*MV!E7+M0DE@)#<10=>I-R)^!%*\9
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M?=6M+PE'P"Z2+DJI,>OW"%S^5&EY[G@W]P[# V<%7@=>![F!,M43H^%#I^:
M!MZ_ <S]RJ"3YMWY*W9C; H8$6M8L$Y9PSHX6V*CC6.W>B5EE39,V.A*S&14
MFW!,FB<-]()Y@8Y_W![R'R,'>F<M\.<JP[DX=+1@52E[!%+L@6HZEC]ZZY T
M^K8.#C9=8AF@DWGGA6E.VOM OY^7:>U!^Z[]-]'CI&!DL5>IBFX\DHCL"A8
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M_I4^XH[^L4%H/6@96Y0AY<D@I7EO_Y,[F\VV7)9V[]F:H1Q&,7"3^K!YE7N
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M_EQ+#<[@35F^@X@654REJ) #^\QL&"FE$.@S\\LF$SKQ8=&KI,ADR2$W-#_
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M*!T7R5"%U:&\!7K*'6,B: DQ_A&+,F2+GTGS8>K\(>K*L4157MU&.LHB=\>
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M*)%: (6XZ+B,B$KCA(7P9<<1>D_M[872(/>?H8-^(, LT'94ZL'B#@ :9=Z
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M8^W;F]V1@7=N^PWHRS]PUX,>S";;/J77O>8A;23&%QT3"PYN%&;!]7,0RGR
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M>UC08!_XC711DAGG /N< 6#-'/T;$8<QF5]^#S:!/J/G2.8-R[-W);D<,':
M.\@[-0X\9E5SE#I$/@8"/ G/'.YDK#5_#XM-'AP650J_X.9 ^AGV<41XIG(K
M%).+/O8HT@:<DN^F6)^BTD@.OVPF<E%1 LGK_ ]8OUD4&]\,IM#]EJIAJ-Y.
MP^"+MYG5>*%GM[=0)6GRL,5:U"WU*K0I4.8J<$5+X[E6F9=)B8C1V.19-B0D
MD[Z6KF%W=+I&^L)U>YLGK.P)F7-H)XG/(<KX<6H3,U8\M>8A<EXQCZ]&3O*+
MEVK://R6[^^IF70,W/@E-:U!XYTYYJ?&OY^0DV.B9+/=S)1/\AGUSIA+E$LV
M2T&'H^AK"^V+V>XWI%1 IC[_W2R5V6V>6#H>R!47I()!?59@DX:P/":L_B$)
M\IU@R_,8@3TP9:LS*?)%8GNZU-7Q&B"C83P_$Z4]=,]+FMPL&NK*9MT*:G8
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M'YE;>^\,U$??\;UG](>3'P>6C<K,;,]MA@%OAF4XXR<_OO^L/\VTK-W8#'_
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M^'KS<L>?5WOX\O7YT:]84'US]?/IC_\?4$L#!!0    ( $&')5MD<+AP(]0
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MEDU3+K^-_HZ?3<L*U)C[["G,_#LPK!_#..LRS^8PA#?A'>DE[)Q\]R4\M6<
M4]C0[QY,4S#>890K&K4=U-][QH0#_=!'FJGY$N>&IV-?=HB7=4_+I)KCN7I&
M5E09I$E5S.'QFNJ%<[VPE>W:LT-FIG -,B:MZ^A9LAFP7N?)1J(Q(+=!!&-:
M'#Z#08 X3<CPY*_ICT)BY#[&&DV3XAV%O3'[<I8U&T[8WT;_+*MW9'X:D0]W
MJU+T],BJ'8_RY!:%9)4N,9X^ YF8SI]HG'T>1]?E+>:PV &?Y6 I@SX0%=49
M YMCF.::IN#6@\0E$VRZ9001#V \"D8 VH]DMTQDW<"K@TZ[+I>IS&#LOKM.
M<S#O8 D>K%#*M[\ORN(!+$!*"8H(,WKE)M6K-#3,$UQGRPS><#PB$5;S2,%6
MSV:<A2O9.L<A(G(!-1^&E:\W-4P)S '&H*^CO.3YJ7'$>#T?"@U]PB^N2IC1
M M41_$IF!E:M+N&W9+VR8D,KK"H+U)D+V KP*4%L<*";NDG!M9@XH 0MSRTE
M.>6BFO+M'[1-0#5JMA)?;Y46=%MP7G"A9K#C8?XK,"C@5<BLAAWYQYQLCT!A
M)3X@EV;\K0HCEP"E9&MOEJ,7OW!R>+RW DPF&.17K_N-LW=9)7.^Q,@GRKLL
M]/NB3G@JGY6S-6Y\"<Q-$:HD><>Y33QJSAW6:K7*X7BA,:=)RX;3B13,'H_P
M2295OL)P]5P,UDEVT,("B.D=E5.8!CFG:-DF_+2+]11]QY58]R[+-,GD3FT+
MWMR'T DV<=J3W([->]?PLYI!47!V$_C9OF6; B39$HSV=L#,;[*?BPRW"'DX
M 9@.5^?\/:QN<46K([?9ZYE43VY0+"9@D3S5,%9-3E]HL,5XV"@KE$9_.3H\
M.CHZ1N^/O3/.(GF]R?>#&QBT4U:X=#ZIBMHDDI=PV/ ()PM0W&@=P)'%6V1Z
M&'@U]_LT.&_\'&PE6 @4F@,6Y##(3"P6E&J9A#EE46[+=3Z/T"IJ<@Z>79>Y
MQ!^K%&]31@FE!%*T8_!F#;QE$"@P0,V8@Z#ENHERL*(:L1 9NS5M8A3+8)2@
M7*_YIX36B,'*X"O%=??6;D914@Z>4#RC#L8!$A_$;).A7J"]!C^44 #J"K3A
MX&_>2*0\P)*)W=UO,6 @+U\/O#VE/6]@L]M7WN<M23OJ#%1BG>8]._%I>@/6
M,VR9)'JS?Q'"+B!^GLXDF/<MN$1%ZF=3X.YN4L<C">9U)S?BN7V>%D5*.8NS
M*LFNXNC-X;Y-\-_^U]<G#[]Y8G9DM5G!D5R#4"EF&S'6AI,#O$UWR@[LH;W?
MF5QT]N;H-I[.9MLG5K,N8(G?/;$GD^3@=G(#UO2^S;";VF=9K1&$"P1'KO-T
M**[6=VE;Q7N'"50BGP;,=Z(>0XU\/\TIW;H[PS%YAUD;1H*&!M:7<*U*0E$W
M-4 PLI6$_FX5L17[S;='1U%RN#R,)BZF0D$6M%8.R&#FP'6TS.8%VC[C4>^5
M^%!85O.0&&]^O.7FD@FQX\J6E-=N4M@*!A*#T2BLZ&$K)X[6!>PH#.@XHXC-
MKIG4&*$1" YZ4N49&D=H>(E;WLJHQ-Y+WC:C6IVD<]!Z'_"@W6S=,:%]TU24
M$<+U)9"ZVZ3U3(<W$<>CCYR._3UU@M\<$&B(^$2M4;Y+'0[703ZG.1C88+%G
M^^N\GR\6G'K?%F_C_>=K*&@+DX@"Y<K)643>@>X.D/L4.J$MRJAYANDN.,B-
MP="M:5Q0]S6%K<:C.7KKJ'!2-UHY!3[\ L)U>F"#@";+N^T9+C:&6',;BR64
MS/&C1XP&!TDA^.S^B]079?@J>;'TY@MQB%5Y<G("TP[P09Y10MMEV$69PA.F
M>3:#J["H04H-_#VY-$T?C.^G#[\I<_!?><!@OE</RL4#FFB;5(")FAVT1#1B
ME#:PRG"W G5[+>E]&CG'8\F5G<SM%&\K<\"(2]^$)11]77*XDTJB@HH*1B0%
M97S'0V5\\M;CT4ZOO;\GG)#6' L/C_B'@IG&(PL/K/?-H-X%R'#R)'I->[O^
M%@<@\_4D^A^,:\+7_RZ<P^ZST<5RAQ"'HY[A$)3!3H-.P)/H<K."]SRMDFDV
M>Q*]2I8I3]*K$E_])$ ZZ*_PFWL4QA^]O8W$T.0&2-D!B\"(8GNUE%8_ZI96
MDUXD;Q+_JEQA=3U05[UGLJ5G\L^2U<#DMS."*["K9MD*S"]U3GY*JG=IXR[P
M ?(HN4K0PT#LL&8HW644?:\S!0[T8_7&(ZO.![.ML7X++^LBZNRX7F4W.$:V
MY7QJE5*O5^#"X58PZ,&A8= =.:DP971@&IH:PYE@W9"-_[8.RZ\;+<SCI,7[
M60H?'G]S^,TW?U5KA$=(QM@ JE'&A$\#.P5+5FEQK*<,2X<&HDX5IJ5=P6!8
M:L))E,ZTZ 0@G&6^GN%QHR "??T ).8#^A=7/<9J-M\UNSIT@J +L#&TXC9V
M\O ZV$B4:L.AVVFE91)KT"VO094.KT&G!%ZL0Y.?KVQ\*MS\>RQ T+R.7@A<
M=D"&.#0M>G##^P#35RN'65 L$PRW1)2N0):&,'B=+2-Y7SPT[ # 2M/F(=^!
M(?<A#!G=)S)!I0J+=G "L_0+(YCT+"+D2@8'9BQN;C>8+J:0GNCNX<L:_>^H
M7!1D9I,28B>XO7];\"Y@%V;U=<] ^8.TNH%9JD'?X<YEBSK(>://ZF:?1A),
M?P_FV"<9*6]-2<G:0+V,9I9#['0J2J(O:5B>+\'CN62=)4]:4SY3X<T'-M,9
M]20Z_5A,@O3#Q*(-CW7E'Z@=00BR1&FE^-F)81Q@6JCI$8'C.DNWW):(6@2V
MWA:,K0>PF)ZG?#%#W-VJ@!B?P=YT*T-_M]9'/NO>>6*PF!08 !^6Q2H)23XT
M-<B\IN9;ND+F^H!6"4\F:MFY*W'L><P3<ON'3SIM-;N=<)\T3<[S!%?;M<(,
MNS!"Z>2.1Y+(IJ*C2.KE<45H>*1 _W+,I=M/*)"@7KT"]:,63E^ _&TD??AM
MY]?CT0#,?^ ^<AD,*;U#$*Y0H7*PP\/^4=?"RM[@]EJY)Y"(XU4U6I*6$^^0
M"!(3URZ=71<$YD2S+&M(_R=:[TX$5 T_ C:/P\/T#R>";>VCT?3.:*"\>?X/
M3P#V!F\$+[LX:,-GN@:4L0=IY]5NK@.E#?H8CB8K[*YHGL,=T*N$MTGGX]&0
MKHBC[><;7UH%AV,MT_@.GG1WJ08W;#T_+),&S X8PS>#*=M@_+Z/T(-&(!$W
MFFI?A8)U@8SO1&$;_+AVX<[P%#>:&0/55FG$#=Z6.$G@ A!MH/O+>5C&>HR)
M2Y+=6<$N5#A!I$]QDIPFYVA.6>1D:U%)C=0I3HR-"2_5;!A[(JJ.+P)1PB8F
MFHD@:M)\P6 >KF)$X6-!/3@D!.SBNQ-WD8/_X.>WA53^%$B5D39\3J8*3:\W
M\#W.'&PE9PCJMTX?VTI^?C<E8PFU:*1%W@@Y3@M8<CF8K=IO/E(JS@C@#.;$
MNC$@<M:&8*C:'8XYF1Z>F(S/#+Z]V:=P4,&$RR@)5BD&F P">&:59 1MG26K
M3,\_AT01& 3>QG7)RF2)\5<W7?@D&COSTQ6!5*<LV-6![LCM.K<5B4V:!S#"
M!TLRF F?7#-) DT2!8/H\&#0>A.<5M9_G2(G >GIG<C90BHLI-[S -OVSX*-
M'8<^T<,CRH?VQ*5=YF(\>D9%:.Y$R.,%1]:1G7U2,NH5DM=M(8D3@:#VF,[1
MBMXA%Z) +_-!YL"!S$*97L>RW/!TVLDP(%AR^75(2I2P@I7[8.S=/BYAA'G5
MN1-_$>S<#Y#-@V8\IZU[M0693QV+1>0;J&.V2\<C9/T(D>X?JT&&G0TZ"+\,
M##08I91/UV#QP-RG&(ZJTZ1"'D@L14VFKB22M'.9EU<PO; E"G1 YEBF6*[8
M*^>C(^L1U'3X@]32G8@I!_%77V>KVBS0Q[[WWOJYS\_>G XXM\]A5>%6,$55
MM88'O*EPI\U20__XU5<V1KFWD_C#Z>F;3T88<;UO&2$_CS^6SSH8RO'HQW+-
MBA\1!\2%N\?S Z?1<W+UX<JM9QMS)< <-7@/YY<+)&(@BM23X_,B1) B/ ZI
M],SA/=!*K=@$P[O\^#H<E.Y^))S*';2A1>(6,(NMDHQTBSX!R4#8E %-AK$=
M_ 7HF<:'!E -D&WH1I74G/"G.-(4 <]9,04SY!"&BXR&T?$)(I-6.P&+9)0^
ME&Q*G#;= ,B>;<A=4K@/[[.UDJU]>)^M_6QWLA>M+T$0SC:1UGT/%<RK,]FN
MU^F $DEB#.:HM#J3G/)5.J/B;"S@!0&'KK-4F&=7Y."2\P^^(L9,U]:EI1"&
M'0=FB-+B"M>1O.V4;&D!L#K,ZW D=\\$F5_^%P7ZBNF\L_:_Q9*;3O?7E'L!
M4I7XB- (>"/>]7C$-,2?@@H*)WBUO_,+\@I3%6_390DV7A=V^O',?\>3V1Y/
M:Y86O>6:40[?Q%CA6EV!O;PBLE37)V 3:8PA!OD[6R^)4R*5+" %2K.JQFCX
M8ETG.955$GP3ED<NT<"'05ON[RJ4LW</?EYYO32DC[L7QD&CE4ZEP)0C7,FR
M%._%QKV::YN7)NI;=@!N4I>ICT.F='B&848_PV&V*??W=A5_PO@PE:+-,>B<
MCD<<;-Y)^DOAR5;UNK]BRDWM&\JI?3J3I3@X_-O_^F;/*+M--Q A$.EIXN3%
M#MC<VL? IWELSXU0*%!(*U)\G@@@+:AJBZ"S/-DT.()YLF19<TUY*PJ($%UX
MLDIFH'#B$$'(B;6?JD/^I9PKI-3'E#;A1 2:TNX%Q:\<MC^Q,!48L+^MK>1W
MM0^<Q?+5+#!@K(2X7A=SJC9!_;:))L=?'QU@%JHV7HAEJ2&L(Y$GN?<&%Y\"
M^$B5R)D$N")#-?FMA*O6@CAQ%=EX!4,B$_"LP#D&P:V:H.7C48X(9HGR62:7
M&Q2:2.(VD9!4,5?B1$X!.[U?.["(>F<QH4HHD":9;S^/J.T-H>V*<L?M)-]U
MMK1L#GUOD'AN),[/Z0(PN3Q"P'"',K-"*]^+F?WM*2,\)JN4SLI@XH2+_MR;
M]0(0PC&.1[BRZQ5&!.7)1?"H19)5[&3#^G'5CN"^:)1P_*=5!M:7!6F=!9W1
MX(YL3'$85/I9S,HK;ICF4]CC$28B_6S5M/_X26;7BVVPRWS$7-E31+X]T' 7
MKE3*',:C>P^\G3[&LJ@L %YR1+F._G)\>'04M#U+YO@05RE6I61O:,^$6T0N
M6OQ7+'_ID78?6% 8(^MP%X%&E61DD&[UZVX86''/ES/8EO>AEBT+W::I=\2[
M1M$11L_PZIJ$+^B!:EV3FM!+&&6]+H)/P(HL9YG\GAIX13<PIC4R(1&8'Z[)
MLV2:Y2CT9@Z4P9>Z+<''VI/_$1 (<1]71&!!D-4ICKMV.*42@6'JT0DL1: E
M[^ =]W?M \S*;&,$7Y<\);"TVK\TZ-,[3*H^K$Q/KRD#.^RVWF*?LM.V\WX=
M>3[[2!I".O*?J!'4#V!,K9"&G&W==77#O42-(M\_!J+!6748W+KO;*0>/FM[
M!';P:EO)N%WG@N'C%2NB<0A!'++'6M=A#8(O;^$]\:\!+O;[=6^MNX"J^U=_
M"T21)[^/:'T;$GQ_I[]+]WFW0*.9]#\,UL =1@MP'X@.$/C*D %U&J0*&['C
MO2=,[@RLG+EG/9 (CK!!,5N3_*&!3SG#/6T[7:B@U<;4EE"Z-JA8(O<;CKA!
M(:?O5^C5WEXSDRQM44*!8&/=/=N+NP J'MT#*@10\>@>4/'9[N1M4G4\^LWZ
MK*/+NO)LST2'G? 2R\/Z6=7179T)^W^>9$L,GV3D05-%Q)6+G*W<74Q58QSU
MD\0JMT[><Q_D_&9@O=P/#$F*!F+8$13>JN2:J(/8X52(]!Z.\EQ*9K# H-AC
M6/$;)C!ZX0F,QJ/G29:#R_0I$!2/P$[8XQS:EMD%9;-IIYWOI_ECIUD;QSYC
M.!NZ-V!)[Y8&OC-E>3(I[^>V@@U;-9M/! #Z>F_G,^#=>RL%_+T1R@^=7;RH
M2F>X__?70NFG->Q%6PFUX4!E\#+E:C&>54?IYW(R/>MHXL6<D[M)*W\+>IC6
M53K7V]70#A+T[?%22B>H4\H@PZ[^9!"4='_EN5;7]QP)QU1IB;XZ])T=YJ:0
M[-&WN*7;*9^0T'Q0XUU8D565$FD,TDH2T@/O!?]E0 /5!TL^%(F#N(16B<A,
M?Q EG^D.$O8%U7NOITB%@6Y"SM?4,!17Z4WX.X%RF%'O]^9X=#*X.>"K^\VQ
MKYOCXOP,M!Y":CZ=(-[C0E1_,@: QWV!=)=LOK<6!J=S-S),SX'Y\)X#\^-G
MO1UMM;/='V[=X[D"T1E=)/T]/5"&NK:E>"%QHZ@OV,.0=')TA%/[UJN^BQ]?
MFW1[P/8Z"=ES@A:L0J4S'G%W4BX91/:Y:5E5S#S>OY)[++N[7&:[@HRZ)&H&
M923P(JS!5S$4TM&[?I@:2>\6?#+)SOW2=&CF>I)"7\=?/3Z*CTZ.=P"ZB-&8
M%"TR03P5!!>E)7L<G^ =CQ_VWG$\^I!;/GRH30@<AP_N#(4&+C =SHAX@0,.
M,/S 1%4;)H=J+!$?;-KV%M0D_C#5WST4Y_?;H;\=C--.7@ZOX_Y.?[>-;Q\4
MAUOZI DB6C1:UZ:^%NI,/J3$,(+0\#Z[705 P/%::UT^=3_*RUOVDSITW^-1
M@7ZI8*VX? ,S2 @PZ&%*)1P-3('JA>N4V99E"GK>/];=%A"D/,T:_L<Y&[I+
M\+]_OGAVAHH'_GL93999L<8*HH5A>H[["<O=G'4EW8"OHZ*()]E@B'"BL:$<
M-U1!; ]/6Y^[5*4&^$-MZI-Z[WS.7: _C^^A/P+]>7P/_?EL=W(HQ8GA=-.+
M1-E0<(\OZ- /]M1(F=B6QP\2:J1*0^&6U\YC$@*5BB#^%166T+_]HSL,J8@#
MX$BGE-S-VT4\;,OMF83RZVJ:]O4F[9!BM+0DKT,M-:A$= 7*@=A=^:N]GU6>
MFH$3(UO5]QMCRLS:LLC7X>2W+-$HSVHIDX*;:U< F?R P B.'<C5FCL@$_3X
MU3\OSM$Y *L 9P"O?)74\^17Q 8311$//OCJA[R<;OWF@HHM=4L(SZ]C9I,F
MZAHHF: I+MRT,^&*E7X(;F[ B@&;Z&K?3(A@*W7[M/0& ,.N*$-4&G?FTCLX
M^)!6_E(9JWY*BN1*BPY\84F_%Q1:RXP5)["\B'_74;?AHGKZU/R3]@0!"N>N
M5TT9,,FZ2$T?H2T.:KB=RGU8F3;9(JV&2K]L(-]=>V9+.6F:L=R<0Q')?%X)
MI]K)-T?'T2M0,'D.EL ;D RWV"#V8IV!7'KX]5&,U2M%"2_U?Z*O'A]]\S#V
M;-DJ%Y H39Y*W-GW3+^Z;IW#N'MD])3XY_N.\18NG=83JWA+H-33$QA*B/NU
MDIGK.65A.9)&I4^.I5_'SQ=[74KY/_]H,3)+Y&@A((4Y$XY<:ZACGF(&G'(X
M DE@PJZ.W37+D7-$3@<Y'VG]+;'<9CU\ !DIJ<+;7N.1&%_47BPT_6(QP;#M
M@31CO27R%'1$;M(JN6H%9H)'N=9)9,--Q)PJ4MP-V!P@G3&J'[_&AC=A[W$U
MPK89D.&;J!698%\FS^7Q-"]++)&^BEX>OCF,)E,*K 5OBWW."3_RS;</C\"H
M&V3D!8GPZ-NCDV'.W@-N_30P\]0UIW?,+<O7#6T\DGDP"9X/MJ%?7Y[][Z=X
M"?[C__"B?O!RCD<?M)[X[/"Y$;.[.-\8VQ9]S#R1-M77:S\"*4X7_!*U[='L
M;Y\P<4WA]XC,TINL>!>]1A]0IIPR)PX\5%972:%IB;(2K@6J(-'R%,R.@BVW
M6!>>D(.?@M_RH YX^I<E<>_-*(^7S;M]@'HFIB[=F%W39BR]1'879@69P=86
M0Q<I:\0E8\IM[@GC[A[.2=T2-RW^&R3E23)$=3LZ&G@P-G_ YX#IU ]4-?P]
M6>%XB7JZ/M-ZV#Y4C*-(ZK* O;+!ZM)TU=BZ<<=M0^^:IDJ.M\)>#C3Q)#44
M;J0!][#;R9]/%W&X\XOOOWOZ_>G;RQ=G+\^C%R\.OWOZ%A[VYN>W9S^>HMO\
MZEET<?KR_+LOGW[_.X_CCU.\)X?'6-0LMALJWL/H=1'6+3/'ERM+]_Q(K;KC
M7KHD[> 4P@+A4FWV[A.JO9SM$NP+<C&R/:E2#2;%=E!UEBQ>3($&.(JYQQ_Y
MHX<4H"C,B6M+BJ2)/P:M,OJYS3&+S^O[X_6ZSBI)?6(F9-"*S<2H..UD=<)4
MU&%T'F3+]*C*_&S-+$4VL43)-VS(4ZUG!L#9)A5@\G]%%W9'9Q-=X(5PKBX(
M_O9GU,3-=Q[$=--Z0MP!9X0OVLD;DA(1,AAJ@V1Y7T)1;?&S"I3D8OON4TE
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MVNY,A36$SA H^]ZM_ TN?!\O&=-,2)MNSK,0J'O1-N!M <IZQ4VF?3!OH K
MQ<+(;_)],(< Y7V1"N.?TYKV]MI69$6G9,6-X"]'AT='1\<*WS;5P>0Z@5/W
M8,%SDS0<JA0)-42WGM36.Z,@[;YMJYN#_FH.7]NT=S,B&G.(:7;_Y@-53F&C
M&[=$@34>*?9IF60% FWXB/]?_C].L(8"2;X)HEWP\').C99F,QOHVL-YEIW7
M!3."0K5&;5_LC2*-=[3_DC NJ77.1>S;)&?O#X9PH09.%FV;[7V;,IFQ[0"\
M^QFS,Y8-*M7[">N?,/9J4K N%Y2&<HTM+E)LG]53:]-J!.:N<SF%,W^WL#_8
M=C<6XS8\D(UA6"MSRMS4J/,"[I^G)?;GP2B\E[U$*J8_'@9CTQTZ]94^L]J+
MA]=KL \59@>V%CIJERS1VP(X:[V=8A"PZY!M#70*5\URGRA]4<QLFZI@-;"X
M81X]W>3)+8\0 5OF.8ES1ETBD:]+N(*;&\QH(S&\)O M>R>!TDKPL@8F7XQ'
MTQ2\@D5K>$';RW:'2QR<H;0_Q\VRAP>P<P+IF% U;,\YX> !=[F$?8R)GK/K
M+%U$Y\[H>,U&!]6ON:^?9P7L6;3VY.N[CJ/?1 YCO5CGBRS/;;<;BQ!PA<\A
M0N A'.Q)=J X ?HK.QC8&>&6>/YOV!+_GN7?+<GTU7V229),7]TGF?[-.W10
M0-VTY5-*[>]FKH6G(\*F(TZ 4X<1;=D.PGHB*CPP,8C8%?_!$?!8!%/"*(ZM
M6 I?DFLDV">?KL](:=@E2><V* V&KK$> LN!9M3_:'@-)M1##Q:,L6/LPQY\
M\-)@IFW3JUR>X$;Y,R\/:#OG8-R"D=6D5#!8<T2! [V<><1(K_:0Q?\&],0U
MEJ_Y.+$Y2,[6OBD;0^;%U245XOW3.2=[I%5K*U6);7#Y\"9"Q'L'L\^3R"6T
MVK\([.RDS]0>,";IGD/C:-\5P>YJ=U]1BP=!'N'%0<^A/O3.5\</]<9!43(U
ME7.F] ]K$&R$5A.^4-J]>!3RS'=-"F] E()/V/1&46D@C/I*/'Y:%2PUI+-6
M4=->/F!=BB>>$C,%X$^8^<'H.W?(K4H8)CR!4S:6C\CM*T>U;'VQ/Y&9W7/Z
M\/BQCDH]3&\PGS4>M9RU#D-7*R_J$Q^N#S+N&2R#,?4\;QR)@99I:2JD+'+*
M[I%@18N\@$.,#8X1N"5[_#]3>_6M16<Q</>2KVU*269Y@@KCE'JY$&<[9L!:
MQH.#ZL%I 9^YX<6AGT9/@U_^\0H&V0VRV>^+6GO^^M6E?>J#NMGD8/<6U%N'
M;+?W!](]1R#CE#^6*GUCTL%?0<W[$L5K)I)+T,XF38W**:U%O!M$?#]5'2J^
M]5);I?2)]TZE_!2K?O#U?J_2E^T*?+H+@&@K2G\;AB@(C]PCB.Y $(79[C^1
MWOH@$-&'9DU:L_9[B,//?N:R@P^"2J"EVBX+">H!]$(-AKG:[DXB]7,XQY>G
M3U^>1V?G+U^^.7WV[,6K'_[KBZ,OZ.^+-Z=G^O<_7CR[_/&_OC@^.OKK%Q\[
MU+NB/Y=O]<ZHM$'?Y/H^\,,OOL>Q/M,K;K-Y<PT/9U3VY;/ON]\='9[0^YX>
MMB_H#9TH1A\1[O_7_A__^LO+M_@_.%F?9L7H?X]IC+L%<_[T"_5TMX62"HK.
M.OUN*W6_/+0\9[LMC]:UW)^C/VJAGNVV4)?<%+-[C.Y7ZM^U4N>[K105B/W[
MUND_PFX[.7QH& ' 3]+TXIX6LF!QKR_DJUV4W\5$'/7T@/>M,XGQQQ9C@F$G
M\EG<:4HTD>EG8<3^VYW1% LGUE4RVRAIBX9"$.U-Q?XUYD=BG4.X$SI@5;J"
MK[5RG&(HTBN BBMA[A%*[1(O>E."7U313_(GHI72JDZC<VI1%>L8],D'!+3H
M( +$6VF/@:BT_2 4K.+CF!AV8>PH(["CB93(:GI',OHSSO,(3AL');0MR&2#
M'V\\D3=/'\(4:H=5)ZJA/?/<=\GV?WV?[9=L_]?WV?[/=B=3#(KHJ[P:BCU/
M" /0#$DJ\BV$H=%*FWX*X41:"65VT@P%65FP=>I,])=[)DPF#J"NO$21,!^,
M1P%+ %6E#=+"$.G,]*!+@O%GF$[Z7Y*1P<,>/L*#39E95M?*!-(#Y#_+DTU#
MO$+S9$G5=A%.$Q*TW&1S+(6:):MD!DH[ULE^+2'$3S^36]_G]YV[K:LG$PKS
M69346GF-R1#,@L=4$">-RV);!%$1I<@<D29\+:5)T63]15CX.D<=A,N,*/1(
M]> _;)<^9"\OYF55*Q$><GJM*Q(G5]BBN2 6'S#: I@K9O)3LM=^65=9/<_X
MV925A-L+670[9T6VD.<+OP-6/(1U^&2+]8>NOBW5NFQ7T(]'M'[E5*Q*M%ZI
M]#3?1(NDOF:$V,;1<RLB)O8&\!LD1\%/''8B#IIYJU6+0K V> IJ ].79W1E
MEP2;3?+M=:^&1FH;8B":^ OQ1;I=K9'9"U7F8CRR)9/35 #46+>%5)%YR1AM
M_R:(I%K#I?!&,]NO]M/F<+:N^6>RPV"+(3VQH)AOK\%;W3PH;PM,#)I.("[
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M#R]:!S @Q8O[5E#-<&+!2UO#\[_X/ENNRKH3-)->64;C4 I1#4^"5[O>-N2
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MW)KX&8/QL,?I= (Q/IHN(X;UD7QS[Y36I:*=)0H7=OYN^YF[>*KWKJBHE.*
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M,CI+5LG,Q0MATR_=MLC3X@K3Z0ZHT@<ZV8XW'(2D2'G]-*3(5**&\*V'7C4
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M<-9A.D'%H#/K\AP8Y,1C19_>,$VV$WC-=5;-I2\TW90ZC2;DVO7T <H:]#'
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M1:AVB6@JGT0OC \;V@J'T>LB.EU?P2.BXV-B>'X<^Q(7L\ (!A'64J<*B0I
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MKZ'1$FLK(;/P=LT3N,3 F6V;(IO[,EGF&5#%.-?1I[K3I@B*@#/4,T024N(
M:1N8V"%&5E_6^K/GX+":D3Q#>!U_H?\;D<D1O:"0+9@G!XE(P#& [\X_,S\K
M<M/7TIED.V88LLN0&C((/%)ERFZJ;"0'Z#X[VL0'[*J\%"3 15J$T5IKDGT;
MY8#C2<CC\%LBW8-B$0V(VL,@ALMT7/_"V-!F+&F,\()BAEQ?^J\K3 ZKIT<^
M-!:JG#]DHIH6\94C6BQ^2_:^WD_,LD1<^PR.+R9I;KTTY=QX13&"=T8QE#[8
ME]1RY81:42K>#& BM=^]$:@H."<:R[AR=575@.WE:((PVHN 9X*%![D82ME
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MZ9>3)YV-RWG3FL_4QLB!R1M)R$SZN51#*6YN'*KOCM5I=%4J,AZL8-T55;/
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M[?*.$"#GT''J2?"Z$( <,HS5]VQE3J4/:^&(N4;WR43B(-^B- ZK4KJ=.8$
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M:M<0#)I9-&8D-Y"\HR/.9E,X'LFS"EBW(8HG766,OP$*"BL:M@\7\O!LPT7
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M33G<NHN<,=-G&E1H)D3W13V"JR@=U?R/RLF$UN=$3QU]%^]BG,*;UJ1L8.4
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M\F92CCY */P__\=WW[Q\^3IY>?#==_^ )B+YQ7?PB_V_QI3T3\Z2,^Q0B^R
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M+- #;-1. ;EP@*V?,*]0NW-__$V^[\ZH>@$NAPF,5C1MK92BVVRM%:C? P:
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M>7][_. *.?3MRG]CWVYK_L]W@'>?G3S_#7G"W9_/7[]Z^K]02P,$%     @
M08<E6_F[UQ6Q7P  LC<" !L   !E83 R-34Y-#0P,65X,3 M-%]C;&5A;BYH
M=&WMO6MSW$:R)OR=$?P/6.UZ@KW1HG6UQY)&[TM)E,T(C:0CTNN=V#BQ 7:C
M28RZ@3: )L7SZS>O55E  =V4)5(V.3%A260W4)>LK+P\^>2S7X[^^>;Y]M:S
M7_;W7L&?"?[OV='!T9O]Y\^^YS_AM]_+KY^]>/?J7\GAT;_>[/_CSJPLFB?)
M_7O+)CG*%UF=O,W.DP_E(BW&_(-Q<IA5^>P.?!&^^OZRWWN:+-+J)"^>)/C1
M>T^3)OO4W$WG^0G\J,I/3IL[SY^]>+[_Z30_SAMXX.ZC9]^_@&&__QHOG&1%
MDU5WGO^M.*Z73[_R2V!:'_9_/C@\^K!W=/#N;?+AX.=?C@Z3O9\_[.__<__M
MT5><Y[]7=9//+N2'>3'-\*'W=A_GQ5>>_.";CT[S.OF0G>1U4Z5-7A;)!Y2
M.MD[J;)L 1_=WMII\$-_FT]_7Y5/G_WZW/WJV?>_/O];13\>)?"113K-DK28
M)K3<V33)BZ9,TCHI9S#.99,MCK,JN3].'MQ[\'B<'&?->985R<MYEA8ORRI+
M#LOY"@<!\SHH)KOC)(49GZ73-)F4U;+D$=* ,C.>E^5BF187=C1C'D8Z.<5W
MX\?K["RKTGFR7%63T[3.JCJI87G2IJPNDE,8+8QTA[Y0K^ _[F,X!O^J]_IC
M\[+M+7C7&$8XGV>3)C_+YA?C)!RA^UIM![E[ T7-R8Z3%UCI>I6BG,$.X+(=
M9I-5E3<YC$'7S7]MG$S3!B1KK5#ADT0P2!;PWWX;DB)=9/3#*LN+9">^7=M;
M45&_<?L6KB0=$K>4VUNXAL?P*URJ&C=F!B>A/*^?7.E@[U_3(M%[[^\F(#:O
MLEE>Y*2_4%QVM[=>ILN\@:__%\I:5BWJ9%6C\,(J%F63E"A_YSG(]Q2_"K\1
M>6Q.TR9)*__SO @$V!RC^C2=SY/3]"RC3RQ E>;%29V<@"(J2)?!P:)7]SYC
M-]F3@=%'["EE1<8;"H^52;3>Z7^M;[_BK;^V$Z)O]E?C]"R?9,'E$-\@N(\:
M6+BJ.<5%/\2+ ^[>'W8F5ZQ=OJ&U QVS@#4X;,K)QV %<<EJ6KS)/*WKY 7<
MM?31&C^J%[RHJ'&R3*OD+)VOLN1_W-N]=^_>_60)%P1L0Y7=V+7=G\W8-BDR
M6,!7<(5&5G@G'R7G.4ADE=5+^'@B%S(I-3"= C/QL(&'D :JLM]7.5I[\/%C
MT ;Y'/ZNMSK^4*7[P4XZ8H62I=4\ATV1K=O9&^&?VUL/[ST[_/7]\^;TV??X
M9S))YUDQA?V<IA=6"\%W7N=S_"M.A?3IS@MZ1O( _OYB5><R4;B79J"TZ%=H
M.01V 6@Z4,/Y+(<![X!U.9]?)"7<:' BS]$"*4[&R?EI/CE%VQ$_+>,>)7#?
MD:FR_Y)U-=F,/>MSGL/Y1W4/BU-E9WEV#J\KJ^#G]>KXW[+BLU6%UX)\%(S=
M$FQ0T=TP#G@@K)JS26<K> A_5'93QX;'*:]K& NO^4^ZMBJ/^*_-%GB$*PPC
MR2,"0E;!=$K77J^,U+Q*"W@)+4)$8/RH:6NL_+2N)+C/XB+TZ/'&TD.B ".D
MW0U>? X&C!T@CHZWMV>6VUM^JU40_[@0)I>60;AIOI80)I>5P>VMKR"$M\J;
MQ.D]/+:<?K:)@4KXYJ[D6>C*77;IIC=\Z;J6P^WZ;;A^1I-U3:]QU.XZV-#N
M0J=Q!>^M.L856G1D%&UD5_'%^G)>UCK2,5X1=.W?[[O/R%P_+>?P^F1ON:Q*
M,+WA,@$+'=8S4\VUF_RVN=U@;M1:;NBVY1 W+R<C'*_^^R'\>ZQWE%E^M9.\
M6\$K5C?)LDKAN[ Z=$UO;T4M!+B#P:%8Y$W#9@M>P#^O\FE:3+*-+(9@#^<4
MSI(=UT\=SVT8[,:>F5](K(+C OO;_KV-J9I-%9F$+_#?8&"I>)$8_6")&B>S
MJEPD#0R<]@#_A'-SNP_!/AS +Q8%FZCOTZJY^.PKX/%-#G#H,E[@\MRNXQ]8
MQ^Z]:.Z,N#I8$\3H1BU"K_/&+O:;LJZS^@\(Z@UV-][/TP*ODU<H<?DQI3;_
M[(X;O/N_W;T+CGDVGSX!+7:2/847_+[*P/J!KR1W[PK<X=FK@_^E@^17WVW*
M)7SDP;+1P=P]+INF7#Q)?L"?'9<5W-/N9R_FZ>0C#@+&6Y?S?'KG>7O:15DM
MX$QO,OLN', -@H9U+S(J^-D=P@,\^QXF$YG7<96E'^\>9[!9,/DE+89]Z ^1
MA^+\[4S,MMBU#EYI5OQ[7')>Y2\@!M_(.:E*\@M6=4_<?^D^ "=B,E]-.5>5
M]FGS'?X4!\_ \2A733+/P62G#V)*WSR10I/RV)K\DKR8H6#10Y<8V"I7]?P"
MC$\Q^LEF#)[!UP?8ETNXUBDX5GCG!ZQ\,\K:C1)F /9_3G[#:HG0BQ78FX\>
MWMO#1R]6\Y.T"2*C$DK;W@KOJ2!EOC=I1F3IIO".*0?YZM5R.:=W\N,HP.H'
M[W\=]T,YZ2>!UA)F5:&2*F<(?( '@:+"><GOXZ9S,BG/"!&";^_9-<9LH$*D
MO"A/@)U _(4?9:T#\W(SQJ"];#F,J&[N^M7WS_%O@,V%68#J@&\)LH0'5V4P
M/=1EN&Y3O/LU3-W_R9SSK&8XWX">OIZ3'-_]6,"# 1PH0!R+G\%JHZ#E!8L%
MB>UQ33=+,P>IF;#K/T[@'J0]9 G([KY>D9S_EE85'HE#3/3!"W:.S<?@*N$S
MMW>"_Y7/@M&H'Y[PAP]1*F$.DP0SN34,HOU8"O%/1S3RVLLWG,P5'S9X7T'_
MI$6@<TV?Q>\G]7*>(X8E/\MA!>GS).S;6U-C(XQ!N"8*'?#+ 0ILGE82@(\=
M5+R&3DHX D\1CH"Q&'@+K-AI>8[9 ]R&L6 +<$0V71!NF%HFDPQ=99;_GH.]
MH^ :#8_P-UVJP6=2%FE>-*EF$8*8-DL"19LH>I(6M"IPJGL4O MYM=:!@5PC
M71"05;H.4&+Z,R/=A:S3.8ED>XE 8.R6@\A.8$=@>E[;=+1UPN/LJFG1:KV;
MP';A,8&90 1K4#<D_]FGR6E:G&13BH: W("^0]&;Z;LY+$(7Y 1T%@>F:)KT
M-C_6/CV,1V>S@=G;$6RT:>RE=*O=?_2(@XD3>;0Y.QPM3. J/,GQ32#&N"&X
M!WIYGY7SU8)T,JBM HS$<G:7/@"?@V-#%G+-64K]"CR^POU=KH[G<)Z#.]U<
MGSHZ5$B!W9U2_@WD)RF7X#S"U^990U'/TJ[C&*-\,(H:MV8*<Z![CC"!N!+9
MLJ'5$\$ZDHT4/:1G)Z5'P29*1 LD%A3(@K-@FEXV*T8/[RH@KW&R3UDUR>L,
M3M"D+&!(M2@1%1X4%PIMTJZ@N>"5$CU!?ME^\SG,SBB[5/Z%;Q[S+V&XA432
M3L%B%7MC>VMO!D<[%UT? #8HXYK690%/N7#70"<G/.:!T7H1S 8?-"E719W-
M=7WEH]^"HW2]%W!XI"-F-8I/CUT:S<][C=L'[7!2:<+>\3>@.0BVZ&))P6]*
M%@\'\;UM!Y8] Q QB#MJ6X%K;$9WZ\6'1?K4/LV8E&!GT!.';$NX]C(&S==Z
M$WV>Q4E0V'4FYYK)W-P30$[4_<<1F==?#;M7R;!W1?J*;T=\G&2FC+>58W !
M!,9YBC:[,"8AH[T3<Z["I]"-=[*:\R:B['"&+9V6R_@@X0ZF4!'8R V,-2?<
M"-LN"P)5HU7 >%V2UF#4-UPX'CSJ%8X'CVZ%XZ8*QV$VIR0QN7J<--S>^H\5
M6)BPID4*5Z)-+5PF=OOPVXC=7M.RFOQX#^J4$7]HI\\O[J9G*<@^FK+. ,<T
M+ER=)YIE]Q:D2CS(^6S&MBP\"_'!?"F++<,F !VDWW%#Z^XCP('A9Q#>H<==
M@]_)<#E&A>>330U_0B//_@8J1H;C]@^>)N^6-/@G.!"1VZ?)_T(<-?SZ+QC6
M-ZNAZ_ T.;I8PG3WP./-)T^3MZ M>:W>EK@"#X) O'X+?W.;)/A*0OR *FNL
M5T.E-3>GM @=JW<%&0;+*B\I_$ .D$$TC2,!.+ QENB=HVZBF!K%8EI:LS<H
M1N%Z!>%*+ :#=/,YC&0PT.]*ES "2+%0]D\H^D^QT+4!* H 4>944@WL#5&U
M( T:O<>\6)6K&GS'M$9 5CNB U;^;K*?]@.BVUXMK]HQO>$UZ)_D\.Y]#D)C
M#2DG)!#>!IN ,0P,)H7!+BZ$PU4>6R2UI*_.\EJO!N_J,K!>7HV32BF5T#;:
M-DXH)VG3P)31@92*5K#KL"JI*+)/R1Y^4MSB_E=$C*# ZI'!ZYN2R(M>X!>"
M$#1%GN'4_/J\&XHN2@U8NBUH!2"X5A-C5(4.E/8,S8.LTI%IW(\VC)_XMZK&
M7]7@EB\Q1,<G:'M+[0I8\IKJWP[#_3()KVXQ7'C,5F!'H[]_C/!!$&RP_"C4
M,$GQ-[WGBZ1O>TM#PT%A[+KD)7_)!DA&LE"1<'1_\+DF1V?98.@6_U&"2L"S
M[*&=,]8P%,HHP3 ">=/  ^<@8.LP@H.?3B4PMUR"$4<ZH5MR-#;2'ELW"GM\
MS++E8#F-/_P@N^LGRB_E]0GRH!28$<<L2!=L;Q79!,:<5A>D;(MZ567KRWQ@
M#[WE2O42,]*![H<N]<+:9(/'P)&9<48IU,%#^E=CKCX14,/:-/G<5I_@,.;S
M#7*UG0G;:A>TW'TJ ,/_8Q86WHNRB@;:/:98O&/*&UPNT!_4C/L(?N&?PVOF
M;/]$UU%/KP;8T%582@[>W9 #J0/[3)XFOGY[BR:6UI'H=3Q"'2S-Y5,-232]
ML+VU<7Z!KB6J)!%G:4(Y?3[%W:,KK Y3\R$^^6(,H%R9_ F5T($NPE..4J([
M+I]V]V&;)V%-I<MH-SGJ:. FFV?+T[) V/;\0AV\,,%(1DNO,N94].,G]^XE
MR]W%;K*#)MR_RNIC\C)O+B@R,V+# Y9WRD;716PH.2SD%,T#& ?5=(7'\"Q/
MX4"G$PKND(R#B&1W%W#:=66Z:=&^0<LN4$#'#(L/=R#IX?J ^ISE<+UM;X7O
MBIB'4GCF[V6G0621,8:%.:7VH ?49&39QI0 ^.G)PWM).K3\DC]S,_47E;\%
M%$LP,(*QI)CA#\Q0^'@_IPX[)K(I!X1A:I1P-WD-VT87 YS1LKO=M*!P"LH"
MCL#]43!R'2#7_4U2Q<^T9;9*9OXE/:-FP@6\'O*IWRE!KL"MS'4[H<UP#84X
MU^I"'8^2MV6#&X)F[]25N@29DQ)T_8D$<'H!F'2KMR2$KX<Z/'1ZQ:Y!1<$=
M5V)%*R5@81-7\T:_(J:4RH9Z-6,VD)U+99+E]! PT$LL[;DP2"U475C3,^^#
MH@66+8R&J3Q Z-1$E$D&C#JJUL0^I"M"S3JZ4ZI)+BI9DKN9M9!9GGV^;J#H
M*2BQ#<]C6V,%CNLB_90O5HND6!%'3&]AAZGG8;O K&_W'506U.,BTB)Y,Q">
MIH^R&S4@$3U[..!2TMUF?<JG'4B+&/*M8<>=VK%ZB)LXL-.P'MQ1^"S3BX54
M"<_SWS%JBVL[31?I259W/<,DZABZ<(<,GTNJ5&!BSAAZ[WR*)8>*XFBDK^VD
MI=.S<H(3CRE^;WE;)3';X%2WP@+NX380;I/+,2>OY:U]H#CS2V^KXB:]RNO)
MO"3OY$#32CQ,35HD/]Q_L'OOIYNDZR<17>_C]4Z0N]Y]5.Z'Y+@'"#&-7A(8
M=L!A!,6"<,W4<L^D9O?5V/DC:HMT/H*1\\D*$XD#ZC1Z9^P(1Y%=R*YM2:1!
M4SB>Y&U<\F1M;T6/%JBD!/:$O N#+8XOP0C#(7,R.QO'I01W SD[GD*!8<=B
MF*4T0KRE>I!]X\U6/[;F:RD8Z!O3U80#6M?#E'7=J4'T"%_G51W3X2@4N#R$
M5<,C4;#W&6#='#J&*P'X:%,,*KY53_%LW[0UAD4^I',]M,H]HEUE&"]U]0(#
M*.L>9+7\GG3J.DSU]M8.V;H(H!1T,%7H<L0-D:%?]_T2AU)UE!'(5BX M7%9
MG59@SJ5-FG#. ?[+AYY"QF4#1JO7&:O"*(;+CU^1Z9M-0&-^)O1=?PMX@^&<
M\\/;]'*87GYXFUZ^:GD]Z' :35;-,4@09] ,JT;H:2"[H@WV@*::@Y^!B1WX
MQ<[C(-XC>2<7Y,6P#YKP\U*,?]%Y\XE#D+"-PNR-K5P6O+YL.)06C-X.DKRD
MNM>?MNF&+EX_J"1I10;(ANG+>?6EF<<VV406)UH]?+4$)G)H':N+V(Z<HRGM
M'&M4@QQS#/POT*7(]CNF\!LF$Y!=N ^,_+GN/-X8XL\CG&XH(4[(>,P&Q2,W
M<HD,[Y6MZG-9K16RU&X8<>&<9,L8AY]+VG (31S&5?J*AK[25 W<N@:=SD%9
MI6H)4Y;HH-TD;W<Z2@YF3Y":;[31:2>N.<$^\)%S4184(DNJN),'91KTI4U4
MBJ_ 25'TIBHT)ER8E$OT[%8%Q?=+99E#D1;D7I#>:(7\+*A2"7-;V3U;.<CC
MF5;I>6VSVJT03B='0!*+IZBV_D7J,XNH_%J14+I %NF_RPHGEA>,]N4/<L2Y
MWY7400Z.*AKR\E6JE(S%#:[AFS71M5",PV3BJ$3*E0[(O5<ED[R:K!;HZ&-8
M@O-JIRNJTP#A:U;D@VFBCE(*#G)2.Y+BXPS4^LCG=P/I 1T:7A+"-F7!2+JL
MA/^93+)Y9F(#E[C!.%;^P_T-H=PQYG%"#D@*)WZGF\QG-S#RN:2.$>+$]<@#
MR^$H6Z04C[I+FS(]ZN;E,!*G&>(IMOXR[OY]3ZF0)E(^0V??AW PG@R>*ZP7
M@W4$!*:P7H:"=5>*"NHYZCV< ]2=16MLY_Z]44"(5IO[I,HF6;[D\^O>?DQ[
M*58<@_C[=LQ/,#=*C!365'("0\/L@_5PH<!.?C90UZK7+ZZ=31*M"U]W4@UB
M$9L 93O3'Q9O=6%3<NUL5"TK/XE $&34ZVZ?'6\WPC:X6&S/*DW+C ='-JD)
M^BO<IB]/TU#M:\J7"=S>'S/*6$RP)#K?S78I383F+D7XZ,&S_!-R#.&'J,*X
M'L4TND?4;*S873EHKT[7@NX_IM11W :2[OT:81!&1$7FM8 ^U79ELP!+QOL
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M1PY.8-78%(4F5O>F.>6676R#O,IK%/+D=HYR'9YEQZ-&&5+7B26>;QUTO#0
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MG')WC=JH:WDPQ*7DSIO.4N0#AI<V/*SF.BKF^V#<VYCM6WFT K##5B#ZH(!
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M>"23]+@\RWH@<2T(UQ D3C%IYN,A2LZ /X/D(FIM?G$\!A)6R0VR)MO^DOW
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M,:OHUA&T1^D+ 0-:1.]BM4@&G-<+TEQDA%8/=(IHA[+BGBSPH[[ :25,,9N
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M[,')/,T7N$J< Q_;M,F8;Y3U#HZ)#*9-@[[[12W>*%U1H_"NWYE@IIPREYC
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M:F&]"L86RY%RN,T.U8=!=^1<+Y0*_MN074AM-(X(QIB[*'@+\Q4$%.MN94(
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M-<Q4@T_<')POOWSF591$[GU.JJ8*3"-?\_2<[UOEYA]S@$-T!7V^'MM+LY\
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MVWP)]^-+A.PN$R#Z$N_; P_YHERUN[7_?]>!-KS\>Y*7[U"BWO[CSD,G/E\
MIODO$+H_TG'CQT>/M-L#F+9?ZE&WI_;;/;67"*!]B?<=S#0=>9$YMDARGI@
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MV>K?OWCWZE\HYM__<O3/-\__'U!+ P04    " !!AR5;^:2H@?!9  !=W@$
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MLYH5$H,0H1ST\0;-#82#NK1">EJ[Z.Y15!F]C=[+HP?>D#M'GS)N]AEM65:
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MWOG*,D.8MM07V%L(@QQ7HBY7<";X"=)5DI6 *(N4BLQZ+&_0_&EP5[?M6(K
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M[/7S?U :[V_GO[]\^O\!4$L#!!0    ( $&')5L";WKK'B$  .FT   ;
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MG.4T2Y_)1DTJ-R?K&SE9YY]E>@#A4/H;Y]B1=YNEP P]K=F"/%S.-OBOC2H
M^6 >'M@FQCJ_K \<$]>Q2:3/05P9QUM]HBG-\B,'>G#C%+AQP5Y/^/P 4TXE
M0%T.Q,CK,^H#^CC0^]ZI-EQ5DKV0[RD;W3E"*/!MOZ>PU0*XJDK8"QL4(;>O
M(_G _/$<_K2L+@+JK,A6M7UYI.^X6=1ED5NNC151.IMB:/#F$S8W1'=M?O]#
MBM'"!HXK6=57NM=(2FKJR\M!@*=B2V.':A?:!-V<-%MB7CRD;]4,<C-14XK*
M >6>8HWLWL,=+-T!<COUU0/B(/#'C('3E937@?D ^.+.K[N['.E<8!PZZ535
M=E_WR16PKBV-<+KW.,U 8_*&MC8*S(P9376C HC%,L [/_\\!(BW=NY?":1/
M3; !.-EJ1GGFH\2QC=UQF0>@)BAO:['S>"O!N2+6[WD<5"PFEW<ELU$9V)W,
MJD_6CQ6,!6CF,(C3?+:"-4Y4FE]PKW6/J(E,!%44.)SXGD4*. 380FC033M3
MK+N9 _$J]\S#K.@OT>]9(*Y:@.\"SC$HA(<[AMG"&0KK-A[5-E9I!WT)*QM2
M/\/$I9W8D*\;E0+QANH)_ND2-V&BKQ4F>K)VF.@-R%N5IC)3>7T;4:&-R+J>
M3@V_DXJ-#.@([$>Z)$&;HJX4G$UC+W&XHAGA1%D%O>4*SO%/A[BR364 /?W>
M7WGYGMJ7(NOS(0/@K]S/U#;&MF%OMG#+)@Q4!Y:F\_:8>K+0QMAZO^5  ^6U
M*6S0G7)CQ(K*S2CUQ5BX!(*%W-/4,O-Y?,3".>4W861$G),E;*U62;DIS54!
M<I\&U4%:7@;]YH M!R4ZD7,Z+6RM&CP#N>0RX4N.P)"IC(C*I\N(<:DZ'8>@
MB?-"V9PW<@#HMD@J;'L&H.2PE(FF%LA!"O52SJ)] V>PLLMCD,M[_=;_&R"C
M'O3#X!O<@S?4)Q#_LFV-Z#8-4J<QD@/R&8L<4=%HD[S^/7PS[B1YLD<=9!3B
M'IV<=I(<2_!3SNQR-Q00-#  ]G?6[SFA#]3S]]T*U&"$18U9L9A82>7V()#>
M#<8#3T@X!]$U9U!A5I7UGU)[?$UQ 8L=3+S*8B[=2F#8LNG.UE9NX70)(!HO
M:; R%H'N]U@DHOJ!F>NEFF.+@7/5P2N*5(Z*O<4U)7BO2;=)RKL7]$X'B1S"
M6]'@4X&Y5%CELQT0]J9K,"DW+RI.6%_(?U*(T#F&5O27ZEK38ICBU1"8ZN1I
M)\1.ZV@%GCI7$@TBRC1!-8^RN# E<I%GC3TT<$0E&&")B=@3@,HH_V Q7:J%
M9'] V_"@TS.0^P7ZXL1@".?X5GR##N7N4;8F4<)<4@GCZFQ>6"B\R(IGIV03
M3C'ZEF';L?MRFV*\A 16H"(ZR(VM;;9TB(F@CC@9$J.KRKJFW?F,VI-*G!#K
M<QV^_/"8+ 3;4G(G:)W]76>NL-&Z8]JGY/.F" .6.:HIZ&Z53CF[,D291C=,
M1J[SR[3O2AY]I-91U@B.M39SD";9K)8SVXH44^<D^78L)O'XU!.4)17[&7&#
MB8]P0GM[N,+,1-1N"39,(41/$ZOW8=*O30CV*9Z8]AMQ_CGGT/J$]S#9=XEX
M!ZQO8*7F):)FA)OV'@@G_S!3''C8=-LZIVRLG3!E29?29>%/DA<,#7MCN=\I
M@*9++S<"J6#;K]Y:'>C'=+3;;U.Y7L3[YTW$VT:\?_ZQ(]YWBG+']>1O/.!6
M.Y63_)P3F)W0\E=.6*>&!I9TGL=4CD ZLO]V64>VN31&L?+KNJ=P/FA,.37P
M!J6#.A;'8H=:,H=BQU!"$)<:@3!H0@4[ZM@"+(>L\.SJUU&H77<+(&SYB(N[
MKNCG&&KC*YB=C;$AA^UTRIF@Q$JY9"A0>'7F&Q^4H*A\<@]6X?Y"8F(XJ=>?
M*+()T_PI1,<APK]=S,*%!SGZCDUJ %J<D9D^];.QLZ2RL>XDWK:@Q4>_9]$-
M1@AJQU5WE2Y>F*@I2C>NM($-@7%<+GN](,<U^:TD:A"9BY.X%B(X_!4^*9?X
M_V1+WH^85E9H78[PK+9%S1X21R[=DIA0JBZ1!R**=04P@C0WK$##B8O!9D[1
M1NTI1J.;/(;XB=AB8X14'#"[8.'W,8>Y0C938%V&3EQUP%(IJTR2TIL4*U9&
M*')'+#"RL(L):9.*8E N][_5GE<<2RJ^"MR9%C]<%+(FDOQM 7X]ED)]U4.'
M1(DN 6 L7&%K;@X<V!XA,E"MTQ!8@H.8P+1A<G[B0VW(;CS\ER\VL<32[R&U
M6&QQX@?7G%'539#YHKD>DGN#."Q9K-CH]O)J!G>@2_8/YI1:,W@W GT=^'2G
MK7LW0M>Z/_"LNFZA-A+LLJ7(!N6A5G8"[O?\*<6C4".1*NROQ9V3=!ZV*K9E
M6\YU92T!O)"CSJS+V[3I&K[/$#?ZBR[5QQDK4!9@;:B2)7@^W03ZOHU WQ"C
M9D06EWRC*+>HUQ(Z=6QP+:CRP[:,5N0#D=U&*^K-ME];&_BAP>U;?=$$W^6%
MSR\IGM;90]50Q%4<=W"J]Z6+49IG5-Z[LL>;Z[*V>C+V<-B8'0>:C=6JTY1*
MA=FGB(PKS]R3J/5L4SLS;@'H(&==[:.@V_O)-G3\=>E8K4?'Q]3]S[#_E5L!
MKNYHV*JI 0OCZX))C6O[JUCE%]L$.D<Q)OB!F40IBQT=.R)[0R-%8WR9U6YR
M?I)?UK?+FW)-=5%M;I+ZVH0U7;<Q=$VQ*V!AJR7CQ.7=N;R\]OW(-RRQ?0>[
M%A*RM1S4?O0N1UCT4SGWK;6.\YE-XG87H%D]D/)%7$=+ R(9<]2KLOXF$JON
M]OT]>QM_J?67[FW\I5]"Y_R_F[G#>PD$#\'A,?#CL^/1>,QWJ9^\BKI&(7G5
M/+=:OI/.!RR[=S!>GU/AJHO.6U$3BI9ET?/9<P<9Y/Y$8O\Q61B@3?=?]XBD
M/BUDB.R M3KX*6O:_BCV3Q#TX]_N/8(UOCHY/@NAW9[*A4Z;IQ^'EV^/.!H-
MC_=/3D=B?'+T[NSPY'@<B</C_0'C"T<.TI"N&?#@A<\??DG,/L:L_94S=M_;
M^]<7(.QE\S3$R:4Y/L6%/8GL?A$8#\P#;-O25*#A#1.Y,#>P4?\<.N+K;L@5
MR/KG(]_=-9]A;'PU;7S!<N>8%C#B,#;PQA.^ . F%OZI'V_B]'\)VSHX^7VT
M?P+BYX_1\=F[T]&WPK2NF>R^E!]](0]Z(\LXQW_.-,P@[]2))"YTS0?R+J_W
MZW,@;_S=C YZ0_KN>E;:XXV59JVTQS^FE7:5)7&]I,Z[1W.-]U^/#MZ!E3(4
M/V6)-',@Q]'I'X?[H_&U G!3"PMO5G(WJ%!\'*R@_ )]H.Y6UNXM.T^O$8+O
MRL$X>/+I0N+/D.> G?_]]?&37SLZ^B>+5+Y 91M3:OQ,Q^(0B'P69+0?H!O<
MM&V:5VIQJWV+'71?1O;-^ )WKJAVPJ:%!;5@HNZVO*BP+65;MM^V<_4]7COY
M]CI $;88+9NBRKDQ4]S8\6>:2KKIPEYCD8MPV_X(>$787!HJ]A,'^4S%N<[\
M)3[+ -G[_K *06&*N+GFS(ZK:\0^[:/9G-;;/ZUGF,Q=VP8=A[;V @SO<VWR
MLOF&C^C;0!;99K%T8/)LEE-NB8KGF(R2]GO2KK:];JY[0UWW",+Y,HVIU*)S
M11+&6#"LW5ZE$/G#:!L;VW:@.&^>YGB&;=@'SGJ^*'!T.*"+/,,V/2YX*#.9
M-O_%OQ)UKM*\L-V*^73[&0*@"MGP._R#3;[A<JI<8MRRNQY7<,/O$2[\1:(6
M<;9&I<@K=[\2@-NVW.V"EMM.="W#XXHR8ES-AMW\T.SF#Y4E6/-/M6=.+V@U
M!@PGX)68<UV8;YCW8.Z+J=PA=77VK/5$0IV#A6GK3+C$R"&#LW]]_^US0I8]
M/\N7=3(W<PFP=*=>>*IA!7)F$P!C@"M/&KSBEVK%FPY#<DQOT.\YGFG\AB [
MB-42/\2(<%S5I<V=OJQF+,%2.1D3-KH/[[G !!M8*S_J]S!MNM3F?7<1.381
MH11J:GWFAH)9%'HKL)SP-KG+QN:X0VSE5-%%C59FOLRQ9NV[T&%4(>T=HS:+
MR%YZVB:7N2N',7466W2XRQ]7G,KV.-&(D]R6]OG+B2^=<^S,$H5MGJ)0F.,E
MY O;U9^NMYF&6L,5S #OW:&>4Z25>.T3H\+4Q<+J1/[^7F9XU#.W2.B2Y=Q=
MRXN?9PEW*'2WQ(:J2-3O$1LAS<K8S&2G#"WUKNKH:IQ<V(';< 9_Y_:!@>A<
M*BVQY-+?+8.;8W$,2IVB2X2-V((9VG8AY[K$5M-T895Q=\.HY+Z_O!,K272;
M0VVP]R^]Q#R4J@4LSU[BHKX^'P'8L,4?DRV>6%NG5;#&=8$<XIOFB4SOSHXS
MO")OO.#=L?E*/J1\>*-2<G$5"R3N@G4&IGN#@R)>1]Q3NF:LSE)SIA,"Z2Z.
M6>5\6>G+:;JZ4' +$HP([#)VC($;H>GPCEZR#D'7C+B?1I<#2$-WM:MK//Y7
M&%6W&J)YL@G1V!#-DTV(YG9#-"]]B&;_Y,W;T?%XB(E4-PC$35527S'+OBR0
M/]%]!M3?6M3&7FV OBW?+M<U<.-2+.U:LW!I;=NGS2QWCL0KO?$V+YV%;<O>
MUMCWT:CP-L^@)<OEQZXQ2T2]4A(8JZC48H*E83N1>/3PT5Z$ETA9+1:[P5 ]
MK$MKQOH0:C3#W0*-O4N]XL+P[V,G6\747;6&%SZ$-[JZVF07G>.N-=QHY5("
MI\AJQ"]ED+N[3ESG'FQ%# )38EVAL,7ULJTS%/N=W;37X1C?7 =57;?# #'U
MSZ&;H*CF9ESEP)9=;8["KGGXQ2__<B*6[ZIMP>,AQ/((!F_[M!"?V-#'P-W-
M8SI 2#LF6C-[US$/MR2APX'1F@^JC/$,%:6M4_Z_G<'#A^%=04OP8%$\ R1V
M;PF>W5VN=_$ $2U1KZ<9_H#EX-F*C%ZJ*;7WBK1-DEQ'HSC-3> S\OOP?1RY
M=7277YZ)DX*TLZ?B2)KJ!U=@?EE?@;DQ;6(]FGGP\N3@+S02'[P^>W/TXO\!
M4$L#!!0    ( $&')5N]#)#*Q2P  #4K 0 ;    96$P,C4U.30T,#%E>#$P
M+3=?8VQE86XN:'1M[5U;<]LXEGY7E?X#-KO395?1CIUT.IW+I$J1E;2G$MEK
M.=/;CQ )2>A0I)H7.YI?O^<"@*!$Q7)'B6^:AQY'H@ 0.#CW\YW7OYU__/"F
MW7K]6Z]S!/\O\'^OSX_//_3>O'[,_P_?/C9?OWY[<O2'&)S_\:'WST>C-"E>
MBL.#62'.]53EHJ\NQ5DZE4G 'P1BH#(]>@0_A)^>7O=WK\149F.=O!3XZ,$K
M4:@OQ9Z,]1@^RO1X4CQZ\_KMF]Z7B1[J @;<?_[Z\5M8]NGWF#!42:$RFO&G
M9)C/7OV8N4Y.SX]/^J+S_JS7^]CKGW_'6?\L\T*/YN9#G40*!SW8?Z:31^Z=
M?_S,YQ.=BY-9H=-$=,:94E/X5NP4\'&[]5,<_56FKUY_>N.^>OWXTYN?,OIX
M5\!/:2]5)'12I$+F(AW!BF:%F@Y5)IX%XLG!DV<XG!+58+W12(6%OE#B2!:J
M-N)P+F02B:$J+I5*!!Q1]T.OT^^>G/7:K<')AT]X7H- '/>[^WA8@9"P)Q<R
MDB),LUF:27J3A0F[Z70FD[D_4T#ST/B=/\Z1!HXZ'P=FR 1>)](7.BIE+#*5
M:]PR?#48%I91P*KQ7WTUS&3^68H=;Z,B.<UQHL#,1/,4Z5C!;S-QJ8L)CB+,
MD@*A9#B!EZA&.)59X2^5!@C3..8]B^$WM(SZ+[3*_=?;OU_W]*S7/3[O?!@\
MO/O9V1?G>-J&7I@85%9(G8A9F843F:LL%S)38L9D ,0&!"(+]]A A66FZ:M3
M\XOJJ@<B FJ.EJ[N8?/5'9QV:K>HW8)%Y*6$ZP'37DYT6"-O 9,)B7/A'0!^
MD9>*7B%7<<Q7$)_V7F0B@2U4O[#?!.YM\NIM^$+:N;X7R=]2PGB[+XZ3=BM,
MDP09 S ]QUN*3":YI ]SX!QPBZ:SF$X9V"L^ *<8?.68QIDY3V)F =(&T18P
M0Q@-N:%ALZ,T$R@_< Z=E"IJM^ 0+W2H\#?=B58CT?L"!T;,_F0T@F\RXJ\I
M2QR80R%?"X#ATDAY&BL1Z3S,%#X0X!.A+(%B_>7BSTB& ./,9SK92T<C2PT?
MU%B&\W;K;9GK1.6YV(&E1&H$_T"Y$J>7NP*6C=(J_*O4F?)^)>R/ H&+PZU4
MV31GBBV'?^*,=+L4OG*D>8=S5>!.P.9K_!&\A;M=#XPFNX99&8$$VY[3!J?>
M'M5WU=M&.+^\!/9A2,/QABP-552"%"9RXW/7R5@H31+5IX",SS2G$=NM&D6X
MLWU@9](_^1V&^JUWUGL'2A1=M-HE=MLT+8N2;OB%2N#^\_E(2\E\R27=(MAV
MI?F$\$A2.H=QFD;TT86,2SF,57T:YC>9"I6&%^ +A?Q JP3.)AVU6RP\4)#A
M^*@(AI^3]#)6T5A%_'-+5[0J9#$C4(O2R_SEJHT=IG'TG7;WZE/]SI,?[HNC
MWKOC_C&IQ.U6IW\$:O%Y[^STK'?>P0]O@MQ>OSOIG_O3[5TJ-"9?BB3-IC*N
M-@T?7*G,?<>]6W>=.W)7F%4>L?AHM\Z1<5W]TWW1R04(K6A9(C A,]TB%V-6
MF$]D'+/N0U=1R02^]$4+2:Z75^S:_>1@GG%5<7?1C5/@YV-/&VVW<-]R*Y[S
M<CIE-<4P.*M+,O>1L1+- D+X*NW *%>_/C"QX6TZL.E8@_J8U_8:54:/5L48
M5#RTF\59"3O[\\$S4<*(&>N;E<[>"1^:4E3MI".P(SEOH%O4;",Y-_(43#@0
ML6(@BS*#3V$9L)_XK16X](_$V%QA.IVJ+$05?2B3SSD>!+[)'VGV671U,2?!
M*LMBDF;Z/\"88)A,D?Y+5D$L+]LMU+7A5JD'>T"&IRRZI7S&8A[VGW1^FLK.
MT(FULQ[L7E9./ARY83</G[P\.!1R?[J_0*D%/&_MK\BXVF@W4<\'(]*R?C+C
MX/,&J4 VJYS-8AVB*OI@#^&=U!EQG!/8.]B?)JXC+H$U%PIM<GJ&/9N7PTR#
MXNVS[J[G8$53*V$^E- GH+_,4;U/QPGQ%YU<J+P@9S(R)#RND<ZF0D81F'(Y
M.QK(C_DVE5GT4Y;CHI!O16JFZ'U$!-PI+-(L-SY4ZX\P)KAQ 9"O"_]MO-BG
M&?H?T.J? H<< M>+<+=@1B?7T< H4O)?CV"' C'*TFF[)6&)8/H0%YVEFEV^
M%UI=NBE]+YP&FR@OTO#S!'15E>7LSJ(]N=2@96CRCTRM\R O8&2T@&0.NS6$
MW<IAX_*1Q#=DEP9Z@M$2PIG6W17:D@=+W^_!6,T2I#(XL@Y+MV*5;/VT/]A'
MPDW29(_^'BFT3N, CA'83("NA@M-QQ^ -9R <3K#/^,TA-$]0[>:,X#S')>Q
MI"/$.Q%-X0[E!=Z2"R=OBWD Q#5&2S< 25UF!3X[3*.'YK-T<_[7WIYXIU4<
MO02;?JQ>P<!_E; _"N87>WLF5/KZZ/C?=G$\Y5Z1SN"1)[/"+F)OF!9%.GTI
M?L'/AFD&1^H^>QO+\+,XW'\&Z\S36$>P!/>ZRZ$&-R;-<M P"7S&;_'Z,:RM
M89E#N-^?]X8*;CZ\RXS>S1_TEX9!\77\A7F[ZQ]6;4IO Q_C#O*F/10ZJAC
M@NFV0FDS;-NQTZ%5Q(ECSXR+*D>E 1V298C20H-&':'= ZQZEFGV&=-HGN[G
M=!/TJ*LO85Q&^!6I\GJL@47 S<_1C"^0\Y? )MSDCJ.X3V+\/];EX2Y$0HZ
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M5?&M9N4P1K]OA:^'L$T4M)3<JHZ4KC =4SOD"@GCSQ3L38R5VQBCN;@F$R=
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M59'\IM[E0/N[K=7^]O*=BXUV\18'M= I*2E:*2D6(B\(\":C4V+5%W1 SR7
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MY&T9,MBPG]YSNU';L3F2-@%@)6G))3="F+IQT](DS(7J]98N@=T=+K4@X8"
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MH]I%IKUUDAB9/PCEC*O//MR4(#4&>BS+1CCAZ:-E-T,WHM,99ABIK,!NR0$
M]LF+YH29%)?+A-R]/-NM=5JWX-*_QWLM+WJ(=R,U+L=-BQ7-VRDR<-5""N!-
MF8R<C8_FD ,/$?[U^Q::ND6\!7*<C#T%EB@NA4O1\JS/ 6$D=$WXLMO0V4GO
M#(=H[1VO)MG8:+SCNR=DQJY <*6F)?@6J?[_?,+!6&\R-QM&<?)-,=@5H4ET
M[<Q'+D? EG$+6=,NV8=&<4.-0 Z2OCOW#^_*F;H@CX(M1B'*ZS=F<X,8IUT$
M[BWT>@.'>"S3GJ<"M4V3<EIC_O!2?)HW\B,'ZLRG81I(+;=$6(E<^+"XA/8L
MYDWZ:!E0(/>92H;OCNN?]1'=( ],/MR;KRC$0&]XP&=>>6+N]3'\+1+S?WQ"
M8_0\9\@R+.J7&P)F_2NH#2.PDX0+E[61,N#";2\T%TF:U#A#)'&&QI'9UFYQ
ME"<"P)EU_"(W)G@Y)YL7\H(*]Y @C>J1.GD45TO*1'+,_B:'%@#B*BO,$'W0
M5KWO1 V/09\Y< H-(3,<SNQP*6[AE%C'2SK>OSM2?',#C'@KX<ZGT#E[*R:[
MO6\H=H.^"T'[2X#BXG^_!0&W84PDZ]P<Q/;7;W3>U;EXQ>:AU<PBOT.$<3*?
M^Y4X!_^1#E@@9Q_;,69M1*'A2\O6;^>_KGW^Z_MO1=%N4?3[;T71OZ0PWS^\
M[L$R=M&[.^<3]:O&L=N-Z EV9\5?P27X J8T\GJ_@&UE0R4ENF#*MUY1@FBE
M6!B.\C7;V#AE)O<^A"F;%//8L9!583:?IKU%ANK^=:^P.F,X.G#9B/<@?B_X
M5A'"@H;/^:$/3K!B UJC(V]V@IQ.S@<BXG[74-))TY)[>$.Z!2E.WQ_'W;+H
M@X3>^P01HJ$1!NWWA'9_;SOB9'SNN&TFX*/O:*9R@\<$FV3IVX.+ ^1AXCC^
MQ)^EXMR-/TAXFT3JNI<2_<PW=7&?Q4N]&K 5 ^H^]I5QBC JV:[>0;BV5B$I
MXF!7>LG$J(3<W'9&@%,B+>ZR&\:I#79D&6<_%2H='+G'5YY-,IL( 3S@HB0(
M:A?9K3K!>?^Z5QL=\W5S0ZDW"5+\KLJ-M=Q[NI$X"I<##8M/1?&$H[V3XG,P
M7=V:=5/1EHIR>_#3UXYLSH=_Q*ZT+;#^CCC33PFWJ=T1URL)BJ-RA)B@O6'/
M%S/"%6WT>=Q6T6M/EC5N9JM+X[MV?4M_6^+;2%+ <<K,$D)SV1/1"QJ8!UFX
M-7<FY=_-Y-EMDO/K'L)_95UBLDSGIJ@'3N*?7A7_L E+,BW'ZJ6- D7AC%M;
M)"D9E3G;XU(<\M+J^S4*WS#,(U$4R3E&/YJM?#Y:2B:<L>'"1-//TVU^Z-,J
MK[&/18Z =41R4I+;"=WO.+SE3VVAP=U?H+*YNH@],RW-\=POTF\Y$<W2<KLD
M?<9'08>*Q%U-FG!!-9CYT-5-#,&1A?8>.U:D9@&,$K2@AKG1S"0NTGNGM:TZ
MTW=W/O7;Y!W\T'GMFP>A<S4/2NL*MUDVAX(V.J20K;,DU\0T'/?LGB#2OZ/E
MQ9^(:6_G"^T/Z.H/3M4?K M7>!X Z[1DM%>(9@#<-/'2:C71B;-S"W/;=B6B
MH2*+LC)JD4Y")UOT5(OT>GUG#0CSW?6[.R<7IS^?J>.$K="#P\/#D3HZ?6(.
MIF2&3I^,U&JU.L 1'0QY0*/=;5LOV">$JQ_D')E89CX6U*P/!?AV:7T> ^SJ
M)9^)(';*74$T!@MMMHY>]$Y"I+D5?]0%P@5]S>$7@$I_T*-)C)G,&;D(J[T8
MN*MMIG*<'/5\PO&-,NJ1ZF.B_ET#XJ/D8-!<5TBRR5D:^!;#QPPYR6M#T<C?
MYAJN+AZUKA2EDK($*O;/=,[BTN^EP=F/</$%!W K?D,*5.WI/>G3\Q['WUJ_
M#DVE;>NH=$&T8RY#I6EW1^+,</5MUZ_%RV<+V%W_E[YY^T;^CL+_7C3*Q(F,
M%W)O\__=Z-H^G!O[X5MNK)L;^^%;;NPOV\-R>J9^/;T\.[FX4+_B?O?S%Z/8
MK$J=S'L%J1VF8GK::VJJ%I/WKXM@!]*X?[:_<OM0>Q=OJL7%\"5^_AK <8'S
MYV(EOS#^WN#]Y?'3ER?JV<G+EQ>OCY^=GOW\T][A'O_^^OCY\_#[M2E9V;2:
MX='#OS6JG9#M(C1-TAU^VF.A/+I\$R98XO!NHK- -4G^7A#<R^=/-M'Z1!-(
M63_Z&#G\K+-_&J%^X\\F,(0_NG?YO)U,/3L'2\Y^VGNP]WDGQ@4HYZ]HZ-]"
M#/$HIH#^]^9Z? E/#6J!WXD?#__6[GUGG5=X^>'?/B<+ A5#3+\",=\_[*[D
ML_)K"X\B6?C@RQM,BL/(*_VEJ2U_HT?U_D3/C:W\6JO]1)'P'VR+O#^FJ%=<
MT_6Y-<B1SZ@(3^F=#R[I"ICHLQ%SS]W#[:WKBL*IXU3/W?]/TKXT[P1T#7+O
M,\[R;\202UME-\&1&3JR3Z35@&#+N01S [RA?X M>F"F@2C_UD@D/!4[UQL%
M)]WY?_CL\^-0K?^[=0 IC[90\I?3@H^Q[OH$WRCNN6F#3X^HB\J,QWS/WE]_
M>Z]*[Z#I^19';;5>6R)H\GY%7>U/2YONSXN49LQL;O8^;(S^3K;H6.KTCSY-
MRENH_^"3*/O,$=2VN09E_4,@^N/K_M3Y;_.*/XNN?S -^&7SOY\P]55:%A]&
ME[N\Q!T+WW*SQ(&'5\_-?OY$Z:?L]."?][R'OV+-$)O_^O6_ %!+ P04
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M>:?-#/:!36T6<Y+ZTH_-$11LUM;UR6/ Y/=Y\AK/E[ZGH1,"1YZ"%3#ED90
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M-M",W31;SMF!1CXR MP7OSL[*^UE)AZ#SAK,\J.K8+K " HZZE$-073'^'#
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M8X*P%H_(C-/&N/]-P/'&I33?UM9.0)7-_"K6QFS4BA,$,JXV(F#/LK'9[,(
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M='^)[O^\__/^SS_:GW\<1OWFHBHS&S:\Y];__G_^<6CS %N-)/>JQ!_NSR]
MHO=AQ?NPXKUW^\OOVGU8\0]QBO=AQ3_HP=Z'%?^H)[LVK/CUQ3 VRPDT0:(/
M'>26BO_?OY;?#C;P\38P%OC%',&')L"I ZU>LJW^!55X-, (*'_4:KFTBDBD
MUVP=QE;E3QU;]<;_-(3RS>[Q_C^1IK]Y=?;3ZQ?_'U!+ P04    " !!AR5;
MFEZ<AA)-  #%E $ &@   &5A,#(U-3DT-# Q97@T+3)?8VQE86XN:'1M[7UI
M<]M(TN9W1O _8+TS$^(&+4L^>J9MCR.HPVV]KRQY);E[.C8V-D "E- &"0X
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M\\61%P8OF)#=89+A7"U-HU"0]9)^SSQH'IO'S22$)GT.K9;7'8LJVJEB"O+
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M^FGEU8*-+LJZ4HQUR.7Q2]90]12'UW%951>*FPG\]>FG;Y1-FPE_:[6$UIQ
M7_&XPE054NI"SR\HC2T380 T*XW'JVN9V->NL/IVT#//;EJ ^>0^6BK1TB?W
MT=+OEI));V[X[7 0X]_H]P)>NX-&WJF"// M#U?<UM)(AZ;4!$O^Q.R/=3T^
M)<8JS(QFLJOG3I%W&;ESG4D3UL9!6W KCU)DL_.)$<:,-&2-)Z/ %ZZ:'C]>
MSIV;LB%R$ 1$[,(&1)$1KGITWE(OE"7B']5/X,]XBN1DDIQ@E4=YMW@Q>UZ
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MT>=D87)A*=7 U\-NOC9S;5Q"#[()6)^MNB4IC)Y.V@4=<\76T-1^TD]8HLW
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M5A B]#Y=*=8P(:R8L[@B@9;$H<AR</_$Q^EG=)0FC-D,%*MV7A8A6F=:4%9
MS/&ZH4VA\+KI=:1!P#R:>1##:T/:-D8:BF,W8]<W"E7W>QO[U],3=O  $[>4
M\+7[)UP6V$?)[\LS.!^WI5<9:RX<Y:53GT[CK'7 $L6C^@];L1KB^-*37M+[
M#(Q<F,_[#D!I@@G44:N'C9ID94.2 %%C]@\U#;&.?M )7=F5X>@GT@^GM1AL
M/9OB0(^W$-\:KC;\/,%:<,\3HH%Q.+VQ*!OUB_T>FZTBB;@G+;7!-D)LP_3G
MH78,!&IGXB#KX%S]'M5.).HD07/9!B2:B)<8Q)<U)5$,R^P51BDGDE?M.?0X
M[5#QO6& )='=0-646L+(<.1#=T.NR2!=Q_\HU8A>R>_2Z9%K9EP-<2KKYAS.
M1D7WTBJTD28IMI6IK5B5R;<82JJ6X3*,^>?S"G(H+SC7C&;1**'%Q#;L?.="
M7*VMRVK_+>@16[^5]GB":=GA3*?0FRB%.,"[&M6:P@8:4??6)A(J[_6[&+4V
M\44 7%1U<C:JI\:X%![.H(_X \H5)[[)^JEMV%ASJK:&XYJ:'W$W'Q64< G[
MXBQKX-=;]N#:G-)\0M#U+ -EOG:!!LG1<#A"V22G*-\^P7RL$,\5J!FD&+6Z
M>"BHSYK]L,_?.(N]G#H595$)BWX+ ?'39HA,$,_38EF!FH_\S-OH &OS;8IH
MEUS&R*L)X!J^IX:G_WCXWX%VZEQ#W^_Y]!H WHH2+F@AYD9HVBBP02F?4/;.
MO.TD]F%Q&T7JLAV"2P1<Y#QEGZ_^:6H[3J#GP6\._1$;+> .N684W\;=^:VA
M7<[)1/C9*B?.5NWW=E:&NMJ=F7!+==:Q.E_DVNT,(DMY+-%-/! OC++@#) :
MW-'E1# I*  ^$;)L&)RFE)Z3'$S#"J$P?"?-C5U%*J_"Y*CM%)@) L_M47)A
MT5:DE;) HFLYZ2P[,#^YS(H\KB55S@ 4LLX*H\^Q<"!O8!/>';_(C9WL_[AW
MLHN3_1_W3O;OCY+;<&%/-UV[!=3IA//=7;PPLQM U;DDXVSV>Z>N$<OK@Z.3
M$;?+?+:]O46X]*VH)ZD9;":XK(.;]-#R^D'R&P9L7=AYY2E;T%3N(=WNT2TQ
M-'JQM(IO1Z)K(\J$G1?8ESUM"@])'T'X\/,Y(S*>,Q2EWP;'2$.*$YL^\\TQ
M_8(0D3G3VS:CERG1/+C?*4B]><K!ZND2<=U<DWF!=%BQF%>-Y14:FC7R32:V
MZ&_F<<E'X!0,NZ'4*#>;6H5<LC"DX7W D4$I*+@@FJBQ(< ,!^(U.P3+<9"A
M@C,<S^RI\-ZFJ>29T]\K"E%I#&#I/<)&A\!DB7-&_[L"7;-E/:CD)O1@N1(@
MA<K$T"'&H4&/%,V%2.Z459@[6DFA]8-)%[*8Q!BE+:@KZ_:GOF@@//+<]/#P
MH4CM^7@O\3%^31.7^@)11S>>#!P.\1YZ;&2W?3M=4:"<746 NX[<B9(;(_'7
MIB&*0A4%2LUS7H!5,+.IA>9W6])(P3.]R8:FS8!KZT=9:G@(DJ>L7#&F-JK=
MOYDYST5\R=5J^@PY%'C'%#N!PSIR^V";NNJV'*;'0\9&--G)A#$HOC=V6-B[
M3"Q&MRZ6>FW#AF/4<:HX2\)LN,%NL0%3HWD2W^25[4L5SR3NY-UXYP)4YZP=
M5@: 6DCO9HS7%XF3CE9^3T&F#E53,,N,O:89Y&6^5 S) +>Y+5:E[+[G0-@K
M=P>Y$7]MI(>FP>?$E1<XZ4!RK';!]'NC  0TRAI9>J4KS2KG.TL,W@!\GP$5
M@W0^()Z[%XOT<(CA2+S ^'/5O]KR8.,]L(EDUR/J.D\*2^*[=OL9V*3I[1?%
M[ZQ%<J4)!_B> KKN[!$U](->)NF=TJ@Y9=J+:^LR;Z2$AR9CP34LB+]6$\07
M:Q JF--02B,C[A7T_[8W!+T,+( 1 5Y>Q8.F]G4M15+R:^,QA8121@6PH[;#
M 5ZJOCQFO*<!K [=-I*\(Q@_8W>P9.# =V/RP#"(=;_G.][0@5G&Y>JND7+B
MF3! /MP&24'T2-T]>;PR1S[=1D-'!%8'/;L!WMOF@'& 8Q5SE&9TJ)APHHC.
MSQ913E3/-G)I%*X64;4Z,&TA^4L5@J/?J8 #Q5/&F-I<?5A%>7Q5V:82($[.
M;4M9E-5Y:K4G#(S.!*,(ZWD>%M.']$"I]IPDA[@ @[YS,B,H#]8O82;K<OOI
M4U_D<0M)08>D2K8)E@NH$GQ5\>*J]YMH-RIDG8:@>$(M($G"K[0[5.<[&WG_
M;//OAJ#:)9]W[2YR(N-)ZJF + =,8USGH#8<3^0$%_=;Y;\@8"=Y$>MX+H'C
M@D+>E)U@*S&;_HAAH&)*7BQ=W@Q(EM:(@M#[C3K!J6B(V./>%$G@_-#*$S?!
M909[RR7V^+1C^%P!C:O*<Q<':8QNG.-Q6=LP&O D<5>[U(_&W9>?K;GX>-=M
M\QQU^6 :,7>-MAR)5#8,_WJ5S_Z(=X6\VR[$9YNBIY0".\! HIL1DO?=\R$V
M@[ J5RPI4DYE,)KAC>1;TU!1&8;&G[8L29!V='7">"K7/>M3<@.$PJN3XC*U
ML3&#%TLMH#KRC%D_(Z"&N&LE)BQ[^O IWJG3A_\8<@^9N86-0.DX%*>F^8R0
M!S[6*IN%&(6HRXOL_'PUCB<?3)&,-SB'O,C*5)&T@<$3X-H[CKQ1&N<4#V+C
MV2!:I3$8:ZQ!DT9)<5^;N,D\PE3%"&QVR$*E?HL-R]UX&PDB'MTX"!AA6P8;
MZ8 BOBH* O=9$%(_,S*L3=-M356K&1AB8WMKP$E("L<-'; &TT[&0H-S:#P#
M.BLH23D;D /UL>HJLUHT>P&+!X&[0C@#WM\/V_%REH+NE&Q4U/'63PFRL/O*
MI#&[0R73\3DEF"'SQ<UD-4;]TZ:S#]N'PIT$IJ%B42]HCS^B8N_E/.-Z9V7K
MI2P77*0_D'G?O*&5UU#'J&]8=:!J><4Q:0G/XGK0(;HZ9JK'7#"PF9ZVA\CX
MSEP&CR5K\]$W 76Z74CZ=ARPSTF<=P)?@TR";DLY8:>_*WY'7@?;2Z^5%#]R
MP5]_NEP18>^+_8HZK\E!L]^?X)="_%*VWE5?J$7%47CC3(X'U:8)#/L\<6HW
MG3'MHY0!>W9%NZ[.GZ!)( T":H5.(UR9?8,+1G<952>JH[%]F7@_A?/8YVW.
MEKKG%V6Q/+_HWB?60MF11S[R-6=I<J8I FW U-P3Y)2V:#)H?H+$!2%=KMC;
M;I>]CEPJZLLM-9X,GAV<^"8BSI#P1)RA(6>EFOL*XYJ<J7;>)74_%,)>*>)J
M>'HV)+U._=(Z\BCV9]IJ8:Z6+0^W&5^B,&/V'B:BK35U360-6&&X 2,&5);Y
MN4,VI=<-&O?!NI<ZA#BZ#1C=JFF;TIY+\A^U"=+<STK2\&OOBOI\BUR2'^]S
M2227Y,?[7)+OEI(Q>*;:Q'Q^E=J&ZHV\3]*9](9RNAPK""8?_]FV18HSH1C6
M4HCAY10R\T7K]3C3""RTL3TPHW,1O3'-/)[FCVR5P9J5R ;L)Z5<SRL.\7R>
M,9K0Q&:$1HQACP8!:[U34?3Z:)("QK_Q)&C(YKF%&F@T;+$VG+O&7YJOM[15
M[4_09 )K$3%\0STF^N)J#&A*+3TF,.W-Z&OH,+@OURLQT=?3842I#2HQT=?3
M890GY8XI,1@Y;;1_-P>8GA?(O/E6!W+:K)?!%2-8=Z*CK<JE&&@PH48S=>>U
M<FCLIK\ZRYC:L\:,BPOF/)V&XEL$!YZ2V]I&5SL]<Q:@1@)$I7<QW\)6%(*F
MZ6T4[XS=J09W[T19:;7,F"[+>59=I)7OV[#F+J?XA'A=#'I;67/E##HWO/2/
MII2:7&#I,F=;4$41I:R4IF+,V'_TV_.B2+!T!G;RMV5RKDN=FZ]M9[(#EZF=
MT\Z4GU#M-_!T@=]I)ERA)[39G7XJ);;A^U^8V&.H5LK6A]@/Z655E!<,S]#R
M@6@?9VTJ-NPJ=/V.]&^TKQ[B#)S[)=:)^A@7=3N _!?^CE$[$UFA/#,\0 J$
MPR!59BK)7,\/'^#7NAL"W3W$@&\4\[S@8*@L C.:8$Y+!(!63!V.T,S4DS M
M7_0%Q2W'(') +TQ2Y^TRV0)3*EM-J[2\%# ,N)Y3SGF)\Q<2G*4)&4%BE2J0
M+=(?SPM8ZCAKM_A!Y"23&S2:Z';<OG+3QI!-4DXP_4#W.E:<Q !3FOK"T#TL
M.,$K*>,K(E@&V%W'<52E" 43+$(R:E6KAU/JM[GQ%#1NKRK55;@ID-_6 :$0
M9.CDR^*#E$/Q2MTXP,DFMKM%?97FJ.!O/P9J!9ES8:=72GT-\[K.Y[QBV3.%
M.(JI3W=%I+;#:C^ ]( +EN8Y%\;=W93\H\+T)@1N<.J8?+_WGKIZF.JJ%Z"-
MP) UF&Q&Z=Z-JPN7R^GJ^DP@3BP\;?U)KN)E08+-P!DDMH&XY:"EF1/F9BK9
MT\RG]^B[F06%TL06\WFPS<D ^/]0U0.&RO_4+YYL]GN_Z*H"6\LEY<IHP+DU
M"I9J*]P^=^#A6(E+P24S:1-A"_1]A0E/J.TK!M#-NZF45[+C@]UBS3))A/N?
M70ZDMG'H!;L<HGM#$<HJJXZQ3=/O.6G Z>LZ1[2Q[ #"9:,4-%86C5X)/4B1
M 9.IP6+""_PVE( YG!_M347$ZH%9-C.F4(E5CPK3=<'2N\(@_5SMPZ*"=YU=
MI%,0U'N8<K44"&S8K[>@H[KD$%W1Y,6^,,0]=SDT)H$3@VRM'B%3BPRK+>8*
M!JD0O@?Q.Y#,C*+;[^4TP9HGF+@)4L:8-[_F:5N0%*V?"^BHC1&WW%>2#6 :
M8*OA:4O4#"A BKLZHRBGJ[Y?7;,T=@,,F[VVU6R&JL!=+'&.Y!85XTI(*BBH
M?XG@4S9*EBBZQK4>=H.\2!A.M[DY9!3)IJ)RHT^.DINDC:"]_<BP&RGB[1W'
M7<Q0 TJIU&6>2(XVHR9(ASHW4]J7/$N7-YKR7;NUG&-]BH8#JJ+P0D1372$<
MP!L":\#/TGIB(9WP# G$I:#LS0)M'SR!E?6'UK9RBVQ >[M8RBXRYRFU0M Q
MX:)DY"0I/T-KS\-$B6VI\UXLL#6>@2:E"XQ_8EQSHB8W:W3$?3V'?3&(M/AB
M-< =HX:;!+^VM^ZC7Q+]VMZZ#W]]M[0L*?<C Z*5B$26=/O7W:#2Y/_C7"SY
MEWD),ZX1:,U)NZ[4UUJ& 8@2K1XT>NBQ=RVC*A;TL*3LTJ82+[<"CI1)[9+?
M/T*5V;8SH#"[14(-ADG['5_MO&S;%!O<T_HO&4TF?URLES:ZM*_,F13(AE*7
M21%6J.NL*=%UZ#=4H&EVHA:]IS+.3NQ;55#A',RL/->06\F2X7MP*%N/ER)N
M-<9[0K9&<\VD--YVT722-2DW>6Z\DC;*9G#E*R.2W(RDJ81I;Q3(-<*DNY4&
MJ:T<?)  '=E2")V*W4BZSN,K]JB:",[0807Z?CDA$!]AA/;*Y,48][VE1IEA
MC@'$9*UN'[NB/%L&ZY4@\B*[3L92HX$W=-GXQF6NFSQDV+TB:%$V#WC=:PB@
MG6UG%_UKWI^N0F&L*,1Z>G>KAXPSA47X4O")Q(Z)]5DB&?MS!">L*ML!8HKU
M(0R+3W3V$?DEJ+ASR8*C6P"4,L'2L7;8T&_,8[A!&DDJFI<RS-7Y_B_\,J.)
MQ=+D/F1%:?&B;!4FL#<<8;")GESRFLP3YWBA?&R@XZN8^M<PSI5L/D8/=>%K
M**I-JN%*:9NJ\W)7VV_DX>2LP&BX;US ;_U^638T35?#=]M[&),"(=D!=.8!
M-=)^,&2<25YU7N]"@Z$ZI$?;:^.RR!*V#],/Q#+H \K.&*/T, U!0>Z0QU^U
M;# >%'*,"-^UE=1#2F'FLA.^FS4)9SA^%3O"8OBJ=M9F65+>!NZQ &URG9/-
MRI0GE5U@GC'M%9D5DCO&\4(V,"S&$@NQVH"S.>>92LK6[C?_SIXC;!IVQ8!K
M55)(.&KYY"A&EL[3,D: $1N9=%'3M@&++C(QJI'!BU4=EWZWJ&8VR+B02(4D
M<1OP"[J R%+:!3UP@SI;E-G!&6^$QS;]:CTAM$;R-':;\/)8R,6-8@G\J6%9
M>+QY>LX8(L1$UC*OFPG<!J_EJ!)&XG3:"CHS0WDKQ9CK-^R2M>Z&MNQ'@8NL
M%*.I3).1E2D'%,&(3I9QD:P,*,-O<$6KA*L(#;_DRCQ3D.?)\G1NSM62#6<:
M4Z8)J3 JHAS2*G:D5H#OCC*H64QJX##*#\4J#X>&;>J1NTK-;]8<K[#]QGVX
MM! OYNUG9-W _KN*+?J7V4'O*&JN=A\&R?2Z<\*:T2)!)LHGUN^%CNR.V?52
M\OA?:B=4[P9.1Y NMR +YX87DOYMG9,&#1.N$,:1)3V0^3OP>M"7ZK#KU$$I
M. 36=L(\QR*;[7KNZU5-_X-6R3BJU:XB:?)A7ESE:7*>5HYE!_N(=:O3NE@\
MXQ"VJ[5TI4 &>,>$ZM"_"XHL-@%IA*6&+"0I,.^57XM+GU0?E33$E:"DX:;8
M7C!O5(56=^WHSR7,.B?5F)W=^YPU:AP91YA2L2SY#),TSJ5ZEP%P\YA8HL++
MM4?NG*\."$W(@FIZG68EG'V1E@).'$<R'^-1I_=PQ:#-L@&&\!NHX!,=PW5Y
M8!*]I497E>3VI,BW WJ9TX7;_2F4+U]SBW[/LHM69A;2)&LIN)UX;V 01+>%
M3:J:*2KAKA@.AI2$)\O?RL0 ;<)-$L]B,L0:\!EML8FH:'X-' M/T@^Y8,WE
MWEE'#\V5Z0(MZTI*T"6ON-)6$"CVA,6ATD*'GD]"\(,J.2*X@=2)QD9UX4S$
M";184&B%F+7XS/E)#!8U<8HHBR\W#54=N"IL2K)4$#>"-<>JAB,B%C66"+C2
MM9MX'"G?-4YQH7ISF,9,%F":8-*YOM%5M4FC-R_TPC5PKA2/.QT5I<+Z]ZFT
MX5E0HMX\[TEZQ#00SYR&OKX7^+>.PFS?1V%,%&;[/@KSW=*RM*PZ=%W1X98?
M9CZ&ZU&A1*RQ",7B)#0IY[Z*0?91"NNE=:/[\J83,1[M;L-90CD:\P)QYX$E
MBM_/- V8>MXF5$&RRRQ/SUU%E)'J"E:@S"H+)IZ;U?K/MQ$AN?TK8OWBS_RF
M#B6K7=W);*B*,"@A*0YNT(Q;VY0!/W!!_'L"7#H+8)7?,:Z[\9N86:Q)M!"
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MK#[:.=[[%:GZT9NSMX>O_C]02P,$%     @ 08<E6Z(7P!^H3   KI<! !H
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M685;2,3N&.+0^Y=<%KQ/R'%EH$1$JB;5:9:GJ!D %:?SA/BDL&9YXJ]EA1<
ME \@W6R"3\-\L_D:@3A:UN=%F?T/?SDR+VY<IV4.%R4I%K5<?IQ)$N&Z:7B1
MNT Q<%7B<D4L&E25%&0:W7*80IG"?:WH\?F2+B4\%,OH\#*1O$WQA-(WRN%N
MYB"0I]-LDLFR%ZA*U/0^%"OQG 4=;F7E> GH1, "%CGR@W[/R+HTP&,<E1NY
M;*4HJ=P5Z( +F"':'@E*&^\,9_$*3V\6)R 8X;@OSXL\)95P3GS$4[WZ/?BB
M)GIM*F%!38NVG)\<IU/4??!1I4OQ4S"G),U!2X4#\.F"-H9/$>AKLL053.-)
M!0IE#K.9%(L5OOS#[CO\WVXQ6:(.&]'GH ;!/LN:TZ>S&(AR YZ2O\9U'4_.
M<0,'9M_@1HC685>1L6H+<Y_!8N8P"185,,T&/?*/88>F'M=Q^LTO0'3RNC0N
M\XP):2,;1/4EO.W9(#HM8[J)NS%S]XT,O_3H3CV"-#(#/:G*1#"<X$V.2Q0?
M-:CF+'\^ !<I$M(+@SI/,L 9L/0;P#KSO+@T+R3%&@9U"CM<8CS&*LX25B/9
M.!!.((=(7\1G0)]G^ *S&S 74NI0/<8G?+TSJA;I!$V8Q.QYO%CDV20>Y\&#
M@3.]S)"@X!W5%#>GC"9Q=0[;:IA)-#E/X2(F97PY1RJ,HX] I'B=Z(J#;A?/
M48T$;L/7&W]/_[ +!DXX21/4MKSIN>V;#("R8<M05;S9"H@#PY.?G@(? 0X/
M=R>P3*O0EJ#1PGIAV^>%V6^\(+,T@;_B9,Z6,>YGFA*5,R>O5PMZG_L.O@*&
M'1O&B;0/3!=>%-IC-^QF%! 72,]G1G.2BXM\JP1.&B /$13FE<0+SU<5[%">
MXW4MRQ39'')>Q: :#,$)%WDW,#K+\!+BHG*;&_057\"MI[.PEI!5H<RC^*YQ
MFCH3%6@%EC9=YKDPQVQRCF22!I9G%Q"MF_^4Z!1X?IXS![PT;*'$DWL^\*^X
MK 5O(K 6,P-B25TDDU7F(O(>J]$WHP\H7^%W9H$R@IHO[-4RK\GHF=N-K9@1
M@RQF"UBF50,EY8H[76/+&PIV.IVBJ0J_A4L$K$HX3[&L+:%UOEXFAP/T>VX$
MF#9I&@60BF\'JOMXU4N1XD_="1M",:?(JP Y,B<;H$Q!44F  YP3\T0*OLX0
M]K6&T59+.%R[YSP#?TC#8DDVDIF/-(2Z1O *]WM"7FA&;VS[(@:>(^_0HK9C
MS^D-F]&;MS\T5D\6!WF(TI1MULD$K!2CO?A:8CSY-"\N0=,Z8Q4@1EV%-2KZ
M+:I4J!:(NF+434>,H'G ;^+%^; ADJQJH^FQX\8W/![V//J]3CK%VVF'4'R"
M5: SV/HY^Z!$;1+1$0N_9YJK:C+BQ"L&ZHKQ3FU&[_C]BP*.EVFVF*+_1]0(
M=3JB-^!M!@4(3TM??D_3A$> Y28\9&R/^'U<?DKK+^G.OH'E V/_KZ=/HW=9
MFB>O@ N=I:]A@'\O4Z ?^$GT]*GQ)N_N_VPFR4,_K8L%//(,_<GRR;BHZV+V
M*OH./QO#U4M+^]G;'*@/)O$2YEL5>9: 3=A8-DC0&7"%ZZR^[;VWDZ!I;05F
M!9\]H2U_\RTL)K"N,=#_IZ>L$;\"6L?-T"_]+O!27+]>B3H6O=?>D&K'O\4M
MYUW^HWK0C5T[]NU:4BK%I$6>E8DAHG0X9(K.(7FU']%I77_9WL0@[Q4>U:8I
MT-!X/3/@_J_BG1[6A YKQRC6GC\&]'"WKTZECL%NWTCA#S*!IO"7;.KY_Y71
M:>-'[.U"5C@O1*D 9@V"YBRK:G$@$%^FD^./K;K1% CD(;9JJN_TU6$.%;<0
M"72LQSMFZUMY@L7R 8&'MD*]9#,_)JNL9CT:%,Z*-&5?*.'/T.[*TPYA1W:]
MD=@D\'S7#4FL.*\*SU?3:?*S34 Z >WY>$6^4-$#A=1;]I(56EI6>4HR#BZ1
M(]Q/B4[!*[NTI7[/4^'@]34Y4HJQ[!LZ#[*+C$3>_]D8/7T[B#;^.?B_^/G&
M"(CG$O?UU:T1/_VYC;[&ZUR#I\_^YO/G1KQ7QW>;\=_?.$^12SB_MEQJ!(7?
MG!Z;82XP@@B6F%D/O*4C 0@78".^YG7/\&T4L&U]]_P;_T5Y.H4M@;,)QY!#
M$E?>A(/\HSE*\!#D!W]_#K] IX55_%^QPP4HZ>=?1A^,CJ:UXFP&)G4&G")?
M]7L+)-"DZ0^YVCN1B3X=-L]0$8=#.7<^+>0FSFC3'$?X8K^'C-%$.4G/0Z60
M?93",'SEOB27T@V'B5JCZ'>")"W0/.>K6"Q2C(W@XH0? %M=YG%)VBAY!@H8
MP?"$A@?J> D[]]W6%HIS>,,Q_92F</C^!#GD;)F?D1[M?)_3-*%(AW.3]GMY
M?%D-<*JTWVJV0W:?Q;5,5AL*ADNF&7E)-E;7)HDH2!%L\*TG"3R0_^%QWF8)
MJRTJD.KT$9D ;/9\DBU@N;Y"S[()+1]F?F_SHD#6>18=;'X F;KA]!#[E1?4
MC:VTXFBZWA+K.F.245MV0WKO]S3!6P),EB1SKT,O+>I#XO5\&\9S(MY3^C6+
M4=80-F #\V5"!KFXC;Q'G1XQR0LV*7_+Q 977R2<"Q CDXFFLAMQE):G(,Q=
MVKNV[FA^#X/X[1N(,P)UW<WSM0@#RO=QN3Z/ OLF ONWR&:0Q* QW9$H;B=C
M!'Q'E=A8$FDA]O\:*=,EA(4)Q-O.]F;>NAWTFRCKCT937U8)_.==*8%K';*D
M15T6RSQ!^X2"LLB%,;$-S \ON*J3@^;H RW*A'R@-J3,YF'K86'9]FV7:*[Z
M5A6:4^X!,"(I@H/.Q;C?:]E:FU^,8UZ'FO^^'6"3=S?P?CO64*:2I44A&]KL
MN!W18U<P6KD89 _ZJ46I;I^N$8'/001N?&^CQBH!:#2IA]HX[_=,<).,WSK^
ME!K)/X$OX@GZ(&"5DZIAU9N\,V6HFU@!&.LD-!<<V.WP!NBL-;#\^ST@[!J6
M*W[IHO-5CF;]\ -M#1L:^&M<"7Z\*"KR@-BX'[\;WJ)CI'?K];IGVE3ZM]'S
ME?[=[]&-'TJ6Z(HTNJ'1^">8D%93?H3)U<!(7UG5YJ!=.&22Q\O*<"]2'C%#
M&]6S+&!59!7[A/*,)"O:<>A+"0<-3/38!#:.3G?^^RVJL?B7?_)LQ["X1:<1
M8WQ69&+ 7?KW,JTXBT>^F*=(J+6SI_H]W(E!T_XR$UH;_? 6%LFZ.NVDC3$%
MWUH&!J7I?O_J^5:_%V_.-J,-I(Q_%>6G:">KV?<X0/)^\6KK6;3H>@*]EV,Z
M W_7?-6<E\4[>5'DRQE*!/07XL0QG^],Z,'&6EO;2RR.[('./8WLEC;FXOE$
M8,*33J*A"P_["Y9V<X/IC&4]@2'07)OR(BI+#][K8TX(FKMS@J^0Z7S(YI^B
MHP5\(\>/*XPC2ON)2\Q".HOG)O4+OZ*D6]R122K&>4$Y[=/E?&(=M#P*,3R:
MU("W?U94-3DB@7TZHO;B!:V95X6=\Y"2HC:2 8D,3#^@NX-) M50(H!9B<P$
M%\))TB3NP]$(\I)H#A!C%EZ2+E)B,GAL90P2 6:7YL!BV9MR5A0@]V @$%/"
M-<[)H!?58A;_6I1(HAF^#5Z?.HZBY!<=AHZ]XR%RL!8(Q<9\43GR$PN&XJ"6
M)X%JIVG*3O+T,TQ=,@CX"EM/\"+.+),S&0KWQ[9O$*]\]AJHD^CJ%<Y#1-WK
MZ&<\7?CZ3QC.5+MA]N%U=+I:P')'93S.)J^CPWB6\EX=%K@#S[P I/D5?O,8
M'/W2J@<ZF936P68&L*K[UCI$=E NTV_1.I(X SZT5F)VZB.= E/[^>]1"<'"
M(J6%1/>IA( *]/OV]-:4$!L0#6_PW2DA_9ZGA43WIX1@ FM3"XGN10G!&CU?
M"XGN40EA_[K30J+?JH3<N_IQ+S+#9PMMFS62A'Q?(#!-54A_Z><)\.XSK@[H
MX)1(;E==8AOH4(;C*T[4L+R.W[8G(S*-'_[K9 \K0>#NX/;01W&5Q/^.?LR+
M<8QEGDBL'M_S'PA\(Y5D^JM^3R22\!-B.@\MLR>AS)[W*1Z .+#VG&ORXUWG
M'-Y7V9F,C%D%L!V[IHS%.9FM#_ CUDE["5"!_-X):E<ACYY+&G9I9S4E\U %
MA*MT$;V%BR*P&M4D+O5[DHD##TW*%#.7)(J-CDY,7 V'@J4\/$DY^==^#O>%
M?*/FU^0CQ17MIN05+& ;3DO8-+O$^KPLEF?G(-'A??(4OAXK8[!*(\:JG&@'
M?E(D&8B<:@5\8A:IB/;N+Z,=OQ+=JT2V>EC,+EZ,G[.GGO04>1\)!(K\@T@?
M#3AD3)K1_.K4,:[>LENG*[@"IP8[#^N[1N*6/1P4XV\'H0>1<P)YG64F)TQ>
MZV5^T2F \#3Z7(%"?SX'@[*8/J7'=3&^#O!20L;VBQ>P)S$L:D;*?JL@IN&F
MEBP]5TX+DS$U':ZFBZ,;#%$P(</#)."Y6IE&(2 K)OV>>= \-H^;*0M-^AQ:
M-:\[WE.TT],4I(&W+1RIMNLWE01)4N*^N)(?_Q1DMN&Z)2O>3/8.?L E8:P0
M==2$@4[N, ^ZZ^7" TLZ3*@.@-^J3XN6V"K@DHAM7;">I>N0*;VAL>DW+%6+
MI%+MAFOT"NZB#6N/K$4YB"R?;D(YO$8N3@4)29K@%T/\X+RXQ")K_C>?&A@5
M\8KFS=.!P^G:L*RR*!RRNNUGK[:VH@^;[S>'4=MZ,RK0FBG;!,^NIQBD0B5=
M?JY1=R<Z-30 1$RQ&Y5B!&>UR8*J20XABE($;P=*,->5-3KX!$LTN8(WM74/
M>)Q4_S-.@2I292=(14I1=H6U2,3 7Q:2-&QNL0JTMDNXAE%6RF]@1=:?;C)I
MF@MMI@(;8N!S]P^]^Y)L*%^&,(.)+5LQ;-7QE8%'))?W62GJ-/NK26 SVO?E
M+QA_>65#6U+F P=E*T,+332!$Y9,>THRC-?PSZON1D.M6L0K?VQ*?,9SH(23
M//OW,F/HA22>Q6=B-<X+S(-&CPE8CW%>KUBVI#$0W5^VAUMPA]O"1=4*^!%_
MY_&I;198=_I?.#.,JO8;6P(R^"_;6^0KT&2Q(:7KXHCXR[/V(Z9"*9O6YP&)
M0-,/;,T89/*<3V@R*9?IP.U*QTO6G)84=+8?8X7'):.)4!?2@>\GH(+#%?(V
M.1BSAHG:2KW8%0S'K!N+#&YIC#C8N]')*3* LS*>H;<E1PR.N(H:!9/X=IA)
MTV<AD\)SVXQ&@D#"6?Y#)9FZ96'+@4N3JLSSE7N>(_A#]'.@7B))$'$'.QB:
MDV\J7< C9C&I[9[?L\EVVT9]A3MF:CD] N[WKL-&FL7%[&( UEK OX:M";AB
MQXUJX+$'12_DE*.495)96.9V>DS-M(,X!D.1-%+UYP8)EZ68O-I6$JT!;_#@
M@>H@Q:(9B)A+. NJCU9N+=CHHJPKQ5B'7/Z^9 U53W%X%9=5=9^XF<!?7_SV
MC;)9*N%OK9;0FA/H*QY7F*I"25W(^06EL64B W(Y6VD\7EW)Q.[:]Q-P=JP/
M6#Y_C$WZL<GGC[')NW>1M7UD.(CQ)?1[ 0_9?B./4L$'^%J^*UYK:7]#4P2"
M)7UB8L>ZMIT0#!7^1#-YTW-=R+L,C[_*? AKOB"9W<JC%%G:?&($'Z/V6$/%
M*,N%JTS'CY=SYQ)LL'<$U! ;K 'W8P29'IVWU(L;B:A%50]X(9XB.70DQU6E
M"-X_W[MC"F82/D;MLZI<D:?4LP:M(3@XY]4->&;%?7NU;10NQV  ']\L$I]S
MI\_ ^@HU% >1'1=EDF[MFR\/[J@ON'(9CC*=5^P%Q@OU=KEZNC^G_(5W<+P(
M#01;AH."CB;[W3RX$%^;6_>+46CEZG'1L*O^;9JM'HE1SM=MTEA'4KL/T=$D
MOGA<H&-%TV>L8%Y; &#KS$&MJMD2Y*G9:3'60-G [4Z6J=F\>")A>#1\Y!]M
MQ[BV(3SJ%C]V-M56J_AHM8O8%H7#N]'I/"Z+3PW>O$'X,T @F#D@ 7?:?SM%
MYRX?^%:M"ZW0:U'P3[-RIMSK%AMFN 9VSH@<#'L X5;3>&)1>^(H$#/H<+8U
M7>3QG.UC] 6P=HP22X2GY^F(E7G+%Z:!6VLYD>^FP6@,NFK$-Q,@5X9884@
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M^:K1OB*DYWFA=2]4-S1$2)GT8BURL% B(S)QXUJQ!C8_I'OHV&9R%$:NSZ_
M?O02[3?JXBPELK6!G<:.C\!*R]&=+5S#$?J'M*R('4R(^Y/U=X;=!9'#A]]J
M;TJP-,P-)947,H).;QW5P,7&G ;Y@7&W=# 0$9H%>6V>HGF)R8ZP+Y?DM\*0
M6F7!L=[:1Z*C2V"5U7FVB!Q9>1"SU)5GX'=<<,6KPIFLD[_1(4+D !&*%Y30
MDXQ@CD%S&^T2M3/X46 3;-X-"HBT,7X3 ]O#I.L6G.'Z" YF2STW[Y1M;,E]
MOV!F,AW8\.[I6"<.OS>,F$=U"DUO..=(DRR8%W.7M.7%^-1"KMIG<A$+73:V
M&[X([;:MDG!3*U&^@2%>J2CC4DV.6B7-^9G:GZR]4U@ ;R6^'V-18>:.^(6]
MF!Z-[=G@9C7P.@^H'T>,N&8GKSU)\3S.B[-B:;T>ZF<.;EY".E<2] WW>1-=
MGUB?[_$YXVAK1]>&?J:OH0.788*I&6Z2-$6^]U8V3^)\LJ0^>7[V"O>^L:_:
M?HXERW)$IFZ<E$&C6I7+7 BEM&C4E0=%7:N 55;+%5(V2W/S4$CXQ7*"9>%K
MX47S-Z+/R<+DPE)8W]?#KK\V<VU<\@RR"5B?K28E*8Q>1=H%'=_$EL;4-M%/
M#J+-P&F )&^+QD["DY:2P$O4&1LD&0%Y\7@5.:%3\;;ZS7E5A07%\<M4M@OK
M;ND7^G8&J-N(/:$5W(.K.?> ]6GC&^_B88WY.<<WWP4\ABC)*NP\Z1B0J0-V
M"C^U,:P,CPK61#6+[Z0NO"VO?\O&]GN_:V>C6]M8UZ7#GR"Y\:GZ2!(XO-[C
M5^@,;<-*91C/"YU* "^\0 UY1<+'F$:DO4U@*^+)RL92O'WVDOTX:JU/(3;1
M1E;%R*!94I!#MP#E'#M]T@:>A2M].J!*;Y?IA;0IQZRQ10%RZVQN9V=,0:=)
MZ!JI<.+'T"GV;)CFME#M>J\QZ#CD99DZ=!HI]6_%^37T#M=191,6>W,,E3+"
M3K-Q[(Y-%AMR09A4E+#G8(@Y3_U>#.\N4_ON)=#2!%];+.?2+=P/FU'Q_\X@
M\G_7R!!I_Z1NYWQB:1C%P]G*""FWK80;M:=2 XP_,Z.C+532=K1RZ$,%EZKM
MG%?!;JX-OBL73/\Y#1*2A-?*H_+1@OBVH2_,=FD,D@VYUX(I?>TKUF7GT:EK
M+<S/:^I2#+57R&-LP[;N=3WEMLI,HA+EK,8:YXCBIS>Z.)<*M(RM=)7-N9Z=
MZHI%NY$O-K___AOT%DI*DLEL(& IFX$FA7HL!+W&R,Z+"/K!]_@RR])"Y&&N
M9XBPO5RO-:=JQ@]E95[/%M/I7[)NN<!-Y,P9);QRFVE.*I2_^^*KWPO:O('F
MB;[R[%?,7<>,SN;41(N"XB:GE;;=ZBA?>ML#>1+!S78JP7F:=T6^K]@A [Q3
MH#(N">6@C*XVH]%<'8QH;5?L'>J1JB6Z=4"ZKK7?;0/S3/SR:)/[MZYQZVEX
M);91IK*'X/NZ)"!T8J^8[SGCYM^4O6#<S,:S%9FR2'8WDV:#T>UZU05J[VT?
MN8G+DD[1GQ$'U5<NDY?#IH-F,:WRTF+'=[!)*K(C[.@(%D?@%5=1KABUSMA@
MEC)#M'*!)B/EK5HN9%/ '$O1Q42]WTL"D2F-LQ>V&_2!G/M^-MU[SK;AL]&P
M.BUCIW5,1&$"<D" @54%HSL4C/LLLKIQ]\Z7CV%F/\S\\C',?.?!AZET!143
M9R>VR:->9$JG)5MV:D$9VGJL<'(Q YDO<_Z=/!-2(:^,;K9T'!U\;"7"DYN5
M!;%HM@OD5;XW,*@-M?J2NMT1+0TW">O=9VC260G*1B%ETCB;4&1\$SR6*F62
M1G1$X[JF[ ]T?BTU<;?)PA';&7F^1W4@Y325"9O &<:Y<4^J;*#*Z^&)FJ8+
ML81M7G]]_9Z 7Z!OS!Q5^W!:,0J]QT/I_.4F'3M[:@'F,=848J <524L#$ @
MO2K-&\*?LQ6EI8E9L74D\@K!8G,X*FY;RM9X\#M3D(2^>*\$+-0!EP/VPV8S
M'#]\UD&Y7N(Q9UQ2%F2<)'R3< P5,9?D "-B;<EC%9T!;ZQ5NB56H!3)DM-9
M3>F7WGHSJI_7C)59L4UZMM9A6L9U43J;22#9.DN+NCH$^1-O-(Y5FVO;OJ?S
M@OQ @<%=V8NKS* >,NWL$C,=3,W6C,>SIBOS MMAQJ1BV-P%@TX2-<!)3C#6
MGIYEDVB4 ,-$&]1_X .FJ) _8T08R K>Q(^TGZHZR%W)1&@R*3R\49X7$^80
M(UJ]YE9DX0>8A!<-QL(U4O64FFN!?UPHN!U9)FU7GDQU6BY/"5DP"@YLS]3J
M/]_PMOHK@4VAI5QK^BZ8PUG8C<93I#=>J\3,YCA;>AI2$,!O7+]VXG($*CTB
MR::X.RB[QFE]F:;7?XNE_:MCK4 G2W(2!=E"Z&1<FHB O87G4/GG53$(NSG4
M?F\<5QQN00- 3MA4/%R+):@KB%O6MDWO.#5DZ]Z2?&5D1+DRS;,VHYVT)"RN
MD2UBX820^[=S[E1CC4EC95K?S:@<+Y'JD1.06'6E$%!T985*I *)D:=1,WBC
M'"_<[GB!$( Q:T?<+)MR!C5S1!,9GTDPLTK<B\0_]0=T4QRS08W+]_AH7B\U
M?(7]FRK:5:Y14]F8S;O8V ;)1=.[XJ+($J,U)\5RS-J'*)$FF:([\;#A/5^K
MJ0\$,[5:CGG3JFLYD(4]YUC!4[;XW%"P4B?%; Q*6*6R!*B8/:8H$B:I8VD%
M'UF%Y# (^V[[O=#@U0PA8$*CDT9Z,>#](/3A,IWD<55QWJA(LS5N/=_NF0@Z
M>L6M&IJ.;N)_7GB.%36OM,R50'G*FE/45!V2I[!Y<&)7"Y0-3FXAMSLZ]9;E
MRFZ+J??O<EH*>@57[Y'@]D*536U.SRSL+KV!J]0-.NP4G]?T2INDXG&JA)N,
M99JN<E:L44LZ,=7"%@,G^H!2R:IXPEY45:Y(96Z-L@KE4L3>BG;W"![6.5';
M.\/2G@!C$X,:%TP@\ Q#79PI&;0"(ZEYHV9\7,YVDUFY[TTC QLBE'HJXBD<
M0&1>$%N>6Z9/_2OYT$3CF$7C<ER1[ZP6E*7H"/5.N"06;ZF-HN-(+0B85#&%
MP28_QU$HJM[*3]82XDSB3L(O"^J[EG,O##]LIO*VR'7"4]8%P!7'MR]M,$N'
M"$OGE5J @K1R5H95:XG0=4L5= 8AH:SE>KYY98T\!UQE<5F<AJ\!HAKES%)]
M,725U!P<4/X5A-OD=%!_L&&#HS2^;E=63QP^ABWZ\($K$"J#].N@=FX3%OG7
MCC]2(A4PB6XOW8;+^S]#L%4A+^WFUWR60QM7Y/MS(/Z*(,8@)'=L:+<P8"6Q
MH0?T%X#R-K?,[XP-6>=>+"/3?L [E'[/G$K!N%)S,; :+QZZT75@.4R2'0+.
MU=&JJ+I,N-]3,^Z>KB&2C6L!M ?3M0-&JD.M,.B_=<H9-09[RA]?O+&P1M!5
M#%L76F07K<EYN3+QJ'G9/(>SN7$D(=7<;$ET8UH.T(J6NT& 6X&LR2M\S902
M+HOKH)?&4 -7ZKU^2E;QH.N*.SQ.5T2@AG!E'Q0@-')C(LV4,&ZI7 7+7OC]
M4OW,)\+.T-][*G?<J?@W!-N^>PRV^<&V[QZ#;7>NGTU(/_L "LHQ*BB[VD<@
MJMGNLB0[59?8K7%4-($-A5TD:)N64ATG+<=;#@Q?51?'!&A%*?**#4\5$RU"
M/4$)#%<*L*%GF]?+<JZ-7\^3<D76/P<@FS/F3@25\:(T,VR'3BO$;[GUK)I2
M;#<%7K+ O+OI=-@R[-'0,,TX@/SQ&,[8BP_JVN0\90 +];F:BL <*"##@0_S
MIVG 5RK#&.E^XR3E@6=P0)?4*ZGP7?U&/*2=@)S4\S(Z 8(R="@&"I(- 7=*
MAWA82W+)3?3/Z+;43TX5^;WZY[4DX#KUDZR+=?IG:\N_C'+9<'JMTRX544AN
M6YLL?KM*J7'?UNJ4D58IO<%O5Z'T@.B"&N5U+TI3G92I=6F5H70(E8G=TBK7
M##=PJ7LNOM;^T=4*)<^U;B)I7Z5@1G]N_?(>ND2^6\Z3>,900"H&;%&S;QC5
M&'(O).UH9B2H?,5)A.9?)$4P!QWU!TZIYVH*)<<J\=55+)EG*;GMN<*#5&'K
M1-3J">4FTEC$F'5]K?8SQ^9]/ 9Z5[GZ"K,F.5E!O=5PD'X/T:1,^,%+@#&H
M1J+EH(LL V9=<NT4\6&Z;83*-NC>%UDS7]L8TW3RE&1LGDT0WPOO@@&=0I$L
M$?$AY[NOC&/!ZE\67T*R#$@6C/' :JXM5)-FQ4L=30RJ3BEY\J$3DI@)'9!9
MDE[04$%_3FF6E"]:\K]T9UKY9,/4/;6+*?RSI+Y<1EHGOM^:)9423RV9)+TB
M)7:=(KB?F9B:$@R7E89W3H/:'V'^%<HWB&1 "!"$:\(=D5UT2\WIY=8WEOB%
MA'6PP==Q*3#T&ZX5 E%TWRMI!=;414%?:330AF=8H;:?A;+*.<:(9[+,J\*$
M<.QV^B AW>W:K8,^7T6NQ)>NLSJ<Y)H'PG&UQN[U>[^'*R'[6<YF7"_G3 ->
MK:7W6"?:\#S'RPH#BY4?5KBR&+EQ(,/6<;!I\91,"\<E@X;#P%3]>7P1JY2Y
MQ@V>-E@$ERAE38N=QN-2$2=&6\6;14DK1-9M<NZ*(+O8,/?F6G4&;W6N1G,V
M/H@"V*,$5U:2-H4<G:&#JJJ89+'TMXY-Z8XJ'?->T^^%WL,NNM]WY&"?D?VD
MC;0U<M@VP*34.E*%AY'HP)0HJ#'LO<I$ET!VQ.C>+OE+ S*(UM1.,G/Q/J+Y
MC-$1XWZO8[:LZ$K\@75J&R?J1@QIJ<6AOA<4"U1-_AKM-#HQNYUEY\.'^\C2
MKL I*K!BM$QU]F_G:CWH]*8N>V68 O?=J]<HUL/?#L)0&,V+8N?AJA>0W.FF
M4N=@!9=8E WMB33NS+:^K9;E!5<#J5\Y[!+5IM30A\!]4/! (8WD8/QA-!O&
M4<]Y_:+YC.F\0E9)QR%P.H(NSU@7;'+(\^OJP8.TL782-SEK+L:]\K#;%;W6
M2/4QBEL1]75Y')1_#&NBQ8'69C(+3&F576G'B45>ITR7_]KUN+V"/LPMBECF
MG2V+U!B]W9<N6!4.LS?Y@.WEPSS%".R<YYPHSO3Q0]Y/I5A2IFS[/U&M/?"7
M"W3TFT,Q29<UZ3ZP-I7(V#$@)8^M4U"QL&G.=L_DO*!%6-20M?JG07L3^#%:
MV%IV'?3=T?#6(]?OM>;0N9&U&;MR8J#3E^8ZVJX[\R#X'L/;R9T0/D>.E-7:
M-4>VIX2F(4G9=RP/=48_.G]B1]FC433O8A\@MF9/=<VTS1!.O;X/#7O5".E
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M2S/ >ZRSPNAS3-+/&YA[#Q<\Z,6F SI'22CT\G#1@\QNQ.,LEW2!S7[OQ+5
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MZ4:J<V@R%C3" L%KY5+\G@9Y@3D-I>HQ:EM!_V]['M"B9[4-4<3E5;83? <
M>BQYH_&8PB\I5[O;4=NN=R\%71XSGLH !H5N\T>>"(Q5L>M5LEW@NS%Y.Q@(
MN=_SG5SH+"SC<O702#GQ#%\@']<EW:\G)^]2YLBGV]3LB';J &,W2'C;B#3.
M9JS.C=*,#A63.Q31W5HC>R0?_E*%N^AWRKE/L8LQINQ6GU91'E]6MC$!B),S
MVP)4^JL;G;O9F?YI,7W:ZDQ/DD/<;4$_-1F?E-_IE^:23V+[Q0M?Y''+/T$8
MI JM":;!J])R5<GAJM*;*"XJ/)R&(&9"+?M(PJ^TZU'G\1IY_W+S;X:@VJ6,
M#^TN<M+@<>JI@"P'3"-3YPPV'$_D!!>M6Y.Q(, B>1'K>"Y9XIS"RY0)8"L,
MFUZL8: 22%XL7;D,^)/6B(+P[8WZMZEHB-B3W"3_X_S0-R#.I8L,]I9+Q_%I
MQ_"YLA=7E><NYM 8W3BBX[*V(2O@2>(:=FD6C;LO/UMS\?&NVP8LZO+!-&+N
M\FLY$JEL&&KU*GK]$1^NX_GEIN@II933,QCE9H3D_< N?3QH!3Q57E92I)PV
M8#3#:\FWIJ&BLOF,%W99DB#MZ R$L4NNY]6GY 8(A3(GQ45JXU &<Y3:"'7D
M]+)^1@ $<==*3 CTY.D+O%,G3_\^Y#XD<PN'@-)Q**YP\QE5U'^N5>8(,0I1
MEQ?9V=EJ'$\^F>(/;W .+Y&5J:)6 U,GSS5E'.6BE,DI'L3&RT&T2F,PUEB#
M)HV28JPV29)YA*GV$.CED(5*_?$:EKOQ41/,.#K_$ C!MG@UTH&ZQ!<%@=8L
M".V=&1G67.DVE*I="0RQL;TUX(0?A4^&;GN#U29CH<$Y-)X!G8&3I)QYQT'Q
M6'4F62V:O5O%@\"=!9P![^^'[5 X2T%W2C8JZE#JI]]8Z'9ETIC=H5+@^(R2
MN9#YXF:R&J/^:5/'A^U#833Z::@(T@N0XX^HB'DYS[B.5]EZ*<L%%U4/9+DW
M;VCE-64QZAMF^*L:57%G6\*S>!5TB*X^E^H,%PS8I:?M(0U^,)?!8\G:?/1-
M0)W:%I*^'0?L<Q+GG<#7().@VU)..%3DBKJ1U\'VTFLEG8X"-U>?+E<?V/MB
MOZ+N77+0'"TB6*$0OY2M=Y4.:E%Q%-XXDT]!-5<"Y3U/G-I-9TS[*.6MGEW1
MKA?S)VB2-8- 4:'3"%<<7^."T5U&U8EJ5FQO']Y/X3SV>9L?I>[Y>5DLS\Z[
M]XFU4';D461ES5F:_&3RI!N0,/<$A3(L2@J:GR!Q04B7*X[1V&6O(Y<JE=[F
M%G@Q//%-1%(AX8GX.4/. #7W%<8U^4GM'$?JH">$O5+$U?#T;$@JF_JE=>11
MQ-BT9L*\*%OV;+.K1&'&3#E,^EIKZIIX++#"FS2N'S3N@W4O=0AQ=!ODMK>Z
MMDUISR71CEK-:.YG)6GXM0_-.AP/(M6@X?85D66S1WV2SJ0KBY. S%9-QO#+
M;8L;91S8S-N)3'(*-/@,Z6K46809V=@>F-&YI-8HM!XE^"-;$5JSZ&V  %)2
MZ+QBQ_CMC-$$*C4C-#RSNS0(V#B=XM7K8$=BBW_C\9V0IG@#X6GT$M'1G)'K
M+\WG]FT%Y3?P_\!:A'E=D_M'7YSY@WQI<?_ M#>CN^#\N"]7L_[H[CB_J )!
MUA_='>=7]N=7P/K7YRA\_YBCX.<H?/^8HW ?4<I&NVYS[=.S D4^RX) UJ&U
MZ%V2O77=.8Y4N7"^!J1I-+]V'B*'Z&WZ8;-F4GN6CW$GP9RGTU LB2"E4W(1
MVTAFIQ?,@IQ(,*;TV/E[V(I"$!D;?<V]G6KH!)U(':VV"]-E.<^J\[3R_0C6
MM.0DK)"$C.%.EC57A* CP4NU:.HVDW,LR>7,!JJ4H?20TE1"&5N+?GM6% F6
MA,!._KI,SG0);_.U[0QMD$VU<Y"9L@JJ:09-0"!<FBEQZ'5L=A.?2NEH6&H4
M)LX7J@&R=0_V0WI9%>4%PPZT_ W:GUB;2@2["EV7(OWV[*N'. /GZHAU CK&
M(-T.H-2&OV.$S$0Q*!,0#Y""SC!(E9D**=<WP@>)M:9]H$.$&,N-(I77''B4
M16#V$,QIB2#"2A6 (S0S]?22EM_WG&*$8U!4P)I(4N=9,I'Y*95CIE5:7@C(
M US/*>>7Q/EK"832A(SZ855QT$BDGYD7'-0QS6ZE!=%W3![.:*+;)_LJ<1N'
M-$DY!?@3W>M8<1(#;FCJYD+WL.!DJJ2,+XE@&:1U'<=1%1#DN+<HNZB+KYY.
MJ3_BQ@NPT[QJ2U>YI8!B6P>$JA/#[UX4GZ3,AU?JQ@%.-K$=$NK+-$>S</L9
M4"O(G',[O5+J1IC7=3[G%8&>*M1*3#-ZN"&L[T!ZP 5+\YP+OAYNT00H>-)+
M#KC!B6/R_=Y'Z@QAJH9 *<2^D348^L94VXFK<Y<WZ>K53-!+_ +:9R!Y@1<%
M"393II_8AL^6@Y9F3I@'J61/L^+!H^]FQA%*$UNDYD'_)@/@_T-5YQ8J:U._
M>+[9[_VBZSYLC9*4X:+9[]8H>)RMT/;< 5!CA2D%<LRD330KT*<3)CRA-IT8
MK#;OIA)5J5\(=O<TRR01[G]V,9":O:$76'*HX U%**NL.L:6<+_GI $7&.A\
MS,:R RB)C1+'6-G!>B7T('GA358$BPDOR-I0 N9P?K0W%1&K!XC8S$Y")58]
M*DS7!28?&DO@O.B#HH)WG9ZG4Q#4NYC>M!089=BO]Z"CND0,77/FQ9DPG#QW
M^2HF61(#6JT^$U.++JK]+!4,4B$L#>)2()D91;??RVF"-4\P<1.D["QO?LW3
MMN ?6C\7X$H;CVTY/27R;AH6J^&Y*[R; 04C<5=G<^GW;I%5UR]-^KHW>R.K
MV81:NU/4M*@8+T'2+D']2P3CL%%41I$LKL:Q&^1%G7"ZS<TAHT@V%94;?7*4
M2"2MZ.SM1X;=2,=N[SCN8H8:4$K%2/-$\J$9#4"ZG+F9TK[D6;J\UI0?VJWE
M?.83-!Q0%847(B+G"LO<?R(0 OPLK2<6J@C/D,!)"LJ4+-#VP1-862]Z;6OK
MR :TMXNE[")S_G4K!!T3+DI&!)("0;3V/*R/V);P[L8"Q^(9:%(FP+@>QJ$K
M:G*SBDJ"'G/8%X-JBB]6 SPT:N"4X)$!U$F$BTDZ\+MN,%?RF7"NB/S+O(0/
M>P2:1M*NEO0Y_3  5Z!9:J-W%7LD,LJR1ZLT9><QE:"X%7!,2FHK?-QV53S:
MSM# Z+LX]0UA^YT6[;QLNP(;1M,Z RF:)K]5-+XVJJLO $V*5D,09E(D$NKV
M: I/'1(&E1V:G:A%5E3&083]8@HJ[(&9E6<:?B=9,I0'#F7KA5+$B\7(2D@_
M:ZZ9!.U-%TTG69- R'/CR;'Q+(/G7)EK[&8D8.ZFK4@@%P*3@E8:L+)R4"("
M>F)3M76J:",I-(\OV0ME8B5#AQOF^S*$0'RT =HK$[<W+D]+C3+#'$-UR5I]
M*'9%0[:XTRN1XD5VG8RE1@-UYK*%C9M1@ZMGB!H?U,*;![SN-02,S/:&B[,U
M[T]7^2M6/&&5N+O50\:<P=)R*4A#8L?$WRR1C.(Y I55E45>GV+^.L-1$YU]
M1GX):L%<LG3H%@"E3+"TI1V@\QMB&&Z01I(JXZ4T<LVY_PN_#&)B<?6X_T]1
M6NP86R4&[ U'&&RB]XLLS7GBC%7*%P4ZOHRI;P1CWLCF8YQ.%^:%XL<D3E=*
M0JN.IUWM=I&'DX&'<6=?(8/?^GUJ;!"8KH;OZO3PY@1.K@/TR -MH_U@^"B3
M7.<\A84&1G2H;Q;C_J+($M:ITT_$,N@#RH,8H_0PC?A [I"75$&E&ZN3C$GA
MN[;2<T@IEIP6SW>S)N$,QZ_\[5CB7=5.0R]+RI# /1;0/:[#L%EC\J32I<PS
MIJT9LT(R81TO9*7,XJVP$*L-4)-S.*BD4>VR\._L&4(H(1H]7*N2@J]1RX]!
M<85TGI8QPF;8:(Z+-+65?G0KB"&"#%XLD;CTN[0T\R[&A7AW)<G40#K0!426
MTBXX@!O4V1K(#LXH&CRVZ1/I":$UDJ>QVX2=Q4(N;B1SXT\-R\+CS=,S1L8@
M)K*6>5U/X#9X+7OB,7JA$T30 13*$"G&G%]NEZQU-]3_/PMT7*48367 _5>F
M7$D$(QJFXR)9&:B!7^&*5@E7.1E^R95#IF#(D^7IW)RK)1O.A*2<#E)A5!0N
MI%6\E5QFOCO*"&$QJ4&$*'\-L] =,JZIE^PJA;U>4ZK"]OGUH9-"O)BWGU$V
M _OO*DKH7V8'O:.HN1IW&"33J\X):]J*!)DHGUB_%SJRK\ 66I]YL;WUF'KA
MIUYL;SWF7MQ3*=]_JAND\/\Y]"]=24&'FAL92G:;=00:1$5@O1BSE01.U@N
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MP'\6?I_^<WJR?W@ZV7LUC7Z:_#R-]J;3H^AD^N/AZ=GT9'H0_0*3M ><'!W
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MCSHQ8IZ7K%%^S,)&-U\D7 L@(Z.)QK(/HB@=0T&8NG2AMNEH?@N!^'@ XHI
M6G?K?":\@*)F7,3,/;_^$'[],:P9&#$(3&%._)OX;C=Z(6 FJD6=$J<*D?IG
MB(4NA.JK0X8[6</O#14_K^CXSQ[1\3<C;*_)E@2MJW*=)ZC!D-L6"34&D(&"
MXKE?E<J%EN@Y6H;)2FJ=SJQ =AX6JFY'NT*%UM>[4.%R#X":23X>-#_&PT%'
M&]O^;$3U-IC[]]W/<'EN/_%AUQM1\<F)4X> '7=]?FPL1CT8W?!!2[;(W=W3
M-5SR,7#)K1^L7UF%"$WFS5BK[\.!<7^2>MS$[U(C',SABWB.5@K8Y;QNZ?WH
MJ$+FJ51YXTT =9[XZHI=OSWV GJ;X8&V@>$ $+N![8KENNP=RN&L[Z @T+ N
M@F_C3O#C55F3C<1Z!GEL&$5[4;^L7>R.<5.)Z$854"+Z<$ W?BS1F-<D](V-
M4C#'D+6&(BA,- ?Z JNZ,0?M'";S/%[7AGJ1?(FAT"C!90'%(ZO9:I1GQ)!1
MU4-K2]BM8/S+QO5Q?+;_WWLHZ>(O_^35SF!SJUX]QUBU2 N!N_3O=5ISG(]\
M4:2(J(U3N88#A,2HK:*9!6WTCW@;BV1?O:K4UHS<<QT=A,)A?WCZ>&<XB+>7
MV]$68L:_RNI=M)\U;)T<(7H_>;KS*%KU/8'VS1F=@0\U7WKG;3$D+\M\O42.
M@!9%7#A&_)T+/EAO; >\1.)(9>B%:61!VEJ+9S:!!<][D88N/, 7E/$V@.F,
M93^!*5"C6_ F:HL/WO QAPP5[IS@*R0Z;[+B772\@F_D^'&'<42!07&%<4KG
M<6&"P_"K\[28DT%SGHK^7E+L^&)=S*T)EV<A@D>+&C'XEV7=D*D2R*=#:L^C
MT%EY7=HUCREL:BL9$<O   6Z.QA&4(_%1YA52$QP(QR,3.P^[*\@0XJF #'&
MZ27I*B4B@\=6Q< 1, P]!Q++!I?SL@2^!Q,!FQ*J<4$ZOX@6R_C7LD(4S7 T
M&#YU%$7Q+SH,[9W'0V1W+B"*]0JC<.2''HS%A"U/ M8NTI3-Z.E[6+K$&/ 5
MMK;B59Q9(F=B&.Z.;'^ 1_/1,\!.PJNGN YA=<^BG_%TX>L_H,-30</ X5ET
M=KV"[4ZJ>);-GT5'\3)E6!V5"(%'GHO2O(7?W+M//[?H@78H)76PFC&FM)4[
ME3J$=U"TT\=('4F< 1W:R#%[Y9%>AJE= 7<HA& "CY)"HKL40D $^FTP_61"
MB'69A@'\Y820X<"30J*[$T(PQ+4MA41W(H0,!VTI)+I#(81-\$X*B3Y6"+ES
M\>-.>(9/%KHZ:R0A^SY#8)RJ$?_2]W.@W>></]!#*1'=;KK$UA>B%,>G',IA
M:1V/-I49&<>/_G4ZQ5P1N#L('OHHKI/XW]&/>3F+,9T2D=6C>_X#@6\DUTQ_
M-1P(1Q)Z0D3G6XO]22CVYW6*!R &K*DS3;[]TE&)=Y68)C-CX & X\ DNC@C
ML[4!OL5\9"]$*A !/$?I*F31<V'%+C"MH7 ?RI%PN3 BMW#:Q.3<96,-!Q*K
M P_-JQ1CF\31C89.#&T->XLE#3M).3S8?@[WA6RCYFVRD>*.#E*R"I8 AK,*
M@&:WV%Q4Y?K\ C@ZC"=/X?"8.X-Y'#'F[43[\$J99,!RZFN@$\M(.;T/?IGL
M^QG?7L:OE<-B-O&BBYTM]22GR'C$$"@X %CZ9,1>99*,BIN#RSB_RX).YW@%
M3@T@#_N[16B7/1QDXWNCT(-(.0&]SC,3-2;#>K%A= K /(T\5R+3+PI0*,O%
M0WI<)[UK'S#%;.P^>0(PB6%32Q+V.RDS+3.UQ/&YA%M8C,GZ<%E?[-W@2@!S
M4CQ,B)[+IFFE"K)@,AR8!\UC1=R.:FCCY]B*>?W^GK(;P*9*!WA@86>VW;_)
M-4B2"N'BDH+\4Y#5AC.;+'LS 3[X 2>-L4#4DS4&,KFK+="?41>>6")F0ID"
M/*H^+=IB)\5+'+U-R7*6SE2F"(@6T#\PF2V27+8/W*.7DA=M67UD8S6!R-+I
M=LF$9TC%*64A21/\8HP?7)17F(;-?_.I@5(17].Z>3EP.'T RVI;[$)VM_OH
MZ<Y.]&;[]?8XZFIO1@3:L&0; MKW%!>#4&&9[QN4W0E/#0X $I/O1D4AP5EM
M,Z-JHT,(HQ3"VXD2C(9EB0X^P21.SO%-;68$'B=E",U2P(I4Z0F2LU)6?6XM
M8C'PRTK"BLTM5H[6;I+7.,HJ>0=V9.WI)MBFO=%VL+!!!CYW_]#[+\F6LF4(
M,9C;Q!9#5AU=&7E(<G67N:1.LK\9!;:C0Y__@O*7U]:U)8E <% V=[342!,X
M88G%ISC$> /]O.ENM,2J57SMSTVAT7@.%*>29_]>9UR<(8F7\;EHC46)D=)H
M,0'M,<Z;:^8M:0Q(]Z?=\0[<X2YS4=D$OL??67P:&RC6'R$8#AZCO/X62( '
M_VEWAVP%&BVV)+E=#!%_>M1]Q.0P98OF(L 1:/D!T,R )Q=\0O-YM4Y'#BH]
M@VPX+4GY[#[& H^+5Q.F+J@#W\]!!(<KY $YZ+.&A=I<OMBE%,<L&PL/[DB,
M.-G+R>D9$H#S*EZBM27'*AUQ';52*G%T6$G;9B&+PG/;CB92HX3S ,:*,_7S
MPHX!EQ95F^=K]SQ[\,=HYT"Y1((@XAYR,#8GWQ:Z@$8L8Q+;/;MGF^QVE?H:
M(6:R/3T$'@YN0T;:Z<=L8@#26L)?X\X"7#KD5CWRR(/"%S+*450SB2S,<WLM
MIF;9P4H'8^$TDA?H)@DGKIC0VTZ<K2GO,!RHM)$FB+&H!F)M(UP%95 KLQ8
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MKP0HH(ZE:&*B[O 5%9&IC(L P WR0,Z=0=OF/:?;\-GHLCH=9:=S3(1A4N2
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M$AJ')-/#D3R4&7WO_*F=94JS:-K%EF/LS9[JI&D;5YYZC1]:^JIATH'DA?Z
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MX=_N/82^A_!O]Q[".ZKW<&2+X[#T?A<)87?=8(&[*[BL.(2&JY],1@:FY+^
M0IU>BF#2LD( 2;7V%K_*_K6JD]%#?5NM64 *6C6J\5E3>D$I,VQQ/">MAWP9
MF/J18SHSGZ57A"QH,''9+2I!Q)C]V#)'Y-R#B.,2H>I,)+%X$\?1K,*>;ZZ^
MO @KV!?55):PQ@$WUS>'?5GK(F*V]95"0#AN=3?1M-0JJ=>*]'2AC*844"C(
MDRPE<#*(7Z@U6YMERS6YYTUE[#-N+NH &&.,5%&A9L]6:+1;N2C3@IW-59I@
M'\H>#^.8:O %;']KT&RK[']8A*"0=2.DDSO!F=DZ[D:)6D6SL*G90!K@#%O8
MS5CK+ROEX>E/L6NE?53RM\1$HZ?\0+K/JHHJ-)[.@&J)ZU8XLF56 CUD0U[<
M(/S$GNA'3U3&9=AVRJK^2[;,L(YJ( ]\S+ZQL0U7\-J?]80<P#K:,0?C&]W'
MUA\9\AFW_<2W<@L/!UO3F_$)FX> .EF)J]C]"9<%X"@1F'D&Y^- >I6QO,L>
M53KUQ2+..@<L'C/*:["9F"&*+TW$)0#3U"(+TWG?V"9="P$[&O6P$:XM;T@2
M0&J,M*%^)=:H#IJ$2R<R%/U$6O%T-H.]0E.<Z-$.%DF&JPVO)YCC[%D==)T@
M#D MJU9>WG# *J)P(FXB2GV+#1/;,JV!J*8_54:S%9DWU 3UFPH[EJC#.,UE
M&Q%K(EIB"N!L2/7AVKY>PH\RV'A9C&./THX5W1L'2!+=#51HJ!N-3$?V:C?E
MAAC?3?2/PGIH2!Y+![!N6'$]QJ5L6G,X7AA-.=<A0)JPY4XLO2)5)K9A+&%1
MALIPX3B?5I#Q=L5Q7;2*5FHH!I%AJS+G3NJ +FO\4=#ZM!F4]GB"@?/AJ*+0
M2!3D':!=K2Q$(0,M#W<'B%3:]68H1AT@/@M4J%2M=XWHJ0LE"@WGRH'X D7S
M$]UD^=1VV&LXF%Y7)UN8E[B1D'( N)0*,4RUBJ!;\N#Z4M)Z0O7/F0?*>NT&
M33E 0^&H5",9(/GV2>' &HN" C8#%Z-^"0^E=+ F/VQ?-X99+WY->314<*!?
MAUYLHAEFW,=%6JYK$/.1GGF #I V7Z>(]LD\B[2:JB3#]]2A\N\/_RO0_YIS
MPX<#'U\#=<BBA%..B+A1269DV""4SRE2IN@:9/W:JJWD:P&'5&D"*G*>LGU5
MOYK:M@5HK_*[^;[':OT((=?1X-LT+9Z3BO"S%4Z<KCH<[%T;[.JV]T&0Z@A?
M=;Y(M;O1.A;SF*,;WQM>&*7!F;IR<$?7<ZFU0,[FN:!E2^$T*>(<4&"Z'@B&
MX9BT-C8PJA@&$P^V5V+4!3QW0(%\95>05L("L:[UO#<QQ+QRF95YW$A8FJG7
MR#(KS%Y@:D?>*M7X%92<NJ/B04^V7:5SY(2"+]]N]2 #C7B6Y1(NL#T<G+H>
M".V6(83_JBFFWP[3RBFV*7"KBXL[B%V#^]V /NY\[(HSFYAUD=^<Z_4V'7*\
M'H$\PHC%/KMUZ0'!G<@YOPG515/JTC9=[KKC&D-CY)Z5V.$X;=]J\:%C<>#S
M@@L'GO,V_287+M+!-6QN38FKT5'Q0@P6']K6699$Z^ >F$".BI0]=HLU%I+R
MVS53FV75H1D()?7T-N67K/9EPE&%L9KGQ2G+?F@+4&J>FBVLI"2N:&D='=(P
M93^T3A'3L%%" ??#G ILQY6V[';79N"FJ03;TN\U][)6M6JELP!+@U*71[1F
M_7?MI#K2CD7-LQ$>:%IP>1"J# S7*C":)CU"MB6]$0D@L9),3Z,8%$OKTNPE
M&7/=[D!M'6N/I:Y'<*7SW%3H]RMFVO/Q!O%KT9H6#<T%%L?<>CS2C1HX,[.K
M0"D,E,.KJ3"LPW?"Y-9,_+5I=Z"*7P*FYCEOP'+^;.$*;QN0M'N<F,Y#8U-$
MW#7MHE =/ 0)UE0ZLDD0Z?;T9<IS$5]RRHX^0_;L?07,9;,G[^_WGCS?D_?W
M>T_>'55M.G*WQS;ZU-* J?N?L4Y,:B^5PA-3&ML?+ <@QJ2;($N"O&'>,9Y5
M'6=)F'FWF#3RFE9#'68 U[974;P4-Y+/)ZQ%3U$';7\RY;698MV276^6U:RP
M!<+>6#6*LL84KY$"&8TOE77"U!=S(%:U X)<F3F/,;ELY,JMR,HT^)Q8Y@(G
M'8@KU1:5X6 2*'"-$HILO=9)6K4SA26FP -\GP$6 VDZ)$Y]$(O0X>JA(_*"
MN)"K3MB6<QMC@(W!NKE<L#.,L/SV%?",.Z@DTS;>BT9RUD&YRECW?<6?KCL;
M. W^H-%(^FFTTC49]^+&6L!;T=2AQ=AJ)K9%@18NQ;1J2H(PI:%H0"X,5]+_
M7>,&&@U8><+Z]C(43YK:X3KJAX2FQC/R\*1<AL'.VK7N>U'N\I@QA@:*H^A6
M@F3L0'<86W<E# N^FY%!A2MT#P>^'0WMD55<77]KJ)QXNC6@#[?&4361)&6=
M#%B90Y]^5;/'H:I]F/W5ZSNC67LV)@!':4:'BO$C"NG\X ]E$_4T:A<5X=+X
M5",'TRJ0O]2&@X:BZNR3Y!Z9851P_>Z:;0FEM,P =G)NVXPBK\Y3*W.CGW,I
M1:$P%>9AN7A(#U0*YL0YQ*(7-(63\DDAI'[V[\D:1MI]\L1G>=Q64(H84A*8
MM7:(*UDEB[C$]W9Y(>6!3D.UCT)M 8G#7VOKI@X5-OS^^^V_]1M7OK6[R-&L
M)ZDG C(?,,U2G;W94#SA$YP7;U7&DBIIR4 LX[EXC OR8%.P@4UB; <PCP/)
M1C*P=/XR5<FT1!3L*]!*L5N(A(A]STU^ :X/;0-B7+K, +:<G8Y/.X+/R<.X
MJSQW;HW6[,;6'5>-]8H!31+KLXOD:-U]>6W#Q<>[;EL#J<L'RXBYD["E2"2R
MH3?72QKV9_QV;=O?;T>OLQJ-.NR0^W:-VJ#!2ZU/H*&G+FYI..#62,:K UH_
MUO5M&N[EAOB\']<73NET_L0RY5@&<3UJ.BY*U65)-\F$426V(+]UB5=F3:A$
MJG"JMKG8"T)IBVOMMN@N-3L9 0,?*S]DR.VHWG@,8L@OVFAN?4@2)N$ZM*KD
M]@Y=*%R! (P (/^56;1)-0G4488%ST?<7X\"$FAL"B$0XV^P^K+9)M$V_[/+
MD6W>IAM0NJH-K:J266T=>)Q1.QRL"].ZSS1V<\KLS>TDTXYP;OW_?O\G4_#8
ML!06QKS@1!U*!^\4<'X$FYJ0U4M8:XMV*.NH1Z78'&,@RCS?&DE@H]*KLH:Q
M@,4O0#0^0-EP+6GN *_7P 0=%],^04]/FY> 48[9&TTSS5;=1LP+F_WI\K4Q
M\K#):@P;QKA!1#/CB1X.<EI@PPM,W ))M/76USYM&YP9S=.JX8@:DUCH>B+[
M^&O]&Z:@O)J>NW:X%8S)G0Q071;2C\-FOF[>FO3=:->N5ZL)M=Y@3T?-\6RB
ML\Y OI8<-!%^E /)N#+\[$ %H YPR$D@0$63F^_5@/5(@=E-'J8NQ!&*V3N\
MW.3)*1(Q)G&TEM0N=2LEN.19NK[5DK^U6\O&H-.X65<8F D#8L;D-88A_41!
M8OA9VLR]%C<4/%J2FEEFU+ 6&^4:.TAC'9,DD=K;Q5QVE546@2P3=$28:@G%
M-"9S&1- +K&8L?9^2<4"S@?@><3&RG&7I82C\1P=%Y0X4@N B\DZQ8'5!%\!
M-FQV)_UP[T[RW4D_W+N3[L@*-S%A\HGP/K' O>Q/T::(BBP7:H%_F4&81$Q
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M8LJLKV1IS 9\L@\AY4A-*G-2U#822 C  @M+A8 D9GGFJ%1U 3T%O%NUTZ\
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M[^QB:38@X2<VW3PZH'X$Z_P\WE3/#U_:_>'Q8ZZTR>$$GY$!BB+]!R)9G][
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MPG9I][Y-]&T^N;UO\S,Z&C]C6./>\<&_$*6_^^GL]:L7_Q]02P,$%     @
M08<E6^#^3%#=1@  \7(! !H   !E83 R-34Y-#0P,65X-"TU7V-L96%N+FAT
M;>U]:U/;6+;H=U?Y/^CFS$SA6PZ!/'JFDTRJ##@=SB'  =*9KENW;LF6#.K(
MDD>2(3Z__J[7WGMM/0RDDY!.R <"MK0?:Z^]WH^7;\[>'KSJ]UZ^&8_VX/\
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MWD1GZ35VR;HJ4)-X/37@[J_B5SVL*1W6KA&L/7L,R.$.KDZD#D%OWXCA!ZE
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MV-FQ6!P5K[@.<T6I=<H&DY0Y5BN7TF0DO)7+A0 %U+$834S41[Z@(C*%<1$
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M%J74Z.2T85@(Y0N7-A'#)G"8$NM^DU5YNU$H-TVU5<K&_DL&!C?5^RZ.]O$
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MO]H>S@:57I!I6[4"<Y"%ATO+6Q\L*D"M9U2(3TSRA=6MN!/\)6$1O&2&Y%Z
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M+T7U"M!*/2-65H%^5Y6@O!;;[Y?7-UW+3W*SWB3_6N&4R"W_!5!+ P04
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M4$L! A0#%     @ 08<E6P^='=[Y*P  2]X  !P              ( !:[$
M &5A,#(U-3DT-# Q97@Q,"TQ,5]C;&5A;BYH=&U02P$"% ,4    " !!AR5;
M\B@VG3$C  !TQ0  '               @ &>W0  96$P,C4U.30T,#%E>#$P
M+3$R7V-L96%N+FAT;5!+ 0(4 Q0    ( $&')5N2+0NA#2P  $G>   <
M          "  0D! 0!E83 R-34Y-#0P,65X,3 M,3-?8VQE86XN:'1M4$L!
M A0#%     @ 08<E6U5S_O.C+@  5Q\! !P              ( !4"T! &5A
M,#(U-3DT-# Q97@Q,"TQ-%]C;&5A;BYH=&U02P$"% ,4    " !!AR5;<?7:
M@G/1  #X0 0 &P              @ $M7 $ 96$P,C4U.30T,#%E>#$P+3%?
M8VQE86XN:'1M4$L! A0#%     @ 08<E6V1PN' CU   \EL$ !L
M     ( !V2T" &5A,#(U-3DT-# Q97@Q,"TR7V-L96%N+FAT;5!+ 0(4 Q0
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M,3 M-E]C;&5A;BYH=&U02P$"% ,4    " !!AR5;O0R0RL4L   U*P$ &P
M            @ &Y%00 96$P,C4U.30T,#%E>#$P+3=?8VQE86XN:'1M4$L!
M A0#%     @ 08<E6[?\QX*"&@  F74  !L              ( !MT($ &5A
M,#(U-3DT-# Q97@Q,"TX7V-L96%N+FAT;5!+ 0(4 Q0    ( $&')5NO*SC4
MHQH   1[   ;              "  7)=! !E83 R-34Y-#0P,65X,3 M.5]C
M;&5A;BYH=&U02P$"% ,4    " !!AR5;1101:6-/  #IG@$ &@
M    @ %.> 0 96$P,C4U.30T,#%E>#0M,5]C;&5A;BYH=&U02P$"% ,4
M" !!AR5;FEZ<AA)-  #%E $ &@              @ 'IQP0 96$P,C4U.30T
M,#%E>#0M,E]C;&5A;BYH=&U02P$"% ,4    " !!AR5;HA? 'ZA,  "NEP$
M&@              @ $S%04 96$P,C4U.30T,#%E>#0M,U]C;&5A;BYH=&U0
M2P$"% ,4    " !!AR5;>:)LFRE'  "'= $ &@              @ $38@4
M96$P,C4U.30T,#%E>#0M-%]C;&5A;BYH=&U02P$"% ,4    " !!AR5;X/Y,
M4-U&  #Q<@$ &@              @ %TJ04 96$P,C4U.30T,#%E>#0M-5]C
M;&5A;BYH=&U02P$"% ,4    " !!AR5;( 6F=BD#  #N"P  $0
M    @ &)\ 4 >F]N92TR,#(U,#@R.2YX<V102P$"% ,4    " !!AR5;?*-.
MP/T*  !_A@  %0              @ 'A\P4 >F]N92TR,#(U,#@R.5]L86(N
M>&UL4$L! A0#%     @ 08<E6]R]@O5=!P  W%<  !4              ( !
M$?\% 'IO;F4M,C R-3 X,CE?<')E+GAM;%!+!08     %P 7 '0&  "A!@8
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>ea0255944-8k_clean_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="zone-20250829.xsd" xlink:type="simple"/>
    <context id="AsOf2025-08-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001956741</identifier>
        </entity>
        <period>
            <startDate>2025-08-29</startDate>
            <endDate>2025-08-29</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-08-29" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-08-29" id="Fact000004">0001956741</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-08-29" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-08-29" id="Fact000010">2025-08-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-08-29" id="Fact000011">CLEANCORE     SOLUTIONS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-08-29" id="Fact000012">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-08-29" id="Fact000013">001-42033</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-08-29" id="Fact000014">88-4042082</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-08-29" id="Fact000015">5920 S. 118th     Circle</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-08-29" id="Fact000016">Omaha</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-08-29" id="Fact000017">NE</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-08-29" id="Fact000018">68137</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-08-29" id="Fact000019">877</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-08-29" id="Fact000020">860-3030</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-08-29" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-08-29" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-08-29" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-08-29" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-08-29" id="Fact000025">Class B Common Stock, par value $0.0001 per     share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-08-29" id="Fact000026">ZONE</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-08-29" id="Fact000027">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-08-29" id="Fact000028">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-08-29" id="Fact000029">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
